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INTRODUCTION 
A glance at recent history: 
The year 1992 is the 10th anniversary of the existence of Community R&D programmes 
in Biotechnology. Indeed it was in 1982 that the pioneer programme for Biomolecular 
Engineering (BEP) was launched to help developing, through integrated transnational 
efforts, the tools needed to bring molecular and cellular biology applications to 
agriculture and agrofood industry. While (only) 103 laboratories participated in BEP, 
some 262 laboratories were initially included in the ensuing Biotechnology Action 
Programme (BAP 1985-1989). To further reinforce the Community R&D effort in 
Biotechnology and to enable Spanish and Portuguese laboratories to join the activities, 
the BAP programme was revised in 1988, bringing the overall number of laboratories to 
378 (with the 116 new contracts, signed after the revision, covering the period 1989-1990). 
At present, in the framework of the BRIDGE programme, as many as 579 laboratories 
are engaged in transnational collaborations. 
A different way to look at the amplification of the EC effort in biotechnology R&D over 
the past 10 years would be to focus on the size of the budgets allocated. The conversion 
into yearly expenses is not straightforward but a reasonable indication stems from two 
extreme figures: 2 million ECU^rear in 1982 compared with about 55 million ECUtyear 
in 1991. A decade has been, therefore, sufficient to witness a quantative change by more 
than an order of magnitude. 
BRIDGE: 
The current programme BRIDGE (Biotechnology Research for Innovation, Development 
and Growth in Europe; 1990-1993) with a budget of 100 Million ECU and implemented 
with the help of CAN-BRIDGE (see table, p. xn), covers the following research areas: 
Information Infrastructure - Processing and analysis of biological data 
Enabling Technologies - Protein design; molecular modelling; 
biotransformation; genome sequencing; 
Cellular Biology - Industrial microorganisms; plants and associated 
microorganisms; animal cells; 
Pre-Nonnative Research - In vitro evaluation of the activity of molecules; 
safety assessment of GMO's. 
The corresponding research activities are conducted in BRIDGE via two types of 
projects: N-projects and T-projects. 
The N-projects (N for Network) are built upon the previous successful BAP experience 
with the European Laboratories Without Walls (ELWW). Basically the N-projects are 
carried out by groups of European laboratories (on average 5.6 per project) which, 
through complementary and highly integrated approaches, are devoted to the removal 
of specific gaps in knowledge and know-how. Although still limited to a fraction of the 
lifetime of the N-projects (in most cases about one year out of three) the progress 
reports in the following pages provide sound illustrations of the "plus value" resulting 
from those integrated approaches. 
DC 
The T-projects (T for Targeted) aim at the removal, through significant investment of 
skills and resources (on average almost 30 laboratories and 100 staff per project), of 
important bottlenecks resulting from structural and scale constraints. Seven T-projects 
are implemented in BRIDGE: 
Sequencing of the yeast genome. 
Molecular indentification of new plant genes. 
Biotechnology of lactic acid bacteria. 
Industrial lipases. 
Regulation of plant cell regeneration. 
High resolution automated microbial identification. 
Animal cell technology. 
The two latter T-projects, which were the subject of later calls for proposals and 
therefore only started after Autumn 1991, are not covered in this 1992 report. For the 
remaining 5 T-projects, the reader will have an opportunity in the following pages not 
only to appreciate the progress achieved but also the kind of underlying specific 
organisational arrangements required to carry on such large and complex projects with 
an abundance of interacting partners. A monitoring unit with representatives of the 
contractors, of the CAN-BRIDGE and of the Commission is attached to each of the T-
projects to help in the implementation and to facilitate communication both internally, 
within the project, and externally with, for instance, industrial platforms. These are open 
independent structures, called upon the initiative of the industries and interested in the 
research carried out in a given T-project They communicate freely with the contractors 
and, in certain cases, dissect results with a view to identifying laboratories suitable to 
carry on further work (on the basis of direct and independent arrangements) on specific 
aspects with a potential for industrial applications. 
Finally, two novelties introduced in BRIDGE and shared by all specific programmes 
under the Illrd Framework Programme of Community R&D activities need to be 
underlined: 
Closest ties with EFTA countries - Although not funded by the EC, laboratories 
from EFTA countries participate in the different projects: 17 laboratories from 
5 EFTA countries are collaborating in BRIDGE. 
Decentralisation - Project coordinators are now responsible for integrating the 
work and stimulating the interface between laboratories participating in the same 
project Their role already instrumental at the level of preparation and 
submission of proposals to the Commission also covers, once a proposal is 
selected and thereafter implemented, several other adrninistratfve and scientific 
duties. 
X 
The progress reports in the following pages, for instance, have been prepared by 
the different project coordinators who have centralised and integrated the 
information provided by the partners in the project In this respect, the 
Commission Services wish to thank all the participants and, in particular, the 
project coordinators, for their valuable contribution. 
D. de Nettancourt, 
Head of Division Biotechnology. 
Directorate-General for Science, 
Research and Development 
Further reading: 
On ELWW: 
E. Magnien, A. Aguilar, P. Wragg and D. de Nettancourt (1989) Biofutur, November, 17 - 30. 
OnBAP: 
Biotechnology R&D in the EC Catalogue of BAP achievements - (1990). A. Vassarotti and E. 
Magnien eds, Editions Scientifiques Elsevier, Pahs, 242 pp. 
Biotechnology R&D in the EC Catalogue of BAP achievements on Risk Assessment for the 
period 1985 - 1990. (1991) L Economidis ed, Printeclair, Brussels, 92 pp. 
Biotechnology R&D in the EC Catalogue of BAP achievement on Protein Design/Bioinfonnatics 
for the period 1989 -1990. (1992) B. Nieuwenhuis ed, Office for Official Publications of the EC, 
Luxembourg, 96 pp. 
On BRIDGE: 
Biotechnology Research for Innovation, Development and Growth in Europe (1990 - 1993). 
Catalogue of contracts with project descriptions. (1992) B. Nieuwenhuis ed., Office for Official 
Publications of the EC, Luxembourg - II, 346 pp. 
The T-projects of BRIDGE, a new tool for technology transfer in the Community. (1991) D. de 
Nettancourt, Agro-Industry Hi-tech, April, 3-9. 
Many additional publications on training, sectorial activities, specific projects and other Biotechnology 
related issues have been produced by the Division Biotechnology of DG XII. To receive an updated listing 
please write to: 
Dr. D. de Nettancourt, 
CEC, DGXII - F2, 
Rue de la Loi 200, 
B-1049 BRUSSELS, 
Belgium. 
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N-PROJECTS 

AREA:A 
INFORMATION INFRASTRUCTURE 
PROCESSING AND ANALYSIS OF BIO(TECHNO)LOGICAL DATA 
(from page 5 to page 37) 
CULTURE COLLECTIONS 
(from page 38 to page 46) 

Title 
Contract number 
Official starring 
date 
Coordinator 
Participants 
Continuation of the expanded services 
of the EMBL Data Library. 
BIOT CT-910254 
1 March 1991 
Graham Cameron, The EMBL Data Library, Heidelberg, Germany 
The EMBL Data Library 
Objectives set for 
the reporting 
period 
Major problems 
encountered 
Results 
During the reporting period we planned four releases of the databases on 
magnetic tape and CD-ROM as well as the continuous updating of the copies 
at EMBnet nodes and accessible via our Fileserver. 
Work was also planned to improve the efficiency of production systems to 
cope with faster data throughput and to take account of requirements 
generated by genome scale sequencing with automated sequencing machines. 
Also anticipated were meetings of the European Advisory Committee and 
the International Advisory Committee, as well as a gathering in Japan of the 
collaborating databank groups (the EMBL Data Library, GenBank, DDBJ). 
1. European network performance has often limited our ability to keep 
EMBnet nodes up-to-date, and required labour-intensive ad hoc 
interventions in the automatic procedures. 
2. The Gulf War resulted in travel restrictions for some of our American 
collaborators which postponed the preceding collaborative meeting, 
with this in mind the collaborative meeting planned for February 1992 
has been put off until May. 
3. The European Advisors did not meet in August 1991 as planned, but held 
a meeting before the meeting of the international meeting in March 1992. 
Increased data throughput has been the most striking recent development in 
the Data Library. Hardware and software developments and refined data 
processing procedures meant that at the end of 1991 we were entering data 
three times faster than at the start of the year. The four releases planned 
during the year were successfully delivered. 
The nucleotide sequence database grew by about 50% in 1991 to over 75 
million base pairs and is now over 80 million base pairs. The growth is 
summarised in figure 1. 
Data management 
Major new investments in hardware for the Data Library have included the 
purchase of a MicroVAX 3100 as a database server and six DECstation 2100 
RISC workstations. This resulted in huge savings on software licenses and 
made available the better user interfaces possible with the workstations. 
This, with software developments using a new version of ORACLE, resulted 
in substantial productivity improvements. Porting of our major applications 
to a client/server environment based on workstations and the MicroVAX 
during 1992 should give even better performance. 
-5 
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Figure 1. Nucleotide Sequence Database growth 
Data Distribution 
Quarterly releases of the databases continue to be distributed on magnetic 
tape and CD-ROM. CD-ROM has now comfortably overtaken magnetic tape 
as the distribution medium of choice, and the number of customers continues to 
increase. Some new indices have been added to allow user software to 
efficiently access the databases on the CD-ROM. A collaboration with 
Oxford University Press resulted in several additional databases described 
in the Nucleic Acids Research 1991 Sequence Supplement being distributed on 
the EMBL CD-ROM. 
Fileserver 
The EMBL file server continued to be popular, with requests for SW1SS-
PROT sequences and Brookhaven structural data increasing dramatically 
and, of course, the constant flood of requests for latest nucleotide sequences 
and the free molecular biological software. More than 170 programs are now 
available. 
The Mail-FastA database searching service is in increasing demand, with an 
average of more than 30 searches per day. Unfortunately the less 
computationally-intensive Quicksearch service has not proven as popular 
and it will probably be replaced by the equally efficient and more widely 
accepted BLAST algorithm. 
A useful by-product of rapid availability of the data is that we receive more 
feedback and input from researchers who will, for example, notify us if 
journal publications contain data we have not yet released. 
EMBnet 
EMBnet continued to flourish with the 15 nodes receiving daily updates. 
EMBnet is funded under a separate BRIDGE contract. 
Data from genome projects 
In 1991 the Data Library incorporated the first data from major genome 
sequencing projects. Both the European yeast chromosome III and the British 
C. elegans sequencing projects submitted data in the course of the year. 
6 -
Sequence data in patents 
Persistent discussion with the European Patent Office (EPO) into ways in 
which sequence dala included within patent applications can be rendered 
public seems to have borne fruit. It is hoped that in early 1992 a contract can 
be finalised whereby the EPO provide the financial resources for the 
database work to be carried out at EMBL. The backlog of data should be 
made publicly available via the usual means during the coming year. 
Patent applications with their first priority in the USA will be processed by 
the NCBI, with whom data will be exchanged. 
Sequence Analysis Research 
Rapid sequence comparison 
The EMBLSCAN tool which was developed in 1990 to rapidly locale 
database entries similar to a new sequence was enhanced for distnbution on 
our CD­ROM as well as being incorporated into the normal production 
procedures of the Data Library. This helps to match published sequences and 
submissions and avoid duplicate entries in the database. 
Multiple sequence alignments 
Higgins' CLUSTAL multiple sequence alignment program, which has become 
something of a standard, has been completely rewritten in collabxiration 
with Alan Bleasby (Daresbury, UK). A single, menu driven program railed 
CLUSTALV was produced which runs on a wide range of computers. Many 
new features were added, including the ability to align old alignments Willi 
each other and the calculation of phylogenelic trees. 
The tree in figure 2, from Waters el al (1991), was calculated using 
CLUSTALV and shows relationships between the rKNAs of six species of 
Plasmodium, the organism that causes Malaria. The tree is based on genetic 
distances calculated from small­subunit rRNA sequences bootstrap confi­
dence limits are shown under each grouping in the tree. The main conclusion 
from the tree is that P.falciparum, the most serious cause of Malaria in hu­
mans, is related to the species parasitising birds. This arose from .1 lateral 
transfer event, where a parasite changed host between birds and humans. 
^ ^ — — — — Acanthamottba (oulgroup) 
~lh 
P berghyi (rodfcntj 
536 
1000 I i 
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P fragile ('..imian) 
­ P falciparum (human) 
— . P. kjphunin UvHin) 
P galltnac&um (avain) 
L. ■ 5% divergence 
Figure 2. A phylogenetk: tree of six Plasmodium species derived from 
SSU rRNA sequences. Branch lengths are proportional to estimated 
sequence divergences Figures below each grouping show bootstrap 
confidence limits from 1000 bootstrap samples. 
Highlights/ 
milestones 
Wider 
considerations 
Cooperative 
activities 
Simultaneous Database Access 
In 1991 Peter Sibbald joined the group as an independent researcher. His first 
project is to explore using multiple databases simultaneously. It is becoming 
clear that databases are already and will become even more distributed. 
Updates to those databases are going to be more frequent and the complexity 
of the data stored will grow. 
This work has received support in equipment contributions from the Digital 
Equipment Corporation as part of their Scientific Innovators Program. 
We have now seen the first data from major genome sequencing projects 
entering the database and began to face up to the challenges that this poses. 
Improvements in the efficiency of the EMBL Data Library enable it to 
provide convenient access to a comprehensive collection of sequence data. 
Today's database, however, at 80 million base pairs, is less than 3% of the 
size of a human genome (20% of the data are human). Efforts to sequence the 
human and other genomes will have profound effects on the scale and 
complexity of the database task. Increased understanding will make the 
information useful in diverse areas, resulting in rising demand for the Data 
Library's services and a need for innovative solutions in new application 
areas. The Data Library must have the stability to provide good services 
today and the resources and vision to develop the services of the future. 
International advisory committee 
The fourth meeting of the International Advisory Committee for Nucleotide 
Sequence Databases took place in Washington March 1991, and the fifth in 
Heidelberg in March 1992. 
International Collaborations 
GenBank/DDBJ — The collaboration with the GenBank and DNA Database 
of Japan (DDBJ) groups and daily data exchange between these groups 
continued, with the annual collaborative working meeting being held in 
Heidelberg (24-28 June 1991). The main topics of the meeting were the 
feature table and more detailed aspects of common annotation conventions. 
The National Center for Biotechnology Information (NCBI) — From October 
1992 NCBI will manage the GenBank project. With this in mind we did 
much in 1991 to solidify the collaborative links with NCBI, both through a 
formal agreement between the two organisations, and through informal 
interactions. Three of the EMBL staff paid a one week visits to NCBI in the 
course of the year to discuss practical aspects of the collaboration such as 
editorial standards and data exchange mechanisms. 
The Martinsried Institute for Protein Sequences (MIPS) — The collaboration 
with MIPS, the European partner in the PIR international protein sequence 
database continued. EMBL forwards protein coding nucleotide sequences to 
MIPS and the protein and nucleotide sequence databases pursue a co-
ordinated data submission policy. 
The Genome Data Base (GDB) — In view of the importance of good links to 
mapping information, we reinforced our collaboration with the Genome Data 
Base from Johns Hopkins University. In August 1991 one week course on the 
use of GDB was offered in collaboration with staff from CEPH in Paris, the 
DKFZ from Heidelberg and the IMP in Vienna and Johns Hopkins and Utah. 
List of joint 
publications with 
trans-national 
authorship 
Genome informatics centres 
The importance of genome project data is well recognised, and in order to 
improve the communication between genome initiatives and the public 
databases, a workshop was organised with representatives from several 
European genome projects to discuss specific problems of data exchange and 
representation. Procedures were discussed to allow the automatic 
incorporation of data from such projects into our database. Future such 
consensus meetings with broader perspectives are planned. 
Data Library Staff (1991) EMBL Data Library Release Notes and User 
Manual, Releases 26,27,28,29, 30. 
Bairoch, A. and Data Library Staff (1991) SWISS-PROT Release Notes and 
User Manual, Releases 17,18,19,20,21. 
Bairoch, A. and Boeckmann, B. (1991) The SWISS-PROT protein sequence 
data bank. Nucl. Acids Res. 19, 2247-2249. 
Fuchs, R. and Cameron, G.N. (1991) Molecular biological databases: The 
challenge of the genome era. Prog. Biophysics Mol. Biol. 56, 215-245. 
Fuchs, R. and Higgins, D. (1991) The EMBL Data Library. In: Collins J. and 
Driesel A.j, (eds) Genome analysis: from sequence to function. Huethig Buch 
Verlag, Heidelberg, pp. 149-150. 
Pelandakis, M., Higgins, D.G. and Solignac, M. (1991) Molecular phylogeny 
of the subgenus Sophophora of Drosophila derived from large subunit of 
ribosomal RNA sequences. Genetica, 84,87-94. 
Powell, R., Higgins, D.G., Wolff, J., Byrnes, L., Stack, M, Sharp, P.M. and 
Gannon, F. (1991) The salmon gene encoding apolipoprotein A-I: cDNA 
sequence, tissue expression and evolution. Gene, 104,155-161. 
Sharp, P.M., Lloyd, A.T. and Higgins, D.G. (1991) Coelacanth's 
relationships. Nature, 353, 218-219. 
Waters, A.P., Higgins, D.G. and McCutchan, T.F. (1991)P/asmodiumm 
falciparum appears to have arisen as a result of lateral transfer between 
avian and human hosts. Proc. Natl. Acad. Sci. USA, 88, 3140-3144. 
Other Bilofsky, H., Informatics in Molecular Biology. "Medical Informatics Europe 
publications/ 1991" K.-P. Adlassnig, et. al. (Eds.), Springer-Verlag, 28-31; 1991. 
Patents Fuchs, R. (1991) MacPattern: Protein pattern searching on the Apple 
Macintosh. CABIOS 7,105-106. 
Fuchs, R., Weber-Schaeuffelen and Zinke, H. (1991) Computer in der 
Molekularbiologie. In: Bertram, S. and Gassen, H.G. (eds) Gentechnische 
Methoden. Gustav Fischer Verlag, Stuttgart pp. 307-315. 
Stoehr, P. (1991) Sequence databases from EMBL and developments in 
electronic access. "Proceedings of the 1991 Chemical Information Conference" 
H. Collier (Ed), Infonortics Ltd, Calne, 187-195. 
Stoehr, P. and Cameron, G. (1991) The EMBL Data Library. Nucl. Acids Res. 
19, 2227-2230. 
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TITLE: CarbBank 
CONTRACT NUMBER: BIOT-CT90-0184 
OFFICIAL STARTING DATE: 01.02.91 
COORDINATOR: Prof. K. Bock, Carlsberg Lab., Dept. Chem., Copenhagen, DK 
PARTICIPANTS: Prof. H. Paulsen, Uni Hamburg, Dept. Org. Chem., Hamburg, FRG 
Prof. J.F.G. Vliegenthart, Uni Utrecht, Dept. Bio-org. Chem., Utrecht, NL 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
The objective of the research program is to establish a Complex Carbohydrate Structural Database 
(CCSD) containing published oligosaccharide structures larger than disaccharides and the 
accompanying database management program CarbBank. The main goal of the reporting period 
(01.02.91 - 31.01.92) was to increase the number of oligosaccharide structures included in the 
database in order to reach a complete coverage of the current literature in the near future. The 
objective for the reporting period was to release a version of the database with at least 3000 
records. 
Furthermore, the development of tools to link the structural database to spectroscopic information 
like 1H- and 13C-NMR data was planned as well as a better connection to other databases. 
MAJOR PROBLEMS ENCOUNTERED: 
A major problem was the collecting of data by manually extracting the oligosaccharide structures 
and the annotation from the original literature. This problem was solved by using the Chemical 
Abstracts Services as a tool to get access to literature in the carbohydrate field as well as to 
extract relevant information. 
RESULTS: 
In January 1992, the latest version of the CarbBank program and the structural database CCSD 
with about 8000 records was released. 
In the beginning of the project the task of collecting the structural data was performed manually 
by a systematic survey of the existing carbohydrate literature. The input of data into the database 
was actually a manual procedure which is very time consuming. 
In the course of this project the computer program CASON was developed in Copenhagen to 
translate the systematic name of a compound as used in the CA registry file to a structural 
representation as used in CarbBank. The Chemical Abstracts (CA) ONLINE service was utilized 
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to search for specific structural elements of N- and O-linked oligosaccharides. The search resulted 
in about 2900 entries which were extracted and subsequently converted using the CASON 
program. These data were divided under the 3 participating groups and verified against the 
original literature. Detected errors like misspellings, structural errors and wrong specification of 
aldose/alditols were corrected. Some structures which were not sufficiently characterized were not 
incorporated into CarbBank. An error report was send to CAS. 
In exchange for the computer program CASON Chemical Abstracts agreed to release all entries 
from CAS containing oligosaccharide structures with more than two monosaccharides for our 
purpose of building up the Complex Carbohydrate Structural Database. Thus by October 1,1991 
we received about 30000 records from CAS covering the carbohydrate literature from 1966 -1991. 
About 15000 were suitable for translation into a format which can be read by CarbBank. About 
4000 records were already in CCSD, so that the remaining 11000 have to be verified and checked 
against the original literature by the curators. This is currently in progress at the participating 
laboratories in Utrecht, Hamburg and Copenhagen. The contract with CAS allows us to workup 
the backlog of already published oligosaccharide structures as well as the ones which will be 
published over the next five years in a manageable manner. 
Due to this more automatical approach of collecting and verifying data our goal of covering the 
whole carbohydrate literature and including relevant structures and references into CarbBank will 
be achieved during the planned timeframe. 
At the laboratory in Utrecht (NL) a computer program SUGABASE was developed to add 1H- and 
13C-NMR data to the structural information included in CarbBank. The database can be searched 
for carbohydrate structures by entering a list of chemical shift values. The resulting carbohydrate 
structures and NMR tables are displayed concurrently, whereby the matching monosaccharide 
residues in the carbohydrate structures and the matching chemical shift values in the NMR tables 
are highlighted. During the reporting period a 13C-NMR module has been appended to the 
database. The database of NMR tables of carbohydrate structures has been extended and 
includes now a total of 508 1H-NMR records and 237 13C-NMR records. The conesponding 
database management program has been improved and the user interface has been changed to 
be IBM SAA/CUA compilable. 
HIGHLIGHTS: 
Due to the contract with Chemical Abstracts the number of structures (8000) currently included in 
the database is much higher than anticipated at this point of time. 
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COOPERATIVE ACTIVITIES: 
Meetings: 
November 1991 Maastricht (NL) - Symposium "Bioirrtormatics in the 90's" and BRIDGE 
meeting 
Prof. J.F.G. Vliegenthart, Prof. H. Paulsen, A. van Kuik, R. Stuike-Prill, A. 
Kleen. 
February 1992 Hamburg (FRG) - CarbBank meeting 
Prof. K. Bock, Prof. J.F.G. Vliegenthart, Prof. H. Paulsen, A. van Kuik, 
R. Stuike-Prill, A. Kleen. 
Otherwise the communication between the participating laboratories and the collaborating group 
in the USA is done by electronic mail, fax and phone without any major problems. 
A cooperation with the US National Library of Medicine / National Center for Biotechnology 
Information (NCBI) will result in the distribution of CarbBank on a CD-ROM together with other 
databases, like amino acid (PIR) and nucleotide sequence (GenBank) databases. This will 
significantly increase the number of distributed copies of the database. Currently, the integration 
of CarbBank into the database retrieval software 'Entrez' developed by NCBI is in progress. After 
completion an easy access of different databases using the same software enviroment will be 
possible. 
Recently, a cooperation with the amino acid sequence databases MIPS and PIR has been set up 
to find a way of cross referencing these databases with CarbBank. 
PUBLICATIONS: 
CarbBank Version 2.2 with the database CCSD5. 
A 1H-NMR database for complex carbohydrate structures. J.A.van Kuik and J.F.G. Vliegenthart 
(1991), TIGG 3, 229-230. 
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TITLE: Protein Sequence Databank 
CONTRACT NUMBER: BIOT-CT90-170 
OFFICIAL STARTING DATE: 01/01/1991 
COORDINATOR: H.W. Mewes, Max-Planck-Institut f. Biocheraie 
W-8033 Martinsried, Gennany 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Development of software tools for rapid distribution of protein sequence data within 
Europe and informatics support of the annotation process. 
MAJOR PROBLEMS ENCOUNTERED: 
We encountered two major problems in achieving the goals set The first problem is 
the situation on the labor which is market is very unfavorable to recruit qualified com-
puter scientists. The project requires a sound knowledge of both programming tech-
niques and modem biology. The second problem is the poor performance and high 
costs of European networks, which did not permit an efficient use of the resources pro-
vided by the on-line system. The current connectivity and bandwidth of academic data 
communications lag far behind the technical development The US gained a consider-
able edge in both resources available for bioinformatics and the network infrastructure. 
RESULTS: 
The Martinsried Institute for Protein Sequences (MIPS) at the Max Planck Institute for 
Biochemistry has developed resources to support the data collection and distribution as 
part of the tripartite collaboration of the Protein Sequence Databanks (PIR-
Intemational). The work funded by the BRIDGE project concentrates on the informatics 
support of the data distribution and the development of a formal Sequence Database 
Definition Language (SDDL) in collaboration with PIR-Washington. 
1. New methods for data distribution: 
Rapid distribution of protein sequence data becomes increasingly important The tradi-
tional distribution by magnetic media is too slow and not frequent enough to fulfill the 
needs of the user community. Releases distributed on magnetic media or on CD-ROMs 
may miss hundreds of new entries due to the delay in release production and distribu-
tion (usually 1-2 months). Local implementations of the data need require skilled per-
sonnel and considerable hardware resources, which are costly. 
Communication software opens access to remote data on network systems. The net-
work performance is not yet satisfactory in many cases. The storage of data at a single 
node is not feasible. We investigated an intermediate solution: data should be 
distributed by a number of EMBnet nodes, covering 'local' needs. Our approach will 
provide nodes with an appropriate software to parse transactions and to install the data 
in a searchable database management system (INQ/ATLAS). 
The project in progress is part of a collaboration with the Technical University of Mu-
nich (K. Heumann, Department of Informatics, headed Prof. Dr. Bayer). 
Data distribution through networks is looked at as a special type of a distributed appli-
cation. The key concept of communication is a client/server model (see fig. 1). The 
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data distribution targets are databases within Europe. Therefore, it is necessary to use 
wide area networks (WAN) as transport media. The software should work as well on 
local area networks (LAN). TC/IP is implemented a protocol using public network and 
local ethemet connections. A typical feature of WANs is that only one­to­one commu­
nication is supported. This is the main difference from LANs which can easily use 
broadcast concepts where one­to­many communication is done. In a WAN communica­
tion, there are many possible sources for errors, for example transport and communica­
tion errors and run­time errors at the remote systems. For both types error logging and 
error recovery are needed. In open networks it is important to protect subnet partners 
from an unauthorized access. Maximum security is achieved if authentication is ex­
tended from only identifying the communication partners to identifying the functional­
ity of the application and the type of data that the remote partner verifies to process. It 
is important to assure maximum software portability to allow the application to operate 
in inhomogenous networks. Therefore, software is layered on a general purpose com­
munication mechanism that hides the underlying network from the application soft­
ware. The communication mechanism used is the remote procedure call (RPC). A re­
mote procedure call functions like a local procedure call, but the caller is resident on a 
different node. 
Node rtruciurc of ■ network partner 
Server 
protocol >od «y­ M.ir.«N«. 
Applicatioo 
Figure 1 Client/Server concept for data distribution 
2. Data exchange between nodes of the PIR­International 
During 1991, a mechanism of updating protein sequence data that relies on the fre­
quent use of a transaction protocol through the INQ (IN­Query­System) became fully 
operative, leading to a rapid increase of the number of entries accessible to the users. 
Entries are updated daily and the dataset PIR3 is downloaded weekly to the on­line 
system. The following data are inserted into INQ: 
• Data from journal scanning, verified by double input 
• Data from EMBL translations verified by double input 
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• Data from EMBL translations marked as 'unpublished' (no double input possible) 
The data must fulfill the following requirements: 
1. The title line must be complete. 
2. The biological source must be checked against the taxonomy database. 
3. The reference must not conflict with any other reference in the database. 
4. The accession number must be unique. 
All updates of entries are automatically submitted to the INQ-database. 
An efficient complete annotation of protein sequences must be done by protein fami-
lies. This requires the exchange and frequent update of protein entries between the 
databanks. Based on the experience gained with the INQ system, we are working on the 
methods for reservation and updating of entries on distributed nodes. The system has 
to fulfill the requirements of a distributed database, a problem that has not yet been 
solved by commercial systems. We intend to build up the system on top of a commer-
cial, object-oriented database management system. The development of such a com-
plex software to fulfill special needs of the protein sequence databanks is in an early 
stage. 
3. User-support and on-line system 
The on-line system provides users with free access to the latest versions of the major 
databanks. Currently, the system holds 238.645 sequences in 13 databases which are 
concurrently accessible interactively by the XQS system. The latest PIR-Intemational 
protein sequences are updated weekly. Sequence comparisons to search for homologies 
can be performed as batch jobs submitted by electronic mail. Searches in the databases 
are also possible through a file-server system. MIPS has dedicated powerful resources 
to support external users (3 VAX computers and one DEC-Station 5125). 
4. Progress in protein classification 
One of the handicaps in the usage and the future development of the present PIR data 
bases is the lack of a complete sequence classification: only 25% of the sequences con-
tained in the PIR1 data base have already been classified by NBRF and MIPS. The other 
75% are gathered in the two databases PIR2 (partially annotated) and PIR3 (preliminary 
entries). 
The goal of the cooperation was to extend the classification of PIR1 to the sequences of 
PIR2 and PIR3 in order to reach a homogeneous structure the whole data base using the 
existing Family Alignment Data Base and the corresponding software tools developed 
at the Max Planck Institute for Experimental Medicine in Gbttingen. For the period 
Nov. 91-Feb. 92 we expected to automatically classify approximately 50% of the total 
data base. 
In order to achieve this goal, the development of two sets of procedures was necessary: 
• Automatic migration of the alignment and relationship data base to a new release 
of the PIR-International sequence data base 
• Automatic classification of sequences in PIR2 and PIR3 according to the classifica-
tion rules of PIR-Intemational 
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This set of programs closed the life-cycle of the Family Alignment Data Base 
(FAMALN-DB) which now consist of 4 major phases: 
1. - Migration to new release 
2. - Scanning the sequence data base for new homologies 
3. - Multialigning new or modified families 
4. - Classification of PIR2/PIR3 sequences 
Several programs had to be modified to account for the PIR-Classification of the se-
quences and to build up the corresponding PIR-Data Base indexes. The PIR-
Classification and the family classification used by the Gottingen group are not a one 
to one mapping. Using an independent classification scheme, we were able to detect 
several inconsistencies in the PIR classification. Most of these have been cleaned up in 
Rel. 31 of the PIR-DB or are going to be cleaned up in the next release. The more im-
portant use of the family classification was to create a preliminary classification of 
many PIR2 and PIR3 sequences. At the end of Rel. 30 life cycle in Feb. 1992 we were 
able to classify: 
inPIRl 
inPIR2: 
inPIR3 
8798 (done by PIR) 
6168 (this project) 
5095 (this project) 
Total: 20.061 sequences = 59% of total 33.989 sequences 
In summary, the major aim of the project has been achieved. In conjunction with the 
new XQS-Systera of PIR, indices allow an unified view of the full PIR-Intemational data 
base, using the superfamily classifications. 
5. FASTA Database 
MIPS compares every protein sequence added to the dataset against all other sequences 
available. The information is valuable for the protein classification and the annotation 
based on the principle of sequence similarity. In addition, most sequence comparisons 
performed by external users repeat comparisons that are already performed at the time 
the sequence was added to the dataset 
The number of possible one to one comparisons for the current set of 50.000 sequences 
is 1.25 million. The task of comparing all available sequences with themselves is feasi-
ble within approximately 40 days of run-time on an ULTRK system. Storage require-
ments will be moderate. Such a database requires a flexible data structure to store re-
sults from newly added sequences. Sequence similarities are symmetric between each 
pair of sequences compared. Therefore, the FASTA search of a new sequence must be 
written to the records of all other similar sequences to result in an up-to-date database 
of protein relations. However, this database will be highly interesting not only for the 
internal purposes of the databank. Once set up, updating will require only moderate ef-
forts with respect to CPU-time and allow the user to retrieve protein similarities ex-
tremely rapidly. Currently the set of 36.150 sequences available in the PIR datasets are 
compared. 
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6. Development of a new format/database structure 
An important step for the development of the sequence databanks was achieved with 
the definition of a standardized format for sequence data exchange. The evolution from 
individual sequence data entries to complex interlinked data structures requires the ex-
tension and formalization of the data definition. 
The CODATA format possessed two major disadvantages: First, the syntax was for-
mally defined, but not the semantics. Second, the rigid definition of the format struc-
ture required the adaptation of the existing sequence databanks, which is an unattain-
able goal. 
The representation of complex biological information in digital computers is only pos-
sible with the application of well-defined semantics, serving for an exact description of 
the data interdependencies. A certain feature, e.g., a modified site, is only valid in rela-
tion to the one-dimensional array of the sequence. These relations are displayed as nu-
meric coordinates, they can also be used to transform one sequence into another (e.g. 
to describe sequence discrepancies). The numeric values have no intrinsic meaning, 
the information is only generated by the combination of two or more different data 
types. Object-oriented languages provide mechanisms to handle these complex data 
types as operations ('messages') of classes to generate transient objects (in contrast to 
the stored, 'persistent' objects). The currently implemented database systems handle 
semantics by specialized software, written on top of standard applications provided by 
the databases management system (DBMS). A formal description of the relations does 
not exist The software must 'know' the relations of certain data fields (tables) and has 
to interpret data dependencies, rendering software data and schema dependent Every 
change in the schema has to be reflected in changes to the software. Although protein 
sequence data and the associated information require only a limited number of da-
tatypes for their description, a large number of different, multiple relations between the 
elements exist. The organization of the databank as 'components' allows an independ-
ent development of complex data structures, like the taxonomy, the superfaraily classi-
fication, the genetic information or the complex protein architecture. 
In collaboration with Dr. D.G. George of PIR-Washington, the theoretical concept of a 
sequence definition language was used to address the current problems by 
1. incorporating high-level data types that include a functional definition of the data 
2. providing a data declaration section that allows the organizational structure and in-
formation content of the database to be formally defined 
3. providing a mechanism that allows interdata dependencies to be resolved selec-
tively and unambiguously 
4. introducing a mechanism for unambiguous reference to information in other data-
base components and thus providing for their interlinkage. 
This approach allows data verification by strong datatyping and a formal control of the 
data set Its realization will be of basic importance for the success of sequence data 
processing. 
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HIGHLIGHTS/MILESTONES 
New methods for data exchange and distribution of protein sequences have been ex-
plored. The concept of data distribution over wide area networks has been investigated. 
A new method for protein family classification has been applied. An advanced se-
quence data description language is under development 
WIDER CONSIDERATIONS 
Protein sequence data are of major importance for the basic research in biomedical sci-
ences as well for the biotechnological infrastructure. The collection and distribution of 
protein sequences in Europe has been subject of our work. MIPS is the European contri-
bution to the international network or protein sequence databanks. During the past 4 
years, the amount of data available increased by a factor of 5.4 fold. In the future im-
proved methods for data processing and distribution will be applied. Structuring the 
database into protein families and development of new concepts for the organization of 
biological data will largely improve the usefulness of the database in the future. 
COOPERATIVE ACTIVITIES 
P. Kreisl participated at the EMBnet meeting on Crete (May 1991). 
H.W. Mewes participated at the Sectorial Meeting of the BRIDGE bioinforraatics 
group at Maastricht NL, Nov. 1991. 
OTHER PUBLICATIONS 
George D.G., Orcutt B.C., Mewes H.W., and Tsugita A.; 'An Object-Oriented Se-
quence Database Definition Language (SDDL)', submitted to Protein Sequences and 
Data Analysis 
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TITLE: Promotion of EMBnet: Computer Network for Bioinformatics in 
Europe 
CONTRACT NR.: BIOT CT91/0273 
OFFICIAL STARTING DATE: 01.04.1991 
COORDINATOR: Prof. Cecilia Saccone, CNR, Rome, Italy 
PARTICIPANTS: Aarhus University, H. Ullitz-Moller, Denmark 
University of Helsinky, J.C. Roos, Finland 
University Ren6 Descartes, G. Cremer, France 
DKFZ, S. Suhai, Germany 
Daresbury Laboratory, A. Bleasby, United Kingdom 
Inst, of Mol. Biol, and Biotech., C. Savakis, Greece 
CSMME - CNR, C. Saccone, Italy 
University of Nijmegen, J.H. Noordik, Netherlands 
Biotechnology Centre Oslo, E. Paulssen, Norway 
C.S.I.C., J.M Carazo, Spain 
Uppsala Biomedical Centre, G. Magnusson, Sweden 
Biozentrum Basel, R. Dolz, Switzerland 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Taking into account that the aim of this project is to reinforce EMBnet 
through the consolidation of the existing node activities, stimulating 
collaboration and promoting new initiative in biocomputing, the objectives 
selected for the initial period were: 
a) the drafting of a feasibility study on connection improvement; a task force 
for telecommunications was appointed; 
b) setting up of a bulletin board - conferencing system 
c) study on the technological tools for data distribution 
d) planning of specialized courses and workshops 
e) hiring of an EMBnet resource project assistant to help in consolidating the 
existing group activities, with the aim of stimulating further collaboration in 
biocomputing, networking and training. 
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A Funding Committee (FC) was created to coordinate and supervise all 
activity relevant to the above-mentioned objectives. This Committee is 
formed by Prof. Cecilia Saccone (CNR, Italy); Martin Bishop (HGMPRC, 
United Kingdom); Reinhard Doelz (Biozentrum, Switzerland); Peter Stoehr 
(EMBL, Germany); Mats Sundvall (BMC, Sweden). 
MAJOR PROBLEMS ENCOUNTERED: 
EMBnet RESOURCE PROJECT ASSISTANT 
This position was advertised in NATURE (voL 352, 4 July, 1991) and 27 
applications were received. The features of applicants were the following: 
average age 33 years, and previous experience in accademic institutions, 
with more or less long stages outside the original countries. 
It can be noted that the majority had a biological background and little 
knowledge in computer sciences. A pool of possible candidates (namely 
Peter Norbert Saurugger from Austria, David W. Featherston from Canada, 
Mark A. Vandeyar from Britain and Jom Wolters from Germany) was then 
selected and they were interviewed in Ban on the occasion of the first 
Funding Committee meeting on 15th October 1991. No one of them was 
estimated suitable for the job. The Funding Committee decided then to hire a 
more experienced person with managerial skills. A call for proposals was 
circulated in January, describing in detail the tasks of this person. During the 
second Committee meeting, held in Heidelberg last March 8th, the hiring of 
Prof. Albert M. Kroon was decided on the basis of his previous experience 
as full professor of biochemistry at the State University Medical School of 
Groningen and at the University of Amsterdam, as well as on his work as 
managing and research & development director at Haarlem Allergen 
Laboratories B.V., and at the HAL Group both in the Netherlands and 
abroad. He also has some experience as advisor for lifesciences policy in the 
College van Besruur, the main board of administrators of the University of 
Amsterdam. 
This caused a delay in the implementation of the job for the project assistant. 
However, the attempt was instrumental, in our opinion, to assess the profile 
of the bioinformatic scientist available on the market. 
RESULTS: 
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TRAINING PROGRAM FOR EMBNET/BRIDGE 
A scheme for the future training programm was decided. This programm 
included: one ad hoc seminar per annum, with a level of funding analogous 
to that for EMBO or FEBS workshops; practical courses; annual business 
meetings. For all courses and seminars, precedence has been given to those 
organised by more than one country. 
IMPROVEMENT OF DATA DISTRIBUTION 
a) A Pilot Project for the Development of improved Data Exchange 
Mechanisms has been started by Rainer Fuchs at the EMBL. The project 
was financed with ECU 6000 and will have a duration of six months. Since 
the data are received by the different nodes on various protocols (DECnet or 
TCP/IP) and they are further manipulated for local distribution according to 
the locally available database management and sequence analysis software, 
it is necessary to develop standards for interfacing the EMBnet data 
distribution mechanism to software which acts on the delivered data. 
b) The acquisition of Multinet TCP/IP software was financed. This software 
allows the improvement of the local communication standard as it is of no 
obstacle for a mixed environment VMS-UNTX, which are the two operative 
systems most widely spread in the EMBnet community. 
BULLETIN BOARD - CONFERENCING SYSTEM 
A bulletin board was set up for the exchange of experience among the 
EMBnet users, who can discuss topics of common interest directly on-line 
using a single e_mail address. Manager of this project has been appointed 
Rob Harper from the Finnish node. 
MILESTONES: A comprehensive study was carried out by Reinhard 
Doelz on the EMBnet status and its possible developments. It listed the 
various services available on-line from EMBnet, with a detailed analysis of 
the connectivity performance - e.g. success rates and reliability rates for data 
transfer. 
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The study also included suggestions for improvement which took into 
account most of the available communication protocols and their pros and 
contras on EMBnet network. A chapter was devoted to hardware, users, 
funding and staff, and another to education, user services and databases. 
Therefore, since this study gives a very accurate idea of problems as well as 
of opportunities for development of EMBnet as a whole, it will be used as 
feasibility study for further developments. 
COOPERATIVE ACTIVITIES: 
This project is, in its very structure, quite different from other BRIDGE 
funded programs in that it is based completely on cooperation of different 
countries, EEC and EFTA, and Institutions. Each single result is the fruit of 
this cooperation. Yet, EMBnet as an organization is open to contribution 
from any other institution and organisation; indeed, a cooperation is under 
way between the so called "special purpose nodes", that is the human 
Genome Mapping Project Resource Centre of the United Kingdom, the 
MIPS in Heidelberg and the INSERTM in France. 
Against this scenario, the Italian node of EMBnet isdiscussing joint research 
with the MIPS, bearing on the development of object-oriented databases. 
Contacts with NCBI have also been established. 
■22 
TITLE: 
Integrated data and knowledge base of protein structure and sequence 
CONTRACT NUMBER: 
BIOT-CT90-0271 (SMA) 
OFFICIAL STARTING DATE: 
1 April 1991 
COORDINATOR: 
Shoshana J. Wodak, Universite Libre de Bruxelles, Bruxelles, BE {partner 1) 
PARTICIPANTS: 
Chris Sander, European Molecular Biology Laboratory, Heidelberg, DE (partner 2) 
Janet Thornton, University College London, London, GB (partner 3) 
Peter Gray, University of Aberdeen, Aberdeen, GB (partner 4) 
Chris Rawlings, Imperial Cancer Research Fund, London, GB (partner 5) 
Michel Moreau, BIM, Everberg, BE (partner 6) 
OBJECTIVES SET FOR THE REPORTING PERIOD 1 July 1991 - 31 March 1992: 
All partners: Design of a standard schema of object types and relations describing protein 
structure and sequence. 
Partners 1 (Brussels) and 3 (UCL): incorporate sequence and structure homology informa-
tion into the respective databases. 
Partner 4 (Aberdeen): Prototype implementation of an Object-Oriented front end. 
MAJOR PROBLEMS ENCOUNTERED: 
Partner 1 (Brussels): 
In order to store data on protein sequence and structure homology, it was necessary to 
develop efficient ways of representing this data in the database. In particular, solutions to 
the problem of representing multiple sequence alignments (based either on pure se-
quence or structure comparisons) had to be devised. 
Partner 3 (UCL): 
To attain the objective of incorporating sequence and structure homology information 
into the database, it was necessary to develop the following computer programs: 
a) a sequence alignment tool for identifying proteins with sequence homology; 
b) a structural alignment tool which can be used either for superposing whole structures 
to identify distantly related proteins or to find common structural motifs which are 
not necessarily the result of divergent evolution. 
To identify structural motifs, a method for generating local structure alignments also 
needed to be adapted. 
Partner 4 (Aberdeen): 
The main problem encountered was the long delay in providing funds. The services of 
Dr. Kemp might have been lost, had not the SERC given us a one-year grant to continue 
some other work. Work on the BRIDGE contract started only in October 1991, after at-
tending the GBF-CAPE Symposium and BRIDGE meeting in Braunschweig. 
Another problem has been the delay in acquiring a license for the SYBASE software, at a 
specially reduced price. However, a great deal of help was provided from Jean Richelle at 
UCMB, and we hope to have a running system soon. 
We are experiencing EPR (Intellectual Property Rights) problems already in using protein 
data provided by other partners for pre-competitive work with a small biotechnology 
company in order to try out our system. The commercialization of the 'value added' data-
bases is fraught with potential IPR problems which could seriously hinder their take-up. 
We are trying to structure our database so that program and data modules can be pur-
chased from various sources for various platforms, but it is not going to be easy. 
Partner 5 (ICRF): 
Anumber of programs have been developed using the logic programing language Prolog 
to check the consistency and completeness of the topological description of protein struc-
tures used in the TOPOL database. Most of the problems encountered could be traced 
back to inconsistencies and incompleteness in the original Brookhaven files. 
RESULTS: 
All partners (more specifically a working group including members of partners 1,3, 4 & 5): 
Very good progress was made in the design of a standard schema of object types and rela-
tions describing protein structure and sequence. A report describing the schema and ob-
jects types on which consensus has been reached is circulating among all partners for 
comments. This mainly concerns the hierarchy of molecular structure elements such as 
macromolecule, subunits, quaternary structure, chain, ligand, solvent, various descrip-
tions of secondary and supersecondary structure elements, residues, atom groups, atoms, 
and finally spatial proximity and specific interaction types made between atoms. A stan-
dard definition of such object types and the relations between them is not only necessary 
for the design of compatible databases, but also and foremost a prerequisite for any stan-
dard exchange protocol of macromolecular data, which is badly needed in the field. 
Partner 1 (Brussels): 
Extensions and enhancements nf AT I the user interface to SESAM: ALI contains meta-
knowledge about SESAM. This includes a list of SESAM tables, data fields, and their 
aliases, as well as the type and relational properties of the fields. Commands have been 
developed in ALI to introduce this metaknowledge interactively, thereby allowing the 
user to bring ALI up-to-date on changes made in SESAM. Further improvements have 
been made to the automatic query building algorithm in ALL When querying SESAM 
through ALI, the user needs to specify only the fields he wishes to view. Those used for 
'join' purposes in different tables are provided automatically by the algorithm. The latter 
furthermore optimizes the query operation by minimizing the number of tables to be ac-
cessed. The procedure whereby this is achieved is very general and works even for very 
complex queries. 
Other enhancements include: 
1) Reorganization of the MENU of ALI into a tree structure that reflects the hierarchic 
concepts of protein structure. This greatly facilitates the specification of data fields 
and conditions in accessing SESAM. 
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2) A set of PLOT and GRAPH commands to produce 2D graphic output (screen or 
printer) of any pair of numerical data fields extracted from SESAM. 
Incorporation of data on protein sequence and structure homology: Having devised ways 
of representing multiple sequence alignments in SESAM, information on aligned se-
quences of 28 protein families including the Globins, Cytochromes-C's Lysozymes, mi-
crobial RNases, have been stored in SESAM. 
Representation and incorporation of data on sequence patterns corresponding to com-
mon structural or functional motifs: An exhaustive repertoire of sequence patterns 
uniquely associated with secondary structures (a,(3, Coil, Turn) at specific positions 
(Rooman & Wodak, 1988, 1990) and their respective territories in all known protein 
structures has been stored in SESAM. 
Partner 2 (EMBL): 
Two algorithms to extract from the database representative sets of protein chains with 
maximum coverage and minimum redundancy have been developed. The first algorithm 
focuses on optimizing a particular property of the selected proteins and works by succes-
sive selection of proteins from an ordered list and exclusion of all neighbours of each 
selected protein. The other algorithm aims at maximizing the size of the selected set and 
works by successive thinning out of clusters of similar proteins. Both algorithms are gen-
erally applicable to other databases in which criteria of similarity can be defined and re-
lated to problems in graph theory. The largest non-redundant set extracted from the cur-
rent release of the Protein Data Bank has 155 protein chains. The selection may be useful 
in statistical approaches to protein folding as well as in the analysis and documentation of 
the known spectrum of three-dimensional protein structures (Uwe Hobohm et ai, in 
press). 
Partner 3 (UCL): 
A sequence alignment tool has been developed which performs all pairwise comparisons 
and generates protein families by single linkage cluster analysis. Sets of nonhomologous 
proteins can easily be derived by selecting a single representative from each family. A 
multiple sequence/structure alignment is also in progress, which will allow us to establish 
sequence and structure constraints for different families and folds. Such information 
could be stored in the databank in the form of templates, generated at different similarity 
levels. 
To identify motifs, a method for generating local structural alignments has been devel-
oped. This can be applied to each family separately, extracting folding motifs for that 
family or across the databank giving universal motifs. It can search for all occurrences of 
known motifs or find new motifs. Plans for future work include an analysis of all families 
within the databank using these techniques. It concerns identification of new motifs and 
extensive characterisation (both sequence and structure) of new and established motifs. 
Research will also include assessing ways of storing such data in the databank. 
We also actively participated in the standard schema design efforts (see all partners). 
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Partner 4 (Aberdeen): 
We have coordinated the standard schema design efforts using the latest database model-
ling techniques (see also all partners) and produced a report of the working group sessions 
in Aberdeen (23-25 January 1992). The design standards described in this report have 
already been through the first stage of refinement through comments. The schema looks 
promising. It includes most of the types of macromolecular data stored by the partners, 
showing how they relate to each other. It is at an abstract conceptual level which allows 
different storage representations to be implemented by different partners, but without 
needing significant changes to application programs based on it The schema is to be 
presented for a final stage of refinement at the EMBL meeting on 22-23 May 1992. 
Our other work has been to prototype an extension to our object-oriented database 
which allows relational database storage routines to be used to store objects. The objects 
are stored in a separate module (partition) of our database, but can contain pointers to 
objects in existing modules. This will make it straightforward to use our Prolog search 
code and object-oriented software in conjunction with data taken from the SESAM data-
base developed by partner I (Brussels), as planned in our original proposal. The proto-
type test is encouraging. 
Partner 5 (ICRF): 
Progress has been achieved in the following areas of project tasks: Definition of the stan-
dard schema, addition/validation of data and knowledge and the development of user 
interfaces. 
Definition of the standard schema (see also all partners): In common with other members 
of the project we have taken part in meetings and discussions to help arrive at a consensus 
conceptual schema that integrates the data and requirements of all the consortium part-
ners. 
Addition & Validation of data and knowledge: 
a) A Rule-based Representation of Protein Folding Rules: Based on a Prolog represen-
tation of general protein folding rules in a/|3 proteins an interface to the TOPOL 
database and programs was implemented. By searching the TOPOL database using 
the folding rules as queries, proteins whose conformation could be shown to comply 
with the folding rules could be identified [1]. The results of the study helped to vali-
date both the TOPOL representation of protein topology and the protein folding 
rules. 
b) Validation of Protein Topology Data: A number of programs have been developed 
using the logic program Prolog to check the consistency and completeness of the to-
pological description of protein structure used in the TOPOL database 
Software and User Interfaces 
a) New PAPAIN User Interface Modules: New graphical interfaces have been devel-
oped to the programs for predicting protein topology described in [l] and the protein 
topology diagramming tool extended to enable a/(3 topologies to be displayed 
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b) PROSITE and PROSEARCH Interface: An interface to the PROSITE database and 
the PROSEARCH programs for locating the position of sequence motifs in protein 
sequence data has been developed and integrated into the PAPAIN interface 
c) X Windows User Interfaces: The PAPAIN suite of user interfaces providing graphical 
manipulation and visualisation of (i) protein topology diagrams (ii) protein second-
ary structure predictions (iii) protein sequence profile analysis and (iv) the TOPOL 
database as well as the developments mentioned above in [3a] and [3b] have been 
converted to run under X windows using the MOTIF window manager. 
[1] Clark, DA, Shirazi, J., Rawlings, CI (1991) Protein topology prediction through constraint-based search and 
the evaluation of topological folding rules, Protein Engineering, 4, 751-750 
Partner 6 (BIM): 
Counselling and guidance were provided (mainly to partner 1) for the following develop-
ments: 
1) design and implementation of the database schema for representing information on 
multiple sequence alignments. In the adopted solution, a table relates pointers to 
individual residues of each protein to a unique pointer to the position in the align-
ment. This is general enough to allow representation of alignments for families with 
any number of members. 
2) Procedures in ALI for accessing and viewing sequence mapped information in SE-
SAM were extended to include motifs of secondary structure elements and to re-
trieve information on aligned sequences. 
3) enhancements of the ALI querying performance, in particular in devising procedures 
for optimizing query design based on user specifications. 
Help was provided to partners 1 and 5 in negotiating acquisition of a SYBASE licence at a 
reduced price. 
HIGHLIGHTS/MILESTONES: 
Significant progress has been made towards reaching a consensus in the design of a stan-
dard schema of object types and relations describing protein structure and sequence. 
WIDER CONSIDERATIONS: 
Work done within this project on the design of standard schema of object types and rela-
tions describing protein structure and sequence is a prerequisite for the development of 
standard exchange protocol of macromolecular data, which is badly needed in the field. 
In particular, it should provide the templates and guidelines for the description of protein 
and nucleic acid data in ASN.l or CIF formats. This in turn will allow for efficient com-
munication between different databases independently of their internal design. Our ef-
forts are thus of direct relevance to those of the IUCr in Chester UK who define standards 
for protein crystal structure data exchange format, and to those of the Protein Databank 
team at Brookhaven who are in the process of redesigning their database and exchange 
formats. Contacts have been established with T. Koetzle and E. Abola (Brookhaven Pro-
tein Databank) and G. Dodson and P. Fitzgerald (IUCr) in view of a closer collaboration. 
COOPERATIVE ACTIVITIES: 
Several joint meetings and workshops were organized within this reporting period: 
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1) All partners met for one day following the CAPE symposium on Prediction and experi­
ment: three­dimensional structures of homologous proteins in Braunschweig 
(18­19 September 1991). At this meeting organizational matters and collaborations 
were discussed. 
2) Partners 1,2,4 and 6 attended the meeting in Maastricht (20­22 November 1991) on 
Bioinformati.es in the 90. Partners 1 and 4 gave presentations related to their database 
work. Following this meeting, the coordinator of the present project {partner 1) pres­
ented it at a half day BRIDGE­database workshop. 
3) Partner 1 (Brussels) was host to a 2­day meeting (12­13 December 1991) devoted to 
laying the grounds to the standard schema design work and to discussing collabora­
tion strategy with the Brookhaven Databank team. A list of problems encountered 
and improvements to be made to the Brookhaven databank format was compiled. 
The necessity for adequate protein structure data validation software was discussed 
and designated as the most concrete and timely area of collaboration with Brookha­
ven. 
4) Partner 3 (UCL) organized a workshop/meeting, supported by EC and CCP11, in 
London on 25­26 March 1992. In this meeting, 100 participants gathered to discuss 
protein structure coordinate data, the new proposed Brookhaven format and data 
validation. Invited speakers included the head of the US Brookhaven Protein Data 
Bank, (T. Koetzle), the scientist in charge of changing formats at Brookhaven (E. 
Abola) and various European speakers and representatives from ESF (European 
Science Foundation) and IUCr (International Union of Crystallography). This meet­
ing has taken a lead in coordinating the European effort to facilitate data input to 
Brookhaven and the development of a validation suite. Within the group at UCL, 
procedures to assess the stereochemical quality of protein structures [Morris et al. 
(1992) Proteins, 12,345­364] have been developed. These will contribute to a com­
bined European effort to validated the coordinate data currently in the Brookhaven 
Databank and future entries 
5) Partner 4 (Aberdeen) acted as hosts to partners 1, 3, 4 & 5 in Aberdeen (23­25 Janu­
ary 1992) for the standard schema design workshop. 
6) Dr. Kemp (partner 4) and Dr. Orengo (partner 3) made short visits each to partner 1 
(Brussels) on different occasions. 
7) The SESAM database of partner 1 has been installed at EMBL and at Aberdeen. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS­NATIONAL AUTHORSHIP: 
Nothing to report. 
OTHER PUBLICATIONS/PATENTS: 
Zhuoan Jiao and EM.D Gray, "Optimisation Of Methods In A Navigational Query Language", Proc. 2nd 
International Conference on Deductive and Object­Oriented Database Systems, December 1991, Germa­
ny. This paper shows how queries calling methods in an object­oriented database can be optimised, with 
several examples taken from the protein database 
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Title: 
Immunoclone and hybridoma database network for Europe. 
Contract number: 
BIOT-CT91-0257 
official starting date: 
01 April 1991 
Coordinator: 
Louis Rechaussat, CERDIC, Nice Sophia-Antipolis (France) 
Participants: 
Associate contractors: 
Alan Doyle, ECACC, Porton Down (UK) 
Tiziana Ruzzon, 1ST, Genoa (Italy) 
Patrick de Baetselier, VUB/IMB, Brussels (Belgium) 
Hans Kurzwelly, DIMDI, Koln (FRG) 
Subcontractor: 
Hans Lucius, Max-Delbruck Centre, Berlin (FRG) 
Objectives for the reporting period: 
1. Development of a scientific and technical database on 
immunoclone descriptions ("Immunoclone Database" -
ICDB), coming from: 
- Scientific literature curently published, 
- Patent applications to the European patent Office, 
- Industrial and commercial catalogues, 
- Participants'collections of hybridomas. 
Altogether, the target is an input capacity of 2,000 
per month after 18 months. 
2. Implementation of a stable consortium agreement, as a 
model for biological database networks in Europe. 
Major problems encountered: 
1. Concerning the whole project: 
A four-month delay of the initial training party for 
several centres because of the delay of the shipment 
of EEC funds, and in consequence delay for the local 
implementation of input capacity; 
Electronic communication deficiency because of the 
lack of infrastructures and know-how in centres' 
environment; 
Conversion of the existing database file into ORACLE 
format longer than expected because of a rate of data 
modifications higher than expected; 
Retirement of the Central laboratory of the 
Netherlands Red Cross (Amsterdam). 
2. Concerning centres: 
CERDIC: Nothing to report; 
ECACC: One coder has left; 
IST: Delays for the implementation of the equipment; 
VUB/IMB:Nothing to report; 
MDC: Nothing to report. 
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3. A review of communication problems with visit(s) to 
concerned site(s) is planned in April 1992. 
An addendum to the contract has been signed, with 
DGXII contract office, stating on the retirement of 
the Central laboratory of NL Red Cross and the 
reimbursement of the EEC funds. 
Results: 
1. Database management implementation: the data input and 
validation software has been achieved in May 1991 and 
a final release was distributed to each centre in 
September. 
2. Hardware and software installation: ORACLE software is 
installed in each centre (except ECACC). Due to local 
situations, the implementations are not as homogenous 
as it was expected, but it does not affect the 
objectives of the project: 
- CERDIC has access to 4 different versions of ORACLE 
(VMS Version on DEC/Vax, Unix versions on IBM/Risk 
6000 and Sun/Sparc 690 and DOS version on 
microcomputer), thanks to the CICA (Centre Inter-
national de Communication Avancee), where it is 
located; 
- VUB/IMB and MDC have the implementation initially 
planned; 
- 1ST has access to a UNIX and a DOS versions. 
- During the period ECACC was currently using ICDB on 
IBM/Stairs accessible from CERDIC. The access to 
ORACLE from CERDIC/CICA server will be possible. 
3. Communication procedures: Electronic communications 
were made between centres through FTP, mail and 
modems. E-mail is used by all centres (ECACC is using 
the commercial E-mail BT-Tymnet), FTP connections are 
used by CERDIC and 1ST, and under test in MDC and VUB. 
The EARN Network has been also prospected. Most of the 
encountered difficulties will be solved in the early 
weeks of the second period of the project. 
4. Data collection: Patent applications and commercial 
catalogues (from 175 major companies worldwide) were 
made avalaible and distributed for coding by CERDIC. 
Accessibility to scientific literature depends on 
local library facilities. They are better for CERDIC, 
ECACC and MDC than for 1ST and VUB/IMB. 
5. Data processing implementation: Two training session 
took place in CERDIC, one in May 1991, for ECACC and 
IST who could support the travel expenses before EEC 
first payment, and a second in September. All the 
centres were producing validated data with the 
software loaded on their own workstation, in October 
1991. 
6. Data processing optimisation: Controls of quality are 
currently done on each centre production which appears 
to be good. There is no need, up to now, for any 
extension of software controls. During the second 
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period of the project, the centres will have to 
increase their production and reduce the elapse time 
between the reception of the tasks and the shipment of 
coded data. Facilities for the use of the database 
under ORACLE will be developed in connection with the 
loading of the database on local workstations. 
7. User-friendly interface: Planned for the second period 
with DIMDI. Highlights/Milestones: 
1. Consortium agreement: In addition to the Bridge 
contract, associate contracts and subcontract, a 
consortium agreement was finalized in November 1991 
and countersigned by each participant. This document 
states on rights and duties for input activities, 
sharing of tasks, copyright, sharing of royalties, 
local use of the database and distribution policy. 
2. Production: The total production during the first 
11-month period of the project was of 8 67 3 new 
records. In addition, 2,900 other records were 
processed by CERDIC on scientific literature for the 
years 1984 to 1988. 
3. Collection of hybridomas: The ECACC hybridoma 
collection was entered in ICDB. 
4. Diffusion: During the period the database was 
accessible on-line on DIMDI in FRG, on Data-Star in 
Switzerland and on the computer host of Conseil 
General of Alpes Maritimes (Minitel). The database was 
updated monthly. The updates are also published in a 
printed form and on floppy disks for microcomputers 
("Immunoclones" journal). CERDIC and ECACC act as 
reference centres for ICDB. IST, MDC and VUB/IMB are 
willing to do so. The general feeling is that ICDB 
needs a wider publicity among the scientific 
community. 
5. Expansion of the network: The Institute of Molecular 
Genetics (Prague, Czechoslovakia) joined the network 
as corresponding member. 
Wider considerations: 
1. Electronic communications in research community: As 
far as networking scientific activity is concerned, 
there is a need of reliable and cheap electronic 
communication links. Many research institution 
equipment and know-how are below the minimum required 
for such activities. This situation may induce serious 
restrictions in the transfer of scientific and 
technological knowledge between the scientific and the 
industrial communities. 
2. Availability of biotechnology products: The data 
processing is a powerful tool for the identification 
of new scientific and industrial products for 
biotechnology. The European countries can take 
advantage to broadcast this information, worldwide. 
But it is very important to link this facility to an 
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improvment of the availability and of the quality 
standards of the described products. Some biological 
products, like monoclonal antibodies and cell line 
cultures have a strategic importance in the worldwide 
competition of pharmacology research and development. 
The combination of information networks and bioproduct 
ressources may have a very positive effect on the 
development of biotechnologies in Europe. 
Cooperative activities: 
1. Thanks to the DGXII/F organization, a plenary session 
of all project members met in Maastricht, after the 
international conference "Biolnformatics in the "90s" 
and the Bridge meeting (November 1991). 
2. The two training parties held in Sophia-Antipolis, at 
CERDIC gave the opportunity to meet the technical 
staff of the project (One week for 3 people in May and 
10 days for 6 people in September 1991). 
3. Joint participation of CERDIC and ECACC to the 
international BioExpo (Paris, April 1991), CERDIC, 
ECACC and 1ST to BioTech '92 (Genoa, April 1992). 
4. In Belgium, a local network was created between 
laboratories that are currently involved in the 
generation of immunoclones. This network is supervised 
by the VUB/IMB and will serve as a mean to obtain data 
from the national collections and to promote ICDB 
within Belgian institutions and biotechnology 
companies. 
5. Representatives of ECACC, IST and DIMDI attended to 
CERDIC Board meeting, Sophia Antipolis, France, in 
July and December 1991. 
List of joint publications: Nothing to report. 
Other publications: 
A Doyle and R S James, Databases for Animal Cell Lines, 
Bioinformatics, 1992;1(1):8-ll. 
32-
TITLE: ELECTRONIC LINKING SERVICES FOR BIOTECHNOLOGISTS AND 
MICROBIOLOGISTS IN EUROPE 
CONTRACT NUMBER: G R A N T 
OFFICIAL STARTING DATE: January 1991 
COORDINATOR: B E KERSOP, HSDN, CAMBRIDGE, GB 
PARTICIPANTS; MSDN is sole contractor. 
OBJECTIVES SET FOR THE REPORTING PERIOD: New users, collaborating 
laboratories, databases and networks to be linked to the MSDN. 
Promotional material, publicity and training to be provided. 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report. 
RESULTS: [Note: The MSDN has received a single grant under the 
BRIDGE programme and has no BRIDGE funded partners. Comments 
regards progress in different laboratories are not relevant. All 
results described below refer to activities emerging from the 
MSDN Secretariat office in Cambridge. Activities are on-going.] 
1991 was a year of major developments for MSDN that have resulted 
in a strong base on which improved and expanded services can be 
built. The three major developments undertaken to enhance the 
services overall were 1) improved database hosting system, 2) 
improved software and 3) establishment of in-house invoicing and 
billing administration. 
1.DATABASE STORAGE/HOSTING: Until now the relatively high charges 
for storing MSDN databases on the BT computer have inhibited 
collaboration by database producers. The MSDN has investigated a 
number of alternative options and is now using another database 
hosting system offering good, yet inexpensive, storage. 
The storage costs on the new system are $100/megabyte data/year. 
This is a very attractive arrangement, since large databases can 
now be hosted for a very modest cost and small databases can be 
combined into 100 megabyte packages for cost purposes, so that 
storage is almost free. Moreover, databases developed by 
scientists without access to any resources (for example, East 
European organisations) can be stored at MSDN expense. It is 
anticipated that the new hosting arrangement will lead to 
considerable interest from scientific database developers to link 
their information to the network. 
The new storage system allows greater flexibility, since charging 
arrangements (for example, addition of royalty on usage, charges 
for downloaded records) can be readily introduced. Changes to the 
charging arrangements with BT were always difficult to make and 
slow to implement and the possibilites for making different 
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charging procedures were limited. 
The change to the new system is now underway and will become 
effective at the beginning of March 1992. Already, the databases 
previously maintained on the BT computer have been reformatted 
and transferred to the new computer, new documentation has been 
prepared for users, new demonstration disks have been developed. 
The work involved in this development has been substantial and, 
because of the importance attached to the change, has taken 
priority over other activities. The new system allows great 
potential for future development, since cost considerations will 
no longer be a factor for determining whether or not to use the 
MSDN services. Already, a number of new, up-dated or enlarged 
databases have agreed to link their databases to the network. 
NEW/UP-DATED/EXPANDED DATABASES FOR ADDITION TO MSDN UNDER NEW 
ARRANGEMENTS: 
* Biotech Knowledge Sources (BKS), maintained by BioCommerce 
DataLtd, renewed monthly, listing publications, videos, 
software, databases and conferences in biotechnology. 
* American Type Culture Collection databases (Bacteria and Media, 
Protists, Recombinant Materials, Cell Lines and Hybridomas), 
up-dated and expanded 
* European Collection of Animal Cell Lines catalogue, greatly 
expanded to include human lines, DNA probes, hybridomas and 
human b-lymphoblastoid lines 
* BIA databases. 
ADDITIONAL DATABASES CURRENTLY UNDER DISCUSSION: 
* Animal virus database 
* IMI catalogue 
* Czech Collection of Algae and Cyanobacteria 
* Aubit Who-What-Where databases. 
IMPROVED SOFTWARE: Since it now seems likely that a larger number 
of databases will elect to be hosted on the MSDN computer rather 
than accessed via electronic gateways, it is desirable that 
improved software should be introduced. The software used for the 
BT-hosted databases was acceptable, but changes to the software 
were difficult if not impossible to implement. It was not 
possible to customise the software for MSDN purposes. 
New software called INFO has been developed by collaborators and 
made available to MSDN. The MSDN has worked with the software 
developers to customise INFO to meet the specialised needs of 
MSDN. INFO is extremely simple, yet flexible and will allow 
greatly facilitated database searching. As more databases become 
linked to the network, the value of this will be much appreciated 
by the user community. Following a period of testing and 
development, INFO is now ready to be made available to the MSDN 
simultaneously with the change-over to the new storage system. 
Already users have been mailed with a description of INFO and a 
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quick reference guide. Additionally, the new system has been 
described in online NEWS and introduced in the latest Newsletter. 
With the introduction of INFO, the MSDN is now in a position to 
provide improved searching of the Directory maintained by the 
MSDN (for locating strains of organisms with specific 
properties), eliminating the original two-stage procedure. 
BILLING: Difficulties with invoices prepared by BT in the past 
have caused much effort on MSDN's part to track and correct. 
Again, the inflexibility of large organisations has been 
frustrating from time to time. A decision has been made to move 
invoicing in-house so that billing can be customised and errors 
can be rapidly tracked and corrected. 
Software has been written that allows the raw BT usage data to be 
transferred to an invoicing package. For the last two months of 
1992, invoices have been prepared and distributed from MSDN's 
invoicing office. To facilitate customer support in North 
America, a part-time support person has been hired to answer 
enquiries and help explain any billing or technical changes. 
Again, this change has been very demanding in manpower and it is 
gratifying that the new system has been introduced successfully 
with a minimum of problems. Indeed, irregularities that existed 
in the BT invoicing procedures have been identified and 
corrected, to the advantage of MSDN. The new system enables MSDN 
to attach special messages, discounts or announcements with the 
invoices, which we anticipate will further improve the service. 
These major service enhancements have been demanding in time and 
effort. We believe they reflect the growing maturity of the 
network and its ability to provide an increasingly valuable 
service to the scientific community. 
TRAINING: In addition to the above activities, the MSDN has been 
involved in providing training in use of the services. The 
following people have spent between 1-4 weeks at the Cambridge 
office, receiving individual tuition: 
Penny Noble - ECACC UK (1 week, January 1991) 
Katja Frohlich - ICECC Germany (1 week, February 1991) 
Carmella Belloch Trinidad - CECT Spain (4 weeks, April 1991) 
Monika Gotowczyc - IOAB Poland (3 days, May 1991) 
Teresa Barreto - IBET Portugal (4 days, December 1991) 
In addition, a training course was held in Glasgow (April, self 
funded), in India (November, UNEP funded), and in Canada 
(September, Environment Canada funded). Further funds for 
training courses in the Cape Verde/Senegal region and in Beijing, 
China have been agreed by UNEP. A workshop in Moscow to finalise 
MSDN-linked networking arrangements has been postponed to April 
1992, because of difficulties in the region. In the meantime 
electronic communication has been established with the Institute 
in Russia and Letters of Agreement have been exchanged. 
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PROMOTION: Up-dated User Manuals and Demonstration disks are 
prepared routinely and can be obtained by application to the 
Secretariat. A number of lectures and demonstrations have been 
given by MSDN in different regions of the world. They include: 
CODATA meeting, Nancy - participation 
ECCO meeting, Valencia - report 
BIA Council meeting, London - demonstration 
UNCED preparatory meetings, London - participation 
IUBS Biodiversity conference, Amsterdam - participation 
IUMS Biodiversity Workshop, Amsterdam - contribution 
DISNET contractors meeting (DGX111) , Amsterdam 
Montreal UNESCO Conference - lecture 
BIOFOCUS meeting, Montreal - participation and lecture 
IBEX Exhibition, Washington/San Francisco USA - lecture/ 
demonstration 
COBIOTECH E/W, Bratislava - lecture 
BIOINFORMATICS in the 90's, Maastricht - lecture, demonstrn. 
In addition, visitors have been received at Cambridge and visits 
made to other organisations. Discussions on future collaboration 
have taken place with the Leatherhead Food RA in the UK and with 
the World Conservation Monitoring Centre. Agreement has been made 
with Graham Cameron of EMBL to discuss ways of linking MSDN and 
EMBL services. 
Throughout all these activities, new contacts have been made and 
new opportunities for collaboration have been discussed. 
During 1991/2, three NEWSLETTERS have been published (attached). 
IRRO WORKSHOP: At the end of 1990 UNEP invited MSDN to set up an 
information resource for the release of organisms into the 
environment. Funds for a workshop to discuss the needs and 
specifications for such a resource were received from UNEP, CEC, 
USDA, EPA and Environment Canada. The workshop was held on two 
sites (because of travel restrictions caused by the Gulf War) . 
The separate meetings were linked electronically. There was 
unanimous agreement that a decentralised system be established to 
distribute information on GMO's and non-GMO's of micro- and 
macro-organisms. Proceedings of the Workshop have been published 
by UNEP and widely distributed (copy attached). Over 1000 copies 
have been supplied to CUBE office for distribution. 
A follow-up meeting was held at REGEM2 conference in the UK. At 
this meeting an IRRO Steering Committee was set up and agreement 
taken to set up online Bulletin Board, NEWS and email using the 
MSDN system, but as a separate network with its own identity. A 
telephone for enquiries about IRRO has been provided by the MSDN 
for the time being. Funds are being sought for the employment of 
an information officer to develop and maintain databases. A 
number of databases have been identified to start the network's 
information capability, and the Steering Committee has been 
enlarged to extend the expertise and geographical spread. 
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BIODIVERSITY: The intense political interest in biodiversity and 
its conservation have led to a number of meetings and conferences 
on the topic. The World Federation for Culture Collections (which 
sponsors MSDN) is planning a Workshop to be held in Brasil in 
1992 to discuss mechanisms to link the different biodiversity 
networks already in operation or planned. The plant, animal, 
insect and microorganism information networks must be linked to 
provide a biodiversity resource if the separate elements are not 
to remain isolated and under-used. The IUBS and IUMS have agreed 
to co-sponsor the Workshop and the Tropical Database and the MSDN 
are organising the event. A computer conference will be 
established on the MSDN system to allow persons unable to attend 
in person to contribute to the discussions. 
OTHER CONTRACTS: The MSDN continues to collaborate with the EPA 
and the NIDR (NIH) in the development of specific databases and 
services. Additionally, the DGX111 IMPACT project continues and 
the MSDN knowledge base will be incorporated into the DISNET 
system and a gateway established between MSDN and DISNET. 
USAGE: Overall, 69 new mailboxes have been requested and usage is 
steadily increasing. It is anticipated that the developments 
described above will lead to a year of increased activity as more 
databases and services are incorporated in the network. 
Usage of the system in the US has not been increasing as well as 
in the rest of the world and steps have been taken to encourage 
awareness by demonstrating at IBEX91 and by appointing a US 
support person. Towards the end of the year a number of new 
mailboxes from the US have been requested and the usage trend 
appears to have been reversed. 
WIDER CONSIDERATIONS: The measures taken in 1991 to develop the 
MSDN system will lead to a sharp increase in the amount of data 
linked to the network. This, combined with the incorporation of 
flexible and easy-to-use software will be attractive to both 
database providers and users alike. The outcome will be increased 
information exchange and increased usage of MSDN. Additionally, 
the improved hosting/searching facility will encourage use of the 
MSDN database storage service and limit the need for increased 
gateways to remote hosts. This in turn will simplify both the 
system for the user and training. 
COOPERATIVE ACTIVITIES: No partners, so nothing to report. But 
please note large numbers of meetings, visits and training 
activities with European scientists listed above. 
PUBLICATIONS: 
* 'Needs and Specifications for an Information Resource for the 
Release of Organisms into the environment', Eds. B E Kirsop, M 
I Krichevsky, UNEP, Nairobi, 1991. 
* Newsletters: February 1991, June 1991, January 1992. 
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TITLE: Information Centre for European 
Culture Collections (ICECC) 
CONTRACT NUMBER: BIOT-CT90-0162 
OFFICIAL STARTING DATE: 01.01.1991 
COORDINATOR: Dr. D. Claus, DSM, Braunschweig, DE 
PARTICIPANTS: DSM, Braunschweig, DE 
OBJECTIVES SET FOR Information on European culture collections; advice on 
THE REPORTING PERIOD: cultures and databases 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report 
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RESULTS 
Advice and information on cultures and culture collections 
The Information Centre for European Culture Collections (ICECC) is a follow up project of 
the CEC­Culture Collection Information Centre supported by the Commission under its 
Biotechnology Action Programme during 1989 and 1990. It reflects the demand from acade­
mic and industrial institutions for a central European contact point for information on 
different types of biological material, on culture collections and their services and holdings. 
Within the reporting period the ICECC has extended its stock of catalogues so that copies 
from all European culture collections are now available. Catalogues from the most important 
collections outside Europe have been also obtained. Thus, the Information Centre is in a 
position to give detailed information on the availability of specific strains and cell lines from 
collections in Europe or world­wide and on strains with known production or degradation 
capabilities. 
On­line access to the World Data Centre for Microorganisms (WDC) in Japan and to 
different national culture collections in Europe have been established in 1991. The database 
of the UK culture collections, the Microbial Culture Information System (MiCIS).is still held 
at the ICECC. Searching of information during 1991 has been considerably improved. 
The ICECC, together with the DSM­Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH, has compiled a list of names of bacteria which are validly published as 
defined in the International Code of Nomenclature of Bacteria. The list is based on the 
Approved Lists of Bacterial Names (1980) and subsequent additions and alterations 
published in the International Journal of Systematic Bacteriology in the form of original 
articles or in the Validations Lists. The list (at present 38 pages) will be updated four times 
a year and is available for a nominal fee. It is also available on floppy disk and on­line. 
A database with the current assignment of all bacterial species to one of the generally 
accepted risk groups is also available. It is based on a list published by the German 
Occupational Safety and Benefit Authority of the Chemical Industry. 
During 1990 and 1991 several requests on the 
safe shipment of cultures have arrived at the 
ICECC Therefore, a booklet on "Instructions 
for Shipping Non­infectious and Infectious Bio­
logical Substances" was prepared and published 
by the ICECC in 1991. On 31 pages the book­
let gives details on the international regulations 
(postal services and air freight). In addition, ne­
cessary stickers for sending such material can 
be obtained from the ICECC. The brochure 
will now be supplemented by appropriate natio­
nal regulations. For information customers a 
list of prices for cultures and other services 
offered European culture collections has been 
published in May 1991. 
INFORMATION CENTRE FOn 
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For discussions on prices within the European Culture Collections' Organization (ECCO) a 
special list was prepared for culture collections only. In this list all prices of the collections 
have been converted to Deutsche Mark in order to make prices comparable. 
From the many requests arriving at the ICECC it can be concluded that the Information 
Centre has now acquired a certain reputation. The following graph summarizes part of the 
daily routine activities of the ICECC. 
Enquiries 1991 from Science and Industry 
(via letter, fax, e-mail, telephone) 
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Science Industry 
Public relation activities 
The ICECC has continued its activities as a promotion centre of the European culture 
collections. It has participated in the BIOEXPO Paris (9-12 March, 1991) on a common 
stand with the French national node of the Microbial Information Network Europe (MINE 
France) and the Microbial Stain Data Network (MSDN, Cambridge) and has presented the 
services provided by the European culture collections. The numerous catalogues of the 
European collections have found considerably interest as well as the services offered by the 
different collections for the identification of bacteria and fungi. 
For the BIOTECHNICA Hannover (22-24 October, 1991) the Information Centre was 
invited by the Commission of the European Communities to share the CEC stand. The whole 
spectrum of services and activities of the European culture collections, including the MINE 
database, was again presented. Emphasis was laid mainly on the presentation of European 
culture collections as depositories for patent strains and on culture collection services for the 
identification of microorganisms. 
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The Centraalbureau voor Schimmelcultuies (CBS), Baarn, and the ICECC joint together the 
BIOINFORMATICS IN THE 90's, which was held on 20-22 November 1991 in Maastricht 
CBS took the opportunity to demonstrate the Microbial Information Network Europe 
(MINE), whereas the Information Centre demonstrated the services offered by the main 
European culture collections. 
During the fairs and meetings promotion material supplied by the different culture 
collections or prepared by the ICECC itself was distributed. Folders for more than 10 
collections were prepared by the ICECC and leaflets on "Biotechnology Resources in 
Europe" and "Patent Depositories in Europe" have been updated. This material was also send 
to prospective customers for general information. 
The third number of the NEWS of the Information Centre for European Culture Collections 
was published in March 1991. 
Contact with European research and biotechnology 
The Information Centre has started a study on the deposit of microorganisms in culture 
collections. Although some scientific journals ask to make available microorganisms 
described in scientific papers, the total number of microorganisms described and deposited 
in culture collections is rather low. The study will be published during 1992. 
During a visit at the Microbial Strain Data Network the ICECC discussed further 
cooperation within Europe. 
On request of a European company working in the field of biotechnology the ICECC has 
performed an extensive search on the ecology and physiology of different bacterial species. 
The incoming money was used for public relations activities of the Information Centre. 
Liaison with international bodies 
During the reporting period the ICECC has contacted the International Air Transport 
Association (IATA) in Montreal. Canada, and the Postal Union in Geneva, Switzerland for 
instructions on the shipping of biological material. The information given was very useful 
in the preparation of the shipping brochure. 
MINE database 
The Microbial Information Network Europe (MINE) have been demonstrated during fairs 
and to visitors of the information centre. The head of ICECC is actively engaged in the 
project as a member of the MINE Responsible Committee for Bacteria. 
Training Centre 
Within the scope of the International Training Program 1991 of the GBF Braunschweig the 
participants were introduced to the work of the ICECC and the MINE database. 
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HIGHLIGHTS/MILESTONES: 
The ICECC Newsletter is distributed world-wide. The Shipping list has found great interest 
WIDER CONSIDERATIONS: 
Are you interested in microbes, their use, shipping or risks? Do you need information on 
European culture collections, their holdings and services? Would you like to know more on 
MINE, the Microbial Information Network Europe? Contact the ICECC-Information Centre 
for European Culture Collections at Braunschweig. 
COOPERATIVE ACTIVITIES: 
The cooperation between ICECC and MINE as well as MSDN has been strengthen. The 
ICECC has sent out a lot of information on MINE and will continue to do so. Naturally, the 
ICECC is very active in the cooperation with the European culture collections. 
The Information Centre was engaded in the preparation of the Xth Annual Meeting of the 
European Culture Collections' Organization held in Valencia, Spain, from June 5 to 8,1991. 
A proposal that Ms Karja Fröhlich, secretary of the ICECC, should take over the task of the 
Secretary of ECCO was unanimously agreed. 
During the Valencia meeting the Advisory Board of the ICECC held its annual meeting. Dr. 
Dieter Claus reported on the activities of the ICECC In the following discussion proposals 
on further activities of the ICECC have been given. The proposals will improve ICECC s 
work. 
LIST OF JOINT PUBLICATIONS/ 
PATENTS WITH TRANSNATIONAL 
AUTHORSHIP: Nothing to report 
OTHER PUBLICATIONS/PATENTS: 
Information Centre for European Culture Collections NEWS, 
No. 3, March 1991 
Instructions for Shipping Non-Infectious and Infectious Biological Substances. ICECC 
Publcarion No. 1, May and October 1991 
Price List of the ECCO culture collections. ICECC Publication No. 2, April 1991 
List of Bacterial Names. ICECC Publication No. 3, December 1991 
TITLE: Microbial Information Network Europe (MINE) 
CONTRACT NUMBER: BIOT­CT 91­0280 (SMA) 
OFFICIAL STARTING DATE: 1 June 1991 
COORDINATOR: 
PARTICD?ANTS: 
Dr. D. van der Mei, CBS, Baarn, NL 
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­IHEM 
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­CFBP 
­CNRZ 
­ADRIA 
­DBVPG 
­CECT 
Brussels 
Ghent 
Louvain­la­Neuve 
Brussels 
Paris 
Paris 
Angers 
Jouy­en­Josas 
Villiers­Bocage 
Perugia 
Burjasot­Valencia 
­ATHU­M Athens 
­ACA­DC 
­BPIC 
­RNAAS 
­CBS 
­LMD 
­Phabagen 
­CDI 
­KIT 
­PD 
­LMW 
­RIVM 
­Ml 
­ECAAC 
­CCAP 
­NCTC 
­NCIMB 
­NCFB 
­CCPF 
­NCWRF 
­NCYC 
­DSM 
­IMET 
­DIMDI 
­IGC 
Athens 
Kiphissia, Athens 
Amsterdam 
Burn, Delft 
Delft 
Utrecht 
Lelystad 
Amsterdam 
Wageningen 
Wageningen 
Bilthoven 
Kew 
Porton Down 
National Node 
DIN 
National Node 
National Node 
National Node 
National Node 
Contractor 
Mr. J. de Brabandere, pm 
Bacteria 
Fungi/Yeasts 
Fungi/Yeasts 
Dr. M. Chauret, pm 
Fungi 
Bacteria 
Bacteria 
Bacteria 
Prof. A. Martini, pm 
Yeasts 
Prof. F. Uruburu, pm 
Bacteria, Fungi, Yeasts 
Prof. G. Kalantzopoulos, pm 
Fungi 
Bacteria 
Bacteria, Fungi 
DIN, National Node Dr. D. Tan der Mei, pm 
National Node 
Ambleside/Porton Down 
Colindale, London 
Aberdeen 
Reading 
Colindale, London 
Watford 
Norwich 
Braunschweig 
Jena 
Köln 
Oeiras 
n 
n 
National Node 
Central Data Node 
National Node 
Fungi, Yeasts 
Bacteria 
Plasmids, Bacterial Mutants 
Animal Pathogens, Mycoplasmas 
Leptospira 
Bacteria, Plant Pathogens 
Bacteria 
Bacteria, Bacterial Serotypes 
Prof. D.L. Hawksworth, pm 
Fungi 
Animal Cell Lines 
Algae, Protozoa 
Bacteria 
Bacteria 
Bacteria 
Fungi 
Fungi 
Yeasts 
Dr. R.M. Kroppenstedt, pm 
Bacteria, Plasmids, Fungi, Yeasts, Plant 
Virusses, Plant and Animal Cell Cultures 
Bacteria 
Dr. H.­E. Kurzwelly 
Prof.Dr. I. Spencer­Martins, pm 
Yeasts 
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S -CCUG Gothenburg Dr. E. Falsea, pm 
Bacteria 
SF -VTT Aspoo Dr. M.-L. SuihVo, pm 
Bacteria, Fungi, Yeasts 
OBJECTIVES SET FOR THE 
REPORTING PERIOD: 
Introduction: 
The MINE-project is a continuation of the work started under BAP, during which the 
format was defined for the storage of data on strains of microorganisms. 
The general objective of MINE concerns the integration and harmonization of the data in 
the participating collections and the subsequent deposition of these data in one Central 
Data Node (CDN), giving the users of data - scientific, industrial and environmental 
organizations - an easy entry to the rich variety of microorganisms present in the 
European collections. 
This project, in which many nationalities and institutions cooperate and information on 
about 130.000 strains has to be processed, is rather complicated and would have been 
impossible without the support of the EC. 
Shaping of the project: 
A rather long time was needed to formulate the project in such a way that all 
participants had a clear idea about what should be done and how, and consensus was 
reached about the organization and structure. Especially the discussion about the CDN 
proved to be cumbersome, a decision only being reached in the beginning of 1991 with 
the unanimous choice of DIMDI, Koln. 
In retrospect this delay was absolutely necessary to prevent inbuilt possibilities for 
conflicts later on. The contract between EC and the head-contractor, the Royal 
Netherlands Academy of Arts and Sciences, was signed on September 24, 1991, leaving 
precious little time for any activities in this first year. It was fortunate that the MINE 
board, in consultation with EC, agreed on an earlier start of the project, by setting the 
official date on June 1, 1991. 
Objectives for 1991: 
The objectives to be reached in 1991 were: 
a) Updating and first integration of the minimum data sets by the collections and Data 
Integrating Nodes (DINs). 
b) Start of correction and harmonization of supplied data by the Responsible Committees 
(RCs). 
c) Initiation of coordinative discussions between DINs and CDN about database 
structure and transfer of data. 
MAJOR PROBLEMS 
ENCOUNTERED: 
No major problems have been encountered, but some problems with respect to the time 
schedule are inevitable, partly as consequence of the start of the project far ahead of EC 
funds becoming available. 
Also the fact that especially the work of the RCs consists of "learning by doing", 
meaning that during the process all kinds of problems, sometimes of a fundamental 
taxonomic character have to be solved, makes it rather difficult to stick to the schedule 
as proposed in the project. 
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Consultative meetings between DINs and RCs and a pragmatic approach should prevent 
too great a deviation from the timetable. In 1992 3 meetings have already been planned 
to ensure optimum coordination of the project. 
RESULTS: 
The collections provided the DINs (Fungi/Yeasts: CBS, Baam; Bacteria: LMG, Ghent) 
with the most recent data. After processing and integration, the DINs prepared the 
Report Files (Fungi/Yeasts: 1700 pages; Bacteria: 1500 pages) for the RCs 
(Fungi/Yeasts ­ chairman Prof.Dr. G.L. Hennebert; Bacteria ­ chairwoman Dr. Danielle 
Janssens). 
The chairpersons, in close cooperation with the DINs (Baam: Gerrit Stegehuis; Ghent: 
Danielle Janssens) established the guidelines for correction and harmonization by RC 
members. 
In a number of meetings between DINs and DIMDI, the format of the central data base 
and coordination of supply of data from the DINs to the CDN were discussed. 
After that testfiles were sent to DIMDI. 
Dates were fixed for demonstrations of the central data base to the MINE member 
collections. 
MINE collections participate in the establishment of an European data base on plasmids, 
virusses and transposable elements; a common format was established along the lines of 
the MINE formats for fungi/yeasts and bacteria. 
HIGHLIGHTS/MILESTONES: 
Nothing to report for 1991. 
WIDER CONSIDERATIONS: 
Biodiversity is becoming a central theme for scientific, political and economical 
consideration. 
In the Global Change and Biodiversity Programmes of IUCN and IUBS worldwide 
attention is demanded for the importance of biodiversity research for conservation of 
endangered habitats and nature and for assessment of processes in Global Change. In 
these programmes the crucial function of collections and of microorganisms is rightfully 
emphasized. The same holds for the ever increasing role and potential of micro­
organisms in biotechnological research and in handling of waste. 
The MINE programme is the first international, albeit still regional approach to get good 
insight in and easy access to the wealth of microorganisms present in collections. 
Undoubtedly MINE will have an impact on the establishment of a truly world wide 
system, essential for the effort to watch and monitor the still far underexploited gene 
pools on our globe. 
COOPERATIVE ACTIVITIES: 
Within the BRIDGE programme: 
Apart from, but closely related to MINE, the Information Centre on European Culture 
Collections (ICECC) as part of the BRIDGE programme was established at DSM, 
Braunschweig. In cooperation with national nodes this centre disseminates, through 
publications and presentations the MINE programme to all interested groups. 
Demonstrations: 
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Bioexpo Paris April 9-12 (ICECC + French node) 
Biotechnica '91 Hannover October 22-24 (ICECC) 
Bioinformatics in the 90's Maastricht November 20-22 (ICECC + Dutch node) 
Other organizations: 
Within Europe: European Culture Collections' Organization (ECCO); 
1991: Combined meeting MINE-ECCO Valencia Spain. 
1992: Combined meeting MINE-ECCO Gothenburg Sweden. 
Global organizations: 
World Federation for Culture Collections (WFCC); 
1992: Beijing China. 
SOME FIGURES ON THE INTEGRATION: 
Number of strains received by DINs: 
Retained after integration: Unique strains: 
Strains present in more than one collection: 
Bacteria 
Fungi/Yeasts 
Bacteria 
Fungi/Yeast 
Bacteria 
Fungi/Yeasts 
32.749 
56.232 
26.286 
42.481 
3 824 
5.615 
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AREA:B 
ENABLING TECHNOLOGIES 
PROTEIN DESIGN / MOLECULAR MODELLING 
(from page 49 to page 75) 
BIOTRANSFORMATION 
(from page 76 to page 94) 
DNA SEQUENCING 
(from page 95 to page 96) 

TITLE: "Engineering of microbial peptide lantibiotics for use in agro­food 
and biomedical industry" 
CONTRACT NUMBER: BIOT­CT91­0265 (MNLA) 
STARTING DATE: 1 May 1991 
COORDINATOR: C.W. Hilbers 
Lab. Biophys. Chem., KUN, Nijmegen, NL 
PARTICIPANTS: H.­G. Sahl, Inst. Med. Microbiol., Fr. Wilhelms Univ. Bonn, FRG 
R. Siezen, Ned. Inst. Zuivel Onderzoek, Ede, NL 
G. Jung, Inst. Org. Chemie, Eberhardt­Karls Univ. Tubingen, FRG 
OBJECTIVES SET FOR REPORTING PERIOD: 
1) Screening for novel lantibiotics and large scale production. 
2) Determination of the chemical and three dimensional struc­
tures, and of biological and physico­chemical properties of 
various wild type, variant­, mutant­ and synthetic (pre­)lan­
tibiotics. 
3) Chemical synthesis of leader peptides, pro­ and prenisin, 
chemically modified lantibiotics, and mutant/variant lanti­
biotics. 
4) Characterization of processes involved in: 
a) biosynthesis: genes, prepeptides and enzymes involved, 
b) cell killing and immunity of producing strains. 
MAJOR PROBLEMS ENCOUNTERED: 
1) No problems. 
2) The structure elucidation of novel lantibiotics will require the 
isolation and purification of additional amounts of material. 
3) No problems. 
4) Identification of the staphylococcal immunity peptide and 
putative processing protease are problematic, due to difficul­
ties with production of antibodies. 
RESULTS: 
ad 1). 
A total of 800 staphylococcal strains were screened for production of lantibiotics. Nine 
strains produced active substances, two of which did not produce sufficient activity for 
characterization. Seven strains produced lantibiotics; one strain produced three active 
lanthionine containing peptides, so that a total of nine lantibiotics was obtained. All peptides 
were purified and analyzed as to molecular mass, amino acid composition and partial 
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sequence. Two peptides proved to be epidermin, seven others represent novel lantibiotics. So 
far, one peptide (called K7) was produced on a large scale (20 mg) for primary and spatial 
structure elucidation. 
Of the twenty six nisin-producing Lactococcus luctix strains tested, twelve were found to 
possess the nisA gene for the natural variant nisin A, and fourteen contained the nisZ gene 
for the variant nisin Z. The gene for a second lantibiotic from Llactis, lactacin 481, was 
identified and characterized (collaboration with J.C. Picard, INRA, Jouy-en-Josas, France). 
ad 2) 
A main goal was the structure elucidation of Intermediates in the biosynthesis of lantibiotics 
such as Pep5 (Bonn group) which were found to arise from a precursor protein consisting of 
a leader sequence followed by the pro-Pep5 part in different stages of dehydrated serine and 
threonine residues. Using sequence analysis and electrospray mass spectrometry the Tiibingen 
group could unequivocally analyse the non-modified ribosomally synthesized pre-Pep5 as well 
as all intermediates which are derived by dehydration of Ser and Thr residues. 
Furthermore the a-helical conformation of the complete natural pre-Pep5 and of all leader 
segments of prelantibiotics has been determined by circular dichroism in lipophilic solvents. 
These Findings point to a common principle of lantibiotic biosynthesis. This a-helical 
character is most likely induced by the lipophilic environment: the nisin leader peptide 
appears a random coil in aqueous solution as indicated by NMR. Its structure determination 
in alcoholic solution is planned. 
The first structural characterizations of the novel lantibiotics isolated by the Bonn group are 
presently carried out in Tubingen using sequencing and MS. Two dimensional NMR studies 
of K7 have been carried out in Nijmegen. The results show that K7 is a novel lantibiotic 
indeed: it contains two dehydroalanines, two dehydrobutyrines, two methyllanthionines and 
possibly also a lysinoalanine; this combination has not been found in any of the other known 
lantibiotics. The typical 'H NMR patterns of 31 residues were identified, most of which could 
be positioned relative to each other in the amino acid sequence. For a complete structure 
determination a complete resonance assignment is required; this can be obtained once the 
amino acid sequence has been established/confirmed by the Tubingen group. An attempt will 
be made to accomplish this also using C NMR but this will require more material. 
Analysis of the structure of purified mutant nisins and nisin degradation products by 2D 
NMR techniques is currently in progress. Initial results indicate that it is possible to exchange 
or introduce additional dehydrated amino acid residues. Activity measurements against various 
indicator strains show that mutants may have altered activity and/or selectivity, and that 
removal of the leader peptide is not a prerequisite for activity. The dehydroalanine residue 
at position 5 is found to be important for activity. Physical properties such as pH-dependence 
of solubility and chemical stability of native and mutant (pre)nisins are being analysed. 
The three dimensional structures of nisin in aqueous solution (Nijmegen), and of gallidermin 
and Pep5 in alcoholic solvents (Tubingen) have been determined by means of 2D NMR. 
Structural studies in more membrane-like environments, such as detergent micelles, are in 
progress. Although the structures appear rather flexible, some common characteristics could 
be discerned. They possess a screw-like shape, with a clearly amphiphilic character, i.e. along 
the long axis of the molecule there is one typically hydrophobic face and one less 
hydrophobic. A high dipole moment was found for gallidermin and Pep5. These findings are 
in agreement with a model in which lantibiotic molecules penetrate the lipid bilayer, a process 
which probably requires a trans membrane voltage, and aggregate to form transmembrane 
pores. 
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ad 3) 
The chemical synthesis of the leader peptide (23 amino acids) and the prolantibiotic part (34 
amino acids) of prenisin have been carried out in Tubingen. The leader peptide has been 
obtained in highly purified form and is being studied by the Nijmegen group using 2D NMR. 
The five cysteine residues containing pronisin has been purified and characterized in its 
cysteine Acm-protected form, and optimized cleavage conditions are being worked out 
presently. The syndietic peptides are analyzed by modern peptide analytic methods including 
HPLC on-line electrospray mass spectrometry, automatic Edman sequencing and cicular 
dichroism. 
The success of total synthesis of the 57 amino acids long prenisin depends largely on the 
optimized couplings of the C-terminal pronisin part. Attempts for coupling the side-chain 
protected leader part to the amine terminus of the pronisin part are being made. 
According to the workplan, chemical modifications of natural nisin are to be carried out in 
the forthcoming period. However, the Tubingen group has already prepared chromophore 
labeled substrates for the leader peptidase of prenisin. Screening for this enzyme and related 
activities are carried out by the Ede group. 
Three different systems have been developed in Ede for the expression of mutant nisin 
genes, one of which also produces nisin A in addition to mutant nisin. By site-directed 
matagenesis more than 20 different mutant (pre)nisins were produced, many of which were 
secreted. Several mutant (pre)nisins were subsequently purified in sufficient quantities for 
structural and functional analysis. Two mutants were obtained with a leader sequence still 
attached to the nisin molecule. 
ad 4). 
A 2 kb fragment covering the Pep5 structural gene {pepA) was sequenced. Two genes 
adjacent to pepA were identified. The upstream gene is necessary for producer self-protection 
("immunity") and codes for a 69 amino acid, probably membrane-associated, peptide. The 
downstream gene codes for a 285 amino acid protein, with sequence homology to serine 
proteases, which could act as a processing protease. For all genes specific mRNAs were 
detected corresponding in size to the structural genes (i.e. there is no polycistronic mRNA in 
the case of Pep5). A relevant 5kb Hind III fragment upstream of pepA was cloned into pBR 
322 and is currently being sequenced. Further, the Bonn group is constructing an expression 
system for production of mutant Pep5 in a S. epidermin 5 variant which is devoid of pED 
503. 
The Pep5 prepeptides have been isolated and characterized by ion spry MS, CD, amino acid 
analysis and sequencing. All biosynthetic intermediates (unmodified, partially and completely 
dehydrated, with and without thioethers) were found in the cytoplasmic cell fraction. This 
implies that all steps of the biosynthesis of Pep5 take place in the cytoplasm. 
Epitope prediction plots were used to synthesize two peptides from the immunity gene, and 
six peptides from the protease gene. Both immunity gene peptides and four protease peptides 
were not immunogeic in rabbits; two protease peptides raised antibodies, bot both sera did 
not stain a protein in the 32 kDa range (the expected size of the protease). Estimation of the 
amount of protease mRNA in cells suggests that the protein concentration in crude cell 
extracts may be too low to be detected in Western blots. 
Analysis of the nisin operon on transposon Tn5276 has shown that several genes are located 
directly downstream of the the structural nisin A gene. These are presently being sequenced. 
Homology analysis suggests that products of these genes may be involved in translocation of 
nisin precursor(s) across the cell membrane, and in cleavage of the leader peptide. 
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HIGHLIGHTS - Isolation of seven novel lantibiotics. 
Detection of the first lantibiotic immunity gene. 
Isolation of Pep5 propeptides in all stages of modification that 
had been postulated. 
Identification of a natural nisin variant: nisin Z. 
Overproduction of nisin by Llactis strains. 
First protein engineering of nisin, resulting in various mutants 
with altered structure and activity. 
Sequencing of genes of nisin operon. 
Synthesis and conformational characterization of all known 
leader peptides of prelantibiotics. 
3D structure determinations of nisin and Pep5. 
WIDER CONSIDERATIONS 
Excellent progress has been made in all facets towards achieving 
our original goal: understanding of the interrelations between bio-
synthesis, producer immunity, structure and function, as a basis for 
the rational design of new lantibiotics. The first novel lantibiotics 
with altered properties have been developped. 
COOPERATIVE ACTIVITIES 
- Meetings: 
Meeting during "The first international workshop on lantibiotics" in Bad Honnef (FRG) on 
April 15-18, 1991 
- Materials exchanged: 
Bonn - Tubingen: 
Bonn - Nijmegen: 
Bonn - Ede 
Ede - Tubingen: 
Tubingen - Bonn: 
Tübingen - Ede: 
Tubingen-Nijmegen: 
9 isolated lantibiotics for MS and sequencing; 10 mg of K7, 
Pep5 for 3D structure elucidation 
10 mg of K7 for NMR 
DNA sequences, purified Pep5 
nisin analogs and degradation products for MS 
synthetic immunogens for preparation of antibodies, chromo-
phor labeled substrate for processing protease of PepS 
chromophor labeled substrate for processing enzyme of 
prenisin, nisin leader peptide 
10 mg of synthetic leader peptide of prenisin 
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- Staff exchanges: 
Tübingen-Nijmegen: coworkers NMR discussion 
Tubingen-Bonn: for precursor peptide work 
Ede-Tubingen: for MS work 
Bonn-Tubingen: for structure elucidations novel lantibiotics 
Ede-Nijmegen: regular visits for NMR analysis of mutants etc. 
JOINT PUBLICATIONS 
- G. Jung and H.-G. Sahl (eds) "Nisin and novel lantibiotics" ESCOM, Leiden (1991) 
therein six joint papers: 
Freund e t al. p. 103-112 
Keliner et al. p. 141-158 
Frey et al. p. 180-188 
Sahl el al. p. 332-346 
Benz a al. p. 359-372 
De Vos el al. p. 457-463 
OTHER PUBLICATIONS 
- in: G. Jung and H.-G. Sahl (eds) "Nisin and novel lantibiolics" ESCOM, Leiden (1991) 
F.J.M. van de Ven el al., p. 35-42 
M. Reis and H.-G. Sahl, p. 320-331 
H.-G. Sahl, p. 347-358 
G. Bierbaum and H.-G. Sahl, p. 386-396 
E. Molitor and H.-G. Sahl, p. 434-439 
G. Jung, p. 1-34 
S. Freund el al, p. 91-102 
A. Beck-Sickingcr et al, p. 218-230 
O.P. Kuipers et al., p. 250-259 
P.J.G. Rauch et al., p. 243-249 
H.S. Rollema el al, p. 123-130 
- in: R. James, C Lazdunski, F. Plauus (eds) "Baclcrial plasm id-coded toxins: bacleriocins, micrococci and 
lantibiolics" Springer, Heidelberg (in press 1992) 
H.-G. Sahl "Lantibiolics, an introduction" 
H.-G. Sahl "Biosynthesis of the landbiotic Pep5 and mode of action of type 
A lantibiotics" 
S. Frcund el al. "NMR study of Pep5" 
R.N.H. Konings el al. "NMR studies of lantibiotics. The 3D structure of 
nisin" 
- G. Jung, Angew. Chem. Int. ed. Engl. 30, 1051-1192 (1991) 
- J. Hugenhollz, O.P. Kuipers. H.S. Rollcma, Vocdingsmiddclentechnologie, 21, 19-22 (1991) 
- O.P. Kuipers, H.J. Bool, W.M. de Vos, Nucl. Ac Res. .19, 4558 (1991) 
- J. W.M. Mulders, I J. Boerrigier. H.S. Rollcma, H.S. Siczen, R.J. de Vos, Eur. J. Biochem. 201, 581-584 
(1991) 
- P.J.G. Rauch, W.M. de Vos, J. Bacteriology £74, 1280-1287 (1992) 
- F.J.M. van de Ven, H.W. van den Hooven, R.N.H. Konings. C.W. Hilbcrs, Eur. J. Biochem. 202, 1181-1188 
(1991) 
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TITLE: MUTTDISCIPLINARY APPROACH TO THE 
ANALYSIS OF ENZYME CATALYSIS, PROTEIN 
STABILITY AND FOLDING 
CONTRACT NUMBER: BIOT CT91 0270 
OFFICIAL STARTING DATE: 01.06.91 
COORDINATOR: Dr. O. Misset, Gist-brocades, Delft, NL 
PARTICIPANTS: Prof. Dr. A.R. Fersht, MRS, Cambridge, GB 
Prof. Dr. S. Wodak, Universite Libre de Bruxelles, 
Brussels, B 
Prof. Dr. P.L. Mateo, University of Granada, 
Granada, ES 
OBJECTIVES SET FOR THE REPORTING PERIOD 
In the Working Programme (as attended to the Contract and the Consortium Agreement) 
it was recognized that the project objective ("Providing more understanding of the 
mechanisms related to protein stability and folding on the one hand and enzyme kinetics 
on the other hand") was a difficult one to plan and measure in quantitative terms. It was 
therefore suggested to relate the "provided understanding" to the number of mutant 
enzymes that are designed, made and tested for this purpose. 
However, the group of Fersht (Cambridge) is working already for many years on Bamase 
and has generated some SO mutants all in relation to stability and activity. 
Therefore, the number of mutants generated will not be used further to measure the 
progress made. Rather, the latter wfll be evaluated using the number of studies on the 
various mutants and wild type enzyme. 
•54-
MAJOR PROBLEMS ENCOUNTERED 
1. Project management problems 
The major problem which was encountered during the execution of the project was the fact that the "Advance Payment" by the EC was made much too late! It prohibited that the project could start efficiently. 
All together this has led to rather unbalanced activities by the four participants groups which is intended to be corrected in the coming time. 
2, Scientific problems 
The modelling activities which were going to be carried out by Wodak and Aehle were delayed since it was found that the earlier 3D­model for the complex of bamase with the penta­ribonucleotide 5'3' (ApAp­cyc 2'3'GMP­ApAp) transition state, derived using mainly manual computer graphic operations, followed by limited energy minimization procedures, displayed some unusual dihedral angle values in the nucleotide portion, probably as a result of applying specific inter­molecular distance constraints. The model was therefore rebuilt, using a systematic and automatic survey of all relevant dihedral angles of the bound nucleotide without imposing distance constraints. 
RESULTS 
The results which have been obtained in the reporting period can be divided into 3 categories. 1. Development of the research tool box. 2. Results aiming at the understanding of the mechanism of folding and stability. 3. Results aiming at the understanding of the mechanism of enzyme kinetics. 
The results will now be described accordingly. 
1. Development of the research tool box 
1.1 Structure determination (Cambridge) Apart from the various X­ray crystal structures which are already available for Bamase (in various complexes), Bycroft, in Fersht's laboratory, has succeeded in determining the solution structure of Bamase by NMR. 
1.2 Modelling tools (Brussels. Delft') * In setting up the simulations of the free energy change upon histidine de­protonation, problems concerning energy parameters (those for protonated histidines are routinely available) had to be solved. It was also necessary to investigate simulations conditons that provide adequate sampling and conver­gence. * Set­up of MD simulations of bamase in presence of 5 phosphate ions (CH,PO,pl) required incorporating the appropriate energy parameters into the BRUGEL and BIOSYM package, and providing initial positions for the phosphate ions relative to the enzyme surface. The latter task was performed on the basis of the analysis of the electrostatic potential on the enzyme accessible surface (computed in earlier studies by the Delphi program). 
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* The BIOSYM software package (Insight II and Discover) was installed on the 
new Silicon Graphics IRIS workstation of Gist-brocades and slightly modified 
for the protein modelling purposes. 
1.3 Synthesis of substrates (Cambridge') 
In order to carry out the kinetic studies on Barnase, the following substrates were 
synthesized by solid state synthesis: 
* " " a,GpApC, CpUpC, CpGpApC (completed) 
" 1 development) 
development) 
2. Results aming at the understanding of the mechanism of folding and stability 
2.1 Thermal analysis CGranada) 
The thermal stability of wild type Bamase (WT) and the T16S-mutant was 
investigated using high-sensitivity Differential Scanning Calorimetry (DSC). From 
the observation that the ratio of the calorimetric to the Van 't Hoff enthalpy was 
0.99 ± 0.02 for WT and 0.97 ± 0.02 for T16S (in the pH range 2.5 - 5.0) was 
concluded that the protein denaturation is an all-or-none, two-state transition. The 
calorimetric enthalpy values were also found to be linear functions of the denatu-
ration temperature, T, (see the figure for WT) with a^C, (= &H/ST) value of 6.2 
± 0.7 and of 6.0 ± 0.3 kJ/K.mol for WT and TS16 respectively. Since these 
values agree well with the corresponding average ACp values obtained directly from 
the individual thermograms, AH appears to depend only on T,. From the above AH 
and ACP values, entropy (AS) and Gibbs energy changes (fiG) for the unfolding of 
both proteins were obtained as a function of temperature. Extrapolation of the AG 
functions shows a maximum in stability for both proteins around 250 K. 
AH/kJ.mol"' 
676 I 
Note: Only a limited amount of work could be carried out as was explained under the 
heading MAJOR PROBLEMS ENCOUNTERED. 
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3, Results aiming at the understaning of the mechanism of enzyme kinetics 
3.1 A study on the subsite specificity of the transesterification reaction catalysed by Bamase (Cambridge) Bamase has a strong preference for guanosine immediately 5' to the phosphodies­ter bond that is broken during the transesterification reaction. Earlier studies have shown that dinucleotide monophosphates (GpN) are poor substrates for bamase relative to RNA. This led us to believe that there must be subsites on bamase. Wodak's laboratory has carried out a number of theoretical studies on bamase subsites and the present work is designed to both test this theoretical work, and also to provide empirical results which will allow the theoretical work to be extended. 
In order to analyse bamase for subsites, the following substrates were purchased (GpA, GpC, GpG, GpU, GpUp) or made by solid state synthesis (GpApA, GpApC, GpUpC, CpGpApC). The kinetics of catalysis of transesterification of these substrates by bamase was measured. Increasing the length of the dinucleotide monophosphate substrate, GpU, by one phosphate to give GpUp gave rise to a 1000 fold increase in k/K. This increase is spread unevenly between ground state and transition state binding, with a decrease of 10­fold in K„ and an increase of 100 fold in k indicating that this subsite contributes to binding of both the ground and transition state. A further increase in length to GpUpC leads to a further 20­fold increase in k /K . . In this case k is nearly doubled relative to GpUp; this increase is more than compensated for DV the 30­fold increase in k ,^. The parameter, k„/K„ approaches diffusion control for the best trimer substrate, GpApA. There appears to be no subsite 5' to the guanosine, i.e. GpApC and CpGpApC have identical kinetics of transesterification. 
In summary for substrates of type Zp0Gp,Xp,Y, where p is phosphate, X, Y and Z are nucleotides and G is guanosine: G occupies the primary specificity site. The most important subsite if for p2, followed by that for Y. There appears to be no subsite for the Z or p. positions. There are differences in base specificity at the two subsites for X ana V downstream of the scissile bond. The binding energies of different substrates have been analysed using thermodynamic cycles. These show that the contributions of the X and Y sites are non­additive. 
3.2 Modelling and analysis of the Bamase: pentanucleotide transition state model (Brussels) The amended bamase­penta­nucleotide transiton state model differs from the initial proposal in the details of the interactions made between the enzyme and the nucleotide. Dihedral angles value of the bound nucleotide, except for the cyclic 2'3' pentacovalent sugar phospate, now correspond to conformations most commonly observed in nucleotides. Salient features of the model include: interactions associated with specific guanine recognition and observed in com­plexes of homologous microbial ribnucleases are maintained. The 02' and 05' atoms of the central phosphate closely interact with the catalytic residues Glu73 and His 102 respectively. This phosphate also forms H bonds with the active site Arg83 and Arg87. The next phosphate in the 3' direction also binds close to the catalytic site of bamase forming additional H bonds with Arg83 and Arg87, thereby completely sealing these residues from water. Subsites are identified for binding the two bases following the guanidine 3' direction. They involve interacti­ons with Trp35 (+1 base) and Phe82 (+2 base). Using the detailed three dimensional picture of the bamase­transition state complex provided by our modelling study, we were then able to rationalize many of the experimental observations made in A. Fersht's laboratory on the kinetics of oligo­nucleotide catalysis in bamase (Day et al, 1992). Our model also seems to agree very well with data on changes in Nuclear Magnetic Resonance (NMR) chemical shifts measured for residues in bamase upon di­ and oligo­nucleotide binding. 
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3.3 Molecular dynamic simulation of barnase in the presence of 5 phosphate ions 
(CH,OPO)Yand water (Brussels and Delft) 
This study is carried out with the purpose of getting more -information about 
substrate recognition and binding. The structure obtained by averaging the 
structures collected during the simulation will be the basis for calculations with the 
software package Delphi. 
The simulation is presently carried out both in Delft (Discover software) and 
Brussels (Brugel software) which allows a direct comparison of the two force 
fields. The system consists in total of one bamase, five methylphosphate and 2359 
water molecules. A rectangular box of 82681 A3 (a = 48.12A, b = 35.7A, c = 
48.13A) is used for the simulation under periodic boundary conditions. It is 
performed at 300 K with constant box volume. 
3.4 Simulation of Histidine (de)protonation 
Preliminary tests determining optimal simulation conditions for convergence and 
sampling of the perturbation pathway have been completed and the final trajecto-
ries required to compute the free energy changes accompanying de-protonation of 
a histidine dipeptide unit in water and the gas phase have been generated. 
Computations of the free energy change from these trajectories are now in 
progress. Equivalent trajectories nave been generated for native barnase. 
4. Summary of research activities executed during the first reporting period 
general 
general 
stability 
stability 
kinetics 
kinetics 
kinetics 
kinetics 
enzyme/compound activities 
Bamase WT 
substrates 
Bamase WT 
Mutant T16S 
Bamase WT 
Bamase WT + 
pentanucleotide 
Bamase WT + 
phosphate 
Dihistidinepeptide 
3D-structure by NMR 
organic synthesis 
thermal analysis (DSC) 
thermal analysis (DSC) 
substrate specificity 
remodelling complex 
MD-simulation 
Simulation (de)protonation 
group 
Fersht 
Fersht 
Mateo 
Mateo 
Fersht 
Wodak 
Wodak/Aehle 
Wodak 
HIGHLIGHTS/MILESTONES 
* Solution structure of Bamase by NMR. 
* A detailed 3D model for the bamase-pentanucleotide transition state complex which is 
consistent with the experimental data on bamase catalysis and with experimental NMR 
measures has helped gain insight into the factors that govern catalysis. 
WIDER CONSIDERATIONS 
One of our aims is to extend our analysis of enzyme-nucleotide interactions, to the 
general case of protein-ligand interactions. This would require efficiently incorporating 
dynamic aspects and explicit solvent contributions. Methods to achieve this are being 
devised. 
COOPERATIVE ACTIVITIES 
The collaborative links between the groups are based on the respective tasks of each 
group in the project and can be visualised as follows: 
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BRIDGE­project Barnase 
Collaborat ive l inks 
Brussels 
Modelling + ♦ Delft | 
Modelling 
Mutation proposals 
Experimental data 
Granada 
Thermal analysis 
t 
Cambndae 
Genetica 
Purification 
Klnetics 
Folding 
NMR 
X­ray 
Mutation propoala 
17 september 1991 
The group of Fersht in Cambridge is very much involved in the protein engineering of Barnase (approximately 8­10 people) and, consequently, their contribution to the BRIDGE project targets is small compared with their own activities. Almost all off the many techniques and disciplines of the protein engineering cycle are carried out in Cambridge. Since Mateo in Granada is responsible for the thermal analysis of Barnase and its mutants, there exists a collaborative link with Fersht who supplies the protein material. The modelling group in Brussels (Wodak) and Delft (Aehle/Missef) interact intensively with respect to Molecular Dynamics Simulations of Barnase. Furthermore, there is a fruitfull collaboration and information exchange with Fersht's group concerning in particular barnase oligonuleotide catalysis. 
Project meetings 1. 05/09/91 in Delft (minutes, d.d. 18/09/91) During this first meeting of the project team, specific goals and cooperations have been set up. 2. 22 and 23/01/92 in the chemical laboratory of Cambridge (minutes, d.d. 10/02/92). During this particularly useful meeting, the wide scope of the ongoing work in Fersht s group was presented to the other BRIDGE members and extensively discus­sed. 
Visits 3. 19/11/91 W. Aehle (Delft) visited Wodak and was introduced to the Brussels group and the field of molecular modelling and MD­simulations. 4. 26/02/92 W. Aehle (Delft) brought a second visit to Wodak in which the MD­simulation work was initiated. 
Lectures 06709/91 Prof. S. Wodak gave a lecture on Molecular Modelling for the Research and Development organisation of Gist­brocades (Delft). 6. 06/09/92 Prof. P.L. Mateo gave a lecture on Differential Scanning Calorimetry for the Research and Development organisation of Gist­brocades (Delft). 
Materials exchanged * Coordinates of Barnase and Bamase:d(GpC) complex were obtained by Aehle from Fersht and Wodak respectively. * 20 mgs of Barnase and the T16S mutant were obtained by Mateo from Fersht. 
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Nothing to report. 
OTHER PUBLICATIONS/PATENTS 
1. Gordon-Beresford, R.M.H., Coulonbeau, C. and Wodak, S. (1992) Biochemistry, 
submitted for publication. 
2. Serrano, L., Bycroft, M. and Fersht, A.R., Aromatic-aromatic interactions and 
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63, 187-194 (1991). 
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bamase during folding, J. Mol. Bio. 219, 5-9 (1991). 
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Biochemistry 30 6775-6779 (1991). 
8. Sali, D., Bycroft, M. and Fersht, A.R., Surface electrostatic interactions contribute 
little to stability of bamase, J. Mol. Biol. 220, 779-788 (1991). 
9. Sancho, J., Meiering, E.M. and Fersht, A.R., Mapping transition states of protein 
unfolding by protein engineering of ligand-binding sites, J. Mol. Biol. 221, 1007-
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TITLE: 
Stability studies and protein design studies with triosephosphate 
isomerases 
CONTRACT NUMBER: 
BIOT-CT90-0182 
OFFICIAL STARTING DATE: 
0 1 / 0 1 / 1 9 9 1 
COORDINATOR: 
R.K. Wierenga, EMBL, Heidelberg, Germany 
PARTICIPANTS: 
Opperdoes. ICP, Brussels. Belgium 
Wierenga, EMBL, Heidelberg, Germany 
Martial, University of Liege, Liege, Belgium 
Hoi, University of Groningen, Groningen, The Netherlands 
Kessler, Technical University of Munich, Munich, Germany 
Renard, Eurogentec, Liege, Belgium 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
(as written in the original workplan) 
Trypanosomal TIM 
Some mutants of TIM should have been overexpressed and purified, for 
example Cys14Gly (tip of loop-1), Val46Ala, Val46Gly (tip of loop-2), 
His47Ser (tip of loop-2), Thr75Gly (tip of loop-3). These mutations will 
destabilise the dimer to varying extents. The purified mutant TIMs will 
be enzymologically characterised (ICP) and crystallisation experiments 
will be carried out with and without class-1 cyclohexapeptides (EMBL). 
Cocrystallisation experiments of wild type TIM plus the class-2 
cyclopeptides (EMBL) will have been done. 
Computer graphics analysis of the subunit-l/subunit-2 interactions 
across the interface of trypanosomal TIM. yeast TIM and chicken TIM 
will have been completed (EMBL). 
Human TIM 
Overexpression of human TIM will have been carried out (Liege). 
Crystallisation experiments will have been initiated (Groningen). The 
Glul04Asp mutation experiments, causing thermolability of human TIM 
will have been initiated. 
E. coli TIM 
Several more mutants of E. coli TIM will become available (Liege). The 
mutations will be selected such as to destabilise the dimer. The E. coli 
mutants will ha\e been enzymologically characterised (ICP). 
Crystallisation experiments will have been initiated (EMBL). 
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O c t a r e l l i n 
Model building studies for the second round of octarellin design will 
have been completed (Liege. EMBL). The mutagenesis for octarellin-2 
will be underwa. 
Psychrophilic TIM and thermophilic TIM 
Overexpression of at least one of these TIMs will have been done 
(Liege). Crystallisation experiments will have been initiated (Groningen). 
C y c l o p e p t i d e s 
Considerable amounts of class-1 and class-2 cyclopeptides will become 
available (Munich). The binding properties of these cyclopeptides to 
wild-type TIMs and mutant TIMs will have been tested (ICP). 
Cocrystallisation experiments of class-1 and class-2 cyclopeptides and 
trypanosomal TIM will have been done (EMBL). 
Loop t ransplanta t ion modelling studies 
Model building studies on the basis of the structures of trypanosomal 
TIM. chicken TIM and yeast TIM will have given some clues as to which 
kind of loop transplantation experiments should be considered 
(Groningen). 
At the end of the first year, large quantities (>100 mg) of wild type 
trypanosomal TIM. mutant trypanosomal TIM, wild type E. coli TIM, 
mutant E. coli TIM, wild type human TIM. and wild type psychrophilic 
TIM (or thermophilic TIM) should be available. Also, large quantities of 
class-1 and class-2 cyclopeptides will be available for testing. The 
enzymological tests carried out with the trypanosomal TIM mutants and 
the E. coli TIM mutants will already indicate some of the properties of 
the TIM mutants. 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report 
RESULTS: 
Due to the good collaborations (see also section "cooperative activities") 
between the various groups, significant progress has been made. Most 
of the results are still being evaluated and several papers are in 
preparation. Here we will only briefly present the most important 
efforts of the different groups. The major results are summarised in the 
next section ("highlights/milestones"). 
I . ICP (Opperdoes, Callens) 
The work concerns the kinetic studies of the cyclohexapeptides and the 
enzymological characterisation of TIM-variants. 
T. brucei TIM is more labile than its homologous counterparts from 
other organisms. This lability could be related to a number of amino-
acid substitutions in the dimer interface area. The availability of 
recombinant T. brucei TIM now allows us to test this hypothesis. As a 
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first approach, a mutation has been introduced in one of the 32 
interface residues. Histidine 47 in loop 2, which is involved in a water-
mediated hydrogen bond with aspartate 85 in helix 3, was replaced by 
an aspargine. This mutant H47N indeed turns out to be much more 
labile. The mutant enzyme has similar affinities for the substrates, but 
exhibits a lower kcat with these substrates. Activity is rapidly lost upon 
dilution, probably due to dissociation into the individual subunits. The 
subunits associate again upon concentration with regain of activity. In 
gel filtration experiments, two major protein peaks can be discerned, 
one representing the inactive monomer and the other the active dimer. 
Contrary to the native enzyme, the pH optimum of the H47N mutant is 
very narrow with an optimum at pH 7, suggesting that the dimer is only 
stable at neutral pH. 
I I . EMBL (Wierenga, Borchert, Noble, Zeelen) 
The efforts are focussed on four topics: 
1. Overexpression and mutagenesis of trypanosomal TIM; 
2. Characterisation of mutant trypanosomal TIM; 
3. Crystallographic binding studies with class II cyclohexapeptides; 
4. Crystal structure determination of E. coli TIM. 
Trypanosomal TIM can now be routinely overexpressed in E. coli and 
purified in large quantities. 
A number of TIM variants have been made in which the dimer is 
expected to be less stable. The following interface residues have been 
changed by site-directed mutagenesis: C14G (at tip of loop-1). and 
V46D, V46G. H47N (at the tip of loop 2). So far only the H47N-variant 
has been characterised to some extent in collaboration with Opperdoes 
(Brussels, Belgium). The H47N-variant is less active than the wild-type 
and the remaining activity depends on the concentration of the variant. 
The H47N-variant is also less stable, as is suggested by circular 
dichroism (CD) measurements and temperature gradient gel 
electrophoresis (TGGE) measurements. Wild-type TIM denatures 
irreversibly at a temperature near 45°C under these conditions. This 
transition temperature for the H47N-variant is approximately 33°C. The 
H47N-variant could not yet be crystallised. 
Cocrystallisation experiments with trypanosomal TIM have been carried 
out in the presence of cyclopeptides synthesised by the Kessler-group 
or by Dr. Nalis (EMBL). New crystal forms were obtained (space group is 
triclinic). These crystals diffract to 1.7A resolution, but no binding of 
cyclopeptides was observed. 
A large number of crystallisation experiments have been carried out 
with E. coli TIM. A few good crystals were obtained. Two datasets (at 
2.8A and at 2.6A of two different crystals) have been collected. The 
structure has been solved b\ molecular replacement. 
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I I I . University of Liege (Martial, Goraj , Mainfroid, 
Rent ier-Delrue, Houbrechts, Lion) 
This contribution concerns mainly: 
gene screening and cloning 
site-directed mutagenesis 
- optimisation of high level production and purification of several 
TIMs studied in the research project 
studies of de novo designed TIM-barrels 
(a) The first objective is the characterisation of a range of different 
bacterial TIMs which differ widely in stability. The TIM genes from the 
thermophil ic bacterium Bacillus stearothermophilus and the 
psychrotrophic Moraxella spp. TA137 have been determined. These 
proteins have been produced in large amounts via the T7 expression 
plasmid and have been purified. Genes encoding TIMs will be isolated 
from other extremophilic bacteria, such as the hyperthermophilic 
Thermatoga maritima eubacterial strain and specific archaebacteria as 
well as the hyperpsychrophilic Vibrio marinus. 
b) Escherichia coli TIM. Large quantities of purified overexpressed E.coli 
TIM have been used for crystallisation and the crystal structure has 
been solved at EMBL. Several mutants, in which Thr75 (interface loop 3) 
has been mutated into Val. Asp, and Trp (as suggested by Wierenga 
group), have already been produced. A "domain-directed" mutagenesis 
experiment has been done with the E. coli TIM barrel, leading to an £ . 
co / / /chicken hybrid TIM. The eighth structural motif "turn/p-
strand/turn/o-helix" was replaced by the equivalent motif present in 
chicken TIM. The hybrid enzyme was successfully produced in E. coli 
and purified. 
c) Human TIM. The cloning of the human TIM gene has been 
performed. Using the E. coli expression system based on the T7 
promoter, large quantities of soluble protein were produced. 
d) A project concerning the de novo protein design of a TIM-barrel 
protein with an 8 times repeated artificial peptide (with a "turn/p-
s t rand/ turn/a-hel ix" motif) is being continued. Concluding that the 
attempted c/P-barrel conformation in Octarellin I may be loosely 
packed, the criteria used to design Octarellin I have been reviewed and 
two new types of polypeptide sequences were designed, based on either 
an 8-fold symmetry (Octarellin II) or on a 4-fold symmetry (Octarellin 
III and IV). 
I V . University of Groningen (Hoi, Terpstra , Pijning, Mande) 
Crystallography, model building and sequence studies concerning TIM 
from human, B. stearothermophilus and Moraxella. 
The following studies were carried out: (i) using interactive computer 
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graphics techniques a model of human triosephosphate isomerase (TIM) 
was constructed using the coordinates of chicken TIM as a starting 
point, (ii) On the basis of this model suggestions were made for site­
directed mutagenesis experiments of human TIM to be carried out in 
Liege. The first set of suggestions was aimed at arriving at monomelic 
human TIMs. The second set was meant as a way to improve the 
stability of TIM by "alanizing" α­helices. (iii) Crystallization studies of 
human TIM have been initiated, so far yielding only millions of useless 
needles, (iv) Comparison of TIM barrel proteins has resulted in ideas 
about transplanting a loop from tryptophan synthase to human TIM 
since the active site of the former enzyme looked most similar to TIM 
among the ten TIM­barrel enzymes with coordinates at our disposal, (v) 
An analysis of the structure­thermostability relationship has been 
carried out for TIMs from Moraxella, and B. stearothermophilus, a 
psychrotrophic and a thermostable member of the TIM family. A joint 
paper with the Liege group on this subject is nearing completion. 
V. Technical University of Munich (Kessler, Kurz) 
The research is focussed on the design, synthesis and conformational 
analysis of cyclic hexapeptides as inhibitors for trypanosomal TIM. 
A number of cyclic hexapeptides have been synthesized and tested in 
Brussels for inhibition of trypanosomal TIM. All structures were totally 
analyzed and their conformations in solution were determined by 
modern 2D NMR spectroscopy in combination with molecular dynamic 
calculations. 
The following results have been observed so far: 
­ All peptides adopt a conformation with two (3­turns in which a D­
amino acid residue occupies the position i+1 of a pil' turn. 
­ Activity of better than 10 µ,molar inhibition of trypanosomal TIM has 
been found in several cyclic hexapeptides. In addition, these compounds 
are selective for trypanosomal TIM and do not inhibit TIM of rabbit, 
dog and E. coli as have been tested. 
­ The structural change from an oxopeptide to the thiopeptide 
cyclo(PhevF[CSNH|­Phe­Gly­Pro­Phe­Val­) results in a drastic increase in 
biological activity (IC50 = 150 µ.M vs. 6 µM). 
­ Molecular modelling studies in collaboration with Prof. K. Muller. 
Hoffman­La Roche. Basle, indicate a possible binding cleft by comparing 
the three­dimensional structure of the cyclic hexapeptides in solution 
and using the X­ray structure of trypanosomal TIM. From these studies 
new compounds were designed which have to be synthesized. 
­ A mutant of TIM (A100W) was designed to prove the binding region. 
Although the above­mentioned cleft is more or less closed, the mutant 
is still active and its activity is still inhibited by the cyclic hexapeptides. 
However, dynamic modelling via MD exhibits that a fitting is still 
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possible in the mutant which could not be foreseen with hand­sphere 
modelling (the work in this respect is still in progress). 
Peptides were synthesized for soaking and cocrystallization 
experiments . 
HIGHLIGHTS/MILESTONES: 
1 ) TIM­variants of trypanosomal TIM and E. coli TIM have been 
made and partly characterised (papers in preparation by Wierenga, 
Opperdoes (trypanosomal TIM) and Martial, Wierenga (E. coli TIM). 
2) The sequences of TIM from thermophilic B. stearothermophilus 
and psychrotrophic Moraxella spp TA137 have been determined (paper 
in preparation by Martial, Hoi et al.). 
3) The structural change from an oxopeptide to the thiopeptide 
cyclo(PheΨ [CSNHl­Phe­Gly­Pro­Phe­Val­) results in a drastic increase in 
biological activity (IC50 = 150 u.M vs. 6 u,M) (paper in press, Angewandte 
Chemie by Kessler, Opperdoes, Wierenga et al.). 
4) The crystal structure of wild type E. coli TIM has been determined 
at 2.6A resolution. Refinement is in progress (paper in preparation by 
Wierenga, Martial). 
WIDER CONSIDERATIONS: Nothing to report 
COOPERATIVE ACTIVITIES: 
Two major joint meetings have been organised so far. 
1. Liege, 25 January 1991 (host: Martial) 
2. Heidelberg­, 23 January 1992 (host: Wierenga) 
In addition, many meetings and visits between individual groups have 
taken place. Protein samples, cyclopeptide samples, sequences and 
various experimental data are exchanged regularly. 
LIST OF JOINT PUBLICATIONS / PATENTS WITH TRANS­
NATIONAL AUTHORSHIP: 
H. Kessler, H. Matter, A. Geyer, H.J. Diehl, M. Kock, G. Kurz, F.R. 
Opperdoes, M. Callens, R.K. Wierenga, Angew. Chem. 1992, in press. 
OTHER PUBLICATIONS/PATENTS: Nothing to report 
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TITLE Design and engineering of alpha-helical 
bundle proteins: modified structures and 
novel functions 
CONTRACT NUMBER BIOT-CT91-0262 (LNBE) 
OFFICIAL STARTING DATE 30 April 1991 
COORDINATOR 
PARTICIPANTS 
OBJECTIVES 
C. Sander, EMBL, Heidelberg, D 
P. Arosio, U of Milano, I 
P.J. Artymiuk, U of Sheffield, UK 
H. Blocker, GBF, Braunschweig, D 
G. Cesareni, U of Roma, I 
H.-J. Hinz, U of Miinster, D 
M. Kokkinidis, MMB, Heraklion, GR 
C. Sander, EMBL, Heidelberg, D 
The immediate goals are to understand, by a 
combination of theory and experiment, the 
structural principles of the 4-alpha-helix 
bundle proteins rop and ferritin, as a basis 
for engineering novel functions. Variations to 
be engineered in the first year included core 
and loop changes, transfer of a ferroxidase site 
and introduction of an immunogenic epitope. 
Where possible, three-dimensional structures 
were to be determined by crystallography. 
RESULTS 
Milano 
The H and L variants of human ferritins are the models for alpha-helix bundle proteins studied 
in Milano. They have 55% sequence identity, and coassemble in natural ferritins into 24-mer 
shells. H ferritin differs from L ferritin in that is has a ferroxidase site and is less stable with 
respect to chemical denaturation. The ferroxidase site is located within the bundle of H ferritin 
and can be inactivated by the substitutions Glu62->Lys + His65->Gly. 
Construction of ferroxidase site in L ferritin. 
The two ferritins have very similar 3D structure, and the construction of a ferroxidase site in L 
ferritin chain appears feasible. The mutagenesis program was planned by computer modelling 
in collaboration with our partner group in Crete. Residues involved in the H ferritin metal 
binding site were introduced into L ferritin by sequential mutageneses of Y27E +E57H 
+E60H +K62E +G65H +F137Y +E141Q +L144A. The substitution K62E abolishes the 
expression of a soluble ferritin E.coli. This problem was not overcome by the further 
substitutions or by modifications of the expression procedures. Thus, in vitro renaturation 
studies have been performed. Preliminary results indicate that: i) the insoluble variants can be 
renatured in low yield, under controlled conditions, ii) the substitutions K62E +G65H are not 
sufficient for ferroxidase activity. The study of more substituted variants is in progress. 
-67-
Ferritin denaturation / renaturation 
H ferritin is significantly less stable to denaturation than L ferritin. Two H ferritin variants with 
H to L ferritin substitutions (E62K +H65G, and C90E) have increased stability. 
Crystallographic studies in collaboration with our partners in Sheffield are aimed at identifying 
the interactions responsible for the stability differences. In addition they may clarify why Cys90 
strongly quenches Trp93 fluorescence, and why the quenching is removed by mutational or 
chemical modification of Cys90. Renaturation studies of purified H and L ferritins and variants 
have been initiated. Preliminary results (see figure Ml) indicate that: i) renaturation and 
denaturation paths are different; ii) H and L ferritins renature in similar conditions; iii) 
heteropolymers of the two chains can be produced in vitro. 
Subunit monomer 
The production of soluble and stable ferritin subunit monomers may allow NMR studies and 
easier comparson with Rop protein. Monomers that do not assemble appear to be readily 
degraded by bacteria during expression. We have substituted in H ferritin one of the residues 
responsable for dimer formation (Leu85) by Cys. When Cys85 is modified by chemical 
reaction reassembly of the chain is prevented, and the peptide remains soluble. Studies are in 
progress, in collaboration with the Sheffield's group to study the conformaiton of the peptide. 
Ferritin as an epitope carrier 
An allergenic peptide of 90 amino acids was genetically fused to the C-terminus of H ferritin. 
The construct is efficiently expressed in bacteria in a soluble form and is easy to purify. 
Preliminary data show that die chimeric product is recognized by IgE of allergic subjects. 
Roma 
Most of the work in the group has concentrated on the characterization of the loop regions of 
Rop and ferritin in order to learn how to modify them without disturbing the general 
conformation of the two molecules. 
Influence of the amino acid sequence of the ferritin D-E loop on folding. 
We have isolated and characterized a number of mutants in which the amino acid sequence of 
the peptide that connects helix D and helix E in the H chain of human ferritin has been 
randomized. Our results indicate that, although no single loop residue is absolutely required for 
ferritin to attain the native conformation, most of the mutants which we have obtained by 
random regional mutagenesis affect its folding/assembly process. Mutants that have positively 
charged residues at position 159, 160 or 161 fail to assemble into the native protein shell and 
form an insoluble aggregate. Interestingly, some loop amino acid sequences cause the E-helix 
to reverse direction and to expose its COOH terminal, normally hidden inside the protein 
cavity, to the solvent This conformation (Flop) is favoured by the absence of Gly at position 
159 and 164. 
Linking an easily selectable phenotype to the folding of a common structural 
motif: Selection of rare turn mutations that prevent the folding of Rop 
We have asked whether the Rop bend region contains any important folding information. We 
have extensively mutated three residues that form the connection between the two oc-helices of 
the Rop protein. The characterization of a collection of random mutants indicated that this 
structure is rather insensitive to amino acid substitutions and that the Rop native structure 
tolerates most amino acid types in these positions. In order to identify the rare amino acid 
sequences that would prevent Rop from folding and/or dimerizing, we have exploited the 
observation that Rop can functionally substitute the dimerization domain of the A. repressor. In 
fact, plasmids expressing a hybrid protein, formed by the amino terminal domain of the X 
repressor covalently linked to Rop, confer immunity to X infection on their hosts. We have 
shown that this property depends on the ability of the Rop moiety to fold and dimerize. The 
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analysis of approximately 1000 Rop mutants containing random amino acid sequences at 
position 30, 31 and 32 allowed us to identify 3 mutant Rop proteins that are not able to 
dimerize, probably as a consequence of their inability to fold properly. In these mutants, the 
two helices are connected by the tripeptides VED, VPD and YPD in place of the wild type 
DAD (positions 30,31 and 32). 
Engineering a highly immunogenic protein by genetic grafting of the 
interleukin 1(5 peptide VQGEESNDK onto the ferritin structure. 
The conclusions described above have taught us a small number of rules that have to be 
followed to modify the loop connecting helix D and E in ferritin without disturbing its the 
folding and assembly. This expertise allowed us to construct a number of hybrid proteins in 
which specific peptides are inserted in this region. Particularly interesting is the case of the 
oligopeptide VQGEESNDK that corresponds to an exposed region of the protein interleukin 1 
p.This oligopeptide was chosen because a group at Sclavo (Siena) had previously shown that 
the isolated peptide maintains the immunostimulatory properties of the nativeinterleukin 1 (5 
molecule. In collaboration with the group in Siena we wanted to test whether it was possible 
to increase the immunogenicity of any protein antigen by grafting the peptide onto its 
structure. We have constructed two hybrid proteins in which the VQGEESNDK peptide was 
inserted either between amino acid Prol61 and Serl62 in the D-E loop or at the carboxy-
terminus of the ferritin protein. In the first construction the oligopeptide is inserted in a region 
exposed to the solvent while the second protein segregates the inserted oligopeptide in the 
inside of the protein cage. Both hybrid peptides fold and assemble correctly into multimeric 
proteins whose structure is very similar to wild type. As predicted by the different localizations 
of the oligopeptide, the first protein is recognized, in the native form, by an antibody specific 
for the VQGEESNDK peptide, while the second is not. When the hybrid protein containing the 
peptide inserted into the loop is injected into mice, the anti-ferritin immune response is 
increased up to levels comparable to what is obtained by coinjection of wild type ferritin and 
native interleukin 1 P . No comparable results are obtained when injecting the carboxy-
terminally extended ferritin, suggesting that the immunostimulatory function of the 
oligopeptide requires its exposure to the solvent on the exterior surface of the ferritin assembly. 
Sheffield 
Engineering of crystal contacts and new ferritin structures 
Early in 1991 we published, with the groups from Milano and Roma, (Lawson et al.. Nature 
349,541-544 (1991) the account of the engineering of metal sites in human H ferritin in order 
to achieve crystallization, and the resulting discovery of the ferroxidase site in ferritin. This 
work was done under the auspices of the EC Biotechnology Action Programme. A number of 
site-directed variants have now been investigated crystallographically. In addition, we have 
recently engineered crystal contacts and solved the structure of the ferritin from Schistosoma 
mansonii. The accompanying table (figure SI) summarizes the ferritin structures and variants 
so far solved in Sheffield. 
Heraklion 
A thorough understanding of the structural principles of 4-oc-helical bundle proteins is required, 
before novel proteins which use this tertiary motif as a structural scaffold can be designed and 
engineered in a rational fashion. The investigation of the relationship between sequence, 
structure and stability by a combination of crystallographic and computational approaches is the 
goal of our part in the collaborative project The specific aims this year were: 
1) Crystallographic analysis of specifically designed ROP mutants and attempts to elucidate 
relationships between the observed changes in structure and stability. 
2) Analysis of sequence/topology relationships for the 4-rx-helix bundle motif in proteins using 
all available sequence and structural data. 
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Refinement of crystal structures of ROP cavity mutants 
A number of ROP mutants with altered hydrophobic cores are now at the final stage of 
crystallographic refinement at very high resolution. Further (non-isomorphous) mutants with 
altered loop regions are being analysed. The major results of the crystallographic analysis are: 
1) The folding of the ROP bundle is determined mainly by hydrophobic core side chain 
interactions and is relatively insensitive to point mutations in the core, or to even drastic 
changes in the loop region: the topology of the bundle and the basic features of core packing 
remain basically unaltered. 
2) The loss of stability of the ROP mutants is usually associated with an increased accessibility 
of the hydrophobic core. When a cavity is generated in the core by a mutation, the decrease of 
stability is correlated with the size of the cavity. For equally sized cavities, the loss of activity is 
correlated with the loss of packing efficiency in the core. 
Sequence/topology relationships of 4-a-helical bundle proteins 
Using sequence and structural information from seven families of 4-a-helical bundle proteins 
we derived relationships between the architecture of the 4-a-helix bundle and the sequences 
which are compatible with it Three types of analyses were carried out: 
1) Analysis in terms of amino acid distributions in the basic building unit of the 4-a-helix 
bundle, a repeat of seven residues a,b,c,d.ef,g (heptad). 
2) Analysis of the amino acid distributions along the axis of the bundle. 
3) Analysis of short loop topologies. 
The analysis of the amino acid distributions in the heptad positions yielded a highly motif-
specific pattern. The results have been incorporated in a program for the evaluation of protein 
sequences of unknown structures (Figure HI) and can be used for structure prediction. The 
axial distribution of amino acids in the bundle (Figure H2) also exhibits a characteristic and 
motif-specific pattern. The statistics from both analyses can be used in the design and 
engineering of 4-a-helical bundle proteins. The conformations of the short interconnecting 
loops in 4-a-helix bundles have been also analysed and have been found to be atypical, 
different from those of classic P-turns. The determination of specific structure/sequence 
relationships has predictive power and can be used in the rational design of proteins. 
Muenster 
Quantification of the forces responsible for protein stability and folding of 
ROP and some of its mutants. ROP is predominantly stabilized by inter-
subunit interactions. 
Differential scanning calorimetry (DSC) studies in the presence and absence of the strong 
denaturing agent guanidinium hydrochloride (GuHCl) showed that the intrahelical forces are of 
minor significance for the overall stability of the protein. The four-helix bundle structure is 
mainly stabilized by the short range van der Waals interactions resulting from optimal packing 
of the hydrophobic core residues. Both the highly cooperative, mono-exponential unfolding 
and the occurrence of hysteresis in equilibrium refolding of native ROP can be rationalized on 
the basis of the assumption that maximal intersubunit interaction must occur. This interpretation 
is corroborated by the results obtained with two cavity mutations Leu41Val and Leu^Val. In 
both mutations the exchange of leucine by the smaller residue valine leads to a decrease in 
stability indicated in the reduced Standard Gibbs free energy change (AG0). More interestingly, 
the energetic interactions reflected in the enthalpy change (AH) are drastically perturbed by this 
seemingly minor exchange. 
The present studies reveal another significant aspect of exchange strategies. The proper location 
of exchanges is of utmost importance due to the delicate balance of stabilizing and destabilizing 
forces. Cavity sizes and their relative position play a decisive role by influencing the 
interactions existing in the native state. This conclusion is illustrated by a comparison of 
unfolding isotherms of Leu1* Wal and Leu^Val mutants shown in Fig. MU1. The Leu^Val 
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mutant exhibits higher resistance to GuHCl unfolding than the Leu48Val mutant, in agreement 
with the results of the DSC studies. These findings are completely consistent with accessible 
surface area calculations by M. Kokkinidis. 
Braunschweig 
Gene planning, synthesis, expression and protein purification of redesigned 
Rop variants 
The group has improved several techniques in the protein engineering cycle of Rop protein. 
Complete gene synthesis was performed for a new topologically redesigned Rop monomer, 
using overlapping cassettes designed using the software GENMON developed by the group. 
Several Rop mutants were produced, including: 
• LmRopl (left handed topologically reconnected Rop monomer): expression in pEX70, 
improvement of direct purification by optimized FPLC protocol, reducing production time 
from three weeks to 4 days. About lOOmg of pure protein (>98%) were produced for structural 
studies 
• LmRop2 (point mutant of LmRopl): expression as fusion protein with maltose binding 
protein. Fusion construct is produced as 50-70% of total cell protein. Efficient purification on 
affinity column, followed by sequence specific protease cleavage. Production cycle reduced to 
3 days for 5-10 mg of pure protein (>98%). Total of about 15-20 mg protein has led to crystals 
suitable for crystallography. 
• DcRop (designed to bind copper): fusion constructs have led to the first purifcation in 
significant amounts of this somewhat unstable variant 
Constructs of Rop with inserted functional loops have been sequenced and protein expression 
is in progress. 
The improvements in expression and purification methods at the GBF Braunschweig were a 
crucial element in the successful solution in Heidelberg of the first crystal structure of a 
topologically reegineered protein. 
Heidelberg 
Reengineering protein topology: LmRopl and LmRop2 
Wild type Rop protein is a homodimeric four-helix bundle, both in the crystal and in solution, 
with two antiparallel helices in each subunit. In a cut-and-link protein design experiment, we 
have rearranged the topology of loops connecting the four helices. One loop was deleted, and 
two new loops and a C-terminal extension were added. The amino acid sequence in a-helical 
segments was kept, except for one point mutation. The designed LmRop gene codes for 120 
residues, almost twice the length of the wild type. The synthetic gene was overexpressed in 
E. coli and the protein purified. Interhelical distance constraints from 2-D nuclear magnetic 
resonance (NMR) spectroscopy and unit cell dimensions of crystals prove that the packing of 
the four helices of LmRop protein is the same as in the wild type protein, in spite of the loop 
rearrangements. This result is consistent with the 'core hypothesis' which asserts that the 
dominant factor determining the native protein fold is the interaction of amino acid residues in 
the structural core. The recognition that topological reconnections can be tolerated without 
affecting the core structure of a globular protein may open up new degrees of freedom in the 
design of useful proteins. Solution of the crystal structure of LmRop2, the more crystallizable 
of two variants, is in progress. 
Design of core and loop mutants of Rop dimer and monomer 
Several designs were made which (1) compensate for holes in the core of Rop (2) add 
functionally interesting loops. Synthesis and protein purification is currently in progress at the 
GBF Braunschweig. 
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Software development 
Several software tools were improved for the design of new protein variants. (1) WHATIF (G. 
Vriend), a comprehensive protein modelling and drug design system. (2) MaxSprout and 
TORSO (L.Holm) for automatic model building and model optimization. (3) MaxHora 
(R.Schneider) for more selective and improved database searches for sequence similarities 
taking into account evolutionary information. 
HIGHLIGHTS/MILESTONES 
Engineering crystal contacts: the first successful design of a metal binding site that helps 
proteins (ferritin) crystallize. The technique holds some promise of removing one of the major 
bottlenecks of protein structure determination in some cases. 
Reengineering protein topology: first successful topological reengineering of a protein 
(Rop) that goes beyond cyclic shift of chain ends. If this can be generalized, protein engineers 
have considerably more latitude in designing protein structures than previously thought. 
Ferritin as an epitope carrier: engineering of a highly immunogenic protein by genetic 
grafting of a peptide, i.e. a protein fragment, from the medically important cytokine interleukin 
1(3 onto a protein (ferritin) that assembles into higher order structures. This type of construction 
may be useful in the development of new vaccines. 
Invention of a genetic selection system for folding mutants: engineering of a hybrid 
between Rop protein and the DNA binding domain of a genetic Switch element (the A. 
repressor), such that ROP acts like the activating principle (dimerizarion domain) of the genetic 
switch. Cells that have a well folded Rop grow better than those which do not. In this way, the 
immense power of evolutionary selection is put at the disposal of the protein engineer. 
WIDER CONSIDERATIONS 
A Bridge collaborative grouping of seven European universities and research institutes has 
concentrated on developing basic protein engineering techniques. As a research vehicle they use 
a particularly simple type of protein structure that occurs many times in nature as a basic protein 
building block and is made of four cylindrical substructures. Using a variety of techniques 
ranging from genetic engineering to biochemical and physical methods and design by computer 
software, the researchers have explored several new engineering principles for protein 
molecules. New functional pieces were introduced into the natural protein frameworks. One of 
them helps the proteins form regular crystalline arrays. Another is a medically important 
activator of the immune system which can thus be repackaged in possibly useful ways in the 
attempt to develop new vaccines. A third design is an unexpected rearrangement of the 
threading of the protein chain which nonetheless spontaneously forms the correct three-
dimensional shape. A fourth design demonstrates how the immense amplification power of 
natural selection can be put at the disposal of the protein engineer a genetic switch element was 
coupled to a protein fragment such that only correctly assembled protein fragments will allow 
cells to grow, amplifying and selecting out the 'best' molecules. In this way, basic 
contributions have been made to the emerging discipline of biomolecular engineering -
engineering at a scale 100 time smaller than the smallest elements of microchips - that will have 
both medical and technological impact in the years to come. 
COOPERATIVE ACTIVITIES 
Dr Rovida from Milano visited Iraklion for an ECE course on protein modelling in September 
1991.The Milano group visited Sheffield in March 1992. Milano received plasmids from 
Roma. Milano provided protein samples and plasmids to Sheffield.Sheffield received from 
Roma cells of ferritins with an interleukin peptide inserted in the DE loop, other DE changes 
and deletions at the N and C termini. Amyra Treffry's group in Sheffield is using an expression 
system from Roam to engineer changes in the ferroxidase centre. Heraklion exchanged with 
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Roma and Regensburg/Münster purified protein, structural and sequence data. Heraklion 
exchanged with Sheffield coordinates used in the analysis of sequence/topology relationships. 
Heidelberg supplied computer models and structural redesign specifications to Braunschweig. 
Braunschweig supplied purified protein to Heidelberg. Heidelberg supplied purified protein to 
Regensburg/Muenster. All groups exchanged information and results and had an intensive 
discussion and planning meeting in Braunschweig in September of 1991. 
LIST OF SELECTED JOINT PUBLICATIONS WITH TRANS-NATIONAL 
AUTHORSHIP 
Lawson, D.M., Artymiuk, P.J., Yewdall, S.J., Livingstone, J.C., Treffry, A., Luzzago, A., 
Levi, S., Arosio, P., Cesareni, G., Thomas, CD., Shaw, W. and Harrison, P.M. (1991) 
Genetic engineering of crystal contacts leads to the structure solution of human H ferritin. 
Nature, 349:541-544. 
Wade, V.J., Levi, S., Arosio, P., Treffry, A., Harrison, P.M. and Mann, S. (1991) Influence 
of site-directed modifications on the formation of iron cores in ferritin. J. Mol. Biol. 221: 1443-
1452. 
Santambrogio, P., Levi, S., Arosio, P., Palagi, L., Vecchio, G., Lawson, D.M., Yewdall, 
S.J., Artymiuk, PJ., Harrison, P.M., Jappelli, R. and Cesareni, G. (--) Evidence that a salt 
bridge in the L chain contributes to the physical stability difference between H and L human 
ferritins. Submitted. 
Levi, S., Santambrogio, P., Cozzi, A., Rovida, E., Alvertini, A., Yewdall, S.J., Harrison, 
P.M., Arosio, P. (1992) Evidence that H and L ferritins have co-operative roles in the iron 
uptake mechanism of human ferritin. Submitted. 
Paliakasis, CD. and Kokkinidis, M. (1991). The stability of the four-α-helix bundle motif. 
Prot. Engineering 4: 849-850. 
Paliakasis, CD. and Kokkinidis, M. (1992) Sequence/topology relationships for the 4-α-helix 
bundle motif in proteins. Submitted. 
S. C. Emery, M. Sagermann, W. Eberle, W. Klaus, H. Blocker, P. Roesch, D.Tsernoglou & 
C. Sander (1992) Reengineering protein topology. Submitted. 
C.Sander and G.Vriend eds. (1992) Protein Design on Computers. Five new proteins: 
Shpilka, Grendel, Fingerclasp, Leather and Aida. Proteins 12, 105-110. 
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Figure M:Ferritin denaturation/renaturation - Milano 
Denaturanon (solid symhols) and renaturation (empty symbols) of ferritin homopolymers of L 
ferritin (rLF) H ferritin (rHF) and of the H ferritin variant Cys90->Glu (C90E). The proteins 
differ in their denaturation profiles, whole rcnaturation is similar 
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Figure BH: Crystal of topological^ reengineered LmRop2 ­ Braunschweig and 
Heidelberg 
Crystals were grown at pH 5.7. with 10% PEG4000, 50 mM NaCl. The crystal is in a drawn 
capillary to prevent slippage during data collection. Crystal symmetry is P2 with three 
molecules in the asymmetric unit. Structure solution is in progress The data set collected on 
this type of crystal is 90% complete to 2.8 A resolution and 6 0 ^ complete between 2.8 and 
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Figure C: Design of a genetic selection system for folding mutants ­ Roma 
Schematic representation of the experiment that demcastrates that ROp can functionally replao 
the C­terminus of the lambda repressor, a genetic switch element. On this basis, a selectioi 
system was constructed that rejects incorrectly folded proteins. 
Figure S: Progress of X­ray analyses of ferritin • Sheffield 
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Figure H: Statistics of the amino acid distributions along the axes of the **» 
helix bundles ­ Heraklion 
Statistics of the amino acid distributions along the axes of the 4­a­helix bundles. N­terminus region up t o the middle of the helix excluding the four N­terminal ones; C­terminal: The four C­terminal residues of the helix; C'ter­half; All residues of the C­terminus region starting from the middle of the helix excluding the four C'terminal ones. The statistics were obtained from different families of 4­a­helix bundel proteins (ROP not included). 
Figure I I D : Crystallography electron density of LmRopZ • Heidelberg 
Stereo view of preliminary electron density of one of the three LmRop2 helical bundles in the 
asymmetric unit. Residues 52­56 at one end of a helix. Map is 2f0­fc. contoured at 1.2 o, with 
data to 2.5A resolution. At the left middle density for a Tyrosine side chain is clearly visible. 
THe electron density is truncated at the right for display purposes. 
De­ and Renaturation 
of the ROP­Mutants 
Leu Val a n d Leu Vol 
with Guonidinium­Hydrochloride 
at 19°C 
­ 3 0 0 0 0 
• L V­Den»tur»llon 
O L V­Ronaturatlon 
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a L V­Renaluratlon 
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Figure MU: Comparison of unfolding Isotherms or Leu41 Vol and Leu48v al 
mutants . Münster 
TITLE: 
New ways of biotransformation in non - aqueous systems for the synthesis of 
pharmaceuticals. Application of supercritical gases, organic solvents, liquid membranes and 
microemulsions. 
CONTRACT NUMBER: BIOT - CT90 - 0176 (TSTS) 
OFFICIAL STARTING DATE: 1 / 2 / 1991 
COORDINATOR: F.N. Kolisis, National Hellenic Research Foundation, Athens, GREECE. 
PARTICIPANTS: 
F.N. Kolisis, Biosystems Technology Lab, Chem. Engineer.Dept., NTUA and 
Institute of Biological Research and Biotechnology, NHRF, Athens, GREECE. 
T. Scheper, Institut fuer Technische Chemie, Hannover Univ., Hannover, GERMANY 
A. Ballesteros, Instituto de Catalysis, CSIC, Madrid, SPAIN. 
D. Combes, Dep. de Genie Biochimique et Alimentaire, INSA, Toulouse, FRANCE 
U. Menge, Gesellschaft fur Biotechnologische Forschung mbh, Braunscweig, GERMANY 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Our objectives for the reporting period are (a) Studies on the enzymatic acylation of 
natural glycosides in organic solvents and on the behavior of enzymes given by different 
participants in microemulsions, (b) Installation of on-line analysis and comparative studies 
of various esterification reactions in aqueous systems, liquid membranes, organic solvents 
and supercritical CO2, (c) Study of native enzymes in hydrolytic and synthetic reactions of 
sugars and lipids and preparation of "new" enzymes by immobilization and chemical 
modification, (d) Study of model reactions in different solvents and screening of reactions 
and enzymes, and (e) Development of screening methods, production of raw materials and 
development of purification processes for new enzymes. 
MAJOR PROBLEMS ENCOUNTERED: 
Problems arised with the experimental setup of the supercritical C0 2 reaction unit. The 
knowledge/equipment of European industries in this area is low. 
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RESULTS: 
Lipases, oxidases and dehydrogenases, enzymes which can be useful for biotransfoi 
new media are prepared by the GBF group. At the moment the other partners can 
with lipases from two bacteria and three fungi: Staphylococcus carnosus (cloned with 
from Staphylococcus hyicus), Pseudomonas spec., Penicillium simplicissimum and notatum, 
Rhizopus arrhizus, partially purified or even in an homogeneous state. The purification of Upases 
to homogeneity suffers from their unusual strong hydrophobic interaction, which reduce the overall 
yield to 10-20%. Significant amounts of Upases are, e.g., lost using ultrafiltration necessary for final 
concentration and buffer exchange. A Geotrichum candidum Upase has been purified by ion-
exchange, hydrophobic interaction and gll filtration chromatography. 42 mg of pure Upase have 
been produced. Another Upase produced by GBF lab and distributed to the other partners was 
from Pr.niriltinm simplicisshnum. This Upase was concentrated from crude fermentation broth by 
ultrafiltration and precipitation with ammonium sulfate. The redissolved precipitated was bound to 
Phenyl Sepharose and eluted with octyI-β>D-glucopyranoside. 40 mg of pure Upase have been 
obtained with this procedure. Other methods used for the purification of this Upase was of aqueous 
two-phase system as weU as the solubilization of the enzyme with various organic additives. A third 
Upase purified was from Pseudomonas cepacia A screening for new Upases has also been started 
by GBF lab. 23 strains of bacteria, 5 from yeast and 18 from filamentous fungi showed hydrorytic 
activity. A considerably high activity of 12 units/ml was produced by filamentous fungi. Some of 
these strains have been identified and a preliminary characterization of these new presumably new 
Upases has been started. 
A number of the above mentioned Upases have been tested in synthetic reactions in microemulsions 
(Athens lab). Esterifications of various aliphatic alcohols (hexanol, cycloexanol, cholesterol, etc) 
with natural fatty acids (oleic, lauric, myristic, capryUc, butyric, etc) have been performed and 
different parameters affecting the enzyme activity were studied. Preliminary results shows that 1,3 
regio specific Upases better catalyzes the esterification of long chain fatty acids, while non-specific 
Upases can catalyze the esterification of secondary alcohols with fatty acids. Transesterification 
between ethyl butyrate and glycerol using native, chemical modified and immobilized Upase in a 
two phase system was also investigated (Madrid lab). Optimal conversion was obtained in the 
presence of 5% water. The selective hydrolysis of peracylated sucrose by several Upases in water, 
two-phases system and AOT-microemulsions has been studied by the same lab. The synthetic 
activity of Upase was further studied in supercritical C02 (Toulouse lab). The enzyme (Lypozyme 
from Mucor miehef) appears quite stable in a range of pressure from 13 to 18 MPa, showing a 
similar behavior as in n-hexane. In addition the first complete kinetic study of enzyme reaction in 
SCC02 in comparison with an organic solvent has been undertaken. This study was based on the 
determination of the kinetic constants of the reaction, related to a mechanism (Bi Bi ping pong), 
suggested by a very good correlation of calculated kinetics curves with experimental data. A 
comparative study of hydrolysis, esterification and transesterification by Upase in organic solvents 
and supercritical C0 2 was carried out (Hannover lab) in an attempt to present the best method 
for enantiomerically pure substances taking into account the advantages of the system used. Also 
a biosensor for determining enantiomeric excesses and an enantiomeric analysis via gas 
chromatography for different chiral compounds have been developed by this laboratory. 
Apart of Upases, proteases have also been tested in the non-conventional media systems. 
Esterification of various natural glycosides by subtiUsin in organic solvents have been performed 
(Athens lab). The various parameters affecting the system as weU as the reaction mechanism have 
been studied. It was found that enzymatic acylation of rutin with fatty acids in organic solvents 
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resulted in a significant change of its cytological properties. 
HIGHLIGHTS/MILESTONES: 
- Influence of surfactant nature and organic solvent hydrophobicity on lipase specificity 
- Influence of reaction phase composition (additives, cosolvents) on enantioselectivity. 
- Influence of reaction conditions (temperature, stirrer speed, reactor design) on 
productivity. 
- enantiomeric separation strategies for a GC process monitoring. 
- on-line determination of enantiomeric excesses of amino acids in different solvent systems 
with the use of an enzyme thermistor as biosensor. 
- Enzyme stability in supercritical C02. 
- Influence of water on enzyme activity. 
- Enzyme reaction mechanism in supercritical CO2. 
- Production and purification of new Upases. 
WIDER CONSIDERATIONS: 
It has been noticed that a better transfer to industrial partners is necessary . Thus, the 
participation in the COMETT-program was initiated. 
COOPERATIVE ACTIVES: 
Exchange of materials: Purified microbial lipases have been send from GBF lab to NHRF 
lab and to Hannover lab. 
Immobilized lipase has been send from SCIC lab to NHRF lab for 
studies of various esterification reactions. 
E X C H A n g e of staff:One member of Hannover lab visited GBF lab for 6 weeks for the 
purification of a microbial lipase. 
One member of Hannover lab visited NHRF lab for 2 weeks as 
assistance in the experimental set up of their supercritical CO2 
reaction unit 
Joint experiments: INSA lab with Hannover lab for the set up of the supercritical C0 2 
unit of the latter. 
Hannover lab with Prof. WA Koning (Hamburg Univ.), Prof. H.H. 
Meyer (Hannover Univ.) and Prof. F. Schubert (Berlin Univ.) for 
the developing of the analysis of chiral compounds and chiral 
biosensor. 
Hannover lab with Merck for exchange of know-how and chemicals 
(about 2000 DM). 
Joint meetings: Meeting of all partners in Athens, 25 October 1991. 
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JOINT PUBLICATIONS: 
L A. Capewell, U. Bornscheuer, T. Scheper, H.H.Meyer and F.N. Kolisis (1992). A comparison of enzymatic reactions in 
aqueous, organic and supercritical phases. Ann. N.Y. Acad. Sci. in press 
2. T. Scheper, U. Boruschetier, A. Capewell, A. Herar, H.G. Hundeck, H.HMeyer, F.N. Kolisis sad F. Schubert (1992). Studien 
zu enzymatischen reaktionen in wassrigen, organischen und uberrkritischen phasen. DECHEMA - Conference, Karlsruhe, 
1 - 3 June. 
3. T. Scheper, U. Bornscheuer, A. Capewell, A. Herar, R R Meyer, RG. Hundeck, F.N. Kolisis and F. Schubert (1992). Studies 
of enzymatic reactions in aqueous, organic and supercritical media. Fundamentals of Biocatalysis in Non-conventional media, 
Noordwijkerhout, 26-29 ApriL 
4. R Stamatis, A. Xenakis, F. N. Kolisis, R Sctajer and U. Menge (1992). Studies on the specificity of lipases catalyzed 
esterification reactions in microemulsions. Fundamentals of Biocatalysis in Non-conventional media, Noordwijkerhout, 26-29 
April 
5. Enzyme catalysis in non-conventional media. Review article by all partners under preparation. 
OTHER PUBLICATIONS: 
L T. Valis, AXenakis a t F.N. Kolisis, (1991). Comparative studies of Lipase from Rhizopus delemar in various 
microemulsion systems, Biocatalysis, in press 
Z. A. Xenakis, T. Valis and F.N. Kolisis, (1991). Microemulsions as a tool for enzymatic studies.The case of Lipase. Progr. 
Colloid Polym. Sci^Si, 508 - 511 
3. G. Kodelia and F.N. Kolisis (1992). Studies on the reaction catalysed by subtilisin for the acylation of flavonoids with fatty 
acids in organic solvents. Ana. N.Y. Acad. Sci. in press 
4. U. Bornscheuer, S. Schapohler, T. Scheper and K. Schugerl (1991). Influences of reaction conditions on the enantioselective 
transesterification using Pseudomonas cepacia lipase. Tetrahedron Asymmetry 2(10), 1011-4. 
5. U. Bornscheuer, S . Schapohler, T. Scheper, W.A. Konig and K. SchugerL Application of enantioselective capillary gas 
chromatography in lipase catalyzed transesterification reactions in organic media. J. of Chromatography, in publication 
process. 
6. MA Cruccs, C Otero, M. Bernabe, M. Martin-Lomas and A. Ballesteros (1992). Enzymatic preparation of acylaled 
sucroses. Annals N.Y. Acad. Scti., in press. 
7. M. L. Rua, T. Diaz-Maurino, C Otero and A. Ballesteros (1992). Isoenzymes of lipase from Candida cy/indracea. 
Structural studies on the carbohydrate chains. Annals NY. Acad. Scii., in press. 
8. E. Pastor, C Otero and A. Ballesteros (1992). Hidrolisis de grasas catalizada por lipasa immobilizada sobre soportes siliceos. 
Proc. XIII Simposio Iberoamericano de Catalisis, S. Mendioroso (ed), in press. 
9. FJ. Plou, C Otero and A. Ballesteros (1992). Preparacion de mejores biocatalizadores por modificacion quimica. Proc XJU 
Simposio Iberoamericano de Catalisis, S. Mendioroz (ed), in press. 
10. A. Marty, W. ChulalaksanaDUkul, R-M. Willemot and J.S. Condoret (1992). Kinetics of the lipase-calalyzed esterification 
in supercritical CO^ Biotechnoi. Bioeng., 39,  273-279. 
11. W. Chulalaksananukul, J.S. Condoret and D. Combes (1992). Kinetics of geranyl acetate synthesis by lipase catalyzed 
transesterification in n-bexane. Enzyme Microb. Teehn in press. 
12. J.S. Condoret, A. Marty and D. Combes (1991). Etude cinetique de catalyse enzymatique en fluide supercritique. Colloque 
Bioconversion et Synthese Organique, Grasse. France, 22-24 Mai 
13. D. Combes, W. Chulalaksananukul, A. Marty and J.S. Condoret (1991). Comparison of immobilized Lipases behavior in 
supercritical COj and n-hexane. RSC conference: Lipases: structure function and application in biotransformations. 
University of Warwick, Coventry, U.K.,, July 16-18. 
14. A. Many, V. Moreau, D. Combes and 3S Condoret (1991). Production en continu d'esters d'acide gras par biocatalyse dans 
du dioxyde de carbone supercritique. 2 e m e Colloque sur les Fluides Supercritiques, Paris, France, 16-17 October. 
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TITLE: 
CONTRACT NUMBER: 
OFFICIAL STARTING DATE: 
COORDINATOR: 
PARTICIPANTS: 
OBJECTIVES SET FOR 
THE REPORTING PERIOD: 
MAJOR PROBLEMS 
ENCOUNTERED: 
Characterization and surface properties of 
semi-synthetic redox enzymes for application in 
biosensor devices 
BIOT-CT91-0279 (RZJE) 
1-October 1991 (effectivily 1 January 1992) 
DipL-Ing. A.F. Buckmann, Gesellschaft fur Biotechno-
logische Forschung mbH (GBF),Braunschweig, 
Germany 
Prof. J.V. Bannister, Cranfield Institute of Technolo-
gy (CIT), Bedfordshire, England 
Dr. C van Dijk, Agrotechnological Research Institute 
(ATO), Wageningen, The Netherlands 
Dr. S.G. Mayhew, University College Dublin (UCD), 
Dublin, Ireland 
Prof. D. Cocco, University of Cagliari (UC), 
Cagliari, Italy 
Dr. J.E. Prenosil, Eidgenossische Technische Hoch-
schule Zurich (ETH), Zurich, Switzerland 
Prof. G. Gottschalk, Wiss-Trans Umwelt GmbH (WT) 
Gottingen, Germany 
Dr. J. Higgings, Cranfield Biotechnology LTD (CBL), 
Bedfordshire, England 
Dr. S. Salden, Euro Diagnostics B.V. (ED), 
Apeldoorn, The Netherlands 
Working out of a method to purify FAD analogues, 
for example, N*-(2-aminoethyl)-FAD by HPLC 
Isolation, characterization, and amino acid sequen-
cing of NADH oxidase from Thermus Aquaticus. 
Nothing to report 
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RESULTS: (GBF): From a reaction mixture partially purified 
N*-(2-aminoethyl)-FAD in mg amounts could be 
obtained. By working with a new HPLC column 
better results may be feasible. 
(CIT): A new purification procedure giving a higher 
yield for NADH oxidase has been divised.Prel-
iminary amino acid sequence of the first 8 
amino acids has been obtained. 
(UC): Confirmation that the physico-chemical 
properties are identical to the previously 
purified NADH oxidase. Effects of pH, tempera-
ture, substrate specificity and kinetic parame-
ters were all identical. 
HIGHLIGHTS/MILESTONES: Nothing to report yet 
WIDER CONSIDERATIONS: Nothing to report yet 
COOPERATIVE ACTIVITIES: Nothing to report yet 
LIST OF JOINT PUBLI- Nothing to report yet 
CATIONS/PATENTS WITH 
TRANSNATIONAL AUTHOR-
SHIP: 
OTHER PUBLICATIONS Nothing to report yet 
/PATENTS: 
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Delft, 
Oeiras, 
r. 29th, : 
, FRG 
NL 
NL 
PT 
1992 
New types of redox enzymeB for the production of chiral synthons: basic re-
search, functionalisation and application. 
Contract Number: BIOT-CT90-0157 
Official starting date: March 1st 1 991 
Coordinator: H. Günther, Org. Chemie + Biochemie, TU München, Garching, FRG 
Participants: 
H. Simon/H. Günther, Org. Chemie + Biochemie, TU München, 
W. Somers, Netherlands Organization for Applied Sci. Res., 
J.A. Duine, Delft University of Technol., Fac. Chem. Technol. 
I. Moura, Centro di Tecnologia Quimica e Biol6gica, 
Objectives set for the working period: March 1 , 1991 to Febr
1. Synthesis of commercially not available mediators 
3. Chemical stability test of new mediators 
4. Supply of new viologen dependent enzymes and/or cells 
5. Large scale production of anaerobeB 
6. Purification of viologen accepting oxidoreductases 
7. Screen for new PQQ enzymes 
8. PQQ enzyme purification 
9. PQQ modification 
10. Enzymology of PQQ holoenzymes 
II. Electroactivity tests 
13. Quantitative electrochemical measurements 
17. EPR spectroscopy 
18. NHR, EPR spectroscopy of modified PQQ enzymes 
20. NMR spectroscopy 
23. Mathematical modelling 
Major problems encountered: nothing to report 
Results: 
For the reduction of prochiral compounds to chiral synthons or the selec-
tive dehydrogenation of one chiral form of a racemic mixture in a prepara-
tive Scale, redox enzymes are useful catalysts if a low cost regeneration 
of pyridine nucleotides, if NAD(P) dependent enzymes are involved, is sim-
ply arrangeable. In a wide variety of aerobic and anaerobic microorganisms 
enzyme activities exist, which reversibly transfer electrons between arti-
ficial 1-electron mediators and pyridine nucleotides. The group in Munich 
coined for these enzymes the name VAPOR (Viologen accepting pyridine nuc-
leotide oxido £eductases). They are interesting in twice a respect: 
i) As catalysts for pyridine nucleotide regeneration and 
ii) because of mechanistic aspects, especially with the change between 1-
electron and 2-electron transfer steps. 
The group in Munich detected in crude extracts of C. thermoaceticum rather 
stable VAPORs of a specific activity between 3.5-8 U*mg-1 protein for the 
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dehydrogenation or reduction of pyridine nucleotides. No significant de-
crease of activity in the crude extracts was detectable during aerobic 
storage for 7 days at -18° C. 
The suitability of these VAPOR activities was tested with respect to pyri-
dine nucleotide regeneration and preparative formation of chiral compounds. 
Experiments performed to separate the proteins carrying VAPOR activity and 
formate dehydrogenase (-FDH)-activity resulted in indistinguishable Re-
values for VAPOR- and FDH activity on two different types of gel-electro-
phoresis. Since FDH of C. thermoaceticun was already characterised by oth-
ers, this may shed light on structure-function relationships, structures 
which accept single electrons and reduce substrates in a two electron 
transfer step. 
Three commercially not available viologens were synthesised: 
i) l,l'-2-(l,3-dioxolane-2''-yl)ethyl-4,4'-bipyridinium salt embodies 
easily available aldehyde groups in the dioxolane moiety, possibly 
useful in immobilisation experiments, 
ii) l,l'-(p-phenylBulfonato)methyl-4,4'-bipyridinium salt, neutral at phy-
siological pH in oxidised and negatively charged in reduced state. 
iii)l-CH3-l'-IHOOCOTj^O-CHj-CHj^-O-CH2CO-NH-fCHjljJ-bipyridinium salt, a 
"mono methylviologen" with a functionalised polyethylene glycol spacer. 
Three B-ketoester oxidoreductases, one from C. kluyveri and two from C. tv-
rooutyricum reducing B-ketoesters to 3-hydroxy esters were purified to ho-
mogeneity and characterised, also an enzyme from C. tyrobutyricum, which 
reduces B-keto acids. All reduce an acetoacetate moieity to [S]-3-hydroxy 
butyrates with ee-values better than 98%. The two enzymes of C. tyrobutyri-
cum reducing the esters are NAD- the other enzymes NADP dependent. 
In electrochemical cells the regeneration of NAD(P)(B) by VAPORs of C. 
thermoaceticum was demonstrated using the above mentioned B-ketoacid-, B-
ketoester oxidoreductases, isocitrate dehydrogenase or glutamate dehydroge-
nase respectively. [R]- as well as [S]-iBocitrate, [S]-glutamate and [R)-4-
chloro-3-hydroxybutyrate, a synthon for [S]-carnitin synthesis were formed 
with productivity numbers all better than 10 000 with respect to cell sus-
pensions of C. thermoaceticum. 
The Delft Enzymology group worked on the characterisation of a quinohaemo-
protein alcohol dehydrogenase (QH-EDH) from Comamonas testosteroni and fur-
ther novel alcohol- and aldehyde oxidoreductases: 
1.a) Purification of apo- and holo-QH-EDH. 
Preparations of apo-QH-EDH that appear homogeneous on native gel-electro-
phoresis, show additional bands when subjected to SDS-PAGE. Analysis of the 
polypeptides was carried out. By making use of the finding that recombina-
tion of apo-QH-EDH with PQQ leads to reduced holo-QH-EDH, separation of ac-
tive and inactive holoenzyme was possible. The purity and stability of apo-
and holo-QH-EDH obtained by different procedures was investigated. 
l.b) cloning of the gene of QH-EDH from Comamonas testosteroni. 
Partial amino acid-sequences were obtained for the 70 kD QH-EDH, as well as 
for the two major polypeptides that were found to accompany QH-EDH. Edman 
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degradation showed that the N-terminus of the major, 40 kD, polypeptide was 
identical to that of the QH-EDH. Synthetic oligo nucleotides complementary 
to the amino acid codons of the available polypeptide sequences were de-
signed as probes to locate the QH-EDH gene. To reduce the degeneracy of the 
probes, use was made of the codon-usage established for a protein from C. 
testosteroni with known nucleotide sequence. Specific hybridisation has 
been observed for two restriction fragments of the C. testosteroni chromo-
l.c) Enantioselective properties of QH-EDH. 
Investigations of the enantioselective oxidation of racemic isopropyliden-
glycerol, solketal, have been conducted. Analysis of the enantioselective 
properties of QH-EDH by novel methods, Bhowed that the selectivity is espe-
cially high (enantiomeric ratio 100) for the first step in which solketal 
is oxidised to the corresponding aldehyde. A low (enantiomeric ratio 3) and 
opposite specificity was measured for the second step, in which the alde-
hyde is oxidised to the carboxylic acid. Preliminary attempts at "cofactor 
engineering" , by recombining apo-QH-EDH with PQQ-analogues- and deriva-
tives, have shown that both the over-all activity as well as the enantiose-
lective properties of the enzyme can be changed. 
2.) Novel alcohol- and aldehyde oxidoreductases. 
Gram-positive methanol-utilisers appear to have a unique set of enzymes 
when compared to their gram-negative counterparts. Thus, Rmylolatopis meth-
anolica appears to contain: two novel types of alcohol dehydrogenase with 
bound NAD and NADP, respectively, functioning as a cofactor; a formaldehyde 
dehydrogenase and a formate ester hydrolase. 
The mechanistic aspects of these enzymes and their enantioselectivity are 
unknown. Work aimed at the complete characterisation of these enzymes is in 
progress. 
The CTQB-group has studied enoate reductase and an alcohol dehydrogenase 
from Munich and Delft, respectively. UV/visible redox titrations of enoate 
reductase do not reveal an extensive formation of a blue semiguinone (ab-
sorbance at 580 nm very low). Redox potentials obtained from the absorbance 
at 450 nm (where all cofactors contribute) are presented in Table 1. 
EPR spectra of the reduced enzyme show rhombic spectra with g-values at 
2.013, 1.943 and 1.860. These spectral features are not observable at tem-
peratures higher than 60 K. A flavin semiguinone radical is observable by 
EPR up to 100 K. EPR redox titrations were performed using dithionite or 
NADH as reductants. Samples poised at different redox potentials were ob-
served at high and low temperatures. The intensity of the rhombic signal 
was measured as well as the intensity of the radical species in function of 
redox potential. Redox potentials of the flavin are presented in Table 1. 
The EPR characteristics can not be used to unambiguously conclude the type 
of iron-sulphur clusters of the protein (1 [4Fe-4S] or 2 [2Fe-2S]). The 
spin integration value obtained by EPR suggests the presence of a [4Fe-4S] 
cluster. The unusual low g-values of the iron-sulphur centre and the posi-
tive redox potential may indicate non-sulphur coordination. 
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Table 1. 
F1ox/F18q P W F l h q [Fe"S] <*> redox pro" 
EPR-Dithionite - 190 mV - 350 mV - 180 mV cess detected 
EPR-NADH - 177 mV n.d. - 167 mV at 450 nm (con-
UV/Visible-Dithionite - 178 mV(*) tribution of all 
UV/Visible-NADH - 167 mV(*) redox centers). 
EPR spectra of apo- and holo- alcohol dehydrogenase from C. testosteroni 
obtained at low temperature showed a rhombic signal with g-values at 3.01, 
2.28 and 1.37 typical of a low-spin heme. This signal observed from both 
forms of protein indicates a conserved coordination structure when PQQ is 
bound. A small broadening is observed on the apo-form. UV/visible redox ti-
trations of apo- and holo- enzyme and the position of the Soret peak indi-
cate non identical redox potentials (Table 2). 
Table 2. 
Heme Redox Potential Soret wavelength 
oxidised reduced 
Apoenzyme + 80 mV 409.4 nm 416.0 nm 
Holoenzyme + 140 mV 408.6 nm 414.4 nm 
In H-NMR spectra of the apoform of the enzyme four heme methyl groups and 
the methyl group from the axial methionine were identified proving the heme 
c as an Met-Bis axial type coordination. 
By adding PQQ to the system (to generate the holoform) a large modification 
was observed especially in one of the heme methyl groups that felt a change 
of - 7 ppm. This, combined with the information of the shift of the Soret 
band and the difference of redox potentials in the heme, suggests that 
these two cofactors must be very close and in interaction. 
Aim of the project at TNO/Zeist is the development of a preparative elec-
trochemical cell. The bio-electrochemical conversion of glucose to gluconic 
acid by glucose oxidase was studied as a model system. Direct adsorption of 
the enzyme on carbon felts and carbon particles was achieved. Almost no bi-
ocatalytic activity was obtained when glucose oxidase was immobilised on 
porous carbon or carbon felts in phosphate buffer pH 7.0 (Table 3). 
The immobilised enzyme activity could be enhanced by the addition of glu-
cose (300 mM) to the immobilisation medium (see Table 3). On porous carbon 
the enzyme activity was retained to up to 20 U*mg-1 protein. 
Electrochemical cells with immobilised glucose oxidase were build to study 
the long term performance. Benzoquinone was used as the electron mediator. 
Typical turnover numbers of 2-3 fimol glucose*min~ *mg~ protein were 
achieved, being only 1-2% of the total enzyme activity used for immobilisa 
tion. Furthermore a fast reduction in biocatalytic activity, reflected in a 
sharp reduction of the catalytic current in the electrochemical cell, is 
found in the initial phase of the conversion. 
Another approach is now under development. Glucose oxidase is able to com-
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Table 3. Immobilisation of glucose oxidase on car-
bon carriers (ca. 20 mg enzyme/g carrier), 
type of addition of glucose Activity 
carrier during immob. (300 mM) (U/mg) 
free enzyme - 130 
carbon felt - < 2 
(carbon Lorraine) + < 2 
porous carbon - < 2 
(Norit Rox 0.8) + 15-20 
passive carbon - < 2 
+ < 2 
municate directly with an electrode via a conducting polymer. The enzyme is 
adsorbed to electrodes consisting of a platinum coated membrane on which a 
layer, consisting of polpyrrole is applied. Thus the enzyme is in direct 
communication with the electrode via the conducting polymer. An advantage 
of this system is that there is no need for a mediator in the reaction _2 medium. Experimental results show that 0.0S U*cm of enzyme activity IS 
immobilised. Calculations reveal that the specific activity of the immobi-
lised enzyme fraction is at least 10 D*mg but probably higher. At this 
moment a PQQ dependent alcohol dehydrogenase from Pseudomonas testosteroni 
is studied with respect to the immobilisation on and the communication with 
the conducting polymer matrix. 
Highlights/Milestones: 
The suitability of new redox enzymes for the enantioselective synthesis by 
enzymatically catalysed reduction or oxidation are demonstrated for a vari-
ety of compounds. One is a synthon for [S]-carnitin synthesis. Enzyme immo-
bilisation experiments for mediator free electrochemical cells are on the 
way. Mechanistic aspects of the catalysed reactions were investigated. 
Wider Considerations: 
NAD(P) dependent oxidoreductases, which represent approx. 2/3 of the known 
oxidoreductases, can be used in preparative organic synthesis only if the 
regeneration of the pyridine nucleotides can be achieved because of their 
high prices. For reductive regeneration suitable processes already exist. 
Here the practical feasability of oxidative processes are demonstrated. 
Cooperative activities: 
Meeting of the group at TUM with J. Houra on the occasion of his lecture on 
March 8 t h 1991 at Martinsried (MPI). 
Visit of I. and J. Moura and J. Caldeira at Garching April 12tn/13th 1991. 
Meeting of all groups on June 21th/22th 1991 at Garching. 
Visit of W. Somers and Mr. Eijsma from TNO in the 30 t h week at Garching. 
Visit of J. Caldeira from CTBQ in Delft from Sept. 22 t h to Sept. 25 t h. 
Supply of P. vulgaris by the group at TUM to TNO (July 1991). 
Supply of pure alcohol dehydrogenase by the group at Delft to CTQB. 
Supply of pure enoate reductase by the group at TUM to CTQB. 
Prescription for the synthesis of 4 viologens by the group at TOM to ATO. 
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TITLE: 
Enantioselective biotechnical resolution of racemic epoxides in the 
production of optically pure epoxides. 
CONTRACT NUMBER: 
BIOT-CT91-0269 (TSTS) 
OFFICIAL STARTING DATE: 
01.06.1991 
COORDINATOR: 
Prof. J.A.M. de Bont Agricult. Univ. Wageningen The Netherlands 
PARTICIPANTS: 
Dr D.J. Leak Imp. College London U.K. 
Dr M.M.R. Fonseca Inst. Sup. Teen. Lisbon Portugal 
Dr V.H.M. Elferink Andeno B.V. Venlo The Netherlands 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
A stereoselective enzyme has been discovered in a Xanthobacter species 
which resolves cheap racemic epoxide mixtures to very valuable optically 
pure epoxides to be used in subsequent industrial chemical synthesis of 
optically pure bio-active compounds. The objective of the present proposal 
is to study epoxide-degrading enzymes with an emphasis on the enzyme from 
Xanthobacter Py2. The goal of the work is to arrive at an understanding on 
basis of which the industrial partner or eventually others can decide on 
industrial application of the method. 
For the reporting period the following specific objectives were set: 
At the Agricultural University Wageningen optimization studies of Xantho-
bacter Py2 as well as screening for other epoxide-degrading organisms. 
At the Imperial College purification and study also by 13C-NMR of the 
epoxide-degrading enzyme from Xanthobacter Py2. 
At the Instituto Superior Tecnico development of analytical techniques, 
immobilization and aqueous phase work, and solvent screening. 
Andeno B.V. was to advise on analytical techniques. 
MAJOR PROBLEMS ENCOUNTERED: 
The work at Imperial College started on 01.10.1991 rather than on 
01.06.1991. For the three other partners the scheduled programme was 
followed. An alternative strategy for the Agricultural University has been 
worked out for the near future since the epoxide-degrading enzyme will 
also be studied via a molecular-genetics approach. 
RESULTS: 
Aspects 1-4 given below have been dealt with at the Agricultural Universi-
ty, aspects 1 and 3 have also been dealt with at Imperial College and 
aspects 5-7 have been completed at Instituto Superior Tecnico. 
(1) Screening programmes 
Screening programmes for the isolation of other and possibly new epoxide-
degrading organisms were set up in Wageningen and London and have now been 
completed. More than twenty organisms were isolated from water, soil and 
mud samples. Interestingly, from preliminary inspections it seemed all 
organisms contained an epoxide-degrading enzyme similar to the enzyme in 
Xanthobacter Py2. However, the screening programme set up at the Imperial 
College apart from the usual organisms also resulted in the isolation of 
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a Corynebacterium which was able to degrade cyclic epoxides. 
(2) Induction of the epoxide-degrading enzyme 
The expression of the epoxide-degrading enzyme in Xanthobacter Py2 was 
studied in chemostat culture. The organism was grown under propene-limited 
conditions and steady states were obtained at various dilution rates. The 
data obtained indicate the expression of the enzyme does not react to 
variations in growth rate. Subsequently, limitations other than propene 
will be tested. 
(3) Cell-free extracts 
The enzymology of epoxide degradation was studied in extracts of Xantho-
bacter Py2 grown on propene. It was demonstrated epoxides were degraded to 
ketones. The exact mechanism, however, remains not clear and two alterna-
tive routes were considered. Until now it has not been possible to purify 
the enzyme. It was recently observed the enzyme could be fractionated in a 
low molecular fraction and an inactive protein which, when combined, 
yielded an active epoxide-degrading preparation. This part of the work 
will be further pursued at Imperial College. 
(4) Mutants of Xanthobacter Pv2 
Initial experiments were undertaken to obtain mutants of Xanthobacter Py2 
unable to grow on epoxides. Such mutants are valuable in transformation 
experiments using a gene bank derived from the wild type Xanthobacter Py2 
in order to eventually obtain the gene encoding for the epoxidedegrading 
enzyme. 
(5) Cell growth 
Xanthobacter Py2 cells were cultivated batchwise in mineral medium (from a 
pre-inoculum grown on yeast extract and glucose) to which 0,1% v/v of 1-
pentene was added as an inducer of the epoxide degrading enzymatic system. 
Due to the low solubility of 1-pentene in the aqueous phase, two approa-
ches were used, namely to inject 1-pentene through the rubber bungs of the 
conical flasks (i) as such and (ii) dissolved in a preselected biocompati-
ble organic solvent. 
(6) Reactional system 
1,2-Epoxyhexane was chosen as a test average molecular weight substrate 
for the degradation studies because it is a commercially available 
epoxyalkane, even though the strain is only enantioselective towards the 
2,3-epoxyalkanes. However, it has been established in Wageningen that if 
cells degrade non-selectively 1,2 epoxyalkanes, they will degrade 2,3-
epoxyalkanes enantioselectively. Free cell activity was measured in 
aqueous-organic systems where the second phase was introduced to serve as 
reservoir for the epoxyalkane. Solvents used include n-hexane, n-heptane, 
n-octane, iso-octane and n-dodecane. 
Although initial rates were solvent independent the highest final 
conversions were obtained in n-dodecane. In order to check whether the 
reaction was mass transfer limited, experiments were carried out at 200 
rpm and 400 rpm. The results indicate that no liquid-liquid mass transfer 
problems exist at the lower shaking speed. 
Cell re-utilization was tested in successive degradation experiments. 
Oxygenation of the degradation medium prolongs the degrading activity of 
cells. 
No difference in cell activity could be detected in cells grown according 
to the two different protocols mentioned under (5). 
(7) Cell immobilization 
Cell immobilization was carried out during growth fin situ) and using pre-
grown cells. In the first case cells were cultivated in the presence of 
pre-formed polyurethane foam cuboids. In the second case cells were 
harvested 48h after inoculation, separated from the fermentation broth by 
centrifugation, resuspended and subsequently immobilized in k-carrageenan 
or added to polyurethane pre-polymer, so that they became entrapped in the 
resulting polyurethane foam. 
The matrix which presented the best performance was by far the pre-formed 
polyurethane foam. The specific activity of these immobilized cells was in 
fact higher by a factor of 3 than that of the free cells. This is an 
indication that the physiological state of the cell at the time of 
immobilization may play an important role in the cell degrading capacity. 
HIGHLIGHTS/MILESTONES: 
Original achievements obtained were the demonstration of epoxide-degrading 
activity in cell extracts and the observation that activity of cells 
immobilized in situ was three times as high as of cells in suspension. 
WIDER CONSIDERATIONS: 
Nothing to report. 
COOPERATIVE ACTIVITIES: 
A researcher from the Instituto Superior Tecnico, Lisbon worked during one 
month in Wageningen to get acquainted with specific aspects of Xanthobac-
ter Py2, as for instance its cultivation on the gaseous compound propene. 
A joint meeting was held on December 20 t h in Wageningen with the partici-
pation of Prof. M.M.R. Da Fonseca (Lisbon), Dr D.J. Leak (London), Dr 
V.H.M. Elferink (Venlo) , Prof.Dr J.A.M. de Bont, Drs J. Swaving, M.M.J.A.-
C.M. de Vaan and C.A.G.-M. Weijers (Wageningen). During the meeting the 
ongoing activities were evaluated and the following future research 
programme was agreed upon. 
Lisbon: 
Continuation of the ongoing activities with an emphasis on: 
- Methods to obtain higher cell densities. 
- Re-utilization of epoxide-degrading cells. 
- Immobilization techniques and optimization of the activity of immobili 
zed cells. 
London: 
- Enzyme purification (follow-up of work at Wageningen). 
- Characterization of the epoxide-degrading enzyme. 
- Purification and determination of the low molecular fraction (together 
with Wageningen). 
- 13C-NMR work. 
- Possibly extension of the work to other organisms. 
Wageningen: 
- Continuation of the work on optimization of Xanthobacter Py2 in 
chemostat culture. 
- Purification of the low molecular weight fraction (together with 
London). 
- Isolation of mutants. 
- Genetics of epoxide degradation in Xanthobacter Py2. 
LIST OF JOINT PUBLICATIONS /PATENTS WITH TRANS-NATIONAL AUTHORSHIP: 
Nothing to report. 
OTHER PUBLICATIONS /PATENTS-
Weijers, C.A.G.M. and Bont, J.A.M. de (1991). 
Enahtioselective degradation of 1,2-epoxyalkanes by Nocardia H8. 
Enzyme Microb. Technol. 13, 306-308. 
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TITLE: Glycosyltransferases from Streptomycetes as tools in 
biotransformations 
CONTRACT NUMBER: BIOT - CT90 - 0155 
OFFICIAL STARTING DATE: 01. 3. 1991 
COORDINATOR: W. Piepersberg, BUGHW FB9, Wuppertal, FRG 
PARTICIPANTS: 
(1) A. Jimenez, Universidad Autonoma, Madrid, Spain 
(2) E. Cundliffe, ULEIC, Leicester, GB 
(3) S. Grabley, B. B r a n , Hoechst AG, Frankfurt a.M., FRG 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
General goal of this project is to identify and develop 
microbial glycosyltransferases <GT) as tools for the 
modification of various aglycons via biotransformation: 
^ - - ^ • E - - 5KJ3 
O-Ph <wn>P 
■ugirprecuzMr uavaied njgir dmvuivc aglyconc glycayliud ■glyconc 
Planed for 1991: 
- cloning and identification of GT genes 
- setting-up of GT assays 
- preparation of aglycons 
MAJOR PROBLEMS ENCOUNTERED: none 
RESULTS: 
DNA p r o b e s w e r e d e s i g n e d from t h e s t r e p t o m y c i n (SM) p r o d u c t i o n 
g e n e s strDELM and H of Streptomyces griseus. The g e n e s strD 
( d T D P - g l u c o s e s y n t h a s e ) , strE (dTDP-g lucose d e h y d r a t a s e ) , strM 
( d T D P - 4 - k e t o - 6 - d e o x y g l u c o s e 3 , 5 - e p i m e r a s e ) strL (dTDP-
d i h y d r o s t r e p t o s e s y n t h a s e ) a r e by v a r i o u s e v i d e n c e i n v o l v e d i n 
t h e 4 s t e p s of d T D P - d i h y d r o s t r e p t o s e f o r m a t i o n ( D i s t l e r e t a l . 
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1987, Pissowotzki et al. 1991). By mutant phenotype strH 
seemed to code for a dihydrostreptosyltransferase (Mansouri 
and Piepersberg 1991). The probes for strD, strE, strLM and 
strH were hybridized against BamHI cleaved genomic DNA 
extracted from 43 different actinomycete strains 27 (63%) of 
which were known to produce 6-deoxyhexose (6D0H) moieties in 
at least one of their known secondary metabolites. 30 strains 
(70%; 11 were not known to produce any 6DOH compounds) gave a 
positive signal at least with one of the probes (Stockmann and 
Piepersberg 1992) . 
The gene strH also seemed to have relatives in 15 of the 
strains tested. 
More intensive genomic mapping by a combination of restriction 
and hybridization was carried out in S. purpurascens R44 
(produces cytorhodines; 6DOHs: rhodosamine, 2-deoxy-L-fucose, 
rhodinose), S. noursei DSM40635 (produces nystatin; 6DOH: 
mycosamine), and S. nodosus DSM40109 (produces amphotericin A, 
B; 6DOH: mycosamine; coordinator; Stockmann and Piepersberg 
1992) . 
In the DNA of the A201A producer S. capreolus also strDE 
hybridizing genomic segments could be mapped. The rhamnosyl-
transferase gene is currently searched for in neighborhood to 
these genes by cloning and analysis (participant l).In the 
tylosin (tyl) gene cluster of S. fradiae strD and strE -
related genes were detected and sequenced; 6DH - transferase 
gene(s) are expected to be located in the same subcluster 
(participant 2) 
To establish a dihydrostreptosyltransferase test we have 
started to establish an enzymatic preparation for the 
substrate, dTDP-dihydrostreptose. For this purpose we have 
started to express the genes strDELM in S. lividans 66 TK23. 
Till now the genes strD and strE have been cloned downstream 
the strong promotor ernE-up in S. lividans. (coordinator) . For 
the clone bearing the strE gene (pKMWE5) preliminary enzyme 
tests have shown an increased dehydratase activity 
(collaboration with A. Stein and L. Elling, Forschungszentrum 
Julich, FRG). 
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Amphotericin B, produced by S. nodosus DSM40109 and NRLL B-
2371, consists of a polyenic polyhydroxylated ring and the 6DH 
residue D-mycosamine. Since the first steps in the 6DH 
biosynthetic pathways are common, it was tried to isolate the 
genes corresponding to strD and strE by heterologous 
hybridization. 
Genomic hybridizations with total DNA from both S. nodosus 
strains cut with BairiHI showed hybridizing fragments of 2.4kb 
(strD-probe) and 2.3 + 4.4kb (strE-probe). The 2.4kb BamHI-
fragment from strain DSM40109 (hybridazing with the strD-
probe) has been cloned. Further subcloning and sequence 
analysis is in progress (participant 3). 
As an initial step for the cloning of glycosyltransferase 
genes implicated in the biosynthesis of A201A from S . 
capreolus, genes for the selfresistance has been cloned. From 
a gene library, constructed in the E. coli - Streptomyces 
shuttle cosmid pJAR4, 5 S. lividans transformants resistant to 
>1000μg A201A / ml were isolated. Comparison of restriction 
maps and successive hybridization experiments showed that the 
clones constitute three groups with apparently different 
determinants for A201A-resistance. 
The possible inactivation of A201A by cell-free extracts from 
S. capreolus was examined. No modifications by either 
phosphorylation, adenylation or acetylation was found. The 
resistance, therefore, could be due to a permeability barrier, 
ribosome modification or drug inactivation by a mechanism 
different to those already examined (participant 1). 
From S. lividans 66 TK21 a chromosomal coded macrolide 
resistance gene was cloned and shown to be a macrolide 
glycosyl transferase (mgt, Jenkins and Cundliffe 1991) . 
Further examinations concerning the specificity of the enzyme 
revealed that (i) the MGT used UDP-glucose to inactivate 
erythromycin or tylosin in vitro, (ii) the target was located 
within mycaminose, the amino sugar attached to C-5 of the 
lactone ring of tylosin, (iii) the MGT preferes a 
monosaccharide substituent at C-5, ideally lacking a 4'-0H and 
(iv) the 2'-0H group of the macrolide antibiotics is a prime 
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site for their modification and inactivation (participant 2; 
Cundliffe 1992). 
citations: 
Cundliffe E (1992) Antimicrob. Agents Chemother. 36:348-352. 
Distler J., Ebert A., Mansouri K, Pissowotzki K, Stockmann M, 
Piepersberg W (1987) Nucleic Acids Res. 15:8041-8056. 
Jenkins G, and Cundliffe E (1991) Gene 108:55-62. 
Mansouri K, Piepersberg W (1991) Mol. Gen. Genet. 228:459-469. 
Pissowotzki K, Mansouri K, Piepersberg W (1991) Mol. Gen. 
Genet 231:113-123. 
Stockmann M, Piepersberg W (1992) FEMS Microbiol. Lett. 
90:185-190. 
HIGHLIGHTS/MILESTONES: 
1. One GT and its gene was identified and characterized by 
specific assays. 
2. Many gene clusters for glycosylation of secondary 
metabolites were detected and partially characterized. 
3. First steps in enzymatic substrate preparation were 
achieved. 
4. Aglycones of the macrolide and polyene classes were 
prepared or found under natural fermentation 
endproducts. 
WIDER CONSIDERATIONS: 
The basics for developement of biotransformations via 
glycosylation of natural and synthetic aglycones have been 
founded. This will largely extend the tools in modulation 
of the specific functionality of natural pharmaceuticals. 
COOPERATIVE ACTIVITIES: 
2 meetings for all contractors: 
- 4.february 1991, Hoechst AG Frankfurt a.M., FRG. 
- 12.october 1991, Universidad Autonoma Madrid, Spain. 
During ISBA-congress 1991 in Madison, Wisconsin, USA: 
coordinator with participants 1 and 2. 
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E x c h a n g e of m a t e r i a l : s e e " r e s u l t s " ( g e n e t i c a n d 
b i o c h e m i c a l t o o l s ) 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANSNATIONAL 
AUTHORSHIP: none 
OTHER PUBLICATIONS/PATENT: 
C u n d l i f f e E ( 1 9 9 2 ) : G l y c o s y l a t i o n of m a c r o l i d e a n t i b i o t i c s i n 
e x t r a c t s o f Streptomyces lividans. A n t i m i c r o b . A g e n t s 
Chemothe r . 3 6 : 3 4 8 - 3 5 2 . 
Jenkins G, and Cundliffe E (1991) : Cloning and 
characterization of two genes from Streptomyces lividans that 
confer inducible resistance to lincomycin and macrolide 
antibiotics. Gene 108:55-62. 
Mansouri K, Piepersberg W (1991) : Genetics of streptomycin 
production in Streptomyces griseus: nucleotide sequence of 
five genes, strFGHIK, including a phosphatase gene. Mol. Gen. 
Genet. 228:459-469. 
Pissowotzki K, Mansouri K, Piepersberg W (1991) : Genetics of 
streptomycin production in Streptomyces griseus: molecular 
structure and putative function of genes strELMB2N. Mol. Gen. 
Genet. 231:113-123. 
Stockmann M, P iepe r sbe rg W (1992): Genera l ly a p p l i c a b l e gene 
p robes for t h e d e t e c t i o n of 6-deoxyhexose metabol ism in 
secondary metabol i t e -produc ing s t r ep tomyce t e s . FEMS Microbio l . 
L e t t . 90:185-190. 
German patent 41 30 967 (HOE 91/F 300) : Verfahren zur 
Isolierung von Sekundarmetabolit-Biosynthesegenen aus 
Aktinomyceten sowie deren Verwendung. 
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Title: Alternative methods of DNA-sequencing. 
Contract No: BIOT-CT90-0252 (SMA) 
Official Start Date: Feb 91 (Actual start date delayed until Dec 91) 
Coordinator: Robert J.G. Carr, CAMR, Porton Down, Wiltshire, UK 
Participants: R. Carr, CAMR, Porton Down, Wiltshire, (UK) 
C. Christiansen, Biotechnology Institute, Lyngby, Copenhagen, (DK) 
G. Charalambos, Optimum Limited, Athens, (GR) 
O. Buchardt, University of Copenhagen, Copenhagen, (DK) 
Reporting Period Objectives: 
Initial use of High Energy Electron Beam Lithography for fabrication of test sub-micron 
apertures in opaque screens. Initial design and construction of optical launch and detection 
system. Immobilisation of DN A binding proteins (e.g. DNA polymerase [ex T.aquaticus]) 
onto model substrate matrices (simulating their future use in apertures on solid substrates 
to permit monitoring of sequential addition of fluorescently labelled bases to single 
stranded DNA and hence determine sequence). (CAMR). 
Initial selection, design and construction of model DNA fragments for calibration pur-
poses for use in both subsequent non-laser based gel scanning system and in the CAMR 
aperture detection system. Selection of applicable fluorophores for coupling to different 
components of sequencing systems. (Biotechnology Institute). 
Determine specification and classification of the functional Hardware and Software 
requirements both for the new sequencing gel reader systems as well as for the near field 
aperture devices. (Optimum Ltd.) 
Major Problems Encountered: 
A change in participant structure (withdrawal of sub-contractor) has necessitated an 
alternative approach to fulfilling some of the original project aims. Accordingly, initial work 
on the development of a non-laser based gel scanner has been replaced with a comprehens-
ive feasibility study on the use of the CAMR optical aperture detection system for a method 
to enable rapid, one-step mapping of DNA (both physical and genetic mapping of large 
(lOsKb) DNA fragments). 
Results: 
CAMR and Biotechnology Institute have, during the three months since the actual start 
date of this project, determined the major design features (optical characteristics, DNA 
manipulation and labelling, electrophoretic cell design, and model test system) of the 
aperture mapping system and model systems for future study identified as an interim step 
to starting the development of the sequencing system. 
Prior to the actual start date of the project, CAMR carried out a study on the immobi-
lisation of Taq polymerase on carbohydrate and glass matrices and substrates to demon-
strate retention of enzymatic activity following immobilisation. Whilst there was evidence 
to show a small degree of activity, the low concentrations obtained were considered to be 
impractical and further attempts were abandoned. 
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Optimum Ltd. have initiated a software simulation of the expected data from the aperture 
devices in order to predict sample volumes required and analysis times necessary for 
sufficient statistical accuracy in sequencing and mapping applications. 
Highlights/Milestones: 
CAMR is now completing installation and commisioning of a complete Electron Beam 
Lithography facility for use in this project. (Facilities include thin film [thermal and spin] 
coating plants, electron beam pattern generation, plasma and chemical etching systems, 
SEM, clean room, etc.). This facility will enable the rapid and dedicated fabrication of 
sub-micron structures for use throughout this single-DNA-molecule characterisation pro-
ject. 
Wider Considerations: 
The proposed mapping application has generated a significant amount of interest from a 
major European biotechnology instrumentation manufacturer. Accordingly, they will now 
be actively supporting (both materially, with significant expertise and knowhow and at no 
cost to the participants or the EC) this aspect of the project with a view to commercially 
exploiting the proposed DNA mapping technique. 
Cooperative activities: 
Up to and during this early, but crucial, definition stage of the project, personnel from all 
the participants have met regularly. A three day meeting was held between all the partici-
pants (Optimum 1, CAMR 2, Biotechnology Institute 3, Danish sub-contractors 2) in 
Denmark [April 91]) and subsequent shorter meeting between CAMR and Biotechnology 
Institute have taken place in both the UK [Mar 92]) and Brugge [Oct 91]. 
Similarly, staff from CAMR have visited Optimum Ltd. in Athens [May 91] to define 
simulation requirements for s/w development. 
Meetings have been held (and are planned) between CAMR and Biotechnology Institute 
and the Instrumentation company on future collaborative work on mapping. 
The participants were also collectively invited to present their work at 
i) the EC meeting on Sequencing the Yeast Genomes II and XI (Brugge, Belgium - Oct 
91) and at 
ii) the EC meeting on Genome Analysis in the EC (Elounda, Crete - May 91). 
Published Work: 
Carr, R. (1991) "A possible Technique for Solution phase Sequencing of DNA", Abs. EC 
Int. Meet, on Genome Analysis in the EC, Crete, May 1991. 
Carr, R., Holmstrom, K., Buchardt, O. and Georgiou, C. (1991) 
"Alternative Methods to DNA Sequencing", Abs. EC BRIDGE Meeting on Sequencing 
the Yeast Chromosomes II and XI, Brugge Sept., 1991, p 90-91. 
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AREA:C 
CELLULAR BIOLOGY 
PHYSIOLOGY AND MOLECULAR GENETICS OF INDUSTRIAL 
MICROORGANISMS 
(from page 99 to page 135) 
BASIC BIOTECHNOLOGY OF PLANTS AND ASSOCIATED 
MICROORGANISMS 
(from page 136 to page 201) 
BIOTECHNOLOGY OF ANIMAL CELLS 
(from page 202 to page 247) 

TITLE: Integration of primary metabolism, secondary metabolism and differentiation in 
Streptomyces coelicolor. A biochemical, physiological and genetical approach 
CONTRACT NUMBER: BIOT-CT91-0255 (SMA) 
OFFICIAL STARTING DATE: 01/04/91 
COORDINATOR: D.A. Hopwood, John Innes Institute, Norwich, GB 
PARTICIPANTS: L. Dijkhuizen. University of Groningen, NL 
P. Postma, University of Amsterdam, NL 
C Hardisson and J. Salas, University of Oviedo, E 
CJ. Thompson, Institut Pasteur, Paris, F 
F. Malpartida, CS.I.C, Madrid, E 
D.A. Hodgson, University of Warwick, UK 
OBJECTIVES SET FOR THE REPORTING PERIOD: Establish unified conditions for S. coelicolor 
cultivation for physiological studies - Assay glucose metabolic enzymes in relation to growth and move 
towards cloning the genes - Measure glucose uptake in relation to growth, glucose kinase activity, glucose 
repression and stringent response - Isolate CR-relieved mutants and move towards characterising the 
mutants - Characterise and isolate adenyl cyclase - Measure enzymes of glycogen and trehalose 
metabolism in relation to growth, glucose Dux, CR and stringent response and start to purify enzymes -
Identify ribosomal proteins that change during growth and development; start to purify and partially 
sequence selected proteins - By 2D gel analysis, start to identify act proteins and effects on them of 
acrII-ORF4 over-expression, of regulatory mutations, and physiological changes (glucose flux, CR and 
stringent response) - Express actII-ORF4 (in E. coli) to isolate protein, leading to antibody production 
and analysis of in vitro activity by DNA binding, etc 
MAJOR PROBLEMS ENCOUNTERED: 
1. Choice of strains and growth conditions: Realisation that there is no strain ideal for both physiological 
and genetic studies has delayed choice of a single strain and of unified conditions for physiological work. 
Nevertheless, there is now an urgent need for unification. Towards this end, the Norwich group has 
started to compare growth and antibiotic production of M145, D132 and MT1109 and to define "minimal" 
nutritional levels needed for growth and antibiotic production. 
2. Assay of Actinorhodin; It has become clear that, in many A3(2) strains, only a minority of blue pigment 
is actinorhodin itself. Strenuous efforts are being made at the University of Bristol (TJ. Simpson) to 
identify the other pigment(s). Since they represent part of the flux of carbon into the actinorhodin 
pathway, it is imperative to be able to assay each compound. 
3. Glycogen biosynthesis: Very low activities of glycogen biosynthetic enzymes (especially absence of 
detectable glycogen synthase), and instability during purification, have limited biochemical progress. 
Meagre information about sequences of homologous enzymes from other organisms is also disappointing. 
To overcome these problems: (1) E. Migueiez (Oviedo) will visit A. Smith (Norwich), an expert on the 
plant enzymes, to modify the biochemical approach and to use antibodies against heterologous enzymes. 
(2) Mutants defective in glycogen synthesis will be obtained and characterised. (3) The availability at 
Norwich, from plant scientists, of a growing unpublished database on glycogen and starch biosynthetic 
genes is allowing the design of better oligonucleotide probes. 
RESULTS: 
1. Glucose metabolic pathways 
University of Groningen (L.V. Bystrykh, A. Alves and L. Dijkhuizen). All three prototrophic S. 
coelicolor strains checked (D132, M145 and MT1109)sporulated equally and MT1109 was chosen for the 
experiments. Initial attempts to grow it in batch flasks, and in a fermentor under steady state conditions, 
were successful, with production of blue pigment in phosphate-limited conditions. In batch flasks, a 
temporal acidification of the culture medium occurred, probably caused by accumulation of pyruvate and/or 
a-ketoglutarate. Glucose was utilized continuously and independently of growth rate (i.e. even after the 
culture entered idiophase). FPLC, HPLC and TLC were used to assay actinorhodin. TLC analysis 
revealed at least three blue pigments. This will be highly significant in future work: direct 
spectrophotometric measurements of actinorhodin production will need to be interpreted with great care. 
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Optimization of the following enzyme assays has been achieved: phosphofructokinase (PFK), 
KDPG (2-keto-3-deoxy-6-phosphogluconate) aldolase, glucose-6-phosphate dehydrogenase (NAD- and 
NADP-dependent), (vphosphogluconate dehydrogenase (NAD- and NADP-dependent), pyruvate 
dehydrogenase, pyruvate kinase (PK) and citrate synthase. No KDPG aldolase was found in cell samples 
from any stage of batch growth, yielding no evidence for the Entner-Doudoroff pathway of glucose 
utilization. The ratio of the two pentosephosphate cycle dehydrogenases, specific either to NAD or NADP 
as electron acceptor, varied greatly depending on growth conditions. 
We are focussing on the glycolytic enzymes for detailed enzymological analysis, especially in view 
of the possible accumulation of pyruvate in the medium. PFK and PK could be partially purified using 
dye-affinity chromatography. The main problem is their instability. Preliminary kinetic studies of PFK 
revealed that this enzyme is regulated in the classical way, namely inhibition by ATP, PEP, and citrate, and 
stimulation by ADP. PK also appears to be regulated at the activity level. Therefore it becomes 
increasingly unlikely that glycolysis is unregulated. Analysis of cell samples from different growth phases 
revealed that PK activity increased proportionately with growth rate, whereas pyruvate dehydrogenase was 
most active at the stage of growth limitation and pigment production. This could cause temporal 
accumulation of pyruvate in the culture medium, but gives no information about the onset of blue pigment 
formation. 
2. Glucose transport and catabolite repression 
Glucose Repression (a): John lnnes Institute (S. Angell and MJ. Bibb). Mutants of S. coelicolor A3(2) 
resistant to 2-deoxyglucose (2-DGlc) cannot use glucose (Glc), are deficient in glucose kinase (GK) 
activity, and are defective in glucose repression. A 2.9 kb DNA fragment that complements a 2-DGlc* 
deletion mutant for all four phenotypes carries two co-transcribed open reading frames for proteins of 20 
kD (ORF2) and 33 kD (ORF3), with ORF3 also transcribed separately. ORF3 alone appears to 
complement all the mutant phenotypes. It is homologous to two repressor proteins, XylR of Bacillus 
subtilis, and NagC of E. coli. Although this might suggest that ORF3 encodes an activator for GK rather 
than the enzyme itself, the ORF3 protein clearly has GK activity. Spontaneous Glc'1' derivatives of an S. 
coelicolor ORF3 deletion mutant are 2-DGlc-sensitive, presumably reflecting the activation or modification 
of another hexokinase. The "revertants" have almost wild type levels of "GK" activity, have a hexokinase 
that migrates differently from that of the wild type GK on non-denaturing gels, and appear to confer d e -
repression on agarase production. 
Glucose Repression (b): E.C. Slater Institute, University of Amsterdam (J. Kwakman and P. Postma). While 
in Norwich, J.K. isolated UV mutants of S. coelicolor M14S that formed zones of agarase activity in the 
presence of Glc Six mutants were apparently also Glc-derepressed for galactose (Gal) uptake. The 
activities of galactokinase and glycerol kinase, enzymes which are also sensitive to glucose repression, as 
well as GK, are being determined. When the mutants are characterized better, the agarase Glc-
derepressed phenorype will be complemented by a genomic bank of 5. coelicolor cloned in a CC31 
derivative (available from K.F. Chater). We are also using Tn50°<5 to isolate genes involved in Glc 
repressioa Several mutants showing Glc derepression of the agarase phenorype are being tested for the 
enzyme activities mentioned above. 
To isolate mutants defective in Glc transport and metabolism, the Tn5096 bank was screened for 
2-DGlc-resistant colonies, yielding three classes of mutants: Glc+ Gal+, Glc+ Gal" and Glc" Gal+. The 
first (and possibly the second) is interesting, since most existing Glc repression-resistant mutants are Glc" 
because of a defective GK The mutants will be characterized further with respect to Glc and 2-DGlc 
uptake, GK activity, and Glc repression-sensitive enzymes. Mutated genes will be cloned either by using 
Tn50°6 or by complementation. We shall concentrate on mutations in genes affecting several different 
(Glc-repressible) processes. 
Transcription of genes involved in antibiotic production in S. coelicolor A3 (2) and the possible role ofppGpp: 
John lnnes Institute (E. Takano, H.C. Gramajo, J. White and MJ. Bibb). Using our conditions for 
reproducible exponential growth and antibiotic production by batch cultures of S. coelicolor M145, 
transcription of structural and putative regulatory genes for actinorhodin and undecylprodigiosin synthesis 
was analysed. Although transcripts for the biosynthetic enzymes appear only at the onset of stationary 
phase, correlating with the appearance of ppGpp, those corresponding to the pathway-specific activator 
genes act II-ORF4 and redD are seen (at low levels) during exponential growth, and increase sharply during 
transition from exponential to stationary phase. Nutritional shiftdown of an exponential culture results 
in production of ppGpp, a rapid decline in GTP, an increase in the aerII-ORF4 transcript, and appearance 
of actinorhodin structural gene transcripts; addition of the GMP synthetase inhibitor decoynine, which 
produces a similar reduction in GTP and growth rate but no detectable ppGpp, does not elicit antibiotic 
100-
production. Transcription of bldA, whose product (tRNAleu/UUA) is required for translation of actII-ORF4 mRNA, occurs during exponential growth, suggesting other limitations on actinorhodin production during 
rapid growth in these conditions. Moreover, translational fusions of the N-terminus of actII-ORF4 
(containing either the wild-type TTA codon or a replacement by TTG) fused to ermE (lincomycin 
resistance) as reporter suggest no limitation in expression at the translational level in exponential liquid 
cultures, or in young agar-grown cultures. Thus, although bldA is required for expression of the act genes, 
it seems not to be responsible for the temporal regulation of expression in these conditions. 
To assess whether the correlation between ppGpp synthesis and transcription of antibiotic 
biosynthetic genes is causal we are trying to clone the ppGpp synthetase gene (relA) of S. coelicolor to 
create a null mutant. Attempts to use the E coli relA gene, and antibody raised to its product, to isolate 
the 5. coelicolor ppGpp synthetase gene have failed. We are now trying to isolate enough of the enzyme 
for N-terminal sequencing to allow a reverse genetic approach. 
Role of cAMP in the S. coelicolor A3(2) life cycle: University of Warwick (F. Amini and DA. Hodgson). S. 
coelicolor produces CAMP throughout its growth cycle, with 10% in the cells and 90% in the medium, as 
in other bacteria. cAMP levels did not vary with carbon source. Adenyl cyclase activity is present in cell-
free extracts, in contrast to the situation in enteric bacteria, in which loss of cell integrity leads to loss of 
most of the adenyl cyclase activity. The activity of the enzyme was as high in cells grown in complex 
medium as those in minimal medium and so the former have been used to study some of the properties 
of the enzyme. It prefers Mn2+ to Mg2*, but in the presence of Mg2+ is stimulated by pyruvate. It is 
present in the cytoplasmic fraction, at most only loosely bound to the membrane. The pH buffer used, 
affects enzyme activity, with PIPES having the most positive effect. We are characterizing the enzyme 
further in order to purify it as a step towards cloning the gene. We have tried cloning by complementation 
of an E coli cya~ strain, but so far without success. We shall now use as a heterologous probe the cya gene 
of Brevibacterium hquefaciens, an actinomycete with a very similar adenyl cyclase to that of S. coelicolor. 
3. Storage compound synthesis and degradation 
University of Oviedo (C. Hardisson, and E Miguelez) and John Innes Institute (K.F. Chater, CJ. 
Bruton andK.A. Plaskitt). Work has started on the enzymes of Streptomyces antibioticus, because glycogen 
is more abundant than in 5. coelicolor in liquid-grown cultures. ADP-glucose pyrophosphorylase, glycogen 
branching enzyme and glycogen phosphorylase activities were all detectable, albeit at low levels, but so far 
not glycogen synthase. 
Several probes have been designed to identify sequences specifying conserved regions of branching 
enzyme and ADP-glucose pyrophosphorylase. Cloning and sequencing of hybridising fragments has failed 
to identify relevant sequences. We have constructed a gene library of S. coelicolor J1501 in the 
bifunctional cosmid pKC505. We hybridized total S. coelicolor chromosomal DNA with two different 
probes: the gene encoding the branching enzyme of Synecoccocus; and part of the strD gene from S. griseus 
which has homology with glycogen pyrophosphorylases from several bacteria. Neither probe hybridised 
with S. coelicolor DNA under the conditions used. We have therefore tried to make a glycogen 
pyrophosphorylase probe by PCR and are characterising three candidate clones. 
When cloned glycogen genes are available, their developmental expression will be studied, 
correlating the observed pattern of glycogen accumulation in the wild-type and in suitable mutants. A 
bldA mutant showed no glycogen in hyphae near the colony surface, unlike the wild-type. The same 
deficiency has now been observed for bldC,D,G and H mutants, whereas a bldF mutant makes abundant 
glycogen. The absence of glycogen from so many bld mutants is consistent with a model implicating 
glycogen metabolism in aerial mycelium development The bldF mutant also differs from most other bid 
mutants in other respects: (1) in producing abundant undecylprodigiosin; (2) in having a bald phenotype 
on all media tested (bldA, C,D,C and H mutants can sporulate when mannitol replaces glucose as carbon 
source); and (3) in being able to express a test gene containing TTA codons (bldA, D, G and H mutants 
all lacked this ability). 
4. Regulatory cascades that lead to actinorhodin production 
Centre for Biotechnology, Madrid (F. Malpartida, R.P. Mellado and M.A. Fernandez-Moreno). 
Transcription of the actinorhodin biosynthetic genes depends on the actII-ORF4 product, a polypeptide 
of 28.7 kD, a target for the bldA tRNALeu/UUA. Our main goal is to understand the factor(s) (apart from 
the bldA product) affecting expression of o«II-ORF4, and the mechanism by which the ActII-ORF4 
protein switches on the act biosynthetic genes, including identification of its target sequences. 
S. hvidans usually fails to produce actinorhodin even when carrying the whole act cluster, including 
actII-ORF4, on a plasmid vector perhaps expression of some gene(s) in a presumptive cascade, whose final 
target is the act genes, is a limiting step in antibiotic production. We screened libraries from S. 
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aniibioticus and S. fradiae (species not known to contain act genes) for clones able to cause actinorhodin 
production in S. lividans. Both libraries yielded such clones. The sequence of one from S. aniibioticus 
shows one ORF as the actinorhodin-activating sequence. Its deduced product, a polypeptide of nearly 300 
aminoacids, contains a typical "helix-turn-helix" domain at its N-terminus: the protein is highly homologous 
to other transcriptional activators of the LysR family. Experiments are in progress to identify its possible 
target sequences within the act cluster, and to seek and analyse a homologous DNA fragment from S. 
coeiicoior. 
The ActII-ORF4 gene has been expressed in E. coli to yield 25% of total protein as ActII-ORF4; 
the expressed protein is produced as inclusion bodies, from which it can be recovered in up to 95% purity. 
Conditions for solubilizing the ActII-ORF4 protein and an "in vitro" assay for its activity are in progress. 
5. Changes in ribosome structure during development 
University of Oviedo (J. Sains). Ribosomal proteins of different stages of development on solid 
and in liquid medium were compared by 2D-PAGE and HPLC. Only one differential protein - present 
in substrate mycelium ribosomes and absent from those of aerial mycelium and sporulating cultures - has 
been clearly detected on solid medium. We are proceeding to identify this differential protein by amino 
terminal sequencing as a prelude to cloning the gene. We have also cloned the L7/L12 ribosomal protein 
gene of S. coeiicoior by screening a cosmid library with a probe corresponding to the homologous protein 
from S. antibioticus. This gene has been sequenced to determine the organisation of the cluster containing 
it and other ribosomal proteins. We are also making fusions between the gene and lacZ to allow 
purification of the hybrid protein to raise antibodies for further protein purification and analysis of 
changes in this protein during development 
6. Variations in proteins regulated by global metabolic switches. 
Instiiut Pasteur, Paris (P. Kaiser and CJ. Thompson). We have initiated studies of global changes 
in gene expression leading to antibiotic (actinorhodin) biosynthesis in S. coeiicoior J1501 using computer-
aided analyses of two-dimensional electropherograms. Various media and culture conditions were 
evaluated for well-defined and reproducible culture conditions that give uniform mycelial growth and a 
sharp boundary between vegetative growth and actinorhodin biosynthesis. A defined minimal growth 
medium (MG), and a complex production medium (SY) were chosen, with standardized shaking 
conditions, giving reproducible growth curves with a characteristic decrease in growth rate 28 h and 24 h 
post-inoculum in MG and SY media respectively. Actinorhodin production started shortly thereafter (30 
hours and 26 hours p.i. respectively). 
We have documented dramatic changes in S. coeiicoior J1501 gene expression as a function of 
growth. Since each 2D gel resolves more than 700 gene products and at least ten gels must be compared, 
critical analysis by visual inspection is impossible; however, at least 30% of the gene products are switched 
on or off as cells approach stationary phase. Preliminary data suggest that this problem is soluble by 
cluster and principal component analysis. During a six month visit, J. Vohradsky (Institute of 
Microbiology, Czechoslovak Academy of Sciences) has analysed 200 spots on six autoradiograms 
representing the growth cycle of S. coeiicoior in liquid. These spots have been grouped into families having 
similar patterns of synthesis. 
The next phase is to test the validity of the statistical methods. We are running a series of gels 
to identify heat shock proteins (with A.M. Puglia during a 1 year sabbatical visit from the University of 
Palermo), ribosomal proteins, and co-regulated genes for the actinorhodin biosynthetic pathway. This will 
show whether the statistical methods can identify spots representing gene products known, from 
independent biological studies, to be co-regulated. If the validity of these methods is thus established, we 
shall be confident in their value as tools to predict regulons and families of developmentally regulated gene 
products. 
HIGHLIGHTS/MILESTONES: Methods successfully developed for reproducible assay of key enzymes 
of glycolysis and oxidative part of pentose phosphate pathway - Evidence for regulation of PFK and PK 
at activity level - Isolation of presumptive CR" mutants - Recognition of the GK ORF - Temporal 
analysis of antibiotic gene transcripts and correlation with ppGpp - Successful analysis of adenyl cyclase 
- Isolation of heterologous genes that activate actinorhodin production - Purification of ActII-ORF4 
protein - Identification of a putative differential ribosomal protein - Cloning of the L7/L12 gene -
Recognition of families of putatively co-regulated proteins on 2D gels. 
WIDER CONSIDERATIONS: Establishment of the consortium has brought together impressive 
multidisciplinary skills in biochemistry, physiology, genetics and molecular biology. Two groups new to 
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Streptomyces - but with key experience of other bacteria - and three groups with skills in other 
streptomycetes have been integrated with three leading S. coelicolor laboratories. Progress has been made 
in most sub-objectives of the project, even though some technical problems have inevitably limited 
progress in others; the latter have been targeted for action. It is already clear that S. coelicolor will indeed 
be suitable for the multi-disciplinary approach that made it, a priori, the most suitable model antibiotic-
producing streptomycete to generate new insights into metabolic switching from primary to secondary 
metabolism. 
CO-OPERATIVE ACTIVITIES: 
1. Annual co-ordinating meeting. On the Great Burgh premises of SmithKline Beecham, by kind 
invitation of Drs Janet Dewdney and John Hodgson (18-19/6/91). All participating laboratories, two 
"associated" (non-BRIDGE-funded) teams (I S Hunter, Robertson Institute of Biotechnology, University 
of Glasgow and C P Smith, Department of Biochemistry and Manchester Biotechnology Centre, UMIST), 
and four of the seven companies who offered support to the BRIDGE programme (SmithKline Beecham 
Pharmaceuticals, Glaxo Group Research, Rhone-Poulenc Rorer Recherche-Developpement and Lepetit 
Research Center) were represented. 
2. Staff exchanges, (i) Working visits: J. Kwakman (Amsterdam): 3 months in Norwich (29.4.91-26.7.91) 
to acquire expertise in Streptomyces handling and mutagenesis; A Alves (Groningen) one week in Warwick 
to learn techniques for reproducible rapid growth of 5. coelicolor in minimal medium, (ii) Co-ordinating 
visits: L. Bystrykh and L. Dijkhuizen (Groningen) to Glasgow (11.11.91), Manchester (12-13.11.91) and 
Norwich (14-15.11.91); J. Kwakman and P. Postma (Amsterdam) to Norwich (20-21.7.91); P. Postma 
(Amsterdam) to Paris (24-25.2.92); F. Malpartida (Madrid) to Norwich (8-12.Z92); K.F. Chater (Norwich) 
to Oviedo (15-18.1.92); D A Hodgson (Warwick) to Norwich (193.91; 14.11.91; 28.2.92); D.A Hopwood 
(Norwich) to Paris (30.11.91-5.12.91). 
3. Exchange of materials Many specialised Streptomyces strains between all participating groups. Specific 
£ coli strains (glucose kinase) from Amsterdam to Norwich for mutant studies. Streptomyces ribosomal 
proteins from Oviedo to Paris for analysis. 
LIST OF JOINT PUBLICATIONS WITH TRANS-NATIONAL AUTHORSHIP": 
Parro, V., Hopwood, D-A, Malpartida, F., Mellado, R.P. 1991. Transcription of genes involved in the 
earliest steps of actinorhodin biosynthesis in Streptomyces coelicolor. Nucleic Acids Research 19, 
2623-2627. 
Fernandez-Moreno, M-A, Caballero, J.L., Hopwood, D.A, Malpartida, F. 1991. The art cluster contains 
regulatory and antibiotic export genes, direct targets for translational control by the bldA tRNA 
gene of Streptomyces. Cell 66, 769-780. 
Caballero, J.L., Malpartida, F., Hopwood, D.A 1991. Transcriptional organization and regulation of an 
antibotic export complex in the producing Streptomyces culture. Molecular and General Genetics, 
228, 372-380. 
Caballero, J.L., Martinez, E., Malpartida, F , Hopwood, D.A 1991. Organisation and functions of the 
actVA region of the actinorhodin biosynthetic gene cluster of Streptomyces coelicolor. Mol. Gen. 
Genet. 230, 401-412. 
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Global changes in gene expression related to antibiotic biosynthesis in Streptomyces hygroscopicus. 
Molecular Microbiology (In press). 
Leskiw, B K, Lawlor, E J, Fernandez-Abalos, J M, Chater, K F (1991) TTA codons in some genes prevent 
their expression in a class of developmental, antibiotic-negative Streptomyces mutants. Proceedings 
of the National Academy of Sciences, USA 88, 2461-2465. 
Strauch, E, Takano, E, Baylis, H A, Bibb, M J (1991) The stringent response in Streptomyces 
coelicolor A3(2). Molecular Microbiology 5, 289-298. 
"it is too early for papers directly stemming from the BRIDGE-funded work. These papers on prior 
studies are, however, of particular relevance to the project results. 
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OBJECTIVES FOR THE REPORTING PERIOD: 
1. Studies relating to the production of heterologous proteins in yeast. 
1 -1 . The isolation and initial characterization of the fermentation-stage-specific promoters of 
genes ESP65 and MOL2. 
1-2. Analysis of the performance of fermentation-stage-specific expression directed by the 
HSP12 promoter for the production of heterologous protein (recombinant trout growth 
hormone) in various fermenter conditions. 
2 . Studies relating to the recovery of heterologous proteins by secretion. 
2-1. Synthesis of a heterologous secretion reporter gene with optimal codon usage for 
expression in yeast, and sequence verification. 
2-2. Incorporation of the newly synthesized high-level expressing secretion reporter gene 
into a yeast vector. 
2-3. Screens for enhanced secretion mutants. 
3 . Studies relating to the recovery of heterologous proteins by cell lysis. 
3-1. Partial characterization and evaluation of biotechnological interest of thermosensitive 
autolytic mutants lyt2, slt2, and lytl. 
3-2. Cloning and/or characterization of genes complementing lytl and lytl. 
3-3. Detailed analysis of protein kinase gene SLT2, including studies on the effect of 
regulated expression. 
3-4. Further isolation of new autolytic mutants. 
3-5. Characterization of cloned exo-l,3-ß-gIucanase genes EXG1 and EXG2 and their 
encoded products. 
3-6. Cloning and initial characterization of the sporulation-induced exo-l,3-ß-glucanase 
gene. 
MAJOR PROBLEMS ENCOUNTERED: 
3-2. There were unexpected difficulties in cloning the LYT2 gene. Previous attempts to 
clone this gene led to the isolation of gene SLT2, a suppressor of lyt2 mutations that codes for 
a protein kinase. New and extensive efforts to clone LYT2 with the use of centromeric gene 
banks, led to repeated isolations of the suppressor kinase gene, but not of gene LYT2. There 
could be several explanations for this difficulty, but a new strategy is being implemented by 
obtaining a genomic library of an slt2 disrupted strain. 
RESULTS: 
1. Studies relating to the production of heterologous proteins in yeast. 
1-1. The isolation and initial characterization of the fermentation-stage-specific promoters of 
penes ESP65 and MOL2. (PAM) 
In order to isolate the two genes, ESP65 and MOL2, a library of genomic DNA from strain 
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S288c was constructed in the E.coli bacteriophage vector λEMBL3. Screening of this library 
with previously isolated cDNA clones of ESP65 and MOL2 resulted in the isolation of several 
clones for each. Previous Southern blot hybridisation analysis of genomic DNA suggested that 
both ESP65 and MOL2 are members of multigene families; there being three members for 
ESP65 and four members for M0L2. Current research is now focusing on a detailed 
characterisation of these clones in order to recover the particular DNA fragments that carry the 
genes into plasmid vectors for further analysis. 
Expression of the genes has been investigated, in conjunction with previously isolated 
genes whose promoters cause transcriptional induction at the end of rapid fermentative growth, 
as a yeast culture transitions through wholly aerobic growth and into stationary phase. 
Northern blot analysis was undertaken of RNA samples isolated during the growth of strain 
S288c on various carbon sources. These studies indicate that two genes, ESP6S and HXK1, 
are subject to strong glucose repression. Two genes (MOL1 and MOL2) are expressed 
transiently and only in molasses medium. Both of the heat shock genes, HSP12 and HSP26, 
show sustained stationary phase induction in all media and are unaffected by carbon source. 
These observations were extended by examining expression of the genes in strains 
carrying mutations in either the glucose/catabolite repression system or the cAMP control 
system. Results of these studies have confirmed Hand ESP65 to be subject to carbon 
catabolite repression but are independent of cAMP control. Interestingly HSP26 expression 
also seems to be influenced by catabolite repression, in contrast to that of HSP12 which is 
clearly independent of this regulation but is under cAMP control. 
1-2. Analysis of the performance of fermentation-stage-specific expression directed by the 
HSP12 promoter for the production of heterologous protein (recombinant trout growth 
hormone') in various fermenter conditions. (JD) 
The HSP12 promoter was fused to a tGHII cDNA devoid of its signal sequence. This 
expression cassette (containing the GAPDH terminator) was cloned into a 2(μm-based yeast-
E.coli shuttle vector pYEGTl 10, and the resulting recombinant plasmid, pYtGH6, introduced 
into yeast strains. 
The intracellular accumulation of tGHII was monitored by SDS-PAGE and Western 
blotting. In shake flasks, cells in stationary phase produced about 4 mg of tGHII per litre of 
rich medium (YPD). In batch fermentation (YPD medium), tGHII accumulation started after 
complete glucose exhaustion. The level of tGHII production was about 100 mg/1. 
The effect of heat shocks before and after glucose depletion was examined. Before 
glucose depletion, a heat shock induced a transient low level expression of tGHII. After 
glucose depletion the heat shock had no effect Pulses of glucose or heat shock given every 5 
hours had no effect on the expression by stationary phase cells. 
Different culture media were tested. No effect was seen on the production on a per cell 
basis. However, the final biomass was higher with CCSV medium. 
The possibility of HSP12 promoter induction after depletion of another essential 
substrate was examined. In a fed-batch fermentation experiment, a sucrose feeding maintained 
a very low glucose concentration in the medium. The first limiting factor was oxygen level 
(dropping to zero during the first 2 days). Oxygen level slowly increased during the next 20 h 
and then rapidly for a few hours. This fluctuating level indicates different metabolic stresses 
induced by the depletion of a substrate like amino acids, vitamins or trace elements. The level 
of tGHII did not change during this fermentation. 
2 . Studies relating to the recovery of heterologous proteins by secretion. 
2-1. Synthesis of a heterologous secretion reporter gene with optimal codon usage for 
expression in veast. and sequence verification. (CH) 
2-1. An insulin reporter was selected as the high expression level secretion reporter, as it 
could be used with a footprint-type assay for colony secretion rather than a halo assay (as, say, 
with a-amylase), enabling more colonies to be screened per plate following mutagenesis. 
Insulin also had the advantage of being small and therefore could be synthesized quickly. This 
choice has been vindicated, as the insulin reporter system has been highly successful and 
greater progress than envisaged has been achieved. 
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A DNA sequence encoding a recombinant single chain human insulin precursor was 
planned that had optimal codon usage for expression in yeast (CBI = 1.0). This was 
synthesized from overlapping oligonucleotides and cloned into pUC19. Clones were 
sequenced and one with the correct predicted sequence identified. 
2-2. Incorporation into a yeast vector, and expression level. (CH) 
The insulin precursor encoding sequence was cloned, in frame, downstream of the MFαl 
prepro leader sequence and promoter in pDP314. This was confirmed by sequencing. Insulin 
product secretion from transformed yeast was confirmed by Western blotting. Shake flask 
cultures yielded 100 mg/ml of the secreted product. This is equivalent to about 98% of all 
secreted molecules being insulin, confirming that the desired high expression level had been 
achieved. Growth rate was reduced in minimal selective medium, but not in rich medium. 
Plasmid stability (both selective and non-selective) and cell viability were unaffected. Thus, a 
non-toxic, mild effect of the high expression level was detected. 
2-3. Screens for enhanced secretion mutants 
2-3.1 With low-level expressing reporters (CH): Using wheat a-amylase (CBI = 0.23) as 
a secretion reporter, mutants showing 25-30% greater secreted product were obtained. There 
appeared to be only a very limited bottleneck to the secretion of this product. 
Using Aspergillus niger glucoamylase (CBI = 3.1) very little secreted product could be 
detected, despite a similar expression vector construction to the a-amylase and a more 
favourable codon bias index. Following mutagenesis, mutants were isolated that provided 1.5-
to 5-fold increase in secreted product. These would seem to define a bottleneck to the secretion 
of this product. 
2-3.2 With the high-level expressing reporter (CH): The "footprint" secretion assay 
enabled the isolation of a number of mutants that secrete up to 20-fold more insulin. The MFαl 
promoter is regulated according to the cell cycle, and an increase of 2-fold or so more may 
result from loss of this regulation. The higher levels of secretion suggest the overcoming of a 
secretory bottleneck. The isolation of mutants with this reporter is considerably in advance of 
schedule. 
2-3.3 Enhanced secretion from industrial strains (WEL): Mutants have been obtained that 
give enhanced secretion of glucoamylases from brewing strains. Due to the polyploid nature of 
the strains, these mutations are thought likely to be dominant characters. 
2-3.4 Screens for mutants showing: ability to release periplasmically localized secretory 
proteins I improved secretion at higher growth temperatures (CH): Use of the unmodified 
acid phosphatase gene as a periplasmic reporter protein has not proved satisfactory. We have 
therefore constructed an MFαllPHOS fusion as a more effective reporter. 
Investigation of the effect of temperature on growth and secretion revealed that growth, 
rather than secretion per se, was diminished as culture temperature was increase. Screens for 
mutants showing increased temperature tolerance have not yet been attempted. 
3 . Studies relating to the recovery of heterologous proteins by cell lysis. 
3-1. Partial characterization and evaluation of biotechnological interest of thermosensitive 
autolytic mutants lvt2. slt2. and Ivtl. (CN) 
Strains with lyt2 or slt2 mutations lysed when actively growing cultures were switched from 
24°C to 37°C; this lysis being prevented by osmotic stabilization with sorbitol, suggesting that 
it is due to a cell wall alteration. Batch fermenter cultures, carried out with a very precise 
control of temperature and other environmental factors, led to an expression of the mutant 
phenotype that could be clearly followed for about 5-6 hours and determined an intense release 
of protein with a decrease in viability of the cells. This information was used to develop a "two-
stage" continuous culture system, which involved the continuous feeding of first stage cells, 
grown at 24°C, to a second stage at 37°C. This two-stage system provided a continuous flow 
of a cell population with more than 50% of the cells lysed and a significant release of protein 
occurring. 
lytl mutations determined cell wall autolysis that was not prevented by sorbitol. 
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indicating that the defect was not mainly a cell wall alteration. The mutation was efficiently 
expressed in fermenter cultures, but the pattern of protein release was significantly different 
from those determined by lyt2 and slt2. 
3-2. Cloning and/or characterization of genes complementing Ivtl and lyt2. (CN) 
Clones "complementing" these mutations tend to be suppressors rather than the wild-type 
genes. A strategy to get round this problem has been described above (MAJOR PROBLEMS 
ENCOUNTERED). A suppressor gene for lyt2 (SLT2) has been isolated and analysis is 
described below. In addition, a suppressor gene for lytl has also been isolated. The clone 
carries the SPO12 gene, described as being critical for meiotic functions. It is interesting that 
suppression of lytl took place with SP012 in a multicopy plasmid, which led to expression of 
the gene during the mitotic cycle, whereas it is normally expressed only during meiosis. 
3-3. Detailed analysis of protein kinase gene SLT2. including studies on the effect of 
regulated expression. (CN) 
Site-directed mutagenesis of SLT2, to change lysine at position 37 (the putative active centre), 
abolished the function of the gene. The gene was not only critical for cell growth - disruption 
determining autolysis - but a critical regulation was also necessary. Over-expression of SLT2, 
under the control of a regulated promoter (GALIO), or inhibition of expression by anti-
messenger plasmid constructions, led to a loss in cell viability due to cell lysis. The usefulness 
of these observations for the purpose of controlling cell lysis is very clear. 
3-4. Further isolation of new autolytic mutants. (CN) 
The complexity of functions related to cell wall dynamics, which can effect secretion and 
release of proteins from yeast, has led to the requirement for isolating and characterizing new 
autolytic mutants. Special attention was paid to those mutants showing an autolytic phenotype 
that can be complemented by osmotic stabilization with sorbitol. Temperature-sensitive 
recessive mutations representative of 3 other complementation groups have been isolated, plus 
a new group of thermosensitive dominant mutations. The phenotypes observed so far are 
highly suggestive of interesting alterations in cell wall dynamics. 
3-5. Characterization of cloned exo-1.3-B-glucanase genes EXG1 and EXG2 and their 
encoded products. (PR) 
Comparison of the predicted amino acid sequences of the EXG1 and EXG2 products revealed 
5 highly conserved regions, which are located in the same relative positions in both 
polypeptides and may be essential for β-glucanase function. Removal of the histidine residues 
at one of these regions (DHHHY) abolishes β-glucanase activity. The effect of different single 
substitutions is currently being investigated. 
EXG1 has been mapped to chromosome XII, 6.1 cM centromere-proximal to CDC25. 
EXG2 is located in chromosome IV, between LYS4 and GCN2, at distances of 6.2 and 4.9 
cM, respectively. 
Regarding the processing of the primary product synthesized from EXG1, site directed 
mutagenesis was carried out to modify the putative KEX2-protease recognition site in order to 
define the extent of the signal peptide at the amino-terminus of the precursor protein. This 
would facilitate the design of different constructions in order to investigate the role of the signal 
sequence, pro-sequence and protease cleavage site in promoting efficient secretion of the exo-
1,3-fβ-glucanasc and, eventually, to direct the export of heterologous proteins. 
3-6. Cloning and initial characterization of the sporulation-induced exo-l.3-β-glucana.se 
gene. SSG1. (PR) 
Molecular cloning of SSG1 was achieved by screening a genomic library with a DNA probe 
obtained by PCR amplification, using synthetic oligos designed according to predicted 
nucleotide sequence. The nucleotide sequence of SSGl shows a 1335 bp open reading frame, 
encoding a 445 amino acid polypeptide of 51790 Da, with one potential N-glycosylation site. 
Northern analysis showed a single transcript of 1.7 kb, which is only present in sporulating 
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diploids (a/α), and does not appear in haploid cells or non-sporulating diploids (a/a) when 
incubated under sporulating conditions. The meiotic time course of SSG1 induction indicates a 
temporal pattern of expression that resembles the "late" class of sporulation-specific transcripts, 
appearing at about 6 hours after transfer to nitrogen-deficient medium, when meiosis I has been 
completed. Homozygous diploids are able to complete sporulation, although with a significant 
delay in appearance of mature asci. 
SSGI has been mapped to the right arm of chromosome XV, 8.2 cM to the centromere-
proximal side of HIS3. 
HIGHLIGHTS / MILESTONES: 
(a). The excellent performance of the HSP12 promoter in producing high yields of a biotech 
product, recombinant trout growth hormone. 
(b). The successful isolation of new mutant yeast strains showing enhanced levels of 
heterologous protein secretion. These are of biotechnological significance as they increase 
product yield by many fold, and, in addition, genetically mark bottlenecks in the expression / 
secretion process. 
(c). The possibility of controlling yeast cell wall dynamics by manipulating genes which 
influence the stability of this structure has been demonstrated; thus extending the usefulness of 
yeast as a host for biotechnological production. In addition, the isolation of new mutants 
affecting cell wall dynamics identifies further gene functions that may be manipulated to 
improve the efficiency of heterologous protein recovery from yeast. 
WIDER CONSIDERATIONS: 
The baking and brewing yeast, Saccharomyces cerevisiae, is a single-celled organism that has 
the same basic cellular organization and processes as higher eukaryotic organisms, including 
humans. Furthermore, it is also the most highly characterized eukaryote, and is easy to 
cultivate and harmless. These features make S.cerevisiae an ideal host for the biotechnological 
production of products normally synthesized by less amenable, or unamenable, higher cells, 
and many examples now exist that show the huge potential of yeast in this regard (such as 
hormones, recombinant vaccines and blood proteins, produced from yeast). However, initial 
levels of production of foreign proteins in yeast have been variable and often disappointing, 
reflecting gaps in basic knowledge of the processes involved in protein biosynthesis and 
recovery. This project is aimed at such key areas and results have extended the capability of 
yeast for the primary production of proteins and their recovery via secretion from the cell, and, 
in the case of non-secretable proteins, cell autolysis. 
COOPERATIVE ACTIVITIES: 
(a). Forma] meetings. 
Regularly scheduled twice-yearly meetings have proved highly successful forums for 
coordinating and furthering the project as an integrated whole. At the outset, the various 
participants provided complementary contributions to the overall project By the second 
meeting in A villa, it had become evident that extensive cross-collaboration and the merging of 
common goals had occurred such that the project had now become fully integrated. 
Meeting 1: June 1991 Leicester, UK. 
Meeting 2: January 1992 Avilla, ES. 
Meeting 3: September 1992 (scheduled) Liege, B. 
(b). Visits. 
Pre-programme visits to Leicester University: CN, JD + colleague, DP, WEL. 
Pre-programme visit to Salamanca University: CH, PM. 
Visit to Departamento de Microbiologia II, Universidad Complutense, Madrid: CH + 2 
colleagues (January 1992). 
(c). Staff exchanges. 
A member of CN's lab (Madrid) spent 3 months (Sept-Nov 1991) in CH's lab 
(Leicester) isolating a class of enhanced secretion mutants. 
A member of CH's lab (Leicester) is to spend 1 week (April 1992) in WEL's lab 
(Luton) to undertake pilot brewery trials with a lager yeast strain that secretes glucoamylase. 
The heterologous glucoamylase gene (from Aspergillus niger ) construct made at Leicester was 
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incorporated into a Whitbread lager yeast strain and its performance in pilsner-style 
fermentation compared with Whitbread's experimental strains containing other heterologous 
glucoamylase genes. 
A member of PM's lab (Leicester) is scheduled to spend 1 week (April or May 1992) in 
WEL's lab (Luton) to determine the effects of growth in wort on ESP65 and MOL1 
expression. 
(d). Materials exchanges. 
PM supplied the HSP12 promoter to JD. CH supplied yeast strains DBY746 and BJ2168 to 
JD. DP supplied MFa promoter/leader sequence vectors pDP314, pDP315 and pDP316 to 
CH. CH and PM supplied protease mutant yeast strains 20B-12, ABYS1, ABYS66 and 
BJ2168, and mating-type switching plasmid pGAL-HO to CN and associates. DP supplied 
plasmids carrying wild-type and disrupted PMRl, and pmrl- yeast strains, to CH. PR 
supplied EXG1 clones to CH. CH supplied a-amylase clone to PR. 
JOINT PUBLICATIONS / PATENTS WITH TRANS-NATIONAL ORIGIN: 
Joint review article in preparation. 
A patent application with respect to one aspect of the project work is under consideration. 
OTHER PUBLICATIONS: 
Torres, L., Martin, H., Garcia-Saez, MJ., Arroyo, J., Molina, M., Sanchez, M. and 
Nombela, C. (1991) A protein kinase gene complements the lytic phenotype of Saccharomyces cerevisiae 
lyl2 mutants. Mol. Microbiol. S, 2845-2854. 
Praekelt, U. and Meacock, PM. (1992) MOL1, a Saccharomyces cerevisiae gene that is highly expressed 
in early stationary phase during growth on molasses. Yeast In press. 
Hadfield, C, Menon, S., Raina, K.K. and Mount, R.C. (1992) The expression and performance of 
cloned genes in yeast. Mycol Res. In press. 
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TITLE: WIDE DOMAIN CONTROL OF PRIMARY AND SECONDARY METABOLISM IN 
ASPERGILLI 
CONTRACT No.: BIOT-CT9O-0169 
PERIOD: 1/3/91 - 1/3/92 
COORDINATOR: Dr. J. VISSER, DEPT. OF GENETICS, WAGENINGEN AGRIC. UNI., NL. 
PARTICIPANTS: 
Prof. H. N. ARST (jr.), BACT. DEPT., ROYAL POSTGRAD. MED. SCHOOL, LONDON, G.B. 
Prof. C. SCAZZOCCHIO, INST, de GENET, et MICROBIOL., ORSAY, PARIS, FR. 
Dr. M. A. PENALVA, CENTRO DE INVESTIGACIONES BIOLOGICAS (CSIC), MADRID, ES. 
Dr. F. NALIN, LYVEN, CAGNY, FR. 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
1) Sequencing of A. nidulans pacC..(GB). 
2) Analysis of IPNS transcription with respect to carbon catabolite repression..(ES). 
3) Making constructs to produce regulatory proteins..(FR). 
4) Preliminary identification of regulatory proteins onpm, ale and IPNS genes..(FR & ES). 
5) Selection and mapping of A. niger mutations affecting carbon catabolite repression and pH 
regulation..(NL). 
6) Metabolic analysis of A. nidulans and A. niger mutant and wild type strains, including 13C- and 31P-
NMR spectroscopy..(NL). 
MAJOR PROBLEMS ENCOUNTERED: 
A) Carbon catabolite repression (CCR). 
1) In sexual backcrosses involving the two mutations described in 'RESULTS (l.Aiii)', the parental type 
is not recovered, although mendelian inheritance of the two copies of the IPNS::lacZ fusion is observed 
(Southern). This fact suggests either (i) close linkage of mutations to argB or (ii) inactivation of repeated 
(chimaeric) genes by entry into meiosis. Alternative strategy: search of hypofunctional mutations in 
negative regulators using increased expression of an IPNS::amdS fusion (single copy) (MADRID). 
2) The construction of a cDNA clone encoding the transactivator PRNA, necessary for the identification 
of its targets, has been achieved just recently (ORSAY). 
B) pH Regulation. 
1) Considerable difficulty has been experienced in obtaining crosses of the heteroallelic pacCx~ X pacCy' 
type because of infertility. It therefore appears that the fine-structure mapping of pacC in order to localise 
mutations for sequence determination is unlikely to be feasible. Dr. David Widdick, the postdoctoral 
research associate supported by this EC Bridge contract, is therefore currently trying out the use of the 
carbodiimide reaction (Ganguly and Prockop, (1990) Nucleic Acids Res. 18 p3933; Ganguly et al (1991) J. 
Biol. Chem. 266 pl2035) as an alternative method to limit the amount of DNA sequencing necessary to 
locate mutations (LONDON). 
2) The delivery and commissioning of a new NMR spectrometer in Wageningen has resulted in a 
temporary loss of measuring time (over a four month period) and necessitated the investigation of alternative 
facilities to continue the pH regulation studies. Hence, the emphasis in these twelve months has been put 
on pH regulation studies with two different methods which have turned out to be complementary and are 
promising tools for further investigations (see also 'RESULTS (2.B)') (WAGENINGEN). 
RESULTS: 
1. MOLECULAR AND GENETIC ANALYSES. 
A) CARBON CATABOLITE REPRESSION. 
i) Selection of A. niger mutants (WAGENINGEN). 
CCR mutants (ere) of A. niger have been successfully isolated. The genetic approach to the 
identification of such mutants has followed the same technique as that applied to A. nidulans whereby UVA 
induced pseudorevertants of areA' are screened for growth on media containing different N sources in the 
presence and absence of repressing levels of glucose. A. niger pseudorevertants supplied with either 
glutamate, alanine, histidine, ornithine, proline or asparagine in both the presence and absence of glucose 
show clear loss of CCR behaviour i.e. no growth on amino acid N- sources in the presence of glucose. 
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Testing the utilisation of NO2,N03 and NH + 3 has confirmed that the pseudorevertants retain the area 
phenotype and therefore constitute CCR mutants. Unlike A. nidulans however, in which the creA locus 
exercises complete control over the pathway for metabolism of alcohol - creA" mutants are sensitive to allyl 
and crotyl alcohols in the presence of repressing levels of glucose - the A. niger mutants generated do not 
display total loss of CCR of this pathway. In a similar vein, only partial sensitivity to fluoroacetate is 
shown in the presence of glucose. The equivocal nature of the sensitivity data may suggest that the alcohol 
and acetate utilisation pathways of A. niger are not under the unique control of a 'creA' equivalent but 
instead indicate the existence and influence of more than one major CCR system and/or a multiplicity of 
enzymes differentially responsive to carbon source. We are currently searching for metabolic systems that 
are regulated solely by 'creA'. 
ii) Cloning of the A. niger creA gene (WAGENINGEN). 
The creA gene (encoding CREA) of A. nidukms has been shown to play a major role in the regulation 
of CCR in that organism. For this reason the identification and isolation of the equivalent gene in A. niger 
is of particular interest in order that the extent of its role in CCR may be investigated in this industrially 
important organism and compared to A. nidulans. 
Southern blots of A. niger genomic digests probed at low stringency with an A. nidukms creA gene 
probe supplied by Dr. Joan Kelly (Adelaide) showed discrete hybridisation signals. An A. niger phage 
library screened under the same stringency conditions yielded hybridising plaques which were re-screened 
and isolated to single clone purity. BamHI, BglH, and Hindlll were used to generate pEMBL subclones 
from the phage recombinants. Mapping of the subclones showed insert sizes ranging from 6kb to llkb. 
The equivalence of the creA gene so isolated from A. niger with that of A. nidukms is strongly indicated by 
the observation that the A. niger gene itself is able to restore the CCR response to the creAd30 mutant of A. 
nidukms similarly to the creA gene of A. nidukms e.g. resistance to allyl and crotyl alcohols in the presence 
of glucose. 
With reference to the program detailed in the original workplan, the cloning of the A. niger creA gene 
has been accomplished (12-30 months, item 5). 
Experiments in progress are also focussing on the nature of the CCR effect on the pelA gene of A. 
niger. It has been observed (Kusters-van Someren el al (1991) Curr. Genet. 20 p293) that this gene 
escapes repression in creA+ A. nidukms transformants. The isolation of the A. niger creA gene will enable 
us to investigate whether or not the product of this gene is directly responsible for the repression of pelA 
i.e. do co-transformants of the creAd30 A. nidukms mutant containing copies of the A. niger creA and pelA 
genes show repression of pelA in the presence of glucose? The outcome of this will, at a later stage, 
become relevant for 'Lyven' which is a pectinase producing company. 
Recent work involving a seven week visit to the EC-BRIDGE participating labs of Dr. B. Felenbok 
and Prof. C. Scazzocchio (Orsay) by Dr. A. P. MacCabe in order to acquire technical expertise in nucleic 
acid/protein binding has provided interesting data regarding the interaction of a fusion protein consisting of 
the 'zinc-finger' domain of the A. nidukms creA product and glutathione S-transferase (CREA::GST) and the 
upstream sequences of the A. niger pelA gene: 
A - lkb DNA fragment containing the fully sequenced upstream regions of the A. niger pelA gene 
was isolated and restriction digested to yield a number of fragments varying in size between 50bp-300bp. 
Methylation interference, methylation protection, and DNAasel footprinting analyses revealed the presence 
of a specific interaction between the fusion protein and a DNA sequence located some 800bp upstream of the 
start of the pelA coding region. This sequence bears similarity to the concensus binding sequence deduced 
by Dr. B. Felenbok for the A.nidukms CREA protein. Interestingly, the complex formed between the 
fusion protein and the pelA upstream target is relatively easily disrupted in comparison to 'homologous' 
complexes i.e. those between the A. nidukms creA 'zinc-finger' fusion protein and A. nidukms DNA target 
sequences. This may account for the observed absence of a CCR effect on the expression of the A. niger 
pelA gene in creA+ A. nidukms transformants. 
iii) CCR effects on iso-penicillin N synthetase (IPNS) transcription (MADRID). 
CCR of IPNS transcription in A. nidukms (as well as of penicillin production) has been shown. 
Levels of IPNS transcript are derepressed in penicillin production broths with 3% lactose, 0.1% fructose, 
0.196 glucose or 1% L-arabinose (i.e. derepressing C-sources or derepressing levels of a repressing C-
source) and repressed in broths with repressing C-sources (3% sucrose or 1% D-glucose). CCR can 
account for the temporal pattern IPNS gene expression during the growth cycle (previously observed by 
Penalva ei al) as derepressed transcript levels are detected at all tested moments of the growth cycle in 
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derepressing C-sources or in a repressing C-source when its concentration drops under the level necessary 
for repression. The behaviour of IPNS transcription across a range of C-sources tested suggests that this 
gene is under the control of the transcriptional repressor CREA. Several creAd (derepressed) alleles 
(provided by the London Laboratory) were tested for IPNS derepression. Only the more hypofunctional 
(cr«Ad2 and creAd30) derepress slightly (3 fold) during some periods of the growth cycle. Homogeneous 
CREA::GST fused protein, containing the CREA DNA-binding region, has been obtained in large quantities 
(constructs provided by the Orsay laboratory) and studies of CREA binding to IPNSP (IPNS promotor fused 
to a reporter) are in progress. Other objectives scheduled for later reports have been accomplished 
partially. Two mutations simultaneously affecting expression of an ipnr.lacZ fusion and penicillin 
production have been isolated. Formal genetic characterisation of these mutations (involving the London 
and Madrid laboratories) has been carried out; other screening strategies will be tested (see 'MAJOR 
PROBLEMS (Al)'). Functional analysis of IPNSP is nearly finished and is especialy useful for the 
identification of cis-acting sites for CCR. 
iv) Interaction of CCR with pathway-specific induction mechanisms of the ale and prn regulons of A. 
nidulans...(ORSAY). 
(a) The ethanol regulon (alc) (Dr. B. Felenbok). 
ALCR 
The transactivator ALCR is the pathway specific protein mediating specific induction of the two 
structural genes alcA, encoding alcohol dehydrogenase I (ADHI), and aldA, encoding aldehyde 
dehydrogenase (AldDH). The activation of transcription of alcA and aldA is very strong and this property 
has been widely exploited for the expression of foreign proteins in biologically active forms. ALCR has 
also been shown to control its own expression. The ALCR protein (821 amino acids) possesses a zinc 
binding domain containing a sequence of six Cys residues. This motif is related to the highly conserved 
zinc DNA-binding domains of the transcription factors of the 'C6' class of the ascomycetes, as exemplified 
by GAL4. At variance with other structures of this class, an asymmetric sequence of sixteen amino acids -
where six are usually present - was found between the third and fourth cysteines; moreover, splicing occurs 
within this loop. 
A structural model has been constructed for the ALCR binuclear zinc domain showing that the motif 
could adopt a folded structure in which two zinc atoms are tetracoordinated by the six cysteines in a folded 
clover-leaf structure. In addition, the structural model of the ALCR DNA-binding region predicted that an 
helix-turn-helix structure appears but with the fl turn replaced by the two zinc atoms. Finally, C-terminal to 
this DNA-binding motif, a putative leucine zipper was found. The in vivo function of these two latter 
sequences remains to be demonstrated. ALCR could combine three types of DNA-binding structures, 
namely zinc cluster, helix-turn-helix and leucine zipper. 
cDNA clones encoding the zinc binding domain of ALCR were used in conjunction with the 
prokaryoyic expression vector pGEX-2T (Smith, D. B. and Johnson, K. S. (1988) Gene 67 p31-40) to 
construct a recombinant in which the zinc binding region of ALCR was fused with the gene encoding 
glutathione S transferase (GST) - resident on pGEX-2T - thus giving rise to the production of a fusion 
protein ALCR::GST which could be purified by affinity chromatography from bacterial cell extracts. 
Targets for the ALCR protein common to alcR and alcA were identified on their cognate promoters by gel 
retardation assays. Zinc was shown to be necessary for the binding activity of ALCR since removal led to 
complete loss of binding; activity could be restored by addition of exogenous zinc. Footprinting 
experiments using DNAasel protection and methylation interference revealed clear protection of a common 
sequence - CCGCA - which occurs in two arrangements, either as a palindrome or a direct repeat. Two 
targets were identified well upstream of the alcR gene transcriptional start point (-460nt) and three were 
located upstream of alcA at positions -120nt and -280nt. The data are consistent with a model in which the 
ALCR protein makes contacts only with the G bases of the targets in the major groove of the DNA. 
CREA 
CREA has been shown to contain two "zinc fingers' of the Cys-His class which are closely related to 
the 'zinc fingers' of MIG1 (involved in glucose repression in yeast) and other mammalian 'zinc fingers' such 
as the Krox family, Spl, etc. (Dowzer and Kelly (1991) Molec. Cell. Biol. U. p5701-5709)). Dr. J. Kelly 
provided a creA cDNA clone which was used in conjunction with the prokaryotic expression vector pGEX-
2T to construct a recombinant in which the zinc binding region of CREA was fused with the gene encoding 
glutathione S transferase in order to produce a CREA::GST fusion protein. 
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Gel retardation assays and DNAasel footprinting of complexes between CREA::GST and both alcR 
and alcA promotors have shown in each case that the protected sequence comprises a core rich in Gs, very 
similar to those found for MIG1 and the Krox family. Three CREA binding sites were identified upstream 
of the alcR gene, and two upstream of alcA. The existence of specific targets for CREA upstream of the 
alcR and alcA genes provides a rationale for the repression of these two genes under CCR conditions, 
(b) The proline cluster (pm) (Prof. C. Scazzocchio). 
The proline utilisation cluster of A. nidulans is under the control of the pathway-specific activator 
PRNA (also belonging to the C6 class of zinc DNA-binding proteins) and the two wide-domain regulatory 
proteins AREA (responsible for nitrogen metabolite repression) and CREA (responsible for CCR). The pm 
cluster is efficiently repressed under both nitrogen metabolite and carbon catabolite repression conditions. 
DNAasel footprint and methylation protection experiments have shown that the sequence containing 
pmd mutations - manifest as derepression of the pmB, C and D genes in the presence of both ammonium 
and glucose - defines the binding site for CREA. Two CREA binding sites were found in the cis-acting 
region, occurring as inverted repeats, with cores rich in Gs and very similar to those found in the alcR and 
alcA promotors. The pmd22 mutation shows an impaired affinity for CREA and a smaller protected region 
in the footprint patterns, thus providing a rationale for the derepression of the pmB, C and D genes under 
glucose and ammonium repression conditions. 
An A. nidulans mutant has been constructed by transformation, lacking that part of the as-acting 
region of the pm cluster defined by the pmd mutations which contains the CREA binding site. This 
transformant was found to be derepressed in the presence of glucose, both at the level of pmB transcription 
and by genetic analysis,but nevertheless repressible by ammonium. Thus, whereas the utilisation of proline 
is normally under the control of AREA, in the absence of the particular part of the cis-acdng region, AREA 
is necessary even in the absence of CREA. Hence, evidence is provided for the presence of an enhancer-
like element whose removal results in the absolute requirement for the product of the areA gene. The 
existence of another transcription factor necessary for the transcription of prnB is proposed, the binding or 
action of which is prevented by CREA. The AREA protein would bypass the need for this factor by CREA 
or in absence of the element to which the transcription factor binds. 
B) pH REGULATION, 
i) Sequencing of the A. nidulans pacC gene (LONDON). 
The Aspergillus nidulans pH regulatory gene pacC complementing activity was subcloned to a 2.6kb 
HindlH-BamHI genomic fragment. A 3319bp genomic region including all of the HindIII-BamHl fragment 
sufficient to complement pacC mutations when integrated ectopically in a single copy has been sequenced. 
In addition two long but not full length cDNA clones together covering 2179bp up to the beginning of the 
poly(A) tail have been sequenced. There are two introns, 53 and 85 nucleotides in length. The 5' end of 
the transcript remains to be mapped. However, a pyrimidine-rich region covering more than 80bp and 
likely to be a feature of the pacC promoter lies within the Hindlll-BamHI fragment and ends about 230bp 
upstream of the most 5' nucleotide present in the cDNA clones. Examination of the sequence between the 
pyrimidine-rich region and the cDNA clone suggests that the initiator methionine codon lies just under 60 
nucleotides upstream of the 5' end of the cDNA clone with no open reading frames of any significant length 
upstream to the pyrimidine-rich region and beyond to the HindlH site. Coupled with an mRNA size 
estimated from northern blots at ~2.4kb, this predicts that pacC encodes a protein of 573 amino acids. 
The derived amino acid sequence contains three 'zinc fingers' of the Cys^His, class near the N-terminus. It 
is possible that the most N-terminal of these is actually a more novel CyS3His 'zinc finger'. There are 13 
copies of the S/TPXX motif which occurs frequendy in DNA-binding proteins. The sequence also contains 
two very acidic regions which might be involved in gene activation and a very basic region in addition to the 
'zinc finger' containing basic regions. Just over 60bp downstream from the termination codon and well 
upstream of the 3' end of the mRNA lie four tandem copies of an 18bp direct repeat whose significance is at 
present unclear. 
Studies of the regulation of pacC mRNA and expression of the pacC protein in E. coli are beginning, 
involving both the London and Madrid laboratories. 
ii) Cloning of A.niger pacC (WAGENINGEN). 
In tandem with the cloning of the ere A gene of A. niger (A(ii) above), we have also cloned a pacC 
related sequence from A. niger using an A. nidulans pacC probe (supplied by Prof. Arst). A. niger pacC 
equivalent phages have been isolated to single clone purity and analysed by Southern blotting. Two 
fragments, one BamHI and one EcoRI each of about 5kb in length, have been subcloned into pEMBL 
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vectors. These constructs are currently being fine-structure mapped and will then be used in transformation 
experiments of defined A. nidulans pacC mutants in order to determine their equivalence to the A. nidulans 
gene. 
The cloning of the A. niger pacC gene has been accomplished earlier than anticipated (12-30 months, 
item 5). 
2. METABOLIC ANALYSIS AND PHYSIOLOGICAL pH REGULATION STUDIES 
A) METABOLIC ANALYSIS OF ASPERGILLUS SPECIES. 
The fermentation conditions for A. nidulans have been improved in order that the fungus grows in 
homogeneous suspension thus permitting monitoring of the time-dependent uptake of substrates and the 
formation of carbon metabolites during in vivo 13C-NMR measurements under carefully defined conditions. 
Moreover, different perchloric acid extraction methods have been tested to ensure that important metabolites, 
such as polyols, glycolytic intermediates and TCA cycle products can be simultaneously isolated at high 
yield. 
B) PHYSIOLOGICAL APPROACH TO STUDY PH REGULATION AND PH HOMEOSTASIS. 
In order to understand the various ion transport systems which are involved in pH homeostasis and pH 
regulation, two approaches to measure the intracellular pH in Aspergillus species have been 
utilised (WAGENINEN): 
i) in vivo 31P-NMR measurements. 
The in vivo 31P-NMR experiments were performed at the Max Planck Institut fur Systemphysiologie, 
Dortmund, Germany, where a capillary system for aeration of samples was used, and at the Agricultural 
University of Wageningen, where aeration was performed via gassing stones which led to very high oxygen 
values in the cell suspension. Both systems yielded different results concerning the steady state pH value in 
A. nidulans. High aeration of the sample tube led to very alkaline pH values in the range between 7.8 and 
8.0; additionally, phosphate and glycerophosphorylcholine (GPC) levels decreased very rapidly so that no 
real steady-state conditions were reached. In contrast, lower aeration (between 7% and 50%) led to more 
acidic intracellular pH values (approximately 7.3) and more stable GPC and phosphate levels for at least 60 
minutes, indicating more steady-state like conditions. 
ii) Intracellular pH measurements using pH sensitive fluorescent indicator dyes. 
In the last few years several fluorescent pH-indicator probes have been developed and employed in 
techniques such as digital imaging microscopy and spectrofluorimetry. So far, application of this method to 
fungal cells has been limited to the marine fungus Dendryphiella salina. (J. Cell Sc. (1990) 96> p731-736). 
Along with the in vivo 31P-NMR technique, the parallel approach to measure intracellular pH 
spectroscopically with pH sensitive fluorescent probes was chosen because of a number of specific 
advantages: it allows in vivo measurements, is very accurate, non-invasive, and even faster than in vivo 31P-
NMR, monitoring rapid pH changes down to milliseconds. 
Several fluorescent dyes such as HPTS-acetate (8-hydroxy 1-3-6-pyrenetrisulfonate), SNAFL, and 
BCECF-AM (2',7'-bis-(2-carboxyethyl)-5(and-6)-carboxyfluorescein) were tested. The membrane-
impermeable pH-indicators HPTS-acetate and SNAFL were loaded into the fungi by application of the acid-
shock method developed for Laaococcus lactis (Molenaar el al BBA (1991) 1115 p75-83). Possibly due to 
the acid shock, the viability of the fungal cells was reduced in comparison to cells which were incubated 
with the BCECF ester which is membrane permeable. The fluorescence microscopic investigations showed 
that the probes tested preferentially accumulated in the vacuole, which was itself also microscopically 
identified. The loss of bright fluorescence (indicating pH changes) in these cell compartments by addition 
of the proton ATPase inhibitor CCCP (carbonyl cyanide m-chlorophenylhydrazone), hints that these 
organelles are involved in pH regulation processes at the subcellular level. Thorough comparative 
transmission electron microscopic (TEM) investigations in A. nidulans and A.niger wild type and A. 
nidulans pal A, C, F and pacC pH mutants (provided by Prof. H. Arst) revealed that a) the size of this 
vacuolar compartment varies during the germination and developmental process of the hyphae, b) vacuolar 
size is dependent on the location within the fungal cell i.e. the size reduces from the spore head to the 
hyphal tip, and c) the number and size of these organelles is somewhat species dependent. 
Determination of the intracellular pH by fluorescence measurements were performed on a Perkin-
Elmer LS 50 spectrofluorimeter with computer controlled data acquisition and storage. This quick 
fluorescence method requires the measurement of the fluorescence intensity at two fixed wavelengths and 
computing the ratio of these intensities. For correlation of the measured fluorescence signal to cytoplasmic 
pH, the probe was calibrated intracellular^ using nigericin and valinomycin in calibration-buffers of 
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different pH values containing high amounts of potassium in order to dissipate intra- and extracellular proton 
gradients. Calibration curves (fluorescence ratio as a function of pH) were constructed from these treatments 
for comparison with experimental pH measurements. Preliminary pH measurements revealed that the 
addition of 10 mM NH4CI to the external medium led to an alkalinisation of the vacuolar compartment of 
0.24 pH-units. The uptake of easily utilised carbon sources, such as glucose, fructose and sucrose resulted in 
a temporary acidification of the vacuoles. These results show that this cell compartment plays an important 
function in pH regulation because externally applied bases induce pH transitions within the vacuole and it 
appears that this compartment helps to diminish cytoplasmic pH changes. 
HIGHLIGHTS/MILESTONES: 
1) Identification of the ALCR and CREA binding sites is the first to be performed with A. nidulans 
transcriptional regulators. The transactivator ALCR seems to share properties of the three main groups of 
DNA-binding proteins. The molecular mechanism of induction and repression of the ethanol regulon is 
now well understood, as is the mechanism of double repression of the pm cluster (ORSAY). 
2) IPNS expression has been shown to be under CCR. As creAd alleles do not fully derepress IPNS 
transcription, three possibilities arise: (i) a gene different from creA controls CCR of secondary 
metabolism; (ii) very little creA function is required for IPNS repression (conclusion based on incomplete 
derepression by creAd30); (iii) the combination of a repressing C-source and a cread30 allele might result 
in a derepressed but non-induced situation. Experiments are in progress to distinguish these posibilities. 
Each is of intrinsic biotechnological interest (MADRID). 
3) Through the use of A. nidulansprobes isolated from genes of defined wide-domain function, namely 
creA and pacC, it has been possible to isolate the equivalent sequences from the industrially valuable 
organism A. niger thus providing a means by which metabolic regulation in this organism can be analysed at 
the molecular level (WAGENINGEN). 
4) In vivo P-NMR spectroscopy is a powerful method to measure the cytoplasmic pH in young 
Aspergillus hyphae in which the vacuoles contain very low amounts of inorganic phosphate and thus are not 
monitored by this method. Additionally, pH sensitive fluorescent dyes (as BCECF) can be used to monitor 
selectively the intracellular pH of the vacuolar compartment of the fungal cells which plays an important role 
in cellular pH regulation (WAGENINGEN). 
5) The presence of 'zinc fingers' and a high frequency of S/TPXX motifs in the derived amino acid 
sequence of pacC suppport our hypothesis that it is a transcriptional regulator. It is the first transcriptional 
regulator mediating pH regulation to be identified in any organism (LONDON). 
WIDER CONSIDERATIONS: 
1) The identification of the ALCR targets on the alcR and alcA promoters will facilitate the construction 
of superinducible promotors able to express higher amounts of heterologous protein. Disruption of the 
CREA binding sites should result in complete glucose derepressed alcR-alcA expression, allowing growth of 
these A. nidulans strains on a glucose medium. This feature is of valuable interest for industrial purposes. 
2) Penicillin production is under CCR; IPNS is under CCR. Non-lethal, pleitropic creAd mutations do 
not fully release IPNS transcription and are useless for penicillin over-production. Mutations affecting ci--
acting regions should avoid inconveniences caused by pleiotropic mutations. 
3) The ability to control gene expression so that it is appropriate to ambient pH is an important feature 
which enables microorganisms to adapt to their environment. Microorganisms alter the repertoire of both 
enzymes and small molecules they secrete in response to ambient pH. We are now on the way to 
understanding how they do so and to being able to alter it. 
4) Present investigations concerning intracellular pH measurements indicate that the fungal vacuole plays 
an important role in cellular pH control and deserves increased attention. 
COOPERATIVE ACTIVITIES: 
1) Prof. H. Arst visited the Orsay laboratory and examined a doctoral thesis in July 1991. E. Espeso 
(Madrid lab) spent six weeks in the London lab in July-August 1991 learning classical genetic techniques, 
analysing transformants and preparing IPNS mRNA from pH regulatory mutants. A large number of A. 
nidukms strains has been supplied by the London laboratory to each of the laboratories in Madrid, Orsay 
and Wageningen. The A. nidukms pacC clone was supplied to the Wageningen laboratory for cloning the 
equivalent gene in A. niger. He also provided advice to the Madrid group on aspects of CCR. 
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2) Dr. J. Visser visited Madrid for scientific discussion and supplied a number of mutations impairing 
glycerol utilisation. Dr. B. Felenbok provided the construct expressing CREA::GST polypeptide in E. coli 
and Prof. C. Scazzocchio provided a number of strains and continuous flow of information on as-acting 
regions of CCR in the proline cluster. Strains carrying lPNS::lacZ fusion have been supplied to Orsay. 
3) Dr. B. Felenbok and Prof. C. Scazzocchio (Orsay) have hosted two post-doctoral fellows (Dr. A. 
Ravagnani and Dr. A. P. MacCabe) who have spent twelve week and seven week visits, respectively, 
learning the techniques of analysis of nucleic acid/protein complexes. 
4) The pH measurements with fluorescent pH sensitive probes and the ultrastructural studies were done in 
collaboration with Prof. Dr. W. Konings and D. Molenaar, Dept. of Microbiology, State University of 
Groningen, NL. Dr. I. von Recklinghausen spent several weeks in Groningen for that purpose. 
The NMR measurements have been performed on the NMR spectrometers of the Molecular Physics 
Department, Agricultural University Wageningen and at the Max-Planck Institut fur Systemphysiologie, 
NMR-Group (Prof. A.W.H. Jans), Dortmund, Germany. 
Dr. 1. von Recklinghausen participated in the International Postgraduate Course 'NMR (Nuclear 
Magnetic Resonance) in Agriculture: Plants, Animals, Products' held from 15 - 26 October 1991 at the 
AMEV Opleidingscentrum in Wageningen. 
PUBLICATIONS: 
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Promotor Region Involved in the Autoregulation of the Transcriptional Activator ALCR in Aspergillus 
nidulans. Mol. Cell. Biol. 12 (5) - in press. 
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Coordinator : SX>. EHRLICH, Genetique Microbienne, INRA, Jouy en Josas, FR 
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L. BOE, Dept. Microbiology, Technical University of Denmark, Lyngby, DK 
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OBJECTIVES 
Isolation of mutant plasmid replication proteins and origins 
Cloning of plasmid segregational stability functions 
Cloning of the phage PBSX lysis gene 
Cloning of basic replicons of large plasmids 
Isolation of topoisomerase I mutants 
Isolation of phage Phi29 DNA polymerase mutants 
Construction of systems to study stability of genes inserted into the chromosome 
MAJOR PROBLEMS ENCOUNTERED 
In most of the participating laboratories the onset of the studies was delayed by the 
unexpected length of the contract processing. Less progress than anticipated was therefore 
made towards several of the objectives. This problem being solved it is foreseen that the 
research will now proceed with the optimal speed. A technical problem arose concerning 
isolation of large plasmid DNA from Gram positive bacteria, envisaged within the strategy of 
replicon cloning. This was solved by cloning replicons from total DNA preparations. 
RESULTS 
Mutant (+) replication origins and proteins (INRA) 
Active site of the replication protein of the plasmid pC194 was analysed by site-directed 
mutagenesis. Alignment of 12 proteins from the related plasmids has shown six conserved 
tyrosines. One of these was contained within a stretch of amino acids resembling the active 
site of the Escherichia coli phage OX 174 Rep protein, in which the Tyr remains bound to 
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DNA upon cleavage initiating rolling circle replication (RCR). Each of the conserved Tyr in 
the pC194 protein was changed to Phe and the activity of the protein was measured in an in 
vivo assay. Five of the changes had little effect, since >50% of the parental protein activity 
was still present In contrast, change of the Tyr which corresponds to C>X174 protein active 
site had a strong effect, since only =5% of the activity remained. To test whether the residual 
activity is due to another hydroxyl-amino acid in the vicinity, another Tyr was changed to Phe 
and two Ser to Ala. None of the single mutations affected the protein activity and the multiple 
mutations in conjunction with a critical Tyr -> Phe change did not abolish the residual 
activity. This indicates that either a hydroxyl group is not required for the activity of the 
protein or that a hydroxyl group from a distant amino acid, or even from a water molecule, 
can catalyse the cleavage. Both alternatives are unexpected and novel for a Rep protein of a 
RCR plasmid. 
Segregational stability junctions (INRA, Trinity College, Technical University) 
(-) origins affect stability of RCR plasmids. The features essential for functioning of the (-) 
origin of the plasmid pBAAl and its role in the plasmid segregation stability were 
investigated. This analysis has revealed that at least two stem-loop structures are important for 
activity. Deletions which affect the integrity of stem-loop I result in total inactivation of the 
origin. Deletion of stem-loop HI results in partial inactivation of the origin. The function of 
the (-) origin was restored by replacing stem-loop in by a different stem-loop structure placed 
at a correct distance from stem-loop I. This suggests that functioning of the minus origin 
requires at least two stem-loop structures: stem-loop I, both the structure and the sequence of 
which may be important, and stem-loop III, only the structure of which is required. The 
analysis has also shown that RNA polymerase is involved in conversion of the single-stranded 
plasmid to the double-stranded form. The minus origin of pBAAl was shown to function not 
only in B. subtilis but also in S. aureus. In addition, another (-) ori was isolated from plasmid 
pTX14-3, and shown not to require RNA polymerase, which is different from previously 
described RCR (-) origins. 
Insertion of foreign segments in RCR plasmids often leads to the appearance of high 
molecular weight plasmid forms (HMW), which, in mm, cause plasmid instability, possibly 
because of (i) lowering number of separate plasmid units in the cell and (ii) slowing the 
growth rate of the plasmid-carrying cells. Using Escherichia coli as a host it was shown that 
such forms arise if a CHI site (an 8 bp sequence) is introduced on a plasmid. This site protects 
HMW molecules, which are probably formed by accidental lack of termination of the RCR, 
from degradation by the RecBCD exonuclease. Plasmid stability should therefore be 
increased if the CHI sites were eliminated from the cloned inserts. A locus which suppresses 
HMW formation, by a presently unknown mechanism, was detected on plasmid pTX14-3. 
Mutation rate on plasmid multimers was increased relative to monomelic plasmids in E. coli, 
raising a possibility that plasmids which form large amounts of HMW are hyper-mutable. It is 
possible that the high mutability is due to the formation of single-stranded regions, by 
homologous base pairing between plasmid copies out of register. Furthermore, the mutation 
rate was affected by the rate of translation errors in E. coli, possibly by generating error-prone 
DNA polymerase. However, such relation was not established yet in B. subtilis. 
A system contributing to the stability of the large theta-replicating plasmid pAM(3l and 
comprising a resolvase and the cognate resolution site was characterised. 
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Lysis gene of the phage PBSX (NOVO, Trinity College) 
In an attempt to introduce the phage lysis gene under repressor control the IPTG-inducible 
SPAC promoter was integrated at various sites of the phage late operon. However, only a low 
level of pbage-specific mRNA and proteins was detected upon induction and the cell lysis 
was not observed, which indicates that the promoter activity was relatively weak. In contrast, 
phage protein production was observed in cells carrying the phage thermosensitive repressor. 
Deletion of most of the phage sequences which encode head and tail proteins will be 
attempted, which should fuse the lysis gene to the late phage promoter. The lysis gene appears 
to map on the phage segment 39, as deduced by sequence homology of the segment with the 
B. subrilis cwlA gene, which encodes N-acetylmuramoyl-L-alanine amidase. 
Replicons of large plasmids (INRA, Trinity College) 
Basic replicons of several large plasmids were cloned, using a method which involved (i) 
cleavage of total DNA isolated from plasmid-containing strains by different restriction 
enzymes, (ii) ligation of the resulting segments to a replicon-cloning vector and (iii) 
transformation of B. subtilis competent cells. Structural and segregational stability of the 
derived plasmids is currently being investigated. 
Replication region of pAMfJl was shown to consist of two domains. One, named replication 
domain, comprises two essential elements, the Rep protein and the origin, which suffice to 
confer broad host range upon the derived plasmids. It also contains several non-essential 
elements, which appear to (i) help initiation of the lagging DNA strand and (ii) interfere with 
the formation of HMW. The other domain, named expression domain, consists of elements 
which ensure expression of the Rep protein. It appears to include two negative regulators, a 
protein and a counter-transcript driven transcription terminator. Two related plasmids, pIP501 
and pSM19035, have a similarly organised replication region. 
B. subtilis topoisomerase (Groningen University, INRA) 
Two approaches are being followed for the isolation of the topoisomerase I gene. One is to 
amplify a segment of the gene by PCR, using primers corresponding to the conserved regions 
of different topoisomerases. Several segments were amplified with these primers and are 
presently being sequenced. If one of them derives from the topoisomerase gene it will be used 
as a probe for cloning of the entire gene. Another approach is to purify topoisomerase I and 
determine its N-terminal sequence, which should allow to design a probe for cloning of the 
corresponding gene. An assay was set to measure the topoisomerase activity in the B. subtilis 
cell extracts and the isolation of the protein has started. 
<S>29 DNA polymerase mutants (CSCI) 
<t>29 DNA polymerase mutants have been isolated in two regions at the carboxyl part of the 
protein, conserved among a-like DNA polymerases, characterised by the motifs "D-NSLYP" 
and "K—NS(L/V)YG" (regions 1 and 2A, respectively). The mutant proteins Tyr254-> Phe 
(Y254F) and Tyr390 -> Phe(Y390F) or Tyr390 -> Ser(Y390S), in conserved regions 1 and 2A, 
respectively, were purified and characterised. The results obtained indicate that residues 
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Tyr254 and Tyr390 are involved, directly or indirectly, in Me2+-dNTP binding. 
A complete alignment of 33 DNA polymerases has allowed to identify, in addition to the most 
conserved regions, Exol, ExoII and ExoIII, other segments of amino acid similarity. These 
contain residues involved in single-stranded DNA binding at the three 3'->5' exonuclease 
domains of E. coli poll. <I>29 DNA polymerase mutants in residues Tyr165 (Y165F and 
Y165C) and Asp169 (D169A) were isolated, purified and characterised. The results indicate 
that the two residues form part of the 4>29 DNA polymerase exonuclease domain. 
Interestingly, none of the three mutant polymerase were able to produce strand displacement, 
which is a property of the wild type d>29 DNA polymerase. This suggests that the strand 
displacement and 3'->5' exonucleases active sites overlap and probably share the single-
stranded DNA binding cleft 
The interaction of protein p6 with the <I>29 DNA ends was also studied by constructing head-
to-tail concatemers of a 24 bp p6 binding sequence (p6 dimer binding unit). The protein binds 
to these sequences at the same position as in the replication origin but with higher affinity. 
Series of pUC19 derived plasmids contained in different number of p6 dimer binding units 
were used to measure changes in linking number induced by protein p6. The observed change 
was .25. Formation of p6 DNA complex was also confirmed by electron microscopy. Site 
directed mutagenesis of the amino end of protein p6, previously shown to be required for 
DNA interaction, has shown that the basic amino acid Lys2 an Arg6 are involved in DNA 
binding. 
Stability of genes inserted in the chromosome (INRA) 
Multiple tandemly repeated copies of foreign genes inserted in the chromosome of B. subtilis 
allow to obtain increased production of the proteins they encode. Recombination between 
directly repeated sequences affects stability of these genes. To study factors which affect such 
recombination, a system consisting of directly repeated sequences of 900 bp, which generate a 
functional tetracycline resistance gene by recombination was developed. The system allows to 
directly select the recombinants and therefore to measure relatively low recombination 
frequencies. 
HIGHLIGHTS/MILESTONES 
(a) Unexpected activity of the Rep protein of a RCR plasmid was revealed. 
(b) CHI sequence was shown to be a critical factor in the formation of high molecular weight 
(HMW) plasmid multimers, which affect the stability of RCR plasmids. 
(c) Phage PBSX lysis gene was identified. 
(d) Replication region of a representative large plasmid was characterised. 
(e) Minus origin of a RCR plasmid was characterised. 
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WIDER CONSIDERATIONS 
Stable maintenance of foreign genetic information is essential for amelioration of industrially 
important microorganisms. Small plasmids which replicate as rolling circles are widely used 
for DNA cloning in Gram positive bacteria, which is an important class of industrial 
microorganisms, and their biology is relatively well known. In contrast, large theta-replicating 
plasmids have been used only recently for cloning in these bacteria and are less well 
characterised. However, the well-known small plasmids seem to be intrinsically less stable 
than the large less-known plasmids. Much of the research during the past year was orientated 
on the one hand towards understanding the instability and improving the stability of the small 
plasmids and on the other towards isolating new and better characterising the known large 
plasmids. Bacillus subrilis was used as a model host, and processes known to affect stability 
of genetic information, such as DNA replication of plasmids and phage were studied. Better 
understanding of the genetic stabil i ty is expected to have impact on a number of 
biotechnology applications. 
COOPERATIVE ACTIVITIES 
Two meetings between people from Novo Nordisk and Trinity College Dublin have taken 
place: (1) lOth-11th of January 1991, (2) 27th-28th of June 1991, both at Trinity College. One 
scientist from Nov Nordisk was working in the Genetics Department at Trinity College from 
January 3rd to July 1st, 1991. Exchange of materials has taken place during the whole period. 
Also, two meetings took place between Genetique Microbienne (INRA) and the Department 
of Genetics (Groningen), one in Groningen in December 1991, and one in Jouy en Josas in 
January 1992. Exchange of material between these two groups took place at the second 
meeting. There was also a continuous exchange of material between the Department of 
Genetics (Trinity College) and Department of Genetics (Groningen). 
PUBLICATIONS 
Individual publications: 
L. Boe (1992) Translational errors as the cause of mutations in Escherichia coli. Mol. Gene. 
Genet, in press. 
The following manuscripts were submitted for publication since the beginning of 1992. 
P. Dabert, S.D. Ehrlich, A. Gruss (1992) The chi sequence protects afainst recBCD 
degradation of DNA in vivo. 
D. Vilette, M. Uzest, S.D. Ehrlich, B. Michel (1992) DNA transcriprion and repressor binding 
affect deletion formation in Eschcricltia coli plasmids. 
I. Biswas, V. Vagner, S.D. Ehrlich (1992) Efficiency of homologous intermolecular 
recombination at different locations of the Bacillus subrilis chromosome. 
E. Le Chatelier, S.D. Ehrlich, L. Jannierc (1992) A family of theta replicating plasmids in 
Gram-positive bacteria. 
E. Le Chatelier, S.D. Ehrlich, L. Janniere (1992) The replication region of the Enterococcus 
faecalis plasmid pAMpl contains and expression and a replication domain. 
L. Seery and K.M. Devine (1992) Analysis of the features contributing to the activity of the 
origin of complementary-strand synthesis of the Bacillus plasmid pBAAl. 
M.A. Blasco, J.M Lazaro, A. Bemad, L. Blanco and M. Salas (1992) 0>29 DNA polymerase 
active site : mutants in conserved residues Tyr254 and Tyr390 are affected in dNTP binding. 
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OBJECTIVES SET FOR THE -Characterization of plasmid sequences required for stability 
REPORTING PERIOD: -Cloning genes involved in TCA cycle 
-Characterization of phage int sequences 
Study of different corynephages 
-Conjugal gene transfer 
-Development of methods for construction of an encyclopedia of 
corynebacteria 
-Gene expression of the tryptophan operon 
-Characterization of promoters of corynebacteria: threonine 
biosynthetic genes 
MAJOR PROBLEMS 
ENCOUNTERED: No major problems have been encountered. 
RESULTS 
1. Characterization of DNA sequences required for plasmid 
replication and stability (Martin) 
The characterization of DNA sequences involved in 
stability and replication of plasmid pBLl (an endogenous 
plasmid of B. lactofermentum from which most of the 
available vectors of corynebacteria are derived) is 
important to develop vectors with high stability in 
submerged cultures. Deletion studies and subcloning of 
essential regions for plasmid replication, stability and 
control of the copy number revealed that the HincII-SphI 
fragment (1.8 kb) of pBLl is essential for its replication 
and it contains two ORFs, 0RF1 which encodes a Rep protein 
and ORF5 of unknown function. The Rep protein encoded by 
0RF1 shows amino acid similarity with several known Rep 
proteins. The 0.8 kb Hindlll-Sphl of pBLl is necessary for 
the stability of pBLl derivatives in B. lactofermentum. We 
have obtained very high copy number (runaway) derivatives of 
pBLl. The copy number of pBLl derivatives increased when 
the terminator of the tryptophan operon from B. 
lactofermentum (Ttrp) was cloned adjacent to the Hindlll 
site which might prevent readthrough from a putative ORF 
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that negatively controls the copy number. There is a good 
homology between the nucleotide sequence of a DNA region 
present in the Hindlll-SphI fragment of pBLl, and the RNA I 
of E. coli (which control the copy number in ColEl-derived 
plasmids) what suggests that an antisense RNA mechanism may 
be involved in the control of the copy number of plasmids in 
corynebacteria. 
2. Characterization of enzymes and cloning genes involved in 
the TCA cycle (Sahm) 
The specific activities of pyruvate kinase (PK), 
citrate synthase (CS), isocitrate dehydrogenase (ICDH), 
isocitrate lyase (ICL), malate synthase (MS), and glutamate 
dehydrogenase (GDH) have been determined in cell extracts 
from C. glutamicum after growth on different media. The 
results show that PK, CS, ICDH, and GDH were present 
constitutively with activities between 0.7 and 1.9 imol/min 
mg protein. ICL and MS are 100-fold inducible by acetate and 
showed specific activities of 2.4 and 0.9 μmol/min mg 
protein, respectively. On activity level no significant 
regulation was observed for CS, for MS, and for GDH. PK is 
stimulated by AMP; ICDH was severely inhibited by 
oxaloacetate and glyoxylate and ICL by phosphoenolpyruvate. 
The C. qlutamicum CS gene (git) and the C. qlutamicum 
GDH gene (gdh) could be isolated by heterologous 
complementation of appropriate E. coli mutants. Subcloning 
and subsequent sequencing of respective DNA fragments 
identified open reading frames coding for polypeptides which 
show significant identity to CSs and GDHs from other 
organisms. Both cloned genes could be expressed in C. 
qlutamicum. Transcriptional analysis of the gdh gene 
revealed that gdh is a monocistronic gene. The promoter 
region of gdh was identified by RNase protection assay. 
3. Study of different corynephages. Characterization of 
corynephages isolated from soil (Blanco) 
Two strategies were developped to isolate 
bacteriophages active on corynebacteria. First by direct 
isolation of phages in soil samples, and secondly by 
induction of integrated prophages in collection strains. All 
these studies were perfomed on 40 coryneform strains 
covering the genera Corvnebacterium. Brevibacterium and 
Arthrobacter. 
Various corynephages were isolated from soil samples. 
Restriction analysis of phage DNA indicated that 24 phages 
were unique. One of them was identical to the previously 
characterized phage CG33. There is only a minor difference 
on the restriction map resulting of the loss of a H_indIII 
site. Twenty three of them are virulent phages, their hosts 
are essentially composed of Arthrobacter species. 
The unique temperate phage, AAU2, made turbid plaques 
on Arthrobacter aureus. It is active only on Arthrobacter 
species. One virulent mutant was isolated that is unable to 
make plaques on the lysogenised strain, and thus seems 
affected on the repressor of lytic functions. AAU2 was 
characterized morphologically. It presents a polyhedral head 
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of 50 run wide and a non contractile tail of 150 run, and it 
was classified in Ackerman group Bl. 
Its genome is composed of a 45 kb double stranded DNA 
with cohesive ends. Its restriction map was achieved for 4 
restriction enzymes. The chromosomal integration site was 
mapped for 10 independent lysogenic strains, and revealed to 
be unique. We have mapped some structural capsid proteins, 
and the phage attachment site. The cloning of integrative 
functions and chromosomal attachment site is in progress. 
4. Induction of integrated prophages (Blanco) 
Since no temperate phages infecting Corvnebacterium 
were isolated from soil samples, integrated prophages on 
Corvnebacterium and Brevibacterium strains were released by 
induction. 
After UV induction 7 strains revealed to be lysogenic. 
Induced phages were able to infect other strains and in all 
cases caused the formation of turbid plaques. Their host 
spectrum is actually limited by restriction of DNA in the 
recipient strain. It could be enhanced by improving the 
titer of the phage stocks. The study of these phages is in 
progress; they constitute good candidates to construct 
broad-host range integrative vectors. 
5. Conjugal gene transfer (Puhler) 
The conjugal gene transfer from E. coli to C. 
glutamicum (Schafer et al., 1990) was investigated in more 
detail with respect to factors which influence the 
efficiency of transfer of mobilizable plasmids. Besides a 
heat treatment step, we found other methods to render 
corynebacterial cells more susceptible to conjugal transfer. 
These include treatments with ethanol, detergents, acids and 
bases. The method using sublethal concentrations of ethanol 
prior to mating produces frequencies as high as the original 
heat treatment, whereas the other methods displayed lower 
frequencies. 
Since all the treatments that led to high frequency 
transfer are thought to introduce changes in the 
cytoplasmic membrane, it is proposed that the restriction 
enzyme(s) influencing the transfer efficiency are membrane 
associated. 
An attempt to clone the gene(s) responsible for the 
restriction phenomenon by complementing a restriction-
deficient C. glutamicum strain was sucessfull. For this 
purpose, a mating method on agar plates was developed that 
allows the simultaneous testing of large quantities of 
clones for restriction. 
The complementing fragment of 6.7 kb will be sequenced 
and a restriction deficient mutant will be constructed by 
gene disruption (Schwarzer and Puhler, 1991) using an 
internal fragment of the gene responsible for restriction. 
6. Development of methods for construction of an 
encyclopedia of corvnebacteria 
A. (Puhler) 
An important tool for the construction of an 
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encyclopedia is the cosmid vector. To expand the use of a 
cosmid gene bank, the vector should be equipped with a 
corynebacterial replication region and the mobilization 
region. To achieve this goal, the corynebacterial replicon 
pBLl was choosen, which displays stable replication and a 
relatively low copy number. The plasmid was introduced into 
the mobilizable E. coli vector pK18::mob and the resulting 
vector was supplied with the cos-fragment from pSUP205 to 
give pEBHCl, a mobilizable shuttle cosmid vector with 
several single restriction sites for cloning and a high 
transfer frequency from E. coli to Corynebacteria. At the 
moment, the feasibility of this vector for cosmid cloning 
and conjugal cosmid transfer is investigated. 
The construction of ordered cosmid clone banks will be 
greatly facilitated, if the location of all repetitive 
sequences in the corynebacterial genome that might cause 
confusion during linking of adjacent cosmid clones is known. 
For these purposes, we investigated known repetitive 
sequences as transposable elements and ribosomal RNA 
clusters in C. alutamicum. 
An AEC-resistant mutant of C. alutamicum displaying a 
defective lysi gene coding for lysine and AEC uptake (Seep-
Feldhaus et al., 1991) was investigated by Southern 
hybridization. Within the lysl gene an insertion of around 
1.5 kb was detected. The region containing the insertion was 
amplified by using the PCR method and cloned. DNA sequencing 
of the inserted DNA region revealed a typical insertion 
element of ca. 1450 bp showing 24 bp inverted repeats. ISCgl 
has 4 to 7 copies in the chromosome of C. alutamicum and is 
also present in B. flavum and C. herculis. 
Bacterial ribosomal RNA clusters contain the coding 
regions for the three ribosomal RNAs and are present in 
multiple copies in the chromosome due to the requirement for 
huge amounts of these RNA species. To investigate the number 
and the location of rRNA clusters in C. alutamicum. PCR was 
performed with primers synthesized according to the known 
sequence (Park et al., 1987) in the case of 5S rRNA and 
according to conserved sequences in the case of 16S rRNA. 
Both rRNA genes were sucessfully amplified and the 5S rDNA 
directly sequenced confirming the identity of our C. 
glutamicum ATCC 13032 and ATCC 13058 strains with the C. 
alutamicum CNF 016 (ATCC 13032) type strain (Park et al., 
1987). 
The PCR products will be cloned and sequenced and the 
locations and copy numbers of the corresponding operons will 
be determined in the near future. 
B. (Martin) 
Using pulse field gel electrophoresis we have 
established that the genome of B. lactofermentumhas a size 
of 2350 kb, and that of C. alutamicum 2400 kb. Restriction 
endonucleases recognizing AT rich sequences like Paci 
(target sequence TTAATTAA) and Dral (target sequence 
TTTAAA) cleave the genomes of B. lactofermentum. c 
alutamicum or B. linens in fragments that can be resolved by 
pulse-field gel electrophoresis (PFGE). Eighteen Paci 
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fragments were found in the genomes of B. lactofermpntum 
and C. alutamicum with a size range of 5-450 kbp. The genome 
of B. linens was resolved into 8 Dral fragments, ranging 
from 90 to 850 kbp. Other restriction enzymes recognizing 
GC-rich octanucleotides like NotI and Sfil also produced 
discrete bands in the genome of B. lactofermentum and C. 
qlutamicum. Other restriction enzymes like Xbal, Sspl and 
Asel have also been useful for mapping large fragments of B. 
linens. 
Cloned genes for amino acid biosynthesis available in the 
laboratory have been located in the different fragments by 
Southern hybridization. Strategies for obtaining linking 
clones are being used to construct ordered encyclopedias of 
the genome of corynebacteria. 
7. Gene expression of the tryptophan biosynthetic genes 
A. Cloning and sequence analysis of the DAHP synthetase 
gene of C. glutamicua (Dunican) 
The DAHP synthetase gene in coryneform bacteria 
catalyses the initial step in the general aromatic amino 
acid pathway. This major pathway controls the flow of 
intermediate metabolites for the synthesis of the amino 
acids tryptophan, phenylalanine and tyrosine. There are 
three isomers of the gene in E. coli each individually feed-
back inhibited by one of the three aromatic amino acids. 
Biochemical evidence suggests that there is only one copy of 
this gene in the coryneform bacteria. 
The DAHP gene was cloned using a synthetic 
oligonucleotide designed from a region conserved in the 
aroF. aroG and aroH genes of E. coli by probing an EMBL111 
bank constructed from C. qlutamicum 218 50. A fragment was 
sub-cloned which was capable of complementing E. coli AB3257 
which has mutations in all three DAHP genes. The gene has 
been sequenced and shows a remarkable similarity to regions 
of the three E. coli aro genes. Circa 45% of the amino acids 
were identical. The DAHP gene of C. qlutamicum contained 375 
amino acids which corresponds closely to the molecular 
weight of the protein isolated biochemically from C. 
qlutamicum. Analysis of the cloned region showed that: 
a) Upstream of the gene there is a region which could serve 
as a promoter for this gene. Sequence information of 
regions upstream and downstream suggests that this C. 
qlutamicum aro gene is not part of a larger operon. 
b) The gene is a little longer than the E. coli genes with 
short additional stretches at the 5• and 3 * ends. 
c) A conserved sequence at amino acid 148 shows very high 
homology with the allosteric site in the aroF gene of E. 
coli. i.e. the amino acid binding pocket for tyrosine 
(Weaver and Herrmann, 1990). For this reason it has been 
decided to designate this C. qlutamicum gene aroF to 
maintain the E. coli nomenclature. 
B. Regulation of the tryptophan operon (Dunican) 
This operon and particularly the trpE (initial gene in 
the operon) has been studied intensely. Work in Galway is 
focused on this gene which was isolated from a derepressed 
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strain of C. alutamicum which was resistant to 5-methyl 
tryptophan. Results show that a region upstream of this trpE 
gene confers resistance to 5-methyl tryptophan when cloned 
into E. coli. The regulatory role of this gene is being 
studied by integrating a portion of this region into wild-
type C. alutamicum. 
C. Gene expression of the tryptophan operon (Martin) 
We are approaching the characterization of the 
expression of genes involved in the tryptophan biosynthesis 
in corynebacteria. Our goal in Leon is to increase 
tryptophan production by gene dosage amplification and by 
removal of the feedback regulatory mechanism that limits 
tryptophan biosynthesis. Initially, four DNA fragments of B. 
lactofermentum that complement mutations in the trpB. 
trpC(F) and trpD genes of E. coli were cloned (Del Real et 
al., 1985). Later the whole operon was cloned into E. coli 
in a 9.6 kb BamHI DNA fragment, using pUC13 as cloning 
vector. This construction, called pULW7, has served as the 
starting point to subclone the operon regulatory signals 
(promoter, attenuator and terminator). These regulatory 
sequences have been characterized and altered by in vitro 
mutagenesis. 
The main promoter of the operon was located in a 0.55 
EcoRI-Hindlll fragment that was subcloned in pUC118. The 
transcription initiation site was determined by Si mapping. 
A protected fragment of 266-267 nt indicated that 
transcription starts in an adenine located 16 bp downstream 
from the putative -10 region. A ribosome binding sequence 
was found 9 bases downstream of the first transcribed 
nucleotide. An inverted repeat overlaps with the -10 region 
of the promoter. 
Northern analysis of total RNA of B. lactofennentum 
using an internal fragment of the trpA-trpB region showed 
that a transcript of about 7 kb is formed, although the 
exact size of this large polycistronic transcript 
corresponding to the entire operon is difficult to estimate 
precisely. By subcloning experiments in which 2.2 kb Nru-
B Q I I I carrying the end of trpC and the trpB and trpA genes 
was subcloned in the vectors pULMJ51 and pULMJ55, it was 
shown that an internal promoter located of the end of the 
trpC gene appears to exist. No significant band of 
hybridization corresponding to this short transcript was 
observed in Northern hybridization of total RNA of B. 
lactofermentum what suggests that this internal promoter is 
not used significantly when the entire operon is being 
transcribed. 
The promoter and attenuator of the operon have been 
changed by directed in vitro mutagenesis. These mutations 
have allowed us to construct mutants with altered expression 
of the tryptophan operon. 
8. Caracterization of promoters of amino acid-producing 
corynebacteria (Martin) 
A characterization of several promoters of 
corynebacteria has been made, including promoters of the 
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pBLl plasmids, the threonine genes, and the tryptophan 
operon of B. lactofermentum. Two different types of DNA 
fragments with promoter activity were found in the cryptic 
plasmid pBLl. Four of the eight promoters cloned from pBLl 
showed promoter activity in E. coli and B. lactofermentum 
while the other four are expressed only in corynebacteria. 
The first group has been named corvnebacterial-E. coli-like 
promoters (CEP) whereas the second group has been designated 
corynebacteria-specific-promoters (CSP). The strength of 
such promoters has been determined by subcloning them in 
promoter-probe vectors (Cadenas et al., 1991). Several 
promoters have been sequenced and characterized by SI 
mapping. CEP promoters are very similar to those of 
consensus E. coli with a standard spacing of 17 nt. The CSP 
promoters are probably similar to the promoters of 
Streptomvces genes involved in the biosynthesis of 
antibiotics and other secondary metabolites. 
There are two' promoters (Phom, PthrB) in the threonine 
cluster hom-thrB of B. lactofermentum that was cloned 
previously. Phom is the main promoter of the cluster in 
corynebacteria, but it is not functional in E. coli. i.e. it 
is a CSP type promoter. PthrB is located between hom and 
thrB, and is expressed both in E. coli and corynebacteria, 
i.e. it is a CEP-type promoter. 
HIGHLIGHTS/MILESTONES:- DNA sequences required for plasmid replication and stability In 
corynebacteria have been characterized. 
• Citrate synthase and glutamate dehydrogenase genes of 
corynebacteria have been cloned ■ 
- Several corynephages have been isolated from soil, and also by 
induction of integrated prophages. 
- An efficient conjugal gene transfer from E.coli to C. glutamicum has 
been developped. 
■ A DNA fragment that complements a restriction deficient 
C. glutamicum strain has been cloned. 
• Methods for construction of cosmid gene banks of corynebacteria 
have been established. A transposable element has been identified ■ 
■ Using restriction endonucleases that recognize very infrequent 
restriction sites and pulse field gel electrophoresis, the genome size 
of several corynebacteria has been determined. The genome of 
C. glutamicum. B. lactofermentum and B. linens has been resolved in 
discrete large fragments and the cloned amino acid biosynthetic 
genes have been mapped, by hybridization, in those fragments . 
- The DAHP synthetase gene (aioF) was cloned and sequenced. 
- Regulation of the tryptophan operon has been studied in the wild 
type and in a 5-methyl tryptophan resistant clone ■ 
- The promoter region of the tryptophan operon of B. lactofermentum 
has been characterized by SI mapping and their strenght studied in 
promoter-probe vectors. ' 
- A 7 kb polycistronic mRNA for the entire tryptophan operon was 
found in B. Iactofermentum. whereas no significative transcription 
occurred from an internal promoter. 
- Two types of promoters were found in corynebacteria. The CSP type 
are only expressed in corynebacteria, whereas the CEP type 
promoters are expressed in E. coli and corynebacteria 
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WIDER CONSIDERATIONS: An array of basic techniques for genetic manipulation of amino acid 
producing corynebacteria and related Gram-positive organisms have 
been developed by the five groups involved in this project New 
improvements for gene transfer technology has lead to cloning 
several genes involved in intemtediary metabolism of corynebacteria. 
i.e. genes that provide precursors (building blocks) for amino acid 
biosynthesis, and also genes directly involved in the production of 
several amino acids (tryptopahn, threonine, lysine, etc.). New 
phage-derived tools are also being Implemented for genetic 
modification of corynebacteria. 
Techniques of pulse field electrophoresis have been sucessfully used 
for isolating large frgments of the genome of several corynebacteria. 
In combination with cosmid gene libraries, this technique is being 
applied for construction of ordered encyclopedias of the genome of 
B. lactofermentum and C. glutamicum. 
Characterization of corynebacterial promoters and regulatory 
sequences, and directed in vitro mutagenesis of those sequences, 
has led to construction of strong expression systems in which 
production of amino acids is deregulated. 
COOPERATIVE ACTIVITY: A close conection has been already established between the five 
participating laboratories. Dunican (Galway) and Martin (Ledn) have 
exchanged strains, plasmids and gene fragments. Blanco (Rennes) 
has provided phages to Sahm. A scientist from Martin laboratory 
(Carmen Guerrero) was working for one month in Galway, and one 
scientist of Galway (Angela Fegan) worked for two months in Ledn. Dr. 
Luis M. Mateos and Ms. Cristina Fernindez from the group of Martin 
worked in Puhler's lab for three (August-November, 1991) and two 
months (September- November, 1991) respectively. 
All the groups involved have also scientific conections with the major 
amino acid-producing companies in Europe, Degussa, SA., Orsan, 
and some smaller companies (Bioproces, SA.). A first coordination 
meeting of the scientist involved in the project was held in Orsan at 
Les Ulis (Paris) on February 1991. The First Annual Meeting of the 
project is scheduled to take place in late May in Paris, after the initial 
11 months of the project. 
UST OF JOINT PUBLICATIONS/PATENTS 
WITH TRANS-NATIONAL AUTHORSHIP: Work is not yet published. 
OTHER PUBLICATIONS/ . Bormann, E f t , Eikmanns, B.J. and Sahm, H. (1992) Mol. Microbiol. 
PATENTS: 6:377-326. 
- Cadenas, R.F., Martin, J.F. and Gil, JA. (1991) Gene 98:117-121. 
- Del Real, G., Aguilar, A. and Martin, J.F. (1985) Biophys. Res. 
Commun. 133:1013-1019. 
- Guerrero, C, Mateos, L.M., Malumbres, M. and Martin, J.F. (1992) 
Appl. Microbiol. Biotechnol. 36:759-762. 
- Martin, J.F., Cadenas, R.F., Malumbres, M., Mateos, L.M., Guerrero, 
C. and Gil, JA. (1990) In: Genetics of Industrial Microorganisms, 
Strasbourg, pp. 285. 
- Park, Y.-H., Hori, H., Suzuki, K.-I., Osawa, S. and Komagata, D. (1987) 
J. Bacteriol. 169:1801-1806. 
- Schaler, A, Kalinowski, J., Simon, ft, Seep-Feldhaus, A-H. and 
PChler, A (1990) J. Bacteriol. 172:1663-1666. 
- Schwarzer, A and Puhler, A (1991) BiolTechnology 9:84-87. 
- Weaver, L.M. and Herrmann, KM. (1990) J. Bacteriol. 
172:6581-65-84. 
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TITLE : Valorization of non-conventional yeasts of industrial 
interest : exploration and molecular engineering of their 
genetic constituents. 
CONTRACT NUMBER BIOT- CT91-0267 (DSCN) 
OFFICIAL STARTING D A T E : 1 April 1991 
COORDINATOR: FUKUHARA, Institut Curie-Section de Biologie, Orsay, FR 
PARTICIPANTS : 1) FUKUHARA, Institut Curie - Biologie, Orsay, FR 
2) FRONTALI, University of Rome, IT 
3) HOLLENBERG, University of Diisseldorf, DR 
4) DOMINGUEZ, University of Salamanca, ES 
5) MEACOCK, University of Leicester Biocentre, UK 
6) FERRERO, Genetics Institute, University of Parma, IT 
7) GA1LLARDIN, INRA, Thiverval-Grignon, FR 
8) FLEER, Rhone-Poulenc Rorer, Vitry-sur-Seine, FR 
9) VERBAKEL, Unilever Laboratorium, Vlaardingen, ND 
OBJECTIVES SET FOR THE REPORTING PERIOD : 
* PARTICIPANT 1 : Genetic and physical mapping of K. lactis genes ; assessment 
of strain variability ; isolation of maximal number of mutations ; construction of yeast-yeast 
shuttle banks ; characterization of killer plasmid promoters. 
* PARTICIPANT 2 : Identification of ADH genes from K. lactis genomic library ; 
identi- fication and sequencing of chromosomal ARS sequences from K. lactis ; identification 
of ARS consensus sequences. 
* PARTICIPANT 3 : Analysis of regulation of methanol oxidase promoter in H. 
polymorpha ; establishement of a K. lactis promoter based expression system. 
* PARTICIPANT 4 : Cloning of the acid phosphatase gene of K. lactis and of 
metalloproteins of K. lactis and Y. lipolytica ; genetic and physical mapping of K. lactis genes; 
isolation of AT. lactis secretory mutations. 
* PARTICIPANT 5 : Analysis of the patterns of protein synthesis vs. environmental 
stresses ; search of stress-response genes ; analysis of specific mRNA abundancies vs. stress 
and growth phase ; attempts of cloning stress response genes or construction of a cDNA 
library from differentially expressed genes. 
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* PARTICIPANT 6 : Isolation and genetic characterization of new Rag" mutations 
involved in sugar metabolism; physiological characterization of Rag¯  mutations; definition of 
parameters of catabolite repression in K. lactis and selection of catabolite repression mutants. 
* PARTICIPANT 7 : Improving conditions for chromosome separation in Y. 
lipolytica ; identification and characterization of SEC genes ; construction of genomic library 
of Y. lipolytica on replicative vectors; assessing maintenance of K. lactis killer plasmids in Y. 
lipolytica. 
* PARTICIPANT 8 : Choice of a reporter gene, construction of expression cassettes 
; construction of vectors allowing targetted integration of expression cassettes ; transfer of the 
same cassettes to stable plasrnid vectors; transformation of selected yeast strains. 
* PARTICIPANT 9 : Develop and evaluate general fermentation characteristics of 
commercial Kluyveromyces strains ; cloning of regulator sequences ; develop cloning system 
for selected commercial Kluyveromyces strains ; evaluation of engineered yeasts 
(Kluyveromyces and Hansenula) for possible application. 
MAJOR PROBLEMS ENCOUNTERED : 8 months delay of the EC funding 
RESULTS: 
The research is progressing on the line defined above. Exchanges of researchers 
and materials, as well as interaction between participants are active. The situation of specific 
topics are summarized below. 
* PARTICIPANT 1 -. 
Mapping of genes in K. lactis has progressed by construction and use of multiply labelled 
strains and centromere linked markers. Data on physical mapping on chromosomes of cloned 
genes are accumulating in parallel, confirming genetic data. To support mapping work, many 
new mutations were isolated and several genes were cloned. Strain diversity is being assessed 
by electrophoretic karyotyping of most of the K. lactis isolates from the CBS collection. K. 
lactis - S. cerevisiae shuttle banks were constructed. A promoter from the killer plasmid kl 
has been characterized and is being examined for a possible use in heterologous gene 
expression. 
* PARTICIPANT 2: 
Four genes encoding alcohol dehydrogenase isozymes have been identified by hybridization to 
ADH2 probes of S. cerevisiae. The genes have been isolated and sequenced. Sequence 
analysis revealed high homology (near 80 %) between the K. lactis and S. cerevisiae genes. 
Two ADH genes of K. lactis have amino terminal extensions suggesting a mitochondrial 
localization of the encoded activities. 
Identification of the gene products is in progress based on the ADH electrophoretic pattern of 
adh mutants obtained by gene disruption. 
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Chromosomal DNA fragments from K. lactis have been tested for the ability of efficiently 
sustaining autonomous replication of plasmids in K. lactis or in S. cerevisiae. 
Some of these fragments have ARS function only in K. lactis while others support 
autonomous replication in both yeasts. 
Comparison of the sequences responsible for ARS function is in progress and the role of a 
dodecanucleotide similar to the core consensus of S. cerevisiae is being assessed by site 
directed mutagenesis. 
* PARTICIPANT 3 : 
Studies on the strong promoter of the methanol oxidase gene in Hansenula polymorpha have 
revealed a complex mode of regulation. Cis-acdng regulatory sequences have been identified. 
Binding of sequence specific factors to three of these elements could be shown both in vitro 
and in vivo. Mutants have been isolated that affect the down regulation of this gene in the 
absence of methanol whereas catabolite repression is retained. These mutants are currendy 
being investigated. In Kluyveromyces lactis, the detailed knowledge on the structure and 
mode of regulation of the P-galactosidase (LAC4) promoter is being exploited to establish 
expression systems for heterologous genes. The system is based on integrative and 
centromere (collaboration with Dr. B. Zonneveld and Y. Steensma, Technical University of 
Delft) containing vectors allowing to construct stable strains expressing heterologous genes. 
As a first indicator gene the bacterial P-glucosidase gene (GUS) was chosen in agreement 
with other participants. To evaluate the effect of over production of the LAC4 controlling 
transcriptional activator LAC9, host strains expressing different levels of LAC9 have been 
constructed. 
* PARTICIPANT 4 -. 
The resistance of different strains of Yarrowia lipolytica was analyzed and copper-sensitive 
mutants have been obtained. Using an integrative bank of Yarrowia lipolytica supplied by 
participant 7, it has been possible to complement one of the mutations. The corresponding 
gene has been cloned and sequenced, proving to be a regulatory gene. In different strains of 
K. lactis provided by participants 1 and 3, we have examined the existence of repressible acid 
phosphatase. The enzyme has been purified and its aminoterminal end is now being 
sequenced. Mutants lacking in this activity have been obtained. Different plasmids have been 
constructed with genes donated by participants 2 and 9 to obtain mutants in the secretory 
pathway. 
* PARTICIPANT 5: 
Four clones of stress-inducible genes isolated from Saccharomyces cerevisiae (HSP12, 
HSP26, ESP30 and ESP35) were used as hybridization probes for a Southern blot analysis of 
K. lactis genomic DNA. Clones hybridizing with these probes (except HSP26) could be 
isolated. It has not been necessary to construct cDNA libraries for their isolation. Regions of 
the K. lactis DNA with homology to the S. cerevisiae probes have been used to examine the 
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expression of their cognate RNAs. The K. lactis sequences are transcribed and they have very 
similar expression to their S. cerevisiae counterparts. The transcription of each of the K. lactis 
genes is specifically regulated as a function of growth media (YPD and molasses were tested) 
and growth phase. Similar approach could be extended to search for homologous sequences to 
other S. cerevisiae genes that have a potentially interesting and useful pattern of expression 
(e.g. UB14, SSA3). The cloned K. lactis genes will be characterized in detail by DNA 
sequencing, RNA transcript mapping, etc, so that their promoter regions can be evaluated for 
heterologous gene expression. The S. cerevisiae probes have been sent to participant 4 who 
will search for homologues in Yarrowia lipotytica. 
* PARTICIPANT 6-. 
Many new mutants of Kluyveromyces lactis affected in carbohydrate metabolism were 
isolated. Some of them belong to the "rag" group (cf. participant 1), some others do not. The 
genetic analysis demonstrated that the isolated mutants define several complementation 
groups. A gene involved in the energetic metabolism was isolated and sequenced. Parameters 
of catabolite repression have been defined. Several selection strategies were used to obtain 
mutants resistant to catabolite repression (non-repressible mutants) and mutants that do not 
derepress sensitive enzymes (non-derepressible mutants). 
* PARTICIPANT 7: 
Karyotyping of wild type Y. lipotytica isolates revealed a pronounced diversity of patterns and 
individual gene probes showed that gross chromosomal rearrangements are associated with 
chromosomal polymorphism. A minimal chromosome number estimate of 5 is proposed. A 
implicative genomic library of Y. lipotytica has been constructed to isolated new genes and 
successfully tested. 
* PARTICIPANT 8: 
We have started to work on the construction of recombinant Kluyveromyces lactis strains 
harboring expression cassettes either integrated at a defined chromosomal locus (RAG2) or 
contained on multi-copy vectors derived from the nature Kluyveromyces plasmid pKDl. The 
expression cassettes were identical in structure except for the expression signals used to 
initiate DNA transcription. The promoters used were S.c. PGK, K.l. LAC4, K.l. ADH3 and 
K.1. ADH4. First results have been obtained in shake flask experiments with respect to 
product yield and transcriptional activity (Northern analysis). Fed-batch studies with a strain 
harboring the reporter gene under control of the ADH4 promoter are scheduled for the month 
of April. 
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* PARTICIPANT 9 : 
The fermentation characteristics of Kluyveromyces marxianus have been studied. The 
fermentation process is aiming at a very high cell density and high production/secretion of the 
homologous enzyme inulinase. The following factors affecting the fermentation process were 
studied : temperature, mixing, sugar concentration, medium composition and carbon dioxide 
levels. Very important was to grow the yeast using high air/oxygen flows in order to avoid the 
generation of toxic metabolites such as acetaldehyde and acetylacetate. In the optimal 
fermentation process 100 gram dry weight per liter was achieved and up to 4 gram per liter 
inulinase was excreted. In this process 8 % of the total cellular protein is inulinase which 
shows that the production and secretion of an enzyme using this fermentation process is very 
deficient. 
HIGHLIGHTS/MILESTONES : Nothing to report. 
WIDER CONSIDERATIONS : 
The annual ELWW Workshop, Biology of Kluyveromyces V, will be organized as a satellite 
meeting of the 16th International Conference on Yeast Genetics and Molecular Biology, 
August 1992 at Vienna. An International Conference on non-conventional yeasts, held at the 
Biozentrum, Basel, also in August 1992, will be an previledged place of information 
exchange. As non-conventional yeasts, the target organisms of the present project are among 
the most significant species in biotechnology. 
COOPERATIVE ACTIVITIES : 
1) The ELWW Workshop, Biology of Kluyveromyces IV, was held at Dusseldorf, 21-22 
September 1991. A first meeting of all the project leaders was also held at this occasion. 
2) A ELWW booklet on the activity of this consortium is being prepared by all the 
participants. 
3) A predoctoral fellow's long term stay from laboratory 4 to laboratory 1 ; a post-doctoral 
fellow's long term stay from laboratory 4 to laboratory 7. 
4) Working visits of researchers : two from laboratory 2 to laboratory 1, two visits from 1 to 
2; one visit from 7 to 4, one visit from 5 to 7 ; one visit from 2 to 7. 
5) Collaboration on the K. lactis expression system between participants 3 and 8. 
6) Many exchanges of materials between the participant laboratories (yeast strains, vectors, 
DNA banks, clones genes, communication of methods). 
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JOINT PUBLICATIONS : 
Participants 1 and 6 : Glucose transport in the yeast Kluyveromyces lactis. I. Properties of an 
inducible low-affinity glucose transporter gene. M. Wesolowski-Louvel, P. Goffrini, I. 
Ferrero and H. Fukuhara. Molec. Gen. Genet., in the press. 
OTHER PUBLICATIONS/PATENTS 
Participant 3 : Co-regulation of the K. lactis lactose permease and P-galactosidase genes is 
achieved by interaction of multiple LAC9 binding sites in a 2.6 kbp divergent promoter. A. 
Godecke, W. Zachariae, A. Arvanitidis and K.D. Breunig. Nucl. Acids Res. 19, 5351-5358 
(1991). 
- 3 articles submitted for publication (participant 1) 
- 1 article submitted for publication (participant 2) 
- 2 articles submitted for publication (participant 4) 
- 2 articles submitted for publication (participant 6) 
- 2 articles submitted for publication (participant 7). 
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MOLECULAR AND GENETIC ANALYSIS OF GENES CONTROLLING FLOWER 
DEVELOPMENT 
Contract 
Official start 
Coordinator 
Participants 
OBJECTIVES 
BIOT 900171 
1991-01-01 
Dr E. Coen, John Innes Institute, Norwich, UK. 
Dr Z. Schwarz-Sommer, Max-Planck-Institut, Koeln, Germany. 
Dr J. Beltran Porter, Consejo Super, de Invest. Cientificas, Valencia, Spain. 
Dr J. Almeida, Inst. Superior de Agronomia, Lisboa, Portugal. 
Dr J. Newbury, Birmingham University, Birmingham, UK. 
The aim is to isolate and study key genes controlling floral morphogenesis in an 
experimentally suitable system and eventually to compare them with their counterparts in other species. 
Antirrhinum provides an excellent model system since two key genes have already been isolated; it 
has well-characterised transposons and an extensive range of mutations affecting floral development 
have been documented. A range of molecular and genetic tools will be established in Antirrhinum to 
facilitate gene cloning and analysis. These include: isolation of a set of active transposons by trapping 
them in previously characterised genes; construction of a combined restriction fragment length 
polymorphism and genetic map; genetic characterisation of floral mutants, construction of double 
mutants and development of a transformation system. These resources will then be exploited to isolate 
genes by transposon-tagging or differential cDNA cloning. In addition, the possibility of using genes 
from Antirrhinum to study their counterparts in other species such as Pisum sativum will be 
investigated. The results of this research should make a major contribution to the isolation of key 
plant genes and to our understanding of flower development 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report 
RESULTS 
1. Transposon-trapping 
One feature of the Antirrhinum system, of great importance for gene isolation, is the 
availability of cloned transposons (short segments of DNA that can move around the genome). If a 
mutation in a gene is caused by insertion of a well characterised transposon, the affected gene can 
usually be isolated. It is therefore essential to isolate and characterise all active transposons that are 
present in Antirrhinum lines routinely used for transposon mutagenesis. The approach adopted in this 
programme is to trap the active transposons in previously isolated genes. For example, the incolorata 
(inc) gene is required for red pigmentation of Antirrhinum flowers; inc mutants have pale or white 
flowers. So far, 14 different inc mutants have been recovered by the Norwich group by screening 
mutagenic lines for pale or white-flowered plants. Because the inc gene has been cloned, it was 
possible to analyse the inc mutations at the molecular level. They showed that the 14 mutants were 
caused by insertions of various types of transposons at different positions in the inc gene. These 
transposons are now being characterised and any novel types will be cloned and used as probes in 
transposon-tagging experiments. In addition to inc. many other loci are also being used as traps in 
this way: five transposons have been trapped at the plena locus (Norwich), three at squamosa (Koeln), 
three at globosa (Koeln) and two at deficiens (Koeln). The overall objective will be to establish a 
"library" of transposons available for general use. 
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2. Targetted tagging 
Many of the mutants in Antirrhinum have arisen from general transposon-mutagenesis 
programmes so that several different types of transposon could be responsible for a mutation. An 
alternative approach is to try and target a specific transposon to the gene of interest. This may be 
possible because several plant transposons have been shown to preferentially transpose to chromosomal 
positions closely linked to the site of excision. To test the feasibility of this approach, an extensive 
crossing programme is being carried out by the Lisbon group to try and select for events in which the 
transposon Tam3 has moved from the pallida (pal) locus to the closely linked divaricata (div) locus. 
2500 progeny from a cross between div and 100 different Pat revertants are being grown to screen 
for new div mutants. Many of the revertants should carry copies of Tam3 in the vicinity of div and 
by growing them at 15°C, Tam3 transpositions should be favoured. In addition, they constructed a 
double mutant for a stable pal allele and div, to be crossed to plants carrying Tam3 at pal grown at 
15°C. This should enable thousands of independent transpositions to be selected for at the seedling 
stage (pal mutants affect seedling pimentation). Furthermore, in collaboration with the Koeln and 
Norwich groups, the flo gene has been mapped relative to div and pal, to give the order pal-div-flo 
(pal-div = 5cM; div-flo = 10-15 cM). Because Tam3 insertions at flo are available, this may provide 
another source of linked Tam3 copies for mutagenesis of div. In parallel with these studies, the Lisbon 
group has also carried out a detailed phenotypic analysis of div and wild-type flowers at various stages 
of development using scanning electron microscopy. 
3. Construction of an RFLP map of Antirrhinum 
The previous section illustrates how the ability to localise genes on a genetic map can be of 
enormous value for gene isolation and analysis. Although a good genetic map of Antirrhinum exists, 
it is of limited value for the rapid assignment of map positions to newly cloned DNA sequences. To 
circumvent this problem, the Koeln group is constructing a combined genetic and Restriction Fragment 
Length Polymorphism (RFLP) map for Antirrhinum. Crosses have been carried out between inbred 
lines of Antirrhinum majus and Antirrhinum molle, two species that are likely to reveal RFLPs. 96 
F2 progeny from these crosses have been probed with about 100 molecular markers (these include 
randomly selected cDNA clones and clones of known loci, which were provided in part by the 
Norwich group). This analysis has already allowed the map position of 80 cloned DNA sequences 
to be determined. Because some of these cloned sequences correspond to previously mapped genetic 
loci, it has also been possible to Stan aligning the RFLP and classical genetic maps. So far, five out 
of the eight Antirrhinum chromosomes, mapped in the past by classical methods, could be assigned 
to RFLP linkage groups. The validity of the RFLP map was confirmed by comparison of linkage data 
obtained by analysis of two independent F2 populations. 
Current work of the Koeln Group is focussing on three areas. Firstly, the linkage map has to 
be refined by mapping further molecular markers which should allow the number of RFLP linkage 
groups to be reduced to eight. Secondly, the mapping of known morphological mutants should lead 
to the alignment of the classical genetic map with the RFLP map. For this reason, they will carry out 
an RFLP analysis of F2 populations segregating for morphological markers known to be located at two 
distant postions within each of the chromosomes of the classical linkage map. Thirdly, to facilitate 
use of the map by other groups, they are preparing recombinant inbreds by repeated selfing of all F2 
individuals of the Amajus x Amolle population used to establish the current map. As this work 
progresses, a more extensive and accurate map will be produced which will be invaluable to all 
Antirrhinum scientists. 
4. Construction of double mutants 
The analysis of how genes interact to control flower development can be greatly aided by 
studying the phenotypes and properties of plants that carry mutations in several genes (e.g. double or 
triple mutants). The Norwich, Koeln and Lisbon groups are involved in this aspect of the programme. 
For example, the Norwich group has constructed and analysed: cyc;ovu, defiple, sepiple, glo;ple, 
flo;glo,flo;squa. The phenotypes obtained have had important implications for models of how flower 
development is controlled. Many other mutant combinations are currently being made in the 
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collaborating laboratories. 
5. Transformation of Antirrhinum 
The ability to modify and introduce genes into plants provides a very useful tool for the 
analysis of gene function. Although genes isolated from Antirrhinum can be introduced into related 
species, such as tobacco, it is not yet possible to re-introduce them into Antirrhinum. This is because 
there is no routine method for transformation and regeneration of Antirrhinum. One aim of the 
programme is to try and develop such a method. An efficient procedure for regeneration from young 
stem explains is being developed by the Birmingham group. 
They have determined suitable conditions for the production of hypocotyl-derived callus and 
the efficient regeneration of shoots and roots, using a range of different varieties of A. majus. 
Transformation experiments were carried out using hypocotyls and a range of wild-type Agrobacterium 
tumefaciens strains. Transformation, as assessed by the formation of opine-producing tumours, was 
achieved in all varieties tested. The strain C58 was identified as being the most virulent and 
agrobacteria containing C58 virulence have been chosen for later work with disarmed vectors. 
T-DNA transfer rates are known to be influenced by a range of factors, including the 
concentration of certain phenolic compounds. The Birmingham group therefore performed 
transformations using combinations of different phenolics, wild-type Agrobacterium strains and 
varieties of Antirrhinum using media of varying pH. In general, transformation was favoured by low 
pH and the inclusion of acetosyringone in the co-cultivation medium. Maximal regeneration of the 
least susceptible variety, however, was obtained with the combination of high pH and the addition of 
syringaldehyde. This indicates that transformation conditions for each Antirrhinum variety will have 
to be optimised. A study to see if correlations exist between the frequency of transformation and the 
endogenous production of phenolic compounds by wounded Antirrhinum tissue is in progress. Initial 
results indicate large variations in both the type and quantity of compounds formed during 24 h after 
wounding. 
Transformations have now been attempted using a range of different disarmed vectors. This 
work has included (I) the use of vectors containing selectable markers for either antibiotic or herbicide 
resistance and (2) the use of different transformation protocols using either hypocotyls, shoot bases 
or whole plants. To date, no transformed plants have been regenerated. However, the use of a 
herbicide resistance marker allowed fewer non-transformed "escapes" and its use should eventually 
lead to a more efficient transformation protocol. 
6. Technology transfer between plant species 
Understanding the genetic control of flower development in Antirrhinum should provide a 
model for studies in other species. To investigate the possibility of extending expertise to other plants, 
the Valencia group is using Antirrhinum DNA probes for the analysis of genes controlling flower 
development in pea. The genetics of pea has been very well researched and many mutants are 
available. One of these gives flowers in which carpels (female organs) grow in place of stamens and 
petals are sepaloid; a phenotype rather like that of the deficiens mutant of Antirrhinum. The Valencia 
group is using the deficiens gene to isolate its counterpart in pea to test whether the phenotypic 
similarities between the mutants in these species reflect the action of a common gene. They have 
constructed a cDNA library from pea flowers and probed it with a deficiens clone. 24 positives were 
isolated and these are currently being characterised. 
In parallel with this work, they have also been characterising the histology of pea floral 
mutants and screening for monoclonal antibodies which will specifically recognise cell types in 
different floral organs. From an initial screen of monoclonal antibodies against extracts from pea 
flowers, they obtained one antibody that recognised the large subunit of Rubisco. They were able to 
use this to identify sepals due to the low amount of Rubisco in the other floral organs, allowing the 
transformation of petals to sepals in the deficiens-\ike mutant to be readily visualised in flower 
sections. A second monoclonal recognised an antigen present in petals at high levels relative to other 
organs. 
One problem encountered in the screens for organ-specific antibodies was the presence of large 
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amounts of proteins common to all flower parts. To alleviate this problem, they are using several 
strategies to eliminate common proteins from the extracts before they are injected into mice. Early 
results with subtracted carpel extracts are encouraging and a similar approach is now being extended 
to other organ types. However, in some organs there is the further complication of abundant proteins 
that may be immuno-dominant. For example, anthers contain an abundant 27kD protein, probably 
located in the pollen sacs, that is present at very early stages of development. To eliminate this 
protein from anther extracts by immunoprecipitation, they are raising a monoclonal antibody that will 
recognise it. This antibody will also be useful as a marker for anthers. The antibodies obtained from 
these screens may be valuable for studying Antirrhinum as well as pea, illustrating that exchange of 
materials and expertise between groups working on different species may be very valuable. 
HIGHLIGHTS AND MILESTONES 
1. Isolation and characterisation of several new plant transposons. 
2. Construction of a combined RFLP and genetic map for Antirrhinum. 
3. Characterisation of novel gene interactions controlling flower development. 
4. Initiation of targetted tagging 
5. Characterisation of monoclonal antibodies recognising floral organs 
6. Optimisation of a regeneration system for Antirrhinum 
WIDER CONSIDERATIONS 
The form, physiology and function of the flower is of central interest to plant developmental 
and reproductive biologists. Furthermore, the flower is of major agronomic importance both for the 
efficient breeding of crops and because many plant products are derived from flower seeds and fruits. 
European scientists have made major advances in the molecular and genetic analysis of flower 
development through studies on Antirrhinum (the garden snapdragon). By studying mutations that 
cause Antirrhinum flowers to develop abnormally, they have been able to start unravelling how genes 
control the development of normal flowers. The technology is also being extended to other species, 
such as pea, so that processes general to all plant species are being uncovered. 
This programme has brought together expertise in different European laboratories to develop 
the most effective tools required for exploiting and extending the Antirrhinum system. They have been 
successful in isolating several novel transposons (jumping genes) from this species and have developed 
a molecular map of its chromosomes. These tools can now be used to help scientists isolate and study 
key genes controlling flower development 
COOPERATIVE ACTIVITIES 
The success of this programme depends on the effective combination of complementary skills 
and resources in the participating laboratories. The disciplines covered include: molecular biology, 
classical genetics, tissue culture, developmental and comparative biology. Each laboratory alone would 
be unable to develop all the tools necessary but in combination it is hoped that will firmly establish 
a powerful and generally useful model system. The particular exchanges that have occured are: 
1. Meetings 
So far we have had one major meeting which was held in Koeln from 17/4/91-21/4/91 and 
involved presentations from all of the participants. A report on this meeting was published in 
Flowering Newsletter (see below). The next meeting will be held in Valencia from 14/5/92-17/5/92. 
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2. Materials 
Many clones of genes have been freely exchanged between participants, including clones of 
flo. pie, def. glo, squa, del, pal. olive, inc. In addition, cloned transposons exchanged include Taml, 
Tam2, Tam3, Tam4, Tam5, Tam6, Tam7, Tam8 and Tam9. Many genetic stocks have also been 
freely exchaged, including those carrying mutations alflo, pie, glo, squa, inc. div, pal, def. 
3. Staff exchanges 
J. Almeida spent July 1991 working with the Norwich Group. 
S. Hantke from the Norwich group worked for 3 weeks with the Koeln group in December, 
1991. 
M. Mooney and P. McSteen from the Norwich Group visited the Birmingham group for 2 days 
in September, 1991. 
E. Andrade from the Lisbon group has joined the Koeln group to work on a PhD. 
JOINT PUBLICATIONS 
Carpenter, R., Coen, E.S., Huijser, P., Schwarz-Sommer, Z., Sommer, H. (1991) The genetic control 
of flower development in Antirrhinum Flowering Newsletter _12, 38-41. 
In addition, we have also submitted a report on the programme to be published as a brochure by the 
Commission. 
OTHER PUBLICATIONS 
Most of the work carried out in this programme has not yet been published. Two reports on 
transformation experiments are: 
Holford, P., Newbury, HJ. (1992) The effects of antibiotics and their breakdown products on the m 
vitro growth of Antirrhinum majus. Plant Cell Reports (in press). 
Holford, P., Hernandez, N, Newbury, H.J. (1992) Factors influencing the efficiency of T-DNA transfer 
during the co-cultivation of Antirrhinum majus with Agrobacterium tumefaciens. Plant Cell Reports 
(in press). 
140-
THE MOLECULAR BASIS OF CELL-CELL INTERACTIONS IN SELF-
INCOMPATIBILITY 
Contract :BIOT 900172 
Signed start :1990-12-01 
Duration :36.0 Months 
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. 
Institut fur Ziichtungsforschung 
Coordinator: 
Dr. R.D. Thompson, MPI fur Ziichtungsforschung, D-5000 Kb In 
Participants: 
Dr. A. Tiezzi, Univ. of Siena, Italy 
Dr. E. Jacobsen, Univ. of. Wageningen, Netherlands 
Dr. G. Wricke, Univ. of Hannover, Germany 
Dr. G. Wullems, Univ. of Nijmegen, Netherlands 
Dr. M.v. Grinsven, Zaadunie B.V., Enkhuizen, Netherlands 
Objectives set for the reporting period 
The objectives set for the first year of this project as 
defined by the original workplan focussed on characterization 
of the potato S-RNAse alleles SI and S2, specifically the 
genomic sequence determination and expression of recombinant 
protein in E. coli/Baculovirus. Further, it was planned to 
test for S-RNAse sequences in potato anther RNA using PCR, to 
set up PCR tests for S-RNAse-related sequences in Rye, and to 
construct a cDNA bank from anther RNA. All of these 
experimental approaches have been pursued and completed. In 
the case of Rye S-RNAse-related sequences, no products were 
identified, and in view of the apparent similarity of this 
system to Brassica SI (see results), efforts to identify SRK-
related sequences by PCR will be attempted instead. A cDNA 
bank has been constructed to fertilised styles rather than 
anthers, in order to include transcripts produced only in 
germinated pollen (see results). 
Major problems encountered 
1. Propagation of potato lines of defined "S" genotype 
2. Identification of pollen transcript of the S-locus 
1. Previous molecular characterization of the potato "S^locus 
was carried out on dihaploid lines identified by Prof. Hermsen 
which are derived from the cross G-254 x B16. As these lines 
are derived from tetraploid material, they display in many 
cases defects at loci previously masked in the tetraploid. 
Thus, many of the lines have yellow leaf margins, and in some 
cases growth and pollen fertility is reduced. At the start of 
the programme, research was impeded as only this material was 
available. The plant material supplied to BRIDGE labs, needed 
to be redeveloped to select against and thereby minimize these 
deleterious effects on plant performance. This work has now 
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been carried out by Professor Jacobsens laboratory (see 
results), and much improved lines are available for study. 
2. A central objective of this project is the identification 
of the pollen component of the S-locus. Since the discovery 
and cloning of SLG cDNAs in 1986, a number of labs have tried 
to demonstrate the presence of a homologous pollen S-locus 
product, without success. The alternative approach, of looking 
for a different, S-linked pollen protein has also not met with 
success. Therefore not unexpectedly, this remains on a problem 
for our project. Efforts to use PCR to identify SLG-homologous 
pollen-transcripts have been so far negative, and alternative 
approaches are being pursued. On the assumption that the 
pollen S-linked gene is distinct in sequence from the SLG, but 
tightly linked to it, RNA filters carrying pollen RNA are 
being hybridized with a series of DNA fragments covering the 
entire SI and S2 SLG-genomic clones. 
Results: 
Identification of S-locus-defined potato plants (Wageningen) 
The potato clones previously used for molecular analysis of S-
locus gene products (Kirch et al., 1989) suffered from genetic 
defects and therefore the development of new S-locus-defined 
clones was of high priority in our investigations. For this 
purpose, the Wageningen group have identified clones of all 
six possible SI genotypes from the same seed stocks studied 
previously. These genotypes were selected on the following 
criteria: 
1) S-allele constitution as assessed by isoelectric 
focussing gel protein pattern 
2) Plant vigour 
3) Tuberization 
30 clones of the newly developed material have been 
distributed to other BRIDGE partners. 
New methods for identifying SI genotypes (Wageningen) 
In order to screen large populations for their S-genotypes, an 
IEF method was established which permits the analysis of up to 
52 samples on one gel. A technique for producing homozygous 
plants more efficiently has been developed, in which during an 
incompatible cross-pollination, pollen from Solarium phureja is 
also supplied; this enhances seed-set and hence yield of 
homozygotes. The diploid clone of S. phureja used carries a 
dominant embryo seed spot marker which allows hybrid seed to 
be distinguished from the desired selfed product. Finally, a 
bilateral compatible system has been established between 
diploid potato (S. tuberosum) and S. verrucosus. S. verrucosum 
is self-compatible, but cannot normally be used as male 
partner in the interspecific cross. However, SI S. tuberosum 
acceptor lines have been identified which overcome this 
problem. This research paves the way for understanding the 
basis of unilateral interspecific incompatibility, as it will 
allow the genetic factors involved to be mapped. 
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Ultrastructural analysis of fertilisation in SI protato lines (Siena) 
Observations were carried out using transmission and scanning electron microscopy on pollen and stigma from S1S3 and S2S3 clones, with the following conclusions. Firstly, a discrepancy was noted between the maturation time of pollen and stigma on the same plant. When anthers release mature pollen grains, the stigma is still immature and first produces stigmatic exudate a few days later. A scanning E.M. comparison of S1S3 and S2S3 pollen grains revealed differing exine structures. Cross sections analysed by transmission E.m. showed no internal differences between pollen grains of the two genotypes. Potato pollen is "bicellular" as it contains a vegetative mucleus and a generative cell. The generative cell is spindle-shaped and located close to the plasma membrane. The generative cell is located at the centre of the mature pollen grain. In some cases a close association between the generative cell and vegetative nucleus is observed. 
Stigma from both S1S3 and S2S3 plants have been compared by scanning E.M. In both cases the stigmatic surface is composed of papillae which at maturity are completely covered with stigmatic exudate. S1S3 stigma are single hemisperical lobes whereas S2S3 stigma exhibit a deep central furrow. It will be of interest to establish whether the genetic basis for morphological differences observed can be related to the S-locus. 
Biochemical basis for gametophytic self-incompatibility (Hannover) 
The physiology of the SI response varies with different species. In Hannover, the two loci S and Z system of Rye is being investigated. In this case, the SI reaction occurs within a few minutes after pollination. Incompatible pollen tubes usually do not penetrate the stigmatic tissue but are arrested at the stigma surface. In view of the involvement of protein kinases in mammalian fast transduction pathways, and the finding of an S-related receptor-like kinase at the 
Brassica S-locus, experiments were initated to check the involvement of kinases in Rye SI. 
An involvement of Ca2+ in the SI response has been established by incubating stigma with two Ca2+ blockers (Verapamil and La 3 +), and monitoring the effect of an attempted self-pollination. The vast majority of pollen tubes grew down to the ovary, indicating a strong delay in the SI response. 
A panel of six inhibitors acting on Tyrosine-specific protein kinases was tested for effects on the Rye Sl-reaction. In two cases, Lavendustin A and its chemical precursor 2-OH-5-(2,5 di OH Benzyl) aminobenzoic acid, "self" pollen tubes behaved as in a compatible pollination, suggesting similar kinases are involved in the SI response. Isoelectric fosussing of 32p-phosphorylated pollen membrane preparations demonstrates the 
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presence of a number of acidic phosphorylated polypeptides. 
Part of the physphorylating activity can be inhibited by 
Lavendustin A. 
Characterization of the potato stylar S-linked RNAse (S-RNAse) 
gene (Koln) 
The S-RNAse SI and S2 genes have been isolated (Kaufmann, 
Salamini and Thompson, 1991) and sequenced, thus permitting us 
to study the sequences necessary for style-specific 
expression. The maps of both S-clones with several restriction 
enzymes show no common features, indicating the highly 
polymorphic character of the S-locus. Both genes possess one 
small (113, 117 bp) intron, inserted in the same region of the 
open reading frame. The coding sequences have been expressed 
E. coli as glutathione-S-transferase fusion proteins, and 
antibodies raised. Using these antibodies, the existence of an 
antigenically-related pollen protein has been investigated. No 
such protein was identifiable on Western blots. The ability of 
isolated S2 protein to associate with specific pollen proteins 
was also analysed using anti S2-AB. No specific association 
was detected. 
SI and S2-RNAse gene sequences were introduced into tobacco 
and potato plants via Agrobacterium-mediated transformation. 
Using translational fusions of the S2 promoter to 8-
glucuronidase, S2-promoter expression was found in pistils and 
pollen of transgenic tobacco plants. Similar results were 
obtained from transient expression experiments in which the 
DNA had been introduced via particle bombardment. In contrast, 
the SI promoter was very weakly expressed, and when introduced 
as the entire gene, no SI polypeptide or transcript could be 
detected. Possibly the SI promoter fragment used lacks an 
enhancer sequence located further away from the coding 
sequence than in S2. The promoters possess sequence homology 
restricted to a few short (< 20 bp) motifs, which may have a 
regulatory role. cDNA and genomic clones for SK2 have been 
isolated. The sequence shows SK2 to be a pistil-specific 
endochitinase, and this activity has been demonstrated for the 
purified protein. Monoclonal antibodies to SK2 are being 
developed by the Siena group. 
Pollen-specific gene expression in SI (Nijmegen) 
During pollen tube development, pollen-specific mRNAs 
accumulate, which may have a function in pollen-tube growth 
and in the pollen-stylar tissue recognition process leading to 
SI. A pollen-specific gene, NTP 303 has been isolated. NTP 303 
is transcribed in developing pollen, after the mid-binucleate 
stage, and in growing pollen tubes (Weterings et al., 1992). 
Its mRNA remains present in growing pollen tubes up to 72 h 
after pollination (Reijnen et al., 1991). Now that de novo 
transcription in germinating pollen has been demonstrated, 
efforts are underway to identify S-locus-determined 
transcripts in a library constructed using mRNA from styles 24 
h after pollination (S1S3 x S1S4). The library will be 
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subtracted with mRNA from mature unpollinated styles (S1S3) 
and screened differentially against pollen (S2S4). 
Transformation methodology for tomato (Enkhuizen) 
Although the majority of participants in this BRIDGE programme 
investigate the gametophytic system of SI in potato, 
Zaadunie's interest is directed towards exploiting this 
Knowledge in tomato, a crop in which Fl-hybrid seed is 
produced commercially by hand-emasculation. Work in this phase 
pf the contract period has focussed on the establishment of a 
transformation protocol for elite lines of tomato. Preliminary 
experiments suggested that many variables can dictate the 
success rate of a protocol. Several protocols were tested in 
order tp identify a usable and if possible, genotype-
independent -transformation method. Variables under 
investigation include: source of the explant and pre-treatment 
of the explant donor, ploidy level of starting material and 
regenerated plants, effect of varying media composition, and 
effectiveness of different Agrobacterium strains. To date, 
although a generally applicable protocol for elite lines of 
tomato is not yet available, sufficient progress has been made 
that efficient transformation of S-protein genes in tomato 
elite lines is now realistic. 
Highlights/Milestones: 
The discovery of de novo mRNA synthesis in germinating pollen 
is particularly significant, as it had previously been assumed 
that gene expression at this stage is directed predominantly 
by stored mRNA. Our strategies for characterizing the SI 
pollen-pistil interaction have been modified accordingly. 
Wider ponsiderations: 
The molecular analysis of gametophytic SI progressed 
significantly following the isolation of the gene encoding the 
female component of the system, and the genetical, cytological 
and biochemical studies summarized here. We are nearer to 
understanding how to exploit this natural system of 
fertilization control, both for the production of hybrids and 
for overcoming certain species barriers. 
Cpoperative activities: 
The BRIDGE project members have met together twice in the past 
twelve months to communicate data and review collaborative 
activities. One such meeting was held together with the second 
Brassica SI BRIDGE group in Enkhuizen, Holland. In addition, a 
number of visits have taken place between the laboratories for 
the purpose of acquiring materials, data or techniques, for 
example, between Wageningen and Koln, Hannover and Koln, 
Nijmegen/Wageningen, and Siena/Koln. Materials exchanged 
inglude S-locus-defined potato clones, DNA clones, antibodies, 
an doligonucleotide probes. 
Joint publications: 
Thompson RD, Unrig H, Hermsen JGTh, Salamini F, Kaufmann H 
(1991) Investigation of a self-compatible mutation in Solanum 
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tuberosum clones inhibiting S-allele activity in pollen 
differentially. Mol Gen Genet 226: 283-288. 
Other publications: 
Cresti M, Tiezzi A (1992) Pollen tube emission, organization 
and tip growth. In: Research in sexual plant reproduction 
(Cresti M, Tiezzi A, eds), Springer-Verlag, in press. 
Kaufmann H, Salamini F, Thompson RD (1991) Sequence 
variability and gene structure at the self-incompatibility 
locus of Solanum tuberosum. Mol Gen Genet 226: 457-466. 
Palevitz BA, Tiezzi A (1992) The organization, composition and 
function of the generative cell and sperm cytoskeleton. In: 
International Review of Cytology, Vol. Sexual reproduction in 
flowering plants, in press. 
Rijnen WH, van Herpen MMA, de Groot PFM, Olmedilla A, 
Schrauwen JAM, Weterings KAP, Wullems GJ (1991) Cellular 
localization of a pollen-specific mRNA by iii situ 
hybridization and confocal lase scanning microscopy. Sex Plant 
Reprod 4: 254-257. 
Tiezzi A, Moscatelli A, Cai G, Bartalesi A, Cresti M (1992) An 
immunoreactive homolog of mammalian kinesin in Sicotiana 
tabacum pollen tube. Cell Mobility and the Cytoskeleton 21: 
132-137. 
Weterings K, Reijen W, Van Aarssen R, Kortstee A, Spijkers J, 
van Herpen M, Schrauwen J, Wullems G (1992) Characterization 
of a pollen-specific cDNA clone from Nicotiana tabacum 
expressed during microsporogenesis and germination. Plant Mol 
Biol, in press. 
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OBJECTIVES REPORTING PERIOD: Extraction of mRNA from isolated embryo sacs and 
ovules. Construction of cDNA library. Cytological analysis of isolated embryo sacs, egg 
cells; development of an in vitro culture system of Petunia pollen tubes for the isolation of 
sperm cells; development a bio-assay for the analysis of directed pollen tube growth; 
selection of fertilization mutants. 
MAJOR PROBLEMS: due to limited financial support, the available manpower became a 
limiting factor. This seriously hampered progress, and it was decided to focus on one model 
species: Petunia. 
RESULTS: mRNAs were extracted from isolated Petunia embryo sacs and ovules (PARIS); 
cell biological aspects of isolated embryo sacs were studied (WAGENINGEN); an in vitro 
culture system for pollen tubes is being developed for the isolation of sperm' cells 
(WAGENINGEN-SIENA-COPENHAGEN); the in vitro fusion system is installed and tested 
(WAGENINGEN); the testing of gamete specific monoclonal antibodies is organized 
(BIRMINGHAM-SIENA-WAGENINGEN); Petunia mutants are collected to be analyzed 
for fertilization defects (BRACKNELL); the bio-assay for directed pollen tube growth 
(gametophyte interaction) is being developed (DUBLIN). 
HIGHLIGHTS: The actual isolation gametophytic mRNA from isolated embryo sacs for the 
construction of a cDNA library. This strongly enhances the prospects for successful 
characterization of gametophyte and gamete specific gene expression. 
WIDER CONSIDERATIONS: Our achievements, as well as results obtained by others, 
Indicate that in vitro fusion of isolated gametes may become a powerful biotechnological 
tool in plant breeding for the realization of interspecific hybridization. 
COOPERATIVE ACTIVrnES: - on January 28, 1991 a plenary meeting was held at 
Wageningen to discuss the project in view of the EC comments and the limited financial 
Support (see report); - Plant materials were transferred from WAGENINGEN to SIENA, 
PARIS, and DUBLIN; - Staff exchange: V. Ferrant (PARIS) stayed from 1 february to 1 
april at WAGENINGEN to leam the embryo sac isolation technique, and to collect isolated 
embryo sacs; F. Doris (DUBLIN) stayed from 15 february to 15 march at WAGENINGEN 
to leam the embryo sac isolation and pollen tube culturing techniques; L. Bruun 
(COPENHAGEN) visited WAGENINGEN on april 17 to discuss the Copenhagen 
contribution to the project, and she stayed 1 month in SIENA; K. Theunis 
(WAGENINGEN) worked in SIENA on sperm cell isolation; Cresti (SIENA) visited 
WAGENINGEN from 19 - 22 april to discuss and organize the Siena participation in the 
project; C. Del Casino (SIENA) stayed in October at WAGENINGEN to leam the in-vitro 
culturing of Petunia pollen tubes, and techniques for micromanipulation and micro-injection 
of pollen tubes; V. Ferrant (PARIS) stayed from 1 September to 1 November at 
WAGENINGEN to develop a technique for the extraction of mRNAs from isolated embryo 
sacs; - The transfer of gamete specific monoclonal antibodies from BIRMINGHAM to 
WAGENINGEN was arranged, for testing on isolated egg cells; - With dr. Kranz 
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(HAMBURG) and dr. Verhoeven (WAGENINGEN) arrangements were made for 
collaboration and future participation in the project. 
JOINT PUBLICATIONS: Murgia M, Detchepare S, Van Went J, Cresti M (1991) Sex 
Plant Reprod 4: 176-181 
Cresti M, Ciampolini F, Van Went J (1991) Ann Bot 68:105-107 
Theunis K, Pierson E, Cresti M (1991) Sex Plant Reprod 4: 145-154 
OTHER PUBLICATIONS: Van Aelst A, Van Went J (1991) Acta Bot Neerl 40:319-328 
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TITLE: Molecular genetics and physiology of self-incompatibility in Brassica crops 
CONTRACT NUMBER: BIOT CT90-0174(SSMA) 
OFFICIAL START DATE: JAN 01 1991 (SEE GENERAL REMARKS) 
COORDINATOR: H.G. DICKINSON, Oxford University, Oxford OX1 3RB, UK. 
PARTICIPANTS: 
INRA, Lyon, France. Professor C. Dumas. 
University of Durham, Durham, UK. Dr R. Croy. 
University of Nijmegen, Nijmegen, The Netherlands. Professor G. Wullems. 
Nickerson-Zwaan B.V., Barendrecht, The Netherlands. Dr E. Van Breukelen. 
Zaadunie B.V., Enkhuizen, The Netherlands. Dr Man Van Grinsven. 
Maribo Seeds, Copenhagen, Denmark. Dr P. Olesen. 
JICPSR, Cambridge Lab., Norwich, UK Dr M. Trick. 
University of Birmingham, Birmingham, UK. Dr C Franklin. 
HRI Wellesboume, UK Dr D. Ockendon. 
Royal Sluis B.V., Enkhuizen, The Netherlands. Dr L Davidse. 
OBJECTIVES SET FOR THE REPORTING PERIOD (YEAR 1 ONLY) 
(set out under target themes, and identifying participants) 
1. IDENTIFICATION AND CHARACTERISATION OF THE MALE COMPONENT OF THE S-
LOCUS 
(Managing contractor: Lyon) 
* Polymerase chain reaction (PCR) cloning of putative male sequences (Lyon) 
* Construction of yeast artificial chromosome (YAC) libraries (Durham) 
* Characterisation of putative male determinants (Oxford) 
* Immunoscreening of expression libraries (Nijmegen) 
* Development of bioassays (Oxford) 
2. BIOCHEMISTRY AND PHYSIOLOGY OF THE SI RESPONSE 
(Managing contractor: Oxford) 
* Structural and physiological changes in pollen and stigma (Oxford) 
* Comparisons with other species (Maribo Seeds) 
* Modelling of S-locus linked glycoprotein (SLG) and other SI molecules (Oxford) 
* Polypeptide changes in pollen following self and cross pollinations (Nijmegen and Oxford) 
* Pollen coating bioassays (Oxford) 
3. ORGANISATION AND EXPRESSION OF THE S-LOCUS, RELATIONSHIPS BETWEEN 
S-ALLELES 
(Managing contractor: JICPSR; Norwich) 
* Immunological and molecular studies of "mutants" (Lyon). 
* Molecular genetics (Norwich, Birmingham) 
* Construction of YAC libraries (Durham) 
* Development of S-allele specific probes (HRI; Wellesboume) 
4. TRANSFER OF S-ALLELES TO NEW UNES 
(Managing contractor: JICPSR; Norwich) 
* Development of transformation strategies (Norwich, Birmingham) 
MAJOR PROBLEMS ENCOUNTERED: 
I.MALE COMPONENT 
* For genomic libraries; availability, and efficiency of PI packaging system; now working 
satisfactorily (Durham) 
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* Failure of pollen grown in vitro in pollination experiments; alternative strategy adopted (Nijmegen) 
* Fractionation of low Mr pollen coat proteins; now achieved (Oxford) 
* Availability of S-specific monoclonals; help received from Lyon (Oxford) 
2. SI RESPO\SE 
* Measurement of Ca2* in stigmatic papillae; now achieved (Oxford) 
3. ORGANISATION OF S-LOCVS 
* Problems with P1 packaging system; see above (Durham) 
* Inefficient transformation strategies; see below (Birmingham and Norwich) 
* Ignorance of SI generics of sugar beet (Maribo Seeds) 
* Making cDNA libraries from small amounts of material (Maribo Seeds) 
4. TRANSFER OF S-ALLELES 
* Transformation strategies in Brassica. These remain unreliable and inefficient. B.napus works well 
but B.oleracea remains intractable. Collaboration with other UK groups (e.g. Nottingham) and the use 
of transient assay systems has helped, but whole-plant transformation remains a serious barrier to 
progress 
GENERAL 
* The quality and pace of research was significantly affected by extreme delays in receiving funds 
from the EC. Many institutes would not allow positions to be advertised before funds had arrived, and 
thus some participants could not commence work until late 1991/early 1992. 
RESULTS 
1. MALE COMPONENT 
In Lyon, a preliminary study based on the use of PCR has demonstrated transcripts homologous to 
the SLG gene in anther tissues during early microsporogenesis (Guilluy et al. 1991). Interestingly, 
these transcripts are 4 kb instead of the 1.6 kb usually found for stigma SLG products. Since January 
1992, a post-doctoral researcher (Dr M.J. Cock) has adopted a similar approach on two P57 
genotypes. The P57 self-compatible line will also give information on the possible changes that may 
have occurred in S-locus expression in the pollen which have resulted in compatibility. 
For the purpose of long range mapping of the S-locus, genomic libraries are being constructed in 
Durham using very high molecular DNA from Brassica oleracea. This DNA, estimated (by pulsed 
field electrophoresis) to be about ISO kB - 200 kB, has been digested to yield the required sizes of 
genomic fragments for cloning, and the digests size fractionated on sucrose density gradients. Desired 
lengths have been pooled and ligated into the precut, phosphatase-treated vector and packaged. Clones 
obtained are currently being analyzed to assess the quality of the library .This vector system, which is 
also being used in Lyon, is regarded as an alternative to YAC libraries. 
New methods have been developed at Oxford for fractionating exine proteins and the characterisation 
of a peptide that interacts with the SLG class of molecules (Doughty et al 1992). The technique for 
isolating exine proteins has also been used by the Nijmegen group, and antibodies have been raised 
in rabbits against these proteins from mature pollen of plants with S5S5 alleles. A cDNA expression 
library is under construction at Nijmegen using mRNA from S3S5 anthers of different age, ranging 
from the uni- to the tri-nucleate stage of pollen development The expression products of the cDNA 
library will be screened against the specific 'exine' antibody pool. 
2. THE SI RESPONSE 
The initial SLG modelling programme at Oxford has now been successfully completed (Dickinson 
et al 1992); Database searches involving consensus sequences from the SLG family of stigmatic 
glycoproteins have revealed strong homologies with domains in several classes of animal proteins. 
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principally the von Willebrand factor and type VI collagea These polypeptides, which are also heavily 
glycosylated, are held to be involved in protein-protein interactions and extracellular matrix formation -
processes which may also be involved in the initial stages of pollination. Detailed modelling of these 
sequences indicate that, despite small differences in amino acid composition, these domains are 
strikingly similar in their 3D molecular architecture. 
The effect of the interaction of pollen coat fractions with stigmatic molecules on male and female cells 
has been studied at Oxford. Changes in polypeptide synthesis and phosphorylation following 
compatible and incompatible pollinations are being followed in vivo, both in the pollen and during 
a stigmatic response that results in expansion of the papillar wall. Changes in Ca2* in the papillar cells 
have also been examined. 
The Maribo Seeds group has been attempting to characterise the genetics and cell biology of SI in 
sugar beet, which may be related to Brassica. Extraction of mRNA from the very small beet styles 
has been optimized and mRNA has been converted to first strand cDNA and used in PCR using 
primers representing conserved gametophytic Si-sequences. Identified PCR products have been 
purified, cloned and sequenced, but the sequences obtained did not resemble those of gametophyric 
Si-systems. A cDNA library from mRNA of beet styles is under construction. Si-clones have been 
received from different laboratories within the BRIDGE programme and have been transformed into 
E. coli, followed by amplification and purification. The clones are ready for Southern blotting and 
hybridization tests.A positive response has been obtained with gametophyric Si-antibodies which have 
been used for immunolabelling of sectioned beet flowers. The allele-specific Petunia antibodies cross-
react with glycoproteins in the transmission tissue. 
3. ORGANISATION AND EXPRESSION OF THE S-LOCUS 
The JICPSR; Norwich laboratory has addressed the question of the implication of the SRK gene in 
SI by the isolation and analysis of a genomic clone from S63 Brassica oleracea which appears to 
contain a receptor kinase sequence. Further DNA sequencing 3' to the previously characterised SLG-
like open reading frame has revealed the presence of sequences similar to those reported for SRK-2 
and SRK-6. A large intron, about 2.5 kb in length, separates the two domains. The complete (9 kb) 
sequence should soon be available for analysis and dissemination. Already, certain features at the first 
exon/intron junction suggest that this gene may be different to the other SRKs characterised A kinase-
specific subclone is currently being used to reprobe genomic blots of segregating F2 families in order 
to establish genetic linkage to the S-locus. We have synthesised PCR primers which have been proven 
to amplify directly a defined fragment from homologous kinase domains from a variety of genomic 
DNAs. It should now be possible, using these advances, to isolate other SRK genes and to eventually 
co-transform B. oleracea with appropriate SLG/SRK gene-pairs to define the S-locus at the molecular 
level. 
The major aim of the Birmingham group is to delineate the nucleotide sequences and trans-acting 
proteins that are involved in the control of expression of the members of the S-gene family. In the 
longer term we aim to determine how the expression levels of the different family members are 
modulated and if the allelic dominance that occurs between different S-alleles is controlled at the 
transcriptional level. A series of constructs has been produced in which sequences 5' to the translation 
initiation codon of the S„ SLR (S-locus related) gene have been fused to a GUS reporter gene. These 
have been used to transfonn tobacco plants and GUS activity within the transgenic plants determined. 
This has revealed that sequences located within a region of 1500 bp upstream of the SLR coding 
sequences are sufficient to specify correct spatial and temporal expression of the transgene. Further 
analysis has demonstrated that sequences controlling spatial expression are located within a 450 bp 
region directly upstream of the gene. Nucleotide sequencing studies of the S63 promoter have indicated 
regions of sequence homology with the comparable region from the S63 SRK gene and with elements 
from other plant genes. 
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For each P57 line, the Lyon laboratories have identified specific SLG- and SLR 1-glycoproteins 
according to N-terminal amino-acid sequence data (Gaude et al. 1991). The striking result of our 
analysis is that the self-compatible line exhibits stigma SLG products, the expression of which is 
similar to the spatial and temporal pattern described for SLG of normally self-incompatible Brassica 
plants. A cDNA clone presumably encoding the Sc-SLG has been isolated. In order to establish the 
homology between pollen recessive S-alleles (i.e. S2, S5 and S15) and the PS7Sc-allele, the Lyon 
group has started an investigation to identify the pollen recessive SLGs by using the molecular probes 
established from the Sc-SLG products (monoclonal antibodies and Sc-SLG cDNA). This work has 
been undertaken with the collaboration of Dr D. Ockendon (HRI, Wellesbourne) who supplied "pollen 
recessive" seeds. 
The aim of the HRI; Wellesbourne group is to use molecular techniques to identify the 50 different 
self-incompatibility [S] alleles which have already been recognised by conventional methods. Genomic 
DNA from a range of genotypes with different S-alleles has been amplified using PCR. The primers 
used in the PCR were selected using data from a multiple sequence alignment of published SLG and 
SLR sequences, together with sequence information provided by other members of the BRIDGE group. 
Initially, primers were selected from conserved regions located towards the two ends of the sequence 
alignment. Using these primers, the amplified PCR product is approximately 1150 bp long. 
In parallel with this work, a start has been made on the development of probes which will allow 
particular S-alleles to be distinguished. Initial studies using probes derived from the whole 1150 bp 
amplified fragment from various cloned SLG and SLR sequences provided by other members of the 
BRIDGE group showed a degree of cross-hybridisation between different members of the S-gene 
family. However, a much shorter probe of 380 bp derived from the cloned SLG-S5 sequence not only 
seems to be SLG specific, but also enabled the recessive alleles S2, S5 and S15 to be distinguished 
from a number of dominant alleles. 
4. TRANSFER OF S-ALLELES 
Brassica oleracea remains difficult to transform (see above). Work in JCTPSR; Norwich and 
Birmingham has generally involved transgenic B.napus or transient assays. Collaboration with the 
Nottingham group, who are using antisense technology to study SI, may prove worthwhile. In the 
meantime both BRIDGE participants are both engaged in active programmes to transform B.oleracea. 
HIGHLIGHTS/MILESTONES 
* SI transcripts from anthers (Lyon) 
* Working packaging system for large DNA quantities (Durham) 
* Coating factors that interact with SLGISLRs (Oxford) 
* Identification of physiological response in pollen and stigma (Oxford). 
* PCR primers for investigating SRK genes (Norwich) 
* Characterisation of promoter regions (Birmingham) 
* "SLG" cDNA clones from self compatibles (Lyon) 
* Promising probes for SLG identification (HRI, Wellesbourne). 
* Potential SLG cDNAs from sugar beet (Copenhagen) 
WIDER CONSIDERATIONS 
The system by which Brassica, an important European crop, prevents inbreeding is under study in a 
programme involving 11 institutes. Universities and industries from 4 member states. Collaboration 
through exchange of materials, information and staff has added considerable value to the project, and 
has directly resulted in progress being made in the search for the male "factor", the structure of the 
gene controlling the process, and the development of probes to identify plant lines with different 
specificity. Joint meetings have proved especially valuable for exchange of ideas and evaluating 
progress. Only integrated groups of this size, and with this width of expertise, can hope to challenge 
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the current supremacy of large American laboratories. 
COOPERATIVE ACTIVITIES 
1. Meetings 
A two day joint meeting of all participants in the project, and those of the gametophytic SI group 
(coordinated by Dr R. Thompson), was held in Enkhuizen, April 18-19,1991, hosted by Zaadunie Ltd. 
A similar meeting is planned for April 1992 in Cologne. 
2. Newsletter 
SINEWS; A collaborative newsletter is published approximately every 4 months containing up-to-date 
information, literature and addresses from all participants from both self-incompatibility groups. 
SINEWS also incorporates an expertise register, containing information on the technology available 
in each laboratory and the willingness/ability of the laboratory in question to host visitors. 
3. Visits between laboratories 
a) Andrew McCubbin from Oxford spent 4 days in Lyon working with Thierry Gaude (April 1991). 
b) Rene Ruiter from Nijmegen visited Oxford (December 1991) to work for 4 days with Andrew 
McCubbin isolating protein coating from pollen grains. 
c) Steen Petersen from Maribo Seeds, visited Richard Thompson at the Max Planck Institute in 
Cologne (February 1991) and again for a gametophytic SI meeting in December 1991. 
d) Richard Thompson visited the Maribo laboratory in Copenhagen and Professor Dickinson (Oxford) 
for one day in December 1991. 
4. Exchange of materials 
a) Seeds of homozygous S2, S5 and S15 Brassica from HRI; Wellesboume to Lyon. 
b) cDNA sequence and clone of P57SC-SL9 supplied by Lyon to Durham, HRI; Wellesboume and 
Maribo Seeds. 
c) DNA probes for S-loci supplied by Martin Trick (IPSR; Norwich) to Maribo Seeds and Lyon. 
d) Richard Thompson (Cologne) exchanged an oligonucleotide and a cloning vector for other 
oligonucleotides and an antibody with Steen Petersen (Maribo Seeds). 
JOINT PUBLICATIONS 
JICPSR; Norwich with Lyon 
Guilluy, CM., Trick, M., Heizmann, P. & Dumas, C. 1991. PCR detection of transcripts homologous to the self-
incompatibility gene in anthers of Brassica. Theor. Appl. Genet. 82, 466-472. 
Trick, M. & Heizmann, P. 1992. Sporophytic self-incompatibility systems: Brassica S-gene family. Int. Rev. 
Cytol. (In press) 
Oxford with Lyon 
Dickinson, H.G., Crabbe, MJ.C. & Gaude, T. 1992. Sporophytic self-incompatibility systems: S-gene products. 
In "Sexual Reproduction in Flowering Plants". Eds. C. Dumas & S. Russell. Int. Rev. Cytol. Series 5.3. (In 
press) 
Oxford with Birmingham 
Elleman, CJ., Franklin-Tong, V. & Dickinson, H.G. 1992. Pollination in species with dry stigmas: the nature 
of the early stigmatic response and the pathway taken by the pollen tubes. New Phytol. (In press) 
OTHER PUBLICATIONS 
(Lyon) Gaude, T., Denoroy, L. & Dumas, C. 1991. Use of a fast protein electrophoretic procedure for N-
terminal sequence analysis to identify S-locus related proteins in stigmas of Brassica oleracea. Electrophoresis 
12, 646-653. 
(Birmingham) Hackett, R.M., Lawrence, MJ. & Franklin, F.C.H. Brassica S-locus related gene promoter 
directs expression in both pollen and pistil of tobacco. The Plant Journal. (In press) 
(Oxford) Doughty, J., McCubbin, A.G., Hedderson, F., EUeman, CJ. & Dickinson, H.G. The role of the pollen 
grain coaling in pollination and self-incompatibility in Brassica oleracea. In "Angiosperm Pollen & Ovules". Eds. 
D. Mulcahy & E. Ottoviano. Springer Verlag. (In press) 
Doughty, J., Hedderson, F., McCubbin, A. & Dickinson, H.G. Coating-borne peptides of the Brassica pollen 
grain interact with S(incompatibility)-locus linked stigmaiic glycoproteins. Submitted to Proc. Natl. Acad. Sci. 
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BIOT-0154-UK 
OFFICIAL STARTING DATE: January 1991 
COORDINATOR: 
PARTICIPANTS: 
1. Angela Karp (IACR, LARS, UK) 
2. P. Brown (Univ. Hamburg, Germany) 
3. M. Buiatti (Univ. Florence, Italy) 
4. F. Sala (Univ. Pavia, Italy) 
5. L.P. Pijnacker (Univ. Groningen, The Netherlands) 
6. Y. Henry (Univ. Paris-Sud, France) 
7. PJ. Kaltsikes (Agric. Univ., Athens) 
8. G. Wersuhn (Humbodt Univ., Germany) 
9. M. Humphreys (AFRC, IGER, UK) 
10. A. Vazquez (Univ. Madrid, Spain) 
OBJECTIVES: 
To identify an integrated research strategy to determine the causes of genetic instability 
in plant tissue culture (somaclonal variation). Somaclonal variation is an important 
problem in genetic manipulation of crop plants and in the micropropagation of 
ornamental and horticultural plant species, where it results in unwanted variations in 
regenerated plants and losses in fertility. Some of the changes which arise can be useful 
for plant breeding, for mutant isolation (when used in conjunction with in vitro selection) 
or as a means of achieving introgession asexually in hybrids. However, these applications 
are currently limited by the unpredictable and uncontrolled way in which the variations 
arise. From both the viewpoint of removing unwanted variations and of generating 
useful variations, it is essential that somaclonal variation is controlled. The main 
objective of the group is to determine the underlying mechanisms and to identify a co-
ordinated research effort directed towards this goal. 
MAJOR PROBLEMS ENCOUNTERED: 
Present efforts are limited by the funding available which can only be used to integrate 
and co-ordinate and which cannot be used for research purposes. Consequently, 
although a clear, co-ordinated research strategy has been identified, it cannot be placed 
into operation, as it requires the initiation of new work. Present research activities of the 
group's members are funded by completely separate programmes (see below) and any 
direct co-ordination is limited under the present contract. Additional funding is needed 
to strengthen and to integrate the research activities by supporting a new, focused activity 
which combines the expertise and efforts of the group's members. 
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RESULTS: 
The following research activities were carried out by the participants (luring the period 
of the grant, under separate research funding: 
Participant 1 
Previous work in the group has studied external and internal factors involved in 
somaclonal variation. Even when external factors are constant, the degree of variation 
induced may differ depending on genotype, suggesting that specific components of plant 
genomes may be involved. Studies are now under way to determine which regions of the 
plant genome change in tissue culture and how these processes relate to evolutionary 
change. The stability of the three genomes of bread wheat in cell suspensions has been 
studied cytologically in relation to morphogenetic response. Instability was greatest in 
the AABBDD hexaploid Triticum aestivum, intermediate in the AABB tetraploids, T. 
dicoccum and T. durum, and least in the diploids T. monococcum (AA) and T. tauschii 
(DD). Differences in stability were also observed between species of the same ploidy 
and stability was greatest in the D genome. In rye (Secede cereale), more variation was 
observed in outbred lines compared with inbred lines. Interesting variants were 
identified in seed storage proteins some of which are consistent with the suspected 
presence of a transposable element Variation in copy number of a 380bp repeated 
sequence in telomeric heterochromatin has been detected by in situ hybridisation 
(collaboration with participant 7). 
Participant 2 
One of the main limitations with the study of somaclonal variation is the difficulty of 
determining how to measure quickly and effectively the genetic variation. Studies in our 
group have previously used RFLP analysis to determine how tissue culture induced stress 
induces alterations in known characterised gene sequences. The development of the 
polymerase chain reaction (PCR) and the associated technique of random amplification 
of polymorphic DNA (RAPD), means that these processes can be easily used in the 
study of variation. Using known gene primers for transforming DNA sequences such as 
the NPT gene which encodes kanamycin resistance, we have been able to study how and 
when variability begins in tissue culture. Refining both techniques we are now able to 
examine variability in single isolated protoplasts. Our results demonstrate that little or 
no variation occurs in transformed DNA sequences until the protoplast begins to divide. 
Consequently, variation levels in micro-calli can be quite high. RAPD analysis of single 
protoplasts shows also that single cells isolated directly from leaf tissue are generally 
identical to controls. It is only when callus formation begins that variability appears. To 
attempt to resolve what levels of variability are induced by tissue culture and the effect 
on transformation, we have studied the stability of two transformed DNA sequences in 
tobacco plants. Over 300 regenerants are being examined for alterations in over forty 
different restriction sites. The plants are all genetically siblings, in that all are derived 
from one single transformed protoplast. The results confirm that tissue culture-induced 
variation considerably affects the efficiency of both transformation and subsequent gene 
expression. 
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Participant 3 
The overall aim of the work carried out until now has been to study the effect of 
changing physiological conditions and of biotic and abiotic stresses on genome stability. 
The systems analysed have been (a) Nicotiana tabacum cell clones grown in the presence 
or absence of atrazine, (b) Lycopersicon esculentum cells in dual culture with a pathogen 
(Fusarium oxysporium f.sp. fycopenici) and tomato cotyledons from plantlets infected by 
the same fungus, and (c) tomato cells grown on media containing different 
auxin\cytokinin equilibria. In all cases, cultures were scored for sequence 
rearrangements, amplifications and methylation using homologous and heterologous 
unique and repeated sequences. In (b), the same screening was carried out also in the 
fungus in the presence or absence of plant cells. Results showed a low frequency of 
sequence rearrangements (changes in restriction patterns) in all cases. Atrazine 
increased the interclonal variability in the copy number of repetitive sequences but 
depressed the average multiplicity level: the presence of the pathogen induced 
amplification in repetitive tomato sequences, particularly in the case of incompatible 
combinations and in cotyledons and changed methylation patterns; multiplicity levels of 
repetitive sequences varied greatly in tomato according to phytohormone levels in culture 
being, however, generally lower than in the leaf amplification events, showing an 
interesting correlation with hypomethylation. 
Participant 4 
Our aim is to assess how much diversity is generated in plant DNA by biotic stresses and 
to propose molecular methods for its evaluation. One approach used was to clone highly 
repeated DNA sequences from two important crop species (tomato and rice) and to 
follow their degree of amplification in different stress conditions. This work was carried 
out in collaboration with M. Buiatti as described above. In rice, amplification of 
repeated DNA sequences in tissue culture is a massive phenomenon. In fact, all tested 
sequences were amplified when cells were grown in a de-differentiated state. In a long 
established cell line, we have also revealed the appearance of a circular, 
extrachromosomal DNA molecule and shown that this molecule includes a long stretch 
of chloroplast DNA. Using specific probes, we are now studying the molecular structure 
of this circular molecule, its function in the cells and its mode of replication. This system 
appears to be a good tool to study the plasticity of the plant chloroplast genome. The 
stability of foreign genes in transgenic tobacco plants has been studied and found to show 
little variation even after an extensive culture phase. 
Participant 5 
Microsporogenesis of a tetraploid Solarium tuberosum (+) S. phureja and a 
hypotetraploid S. tuberosum (+) desynaptic mutant has been compared with dihaploid 
fusion partners. The somatic hybrid had a first meiotic division like tetrrploid potato. 
Abnormal spindle orientation occurred at second meiosis, leading to unrr iuced gametes 
at various frequencies. Pollen fertility could not be predicted from the fertility of the 
fusion partners. 
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Cell cultures of wheat genotypes were initiated and sister chromatid exchanges studied 
to detect factors influencing DNA duplication in cell cultures. Correlations will be made 
with meiotic aberrations in regenerates from the same calli. 
Karyokinesis and cytokinesis of leaf protoplasts of tobacco and potato were compared 
with those of protoplasts embedded in alginate. Embedding did not influence the 
frequency of acytokinesis but the calli became more compact through more cells. 
Acytokinesis decreased through evacuolisation. 
Participant 6 
A large range of variation was found between aneuploid stocks of Chinese Spring tested 
for their in vitro response to tissue culture. Results indicate genes with major effects 
located on the long arms of homologous group 3 chromosomes and on 1AL. 
Experimental data provide evidence that (1) the induction of the somatic cell towards 
embryogenesis is limited to the scutellar cells, (2) tie second step is concerned with the 
development of the induced cells into embryos or meristems, (3) plants are produced 
mostly from somatic embryo development and (4) particular steps are controlled by few 
genes. Most of the chromosome variation originated in the immature embryos produced 
from unbalanced gametes but accumulated in vitro, suggesting that somatic 
embryogenesis does not ensure normality. Changes in mitochondrial DNA organisation 
which occur during tissue culture appear to be under nuclear control and are correlated 
with the embryogenic capacity of the lines. The heritability of these changes was shown 
to be maternal in reciprocal crosses, but some progenies had changed mitochondrial 
DNA compared with the female parent 
Participant 7 
Extensive field trials have been carried out on sornaclones of rye and triticale. 
Somaclonal families were found to differ not only with respect to means but also with 
respect to the correlations between the traits. The somaclonal families also had more 
variance. This variance is genetic in origin and by affecting heritability values it also 
affects response to selection. In all lines, some plants were identified with traits superior 
to the controls. 
Participant 8 
Work in this group has been directed towards methodical elaborations. This comprised: 
(1) introduction of techniques to test the rate of sister chromatid exchange (SCE) and 
karyotype aberrations using in vivo cultivated material, short term in vitro cultivated 
explants and cultivated cells, (2) search for an experimental system for combined analysis 
of SCE rate and genetic recombination rate which allows a direct comparison between 
both criterions - (the first tests using this system) and (3) standardization of procedures 
to induce mitosis starting from differentiated somatic cells of in vivo grown plants and 
analysis of genetic diversity of first mitosis after transfer of tissues to in vitro conditions. 
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HIGHLIGHTS\MILESTONES: 
Tissue culture-induced variation considerably affects the efficiency of transformation and 
subsequent expression of transformed genes. Changes can be detected in single isolated 
cells using PCR and RAPD technology. The stability of the wheat genome in cell 
suspension and protoplasts depends upon its composition. Nuclear genes control changes 
in the mitochondrial genome during somatic embryogenesis and major genes on 
chromosomes 1AL, 3AL, 3BL and 3DL control embryo induction in somatic cultures. 
Changes in copy number of repeated sequences occur in response to biotic and abiotic 
stress. In rice, amplification of the genome is a massive phenomenon and this includes 
sequences in the chloroplast genome. Sister chromatid exchanges can be used as a 
measure of genetic change in vivo and in vitro. 
WIDER CONSIDERATIONS: 
Research on genetic instability in tissue culture provides clear evidence of the extreme 
plasticity of the plant genome under stress and has implications for obtaining efficient 
transformation and for our understanding of the generation of genetic diversity. In 
effect, tissue culture provides an experimental system for studying evolutionary processes 
in action. 
JOINT PUBLICATIONS: 
Karp, A., Owen, P., Steele, S.H., Bebeli, P J and Kaltsikes, PJ. (1992) Variation in 
telomeric heterochromatin in somaclones of rye. Genome (in press) 
OTHER PUBLICATIONS\ PATENTS: 
Nothing to report. 
ADDENDUM 
Participant 9 
Although belonging to different genera of grasses, fescue species have strong evolutionary 
links with ryegrasses and gene exchange is possible albeit at low frequency. Compared 
to ryegrasses, fescues are more broadly adapted to less fertile conditions, greater climatic 
extremes and more extensive grassland use. Considerable potential exists to combine 
adaptive traits from fescues with the excellent growth and nutritive quality features of 
ryegrasses through reciprocal introgression of genetic material between species. Such 
introgression programmes rely on recombination through meiosis. Cell culture induces 
chromosome breakage and reunion in ryegrass/fescue hybrids and has led to improved 
frequency of interspecific chromosome association in regenerated plants. The tissue 
culture induced chromosome rearrangements and genetic exchange should enhance 
recovery of ryegrass-like plants with translocated genes from fescue species for characters 
such as drought resistance. Using unique drought resistant ryegrass lines derived from 
this programme at IGER, drought responsive genes will be isolated and identified which 
are functionally related to drought resistance. These will contribute significantly to our 
understanding of how plants respond to drought at the biochemical and physiological 
levels. 
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TITLE: The molecular biology of the cell-to-cell movement of plant 
viruses in relation to plasmodesmatal function. 
CONTRACT NUMBER: BIOT 900156 
OFFICIAL START DATE: 1/01/91 
COORDINATOR: (01) Prof. R. Hull, John Innes Institute, Norwich, UK-
PARTICIPANTS: (02) Prof K. Roberts, John Innes Institute, Norwich, UK. 
(03) Dr. T. Colbum, IBMP, Strasbourg, France. 
(04) Dr. J. Kallerhoff, BIOCEM, Aubiere, France. 
(05) Dr. I. Garcia-Luque, CIB-CISC, Madrid, Spain. 
*Dr. J. Kallerhoff was replaced by Dr. S. Ben Tahar during the year. 
OBJECTIVES for 1991: 
A) How many apparently different mechanisms are there of cell-to-cell movement of 
viruses? [It was decided at the group meeting to change this objective to - Are there 
different mechanisms in the cell-to-cell spread of the viruses being studied in the 
project?]. 
i) Cloning and sequencing of RNA 3 from CMV. 
ii) Antiserum against CMV movement protein, 
iii) In vivo localization of the movement proteins of various viruses. 
B) What are the basic interactions between the virus, movement proteins and 
plasmodesmata? 
i) Optimization of in vitro expression systems, use of purified protein in 
binding studies, mutagenesis of protein in infectious clones, 
ii) In vitro expression of proteins of various viruses, raising anrisera against 
these proteins and mutagenesis of genes. 
C) What is the physical structure of plasmodesmata and how do receptor proteins fit 
in? 
i) Setting up microinjection system, high resolution study of normal 
plasmodesmata. 
D) What are the infection units of different viruses which move through 
plasmodesmata? 
Nothing planned for year 1. 
E) Methods for blocking viral movement through plasmodesmata. 
i) Development of transformation and regeneration systems for beet and 
melon. 
MAJOR PROBLEMS: 
The problems fell under three main headings:-
- Participant 01 had difficulties with obtaining a suitable postdoctoral scientist who, soon 
after he started was offered a permanent position elsewhere. The post-doctoral position has 
been refilled, hopefully for the duration of the project. 
- Technical problems, which were initially encountered with the systems for microinjection 
and high resolution microscopy of plasmodesmata, are being worked on and there appear to 
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be promising solutions. Several groups have had problems with yield and solubility of 
expressed movement proteins. This was discussed at the group meeting in Strasbourg and 
various ideas were suggeted for overcoming it 
- Two groups find that the initial choice of plant species for transformation was probably 
not the best. Nicotiana benthamiana has proved difficult to regenerate and gives only low 
yield of seeds. Participant 03 is changing to N. tabacum for transformation. The 
transformation and regeneration of melon and sugar beet have been found to require such long 
periods of time that the experimental throughput using these hosts would be very limiting. 
Participant 04 is changing to N. tabacum for the cucumber mosaic virus (CMV) studies and 
is seeking a suitable host for beet necrotic yellow vein virus (BNYVV). 
RESULTS: (Principal investigator name and laboratory number in parentheses). 
Most of the effort in this first year has been directed at developing systems, solving 
problems and obtaining experimental materials from which the main cooperative aspects of 
the project can be built. 
Expression of movement proteins. 
The gene 1 product of cauliflower mosaic virus has been expressed in yeast 
(Lebeurier, 03), E. coli and a baculovirus system (Maule, 01). The recombinant protein from 
all systems was shown not to be N-glycosylated and that from the baculovirus system was 
not phosphorylated. The expressed proteins had the same apparent moL w t . (42 kDa in 
contrast to 38 kDa predicted from the sequence) as the protein synthesised in infected plants. 
The movement protein of alfalfa mosaic virus (A1MV) expressed in yeast and E. coli 
has the same mobility as that from plants which suggests that none of the proteins is post-
translationally modified. A series of 8 contiguous in-frame deletions covering the whole 
sequence of the A1MV movement protein gene have been made and are being expressed in 
E. coli (Godefroy-Colburn, 03). 
The nucleotide sequence of RNA 3 of a Spanish strain of CMV (CMV-24) has been 
determined and the open reading frame, encoding the putative movement protein, shown to 
be 279 amino acids long. The nucleotide sequence of this region is very similar to that of 
Fny-CMV which was isolated from muskmelon in New York State, USA and the deduced 
protein sequence is identical. The CMV movement protein has been expressed using the T7 
RNA polymerase system in E. coli by cloning into pT7-7. Expression levels were higher in 
E. coli strain K38 than in BL21 (DE3) at 2h post-induction but at 7h post-induction they were 
higher in BL21 than in K38 (Garcia-Luque, 05). 
A comparison has been made of the production and properties of the 30 kDa 
movement protein of tobacco mosaic virus (TMV) in the baculovirus system, in plants, from 
in vitro translation of mRNA transcribed from a cDNA clone and in E. coli. The protein 
from translation and from plants was produced at low level and that from plants was difficult 
to purify. Baculovirus and E. coli expression gave high yields with the maximum level of 
P30 production in the baculovirus system between 48 and 72 h post infection of the SF21 
insect cells. However, in both systems the major problem was insolubility (Hull, 01). 
Genomic location of movement protein genes in different viruses. 
BNYW RNA 1 is infectious to protoplasts which shows that it can autoreplicate but 
RNA 2 is required for infection of a local lesion host such as Chenopodium quinoa. This 
indicates that RNA 2, which has 6 open reading frames, carries functions for cell-to-cell 
movement. Disabling mutations have been introduced into each of the open reading frames 
in RNA 2 and the ability of transcripts carrying each mutation to replicate when coinoculated 
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with RNA 1 was tested both in protoplasts and on leaves. Three adjacent genes encoding 
proteins of 42, 13 and 15 kDa (the 'triple block') were found to be non-essential for virus 
multiplication in protoplasts but required for local lesion formation in leaves. This suggests 
that the 'triple block' proteins are required for cell-to-cell movement. Mutations in the viral 
coat protein did not interfere with local lesion production whereas those in the 3' proximal 
gene, encoding a protein of 14 kDa (P14), were not lethal but dramatically down regulated 
production of viral RNAs and proteins. This suggests that P14 regulates expression of other 
RNA 2 gene products and thus indirectly influences cell-to-cell movement (Richards, 03). 
Grapevine fanleaf virus (GFLV) RNA 2 encodes a 122 kDa polyprotein with the viral 
coat protein in its C-terminal portion. The viral proteinase encoded by GFLV RNA 1 
processes the RNA 2 polyprotein into the 56 kDa coat protein and a 66 kDa product which 
is further processed to 37 and 29 kDa proteins. The 37 kDa protein shows amino acid 
sequence homology to TMV 30 kDa movement protein. A fusion product of the 37 kDa 
protein with the N-terminal portion of the CI repressor from phage A. has been produced in 
E. coli and a specific antiserum reacting with a protein of apparent MW of 44 kDa in extracts 
from infected leaves was obtained (Pinck, 03). 
Properties of movement proteins. 
As noted above, problems have been encountered with insolubility of expressed 
movement proteins. A wide range of treatments have been tested in attempts to improve 
solubility. For instance, with the TMV P30 some of the protein could be solubilized by 
treating it first with Sarkosyl and then replacing the Sarkosyl with Triton X-100 (Hull, 01). 
The A1MV movement protein (obtained from yeast or E. coli) has been shown to bind 
single-stranded nucleic acids cooperatively. The binding is biphasic: the first phase is very 
fast and non-cooperative whereas the second phase is slow, temperature dependent and 
cooperative (Godefroy-Colbum, 03). 
Baculovirus-expressed CaMV gene 1 product aggregates as regular fibrillar arrays. 
The protein can be solubilized in acid and under denaturing conditions (e.g. >6M urea, 6M 
guanidine HC1 or 4M urea, 1M NaCl at 70°C). The CaMV gene product expressed from E. 
coli binds single-stranded RNA, confirming the report from Citovsky (Proc. Natl. Acad. Sci. 
USA 88:2476, 1991). Constructs of CaMV with various deletions in gene 1 have been 
introduced into leaf disks by agroinoculation. This leaf disk assay showed that the deleted 
genomes multiplied in single cells but did not spread into whole tissues. This is the first 
formal identification of CaMV gene 1 product as the movement protein (Maule, 01). 
In attempts to recognise one or more host proteins to which TMV P30 bound, extracts 
of host proteins were electrophoresed into a polyacrylamide gel and blotted onto a 
nitrocellulose membrane. This membrane was then treated with Sarkosyl/Triton solubilized 
baculovirus-expressed P30, washed and then any binding of P30 to proteins transferred from 
the gel was detected with anti-P30 antiserum. No bands were reliably detected. To enhance 
the sensitivity of this sandwich hybridization method "S-labelled P30 was used to probe the 
nitrocellulose blot. Even this approach did not rclaibly detect any host protein to which P30 
bound (Hull, 01). 
An antiserum (supplied by participant 03) was used to localize B N Y W P42 in sugar 
beet plants which had been infected for 5 weeks. The protein was found in subcellular 
fractions containing membranes and cell walls (Kallerhoff, 04). 
Ultrastructure of plasmodesmata. 
A reliable method has been developed for the preparation of clean cell wall fragments 
containing intact plasmodesmata. This method involved grinding plasmolysed tobacco leaves 
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or maize roots in liquid N2, followed by extrusion through a French Press and then repeated 
washing with extraction buffer. This produced cell wall fragments ranging in size from 1)1 
to several ji which, on embedding and sectioning, were shown by electron microscopy to 
contain seemingly intact plasmodesmata. After negative staining these preparations have 
proved suitable for high-resolution conventional electron microscopy with a tilting stage to 
give 3-D imaging. In initial experiments using uranyl acetate or methylamine tungstate as 
negative stains, substructure was revealed in the plasmodesmatal neck (Roberts, 02). 
Transformation of plants. 
Using several previously produced lines of N. tabacum expressing the complete and 
N-terminally deleted A1MV movement protein lacking respectively 12 and 77 amino acids 
(designated A[l-12] and A[l-77]), it was shown that A[l-12], as well as the unmodified 
protein, fractionated with cell walls whereas A[l-77] occurred only in cytoplasmic fractions. 
This suggested that the domain covered by amino acids 13-77 is involved in cell wall 
targetting. Various other transformations of N. benthamiana and N. tabacum have been made 
with the complete protein and with the deletions described above. Those in N. benthamiana 
expressed at a relatively low level. Examination of the transgenic N. tabacum by immuno-
electron microscopy revealed the unmodified and the A[l-12] protein in plasmodesmata and 
the A[l-77] in the cytoplasm and vacuole, thus confirming the cell fractionation results 
(Stussi-Garaud, 03). 
Arabidopsis thaliana plants which have been transformed with CaMV gene 1 and the 
TMV 30K gene are currently being tested for expression and complementation (Maule, 01). 
For transformation of plants with the B N Y V V gene encoding P42 (obtained from 
participant 03) the gene was placed downstream of the TMV 'CI' sequence and cloned 
between the cauliflower mosaic virus 3SS promoter and the nos terminator. This was then 
cloned into the transformation vector pGA 492, which has successfully been used to transform 
sugar beet with the B N Y W coat protein gene, to give pGA MP42A. pGA MP42A was 
introduced into Agrobacterium to transform sugar beet and tobacco but, in the first round of 
experiments, no transformants were obtained which expressed P42 (Kallerhoff, 04). 
HlGHLIGHTS/MILESTONES: 
- Localization of cell wall targetting region of A1MV movement protein to an N-
terminal domain of the gene. 
- Single-stranded nucleic acid binding properties of A1MV movement protein. 
- Cloning of movement protein gene of CMV. 
- Recognition that each of the 'triple block' genes of B N Y W are involved in cell-to-
cell movement. 
- Development of a method for the preparation of cell wall fragments containing 
plasmodesmata 
WIDER CONSIDERATIONS: 
During this year we have made good progress at developing a strong research base 
from which we will build up the main thrust of the project. While there have been no real 
'major' new findings we have added significantly to the knowledge of these movement 
proteins. 
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COOPERATIVE ACTIVITIES: 
- March 18-19th 1991, R. Hull visited CIBC, Madrid to discuss programme with L 
Garcia-Luque. 
- 13-20th September 1991, G. Demangeat visited R. Hull to discuss progress of 
project. 
- January 8-10th 1992, group meeting at IB MP Strasbourg attended by all participants 
and coworkers in Strasbourg. During this meeting there was detailed analysis of 
progress and problems and planning of future experiments and collaborations. 
- Six issues of the group newsletter, View through the Plasmodesma, bringing news 
and information to members of the group. 
JOINT PUBLICATIONS: 
Atkins, D., Hull, R., Wells, B., Roberts, K., Moore, P. and Beachy, R.N. (1991) The TMV 
30kD movement protein in transgenic tobacco plants is localized to plasmodesmata. J. Gen. 
Virol. 72:209-211. 
Atkins, D., Roberts, K., Hull, R., Prehoud, C. and Bishop, D.H.L. (1991) Expression of the 
tobacco mosaic virus movement protein using a baculovirus expression system. J. Gen. Virol. 
72:2831-2835. 
OTHER PUBLICATIONS: 
Gilmer, D., Bouzoubaa, S., Hehn, A., Guilley, H., Richards, K. and Jonard, G. (1992) 
Efficient cell-to-cell movement of beet necrotic yellow vein virus requires 3' proximal genes 
located on RNA 2. Virology (in press). 
Kirchherr, D., Wurch, T., Mesnard, J.M. and Lebeurier, G. (1991) Expression of cauliflower 
mosaic virus gene 1 in Saccharomyces cerevisiae. Res. ViroL 142:297-302. 
Maule, AJ., Usmany, M, Wilson, LG., Boudazin, G. and Vlak, J.M. (1992) Biophysical and 
biochemical properties of baculovirus-expressed CaMV PI protein. Virus Genes 6:5. 
Schoumacher, F., Erny, C, Bema, A., Godefroy-Colburn, T. and Stussi-Garaud, C. (1992) 
Nucleic acid-binding properties of the alfalfa mosaic virus movement protein produced in 
yeast Virology 188: (in press). 
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TITLE: Genes required for pathogenicity of bacteria to plants and 
application of knowledge in biological control of diseases of 
crops. 
CONTRACT NUMBER: BIOT-CT90-0168 (UK) 
OFFICIAL STARTING 1st February, 1991 
DATE: 
COORDINATOR: DR. M.J. DANIELS, The Sainsbury Laboratory (SL) Norwich, 
UK. 
PARTICIPANTS: DR. U. BONAS, Inst, fiir Genbiologische Forschung (IGF), 
Berlin, GE. 
DR. A. VIVIAN, Bristol Polytechnic (BP), Bristol, UK. 
DR. C. BOUCHER, Lab. de Biol. Molec. des Relations Plantes-
Microorganisms (LBMRPM), Toulouse, FR. 
MR. M. GUILLON, Calliope, Beziers, FR. 
DR. M. KOKKTNIDIS, DR. N. PANOPOULOUS, Inst. for 
Molecular Biology & Biotechnology (IMBB), Heraklion, GR. 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
hrp genes of Pseudomonas and Xanthomonas (required for pathogenicity and resistance 
induction): sequencing, characterisation of products, control of expression, role in 
pathogenicity, and regulation of other genes. 
avr genes of Pseudomonas and Xanthomonas (determine inability to colonise certain hosts): 
sequencing, role in non-host interactions, structure-function relationships. 
rpf genes of Xanthomonas (regulate pathogenicity functions): characterisation of Rpf C 
protein, sequencing of rpfN gene, interaction of RpfN protein with promoters of pathogenicity 
genes. 
hrp mutants of Pseudomonas solanacearum: use as biological control agents against bacterial 
wilt. 
MAJOR PROBLEMS ENCOUNTERED: NONE. 
RESULTS: 
hrp genes: 
IGF: Cross-complementation of Xanthomonas campestris pv. vesicatoria (Xcv) hrp 
mutants by hrp sequences from Xcc that were cloned by SL indicate functional conservation 
of hrp genes between the two bacteria. The DNA sequence of a 13 kb portion of the hrp 
region of Xcv containing 4 operons was determined. Several putative hrp proteins show 
homology to putative hrp proteins from Pseudomonas solanacearum the sequences of which 
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were determined by LBMRPM. In addition, striking similarities to Yersinia proteins were 
found. The homologous Yersinia proteins are involved in protein export and necessary for 
pathogenicity indicating that pathogenicity determinants might be conserved between plant 
and animal pathogenic bacteria. Expression studies in Xcv showed that hrp gene activity is 
suppressed in complex media but induced in the plant Furthermore, for one of the hrp loci, 
hrpF, a minimal medium was defined that allows gene induction without a plant-derived 
molecule. A more detailed analysis of the hrp promoters and of the hrpB operon is in 
progress. So far, four HrpB proteins can be expressed in E.coli so that we will be able to 
study these proteins using specific antibodies in the near future. 
LBMRPM has concentrated its efforts on sequencing the P. solanacearum hrp gene 
cluster. 18 kb out of 23 kb has been sequenced, allowing the identification of 18 open 
reading frames (ORFs) with high coding probabilities. Seven of them are predicted to have 
transmembrane domains and are therefore probably located in the bacterial cell envelope. 
Search for homologous proteins in data banks has revealed that at least five of the putative 
Hrp proteins have homology with the products of pathogenicity genes .of the animal pathogen 
Yersinia. The homologous Yersinia proteins are all essential and specific for the secretion 
of protein extracellular pathogenicity determinants called Yop(s). Therefore we propose that 
in P. solanacearum hrp genes might be involved in the secretion of macromolecular 
compound(s) which might directly or indirectly act as mediators) in the interaction of the 
bacteria with the plant. DNA sequence analysis has also revealed the presence of two 
possible regulatory genes within the hrp gene cluster. The role of the protein encoded by one 
of these genes in activating the transcription of 4 out of the 6 transcriptional units present in 
the hrp gene cluster is now established. 
Finally, preliminary work shows that at least certain hrp genes are conserved among 
P. solanacearum, X. campestris, P. syringae and Erwinia amylovora (LBMRPM, SL, IGF). 
In X.c. campestris, hrp genes are expressed most strongly under starvation conditions 
(SL). Functional hrp genes are not required for expression of the avirulence gene avrXca 
(which interacts with Arabidopsis thaliana), or for production of pathogenicity determinants 
such as extracellular enzymes and polysaccharide. On the other hand, mutants defective in 
these factors can still induce the hypersensitive resistance response (HR) in appropriate plants, 
whereas hrp mutants cannot. Thus, at least two independent groups of genes are required for 
plant-bacterial interactions (SL). 
In the bean halo blight pathogen, Pseudomonas syringae pv. phaseolicola, a 22 kb 
cluster contains several hrp genes/operons (L, A, B, C, D, E, F and RS) that share common 
regulation. Three other hrp genes (M, Q, and T) are found in distinct locations in the 
genome. The expression of the genes in the hrp regulon is under complex genetic and 
physiological regulation by 1) a plant factor(s), 2) pH, 3) osmotic strength, 4) nutritional 
status, 5) the S, R, L, T, and Q genes, and 6) the sigma-54 subunit of RNA polymerase. 
At IMBB an open reading frame of 302 codons has been identified as the region 
encoding a 34.5 kD polypeptide with homology to the highly conserved domain of several 
regulatory proteins of bacteria that promote transcription from sigma-54-dependent promoters. 
This gene, designated hrpS, was shown to be a regulator of several hrp operons in P. s. 
phaseolicola. 
One objective is to characterize the molecular structure of the HrpS protein and its 
interaction with hrp gene promoters. 2.5 mg HrpS protein with a purity better than 90% was 
prepared with the aim of growing crystals of sufficient quality for high resolution diffraction 
studies. Various forms of crystals were obtained using the hanging-drop technique, and 
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experiments are presently under way to improve their quality. Freshly purified HrpS protein 
tends to form dimers and to some lesser extent higher oligomers. 
The emphasis on overproduction and purification of the HrpS protein is linked to 
efforts to investigate two other questions regarding the mechanism of hrp gene expression 
control. 1. Does hrpS regulate the other hrp operons directly.?. Purified HrpS protein is being 
used in DNA footprint and gel retardation analysis of hrp gene promoter regions. Several hrp 
gene promoters may be controlled by sigma54-dependent activator proteins (such as HrpS). 
2. Does the HrpS protein act in transcription as is or does it require either post-translational 
modification or inducer binding. Recent findings suggest that hrpS may be controlled by the 
Q and T genes and by a plant factor(s). Unpublished DNA sequence data for P. s. 
phaseolicola and P. solanacearum hrp genes was exchanged with LBMRPM, showing Hrp 
protein homologies between the two pathogens. 
Calliope and LBMRPM have been developing biological control against P. 
solanacearum based on the introduction of bacterial antagonists (avirulent hrp mutants) into 
the vascular system of the host plant. The mutants are unable to produce disease in young 
susceptible tomato plants, even though most of them retain the ability to colonise and to 
multiply to some extent in the plant. The mutants prevent subsequent colonization of the 
plant by a virulent strain. The group is extending these promising results, obtained under P3 
containment laboratory conditions in Toulouse, to field experiments in naturally infested soils 
in Guadeloupe. Further protective mutants have been obtained by insertion into the hrp genes 
of an Omega-Km cassette, which is no longer transposable. These mutants are derived from 
native virulent strains isolated in Guadeloupe. Experiments in a contained environment, over 
a 12 month period in Guadeloupe showed that effective protection against bacterial wilt with 
such mutants affects neither plant development nor fruit production. Isolations from root, 
collar and stems of protected tomato plants indicate that the mutants are restricted to root and 
collar level. Bacteriocins are produced in planta by some strains. These strains possess a 
competitive advantage which will be used in selecting the appropriate protective mutants. 
avr genes: 
The avirulence gene avrBs3 fromX. c. vesicatoria contains repeat motifs in the central 
region. The importance of the repeats in avrBs3 was studied at IGF by generating deletion 
derivatives containing a smaller number of repeats. The avirulence protein function and the 
specificity of the interaction was changed with several of the new derivatives, some of which 
induce now a hypersensitive response on formerly susceptible pepper or tomato cultivars. We 
thus "unmasked" hitherto unknown resistance genes in the plant. Funhennore, genetic 
analysis of one of the "new" resistance genes revealed linkage or identity to the "recessive" 
allele of the known resistance locus Bs3. The sequence analysis of a naturally occurring 
avrBsi-allele which induces resistance in tomato but not in pepper confirmed the importance 
of the repeats for the specificity of the avirulence protein. 
At BP, the DNA sequence of an avr gene (A2) determining race 2 specificity in 
Pseudomonas syringae pv. pisi (Psp) has been obtained. Database searches have failed to 
reveal significant homology to any DNA or protein sequences. The derived protein sequence 
indicates a cytosolic location for the gene product. Attempts are being made to express this 
gene in E. coli. The cloning of this gene led to the cloning by homology of an avr gene from 
P. s. pv. maculicola (Psm), which confers race 2 cultivar-specificity in Psp toward pea (Pisum 
sativum). Collaboration with J. DangI at MPI, Koln has shown that this homologue acts as 
an avr gene in ecotype-specificity of Psm in Arabidopsis thaliana. A second avr gene (A3), 
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determining race 3 specificity in Psp, is currently being sequenced. This gene has been 
shown to be plasmid-bome and is the only gene responsible for race 3 incompatibility towards 
pea cultivar Belinda. 
Non-host resistance: We have shown (with J.W. Mansfield (Wye) and J.D. Taylor 
(HRI) that the A2 gene from Psp behaves as an avr gene in P. s. pv. phaseolicola toward 
certain cultivars of its host bean. This has enabled the investigation of non-host resistance 
genes in bean and shown that the A2 gene interacts with two resistance genes. 
Introducing avr genes into different races of Psp sometimes resulted in anomalous 
reactions towards the host. The results imply that the avr gene responsible for race 4 
specificity is suppressed in race 6 strains, and attempts are in progress to identify and clone 
this putative suppressor. 
At SL an avirulence gene from X.c. campestris has been characterised and sequenced. 
The gene interacts with gene(s) in Arabidopsis thaliana to confer avirulence on bacteria 
carrying it. However virulence to Brassica hosts is unaffected. The avirulence gene is not 
dependent on functional hrp genes for its expression. 
rpf genes: 
rpf genes in X.c. campestris are pleiotropic regulatory genes which control synthesis 
of pathogenicity factors such as extracellular enzymes and polysaccharide. One group of 
clustered genes, rpfA-G, act positively. Sequencing has shown that rpfC and rpfG products 
belong to the class of sensor-regulator proteins. The rpfC product is unusual in combining 
both sensor and regulator domains in the same protein. The protein is being purified to allow 
biochemical and genetic studies of its regulatory activity, probably involving phosphorylation, 
and its interaction with other rpf genes, and with the target genes. rpfN by contrast acts 
negatively on the same targets. The gene has been sequenced, but comparison of the 
sequence of the presumptive protein product with databases has yielded no information about 
relatedness to known proteins. A conserved sequence upstream of the coding regions of two 
of the regulated genes appears to be the site of RpfN action, demonstrated by DNA binding 
studies and "footprint" analysis. The relationship of the rpfA-G, rpfN, and other regulatory 
genes (e.g. clp), is under investigation, with a view to understanding the modulation of 
pathogen activity during disease development 
HIGHLIGHTS: 
(i) hrp gene products of P. solanacearum, P. syringae and X. campestris are related to 
pathogenicity proteins of the human pathogen Yersinia, suggesting that certain aspects of plant 
and animal disease involve analogous mechanisms. 
(ii) Repeat structures in some avr genes are important in determining specificity. Some 
avirulence genes are able to give both race-cultivar specificity and pathovar-non-host 
specificity, suggesting that a basic fundamental mechanism underlies host-pathogen 
specificity. 
(iii) A suppressor of avr gene action may have been discovered. 
(iv) Production of pathogenicity factors is under control by a series of overlapping systems. 
(v) Pretreatment of plants with avirulent hrp mutants of P. solanacearum protects against 
subsequent infection by virulent strains. 
WIDER IMPLICATIONS: 
Our work has shown that a diverse group of plant pathogens use very similar mechanisms for 
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causing disease. Thus, if we can determine how to interfere with the pathogenicity process, 
this is likely to have general applicability. The use of avirulent mutants for biological control 
is a promising strategy for limiting disease, and will in addition give information about plant 
disease resistance mechanisms. 
COOPERATIVE ACTIVITIES: 
The group had a joint meeting at IMBB, kindly arranged by M. Kokkinidis, at which the 
background and progress of the project was fully discussed and collaborative activities were 
planned. Numerous exchanges of biomaterials and unpublished information have taken place 
between the groups. 
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TITLE : Molecular basis of signalling in Rhizobium meliloti-Medicago interactions and 
genetic improvement of nodulation ability 
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OBJECTIVES SET FOR THE REPORTING PERIOD 
Rhizobium bacteria, in symbiosis with leguminous host plants, are able to fix atmospheric 
N2 in the absence of combined nitrogen. The formation of nitrogen-fixing root nodules 
requires specific interactions of certain combinations of plants and Rhizobium strains. The 
host-specific recognition is established at multiple stages during the development of 
symbiosis. Signals are emitted by both partners and are recognized by the other. The aim of 
this project is to elucidate how the signal molecules determined by the Rhizobium 
nodulation (nod, not) genes evoke responses in the plant host leading to root nodule 
development Furthermore, the molecular basis for increased competitiveness conferred by 
the nod genes and by another class of bacterial genes, the nfe genes are being investigated. 
Based on these studies, methods for improving the efficiency and competitiveness of 
Rhizobium strains to be used as field inoculants will be developed. Finally, modem 
analytical technology will be developed and applied for plant molecular genetic studies of 
the plant partner. 
The following tasks were planned to be started: 
i) Studies on the control of nod and nfe gene expression and genetic improvement of 
nodulation ability. 
01: Identification of nod gene transacting factors {syrM, nodD3) and repressor structure 
determination (with 02). 
02: Expression of nod genes in tobacco and alfalfa and study of nod gene function. 
03: DNA sequence of the nfe region, expression of nfe genes in other Rhizobium 
strains, 
ii) Structural and functional analysis of signal molecules synthetised by the Nod proteins. 
01: Construction of Nod factor overproducing strains of R. meliloti. 
01 and 02: Purification of Nod factors. 
iii) Identification of Medicago genes activated by the Rhizobium signals. 
0 1 : Studies of gene expression and identification of genes. 
03: Plant nodulin genes in relation to nfe expression. 
04: Improvement of plant DNA extraction and construction of RFLP map of Medicago. 
iv) The effect of Rhizobium signals on flavonoid biosynthesis. 
01: Isolation of genes of the phenylpropanoid pathway and plant defense genes in 
relation to the development of symbiosis. 
03 : Plant defense genes in relation to nfe expression. 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report. 
RESULTS: 
Topics i.01, ii.01 and 02 has progressed faster and completed earlier, while iii.03 and iv.03 
starts only in 1992. 
i) 01 : At the ISV positive as well as negative transacting factors and their genes in 
Rhizobium meliloti have been characterized: the transcriptional activators NodD3 and SyrM 
and the repressor NolR (Kondorosi et al., 1991b ; 1991c). Studies on NolR were done 
together with MPI. We showed that these factors, in addition to NodDl, NodD2 and 
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specific plant signals, flavonoids, regulate the expression of the bacterial nodulation (nod) 
genes which are involved in the production of signal molecules, the so-called Nod factors. 
It has been demonstrated that the different regulatory proteins form an interdependent 
network. This involves amplifying circuits by positive autoregulation as well as the 
induction of different activator proteins by each other. Fine tuning is achieved by the 
inhibitory action of the NolR. Other, yet uncharacterized proteins were shown to participate 
in the interactions between the major regulatory elements. This complex regulation enables 
the bacterial cell to respond efficiently to a broad spectrum of environmental stimuli like 
different flavonoids excreted by a variety of host plants, as well as the concentration of 
combined nitrogen, and allows the production of optimal amounts of Nod signals. 
Understanding the determinants of this regulatory network has already allowed to extend the 
host range of R. meliloti (Kondorosi et al., 1991c) and will offer the possibility to improve 
the nodulation efficiency. 
02: Various rhizobial genes (such as nodABC and hsnD) had been shown to be involved in 
catalyzing steps in the synthesis and specific modification of the Nod factors. Recently it 
was demonstrated at the MPI that the NodA and NodB proteins are sufficient to produce 
compounds that stimulate the mitosis of plant protoplasts. In order to test whether this new 
class of plant growth factors could also play a role in non-legumes at the MPI, the nodA 
and nodB genes were introduced and expressed in tobacco. Transgenic tobacco plants 
expressing nodA and nodB under the control of the relatively weak dual TR promoter 
showed an effect on cell differentiation leading to the formation of bifurcated leaves and to 
the formation of two or more stems emerging independendy of the leaf axle. 
Transgenic tobacco plants expressing only the nodA gene under the control of the strong 
35S CaMV promoter exhibited slightly reduced growth, a reduction in the internode 
distance and an altered leaf morphology. Expression of the single nodB gene (35S 
promoter) was shown to be responsible for strongly reduced growth and a compact 
inflorescence. Many flowers had only four petals and four anthers instead of five. In all 
cases heterostyly with increased stigma size was found, so that the plants are unable to self-
pollinate. 
To express nodA and nodB in tobacco both under control of a strong promoter, the 
nodA transgenic plants have been crossed with nodB-transgenics. These plants combined 
the properties of the parental plants, resulting in an extremely reduced growth, small 
internode distances, heterostyly, reduced apical dominance and strongly curled leaves. 
The generation of nodABC, nodC, and hsnD (nodH) transgenic tobacco plants is in 
progress. In collaboration with the ISV the same nod genes and their combinations are also 
being transformed into alfalfa (M. sativa). The comparison of the effects in tobacco versus 
alfalfa will permit to discriminate between the unspecific and symbiosis-specific functions 
of the Nod signals in plant development. 
To explain the effects on growth and differentiation caused by the nod genes, the 
biochemical functions of the corresponding nod gene products have to be elucidated. Since 
the nodB transgenic tobacco showed the most pronounced phenotype, first the function of 
NodB was investigated at the MPI. Therefore, the protein has been overproduced in E. coli 
and was purified by immunoaffinity chromatography or by renaruration of active NodB 
from inclusion bodies. A function of the NodB protein has been demonstrated which is now 
being confirmed. Several other nod gene functions are under study, in collaboration 
between the MPI (providing purified Nod proteins and antibodies) and the ISV (providing 
precursor molecules and purified standards from over-producing R. meliloti strains). 
An interesting observation was made at the MPI by showing that the nod inducers 
stimulate also the production of the phytohormone IAA in R. meliloti. (Prinsen et al., 
1991). 
03: The success of the inoculation practice of legume seeds requires that the inoculant 
strains be highly effective in nitrogen fixation and highly competitive against soil strains in 
nodule occupancy. At the EEZ, the nfe genes were found to control competitiveness in R. 
meliloti. 9 Kb of the nfe DNA region of R. meliloti GR4 have been sequenced and 
preliminary results indicate the existence of 8 ORFs. Data bank search revealed that ORF3 
and ORF4 have homology with the ocd gene product of Agrobacterium tumefaciens and 
with the insertion sequence ISRm3, respectively. The ocd gene, that has been reported only 
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in few bacterial species, encodes for ornithine cyclodeaminase that converts ornithine to 
proline. In Agrobacterium it was shown to be involved in opine catabolism. Although this 
gene locus seems to have its own functional promotor in R. meliloti GR4, it can also be 
transcribed, from the m/-like promoter upstream of ORF2. DNA sequence data predict a 
protein of 320 residues wich was supported also by SDS-PAGE. The functionality of the 
ocd gene product has been proved using labelled ornithine. Implication of this enzyme 
activity in the expression of the competitiveness of R. meliloti is under study. 
The ORF4, located downstream of the ocd-like gene, corresponds to IS element ISRm3 
which is present only in one copy in the GR4 genome. The significance of this IS in the 
genetic organization of the nfe region is not known. 
When a clone (pRmNT40) containing the nfe genes was transferred to different R. 
meliloti strains, most of them showed an increased competitiveness (strains 2011,41, etc.). 
Strain L5.30 however, did not change, and surprisingly, AK631 a derivative of 41 
(obtained from the ISV) hast lost its competitive ability. No explanation has been found so 
far for this behaviour since the nodulation kinetics for AK631 and AK631 (pRmNT40) in 
single infections are similar. The genetic determinant influencing competitiveness in strain 
AK631 will be investigated in collaboration with the ISV. 
ii) 01 and 02: Using the new knowledge about the regulatory factors (see i 01) has 
allowed the manipulation of R. meliloti strains lacking the negatively acting factors but 
containing higher amounts of positive transacting factors. These strains produced more than 
thousand fold higher quantitites of Nod signals in comparison to the wild type strains 
(Schultze et al., 1992). This engineering step was a prerequisite to purify and characterize 
the Nod metabolites. From one of the overproducing strains high amounts of a family of 
sulfated lipo-oligosaccharides were extracted and the chemical structures of the molecules 
were determined (Schultze et al., 1992). The ability of the Nod factors to induce 
morphological and developmental changes on plant roots, like root hair deformation and 
induction of nodule structures were investigated. The differential activity on host versus 
non-host plants of related lipo-oligosaccharides allowed to identify some of the structural 
features (e. g. oligosaccharide chain length) influencing the host plant-specific recognition. 
The purified lipo-oligosaccharides are now being used at the ISV to elucidate the 
specific signal perception and transduction by the host plant. For this aim the Nod signal 
molecules were radiolabeled and used to identify receptor molecules within host plant 
tissues. To study the signal transduction the molecular effects, like induction of gene 
expression, influences on the cell cycle control and physiological changes like pH and Ca2+ 
concentration, either in plant roots, root hairs or cells in suspension culture are being 
studied. Understanding the signal perception and transduction as well as the structural 
requirements may allow to engineer Rhizobium strains producing optimal concentrations of 
Nod factors, and possibly in long term, to generate plant varieties responding more 
efficiently to the bacterial signals. 
iii) 01 : In a search for plant genes activated by the Nod factors at the ISV a Medicago 
genomic clone homologous to the already characterized pea early nodulin Enodl2 has been 
isolated. This clone was sequenced and fusions of the putative promoter to the GUS 
reporter gene were constructed. These constructions have been introduced into Medicago 
sariva . These plants will be useful tools to analyze specific expression, and inducibility of 
this early nodulation gene by the Nod factors. Other genes activated by the Nod factors and 
cloned by differential screening of a cDNA bank prepared from Rhizobium -infected root 
hair RNA are being characterized. 
04: A complete procedure of DNA extraction is a combination of unit operations including 
pre-treatment, lysis, removal of debris, extraction and eventually resuspension. BERTIN 
has developed a process consisting of an unique combination of novel techniques including, 
in a same cartridge, isolation of nuclei, nuclear lysis and dialysis. This process was 
compared for Medicago sativa to classical techniques. In a first time, DNA was perfectly 
digestible by restriction enzymes, but was of poor quality (.DO 260/280 = 1.25). 
Improvements comprising grinding in the presence of liquid nitrogen followed by a rapid 
lysis and a solvent extraction before the lysis/dialysis process in the cartridge, allowed to 
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obtain a better quality (DO 260/280 = 1.85). At present semi-automatic prototypes allowing 
to extract DNA from various plant materials are available at BERTIN. 
A multisouthern/northem electrophoresis and blotter system has been developed and 
used to obtain first blots starring from M. saliva . The technology is perfectly defined and 
during a simple run one can obtain automatically 4 blots with 24 lanes per blot, plus 3 lanes 
for markers. This system is now available to establish RFLP maps. The major advantage of 
RLFPs in variety identification being lied in the availability of an almost infinite number of 
combinations of the restriction enzymes and probes. The establishment of the RFLP map of 
M. truncatula has not begun as foreseen, since it was preferred to fully automatize the 
system in order to make more efficient the preparation of blots before starting. The map will 
now be established by using markers selected in collaboration with all the partners, 
iv) 01: The phenylpropanoid pathway seems to have special importance in the development 
of Rhizobium-legume symbiosis. Certain flavonoid products are nod gene activators. In 
addition, rhizobia might control the expression of genes of this pathway, thus avoiding the 
activation of plant defense involving the synthesis of certain isoflavonoids. To study the 
possible control of the pathway by Rhizobium, the control of expression of these genes and 
the effect of their altered expression by the antisense DNA approach are under investigation 
at the ISV.Genomic or cDNA clones for proteins involved in the phenylpropanoid pathway 
(chalcone synthase, flavanone-3-hydroxylase, dihydroflavanole-4-reductase, isoflavone 
reductase), in lignin synthesis (peroxidase) as well as for pathogenesis related proteins were 
isolated from M. sativa.The genes are being used to determine in what extent Rhizobium is 
controlling the plant defense mechanisms during symbiosis and the synthesis of nod gene 
activator or inhibitor flavonoids. The clones are also available for projects iii.03 and iv.03. 
The flavonoid production by the plant in response to different growth conditions and during 
nodulation was studied. Plants grown in the presence of a nitrogen source where no 
symbiosis is needed, were shown to produce flavonoids which can repress R. meliloti nod 
gene expression, while plants grown in the absence of nitrogen source produced nod gene 
activators. Moreover, nodulated plants produced reduced amounts of activating compounds. 
All these compounds are now being purified and analyzed. 
HIGHLIGHTS/MILESTONES: 
The knowledge gained about the regulation of nod gene expression has enabled us to 
engineer Rhizobium meliloti strains having an extended host range as well as strains 
producing several thousand fold higher amounts of Nod signals. This allowed us to 
describe a one step purification scheme and to characterize Nod signal molecules which 
were previously undetectable. 
The factors produced by the NodA and NodB protein alone or in combination are active 
in non-legumes and the expression of these genes affects the phytohormone balance in 
transgenic tobacco. Morphological abnormalities of the transgenic plants further indicate that 
tobacco must contain the necessary substrates allowing the nodA and nodB encoded 
proteins to synthesize growth controlling factors and also the necessary receptors to respond 
to the presence of these regulatory molecules. 
A gene (ocd) encoding the enzyme ornithine cyclodeaminase that converts ornithine into 
proline has been found in R. meliloti GR4 as one of the nfe genes. This gene could provide 
bacteria with better abilities to nodulate Medicago. 
A semi-automatic prototype for DNA extraction is available. It will be used to confirm 
the protocols on various plant materials and could allow to furnish DNA to various groups. 
An automatic system to realize blots has been developed and improved. It will allow to 
furnish blots to various groups and to establish a RFLP map of Medicago truncatula more 
efficiently. 
WIDER CONSIDERATIONS : 
The ability of this new class of oligosaccharide signals to control plant growth and 
development could increase our knowledge on cellular mechanisms of plant differentiation. 
This knowledge could also have a significant impact on plant breeding and agricultural 
yields. 
172-
COOPERATIVE ACTIVITIES : 
Cooperation in the various research topics are specified in the RESULTS. 
A. SAVOURE from BERTIN has been working full-time at ISV. Six meetings were 
held during the year either at BERTIN or at ISV. Another person has worked closely with 
ISV on plant DNA extraction during three months. 
ISV, MPI and F.F.7 had regular exchange of plasmids, bacteria and information. 
With other laboratories participating in the BRIDGE. Integrated Action, with Univ. 
Bielefeld (Prof. A. Pűhler): One week stay of two Spanish scientists and a three month stay 
of a fellow in Bielefeld and two German scientists in Granada. 
20­22 January 1991 : Meeting of all participants of the BRIDGE project at IS V in Gif. 
26­29 August 1991: Visit of Dr. E. Kondorosi (ISV) at MPI for discussion of 
results, collaborations and exchange of strains. 
7 October 1991 : Visit of Prof. H. Van Onckelen (Univ. Antwerp, Participant of 
other BRIDGE project) at MPI for discussion of results, 
collaboration and collection of samples. 
27 October 1991 : BRIDGE ELWW meeting on "Rhizobium­legume symbiosis" in 
Capri. 
5­8 November 1991 : Visit of Dr. M. Schultze (ISV) at MPI for discussions. 
24 February 1992 : Visit of Prof. H. Van Onckelen at MPI for discussion and 
collection of samples. 
9 and 10 March 1992 : Visit of Drs. H. Rohrig and J. Schmidt (MPI) at IS V for 
discussion of results, cooperation and exchange of material. 
14­17 March 1992: Meeting of all participants of the BRIDGE project at EEZ. 
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THE MOLECULAR BASIS OF PATHOGENICITY, AVIRULENCE AND RESISTANCE IN 
THE INTERACTION BETWEEN THE FUNGAL PATHOGEN CLADOSPORIUM FULVUM 
(SYN. FULVIA FULVA) AND TOMATO. 
CONTRACT NUMBER: BIOT-CT90-0163(TSTS) 
OFFICIAL STARTING DATE: 31/03/91 
COORDINATOR: P.J.G.M. DE WIT, AGRICULTURAL UNIVERSITY, WAGENINGEN, 
NL. 
PARTICIPANTS: R.P. OLIVER, UNIVERSITY OF EAST ANGLIA, NORWICH, UK. 
H.W.J. VAN DEN BROEK, AGRICULTURAL UNIVERSITY, 
WAGENINGEN, NL. 
B.J.C. CORNEUSSEN, MOGEN INTERNATIONAL NV, LEIDEN, NL. 
S.C. FRY, UNIVERSITY OF EDINBURGH, EDINBURGH, UK. 
F. CERVONE, UNIVERSITY OF ROME, ROME, IT. 
OBJECTIVES SET FOR THE REPORTING PERIOD 
The common interest of all participants is the unraveling of the molecular basis of the plant-fungus 
interaction tomato-Cladosporium fulvum. The laboratory of the coordinator has exchanged various 
materials with the laboratories of Oliver (probes for avirulence gene avr9, chromosome-specific 
probes), van den Broek (avirulence gene avr9, pathogenicity genes PI and PIT), Cornelissen 
(antibodies against several PR proteins, PR proteins, fungal isolates), Cervone (tomato DNA) and Fry 
(apoplastic fluids of C. fulvum-infected tomato). 
De Wit would isolate new PR proteins and isolate cDNAs encoding those proteins. He would also 
isolate new avirulence and pathogenicity genes of C fitlvum. Oliver would produce pathogenicity 
mutants of C. fitlvum, which either occurred spontaneously or were created artificially by 
transformation with the vector pAN8-l. In addition, he would set up genetic mapping in C. fitlvum by 
protoplast fusions between different races carrying different markers. His studies on retrotransposons 
would be continued. Van den Broek would perform in vivo directed mutagenesis of the the putative 
pathogenicity gene P17 and the avirulence gene avr9 of C. fulvum. Also gene targeting would be 
initiated. Comelissen would optimize the transformation and regeneration procedure for tomato and 
tobacco; the plants would be transformed with different cDNAs, especially those encoding 0-1,3-
glucanases, chitinases and the polygalacturonase inhibitor protein (PGIP). Fry would determine 
polysaccharide degrading activities of proteins occurring in apoplastic fluids and identify the 
preliminary structure of the released oligosaccharides. Cervone would isolate the bean cDNA encoding 
PGIP and purify PGIP from tomato. 
MAJOR PROBLEMS ENCOUNTERED 
Nothing to report. 
RESULTS 
Lab 01, de Wit's research group. Upon inoculation of tomato leaves with C fitlvum several 
pathogenesis-related (PR) proteins accumulate which could be involved in induced resistance. Some of 
the purified PR proteins were shown to be hydrolytic enzymes; they have 8-1,3-glucanase or chitinase 
activity and are potentially able to degrade fungal cell walls which consist of glucans and/or chitin. In 
in vitro bioassays growth of the fungus Trichoderma wide was inhibited by combined activities as low 
as 0.5 nkatal for the B-l,3-glucanases and 1500 cpm for the chitinases. C fitlvum was shown to be 
insensitive to the hydrolytic enzymes; combined activities as high as 14 nkatal for the B-1,3-glucanases 
and 50.000 cpm for the chitinases did not inhibit growth of the fungus. 
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Genomic and cDNA clones encoding the putative pathogenicity proteins PI and P17 have been isolated 
and and sequenced, and in addition the first fungal avirulence gene avr9 was cloned and sequenced. 
The final proof that a true fungal avirulence gene had been cloned came from transformation studies of 
races virulent on Cf9 genotypes with the avr9 gene. The transfbrmants became avirulent on Cf9 
genotypes of tomato. The putative product of avirulence gene avr4 has been purified and partially 
sequenced. To this end proteins present in apoplastic fluid isolated from the interaction between tomato 
cultivar CfS and race 5 of C fulvum were fractionated by gel filtration on a Sephadex G-50 column 
and the fractions obtained were screened for the presence of the putative product of avirulence gene 
avr4 by assaying for necrosis-inducing activity on tomato cultivar Cf4. Active fractions were further 
purified by reversed-phase FPLC. Several fractions were obtained that specifically induced necrosis in 
tomato cultivar Cf4. Some of the necrosis-inducing fractions contained only one protein which migrated 
as a 12 kD band on SDS-polyacrylamide gels. The amino acid sequence of the N-terminal part and of a 
peptide that was obtained after digestion of the 12 kD protein with trypsin was determined and 
degenerated oligonucleotide probes were synthesized. These probes should enable us to isolate the gene 
encoding the 12 kD protein by performing a PCR reaction on DNA isolated from race 5 of C fulvum 
or cDNA synthesized from mRNA isolated from a CfS/race 5 interaction. 
Lab 02, Oliver's research group. Hundred transformants created with the vector pAN8-l have been 
screened for change in pathogenicity. Two of them appeared to be significantly reduced in 
pathogenicity. The two mutants will be analysed in detail. Progress has been made with the purification 
of the enzyme mannitol dehydrogenase, an enzyme involved in the primary carbon sequestration of C 
fulvum. The pale and white forms of C. fulvum which occur frequently during subculturing have been 
analyzed in some detail. The white form is non-pathogenic and sporulates at only 1 % of the wild-type. 
The pale form is still pathogenic. The white form has only 5% of the mitochondria of the wild type 
and is rather sensitive to UV. The white form grows rapidly on saccharose or glucose. About a 
hundred progeny from a protoplast fusion cross between race 4 and race 5 have been collected and 
purified by single spore collection. They have been assayed for race-specific virulence, nitrate 
phenotype and hygromycin resistance. In the coming year they will be screened for other 
characteristics as well. In the region of avirulence gene avr9 a genomic walk has been initiated in order 
to get more information on the flanking sequences. Several probes have been exchanged between lab 
01 and lab 02 for karyotyping C fulvum on CHEF gels. From C fulvum two telomeric sequences have 
been obtained which will be used to construct a replicating vector in the future. Finally the role of the 
retrotransposon in creating races with new virulences has been addressed. 
Lab 03, van den Broek's research group. The avirulence gene avr9 and the putative pathogenicity 
gene P17 have been subjected to in vivo directed mutagenesis. Disruption of P17 has been realized 
following the transformation of a wild-type strain of race S with a plasmid construct containing the PI 7 
encoding sequence interrupted by a hygromycin resistance gene. In two out of about a hundred 
transformants, the resident gene was replaced by the mutated one. However, these transformants could 
still infect tomato seedlings, while producing a P17 protein lacking 23% of its amino acids. A new 
construct has now been made in which the complete coding sequence of P17 has been removed. In 
addition transformants of race 5 which overpoduce the P17 protein upto a 10 times higher level than 
the wild-type have been selected. However, this overproduction did not seem to affect pathogenicity. 
Similarly, a plasmid construct has been made in which the complete coding sequence of the aw9 gene 
has been removed. This plasmid has been used to disrupt the avr9 gene in wild-type avr9-containing 
races, which will be assayed for virulence on Cf9 genotypes of tomato. To identify upstream regulatory 
sequences in the promoters of the different cloned pathogenicity and avirulence genes, promoter 
deletions have to be generated and reintroduced in the genome at a specific site. The establishment of a 
gene targeting system in C fulvum, using a pyrimidine biosynthetic gene as the target genomic locus, 
is one of the priorities. 
Lab 04, Cornelissen's research group. Various parameters have been changed in the existing protocol 
to optimize and improve the transformation and regeneration efficiency of tomato. Cotyledons of 
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seedlings harvested two days after germination have been used as explants. Different light and cold 
regimes did not significantly influence regeneration efficiencies. Regeneration could be improved by 
incubating the explants upside down. 2,4 D did not improve regeneration when compared with Petunia 
feeder layers. Rooting of shoots was found to occur earlier when kanamycin concentrations of 30 mg /l 
were used rather than 100 mg/l. The influence of various Agrobacterium rumefaciens helper plasmids 
on the transformation frequency was investigated. Of the three types of Ti helper plasmids which were 
compared the leucinopine helper plasmid gave the best results. Cervone was provided with four 
oligonucleotide primers to facilitate the cloning of bean PGIP. In addition, plasmids pMOG402 and 
pMOG464 were provided: pMOG402 is a binary vector containing the kanamycin resistance marker 
gene and pMOG464 is a pUC derivative containing a gene-expression cassette consisting of the 35S 
promoter and the nopaline synthase transcription termination signal. After cloning the PGIP gene in the 
expression cassette and subsequently in the binary vector, it will be introduced in tomato. Several 
tomato plants transgenic for chimeric β-1,3-glucanase and chitinases genes are available now for 
analysis by Fry. 
Lab 05, Fry's research group. Various purified polysaccharides from plants and other sources have 
been subjected to enzyme- and acid-catalysed hydrolysis under various conditions and the released 
oligosaccharides have been purified and assayed for biological activity by observing their effects on L-
(U-14C)leucine incorporation by suspension cultured tomato cells. A low molecular weight sub-class of 
rhamnogalacturonan II was most active in inhibiting the incorporation of L-(U-14C)leucine into 
suspension cultures up to 60%. The effect of precursors other than L-(U-14C)leucine was investigated. 
Rhamnogalacturonan II did also inhibit the incorporation of 14C from D-(6-14C)glucuronic acid into 
D-galacturonic acid residues of pectins and of 14C from D-(l-14C)glucosamine into glycoproteins.The 
effect of rhamnogalacturonan II seems to be on a number of rather narrowly-defined biosyntheses. 
Apoplastic fluids from both healthy and C. fulvum-infected tomato leaves containing different classes of 
oligosaccharides inhibited the L-(U-14C)leucine incorporation in tomato suspension cells. However, it 
appeared that the endogenous L-leucine possibly interferes with the uptake and incorporation of L-(U-
14C)leucine. This means that components of apoplastic fluids need to be purified before assessing their 
ability to affect the incorporation of L-(U-14C)leucine by possible oligosaccharides. IAA did not 
influence the incorporation of L-(U-14C)leucine. Apoplastic fluids from C . fulvum-infected leaves 
contain enzymes which not only release fragments from (U-14C)-labelled plant cell walls but also from 
(U-14C)-labelled fungal walls. The free sugars which were released contained glucose, glucosamine 
and N-acetyl glucosamine but no mannose, while the released basic oligosaccharides contained glucose, 
glucosamine and sometimes mannose. The released plant and fungal oligosaccharides at the interface 
between host and pathogen may be of importance if they act synergistically to enhance (or even 
suppress) the host defence response. 
Lab 06, Cervone's research group. The polygalacturonase-inhibiting protein (PGIP) from bean has 
been partially cloned by the polymerase chain reaction (PCR) on tomato DNA using primers which 
were designed based on the amino acid sequence of the N-terminus and a tryptic peptide of the bean 
PGIP. In this way a 758 bp fragment was isolated which was subsequently used as a probe to islate the 
PGIP gene from a genomic library of Phaseolus vulgaris cv. Saxa. A single open reading frame of 
1026 nucleotides (342 amino acids) was present in the genomic clone. Northern analysis with the 
labelled PCR-cloned fragment on poly(A)+ RNA isolated from different bean tissues showed a 1.2 kb 
transcript present in suspension-cultured cells and to a lesser extent in leaves, hypocotyls and flowers. 
A cDNA clone containing two third of the coding region of the PGIP gene was sequenced. The 
nucleotide and deduced amino acid sequences of the PGIP gene from two different cultivars of bean 
showed 96.4% and 97.4% identity, respectively. The entire coding region of the cloned genomic PGIP 
gene, which is not interrupted by introns, has been inserted in the plasmid pMOG402 for transgenic 
expression in tomato. Apoplastic fluids from tomato exhibited very low PGIP activity. Preliminary 
experiments using bean PGIP nucleotide sequences on Southern blots containing total tomato DNA 
revealed that a very high homology existed between the bean and the tomato gene. So, the original 
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plan of cloning the tomato PGIP starting from the purified tomato protein has been abando] 
approach utilizing the heterologous bean probe is now being undertaken. 
HIGHLIGHTS 
1. The first fungal avirulence gene, avr9, of C. fulvum (hat fits a gene-for-gene relationship 
has been cloned. Cloning of another avirulence gene avr4 is within reach. 
2. Gene disruption has been successfully performed in C. fulvum. 
3. Transformation of C. fulvum with the vector pAN8-l has resulted in a number of mutants 
with reduced pathogenicity. 
4. Two telomere sequences of C. fulvum with the sequence TTAGGG have been isolated. 
5. Tomato plants transgenic for chimeric β-1,3-glucanase and chitinase genes have been 
obtained. 
6. Apoplastic fluids of C. fulvum-inlected tomato leaves contain enzymes that release 
oligosaccharides from plant and fungal cell walls. 
7. The cloning of a polygalacturonase inhibitor protein (PGIP) from Phaseolus vulgaris is 
completed. 
WIDER CONSIDERATIONS 
Molecular characterization of gene-for-gene systems is in progress. Of the many bacterial genes and 
one fungal avirulence gene cloned to date, none showed homology with other characterized genes. It is 
likely that the primary function of avirulence genes varies considerably. In some cases an avirulence 
gene may be so important for the pathogen that loss of it would be detrimental. A property all 
avirulence genes have in common is the antigenicity of their direct or indirect products. Through these 
products the pathogens are recognized by the host which responds by inducing a hypersensitive 
response (HR).The primary function of resistance genes is still a matter of speculation, as none have 
yet been cloned. However, without knowing the primary function of either avirulence and resistance 
genes, their 'secondary' function (the induction of HR by their interacting products) could perhaps be 
exploited to engineer transgenic disease-resistant plants. Future experiments should tell us whether 
transformation of plants with highly controlled avirulence-resistance gene cassettes indeed become 
resistant to various pathogens. Regardless of the results of this concept, such transgenic plants can 
teach us more about stimulus perception and signal transduction in gene-for-gene systems. 
COOPERATIVE ACTIVITIES 
All participants and coworkers gathered for a two-day workshop at the Agricultural University in 
Wageningen on June 6-7, 1991. Fifteen lectures and five posters were presented. The book of abstacts 
was distributed among the participants and a number of copies was presented to Dr. Vassarotti, the 
coordinator of this project in Brussels. Detailed and overall research plans were discussed and 
arrangements were made for the exchange of materials and joint experiments. The exchange of 
materials between the labs 01, 02, 03 and 04 was most frequent. In the coming year the exchange of 
material between labs 04, OS and 06 will be intensified. Several visitors came to the different labs to 
discuss research, exchange of expertise and ways of cooperation in the near future. Two scientists 
applied for a scolarship at EC to work for one year within the framework of BRIDGE, but their 
reseach proposals were not granted by EC. Oliver has made a Bursary scheme application with Thomas 
Sandal, a Danish PhD student, linked to this grant. All participants will have their next two-day 
workshop in Rome on June 12-13, 1992. 
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OBJECTIVES 
Symbiotic nitrogen fixation occurs in a specialized plant organ, the nodule, whose endodermis and 
parenchyma cells constitute a diffusion barrier resulting in a low oxygen pressure in the zone invaded by 
the bacteria. It has been shown recently that bacterial nif and fix genes can be induced in microaerobic 
cultures, which points to oxygen as a most likely key signal for triggering nitrogen fixation inside the 
plant. 
The energy required for nitrogen reduction is provided to the bacteroids in the form of dicarboxylic acids 
(dCA) as evidenced by the fact that mutants deficient in sugar utilization are Fix+ whereas dctA mutants 
affected in the transport of dCA are Fix'. Recent data indicate that the regulatory genes which control 
dctA expression in bacterial cultures do not operate in bacteroids which implicates a specific signal and 
regulatory pathway for the expression of dctA inside the plant. 
The relationship between nitrogen fixation and nitrogen metabolism in a symbiotic association, although 
crucial for the full understanding of the possible regulatory circuits, remains an open question. It is 
known that the bacterial regulatory pathway which connects nitrogen compounds catabolism and 
assimilation to the availability of utilisabie nitrogen sources does not control the expression of nif and fix 
genes in symbiosis. The expression and/or activity of bacterial glutamine synthetases is turned down by a 
still unknown symbiotic signal. On the other hand recent data point to a possible role of plant glutamine 
synthetase(s) in modulating the efficiency of the bacterial nitrogen fixing apparatus. 
Molecular mechanisms involved in gene regulation, signal perception and transduction will be studied. 
Because of the similarities of these mechanisms throughout the whole living world, knowledge gained 
from the sudy of prokaryotic systems especially suited for genetic analysis will be of general interest. 
The integrated approach of the project will result in an overall picture of regulatory networks operative 
in the nodule. 
The knowledge gained at these two levels will permit strategies to be developed to genetically manipulate 
the system in order to modify the regulatory circuits and metabolic fluxes and eventually increase the 
symbiotic nitrogen fixation potential. 
The two symbiotic systems that our project will help improving are of agricultural importance all over 
Europe. A major environmental problem currently exists due to the extensive use of fertilizers in the 
European agricultural sector. Much of the synthetic nitrogen applied to crops is lost from the soil, 
leading to problems such as eutrophy in lakes and rivers and drinking water pollution. Therefore besides 
reduction in costs resulting from reduced use of fertilizers, symbiotic nitrogen fixation provides a 
buffered mineral nitrogen source which is less susceptible to being washed out into the ground water and 
thus less harmful to the environment. 
The genetic components of the nif fix R. meliloti regulatory pathway which responds to oxygen have been 
identified. Molecular mechanisms responsible for signal perception and transduction by the FixL sensor 
and for target genes activation by Fix! will be studied (1). The genetic data available in R. meliloti will be 
used for the identification of the functionally homologous pathway which operates in R. leguminosamm 
and the possible variations between both pathways (2). Comparative studies of the homologous 
components of the two regulatory pathways will allow an identification of the conserved domains of the 
regulatory proteins and common regulatory sequences in the target genes (3). When differences will be 
observed, the resulting information will be used to construct chimaeric regulatory proteins or promoters 
(4). The signal and regulatory protein(s) responsible for symbiotic dctA expression will be identified (5). 
The mechanism by which the dct regulatory system which senses dCA concentration in bacterial cultures, 
although not essential for dctA symbiotic activation interferes with nif gene expression will be 
investigated (6). The various factors which regulate the expression or activity of bacterial glutamine 
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synthetases will be identified (7). The role of GSIII in bacteroid nitrogen metabolism will be examined 
(8). Genetic analysis of the export of fixed nitrogen towards the plant cell will be undertaken (9). The 
effect of various nitrogen and carbon sources on the microaerobic expression of nif genes will be 
investigated (10). The glutamine synthetase genes of the autogamous diploids Medicago saliva will be 
identified (11) and modulation of glutamine synthetase levels will be achieved by expression of antisens 
messenger RNA (12). Bacterial strains and plant lines with modified regulatory circuits will be assayed 
for their symbiotic nitrogen fixation efficiency (13). 
Task Year 1 Year 12 Year 3 
3 
4 
5 
6 
8 
10 
11 
12 
13 
MAJOR PROBLEMS ENCOUNTERED : Nothing to report 
RESULTS 
1. Oxygen regulation of nitrogen fixation gene expression in R. meliloti and R. leguminosarum 
(objectives 1,2 and 3 ; Toulouse and Bielefeld) 
In the course of the BAP programme we had provided evidence that FixL is an oxygen sensor which 
allows the transcriptional activator FixJ to activate the expression of two R. meliloti regulons needed for 
symbiotic nitrogen fixation, the nif regulon and the faN regulon, in response to low oxygen 
concentration. FixJ mediated activation of the two regulons involves the FixJ controlled expression of two 
transcriptional activators, FixK active on the fixN regulon and NifA active on the nif regulon. The 
expression of nif A, in addition to being activated by FixJ is repressed by FixK which provides an 
additional link between the two regulons. Sequence examination allowed us to predict that FixL consists 
of three domains : a N-terminal hydrophobic domain which probably anchors the protein to the 
cytoplasmic membrane, a central cytoplasmic domain and a C-termina! domain which is common to all 
sensors and responsible for the activation of the cognate transcriptional activator. We constructed FixL 
derivatives in which either the hydrophobic domain or the central cytoplasmic domain were deleted. 
Whereas the derivative lacking the hydrophobic domain was still able to activate FixJ at low oxygen 
concentration, the FixL protein lacking the central cytoplasmic domain was able to activate FixJ 
independently of oxygen concentration (de Philip el al., submitted). 
The fixK promoter has been analysed by deletion and oligonucleotide directed mutagenesis. A putative 
FixK binding sequence has been identified -487 bp from the transcription start and its mutation partly 
alleviates negative regulation. Two regions involved in activation by FixJ have been identified. One of 
them from -33 to -54 shows strong conservation with other FixJ responsive regulatory sequences such as 
R. melilotipnifA or Azorhizobium caulinodanspfixK. A second region at -60 is not present in pnifA which 
could explain the differential behaviour of the two promoters (Waelkens et al., in press). We are 
presently devising an in vitro transcription system to study the role of FixJ in the activation of the nifA 
and fixK promoters. 
In R. leguminosarum circumstantial evidence indicates that regulatory genes homologous to FixLJ could 
be absent. Hybridization experiments using R. meliloti probes have failed to show any homologous R. 
leguminosarum sequence. Heterologous complementation studies did not allow us to show the presence 
in R. leguminosarum of genes functionally f f i x L f whereas they permitted the identification of 
fnrN, a fix homologue. However by contrast with the situation in R. meliloti fnrN is subject to positive 
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autoregulation and furthermore this autoregulation is oxygen dependent. Expression of a fnrN-lacZ 
fusion in R. meliloti depends on the presence of a functional fixK gene. This proves lhatfixK can replace 
fnrN as a transcriptional activator and provides additional evidence that fnrN is not activated by fixLf. 
Whereas FixK activity does not seem to be controlled by oxygen cell the available data indicate that FnrN 
responds to oxygen. This may be attributed to the fact that contrary to FixK FnrN contains a N­terminal 
cystein cluster. 
fnrN was first identified by its ability to complement a R. meliloti fix/ mutant for fixN expression. 
Therefore the question arose whether genes equivalent to fixN were present in R. leguminosamm. 
Hybridization studies have revealed the existence of two fixN copies in R. leguminosamm, like in 
R. meliloti. Work is in progress to study the regulation of these genes and particularly determine whether 
they are under the control of fnrN. 
The likely absence of fixU homologues in R. leguminosamm raises the question of the control of nifA 
expression. We are currently testing the hypothesis that nifA could be subject to autoregulation in R. 
leguminosamm. 
Comparison of oxygen control in R. meliloti and R. leguminosamm suggests that fix and nif genes could 
belong to completely separate regulons in R. leguminosamm whereas they are connected through fjrl J 
central control in R. meliloti. 
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2. Carbon metabolism and efficiency of nitrogen fixation (objectives 5, 6 and 10 ; Cork) 
In order to study the relationship between symbiotic nitrogen fixation and carbon metabolism we paid 
special attention to the regulation of dicarboxylic acid transport since dCA appears to be a major carbon 
source for nitrogen fixing bacteroids. 
Because the dctA gene which is needed for dcA transport can be expressed in symbiotic conditions 
independently of the dccBD regulatory genes which operate in free living conditions, we isolated 
spontaneous secondary mutants of an R. meliloti dctD strain that are capable of growth on dcA as role 
carbon source. Such mutants should provide a way for identifying an alternative symbiotic activator of 
dctA expression. Alternatively they could allow the identification of a repressor oidctA expression in free 
living conditions. 
A link between da regulatory system and nif gene expression was suspected because of a repressing 
effect of some dctB mutations on R. meliloti nifHDK expression. A deletion analysis of the nifHDK 
promoter failed to implicate any particular region in binding of a repressor molecule. 
A negative effect has been observed of the presence of lactose in the growth medium on the expression 
of both dctA and nifA. Catabolism of the carbon compound is not required and the effect is not mediated 
th rough yixU. 
In order to facilitate genetic manipulation of the various components and to study dctA expression in a 
well defined genetic background, the Dct system has been reconstituted in the heterologous E. coli. 
Expression of the dctA gene was found to be absolutely dependent on the presence of the homologous 
dctBD genes and to respond to the presence of dCA in the medium. 
3. Nitrogen metabolism and symbiotic nitrogen fixation 
3.1. Bacterial nitrogen metabolism (objectives 7, 8, 9 and 10; Dublin and Naples) 
In order to understand the nature of the shift from free living toward symbiotic bacterial nitrogen 
metabolism, we characterized components of nitrogen assimilation pathway in R. leguminosamm such as 
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GSII and GSIII as well as its genetic regulatory elements, glnB which encodes the PII regulatory protein 
and the nitrogen general activator ntrC. In particular we have shown that the glnT gene codes for a newly 
recognized glutamine synthetase GSIII of R. leguminosamm which is expressed in K. pneumoniae where 
it can complement a glnA mutant. We purified this protein, determined the aminoterminal sequence and 
obtained an antiserum. We sequenced the corresponding DNA and identified an ORF coding for GSIII 
(Chiurazzi et al., in press). 
We found that expression of the R. leguminosamm gene coding for GSII requires in K. pneumoniae the 
ntrC gene. In this way we identified the gfnll gene, sequenced it and studied its promoter. We have shown 
that it is a sigma 54-dependent promoter requiring a UAS for NtrC activation (Patriarca et al., in press). 
We have also characterized GSII. We find that addition of NH4C1 to a derepressed culture causes a 
specific decrease in transferase activity that may only be interpreted as a post-translational modification 
(Manco el al., in press). Previous authors reported that GSII transferase activity is not present in 
bacteroids. If the presumed post-translational modification is present in bacteroids it is possible that the 
enzyme is present, but inactive when transferase activity is assayed. We find the presence of GSII in the 
nodule by immunofluorescence and immunogold. When analyzed by immunogold we find a positive 
signal at the periphery of the bacteria, suggesting that GSII might be associated with the membrane(s). 
Using an appropriate DNA construction we obtained, by translational fusion, a pure protein containing 
most of PII, which we used to raise an antiserum. An immunoblot after SDS-PAGE ofR. leguminosamm 
extracts shows a single band of the expected molecular weight. 
We found that the glnB promoter is of the sigma 54 type and does not require an upstream activating 
sequence in K. pneumoniae. In collaboration with Dr Merrick we have shown that the glnB promoter 
may be activated also by a heterologous activator, the product of the nifA gene. More recently we began 
studying the glnB promoter in R. leguminosamm. We have shown the presence of a high NtrC-
independent level of expression and a partial positive role for NtrC interacting with a sequence located 
between 511 and 203 bp upstream of the transcription initiation site. This sequence does not contain 
canonical NtrC binding site sequences. 
We characterized a ntrC mutant. More recently we began sequencing the upstream region of ntrC, 
containing the ntrC gene. Preliminary results suggest that the promoter of the ntrBC genes may be 
located more than 600 bp upstream of the ntrB initiation codon and that this region might be 
untranslated. 
The study of bacterial ammonium transport is crucial for the understanding of the interaction between 
nitrogen fixation and plant nitrogen metabolism. Preliminary studies have focussed on the mechanism by 
which ammonium is actively taken up by living cells and the conditions that influence the expression of 
active transport. The underlying hypothesis is that some of the mechanisms involved in ammonium 
uptake could also play a role in the transport to the plant during nitrogen fixing symbiosis. Work has 
been concentrated on (i) assays to monitor ammonium transport (ii) isolation of mutants altered in 
ammonium uptake ability (iii) analysis of membrane proteins induced by alterations in nitrogen status, 
(i) Transport assays : Radiolabeled methylammonium has been used as a model substrate to 
demonstrate the presence of a high affinity ammonium transport system in R. meliloti 2011 when 
methylammonium is the sole nitrogen source. The competitive inhibition of methylammonium uptake 
observed when ammonium is added provides evidence that this system operates for ammonium uptake 
also, (ii) Mutant isolation : Following transposon mutagenesis cells were exposed to penicillin and 
lysozyme while growing in OS mM NH4C1 to enrich for mutants defective in ammonium uptake ability. 
Surviving cells were plated on rich medium and replicated to media having a sole nitrogen source of 
0.5mM NH4C1 or 20mM NH4C1. Mutants that are unable to grow on low ammonium are being tested to 
determine whether the mutation is associated with regulation or ammonium transport, (iii) Analysis of 
membrane proteins : Cells were grown in minimal medium containing a variety of nitrogen sources. Cell 
envelope material was isolated following sonication and treated with sarkosyl to selectively dissolve the 
inner membrane. The outer membrane protein patterns were analysed by SDS-PAGE. Proteins present 
in the outer membranes of cells grown in 0.5mM NH4CI but not in cells grown in 20mM NH4CI were 
reproducibly detected. One such protein was also detected in cells grown in 0.1 % glutamate. 
Optimisation of the production and detection of these proteins has been carried out to permit further 
characterisation. 
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3.2. Plant nitrogen metabolism and nitrogen fixation (objectives 10, 11 and 12; Toulouse and Cork) 
Two approaches have been taken in an effort to understand how plant nitrogen metabolism inteferes 
with symbiotic nitrogen fixation. 
Because the first step in the assimilation of fixed nitrogen by the plant partner is catalysed by plant 
glut amine synthetase, identification of Medicago truncatula GS genes and study of their expression has 
been undertaken. Three members of the GS gene family have been identified ; the expression of two of 
them Mtgsl6 and Mtgs8 is significantly enhanced in the nodule, simultaneously with the appearance of 
Leghemoglobin mRNA. 
Several constructions have been achieved which should allow either an increase or a decrease of GS 
expression in the plant nodule. Several Medicago saliva transgenic plants are currently under study. If 
indeed these plants show an altered level of GS expression in the nodule compared with control plants, 
nitrogen fixing efficiency as well as expression of nif and fix R. meliloti genes will be measured. 
In parallel with this approach, the influence of various nitrogen sources on nif and fix gene expression in 
R. meliloti has been studied. We have shown that ammonia and nitrate depress the level of nif gene 
expression and that this effect is mediated by FixL (Noonan et al., in press). 
In conclusion, it can be stated that a coherent view of the influence of major physiological parameters i.e. 
oxygen concentraton, carbon and nitrogen metabolism on the regulation of nitrogen fixation gene 
expression is emerging through the integrated approach conducted in the participating laboratories. In 
addition comparison of two symbiotic systems leads to the view that response to a given regulatory signal 
can result from different combinations of related but non identical regulatory proteins. 
HIGHLIGHTS/MILESTONES 
Influence of nitrogen source on nif gene expression. This finding could provide a link between plant 
nitrogen metabolism and symbiotic efficiency. 
WIDER CONSIDERATIONS 
Symbiotic nitrogen fixation is a finely tuned biochemical process which interferes with major metabolic 
pathways of both symbiotic partners. Therefore its improvement ultimately depends on a better 
understanding of regulatory circuits in both partners and of their mutual interactions. Such complex 
systems are particulary suited to the integrative approach allowed by European programmes. 
COOPERATIVE ACTIVITIES 
One meeting in Paris 8-9 April 1991 
One meeting in Naples 28 October 1991. 
Visit of M. Iaccarino to Toulouse 29 January-1 February 1992 
LIST OF JOINT PUBLICATIONS 
De Philip, P., Boistard, P., Schlüther, A., Patschkowski, T., Puhler, A., Priefer, U., O'Gara, F., Boesten, 
B. and Noonan, B. Developmental and metabolic regulation of nitrogen fixation gene expression in 
Rhizobium meliloti. Canadian Journal of Microbiology (In press). 
OTHER PUBLICATIONS 
Noonan, B., Moherway, M. and O'Gara, F. (1992). Ammonia regulation of the R. meliloti nitrogenase 
structural and regulatory genes under free-living conditions : Involvement of the fixL gene product. 
Molecular and General Genetics. (In press). 
Manco, G., Rossi, M., Defez, R., Lamberti, A., Percuoco, G. and Iaccarino, M. (1992). Dissociation of 
enzymatic activities of glutamine synthetase II after NH4C1 treatment. Journal of General Microbiology 
(In press). 
Chiurazzi, M., Meza, R., Lara, M. Lahm, A., Defez, R., Iaccarino, M., and Espin, G. (1992). The 
Rhizobium leguminosarum biovar phaseoli glnT gene. Gene (In press). 
Patriaraca, EJ., Chiurazzi M., Manco, G., Riccio, A., Lamberti, A., De Paolis, A., Rossi, M., Defez, R. 
and Iaccarino, M. (1992). Activation of the Rhizobium leguminosarum glnll gene by NtrC is dependent 
on upstream DNA sequences. Molecular and General Genetics (In press). 
Waelkens, F., Foglia, A., Morel, ., Fourment, J., Batut, J. and Boistard, P. Molecular genetic analysis of 
the Rhizobium meliloti fixK promoter : identification of sequences involved in positive and negative 
regulation. Molecular Microbiology (In press). 
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Title 
Contract number 
Tomato transposon tagging : isolation of genes involved in 
disease resistance, hormone biosynthesis and plant cell 
development 
BIOT-900192 
Official starting date 01-01-91 
Coordinator Dr. J. Hille, VU Amsterdam, NL. 
Participants Dr. K. Thercs / Prof. P. Starlinger, Universitat zu Küln, DE. 
Dr. J. Jones, Sainsbury lab, Norwich, GB. 
Dr. I. Taylor, University of Nottingham, GB. 
IT. R. Dankert, RZ Research, Metslawier, NL. 
Objectives set for the Thejoim project is to develop a tomato transposon tagging 
reporting period system in order to enable each group to clone different genes. To 
this end it is aimed to joindy obtain a series of plants each carry-
ing a transposable element insertion (either Ac or a derivative) in different positions that are 
equally spaced over the twelve chromosomes of tomato and to demonstrate the feasibility of 
this series for cloning specific genes by targeted transposon tagging. Within the first fifteen 
months it was aimed to (1) construct suitable T-DNA based vectors, (2) obtain transgenic 
tomato genotypes and (3) to initiate mapping of the T-DNA insertions in a RFLP analysis. 
Major problems For routine practical purposes the inverted polymerase chain 
encountered reaction (IPCR) technique, to obtain T-DNA flanking plant DNA 
for RFLP analysis, showed to be problematic in several labs. 
The main problems have been solved, but still to obtain reliable IPCR products takes more time 
than anticipated. Cloning and sequencing of IPCR products remains necessary to be able to 
subsequently use them in a RFLP analysis. 
Results Constructs have been designed to enable Agrobacterium strains 
to carry transposable elements into the tomato genome on T-
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DNA. Both the autonomous Ac­element and non­autonomous Ac­derivatives(Ds) have been 
located in various antibiotic resistance genes to permit selection for excision. Reintegration of 
Ds after excision is indicated by different marker genes inserted into the element itself. 
All groups have introduced the T­DNA vectors into tomato by Agrobacterium mediated gene 
transfer, selecting for more then fifty independent transformants per group. These transgenic 
tomato lines are being analyzed for integrity and copy number of the introduced T­DNA's, for 
ploidy level and for fertility in crosses. 
The chromosomal positions of T­DNA inserts have mainly been determined using a molecular 
approach. In most cases the IPCR technique was used to amplify a DNA fragment that borders 
the site of T­DNA insertion and can serve as a hybridization probe for the subsequent RFLP 
analysis. In some cases, when an origin for replication in E. coli was present within the T­
DNA, plasmid rescue was used to directly clone flanking plant DNA sequences. Alltogether, 
60 locations for transposable elements have been established in tomato (see figure). On all the 
twelve different chromosomes of tomato inserts have been mapped. Although on some chro­
mosomes(like 2) many inserts have been mapped and on some (like 6) only one, it is too early 
to draw conclusions about T­DNA insertion specificity in tomato. 
Transposon positions 
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Measurements have been made of Ac germinal excision frequency for six different loci. There 
is marked between transformant variation in transposition frequency. Typical germinal excision 
frequencies range from 2% - 25%, but are usually around 6% - 8%. A number of Ds 
containing tomato lines have been crossed to Ac lines in order to transactivate the Ds elements. 
For transactivation both the autonomous Ac element, stabilized Ac elements and stabilized Ac 
elements in which the endogenous promoter has been replaced by different tissue specific 
promoters, are being used. Both excision of Ds from the original position and integration on 
new chromosomal locations could be established. 
The fact that we have tomato lines where the primary insertion site is linked to our genes of in-
terest means that we are able to begin a programme of transposon mutagenesis. First experi-
ments have been initiated in all groups. 
Amsterdam 
Up to now 9 transposable element inserts were mapped on chromosome 3, on which also the 
fungal disease resistance locus Asc is located. A transgenic tomato line, homozygous for the 
Asc locus and a Ds element on chromosome 3 was crossed with a line also homozygous for 
Asc and containing Ac on chromosome 3.The resulting progeny in which, both, Ac and Ds can 
transpose, was crossed on a large scale with a sensitive male sterile tomato line {asc, asc). 
Currently, this seed population, heterozygous for the Asc locus is analyzed for Altemaria sus-
ceptible mutants in order to screen for transposon induced mutations at Arc. 
Cologne 
One Ds insertion maps on chromosome 7 in proximity to the Lanceolate locus. This is our gene 
of interest because it plays an important role in the process of plant development. Plants con-
taining the Ds element on chromosome 7 and an Ac element were pollinated with pollen from 
heterozygous Lal+ plants with the goal of tagging the Lanceolate locus. About 10000 seeds 
were obtained and will be screened for "reduced" phenotypes, the phenotypc of the homozy-
gous mutant 
Nottingham 
The ultimate aim is to obtain transposon induced wilty mutants as a result of insertion into 
genes encoding enzymes involved in biosynthesis of the plant hormone, ABA. Transposon 
containing T-DNA's have been located linked to the target genes sitiens (chromosome 1) and 
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also notabilis and flacca (chromosome 7). Currently, a programme of transposon mutagenesis 
of these genes has been initiated. 
Norwich 
The locations of our target genes Cf-2, Cf-4, Cf-5 and Cf-9 have been remapped. To our sur-
prise, an extensive mapping effort revealed that they all were to various degrees incorrectly as-
signed. Cf-2 and Cf-5 lie at the same locus, about 2 cM proximal to yellow virescent on chro-
mosome 6. Cf-4 and Cf-9 also map to a very similar or identical position, about 20 cM proxi-
mal to aurea on chromosome 1. This very interesting result is consistent with data from other 
systems in which resistance gene loci exhibit extensive allelic series with different biological 
specificities, suggesting they are complex loci. 
Tagging Cf-genes with a linked transposon requires several backcrosses prior to being able to 
initiate crosses. Currently we are doing these backcrosses, but in order to accelerate the pro-
gramme a "brute force" approach has been adopted involving crossing stocks homozygous for 
Cf-2 or Cf-5, and that carry active Ac at either unlinked or unknown locations, to Cf-0, and 
looking for mutations in the Cf-gene. We crossed to a Cf-0 line that was also mutant at other 
loci, such as yellow virescent (yv) or anthocyanin absent (aa), so that mutations at both these 
loci and the Cf-genes could be screened simultaneously. In a large scale crossing programme 
over 300000 seeds have been produced. The resulting seedlings are being screened and several 
promising mutations have already been identified. Conceivably, there will be a signal to noise 
problem, in that some mutations will be caused by mechanisms other than insertional inactiva-
tion of the gene, but if enough mutations are characterized, at least one should be tagged. 
Highlights/Milestones A set of tomato genotypes has been obtained with mapped 
transposon inserts. Stocks are available with a transposable 
element for each tomato chromosome. 
The first transposon tagging experiments in tomato have been 
initiated, both using linked and unlinked transposons. A number 
of putative mutants has been identified and awaits further 
characterization. 
Wider considerations Excellent progress has been made towards our objectives. We 
are now in a position to tag genes of interest, such as genes 
involved in disease resistance, hormone biosynthesis and plant 
cell development. 
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Cooperative activities The annual meeting exchanging the results of the participants 
obtained sofar, was held for the third time, now in Cologne, 
from 25-27 november 1991. 
A post doc from Cologne was working during 10 days in Amsterdam (7-17 October 1991) and 
a post doc from Nottingham worked for six weeks in Norwich. 
All groups have exchanged on a very regular basis both information, plasmid constructs and 
mapped tomato genotypes. This made it possible for each group to use the most suitable mate-
rials for their further research. 
List of joint publications/patents with trans-national authorship 
Haring. M.A.. Scofield, S.. Teeuwen-de Vroomen. M.J., Leuring, G.S., Nijkamp. HJJ.. and Hille. I. (1991). Novel 
DNA structures resulting from dTam3 excision in tobacco. Plant Mol. Biol. 17 : 995 - 1004. 
Other publications/patents 
Dean, C , Sjodin. C , Bancroft, I., Lawson, E.. Lister, C , Scofield, S , and Jones, J.(1991). Development of an effi-
cient transposon tagging system in Arabidopsis thaliana. In : Molecular Biology of Plant Development (eds. : GJ. 
Jenkins and W. Schuch) Company of Biologists pp. 63-76. 
Dean, C„ Sjodin, C , Page, T., Jones, J.D.G.. and Lister, C. (1992). Behaviour of the maize transposable element Ac 
in Arabidopsis thaliana L. Plant J. 2 : 69-81. 
Duckham, 5.C., Linforth, R.S.T., and Taylor. I.B. (1991). Abscisic-acid deficient mutants at the aba gene locus of 
Arabidopsis thaliana are unpaired in the epoxidation of zeaxanthin. Plant, Cell and Environment 14 : 601-606. 
Haring, M.A., Teeuwen-de Vroomen. MJ., Nijkamp, HJ.J., and Hille, J. (1991). Trans-activation of an artificial 
dTam3 transposable element in transgenic tobacco plants. Plant Mol. Biol. 16 : 39-47. 
Haring, M.A., Rommens, C.M.T.. Nijkamp, H.JJ., and Hille, J. (1991). The use of transgenic plants to understand 
transposition mechanisms and to develop transposon tagging strategies. Plant Mol. Biol. 16 : 449-461. 
Hille, J., Zabel, P., and Koornneef, M. (1991). Genetic transformation of tomato and prospects for gene transfer. In : 
"Monographs on Theoretical and Applied Genetics 14 : Genetic improvement of tomato" (Kalloo, ed.) Springer Verlag 
Heidelberg. pp283-291. 
Rommens. C.M.T., Kneppers, T.J.A., Haring, M A , Nijkamp, H.JJ., and Hille, J. (1991). A transposon tagging 
strategy with Ac on plant cell level in heterologous plant species. Plant Science 74 : 99-106. 
Rommens, C.M.T., Biezen. E.A. van der, Ouwerkerk, P.B.F.. Nijkamp. HJJ., and Hille. J. (1991). Ac-induced disrup-
tion of the double Ds structure in tomato. Mol. Gen. Genet 228 : 453-458. 
Rommens, C.M.T., Haaren, M.J.J. van. BucheL A.S., Mol, J.N.M., Tunen. AJ. van, Nijkamp. H.J.J., and Hille, 
J.(1992). Transactivation of Ds by Ac-transposase fusions in tobacco. MoL Gen. Genet. 231 : 433-441. 
Witsenboer, H . M A , Kloosterziel. K.M., Hateboer. G., Nijkamp, HJJ. , and Hille, J. (1992). Tomato susceptibility 
to Alternaria stem canker : parameters involved in host-specific toxin induced leaf necrosis. Plant Science, 81 : 127-
134. 
Haaren, MJJ. van, Nijkamp, HJJ., and Hille, J. (1991). Werkwijze voor het aanbrengen van een deletie- of inver-
sie- mutatie in een plantengenoom ; daarvoor bruikbaar recombinant DNA ; gemuteerde plant. Nederlandse octrooiaan-
vrage nr. 9101620. 
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OBJECTIVES SET FOR THE REPORTING PERIOD: 
The objective of this BRIDGE programme is to identify genes 
regulating metabolic pathways of nitrate assimilation and anthocyanin 
biosynthesis and to isolate and characterize clones of transcription factors 
involved in these processes. 
RESULTS: 
The regulation of the nitrate assimilatory pathway has been studied at Rothamsted and 
Versailles. The nitrate assimilatory pathway has been shown to be regulated by N-
metabolites in Nicotiana. At Rothamsted, where mutants affected in glutamine synthetase 
have been obtained, a start has been made on examining the effect of endogenous 
glutamate and glutamine concentrations on the expression of NR in barley leaves. At 
Rothamsted, conditions have been established for the seletion of constitutive nitrate 
reductase-producing mutants of Arabidopsis. Considerable difficulties were encountered 
in finding the right conditions for the plants, such that adequate and even growth could be 
obtained in the absence of nitrate, an essential requirement for the selection procedure. As 
a back-up for the Arabidopsis screen, mutants are also selected from chemically 
mutagenised barley seed, and this screen is already producing positive results. 
In Versailles, a nia promoter has been linked to a GUS reporter sequence and found 
to be expressed in transient experiments performed on protoplasts. However none of the 
regulations known to affect nia gene expression was detectable under these conditions. 
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The regulation of the reporter gene will be studied in stable transformants and in transient 
expression by particule gun bombardment in leaves of plantlets grown in vitro on nitrate 
or ammonium. The recognition of the nia promoter by transcription factors has been 
studied in Versailles in collaboration with the Roma group. In Roma, transcription factors 
involved in light regulation of plant genes are being characterized. The tomato light-
regulated RbcS, Cab and nia promoters all show a conserved GATAA motif at variable 
distances upstream from the TATA box. Oligonucleotides containing this region from the 
three promoters were synthetized and used in gel retardation assays with tomato nuclear 
extracts. All three oligonucleotides bound one or more factors present in the extract. The 
binding was specific, as judged from competition experiments with homologous, 
heterologous and mutated sequences. Cross-competition experiments also show that 
promoters bind at least one common factor. 
In Versailles gel retardation experiments were performed with the nit-2 transcription 
factor regulating N- metabolism in Neurospora. Selective and specific gel retardation was 
detected in two domains of the nia promoters from tomato. Nit-2 is a member of the zinc 
finger type transcription factor family. Oligonucleotides derived from consensus 
sequences shared by the zinc finger domains of several members of the family were 
synthesized with the help of the Madrid group and used for PCR amplifications. A clone 
showing 52 % homology to Nit-2 was identified after cloning and sequencing of the 
amplification products. The obtained clone is used to identify the corresponding single 
copy gene from N. plumbaginifolia. In parallel, a yeast mutant defective for the gln-3 
gene homologous to nit-2 and also involved in the regulation of N-metabolism has been 
used for screening of cDNAs from Arabidopsis thaliana able to complement the metabolic 
deficiency resulting from the mutation affecting gln-3. Two clones have been identified 
which reproducibly complement the mutation. They will be sequenced to study their 
eventual homology to nit-2 and gln-3. In Roma, the screening of an Arabidopsis genomic 
library using a mouse zing finger probe of the Cys2-His2 type has been proven, up to 
now, unsuccessful. 
Nitrate reductase expression is highly integrated in the metabolic activity of higher 
plants. Tobacco plants in which nitrate reductase is constitutively expressed have been 
obtained by transformation of a nitrate reductase cDNA put under the control of 
transcription signals derived from the caMV. Once characterized for the expression of the 
transgene, these plants will be evaluated for their physiological characteristics by SETTA. 
At the John Innes, the characterisation of regulatory mutants affecting anthocyanin 
production in Antirrhinum majus has been performed. Several new interesting mutants 
have been identified: 
a) Mixta. In the backcrossing procedure the mixta mutation that affects the shade of colour 
in the flower was found to be somatically and germinally unstable.The transposon, Tarn 
4, has been shown to co-segregate with the mutant phenotype. 
b)Extenta. This mutation gives rise to seedlings with extended hypocotyls and pale 
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cotyledons similar to the aurea mutations of tomato. The itensity of floral pigmentation is 
also affected. The similarity of phenotype to aurea and hy 3 in Arabidopsis suggests that 
externa may be a mutation affecting phytochrome production or action. 
c) Delila. In further analysis of a stable allele of delila (line JI:8), a novel instability, 
allowing gene expression in cells of particular tube, has been activated. Del has now been 
cloned and shown to encode a myc homologous transcription factor. 
d) Lavata, violacea. Two more mutations affecting pigment distribution and intensity have 
been established as near isogenic lines. 
The role of Del as both an activator and a repressor of transcription has been established. 
It has also been shown that a coordinated expression of flavanone-3-hydroylase (F3H), 
dihydroflavanol-4- reductase (DFR), Candi, and UDP glucose-flavonoid 3-0- glucosyl 
transferase (UDGT) is taking place during flower development and across the cells of the 
flower. Chalcone synthase (CHS), chalcone isomerase (CHI) and phenylalanine 
ammonia lyase (PAL) appear to be regulated separately.The genomic sequences encoding 
seven of the anthocyanin biosynthetic genes are being characterized by sequencing. 
Common motifs are contained amongst these different 5' promoter sequences which fit 
the consensus motifs for myb and myc transcription factors. 
Six myb-homologous genes from Antirrhinum flowers (two of which are flowers 
specific) have been cloned. The expression patterns of each clone has been studied in a 
range of organs, during flower development and in light and dark. None of them, by 
theses criteria, are particularly good candidates for regulating anthocyanin biosynthesis. 
None of the myb genes appears to be the El, del or ros gene product, as tested through 
RNA analysis of the mutants and through RFLP analysis. The expression of one myb 
gene, 340, has been studied by in situ hybridisation and found to be primarily expressed 
in the nectary and transmitting tract of the style. The 308 promoter is active in the petals 
particularly the coloured lobe area, the sepals, the stigmatic surface and the anther 
filaments. The 305 promoter is active in flower petals, sepals, the style and the nectary. 
To complement the in vitro analysis of myb gene function described above, tobacco 
plants overexpressing (double 35S enhancer), antisense and truncated constructs for each 
myb gene are being obtainedTo date we have observed no phenotypic influence using the 
truncated myb gene constructs, expressing only the DNA-binding domain. The antisense 
constructs for myb 340 have given plants of reduced stature. Two of the transformants 
were male sterile. One had white flowers. It is therefore possible that in this plant the 
longer antisense 340 can interfere with the myb gene controlling floral anthocyanin 
production in tobacco. Overexpression of one constitutive myb gene, myb-308 gives pale 
wilting leaves with darkers veins. Production of myb-315antisense appears to be lethal in 
that no transgenetics of tobacco have been produced and root growth in Antirrhinum is 
severely inhibited Complementary DNA clones homologous to the Bzip class of 
transcription factors shown to bind to the CHS promoter from parsley are being 
screeened. A number of cDNA clones containing this specific motif have been identified 
and they show a close correlation in their expression to the anthocyanin biosynthetic 
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genes. There are some data to support the view that members of this gene family may be 
mediators of the light signal controlling expression of anthocyanin biosynthetic genes. 
/ 
the clones are currently being investigated by probing northern blots containing polyA* 
RNA isolated from hypocotyl, leaf, root, green and red fruits, immature and mature 
flowers. With a view to future antisense/sense expression of the isolated genes in planta, 
transformation experiments using constructs containing the GUS marker gene have been 
carried out in order to develop a tomato transformation system. 
In Madrid, anthocyanin biosynthesis has been studied in Petunia. Three cDNA clones 
corresponding to almost full copy myb genes and one which represented a 3' incomplete 
cDNA for a third myb gene had previously been isolated To search for a putative CI 
homolog from Petunia, PCR amplification of flower cDNAs were preformed with two 
mixtures oligonucleotides corresponding to two S aa stretches highly conserved in all 
plant myb proteins. Five additional myb genes could be identified. One of them showed 
high identity to CI (90 % aa identity).Work is in progress to establish whether or not this 
CI-like myb gene is able to substitute for the CI function in tansient expression 
experiments. In addition RFLP mapping of the 8 myb genes from Petunia is underway. 
DNA binding studies has been performed with myb Ph3 proteins showing that it binds to 
a sequence very similar to that recognized by the animal myb oncoprotein (CA/CGTTA/G) 
Work is in progress to establish whether or not the relative binding affinity for different 
versions of the consensus binding sequence is the same for different myb Ph proteins. 
Several in vitro mutagenized myb cDNAs have been prepared to evaluate the role of 
conserved residues in DNA binding properties of myb proteins. Transgenic Petunia plants 
expressing a myb Ph3 antdsense RNA have been obtained. One plant and its progeny 
showed reduced flower colouration. The molecular basis of this effect is under study. 
The regulation of anthocyanin accumulation is studied in maize by the Milano group. 
The genetic system under investigation is defined by two major components: a gene, Sn, 
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conferring tissue specific anthocyanin accumulation in different plant regions and another 
gene, R, lying two units Sn proximal, required for pigment accumulation in tissue not of 
Sn competence.The analysis of a recently cloned Sn cDNA sequence, a transcription 
factor of anthocyanin pathways in maize has been performed. The whole cDNA sequence 
of the Sn:bol 3 allele has been completed and compared with the cDNA sequences of Lc 
and of the S component of the R complex, referred as R-S. The putative protein encoded 
by the 616-amino acid open reading frame has features to those of transcriptional 
activators. It contains a large acidic domain (aminoacids 188-324) with 35 acidic and 8 
basic aminoacids for a cumulative negative charge of -27 and a basic region (aminoacids 
421 -514) part of which was found to have similarity to the myc family of oncogene 
proteins. A comparison between the three cDNA sequences of Sn, Lc and the S 
component of R (R-S) disclosed a very high degree of homology particularly in the 
translated region. These findings support the hypothesis that Sn, Lc and R genes encode 
functionally related proteins that act as transcriptional activators of the genes encoding the 
enzymes of the anthocyanin biosynthetic pathway. A Sn genomic clone has been isolated 
and sequences 1.5 kb of the region upstream the transcription start site performed. 
Besides the canonical regulation sites (TATA box and CAAT-like box), the presence of 
several putative sites involved in the control of transcription was detected Other promoter 
regions of different Sn and R alleles are being currently characterized in order to 
understand by comparison the basis of tissue specificity and light inducibility. 
Pericarp and aleurone anthocyanin accumumation is a process controlled by two 
homologous genes, Sn and R that allow a dramatic increase in pigmentation in response 
to white light irradiation. Irradiation of these two issues at succeding developmental times 
during seed formation and in different genotypes has disclosed the following points: 
1) The two tissues differ in their response to light during their development 
2) Irradiation of Rsc Sn developping seeds with light of different quality, but equal 
fluence rate, indicaes that both red and blue light elicit a positive response in the aleurone 
while in the pericarp only blue light is effective. 
3) Presence of R-se and Sn together in the genome leads to a drastic reduction in pericarp 
pigmentation in comparison to that observed in r Sn genotypes. White and blue light 
treatments lead to an enhanced transient accumulation on Sn mRNA in the pericarps with 
a maximum level of induction after 18-24 h of illumination. C2 and Al transcripts 
increased in a coordinated manner after 24 h of illumination as expected, considering the 
regulatory role played by Sn. Different results were obtained when aleurone were 
analysed. Following white, blue and red light treatments the structural genes mRNA 
levels increased following a kinetic similar to that one observed in the pericarps, white R 
transcript was not affected by light treatment suggesting that R is controlled at the post-
transcriptional level. Tissue specific expression was studied by northern analysis. Results 
obtained correlate perfectly with the phenotypic expression. Presence of R or Sn 
transcripts correlated precisely with the induction of Al and C2 messengers and with the 
accumulation of the anthocyanin pigment Absence of the a gene of the R family, as in the 
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r-g genotype, shows, in all the tissues examined, a lack of R, Al and C2 transcripts 
correlating with colorless phenotypes. Labelled antisense and sense RNA probes were 
hybridized to serial sections of developping seeds of different genotypes. As expected, a 
specific localization (aleurone or pericarp) of regulatory and structural genes hybridization 
signal is correlated to the presence of the R or Sn genes respectively. 
HIGHLIGHTS/MILESTONES 
During the first year of this program several new regulatory mutants affecting 
anthocyanin biosynthesis have been identified. Simultaneously different genes coding for 
transcription factors are being cloned in the contracting laboratories. DNA retardation 
experiments, RFLP analysis, mutant complementation and antisense strategies will be 
used as tools to identify the ructions of these newly identified genes in the coming years. 
WIDER CONSIDERATIONS 
The identification of new plant regulatory genes has been succesfully achieved in 
several of the contributing laboratories involved in this BRIDGE program. Our efforts 
will now be put on the identification of their targets, and we are expecting major 
breakthrough with respect to the identification of their function during the coming years. 
COOPERATIVE ACTrvrTIES 
All project leaders met at Rothamsted Experimental Station in March 1991 to start the 
collaboratoins.A second meeting of all participants will be organized next May at ENEA 
in Roma. 
Materiels (vectors, clones) and sequence information have been exchanged between 
Norwich and the group of Dr Paz-Ares and a meeting in Madrid (November, 1991) was 
organized to discuss results and plan future collaborative projects including a joint effort 
on RFLP mapping of myb genes in Petunia. Dr Paz-Ares also visited Versailles last 
March to further discuss strategies of cloning transcription factors. Francesca Sparvoli 
from the Milano group is in Norwich since October 1991 for a joint project to isolate a 
number of clones encoding anthocyanins biosynthetic enzymes and regulatory genes 
encoding myb and myc related transcription factor from grape using maize and 
Antirrhinum clones as heterologous probes. 
The collaboration between INRA and SETTA has not started yet Authorizations for 
field experiments involving transgenic plants have been requested, and we are waiting for 
these authorizations to start these field experiments.The industrial-academic collaboration 
between AGC and the JICPSR group is working well. Meeting have taken place a regular 
intervals between the two laboratories, four to date, and have proved a good forum for the 
exchange of information and materials. The JICPSR group has supplied probes and 
sequence data and AGC personel have visited the John Innes Institute to obtain details of 
tomato transformation. 
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Objectives set for the reporting period 
Crop productivity depends on the ability of the plant to transport the assimilates from 
the leaf blade to the receiving organs harvested for human consumption. This transport is 
controlled by the distribution and the activity of specific membrane transporters. The general 
aim of the project is therefore to characterize and to identify plant plasmalemma transporters 
(sucrose, amino acids, ions) and tonoplast transporters (malate), and to clone the 
corresponding genes. Sucrose is the major mobile carbohydrate in the plant and may be finally 
stored as sucrose or as starch in fruits. Amino acid transport is necessary for the synthesis of 
storage proteins found in cereals and legumes. Malate is one of the major solutes accumulated 
in vacuoles of higher plants, being involved in transient storage of carbon, charge balance, 
cytoplasmic homeostasis and turgor maintenance. Finally, ion transport across the 
plasmalemma is necessary for the maintenance of cell metabolism. 
The objectives set for the reporting period consisted mainly in designing the techniques 
and the tools that were necessary to achieve the general objective. From a general standpoint, it 
was planned to compare and to adapt several methods of preparation of purified plasmalemma 
and tonoplast since very large amounts of membranes are necessary to run the experiments 
planned. For the sucrose carrier, already putatively identified as a 42 kD polypeptide in 
previous work, it was planned to prepare polyclonal and monoclonal antibodies directed to the 
42 kD polypeptide, to screen cDNA libraries in sugar beet , and to start reconstitution 
experiments in proteoliposomes. In parallel, it was planned to develop a oocyte expression 
assay in order to check the identity of genes putatively identified as genes coding for 
transporters by the molecular biology approaches. For the amino acid carriers, the objective 
was to design differential labeling procedures, and to start PCR (polymerase chain reaction) 
with heterologous primers from bacteria. To develop a mutational approach towards the ion 
carriers in Arabidopsis, it was necessary to characterize the physiology of transport in this 
species, and to start the selection of mutants. Concerning the malate carrier, the objective set 
consisted in the comparison of translation products from induced and non-induced plants, and 
in the development of strategies based on monoclonal antibodies and differential labeling. 
Major problems encountered 
Most of the problems appearing during the work were expected, and none of them 
really impaired the achievement of intermediary or final objectives. General problems include 
the very large amounts of membranes that must be prepared to characterize the carriers, and the 
difficulty to work with membrane proteins (vs soluble proteins). Initial strategies have been 
improved to take these problems into account An additional strategy, not initially included in 
the proposal (heterologous complementation of yeasts), which has appeared recently and has 
proven very powerful to identify membrane carriers (Sentenac et al., 1992) is now developed 
in the project. 
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Results 
I. Plasma membrane 
1. Preparation of plasma membranes. The groups of Poitiers and Toulouse have 
compared the yield, purity and functional status of plasma membrane fractions prepared by 
phase partitioning or by free flow electrophoresis. Both methods yield highly purified plasma 
membranes. Yet, the phase partitioning technique was faster and gave higher yields. 
Moreover, upon storage, the membranes prepared by free flow electrophoresis rapidly lost 
much of their transport activity (H+ and sucrose). Phase partitioning, although expensive and 
somewhat tedious, is therefore routinely used to prepare the plasma membranes used for the 
biochemical studies on transporters. 
2.The sucrose carrier 
2a. Biochemistry. Several polyclonal sera and ascitic fluids directed against the 42 
kD region of the plasmalemma have been raised in Poitiers. These sera selectively inhibited 
proton-driven uptake of sucrose into purified plasma membrane vesicles, while they had no 
effect on proton-driven valine uptake. This confirmed, en a functional basis, the previous 
hypothesis that a 42 kD polypeptide is involved in sucrose transport across the plasmalemma. 
The 42 kD polypeptide has been identified after denaturating gel electrophoresis. Successful 
attempts were made to purify the sucrose carrier in a functional state, using solubilisation of the 
plasma membrane proteins by non-denaturating detergents and high performance liquid 
chromatography. The solubilized proteins were separated by gel filtration and by ion-exchange 
(Mono-Q) chromatography. Two batches of membrane proteins were used. One batch was 
labeled by [3H]/[14C]N-ethylmaleimide in the presence of sucrose, according to procedures 
which differentially label the sucrose carrier. The other batch was unlabeled, and the fractions 
eluted from the column were monitored for their ability to be recognized by the anti-42 kD sera 
(ELISA test). Under non-denaturating conditions, a peak of differential label coincides with an 
ELISA reactive peak at 120 kD upon gel filtration. When the 120 kD peak is recovered and 
denatured by SDS, the 120 kD cluster yields a peak of differential label at 42 kD, which 
coincides with an ELISA reactive peak at 42 kD. Therefore, at least under these in vitro 
conditions, the 42 kD polypeptide is part of a higher molecular weight cluster (120 kD). The 
120 kD fraction has been used to design a procedure for the reconstitution of proton-driven 
transport activity into proteoliposomes. The 120 kD fraction has been further separated on a 
Mono-Q column eluted by a NaCl gradient, and the proteins eluted were tested both for their 
ability to be recognized by the anti-42 kD sera, and for their ability to transport sucrose after 
reconstitution in proteoliposomes. A peak eluted at 0.31 M NaCl was found to react with the 
anti-42 kD sera, exhibited a high activity of sucrose transport, but did not transport valine. Gel 
electrophoresis showed that this fraction was strongly enriched in two very close bands at 42 
kD . Further improvements to the purification (affinity chromatography) and the reconstitution 
steps are presently made. 
Unlike the plasma membrane vesicles (PMV) prepared from mature exporting sugar 
beet leaves, the PMV prepared from young importing leaves are devoid of proton-driven 
sucrose transport activity. Monodimensional gel electrophoresis showed that PMVs from 
young leaves are depleted in a 42 kD polypeptide. These data provide another line of functional 
evidence for the identity of this polypeptide as a component of the sucrose carrier. 
Furthermore, the Berlin group has separated the proteins by two-dimensional electrophoresis 
(2D-PAGE) using immobilized pH gradients in the first dimension. Both in potato tubers and 
in sugar beet leaves, a whole set of proteins mainly in the 40 kD range are absent from the 
importing stage but are apparent at the exporting stage. The 2D-PAGE system has been scaled 
up and proteins have been transferred to PVDF membranes with the intention to sequence 
individual polypeptides. Purified fractions of the 42 kD protein prepared by non- denaturating 
high performance liquid chromatography in Poitiers are being analysed by 2D-PAGE to further 
narrow down the number of candidates to be characterized 
Initial attempts to prepare monoclonal antibodies : gainst the sucrose carrier have not 
been successful, possibly because the antigen used was -Jie denatured 42 kD region of the 
plasma membrane. Further attempts will therefore be made with the non denatured fraction 
prepared by high performance liquid chromatography. 
2b. Molecular biology. The Berlin group has constructed a directional expression 
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cDNA library in X gt 11-Not from mature sugarbeet leaves. Approx. 5 x 10s plaques were 
screened using a biotinylated second antibody and streptavidin/peroxidase complex to detect 
the binding of the primary anri-42 kD antiserum (prepared in Poitiers). Ten positive plaques 
were obtained, purified and further analysed after subcloning. Complete DNA-sequencing 
showed that three clones, the biggest being 1.6 kb in size, are highly homologous to the 
propionyl CoA carboxylase gene from vertebrates and seem to encode a biotin binding protein. 
Related genes have been previously isolated as cloning artefacts due to direct interaction of 
streptavidin with the protein. No transcript was detectable in Northern blots of RNA isolated 
from different organs of sugarbeet. For the other clones of which substantial parts are 
sequenced, no homology was found in the data banks. The clones are still under investigation. 
Northern blot analysis showed differential expression in different organs of sugarbeet. 
To identify a sucrose transporter in yeast by complementation, we needed a strain 
unable to transport, but able to metabolise sucrose if taken up via a functional plant carrier 
protein. The Berlin group showed that compared to wild type strains, a yeast strain deficient in 
invertase (sue) is retarded in growth on media containing sucrose as the sole carbon source. 
This strain, which does not transport sucrose, has been stably transformed with a gene coding 
for a sucrose hydrolysing activity. This strain still is not able to grow efficiently on sucrose. A 
cDNA expression library from mature spinach leaves has been constructed in a yeast 
expression vector. The cDNA library was transformed into the modified yeast strain and the 
recombinant clones were selected on media containing sucrose as the sole carbon source. We 
are currently characterizing clones that regained their ability to grow on sucrose. Other cDNA 
libraries presendy prepared will be tested. 
Our project also plans to use the oocyte expression assay to test the identity of genes 
coding for transport proteins. At the outset of this project, no plant transporter had been 
functionally expressed in Xenopus oocytes. The group in Rothamsted has used a full-length 
cDNA clone for the STP1 H+/hexose cotransporter from Arabidopsis (kindly provided by Dr. 
N. Sauer). This cDNA has been transcribed in vitro and the mRNA injected into oocytes. 
Under optimized conditions, oocytes injected with the STP1 mRNA accumulated 3-O-methyl 
glucose at rates up to 3000 times greater than water-injected controls. These results 
demonstrate for the first time that a plant membrane transporter can be functionally expressed 
in oocytes, and therefore that the strategy planned is valid. 
3.The amino acid carrier 
3a.Biochemistry. The initial objective assigned to the Poitiers group for this period 
was to develop differential labeling methods for the amino acid carrier, similar to what had 
been done before for the sucrose carrier. Proton-driven valine transport into purified PMV 
from sugar beet leaves was characterized. A full range of inhibitors and conditions was tested 
to find a substrate-protectable inhibition of valine transport. Amino acid uptake was relatively 
insensitive to a variety of chemicals: DIDS , SITS , iodoacetamide, iodoacetate, phenylglyoxal 
(all tested at 2 mM). A variety of conditions was tested to try to find some inhibition by NEM, 
but without success. PCMBS, mersalyl or DEPC inhibited valine uptake significantly. Valine 
has no protective effect against PCMBS inhibition. L-Valine, D-valine and glycine are able to 
protect partially the carrier against mersalyle inhibition, while sucrose exerts no such 
protection. Unfortunately, mersalyl, which might be used to label differentially the amino acid 
carriers, is not available as a labelled compound. Therefore, attempts will be made to separate 
the membrane proteins on a mersalyl-column in the presence or in the absence of amino acids 
in the elution buffer. Since good progress is also currently made by affinity chromatography of 
the sucrose carrier, a similar strategy will also be developed for the amino acid carriers with 
valine-substituted columns. 
Importantly, after several modifications of the procedure initially designed for the 
sucrose carrier, we are now able to reconstitute "routinely" amino acid transporters into 
proteoliposomes. This reconstitution procedure is necessary to identify plasma membrane 
fractions that are competent in amino acid transport after separation of the proteins on either of 
the column used (mersalyl, or valine-substituted columns). 
3b.Molecular biology. A PCR (polymerase chain reaction) approach was 
successfully used in Rothamsted to isolate plant homologues of the ABC superfamily of ATP-
dependent transport proteins. These transporters have diverse substrate specificities but some 
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bacterial members of the family are amino acid carriers. Two highly conserved amino acid 
sequences have been used to design two sets of mixed primers. DNA fragments of the 
expected size (ca 300 bp) were amplified from barley root mRNA and these were cloned and 
sequenced. Two related barley genes (45 % identical at the amino acid level) with significant 
homology to the mammalian P-glycoproteins were identified. A third clone also encoded a 
sequence with homologies to the ABC superfamily. The function of these three putative ATP-
dependent transporters in barley roots has still to be determined. The success of these 
experiments has established the feasibility of the PCR approach to cloning plant homologues of 
well characterized families of transport proteins. 
All eukaryoric amino acid permeases so far sequenced (five fungal and one human) 
belong to a single gene family, and members of the same family occur in bacteria. A set of four 
inosine containing primers based on conserved sequences in this amino acid permease family 
was designed. These primers were tested on a model template consisting of a fragment of the 
Aspergillus nidulans prnB (proline permease) gene and it was shown that they are able to 
amplify fragments of the expected size. These primers are now being used in Rothamsted to try 
to amplify amino acid permease sequences from plant genomic DNA. 
Several unsuccessful attempts have been made in Rothamsted, using different batches 
of oocytes and different preparations of barley polyA+ RNA, to detect the expression of a plant 
amino acid carrier by monitoring uptake of radiolabelled amino acids into the injected cells. 
Other sources of polyA+ RNA will be tried, such as castor bean cotyledons, which should be 
enriched for amino acid permease mRNAs. 
In Saccharomyces cerevisiae, several amino acid transport mutants are known (Cooper, 
1982). Several of the respective genes have been isolated by complementation of the mutants. 
We intend to use the well established selection systems to isolate amino acid transporters from 
plants. 
4.The ion carriers 
4a.Physiology.The initial objective was to characterize important physiological 
features of transport in Arabidopsis at various levels (seedlings, isolated cells, protoplasts, 
membrane vesicles). Satisfactory conditions have been set up for the growth of Arabidopsis in 
liquid medium and for the establishment of cell suspension cultures. H+ transport and the 
uptake and the effect on membrane potential of several ions (K+, Na+, NH4+, Cs+, CI", SO4" 
, NO3 )¯ were studied in Arabidopsis seedlings. The reciprocal interactions (for uptake) among 
K+, Na+, NH4+ Cs+, CI" and SO4- were also determined. 
The sensitivity of ion transport to physical and chemical factors was studied. Using 3 
day-germinated seedlings, it was shown that the stimulation (by K+ or K+ plus FC) or the 
inhibition of proton extrusion (by vanadate or by erythrosin B) is associated with an 
alkalinizadon or, respectively, an acidification of both cytosol and vacuole. In cultured cells, 
low water potential media induce a strong stimulation of H+ extrusion. The effects of FC and 
of the osmotic pressure on H+ extrusion are synergistic. 
In protoplasts, two kinds of channels were identified: a) hyperpolarization-activated 
cationic channels, permeable to K+, inhibited by triethylammonium ; b) depolarization-
activated channels, permeable to K+ or to C1¯  and also to polyamines (putrescine, spermidine 
and spermine). 
In microsomes from 72-h-old seedlings and purified plasma membranes, specific 
activities of H+-ATPase and of Ca^+.ATPase were measured and their sensitivity to various 
effectors was studied. The H+-ATPase of Arabidopsis vesicles was stimulated by fusicoccin, 
and the Ca2+-ATPase was stimulated by calmodulin. 
4b.Mutagenesis. Mutants putatively altered in K+ uptake have been screened for in 
M2 progeny from EMS-mutagenized M1 plants by selecting slow-growing seedlings in a 
medium containing NH4+ and sub-optimal K+ concentration, or by selecting for resistance to 
toxic concentrations of compounds such as Cs+ or tetraethylammonium which interfere with 
K+ uptake. 
Mutants altered in the proton pump activity or sensitivity to fusicoccin have been 
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selected by resistance to hygromycin B or to toxic cations (paraquat) whose uptake is promoted 
by fusicoccin. A recessive mutant, resistant to Cs+ when heterozygote and slow-growing at 
sub-optimal K+ concentration when homozygous together with two independent mutants 
insensitive to fusicoccin, have been isolated. Future work will complete the characterization of 
ion transport in the wild type, extending it to sugar and aminoacids symports with H+, and 
initiate the characterization of transport in the mutants already at our disposal (isolated by us or 
by other workers). 
II. Tonoplast 
1. Malate transport at the tonoplast of CAM plants (Kalanchoe daigremontiana) 
Malate influx has been studied in Oxford, using the patch-clamp technique. Whole-
vacuole experiments characterized an electrophoretic, inwardly directed transport system highly 
selective for malate and certain other four- and five-carbon dicarboxylates. The malate currents 
show relatively slow activation kinetics and are strongly rectifying, favouring malate transport 
into the vacuole at inside-positive vacuolar potentials. Recordings in isolated membrane 
patches revealed a small channel with a unitary conductance of 3.4 pS and high open 
probability. Thus, the malate-influx system at the tonoplast in CAM plants appears to be a 
novel anion-selective ion channel (submitted). 
Tonoplast vesicles were used for further transport studies and for the production of 
monoclonal antibodies. A membrane-filtration technique allowed characterization of the 
inhibitor sensitivity of the malate transporter. Malate transport is sensitive to sulphydryl 
reagents and to reagents that covalently react with positively charged amino-acid residues (i.e. 
His, Lys, Arg). In particular, inhibition of malate transport by the lysyl reagent pyridoxal 
phosphate was almost completely substrate-protectable, suggesting that a lysine residue might 
form part of the dicarboxylate recognition site of the malate transport system. However, the 
differential labelling approach to identify the malate channel protein will not be pursued as a 
priority because the malate channel is believed to be a low-abundance membrane protein that 
might be well below the limits of detection. 
Monoclonal antibodies have been raised in mice against native tonoplast membrane. 
Single-cell lines have been selected by the limiting dilution method for subsequent cloning, and 
the supematants are being screened for their possible ability to inhibit malate transport at the 
tonoplast. Preliminary screening has been performed in assays of malate-dependent H+ 
transport, and those supematants with an inhibitory effect subsequently tested in the 
membrane-filtration assay. Recently, three monoclonal antibodies have been identified that 
significantly inhibit malate transport. These antibodies will now be further characterized by 
western blotting and by cross-reaction with translation products from membrane-bound 
polysomal RNA. 
We are also attempting to identify transcripts associated with synthesis of the proteins 
at particular stages of CAM induction. Essential for this approach is the isolation and 
purification of RNA and DNA from Kalanchoe leaf tissue, a task that has not previously been 
attempted. A successful protocol was developed that yields RNA and DNA free from 
contamination by the acidic polysaccharides characteristically present in species of the 
Crassulaceae. Further, we have succeeded in isolating membrane-bound polysomal mRNA 
from Kalanchoe mesophyll cells, which we anticipate will be enriched in transcripts for 
membrane proteins. These protocols will now be used to compare transcript levels at different 
stages of CAM induction, and also for immunoprecipitation of tonoplast proteins using the 
monoclonal antibodies raised above. Additionally, PCR primers have been designed against 
conserved regions of genes from three known superfamilies of membrane transport proteins 
(the ABC proteins, Nod 26 family, and the sugar transport family), and these will be tested for 
hybridization to cDNA from CAM and non-CAM tissue using the approach developed by the 
Rothamsted group. 
2. Malate transport in C3 plants 
Inhibitor studies performed in Toulouse with vacuoles from Catharanthus showed that 
a histidyl residue(s) is involved either in the binding or the translocation of malate. The 
histidine-specific reagents diethylpyrocarbonate and Rose Bengal efficiendy inhibited the 
activity of the malate carrier in a substrate-protectable manner. A photoactivable analog of 
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malate has been synthesized with the co-operation of a chemistry group. The probe, 
radiolabelled with 1 2 5 I , will be used to identify the carrier. 
Highl ight s /mi l e s tones . Reconstitution procedures for the sucrose carrier and the amino 
acid carriers. Complementation studies with yeasts. First demonstration that a plant membrane 
protein can be successfully synthesized and targeted to the oocyte plasma membrane. Isolation 
of Arabidopsis mutants for K+ uptake. Identification of a novel malate-selective ion channel in 
the tonoplast of CAM plants. Library of monoclonal antibodies against the native tonoplast 
membrane of Kalanchoe. Development of a protocol for successful isolation of RNA and D N A 
from Kalanchoe mesophyll cells. 
Wider considerations. From current progress in this project and in other groups, it may be 
foreseen that genetic engineering of transport proteins in plants will be possible in the near 
future. This open new insights on possible manipulation of the plant content, and on its stress 
tolerance, for example. 
Cooperative activities. Two 2-days internal plenary meetings were held in Poitiers (07 /91) 
and in Milan (01/92). A general meeting with external participants will be held in Oxford (June 
25, 26 1992). Short duration bidirectional exchanges (2-3 weeks) of scientists occurred 
between Poitiers and Berlin to share techniques. Membranes are exchanged between Poitiers 
and Toulouse. Membranes and antibodies are supplied to the Berlin group by Poitiers. Other 
exchanges between Poitiers/Milan, Berlin/Rothamsted, Oxford/Toulouse and Rothamsted/Ox-
ford are planned in the near future. 
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OBJECTIVES: 
The general objective of the proposed project is the con-
struction of artifical chromosomes for mammalian cells by as-
sembling biologically relevant DNA sequences from chromosomes 
and naturally occurring linear plasmids. The reason for 
creating such constructs is that so far no satisfactory auto-
nomously replicating vectors exist for higher eucaryotic cells 
and organisms and it may well be that the ideal eucaryotic 
vector may have to mimic a chromosome. This kind of construct 
will allow directed genetic engineering of higher eucaryotes, 
will help to isolate other biologically important sequences, 
will be useful in the production of medically important mole-
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cules, will help to unterstand differentiation processes and 
may prove to be a safe and reproducible method for the somatic 
therapy of some genetic diseases. 
Intermediate objectives are the isolation of the dif­
ferent chromosomal sequences that will be required for the 
construction of an artificial mammalian chromosome. These will 
include origins of replication and telomeric sequences, which 
are essential even for the construction of linear plasmids, 
intermediate structures on the way to artificial chromosomes. 
In the final stages of the project it will be necessary for 
functional centromeric or other stabilizing sequences to 
become available, for the actual construction of the 
chromosome. Telomeric sequences have been isolated from a 
number of organisms including man; the mechanisms by which 
they function in higher organisms are still obscure to a great 
extent. Much is being learned about replication origins, but a 
functional, non viral, origin still awaits isolation. 
Centromeres have been isolated in yeast, but not in higher 
organisms. The attainment of these intermediate steps will 
constitute important achievements in basic cell biology. 
RESULTS: 
There are three functional elements necessary to turn a 
segment of DNA into an artificial chromosome: Telomeres, 
replicators and centromeres or other stabilizing sequences. 
The major effort therefore was made to identify and isolate 
such sequences from different sources as well as to assemble 
the different elements and test them in several organisms 
(number in parenthesis indicate the groups performing the 
experiments). 
TELOMERES: Telomeres are the best characterized elements of 
the eucaryotic chromosome. While all telomeric repeats 
function in yeast, this is not the case for higher eucaryotic 
cells. If mammalian cells are transfected with YACs (yeast 
artifical chromosomes), the YAC integrates into the genome. 
Therefore, mammalian telomeres were ligated to a YAC carrying 
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the neomycin resistance gene under the control of the TK 
promoter. Cells transfected with this construct became G418 
resistant, i. e. the neomycin resistance gene is expressed. 
Further experiments will show whether this construct is extra-
chromosomally stable (3). Experiments to study the re-
quirements to keep a linear DNA molecular physically stable 
were performed by injecting constructs with different telo-
meric structures in Xenopus oocytes. It clearly could be shown 
that the native DNA structure is sufficient to prevent a 
linear DNA molecule from exonucleolytic digestion (1, 5). 
Teloraeric sequences adopt a special DNA structure. A number of 
vectors containing different telomeric repeats were con-
structed and the conformation adopted by these sequences 
analyzed (1, 2, 5). Further work concentrated on the charac-
terization of telomeres from the parasite Eimeria and from 
Xenopus laevis. While Eimeria telomeres are identical to those 
of Plasmodium and the plant Arabidopsis (6), the Xenopus telo-
meres are homologous the human telomeric repeat (1, 3). A 
protein that binds specifically to the single stranded pro-
trusian of yeast telomeres was identified. This protein inter-
acts with the well known RAP 1 protein (5). 
REPLICATION ORIGINS: In contrast to the ARS (autonomous repli-
cating sequences) in yeast nothing is known about mammalian 
origins of replication. However, cytological data indicate 
that in S phase initiation of replication occurs about every 
100 kb apart. Since a YAC easily can span this length, a 
mammalian YAC library was constructed and is now tested for 
replication capacity (3). Using a different approach, mam-
malian DNA was restricted to about 20 kb and ligated to the 
pMAMneo vector. After introduction into mammalian cells, they 
were selected for G418 resistance. None of the cells survived 
for longer than one generation. These data are consistent with 
the notion that the information for replication initiation is 
present on long DNA fragments but that it is not sufficient 
for maintenance of replication (5). A simple and efficient 
method for the mapping of eucaryotic origins of replication 
was established and, using SV40 and polyoma virus as model 
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system, the feasibility of this method was demonstrated (4). 
In an attempt to isolate sequences involved in copy number 
control, the mouse amplification promoting sequences (APS) 
were inserted in a BPV-1 containing vector. Insertion of these 
sequences results in a drastic reduction of plasmid copy 
number. As working hypothesis we assumed, that the amplifica-
tion promoting sequences act with the aid of BPV coded trans-
acting factors as an origin of replication. Such constructs 
then would carry two origins of replication (from BPV and APS) 
and replication would be badly disturbed. This hypothesis is 
now experimentally tested (1, 4). 
CENTROMERES: Centromeres seem to be the most complicated 
sequences, so far they are mapped down to the megabase level. 
Conversion vectors carrying large mammalian DNA fragments are 
constructed and will be tested for mitotic stability (3). 
However, it may turn out that for the construction of an 
artificial chromosome other stabilizing sequences may be 
easier to obtain and handle. 
FURTHER EXPERIMENTS concentrated on the study of the struc-
tural organization of pericentromeric satellite DNA sequences 
and the construction of an extrachromosomally replicating 
expression vector for Xenopus. The structural organization of 
mouse and Drosophila satellite DNA was studied and analyzed 
(2). From mouse nuclear extracts proteins were isolated that 
bind specifically to these sequences. In this context the 
structural analysis of a d(GA.CT)jj sequences was completed. 
This sequence adopts a special structure and increases the 
rate of recombination about 5-10 fold (2) . 
Based on the observation that a BPV-1 containing vector 
replicates extrachromosomally in Xenopus embryos an expression 
vector containing actin sequences in antisense orientation was 
constructed and injected into Xenopus embryos. It could be 
shown that transcripts produced by this vector specifically 
inhibit actin gene expression. This kind of vector may prove 
usefull for the identification of as yet uncharacterized 
sequences (1). 
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MILESTONES: All the experiments described above are important 
prerequisites for the construction of an artificial chromosome 
for higher eucaryotes. Furthermore, many of the results ob-
tained, like the work on replication origins, centromeres, 
recombination or DNA structures adopted by specific sequences, 
are of major interest for basic biological questions. 
WIDER CONSIDERATIONS: An artifical chromosome provides the 
chance for safe and specific genetic manipulation of higher 
organisms. Since these constructs never will integrate into 
the genome and not disturb gene balance in the organisms they 
may be the ideal vector for somatic gene therapy. 
COOPERATIVE ACTIVITIES: There are strong interactions between 
all participating groups as well as exchange of material and 
staff between the different laboratories. Two group meetings 
were held in Tubingen and one took place in Lisbon in con-
junction with another group of the BRIDGE programm. 
LIST OF JOINT PUBLICATIONS 
Schmid, M. , Steinbeisser, H., Ascenzioni, F., Trendelenburg, 
M.F. and Lipps, H. J. (1991): Native yeast telomeres are 
sufficient to stabilize linear DNA in Xenopus oocytes. 
Gene 106, 121-124. 
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TITLE: Improved techniques for establishing a high expression production system for 
recombinant proteins from animal cells 
CONTRACT NUMBER: BIOT­CT 90­0185 
OFFICIAL STARTING DATE: 01­04­1991 
COORDINATOR: 
DrHHauser, GBF, 3300 Braunschweig, FJi.G. 
PARTICIPANTS: 
DrHHauser, GBF, 3300 Braunschweig, FJi.G. 
ProfDrMJ.T.Carrondo, IBET, 2780 Oeiras, Portugal 
ProfDrB.Griffiths, PHLS CAMR, Porton, Salisbury, Wiltshire SP4, OJG, UK 
Manfred Mistier (Subcontractor of Prof. Griffiths), Schott Engineering, 6500 
Mainz 1, FJi.G. 
Dr.U.Weidle, BoehringerlMannheim, 8122 Penzberg, FJi.G. 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
For the genetic work in the initial year of the project the evaluation of feasibi­
lity of selection principles, genetic manipulation and gene targeting was 
planned. Cell biology work intended to evaluate the chosen cell lines and the 
base line assessment of cell culture properties and methods. This should 
include the establishment of bioreactors with macroporous supports and 
aggregated culture systems. 
MAJOR PROBLEMS ENCOUNTERED: 
Stability of one type of recombinant cell clone was critical in the initial part 
of the work. 
RESULTS: Genetic work: A system was established which allows the identification and 
isolation of highly active chromosomal loci in production cell lines. Expres­
sion levels of a reporter gene which is integrated as a single copy into the 
chromosome of a large number of cell clones indicate the transcriptional 
activity of the integration loci. The isolation of flanking DNA sequences of 
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these highly transcribed reporter genes involve the next step. To achieve this, 
inverse PCR was established. Single copy chromosomal DNA fragments 
which are appropriate for targeting have been identified. 
For directing the genes of interest into the defined, favourable chromosomal 
loci, gene targeting vectors are under investigation. 
Bioreaction: Two cell lines secreting recombinant antibody, based on BHK-21 
and SP2-0 were established by conventional transfection procedures and used 
for physiological studies in bioreactors. Cultivation was carried out in reactors 
in suspension culture, on microcarriers and in fixed bed bioreactor systems. 
While batch microcarrier cultures of recombinant BHK cells show negative 
correlation between growth and productivity in the myeloma cell lines suspen-
sion culture the productivity is strongly correlated to cell growth. 
Aggregation: In addition, a new sampling system for aggreate flocks has been 
developed. The influence of the variables that control aggregate size and 
number have been studied, namely medium composition (with different 
amounts of serum and a serum free medium formulation) and inoculum 
concentration; neither had an appreciable influence on aggregate formation and 
size. 
Aggregate size is basically dependent on hydrodynamics. Bioreaction using 
different spinner and impeller geometries shows that this is a generic property, 
independent of those variables. The next developments of the work are: 
optimization of aggregates, productivity and stability evaluation, stability 
growth in continuous cultues during long periods of time. 
A theoretical model is under development to evaluate the transport phenomena 
through macropouros supports with different characteristics will be performed 
once the model is tested against literature data. 
BHK cells grown in continuous culture in fixed bed bioreactors show at least 
twofold higher volumetric activity compared to batch microcarrier cultures 
grown with the same available volume of media. The maximum specific 
productivity of the microcarrier cultures lies within the range of average 
specific productivities for fixed bed reacture cultures. However, while the 
maximum values for the microcarrier cultures are for a single time point, the 
- 2 0 8 -
values for the fixed bed reactme cultures are the average for up to 10 days. 
HIGHLIGHTS/MILESTONES: 
Natural aggregation is a generic phenomenon. Aggregates size is only a 
function of the cell line and hydrodynamics of the system. The correlation of 
cell growth and productivity depends on the cell line. 
WIDER CONSIDERATIONS: 
The major result of the first year of this project is that all bottleneck technolo-
gies could be established. These include the methods of identifying transcrip-
tionally active chromosomal loci in which the genes of interest have to be 
targeted, the establishment of aggregated cell bioreactor system and the 
bioreaction on a fixed bed bioreaction system. At this time bioreaction is 
carried out with production cell lines constitutively secreting recombinant 
antibody. After having established recombinant cell lines with the genes of 
interest at defined chromosomal loci their expression will be challenged in the 
established bioreaction systems. 
COOPERATIVE ACTIVmES: 
During the initial year of the project, members of the Portuguese group went 
to PHLS and GBF to establish common laboratory procedures and protocols, 
namely the quantification and secondary products like glutamine and ammoni-
um or specific products obtained from the genetically modified cells. Short 
course at Boehringer/Mannheim to learn the modus operandi with SP2/0 also 
took place. Vice versa a member of the CAMR spent one week at IBET in 
order to exchange information. ELWW-Meeting on May 1991 on "Host-vector 
systems for animal cell biotechnology" was held in Oeiras, Portugal. 
JOINT PUBLICATIONS: 
Moreira, J. L., Wirth, M., Fitzek, M. and H. Hauser: Evaluation of reporter 
genes in mammalian cell lines. Methods in Molecular and Cellular Biology 3 
(1992), 23-29 
OTHER PUBLICATIONS/PATENTS: Nothing to report 
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OBJECTIVES SET FOR THE REPORTING PERIOD: 
The overall objective of the Bridge Project is to study the regulatory proteins and 
genes which control the synthesis of some representative liver-specific proteins. 
The specific aims of the proposed research are: 1) To isolate and characterize several 
genes involved in the transcriptional regulation of liver-specific proteins including genes 
involved in hepatocyte differentiation. 2) To study the mechanism of transcriptional 
regulation and the functions of the regulatory genes by reverse genetics (site directed 
mutagenesis in vitro transcription, homologous recombination, anti-sense RNA, ectopic and 
unregulated expression in transgenic animals). 3) To identify and characterize the promoter 
elements and trans-acting factors involved in the transcriptional control of the regulatory 
genes in an attempt to define putative regulatory cascades in gene regulation. 4) To study the 
role of extracellular signals (matrix components and growth factors) in the regulation of 
liver-specific genesin advanced tissue culture systems employing different extracellular 
matrices. 
MAJOR PROBLEMS ENCOUNTERED: 
There are no major problems in pursuing our original specific aims. 
RESULTS: 
01 Vassilis Zannis and John Talianidis 
I. Molecular Cloning of the cDNAs of Transcription Factors Modulating the ApoCm 
Gene: A unidirectional cDNA library from rat liver mRNA in Xgt22 has been constructed 
which allows the expression and detection of B-galactosidase fusion proteins from the cloned 
inserts. By screening with the method developed by S. McKnight, we have purified several 
clones putatively encoding transcription factors binding to the apoCIII elements B, C, and D. 
Further characterization of these clones is in progress. 
II. Definition of the Binding Domains of the Various Transcription Factors on the 
ApoA-I Promoter and Evaluation of Their Importance for the Transcription of the 
ApoA-I Gene: Footprinting analysis showed that the heat stable activities NF-BA2.3 and 
C/EBP bind between nucleotides -175 to -155, whereas the heat labile activities 1 and 3 bind 
in the -168 to -148 region. The importance of the factors which recognize the regulatory 
region C for the transcription of the apoA-I gene was established by in vitro mutagenesis of 
this region. Mutations in the -171 to -166 region and the -158 to -153 region which 
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diminished the binding of the heat stable activities reduced transcription to 8 to 14% of 
control. In contrast, a mutation in the -164 to -159 region which abolished the binding of the 
heat labile activity AIC1 increased transcription 4.6 fold. The findings suggest that the heat 
stable NF-BA2.3 are posistive regulators and the factor AIC1 is a negative regulator of the 
apoA-I gene transcription. 
02 Vincenco DeSimone 
LFB1/HNF1 and LFB3: Sites of Synthesis and Their Role in Liver Differentiation 
LFB1 and LFB3 are two transacting factors which play a central role in the 
expression of liver-specific genes. The developmental expression pattem of these two genes 
has been characterized in great detail by RNase protection, western blot and in situ 
hybridization. It was shown that LFB3 expression is not directly correlated with the liver-
specific phenotype. LFB3 and LFB1 are expressed in the epithelial component of many 
organs of endodermal and mesodermal origin, suggesting that they may play a more general 
role associated with the differentiation of specialized epithelia. A more detailed analysis of 
the expression pattem during the development of the kidney shows that LFB3 transcription 
starts with the induction of the presumptive mesenchymal cells, while LFB1 appears only 
when the proximal and the distal tubules start to be detectable. The induction pattern of 
LFB3 can be reproduced in the transfilter organ culture system, in which the presumptive 
kidney mesenchymal tissue can be grown in vitro and induced to differentiate by 
(^cultivation with spinal cord explants. In this system, LFB3 expression "bursts" between 
24 and 48 hours after induction, when the first morphologic differentiation of the 
nephrogenic vesicles occur. 
03 Ricardo Cortese 
I. Cloning of two zinc finger proteins which bind to the α1-antitrypsin promoter 
Two partial cDNAs coding for DNA-binding proteins (AT-BP1 and AT-BP2) have 
been isolated. Both proteins bind to the B-domain of the α1-antitrypsin promoter, an element 
which is important for the liver-specific expression of al-antitrypsin. Analysis of the cDNA 
sequences encoding these proteins reveal that both contain two zinc fingers of the Cys2-His2 
type followed by a highly acidic stretch of 20 amino acids. AT-BP1 contains a second 
putative DNA binding domain consisting of an 8-fold repeat of a SPKK (Ser Pro Lys/Arg-
Lys/Arg) motif. Both proteins bind to the NF-kappa B recognition site in the MHC gene 
enhancer with significantly higher affinity than to the kappa immunoglobulin gene enhancer, 
or to the B-domain of the a 1-antitrypsin gene promoter. Analysis of mRNA expression 
shows that AT-BP1 and AT-BP2 are expressed in all the tissues examined. 
n . Secondary structure and conformational stability of the dimerization domain of 
the transcription factor LFB1: The structure of a 32 residue dimerization domain of LFB1 
solution has been determined by nuclear magnetic resonance. Three structurally distinct 
regions can be distinguished. The N-terminal region from residues 1 to 6 is extended. Two 
helical regions span from residues 7 to 18 and from 23 to 32. The absence of dipolar effects 
involving residues more than four positions apart in the sequence excludes the possibilities 
both of a four-helix bundle formed by two hairpins and of an antiparallel dimer; the domain 
must therefore be arranged as a parallel dimer formed by kinked monomers. This structural 
solution presents important differences from the leucine zipper-type structure observed in 
other transcriptional activators. The thermodynamic parameters associated with the unfolding 
of the 32 residue long dimerization domain were determined under the two-state assumption 
by the van't Hoff procedure. The enthalpy of unfolding increases linearly with temperature, 
and the corresponding value of delta Cp, the different in heat capacity between the unfolded 
and the folded forms of the peptide, is estimated to be ca. 0.7 kcal mol"1. These results 
indicate that the dimerization domain of LF-B1 can fold and dimerize independently of the 
rest of the protein, with a thermodynamic stability comparable to that of a small globular 
protein. 
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04 Giorgio Bressan 
The Extracellular Matrix in Liver Function and Morphogenesis. Targeted Disruption of 
the Alfal Type VI Collagen Gene in Embryonic Stem Cells 
The biological function of type VI collagen has been undertaken following the 
targeted gene disruption approach in the mouse. A 9 kb genomic clone of the alfal (VI) 
gene was isolated and was used for further constructions. A neo cassette was inserted into 
an Eco47m site within the second exon and an Herpes simplex tk cassette was placed at the 
3' end of the fragment and the construct was electroporated into embryonic stem (ES) cells 
of the D3 strain at passage 11 and colonies resistant either to G418 or G418+gancyclovir or 
G418+F1AU were selected. Clones with the expected recombination event were confirmed 
by Southern blotting employing probes external to the construct and various restriction 
enzymes. The frequency of targeted disruption of the alfal (VI) collagen gene was 1 in 90 
G418 resistant clones. Cells of the selected clones are being injected into mouse blastocysts 
in order to derive alfal (VI)-deficient animals. 
05 Jean Chambaz 
Regulation of the Human ApoA-II Gene by the Synergistic Action of Factors Binding to 
the Proximal and Distal Regulatory Elements 
It has been shown that the human apoA-II promoter contains a set of 14 regulatory 
elements (A to N). Deletion or nucleotide substitution analysis in elements L (nucleotides -
803 to -773) and K (nucleotides -760 to -743) reduced hepatic transcription to 25 and 20% 
and intestinal transcription to 8 and 4% of control, respectively, as measured by CAT assays, 
indicating that these elements play an important regulatory role. Nucleotide substitutions in 
element AB (nucleotides -65 to -33) reduced hepatic and intestinal transcription to 60 and 
36% of control, respectively. DNA binding and competition assays have shown that 
elements AB, K, and L bind with different affinities to a newly characterized heat-stable 
factor, CHIB1, which is a transcription activator of the human apoCIII gene. In addition, 
elements AB and K bind a heat-labile activity, designated AIIAB1, and element L binds to 
several CCAAT box binding activities. Mutations in domain L that prevented the binding of 
CCAAT box binding activities reduced both hepatic and intestinal transcription to 30% of 
control, indicating the importance of these factors in transcription. Simultaneous nucleotide 
substitutions that prevented the binding of CIIIB1 activity in elements AB, K, and L reduced 
hepatic and intestinal transcription to 7 and 6% of control, respectively, suggesting that the 
synergistic interaction of CIIIB1 (bound to the proximal and distal regulatory elements) with 
CCAAT box proteins (bound to element L) can modulate the level of transcription of the 
human apoA-II gene. 
06 Moshe Yaniv 
I. Transcriptional Regulation of the HNF1/LFB1 Gene: A 3 kb DNA fragment containing 
the HNF1 promoter when linked to β-galactosidase, confers enzymatic activity both after 
transfection in HepG2 hepatoma cells or in transgenic animals. The profile of expression in 
the mice closely resembles the expression of the endogenous gene, suggesting that tissue 
specificity is conferred by this fragment. Transfection experiments in hepatic cells have 
shown that a minimal promoter of 80 bp was still active. This segment contains a binding 
site for another liver enriched transcription factor, HNF4. The role of HNF4 in the control 
of HNF1 was further confirmed in transfection of non hepatic cells. While the HNF1 
promoter was inactive in these cells, it was activated by cotransfection with a clone coding 
for HNF4. 
n . Structure of the Transactivation Domain of HNF1/LFB1 
Deletion and domain swap experiments have shown that the C-terminal part of HNF1 
or vHNFl are responsible for transcriptional activation. Further experiments were 
undertaken to localize more precisely the residues involved in this activity and the potential 
targets for the action of HNF1 in the general transcriptional machinery. 
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III. Chromosomal Mapping of HNF1 and vHNFl Genes in Man and Mouse 
HNF1 is found on human 12 q 24.3 and mouse S E4-G1. vHNFl was found on 
human 17 q 11.2-q 21.1 and mouse 11 B4-D. The mouse gene was mapped more precisely 
relative to other known genes on mouse chromosome 11 by inter subspecific mouse 
backcross to give the order centromer Edp-l-5.8cM-vHNFl-16.3cM-Erba. vHNFl is clearly 
separated from the Hox-1 cluster of homoetic genes that was mapped 0.7 ± 0.7 cM proximal 
to Erba. 
07 Gennaro Ciliberto 
Signal Transduction by D-6 in Hepatic Cells: The ability of various recombinant IL-6DBP 
derivatives, under the control of strong eukaryotic promoter, to stimulate transcription from 
the IL-6RE-CAT reporter gene in the presence and absence of IL-6 in HepG2 cells was 
analyzed. The reporter plasmid contained four copies of the CRPa IL-6RE fused to the 
TATA box and transcriptional initiation site of the CRP gene. The results from an initial set 
of domain-swap experiments showed that whilst C/EBP transactivates in anIL-a6 independent 
manner, activation by IL-6DBP is dramatically induced by IL-6. In contrast, a truncated 
form of IL-6DBP, coding for a smaller protein containing the leucine zipper and basic amino 
acid region, fails to transactivate despite being expressed at comparable level as full length 
IL-6DBP and also efficiently translocated to the nucleus. This suggests that the activation 
domain is located in the amino terminus of the protein, a conclusion supported by the 
observation that the amino terminal amino acids of IL-6DBP can impart the same level of 
constitutive and IL-6 induced activity of the reporter gene when fused to the DNA binding 
domain of C/EBP. 
A second member of the C/EBP family of transcription factors is involved in the IL-6 
signal transduction pathway in hepatic cells. Differently from 1L-6DBP, this protein, named 
C/EBP5, is under transcriptional control by IL-6: mRNA and protein are undetectable is 
unstimulated cells and their levels are strongly stimulated by IL-6. Basically, activation of 
C/EBP5 temporally follows IL-6DBP activation. Therefore at least two members of the 
same family of transcription factors is controlled by IL-6 through different mechanisms. 
08 Mary Weiss 
Establishing the Transcription Rate of Liver Specific Genes: Cell Phenotype, Promoter 
Structure and Binding Affinity Modulate Transactivation by HNF1/LFB1 and LAP. 
Co-transfection of expression vectors encoding transcription factors as well as of 
reporter CAT plasmids containing binding sites for the transcription factors into cells of 
different phenotypes provides a means of evaluating transactivation potential in different 
contexts. For this work, a panel of hepatoma lines and their variants, expressing different 
levels of the endogenous factors, have been employed. 
Well differentiated hepatoma cells produce abundant HNF1 and show high levels of 
expression of a reporter CAT gene whose expression is directed by the albumin promoter. 
Addition of exogenous HNF1 does not enhance the expression of the albumin promoter-
reporter gene constructs. Dedifferentiated variants do not produce endogenous HNF1, nor 
do they express the albumin-CAT gene. Here strong transactivation of the CAT gene by 
exogenous HNF1 is observed. When the albumin HNF-1 binding site is substituted by a 
sequence of weaker binding affinity, exogenous HNF1 possesses transactivation potential in 
all cell lines, whether or not endogenous HNF1 is abundant. It can be concluded that the 
threshold of activity of a given transcription factor on a particular promoter can vary 
depending upon the affinity of the factor for the cognate binding site. 
LAP is a member of the leucine zipper C/EBP family of transcription factors. It has 
been shown to be an activator of transcription using an artificial promoter composed of a 
binding site linked to the albumin TATA sequence. However, when used in a transactivation 
test employing the authentic albumin promoter, which contains the same sequences as the 
artificial promoter but combined with other binding sites (HNF1 and a CCAAT site), 
exogenous LAP represses expression. A likely interpretation is that exogenous LAP 
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displaces C/EBP, the latter being a more powerful activator of transcription. 
09 George Mignot 
T.M. Innovation is currently optimizing the culture condition required for culture of 
new types of hepatic cell lines, and will scale up hepatocyte cultures using macroporous 
carriers (gelatin or glass spheres) to achieve high cell densities with a combination of high 
microcarrier concentration and perfusion system. Expression of recombinant factor IX will 
include study of the quality of the molecule expressed in hepatocyte lines and analysis of 
specific activity. 
12 George Brownlee 
Characterization of the Clotting Factor IX Promoter 
In this last year the discovery of the mutation in the patient Haemophilia B 
Brandenburg in Germany (a G-*C mutation at -26) has given new insight into further liver-
specific and ubiquitous transcription factors, involved in the regulation of the factor IX gene. 
A remarkable property of the Haemophilia B promoter mutants is that patients have a more-
or-less severe bleeding disorder, requiring treatment during childhood, but that shortly after 
puberty the patients improve and no longer need treatment. Brandenburg proved to be 
different from all the other promoter mutants in that he failed to improve after puberty. The 
reason for this rums out to be that there is an androgen responsive element (ARE) in the 
factor DC promoter, which the mutation in Brandenburg disrupts. By using conventional 
transient assay systems in HepG2 cells, we have been able to show that this ARE functions 
in these cells, requiring the androgen receptor and testosterone for activity. When this ARE 
is mutated as in Brandenburg it fails to respond. These functional assays have been 
confirmed by gel shifts with the DNA binding domain of a recombinant androgen receptor. 
The reason for the reduced expression of factor IX before puberty is that there is a LF-
A1/HNF4 binding site partly overlapping with the ARE. This was demonstrated in gel shifts 
with purified LF-A1, comparing the wild-type promoter and the Brandenburg mutants as 
competitors. Competition with the classic factor IX promoter mutant, Haemophilia B 
Ley den, which has a mutation at -20, also fails to bind LF-A1. 
In summary then, it has been shown that the -20 promoter mutants interfere with the 
binding to the liver-specific transcription factor LF-A1/HNF4, while the -26 Brandenburg 
mutant interferes with the binding of both LF-A1/HNF4 and an androgen responsive 
element. The molecular details of how the binding of the androgen receptor "rescues" the 
effect of nearby mutations in the binding sites of other transcription factors remains obscure. 
13 Anna Maria Rollier 
Analysis of the Expression of Albumin Promoter in Human and Murine Hepatoma Cells 
HepG2 and BW1J are albumin producing hepatoma cells which fail to show transient 
expression of a reporter gene driven by the rat albumin proximal promoter. HepG2 and 
BW1J cells have been examined for the presence of HNF1 and C/EBP mRNA. A significant 
signal has been observed when polyA+ RNA from both cell lines is used to prepare 
Northern blots probed with HNF1 and C/EBP cDNA. Gel shift assays using PE element as 
a probe have been therefore performed to test the binding properties of the critical 
transcription factor HNF1. Bands equivalent to those obtained with rat liver have been 
observed with the human and murine hepatoma cells. Two versions of rat albumin promoter 
spanning respectively from -151 to +16 and from -68 to + 4 were co-transfected with 
different amounts of HNF1 expression vector. Both fragments of the promoter are activated 
in HepG2 cells and the factor of transactivation obtained is 15-fold for the -68/+4 version 
and 8-fold for the -151/ + 16 version. In BW1J cells a weaker level (2 to 4-fold) of 
transactivation was observed only for the -151/+16 albumin promoter as not only the activity 
of the shorter promoter fragment alone is undetectable, but often also its activity in the 
presence of HNF1 is too weak to be measured. 
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HIGHLIGHTS/MILESTONES: 
1) Characterization of the regulatory proteins which control the transcription of the 
human apolipoprotein Oil and A-II, the albumin and a\ antitrypsin genes, and clotting 
factor DC gene and cloning of cDNAs encoding new regulatory proteins. 
2) Analysis of the sites of synthesis of previously cloned factors such as LFB1/HNF1, 
LFB3, C/EBP, and HNF4, EL-6DBP, and LAP, their role in the regulation of transcription 
of liver-specific genes and in liver differentiation. 
3) Analysis by NMR of the secondary structure in solution and the conformational 
stability of the dimerization domain of the transcription factor HNF1/LFB1. Localization of 
the transactivation domain of HNF1/LFB1 in the C-terminal region. 
4) Transcriptional regulation of the regulatory protein HNF1/LFB1 by another regulatory 
protein HNF4 in vitro. 
5) Documentation that interaction of IL-6, IL-6 receptor mediates signal transduction in 
HepG2 cells via IL-6DBP and other members of the C/EBP gene family. 
WIDER CONSIDERATIONS: 
The transnational BRIDGE project entitled "Structural and Functional Analysis of 
Regulatory Genes Controlling Liver-specific Expression" involves 12 laboratories from 4 
countries. This vast undertaking includes research projects of both fundamental and applied 
interest: interactions between the two types of projects is expected to open new avenues of 
approach to the development of products of pharmaceutical interest and to the treatment of 
disease, such as hemophilia, atherosclerosis, and liver diseases. Focus on the liver is 
dictated by the fact that this organ is the site of synthesis of many proteins that are crucial in 
the normal functioning of the organism as well as in diverse pathological states. Some 
representative vital functions of the liver are: a) synthesis and degradation of sugars and fats 
that are required as the source of energy (fuel) in our body; b) synthesis of nucleotides and 
amino acids which are the building blocks of our genetic material (DNA) and of proteins 
respectively; c) synthesis of most of the proteins found in plasma, several of which, such as 
factors DC, XII, apoA-I, are of pharmacological importance; d) synthesis and secretion of 
bile acids required for the solubilization and digestion of fats; e) synthesis and catabolism of 
the macromolecules (lipoproteins, LDL, HDL, etc.) which carry cholesterol and fats in our 
blood stream and redistribute it to different cells; f) detoxification of the body and catabolism 
of drugs. 
The project involves the study of the regulatory proteins and genes which control the 
synthesis of some representative liver-specific proteins, such as albumin, apolipoproteins, 
clotting factors, acute phase proteins that are produced in response to inflammation, etc. 
While each of these proteins is essential for normal function, pathological states may result 
from the production not only of not enough protein, but in some cases from too much. This 
explains why an understanding of the gene controlling processes is essential. 
The basic knowledge that will emerge from this biotechnology project has numerous 
industrial and pharmaceutical applications as follows: 
1. Specific regulatory genes and target genes can be introduced into hepatocytes in order to 
generate a uniquely tailored type of hepatocyte which produces large quantities of a liver-
specific protein of pharmaceutical importance such as factor IX, VIII or XII. 
2. Drugs can also be designed based on a) the precise knowledge of the three dimensional 
interaction of the regulatory proteins with its recognition site on the DNA, b) the interaction 
of the different regulatory factors (protein-protein interaction), and c) the interaction of a 
regulatory protein with an activating hormone. Such drugs may selectively promote or 
inhibit the attachment of a factor to its target gene and, thus, may increase or decrease the 
transcription of the gene. 
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3. Improved hepatocyte cultures can also be used for toxicology tests that are currently 
performed using livers of animals. Such cultures can be generated by introducing the 
required regulatory genes or by changing the culture medium or the extracellular matrix to 
which cells attach and grow. 
4. Some of the regulatory proteins may play a role in liver differentiation and regeneration. 
Drugs which modify the action of these proteins may be used to control liver regeneration. 
COOPERATIVE ACTIVITIES: 
1) All the participants of the BRIDGE project met in Sorento, Italy on June 1, 1991. In the 
context of the meeting, gene expression during liver differentiation and disease hald on June 
2-6, 1992. 
2) Dr. Yaniv visited the laboratory of Dr. Zannis October 14-20, 1992. 
3) Dr. Zannis visited the laboratories of Dr. Chambaz, Dr. Yaniv, Dr. Weiss on October 
25-27, 1991 and the laboratories of Dr. Cortese and Dr. Ciliberto on October 28 and 29, 
1991. Work was done towards writing the blue booklet report. 
4) Dr. Zannis visited the laboratory of Dr. Chambaz on March 18, 1992. 
5) A meeting has been planned for all the participants at Iraklion, Crete on September 10-
12, 1992. 
cDNA clones, purified proteins and antibodies for IL-6DBB, LFB3, C/EBP-y, C/EBP«, 
NF1 have been given by Drs. Cortese, Yaniv, Ciliberto, and DeSimone to the participating 
laboratories. Various hepatocyte cell lines have also been made available by Dr. Weiss to 
the other participants. Various other biological materials and techniques have been 
transferred among the participating laboratories. 
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7. Pastore, A., DeFrancesco, R., Barbato, G., Castiglione-Morelli, M.A., Motta, A., 
and Cortese, R. (1991) 1H resonance assignment and secondary structure 
determination of the dimerization domain of transcription factor LFB1. Biochemistry 
30:148-153. 
8. DeFrancesco, R., Pastore, A., Vecchio, G., and Cortese, R. (1991) Circular 
dichroism study on the conformational stability of the dimerization of transcription 
factor LFB1. Biochemistry 30:143-147. 
9. Poli, V., Mancini, F.P., and Cortese, R. (1990) IL-6DBP, a nuclear protein 
involved in interleukin-6 signal transduction, defines a new family of leucine zipper 
proteins related to C/EBP. Cell 63:643-653. 
10. Selmin, O., Volpin, D., and Bressan, G.M. (1991) Changes of cellular expression 
of mRNA for tropoelastin in the intraembryonic arterial vessels of developing chick 
revealed by in situ hybridization. Matrix 11:347-358. 
11. Marigo, V., Sitta, A., Volpin, D., and Bressan, G.M. (1992) Mapping of binding 
sites for monoclonal antibodies to chick tropoelastin by recombinant DNA 
techniques. Connective Tissue Res. 27:1-16. 
12. Marigo, V., Daga-Gordini, D., Sitta, A., Volpin, D., and Bressan, G.M. (1992) 
Effect of monoclonal antibodies to defined regions of tropoelastin on elastogenesis in 
vitro. Eur. J. Cell Biol. In Press. 
13. Rey-Campos, J., Chouard, T., Yaniv, M., and Cereghini, S. (1991) vHNFl is a 
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EMBO J. 10:1445-1457. 
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19:3553-3559. 
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OBJECTIVES SET FOR THE REPORTING PERIOD: 
The project objectives are as follows -
1) To produce a genetic map with markers spaced at approximately 20 centiMorgan intervals 
over at least 90% of the pig genome. 
2) To produce a physical map with at least one distal and one proximal landmark locus 
mapped on each porcine chromosome arm and also genetically mapped. 
3) To develop a flow karyotype for the pig based on FACS sorted chromosomes. 
4) To develop PCR based techniques to enable rapid genotyping for polymorphic markers. 
5) To evaluate synteny conservation between pigs, man, mice and cattle. 
6) To develop and evaluate the statistical techniques required to analyse data from QTL 
mapping experiments and to plan and initiate the mapping of QTLs in the pig. 
Specific targets for the first twelve month period include -
a). Reference family foundation stock karyotyped for abnormalities. 
b). 100 markers of PIC > 0.3 in reference families identified. 
c). Degree of polymorphism in reference families established, comparison of information 
content and complementarity of different reference families. 
d). Use of microsatellites with PCR genotyping established. 
MAJOR PROBLEMS ENCOUNTERED: 
No major problems have been encountered. 
RESULTS: 
The overall objectives of PiGMaP are to develop a 20 centiMorgan genetic (linkage) map 
covering 90% of the genome; to produce a physical map with at least one distal and one 
proximal landmark locus mapped on each chromosome arm and to plan experiments to map 
the so-called quantitative trait loci (or QTLs) [refs 1,2, 6 ,7,23,24,25, 32, 34]. 
Genetic (linkage) mapping 
The genetic (linkage) map is being developed by a group of ten laboratories within the 
collaboration. Reference pedigrees have been established in five centres (Edinburgh, France, 
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Germany, the Netherlands, Sweden). These pedigrees take the form of three-generation 
families in which grandparents from genetically divergent breeds have been crossed to 
produce the parental (F1) generation which have subsequently been intercrossed In the 
Scottish, French and Dutch pedigrees the founder grandparental breeds are the Chinese 
Meishan and the European Large White (Yorkshire). The Swedish and German pedigrees 
have European Wild Boar and European improved breeds as their grandparents. The 
karyotypes of some of the founder animals were checked for abnormalities. These pedigrees 
were established ahead of schedule. Distribution of DNA from 100 F2 pigs plus their 
respective parents and grandparents to all ten laboratories for genotyping has begun and will 
be completed ahead of schedule in May 1992. The 100 F2 pigs correspond to two litters of ten 
pigs from each centre with four grandparents, two female parents and a single male parent 
Three classes of molecular genetic markers are being employed in the genetic mapping 
studies. First, expressed sequences are being used in Southern blot analyses to detect diallelic 
RFLP loci. The diverse origins of the founding breeding stock means that many loci screened 
in this manner do indeed prove to be polymorphic. Both homologous (mainly cDNA) and 
heterologous (human, rodent, and other mammalian) probes are being used to develop these 
RFLP markers. Over fifty such RFLPs have been characterised by the Edinburgh, Foulum, 
Oslo and Uppsala groups and include polymorphisms at the ADH,ALB,BF, CASAS1, 
CASAS2, CASB, FGA, FGB, FGG, GH, LPL, PI, PLAU, PPLA2, PP2ARB, TF, TSHB, 
PDGFRA,PDGFRB and UBB loci [refs - 13, 14, 15, 26, 27, 28, 33, 35]. These expressed 
sequences will provide the means of integrating the genetic and physical maps as well as for 
exploring comparative aspects of gene mapping. Hypervariable markers based upon both 
minisateUite and microsatellite loci are also being developed. The Merelbeke, Hohenheim and 
Leicester groups have isolated and characterised sixteen new locus specific minisateUite 
(VNTR) loci [refs - 18, 21. The structure, number of repeat blocks and chromosomal 
distribution of porcine microsatellitte loci (dG-dT)n - (dC-dA)n have been found to exhibit 
the same desirable features as their human counterparts [ref - 38]. Already, over 200 
microsatellite loci have been sequenced by groups in Copenhagen, Edinburgh, Hohenheim, 
Merelbeke, Toulouse, Uppsala and Wageningen. Primers for polymerase chain reaction 
amplification and genotyping of several of these loci have been designed and the highly 
polymorphic nature of the loci confirmed [refs - 22, 37, 38]. The PCR based methods of rapid 
microsatellite genotyping have been established, as planned. Thus, the objectives of 
identifying 100 markers of PIC > 0.3 and determining the degree of polymorphism in the 
reference pedigrees have been fulfilled. 
Protein polymorphisms and SLA genotypes have also been determined in some of the 
reference pedigrees. 
A pilot linkage mapping experiment involving seven laboratories and 20 F2 pigs was carried 
out in the six weeks prior to the second PiGMaP project meeting held in Toulouse in 
December 1991. A total of 35 loci were genotyped and four new linkage groups identified. 
One of these new linkage groups encompasses CASAS1, CASAS2, CASB, FGA, FGB, FGG, 
PDGFRA, two microsatellite loci, ALB, and the dominant white coat colour locus and can be 
assigned to chromosome 8 from knowledge of the location of ALB. 
Physical mapping 
Participants in Copenhagen, Toulouse, Uppsala and Utrecht are applying in situ hybridisation 
techniques to the assignment of genes to chromosomes. Improvements to the banding 
techniques used to identify the individual chromosomes have been effected [ref 40]. Amongst 
the loci which have been mapped by this approach are - APOE (chr 6), ATPB & ATP1A (chr 
4), CP (chr 13), CS (chr 5), DYZ-1 (chr Y), ENOl (chr 6), GH (chr 12), 1NSR (chr 2), LHCGR 
(chr 3), LPL (chr 14), PEPN (chr 7), rRNA (chr 8, 10 & 16), PGD (chr 6), TGFB (chr 6), TF 
(chr 13) [refs - 3, 5. 8, 10, 11, 12, 16, 19, 20, 29, 36, 39, 41]. This physical mapping of 
functional genes to chromosomes is essential to the alignment of the porcine gene map with 
the maps of other species, in particular with those of humans and mice. 
Synteny mapping is also being effected by analysis of somatic hybrid cell lines. The cell lines 
available at the outset did not constitute a mapping panel and therefore further hybrid cell 
lines are being developed by the Copenhagen, Cambridge, Toulouse and Utrecht groups 
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[ref 9]. A total of 50 and 130 hybrid clones in Cambridge and Utrecht respectively, are being 
characterised prior to their selection (or rejection) for a mapping panel of cells. A fluorescent 
in situ hybridization procedure with a porcine SINE (short interspersed elements) probe has 
been developed which enables the identification of pig chromosomes in pig x rodent hybrid 
cells [ref - 4]. Synteny mapping studies have confirmed the localization of the following loci -
GPI (chr 6), MPI (chr 7), PEPN (chr 7), SLA (chr 7), and SOD1 (chr 9). 
The number of loci assigned to chromosomes either directly or through' linkage to or synteny 
with direct assignments has doubled during the first year of the collaboration and now 
approaches 100. Genes have now been assigned to IS of the 18 autosomes. 
The polydisperse nature of the porcine karyotype allows the chromosomes to be sorted 
effectively by the use of a dual laser FACS machine. The flow sorting of pig chromosomes 
has been achieved by groups in France and Cambridge. The determination of the 
chromosomal identity of the flow sorted peaks should be completed within the next few 
months, well ahead of schedule (original target 24 months). Two of the French groups have 
combined a PCR amplification of each of die twenty flow sorted peaks with chromosome 
painting to effect the identification. The CYP21 and TNFA loci have been assigned to 
chromosome 7 by PCR analysis of flow sorted chromosomes. Already the flow sorted 
material has been used to develop chromosome specific libraries for chromosomes 1, 6, and 
13, again well ahead of schedule (original target 30 months) [ref - 31]. A novel PCR 
technique has been used to create biorinylated chromosome-specific probes from the flow 
sorted material. Two new reciprocal translocations (6/8 and 6/15) have been identified which 
may prove to be useful as markers for physical mapping or flow cytometry [ref - 17]. 
Repetitive sequences and the physical components of chromosomes - telomeres and 
centromeres are also being studied [refs - 4, 30]. The characterisation of porcine SINE 
sequences has proved to be useful in the amplification of the limited amounts of DNA 
produced by flow cytometry or chromosome scraping and in the characterisation of the 
chromosome content of somatic hybrid cell lines. The PRE-1 SINE sequences have been 
shown to unevenly distributed along the chromosomes, and are clustered around the 
centromeric regions. 
HIGHLIGHTS/MILESTONES: 
The first year of PiGMaP has been marked by the friendly and open collaboration between the 
participants. Several targets have been reached ahead of schedule. In particular, the 
development of a flow karyotype, the establishment of the necessary reference pedigrees and 
PCR based genotyping of microsatellite loci have been successfully achieved. 
WIDER CONSIDERATIONS: 
The pig gene mapping project (PiGMaP) has brought together key laboratories in six EC 
countries and two EFTA countries in a coordinated and collaborative programme to develop a 
porcine gene map. In the first year of activity the resources required to develop the gene map 
have been assembled. The pig pedigrees and polymorphic genetic markers necessary for 
genetic (or linkage) mapping have been established. The number of genes assigned (or 
mapped) to chromosomes has almost doubled and approaches 100. Techniques for physical 
sorting the pig chromosomes have been exploited to develop chromosome specific libraries 
(or gene banks). Consideration has also been given to the future exploitation of the gene map 
in locating the genes responsible for controlling traits such as growth and reproductive 
performance. The initial grouping of fifteen laboratories has been extended to seventeen in 
the context of a European Laboratory Without Walls. Preliminary discussions have taken 
place with groups from the United States of America and Australia on the basis for widening 
the collaboration. 
COOPERATIVE ACTIVITIES: 
The collaboration between the participating laboratories has operated at several levels. The 
reference animals necessary for the genetic (or linkage) mapping are provided by five groups. 
DNA from these animals is shared by a wider grouping of ten laboratories. A pilot linkage 
study involved seven groups genotyping a shared pool of animals. DNA prepared from 12 
primary pig x mouse hybrid cells have been distributed by the Copenhagen group to other 
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participants for synteny mapping studies. Chromosome specific libraries have been created by 
combining chromosome sorting in some laboratories with PCR amplification and cloning in 
other laboratories and the libraries have subsequently been distributed to other participants. 
Groups isolating markers have collaborated with those using in situ hybridization to assign 
marker loci to chromosomes. In particular, lambda and cosmid genomic clones, which have 
been shown to contain polymorphic microsatellite loci are being mapped to chromosomes. 
The development of SINE priming involved a three way collaboration [ref - 4]. 
Three project meetings have been held in the first reporting period. The first meeting, at 
which all the participating laboratories were represented, was held in Edinburgh on April 15th 
1991, immediately after the 2nd European Farm Aninal Genome meeting. Five laboratories 
took part in a meeting held at Jouy-en-Josas, France in June 1991 to discuss the design of the 
experiments to map the quantitative trait loci (QTLs). The recommendations for the design of 
the reference mapping populations made at the June meeting have subsequently been adopted. 
Finally, a full project meeting was held at INRA, Toulouse on the 6th and 7th December, 
1991. Not only were all participating laboratories represented but also three US groups and 
one Australian group attended, two with the support of EC funds. 
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OBJECTIVES SET FOR THE REPORTING PERIOD : 
The initial objectives set for the reporting period put special emphasis on the smooth 
integration of the participating groups, the introduction of new concepts and 
techniques, and the development of basic research tools. Starting up the project 
included a major effort to stimulate contacts and exchanges. 
More specifically the following objectives were set : (1) ploidy manipulation 
(gynogenesis and triploidy) of seabass and African catfish. Cloning of fish is an ideal 
tool to standardise assay conditions. (2) Cloning of several genes from cDNA banks 
and genes with their promoters from gDNA banks {PRL, Xmrk, MT, GH, Insulin, Ig, 
smoltification genes) of tilapia, swordtail, seabass, rainbow trout, Atlantic cod and 
Atlantic salmon, and a nucleocapsid gene of the virus VHS. These genes are the 
focus of gene regulation studies. (3) The in vitro testing of selected genes (PRL, 
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Xmrk, Ig), including the selection of appropriate reporter genes. (4) The 
establishment of a small aquarium fish species model. (5) The in vivo testing of 
selected genes (Ig, Xmrk), including the optimisation of techniques for the testing of 
genes in embryos. (6) The adaptation of seabass to controlled conditions. 
MAJOR PROBLEMS ENCOUNTERED : 
In general, the groups participating in the project have not run in major problems. 
Progress is substantial and the satisfaction with the research effort seems to be good. 
Problems vary from administrative bottlenecks (funding did not arrive in time 
because of an administrative dispute within a university; the absence of clear 
administrative precedents) over practical problems (moving from one institute to 
another one; lack of sufficiently qualified personnel; insufficient funding to strongly 
reorient research interests) to scientific problems (incomplete gene library, difficult 
husbandry of fish, delayed progress with the biological characterisation of fish). 
RESULTS: 
The growing integration among BRIDGE members makes it very interesting to 
summarise the results. 
The University of Leuven has tested reporter gene constructs provided by the Univ. 
de Liege to optimise the in vivo transfer of genes in zebrafish and African catfish. A 
strong transient expression has been observed within days after fertilisation. Ploidy 
manipulation of African catfish (gynogenesis) resulted in the identification of the 
critical periods for heat, cold and pressure shocking and the verification by means of 
DNA fingerprinting. 
The Univ. de Liege cloned and characterised successfully the riPRL-1 gene. Four 
reporter genes (Ampr-, Luc, Gal and CAT) coupled either to the CMV promoter or 
to the promoterless construct were tested in EPC cells grown in vitro. This resulted in 
the choice of the LUC reporter gene which was recommended to all BRIDGE 
members. 
Eurogentec provided help with the cell culture and initial electroporation 
experiments. 
The group at the Univ. di Padova has spliced chimaeric constructs of rtGH and 
rtlnsulin. Pituitary protein interaction with the rtGH gene promoter has been studied 
in vitro in collaboration with the Liege group. The highly conservative nature through 
evolution of the Pit-1 site has been invoked. Seabass GH cDNA has been cloned, the 
nucleotide sequence determined and the protein expressed. Collaboration with 
Sepia International (France) on the supply of seabass eggs is in progress. 
The C.S.I.C. has conditioned seabass for spawning (photo- and hormonal induction). 
The optimal conditions for ploidy manipulation of seabass (gynogenesis) through 
heat shocks were identified. Verification of the ploidy level occurs with flow 
cytometry. Finally, the sex of seabass was influenced chemically. 
I.N.R.A. has defined ameliorated conditions for in vitro and in vivo tranformation. 
Several fusion genes (RSV, SV40, and CMV promoters; GH and CAT genes) were 
assayed for their potential for in vitro expression. The same strategy was followed for 
in vivo expression (CMV and RSV promoters; CAT, GH,Xrnrk and Ig genes). Finally 
the nucleocapsid protein gene from the VHS virus has been characterised 
extensively; strong promoters of the OMV Herpes virus are being screened. 
The Univ. Wurzburg has started using the medaka fish system to analyse the function 
and regulation of certain proto-oncogenes and oncogenes during vertebrate 
development They showed that the high rate of tumor induction in Xmrk-injected 
medaka embryos is dependent on the presence of an inducing ligand. The Xmrk 
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proto-oncogene has been cloned. 
The Univ. College Galway has cloned three genes which are differentially expressed 
during smoltification. Seven other genes expressed at high levels in salmon liver were 
isolated; six were identified. The a. globin promoter has been successfully cloned; 
preliminary steps have been taken to clone other salmon promoters. 
The Univ. of Uppsala has collaborated with I.N.R.A. to test a gene construct of the 
murine immunoglobulin promoter/enhancer for expression in vivo. Enhanced 
expression of the fusion gene has been detected in white blood cells. Gene libraries 
have been constructed from lymphoid tissue and from germline DNA of Atlantic cod 
and rainbow trout; these fish Ig genes have been isolated and sequenced. 
HIGHLIGHTS/MILESTONES: 
Highlights include: 
- the first proof of a phenotypic effect of the Xmrk oncogene in fish. 
- the potential conservation through evolution of a "Pit-1 -like" protein and binding 
site on the prolactin gene. 
- the evolutionary significance of several fish genes studied. 
- the tissue-specific expression of a murine immunoglobulin promoter/enhancer in 
fish. 
- a reliable method for the spawning, fertilisation and sex manipulation of seabass. 
- the steady convergence offish gene research towards one principal model fish. 
WIDER CONSIDERATIONS: 
Fish are very suitable vertebrate models for the study of genes and the nature of their 
control. 
The European Community (BRIDGE programme) is funding a significant research 
project on fish genes and the nature of the elements controlling their expression since 
January 1991. Although a single fish carries in each cell the same battery of genes, 
the expression of these genes is highly specific. For example, the hormone prolactin 
is produced in the pituitary gland. Vertebrate and biomedical research has depended 
on mammalian models (such as mice) for molecular biological research. This project 
proves that fish are scientifically comparable and economically more reasonable 
models to study. Eight laboratories and two industrial partners from six EC countries 
and one EFTA member country have the common goal to integrate fish gene 
research. Applications of this research have already appeared in the field of cancer 
research and mid term applications are expected in the fields of disease control and 
selection. Spin off applications include the domestication of seabass and African 
catfish. 
COOPERATIVE ACTIVITIES: 
Two meetings were organised; a first contact among all members occured at a 
successful meeting in Leuven (Belgium) (11-12 April 1991, organised by Prof. F. 
OUevier ). At a second well-attended meeting in Padova (Italy) (5-6 December 1991, 
organised by Prof. L. Colombo) the latest research progress was presented. It was 
decided to compile a data bank on model fish, fish cell lines, gene banks and cloned 
genes available to the project Meanwhile numerous informal contacts were made by 
the coordinator and among members. Short term staff exchanges occurred among 
I.N.R.A. and Univ. Wurzburg, Univ. de Liege and Univ. Leuven; long term 
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exchanges occurred among LN.R-A. and UHJV. of Uppsala, Univ. di Padova and 
Univ. de Liege. Exchange of scientific material and consultation on technical aspects 
occurred among all partners (exchange of reporter genes LUC and fiGal, of medaka 
fish, of seabass eggs, of gene sequences, of specific gene constructs and of cell lines). 
Results were presented at the following international meetings : International Marine 
Biotechnology Symposium (Baltimore, USA), Biotechnology of Reproduction in 
Aqautic Animals (Toba, Japan), Research for Aquaculture (Anribes, France) and 
Scandinavian Meeting of Fish Immunology (Tromso, Norway). Moreover, spinoff 
research initiated by the BRIDGE project includes DNA fingerprinting in fish, 
genotyping of fish with sex specific DNA probes and general fish husbandry 
procedures. 
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TITLE: 
Study of the avian herpesvirus genome Marek's disease virus 
CONTRACT NUMBER: 
BIOT CT90-0173 
OFFICIAL STARTING DATE: 
1.8.91 
COORDINATOR: 
Dr. L.J.N. Ross, AFRC LAH, Houghton Laboratory, Houghton, UK 
PARTICD?ANTS: 
Mrs. A. Rey-Senelonge, IFFA Laboratory, Rh6ne- Merieux, Lyon, F 
Prof. E.F. Kaleta, Justus Liebig Universitat, Giessen, FRG 
OBJECTIVES: 
The objectives for the first 7 months were (1) To identify by partial sequencing the 
Marek's disease virus (MD V) homologues of gH, gD of herpes simplex virus (HS V). (2) 
To prepare probes to identify homologues of gD, gH and non-essential genes of 
herpesvirus of turkeys (HVT). (3) To prepare HVT DNA for construction of vectors, 
cloning and partial sequencing of non-essential genes. 
MAJOR PROBLEMS ENCOUNTERED: 
None 
RESULTS: 
Cosmid libraries of overlapping DNA fragments spanning the entire genome of MDV 
and HVT have been prepared. Several genes of MDV and HVT have been identified 
by random sequencing of selected regions of genomic DNA and comparison of the 
deduced proteins to the amino acid sequence of known herpesvirus proteins. The genes 
identified include the MDV homologues of gH, gD, protein kinase (PK) and gl of HSV 
and the HVT homologues of gB, gD, PK and gl of HSV. Sequencing of MDV gH and 
of a 3.7 kbp fragment mapping in the unique short region (U.) of HVT which comprises 
PK, gD and gI is in progress. 
The potential of using the thymidine kinase (TK) gene of HVT as an insertion site for 
expressing foreign genes has been investigated. A 3.9 kbp fragment of MDV DNA 
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containing the gB gene and 5' non-coding sequences has been inserted into the TK gene 
using a synthetic oligonucleotide adaptor containing an EcoRV cloning site. Expression 
of authentic MDV gB was demonstrated in vitro using an MDV-specific anti-peptide 
serum. The HVT recombinant was genetically stable in vitro and in vivo as shown by 
Southern blot analysis of viral DNA recovered from infected cells. Work is in progress 
to study the replication of the recombinant in vivo and its efficacy as a vaccine. 
Rh6ne-Merieux laboratory has cloned and sequenced the HVT homologue of the 
ribonucleotide reductase (RR) gene of HSV and has investigated its potential as an 
insertion site for expressing foreign genes using the marker gene beta-galactosidase. 
Houghton and Rhdne-Merieux laboratories have worked in close contact and have 
exchanged cloned materials and information on transfection techniques and the 
generation of virus recombinants. According to plan, Houghton has concentrated on 
MDV glycoprotein genes and HVT TK and PK genes whilst Rh6ne-M6rieux has worked 
on the RR gene of HVT. It is envisaged that work at Giessen University will involve an 
investigation of the safety and efficacy of the recombinant vaccines generated as soon as 
they are available. 
HIGHLIGHTS/MILESTONES: 
MDV and HVT homologues of gH, gD, PK, gl genes of HSV have been identified. The 
RR gene of HVT has been sequenced. It has been demonstrated that HVT can tolerate 
the insertion of a 3.9 kbp MDV DNA at the TK locus and that authentic MDV gB is 
synthesised by the recombinant under the control of the MDV gB promoter. 
WIDER CONSIDERATIONS: 
Much progress has been made in identifying genes of MDV and HVT by comparison of 
the predicted amino acid sequence of random DNA fragments to known herpesvirus 
proteins. The results have shown that HVT, a vaccine widely used in chickens, has 
potential as a vector and that it can accommodate at least 3.9 kbp of foreign DNA The 
ability of the recombinants to replicate in vivo remains to be determined and the search 
for insertion sites compatible with maximum replication in vivo is continuing. 
COOPERATIVE ACTIVITIES: 
Houghton and Rhone-Meneux laboratories have exchanged cloned DNAs, 
immunological reagents and information on production of infectious DNA and 
recombinant virus. A meeting between the two laboratories took place at IAH, Compton 
Laboratory on 5th November, 1991 to discuss progress and decide on priorities for the 
following 6 months. Exchange of information takes place regularly by telephone. 
LIST OF JOINT PUBLICATIONS/PATENTS: 
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OTHER PUBLICATIONS/PATENTS: 
Ross, L.J.N., Binns, M.M and Pastorek, J. (1991). DNA sequence and organization of 
genes in a 5.5 Kbp EcoRI fragment mapping in the short unique segment of Marek's 
disease virus (strain RB1B). J.Gen.Virol. 72, 949-954 
Ross, L.J.N. and Binns, M.M. (1991). Properties and evolutionary relationships of the 
Marek's disease virus homologues of protein kinase, glycoprotein D and glycoprotein I 
of herpes simplex virus. J. Gen. Virol. 72, 939-947 
Ross, L.J.N., Binns, M.M., Pastorek, J. and Scott, S. (1991). Construction and properties 
of a herpesvirus of turkeys recombinant which expresses glycoprotein B of Marek's 
disease virus (part of this work was presented at the International Herpesvirus 
Workshop, Asilomar, California, July 1991. 
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TITLE: "Development of second generation vaccines against parvoviruses" 
CONTRACT NUMBER: BIOT - CT91-0256 
OFFICIAL STARTING DATE: I.February. 1991 
COORDINATOR: Jose Ignacio Casal. INGENASA. Madrid. ES. 
PARTICIPANTS: Rob Meloen. Central Veterinary Institute. Lelystad. NL 
Kristian Dalsgaard. State Veterinary Institute for Virus Research. Lindholm. DK. 
OBJECTIVES SET FOR THE REPORTING PERIOD: Production of PPV antigens. 
Production and maintenance of specific monoclonal antibodies. Recombinant 
polypeptide expression. Optimization of the recombinant protein purification. Field 
trials. Fine mapping of PPV. 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report 
RESULTS: Porcine parvovirus (PPV) is one of the major causes of reproductive 
failure in pigs. The control of the disease is usually carried out with conventional 
vaccines made of inactivated viruses. 
In order to develop a more cost effective (for PPV) and safer (in the 
case of canine parvovirus [CPV]) subunit vaccine, the first strategy was the 
identification of the proteins containing the key epitopes involved in neutralization. 
From previous studies made with CPV, we know that the neutralizing MAbs reacted 
simultaneously with VP1 and VP2. This means that VP2 is the protein which, 
contains the neutralizing epitopes of parvovirus. 
Ingenasa's group was the first in reporting the synthesis and sequencing 
of an infectious clone containing the complete genome of PPV. Using this clone as 
starting material we isolated the VP2 gene. Before the initiation of this BRIDGE 
project we cloned this gene and several fragments in different E.coli expression 
systems. The products obtained were immunologically poor, probably due to an 
unproper folding of the expressed polypeptides. To overcome these shortcomings, 
we changed to the baculovirus expression system. The VP2 gene was cloned into 
the baculovirus transfer vector pJVPIOZ, under control of the polyhedrin promoter, 
we use this vector where the lacZ gene is expressed under control of the p10 
promoter of baculovirus. The resulting vector containing the PPV VP2 gene was 
named pPPVExS. After transfection of Spodoptera frugiperda cells with pPPVExS and 
wild-type AcNPV DNA, recombinant viruses were easily detected by the expression 
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of B­galactosidase. Most of the work realized during the past 12 months was 
dedicated to the characterization of the product obtained by the baculovirus 
expression. Other aspects covered this year were related to the production of PPV 
antigens and the production and maintenance of specific monoclonal antibodies. 
Finally, we have started a detailed mapping study by PEPSCAN. 
Production of PPV antigens (SVIV) 
PPV virus has been grown to high titre in cell cultures of primary pig kidney 
cells. The virus has been inactivated by binary ethylene imine, and the product 
distributed to the participants: for the production of PPV­specific monoclonal 
antibodies at SVIV and INGENASA, for the production of rabbit polyclonal antisera 
and, finally, as a reference for morphological studies by electron microscopy. 
Production and maintenance of specific monoclonal antibodies (INGENASA, 
SVIV) 
Production of hybrid cell secreting monoclonal antibodies specific for PPV was 
performed according to well know procedures, using spleen cells from PPV 
immunized mice. After, at least, three cloning steps, hybridoma supernatants were 
screened by ELISA and IHA assay. The MAbs isotype was determined by 
immunodifusion with antisera specific for murine antibodies heavy and light chain. 
The general properties of PPV­specific MAbs obtained at Ingenasa are shown 
in the Table. Four out of six MAbs are able to inhibit virus haemagglutination, all of 
them are useful for antigenic studies of PPV virions and recombinant proteins by 
immunoelectromicroscopy, immunobloting and for Pepscan studies. 
BIOLOGICAL ftCTITITY 
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A panel of 16 monoclonal antibodies against porcine parvovirus were 
produced at SVIV and have been purified in suitable amounts for further analysis. 
These monoclonals have been tested in a number of assays against PPV, including 
ELISA, virus neutralization, staining techniques, Immunoelectrophoresis, western blot, 
dot blot and an indirect affinity determination assay. The affinity assay used has 
revealed that the conformational changes induced in infective virus vs. empty virus 
particles by the chaotropic ion isothiocyanate, make it possible to discriminate 
between the two. This assay may help in characterizing the recombinant virus­like 
particles. 
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The antibodies are currently being tested for their ability to specifically 
introduce gold labels onto the surface of PPV particles; this is a very powerful 
technique for electron microscopy. A number of the monodonals have already 
proved useful in this respect, and it is anticipated that the technique will contribute 
considerably to the mapping of surface epitopes on the virus and the recombinant 
capsids produced in the baculovirus system. 
Recombinant polypeptide expression (INGENASA) 
Proteins were isolated from uninfected and recombinant AcNPV-infected Sf9 
cells at 72 h post-infection and analyzed in SDS-polyacrylamide gels. Coomassie-
blue staining of the gels showed the presence of a protein of 64 KDa, the expected 
molecular weight of the PPV VP2, in the recombinant viruses. Identity of this protein 
as VP2 was confirmed in immunoblot analysis. Recombinant virus also expressed 
B-galactosidase. This protein was identified by immunoblot using a specific rabbit 
polyclonal serum. 
Also, cells infected with recombinant virus were fixed and subjected to indirect 
immunofluorescence. Infected cells gave a clear positive signal characterized by the 
presence of diffuse fluorescence in the cytoplasm of the cells, not in the nucleus. 
Uninfected or wild type infected cells yielded a negative signal. 
Optimization of the recombinant protein purification (INGENASA) 
The expressed VP2 was found to be present in the cytoplasmic extract of 
S.frugiperda cells infected with AcPPV8. This fraction was treated with DNAse and 
RNAse to remove nucleic acids. Subsequent precipitation with 20% ammonium 
sulphate gave a protein fraction that contained mostly VP2 and S-gal. To confirm the 
identity of the purified proteins, aliquots of this material were analyzed by western 
blot using rabbit anti-PPV antisera. A 64 K band of both crude and purified samples 
reacted strongly with anti-PPV antisera. Further purification, to selectively remove the 
6-gal contamination, was done by affinity chromatography, using anti-B-gal IgG 
conjugated to Sepharose. The eluted material gave a single, major band cor-
responding to 64 K on SDS-PAGE, with only very little contamination of B-gal. 
Electron micrographs of purified preparations of VP2 showed a large number 
of virus-like particles (VLPs), with a morphology very similar to the original virus PPV 
(Fig. 1). The diameter of the particles was estimated to be in the order of 20 nm, i.e., 
comparable to those of PPV. The particles were layered on self-forming CsCI 
gradients, banding at a density of 1.33 g/cm3. This density is similar to that 
corresponding to empty viral capsids (1.33) and lower than full DNA-containing viral 
capsids (1.38). The estimated amount of VP2 particles produced was between 5-
10 mg/109 cells, based on the comparison with standard amounts of a reference 
protein included in the polyacrylamide gels. 
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Methods for quantification of the recombinant VP2 capsids have been 
established, i.e. ELISA, HA and rocket electrophoresis. These particles exhibited the 
same or higher hemagglutinating titers (up to 106 UHA/ml) as observed with 
authentic virus. The hemagglutination titer of these VP2 preparations is a good 
indication of the amount of particles with respect to soluble protein. Another method 
to characterize the amount of particles is the use of a quantitative Im-
munoelectrophoresis in agarose gel, rocket electrophoresis. This technique is 
especially useful for quantification, because it only measures the amount of VP2 
present as actual particles. When these results are related to the ELISA and HA 
values, estimates of the degree of assembly of the recombinant products can be 
calculated. In this way, it was possible to standardize the antigenic mass of VLPs 
and adjust the amount of antigen in a pig vaccine dose to the same amount as 
usually included in a conventional inactivated vaccine (approximately 3 M9 of virus). 
Animal experiments (SVIV, INGENASA) 
As in a standard potency test for the commercial vaccine, two pigs were 
immunized subcutaneously twice with three weeks interval, the second dose being 
half the volume of the initial dose (2 ml -1 ml). In the preliminary experiments the 
vaccine has been formulated with the adjuvant QuilA and aluminium hydroxide. 
Serum samples were taken prior to and 10 days after the second vaccination. Serum 
antibodies against PPV were assayed by three different methods: 1. Anti PPV-virion 
ELISA test. 2. Hemagglutination inhibition. 3. Neutralization of PPV. All antibody titres 
obtained by the recombinant VLP vaccine (data not shown) were of the same 
magnitude as usually obtained by the commercial inactivated vaccine (Fig. 2), 
indicating that VLPs are highly immunogenic and may replace inactivated virions. 
Despite one pig had residual maternal antibody, the response to the vaccine was not 
inhibited and reached similar levels to that from the seronegative pig. 
Fine mapping of parvovirus epitopes with PEPSCAN (CDI, INGENASA, SVIV) 
These experiments were performed by using antibody samples (monoclonals 
from INGENASA, anti-CPV antisera from both INGENASA and SVIV, sera from 
infected dogs) directed against canine parvovirus in a PEPSCAN-EUSA on 740 
overlapping nonapeptides covering the whole sequence of the 748 residues long 
capsid protein VP1 of CPV immobilized to polyethylene rods. Ant'-PPV antisera and 
monoclonals are now under investigation in a PEPSCAN with overlapping 
dodecapeptides. 
The PEPSCAN has been successfully (and currently) employed for the 
delineation of sequential epitopes on the capsid protein of parvovirus. The efforts 
have already resulted in the delineation of ten sites in canine parvovirus of which 
some are at strategic locations around potential receptor binding sites on the viral 
surface. The surface location of six of these epitopes was shown in PEPSCAN in 
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adsorption experiments with whole virions. Furthermore, in these experiments 
neutralizing capacity was lost in antisera from infected animals showing the 
significance of a few select sequences in the VP2 protein. The results of this work 
are corroborated and emphasized by detailed structural information on the canine 
parvovirus which came available during the report period (Tsa et al., 1991, Science 
251:1456-1464). Based on these data on epitopes, homology and capsid structure, 
peptides have been selected and synthesized, which could represent neutralizing 
epitopes for both porcine and canine parvovirus. Rabbits and mice are now under 
investigation for eliciting antibodies to these peptides to find candidates for 
neutralization and protection studies. 
HIGHLIGHTS/MILESTONES: The major achievement up to now has been the 
production of porcine parvo-like capsids, similar to the original virus. These particles 
have shown a high immunogenic activity, eliciting an immune response in pigs 
indistinguishable from that obtained with a commercial inactivated vaccine. This is 
a promising feature for the commercial application of these particles as a vaccine. 
The baculovirus/insect cell line system is already in its present for capable of 
producing attractive amounts of antigen at a low price. Another interesting point is 
the efficacy of this putative subunit vaccine when combined with standard adjuvants, 
such as alumina and QuilA, probably due to the high immunogenicity of the capsid 
structure. 
WIDER CONSIDERATIONS: Due to the rather simple structure of the parvoviruses, 
they constitute a good model for the preparation of recombinant subunit vaccines. 
So far, procaryotic (E.coli) expression has failed to give useful products. It is 
therefore of major importance that the eucaryotic insect cell/baculovirus expression 
system has been able to produce parvovirus VP2 protein in a conformation which 
seems to be indistinguishable from native capsids and carrying all immunodominant 
epitopes. It will facilitate the development of large scale fermentor techniques leading 
to a more cost effective and nucleic acid-free 2nd generation parvovirus vaccines in 
a foreseable future. This vaccines will be extremely safe, innocuous for the animal 
and devoid of any residual infectivity. They should constitute the technologically 
improved alternative to the "classical' vaccines. 
COOPERATIVE ACTIVITIES: During the last year there has been three meetings 
of the research teams in Madrid, Lindholm and Lelystad (in February, August and 
December, respectively). There has been a continuous flow of information between 
the three laboratories with exchange of virus, particles, monoclonal antibodies and 
different polyclonal antisera from dog, pig and rabbit. 
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LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS­NATIONAL AUTHORS 
SHIP: C. Martinez, K. Daisgaard, J.A. Lopez de Turiso, E. Cortes, C. Vela and 
J.I. Casal. (1992). Production of porcine parvovirus empty capsids with high 
immunogenic activity. Vaccine. In press. 
C. Martinez, K. Dalsgaard, J.A. Lopez de Turiso, E. Cortes, C. Vela y J.I. 
Casal. (1991). Procedimiento para la produccion de una vacuna subunidad contra 
el Parvovirus Porcino. Patent Application # P9100845. Spain. 
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Tide: ENGINEERING AND IMMUNOGENICITY OF FOOT-AND-MOUTH 
DISEASE VIRUS PROCAPSIDS IN INSECT CELLS 
Contract number: BIOT-CT90-0190 
Official starting date: 01/07/91 
Coordinator: Dr GJ Belsham, AFRC IAH, Pirbright, GB 
Participants: Dr J Vlak, Agricultural Univ., Wageningen, NL 
Dr E Domingo, CSIC, Madrid, ES 
Dr M Lombard, Rhone-Merieux, Lyon, FR 
Objectives set for the reporting period: 
a) construction of foot-and-mouth disease virus (FMDV) cDNA cassettes encoding the 
structural protein precursor P1-2A and the 3C protease which will produce the procapsid 
components 1AB, 1C and ID. Preliminary characterization of the properties of the 
cassettes to ensure correct protein production and processing should also be undertaken. 
b) insertion of cassettes into baculovirus transfer vectors and production of recombinant 
baculoviruses. 
c) construction of deletion mutants for analysis of gene toxicity accounting for low level 
expression from previous constructs. Analysis of transcription and translation levels. 
d) structural analysis of expressed procapsids. 
Major problems encountered: 
i) There appears to be some instability of some of the cDNA cassettes when introduced into 
baculovirus transfer vectors and recombined into the virus. This may be due to the inverted 
duplication of a short sequence specifying termination and polyadenylation signals. In new 
constructs this duplication has been avoided and no problems have been encountered in the 
construction of the recombinant transfer vectors. 
Results: ^ 
a) cDNA cassettes for all three European serotypes A,0 and C of FMDV have been 
synthesized in the form ATG-P1-2A+3C (see figure for the type C construct (pMM51) as 
an example) by workers in Pirbright and Madrid. Each of these cassettes has been shown 
to synthesize correctly processed 1AB, 1C and ID when analysed in a transient expression 
system. 
b) Each of these cassettes have been introduced into baculovirus transfer vectors and have 
now been transferred to Wageningen and transfected into insect cells to allow the isolation 
of recombinant viruses. 
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c) Other studies in Wageningen on the level of RNA transcripts being produced from the 
polyhedrin promoter in bacuIovirus/FMDV recombinants indicate that the rate of 
transcription is reduced by the presence of the 3C FMDV sequences. Translation of the Pl-
2A precursor in the absence of 3C is also low however. This suggests that the low level 
of FMDV protein production seen with existing baculovirus/FMDV recombinants is due 
to effect of 3C on mRNA transcription superimposed on a low level efficiency of 
translation. In order to analyse which section of the FMDV genome is adversely affecting 
the level of translation within baculovirus infected cells specific regions of the cassette are 
being deleted. The latest cassettes all lack the L protein. Further truncated versions of the 
L deleted cassette MMS1 (see figure) have been isolated and are being introduced into 
transfer vectors for analysis. The 3C protease has also been constructed individually which 
may be useful for independent expression of the structural protein precursor and the 
protease. Constructs aimed at expressing reduced yields of 3C are also being produced in 
Pirbright. 
d) Characterization of FMDV procapsid proteins expressed in mammalian cells using 
vaccinia virus vectors containing the type O and type A cassettes has been performed in 
Pirbright and indicates that assembly to particles sedimenting at 70S in sucrose gradients 
occurs (this material cosediments with empty capsid particles from FMDV infected cells). 
Furthermore empty 30nm particles have been observed when extracts have been examined 
using electron microscopy. 
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e) An aspect of work which was not anticipated has been the determination of the internal 
Ph of insect cells infected with baculovirus. This has been a highly cooperative expt 
performed in Madrid using a variety of materials supplied from Wageningen. The 
importance of this study is due to the lability of FMDV at low Ph. Measurements of the 
distribution of radiolabelled markers have shown that the internal Ph of uninfected 
Spodoptera frugiperda cells is maintained close to pH7 when the external Ph is varied over 
the range of 6.25 (standard conditions) to 6.8. Furthermore within baculovirus infected 
cells the Ph appears to be very similar to that found within uninfected cells. Thus it seems 
that the internal Ph of insect cells should not preclude the efficient assembly of FMDV 
empty particles. 
f) new transfer vectors allowing the ready production of baculovirus recombinants 
containing foreign genes at two separate sites have been produced in Wageningen. 
Highlights/milestones: 
1) Production within cells of FMDV empty capsid particles visible by electron microscopy 
and biochemical analyses from self processing precursors expressed from cDNA. 
2) The intracellular Ph of Spodoptera frugiperda cells has been determined, this will be 
useful in designing experiments with a range of different proteins whose properties are 
acutely pH sensitive. 
3) The successful construction of self processing cDNA cassettes of FMDV for all 
European serotypes. 
4) Development of vectors allowing coexpression of multiple foreign genes from a single 
recombinant virus. 
Wider considerations: 
Recombinant DNA techniques have been used to construct vectors containing regions of 
cDNA (termed cassettes) which can express proteins from foot-and-mouth disease virus 
which self-assemble into virus-like particles but which are completely non-infectious. This 
has been achieved for each of the three different serotypes of foot-and-mouth disease virus 
which threaten Europe. It has been established that the intracellular environment of insect 
cells should not adversely affect the synthesis of these particles. Hence current work on the 
isolation of recombinant baculoviruses (which only grow in insect cells) carrying the 
cassettes mentioned above will proceed, these viruses are capable of expressing foreign 
proteins at high level. If successful the potential of these non-infectious virus-like particles 
as vaccines will be assessed. 
Cooperative activities: 
All participants met for a two day meeting in Madrid in June 1991 to discuss the state of 
the work. Dr Miguel Medina from Madrid spent several weeks in Wageningen at the end 
of 1991 constructing baculovirus transfer vectors containing the type C cDNA. Extensive 
transfer of clones occurs especially between Pirbright, Wageningen and Madrid in all 
directions and regular telephone and FAX communication occurs. Furthermore a range of 
materials have been supplied to Rhone-Merieux from Wageningen for the production of 
analytical antisera. A further meeting of participants occurred during the ELWW on 
'Veterinary viral vaccines' organized by Dr J Vlak and held in Wageningen in November 
1991 which brought together participants from each of the BRIDGE programme projects 
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in this subject area. A second meeting of this ELWW has been planned for 1992. 
List of joint publications/patents with trans-national authorship: 
Belsham GJ, Abrams CC, King AMQ, Roosien J & Vlak JM (1991) Myristoylation of 
foot-and-mouth disease virus capsid protein precursors is independent of other viral 
proteins and occurs in both mammalian and insect cells. J Gen Virol 72 747-7S1. 
Other relevant publications: 
Kool M, Voncken JW, van Lier FLJ, Tramper J & Vlak JM (1991) Detection and analysis 
of Autographa californica polyhedrosis virus mutants with defective interfering properties. 
Virology 183 739-746. 
Vlak JM, Schouten A, Roelvink PW, Martens JWM & Zuidema D (1991) Engineering of 
novel baculovirus vectors for the expression of foreign genes in insects. In: Insect 
Molecular Science (HH Hagedorn, JG Hildebrand, MG Kidwell and J Law, Eds) Plenum 
Press p87ff. 
Kitson JDA, Burke KL, Pullen LA, Belsham GJ & Almond JWA (1991) Chimeric 
polioviruses that include sequences derived from two independent antigenic sites of foot-
and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea 
pigs. J Virol 65 3068-3075. 
Belsham GJ (1992) Dual initiation sites of protein synthesis on foot-and-mouth disease 
virus RNA are selected following internal entry and scanning of ribosomes in vivo. EMBO 
J 11 1105-1110. 
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TITLE: 
Towards a second generation vaccine against bovine herpesvirus type 1 (BHV-1): 
Immunological characterization of herpes viral glycoproteins and construction of BHV-1 
deletion mutants 
CONTRACT NUMBER: BIOT-0191-C(EDB) 
OFFICIAL STARTING DATE: 01. 02. 91 
COORDINATOR: G. M. Keil, BFAV, D-7400 Tübingen, Germany 
PARTICIPANTS: J. van Oirschot, CDI. 8200 AB Lelystad, Netherlands 
P. P. Pastoret, Univ. of Liege, 4000 Sart Tilman-Liege, Belgium 
U. H. Koszinowski, Univ. of Ulm, 7900 Ulm. Germany 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Objectives were 1.) to identify, characterize and, if necessary, sequence genes coding for 
nonessential glycoproteins of BHV-1 and 2.) glycoprotein B of murine cytomegalovirus and 
to express the respective genes using recombinant vaccinia viruses, 3.) to develop isotype 
specific ELISAs to monitor mucosal and systemic immunity in cattle vaccinated and 
challenged with BHV-1 and 4.) to set up methods to analyse both the activity of glycoprotein 
specicific cytotoxic T-lymphocytes and the proliferative response of lymphocytes isolated 
from BHV-1 infected cattle. 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report 
RESULTS: 
BFAV Tubingen: Work in this laboratory concentrated on the characterization and 
expression of the genes coding for glycoproteins C, E, G, and I (nomenclature of herpes 
simplex virus glycoproteins) of BHV-1 that were integrated into vaccinia virus recombination 
vectors. In detail: 
The sequence for gC was taken from the literature (Fitzpatrick et al. Virology 173:46-57, 
1989). The gC ORF was isolated from a cloned genomic DNA fragment and recombined into 
vaccinia virus. Rabbits were infected with the recombinant vaccinia virus VacgC. Antibodies 
induced in the animals were used for radioimmunoprecipitations and reacted with the gC of 
all BHV-1 strains tested. VacgC was given to Liege. 
The gene coding for gG of BHV-1 strain N569 was characterized. It is located upstream of 
gD in the unique short region of the viral genome. Using antibodies raised in rabbits by 
VacgG it could be shown that gG is an early glycoprotein and that it is secreted from 
infected cells. The sera against N569 VacgG did not react with gG of other BHV-1 strains 
in radioimmunoprecipitations and immunoblots. Comparison of the NS69 sequence with 
partial sequences of gG of BHV-1 strain Los Angeles revealed a less than 80% identity of 
the corresponding aminoacids. Thus gG seems to differ considerably among different BHV-1 
strains. 
The ORF for gl is located downstream of gD and contained within the mRNA coding for gD. 
A less abundant mRNA is transcribed only from sequences containing the gl ORF. To prove 
that gl is expressed under control of an own promoter, sequences upstream of the gl ORF 
were fused to the ORFs of firefly luciferase and 6-galactosidase. Transient expression assays 
in transfected cells showed that the sequences between the gD ORF and the gl ORF have 
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promoter activity with the characteristics of early regulated herpesviral transcription elements. 
The mRNAs for gD and gi use the same polyadenylation signal downstream the gl ORF. 
Generation of gl deletion mutants must consider this gene organization to avoid inactivation 
of the essential gD gene e.g. by removing the polyadenylation signal. The gl ORF was 
integrated into vaccinia virus. Sera of infected rabbits (and also sera raised against selected 
oligopeptides) did not react specifically with proteins of BHV-1 infected cells and sera from 
BHV-1 infected cattle did not react with Vacgl induced infected cell proteins. Thus the 
nature of gl remains obscure. 
The sequence of gE and a plasmid containing the gE gene was provided by J. van Oirschot. 
RNA studies showed that transcription of gE is also early regulated and that the 
approximately 3.3kb transcripts terminate about 1 kb downstream the gE ORF. This indicates 
that the gE mRNAs might coterminate with downstream located transcripts because, as for 
gD, no polyA-signal is located directly 3' to the ORF. The gE ORF was integrated into a 
recombination vector for the insertion into vaccinia virus. 
CDI Lelystad: Because a relation may exist between vaccine-induced immunity and the 
level of mucosal immunity, we have developed tests to measure IgA, IgM, IgG, and IgG2 
responses against BHV-1. 
Isotype-specific ELISAs for detecting antibodies against BHV-1 
For demonstrating BHV-1 specific immunoglobulin isotypes, two types of assays were 
developed: an antibody capture assay (ACA) for the detection of IgA and IgM, and an 
indirect double antibody sandwich assay (IDAS) for the detection of IgG, and IgG2. In the 
ACA, micro-ELISA plates are coated with monoclonal antibodies against bovine IgA or IgM 
and then incubated with the test sample, antigen, enzyme labelled monoclonal antibody 
directed against gB of BHV-1 and substrate solution. In the IDAS, plates are coated with the 
monoclonal antibody against gB of BHV-1 and then incubated with the antigen, test sample, 
enzyme labeled monoclonal antibody against IgG, or IgG2 and substrate solution. 
Table I. Isotype specificity and sensitivity of isotype specific ELISAs compared with a 24 h 
neutralization test with and without complement 
Sample ELISA Neutralization test 
IgG, IgGj IgM IgA + C - C 
serum* 
serum 
serum 
serum 
serum 5 
serum 
serum* 
nasal secretion 
eye secretion 
nasal secretion 
eye secretion 
nasal secretion 
2.4" 
1.9 
4.3 
3.1 
-
-
-
-
-
-
-
-
-
-
3.7 
2.5 
2.1 
-
-
-
-
-
-
-
-
3.4 
-
3.2 
-
3.4 
1.8 
1.2 
1.5 
-
-
1.5 
-
-
-
1.3 
-
-
-
-
-
2.4 
2.4 
1.8 
1.2 
2.1 
>3.6 
2.4 
1.2 
1.5 
0.3 
-
-
1.2 
1.2 
1.5 
0.9 
0.9 
>3.6 
2.1 
1.2 
0.6 
-
-
-
0.9 
0.9 
0.3 
"Samples Out were purified for antibodies of a particular isotype by immunoaffinitychromalography; 
aTitre in isotype-specific ELISa and neutralization test expressed as log,,; -Negative 
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Specificity and sensitivity: Table 1 shows the specificity of the IDAS and ACA for the 
detection of antibodies against BHV-1. Selected samples with a high titre for one isotype did 
not react in the assays for the other isotypes. BHV-1 positive sera did not react with control 
antigen and all BHV-1 negative sera tested were scored negative (data not shown). 
To asses the relative sensitivity of the isotype specific BHV-1 ELISAs, selected samples were 
tested by a 24 hr neutralization assay with and without complement (Table 1). The 24 hr 
neutralization test is about 10 times more sensitive than the conventional 1 hr neutralization 
test The litres scored in the IDAS and ACA were higher than those in neutralization test 
Neutralizing antibodies were not found in two secretions that scored positive for IgM 
antibodies. The titres in the neutralization test were significantly increased, primarily in 
samples containing IgM antibodies, by adding guinea pig serum as source of complement 
Kinetics of isotvpe-specific antibody responses in sera and nasal secretions of experimentally 
infected calves: Antibody responses against BHV-1 were found in sera, in nasal and ocular 
secretions, but not in genital secretions, from all calves infected with either of 3 BHV-1 
strains. No antibody response was detected in uninfected control calves. 
Antibody responses in serum: Antibody responses were detected earlier in serum than in 
nasal secretions. IgM Antibodies were usually detected between post infection day (PID) 8-9 
and PID 28. IgA antibodies were detected 2-3 days later than IgM antibodies. IgG, antibodies 
were first demonstrated on PID 13, while IgG2 antibodies generally appeared some days later. 
The IgG, and IgG, antibodies persisted at a high level for more than 100 days. 
Antibody responses in nasal secretions: Antibodies of the IgM isotype first appeared in nasal 
secretions on PID 9-10 and were detectable until PID 28. As in serum IgA antibodies were 
detected 2-3 days later than IgM antibodies. The IgA antibodies persisted at a low level in 
most infected calves. IgG, and IgG, antibodies were not detected. Thus, sensitive and specific 
assays were developed to measure IgM, IgA and IgG antibodies against BHV-1 that will be 
employed to monitor isotype specific antibody responses in sera and nasal secretions of 
calves inoculated with spefic glycoprotein deficient deletion mutants of BHV-1. It will be 
determined wether a correlation exists between isotype specific antibody titres in serum or 
nasal secretions and protective immunity against challenge infection. 
University of Liege: To evaluate the cellular immune response to an antigen three different 
properties of T-lymphocytes can be measured in in vitro assays: 
1.) Cytotoxicity: 51 chromium release assay to detect activity of cytotoxic T-lymphocytes 
(CTL). The first method used consisted of in vitro stimulation of bulk cultures of 
mononuclear cells in the presence of antigen and interleukine 2. These effector cells were 
added to infected, slCr labeled autologous target cells and cytotoxicity was evaluated from 
the amount of released 5lCr. This approach, however, detectet mainly non-specific natural 
killer-like cytotoxic activity. Therefore the limiting dilution method was prefered that allows 
- by statistical calculations - an estimation of the frequency of cytotoxic T-cell precursors that 
are present among the mononuclear cells. Advantages of this method are that quantitative 
results are obtained and that the problem that specific CTL are overgrown by natural killer 
cells is avoided. The main results obtained until now are that the way of antigenic 
stimulation used (UV-inactivated virus or infected fibroblasts) influences the CTL response 
that is identified. Thus expansion of mononuclear cells in the presence of IL2 and without 
antigen will be prefered for all subsequent experiments. We could furthermore demonstrate 
that among the major glycoproteins both gC and gD were target antigens for the CTL 
response in infected cattle. The method will be used to analyze the cytotoxic response to the 
minor glycoproteins by comparing lysis of wild type virus infected target cells to lysis of 
target cells infected with vaccinia virus recombinants and BHV-1 deletion mutants. 2.) 
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Lvmphoproliferation: measurement of 3H-thymidine incorporation to detect the ability of 
helper T-lymphocytes to proliferate in response to the antigen. The limiting dilution method 
has been set up for the proliferative response. The principle is similar to limiting dilution 
analysis of cytotoxic cells, but at the end of the culture period, "H--thymidine is added to the 
cultures to identify proliferating cells. This proliferation assay can be performed in the 
presence of IL2, but we were able to demonstrate that in the presence of IL2 probably mainly 
proliferating natural killer cells were detected. Thus, assays performed without addition of 
IL2 will be prefered. The frequency of specific proliferating T lymphocytes is the difference 
between frequencies measured in the presence and absence of stimulating antigen 
(UV-inactivated virus). 
This method will be used to determine whether the deletion mutants are able to stimulate a 
proliferative response that is quantitatively similar to the one induced by wild type virus. 
Moreover, by using both deletion mutants and wild type virus as stimulating antigen, we will 
determine whih of the nonessential glycoproteins is recognized by helper T lymphocytes of 
immune cattle. 
3.) Cytokine (IL2) production: detects activity of helper T-lyraphocytes. 
The methods to analyse the CTL activity and the proliferative response of infected cattle 
were established. 
University of Ulm: The gene encoding glycoprotein B of murine cytomegalovirus (MCMV) 
strain Smith was identified, sequenced and expressed by recombinant vaccinia virus. Similar 
to the location in the genome of human cytomegalovirus (HCMV) the gB gene was found 
adjacent to the polymerase gene. The open reading frame consists of 2784 nucleotides 
capable of encoding a protein of 928 amino acids. Comparison with the gB homologs of 
other herpesviruses revealed a high degree of homology. The similarity between the MCMV 
gB and the HCMV gB is most prominent as 45% of the amino acids are identical. In 
addition, all cysteine residues are at homologous positions indicating a similar tertiary 
structure of the two proteins. In contrast to HCMV the MCMV gB mRNA is a true late 
transcript A recombinant vaccinia virus expressing the MCMV gB gene has been constructed 
(Vac-gB) . Antibodies raised against the Vac-gB recombinant precpitated proteins of 130, 
105, and 52 kDa from MCMV infected cells. The identity of the MCMV gB with the major 
envelope glycoprotein of MCMV described by Loh et al. (Virology 166:206-216,1988) was 
shown. Immunization of mice with Vac-gB gave rise to neutralizing antibodies. 
HIGHLIGHTS/MILESTONES: Highly specific and sensitive tests were developed to study 
mucosal immunity after BHV-1 vaccination and infection, to identify viral glycoproteins 
inducing a specific CTL response in herpesvirus infected animals and to evaluate the 
contribution of individual glycoproteins to the cellular immune response. The open reading 
frames for all known nonessential glycoproteins of BHV-1 and glycoprotein B of murine 
cytomegalovirus were isolated and, with the exception of the ORF for gE(BHV-l), integrated 
into the genome of vaccinia virus. 
WIDER CONSIDERATIONS: Tests were developed to study the antibody responses 
against BHV-1 on the mucosae of infected or vaccinated cattle. If this mucosal immunity is 
correlated with the induced protection by vaccination, which is presently determined in 
challenge experiments, it may make the severe experimental infections in cattle no longer 
necessary. Concerning the design of a BHV-1 marker vaccine that contains a deletion of a 
nonessential glycoprotein gene, the results obtained so far with the recombinant vaccinia 
viruses indicate that both gG and gl are not suitable for this purpose because gG shows a 
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significant strain heterogeneity in the arainoacid sequence and gl appears to be at least weak 
immunogenic with respect to the humoral immune response. 
COOPERATIVE ACTIVITIES: 
Joint meetings were held in Liege (06.02.1991) and Wageningen (29.11.1991) during the 
ELWW meeting on veterinary viral vaccines. All partners of the project participate in this 
ELWW and made contributions for the "Blue Brochure". Scientists from all laboratories 
attended the 16th International Herpesvirus Workshop in Asilomar (07. ­ 12. 07. 1991) where 
also aspects the common project were discussed. 
Exchange of material: The nucleotide sequences of gl and gG, the Vacgl recombinant and 
monoclonal antibodies to identify gB, gC, gD were sent from G. M. Keil to J.van Oirschot 
who provided G.M.Keil with the sequence of gE, a plasmid containing the gE gene and 
monoclonal antibodies directed against gE. J. van Oirschot obtained from P. P. Pastoret 
monoclonal antibodies against a hitherto unidentified glycoprotein and provided P. P. Pastoret 
with blood from cattle inoculated with various BHV­1 strains for determining cytotoxic T­
cell responses against BHV­1. G. M. Keil received the VacgB recombinant from U. H. 
Koszinowski for the preparation of antisera. The resulting sera were sent to U. H. Kos­
zinowski. P. P. Pastoret gave data on the glycoproteins involved in the cellular immune 
response to G. M. Keil from whom he got vaccinia virus recombinants. 
Exchange of staff: In December 1991 a scientist from Ulm was in Tubingen for two weeks 
for joint experiments to characterize the gene organization in the 5' region of MCMV­gB 
JOINT PUBLICATIONS/PATENTS: 
Rapp, M , Messerle, M, Buhler, B., Tannheimer, M, Keil, G. M. and Koszinowski, U. H. 
Identification of the Murine Cytomegalovirus Glycoprotein B Gene and its Expression by 
Recombinant Vaccinia Virus. J.Virol., in press 
OTHER PUBLICATIONS/PATENTS: 
Denis, M., Slaoui, P.­P. Pastoret and Thiry, E. Specific anti­Bovine Herpesvirus 1 cytotoxic 
T Lymphocytes: a method to identify their target antigen. Proc. XVIth Int. 
Herpesvirus Workshop, Pacific Grove, Ca, July 7­12, p. 246 
Fehler, F., Herrmann, J. M., Saalmuller, A., Mettenleiter, T.C. and Keil, G.M. 1992. 
Glycoprotein IV of Bovine Herpesvirus 1­expressing Cell Line Complements and 
Rescues a Conditionally Lethal Viral Mutant. J.Virol. 66: 831 ­ 839 
Madic, J., Magdalena, J., Quak, J., Veldhuis, M.A. and Van Oirschot, J.T. Epitope­specific 
and isotype­specific antibody responses in sera and mucosal secretions of calves 
experimentally infected with bovine herpes virus type 1. Proc. 2nd Congress of the 
European Society for Veterinary Virology, Uppsala, 23­26 sept, 1991, p. 129. 
Maes, R.K., Rijsewijk, F.A.M. and Van Oirschot, J.T. PCR based detection of bovine 
herpesvirus type 1 DNA in bovine semen. Proc. XVIth Int. Herpesvirus Workshop, 
Pacific Grove, Ca, July 7­12, p. 247 
Rijsewijk, F.A.M. and Van Oirschot, J.T. Bovine herpesvirus type 1 deletion mutants with 
natural or constructed deletions in the glycoprotein gE gene, to be used as vaccines 
and vaccine vectors and methods based on antibody detection against gE to 
distinguish infected from vaccinated cattle. Patent pending. 
Van Oirschot, J.T. Risk assessment of using semen from BHV­1 seropositive bulls for 
artificial insemination. A Holland Genetics Report, 1991. 
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AREA:D 
PRE-NORMATIVE RESEARCH 
IN VITRO EVALUATION OF THE TOXICITY AND PHARMACOLOGICAL 
ACTIVITY OF MOLECULES 
(from page 250 to page 289) 
BIOSAFETY 
(from page 290 to page 346) 
TITLE : DEVELOPMENT OF HUMAN ENDOTHELIAL CELL LINES WITH 
PRESERVED MORPHOLOGICAL AND FUNCTIONAL CHARACTERISTICS 
UTILIZATION IN TOXICOLOGICAL AND PHARMACOLOGICAL TESTS. 
CONTRACT NUMBER : BIOT-CT90-0195. 
OFFICIAL STARTING DATE: 1/1/1991 
COORDINATOR: E. Dejana, Mario Negri Inst, for Pharm-Res., Milan, IT, Ol 
PARTICIPANTS : J.Gordon, British Biotechnol. Ltd, Oxford, GB, 02 
C.de Castellanau, St.Pau Res.Fund.Biomed. Res. Inst., Barcelona, ES, 03 
OBJECTIVES SET FOR THE REPORTING PERIOD: The objectives of this first 
period of work have been : i) immortalization of endothelial cells with retroviral vectors; ii) 
construction of new viral vectors; iii) establishment of functional assay syterns for endothelial 
cells. 
MAJOR PROBLEMS ENCOUNTERED : Nothing to report 
RESULTS : In general participant 01 is involved in immortalizing normal endothelial cells 
with retroviral vectors containing various genes and in establishing standard functional 
assays for endothelial cells.During this first period of work the following milestones have 
been achieved : 1) three different retroviral vectors have been constructed; 2) normal cultured 
umbilical vein endothelial cells have been infected with two of the mentioned retroviral 
vectors and positively selected for their acquired antibiotic resistance; 3) two different 
episomal vectors have been prepared; 4) infected cells have been characterized for few 
functional parameters. 
The amphotropic retroviral vector used is a gag+ LN vector (fig l).This vector is composed 
of two LTRs, the gag+ packaging site, a multiple cloning site, an internal SV40 promoter and 
a neomycin resistance gene. 
Three different genes have been cloned downstream the SV40 promoter in the LXSN vector: 
an activated H-ras allele derived from Harvey sarcoma virus; ii) the coding portion of a 
novel SH2-containing gene (SHC) and iii) the polyoma middle T antigen.These genes have 
been chosen for their transforming potential. The three recombinant vectors and the LXSN 
vector have been tranfected in the murine, ecotropic psi2 packaging cell line by the calcium 
phosphate coprecipitation method. Supematants of the transfected cells have been used to 
infect the amphotropic PA317 packaging cell line. Normal cultured human umbilical vein 
endothelial cells have been infected with Ras and SHC containing constructs by substituting 
their regular culture medium with supenatants of PA317 clones. Cells have been selected 
for their antibiotic resistance. Northern blot analysis of total RNA extracted from these cells 
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Fig, 1: The anphotropic gag+LN retroviral vector used in this study. The vector (LXSN) is composed of two 
LTRs, the gag+packaging site, a multiple cloning site, an internal SV40 promoter and a nomycin resistance 
gene. Three different genes have been cloned downstream the SV40 promoter an activated H­ras allele 
(LraSN); the coding portion of a new SH2­containing gene (LshcSN); the polyoma middle T antigen 
(LmTSN). 
showed high levels of expression of correctly spliced oncogenes. 
The rxansfected cells have been studied for the expression of specific endothelial markers and 
for their morphology. Specific markers used are von Willebrand factor, PECAM/CD31 and 
7B4 antigen. These proteins have been proven to be selectively expressed in endothelial 
cells. Indirect immunoflurescence experiments have been performed with specific 
monoclonal and polyclonal antibodies. 
Cell morphology have been evaluated by phase contrast microscopy. Cytoskeletal 
organization have been also studied by indirect immunofluorescence technique. 
As a second approach in transfection and expression of oncogenes we used a recently 
developed vector (pHEBO) which contains the hygromycin B resistance gene (hph) as a 
selectable marker and can replicate as a plasmid because it carries the EBV origin of 
replication (oriP) and the EBV nuclear antigen (EBNA).The cytoplasmic replication of 
pHEBO vectors leads to higher expression of the cloned genes in recipient cells, when 
compared to recombinant vectors that integrate in the host genome, because of the high gene 
copy number generated. 
The coding portions of the genes to be studied have been introduced in pHEBO vectors 
making use of a convenient multiple cloning site. 
Participant 02 has concentrated his work on planning, obtaining the necessary plasmids and 
strains and establishing the appropriate protocols for the handling of oncogenic DNA.Work 
has now started on developing conditions for the transfection of endothelial cells and on 
construction of oncogene expression vectors.On the basis of the results obtained above, 
integrative plasmids will then be used. One of the key objective is to develop an efficient and 
reproducible procedure for transfection of endothelial cells. Different potential reporter genes 
have been evluated and the best option considered was the Firefly Luciferase. Suitable 
luciferase containing plasmids have been obtained. Large scale DNA preparations have been 
made of plasmids carrying the luciferase gene under the control of the RSV­LTR and hCMV 
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promoters. Studies are underway to find out the most efficient way to introduce DNA 
contracts into endothelial cells. Different transfection procedure are under evaluation: 
calcium phosphate precipitation, electroporation and lipofection. The transient expression 
studies using luciferase as a reporter gene should provide information on the transfection 
efficiency of human umbilical vein endothelial cells and a comparative analysis of the two 
promoters hCMV and RSV. 
Participant 03 established a series of functional assay systems to be used in the endothelial 
cell lines : i) Arachidonic acid metabolism. Different approaches have been used for studying 
endogenous and exogenous arachidonic acid metabolism in basal and stimulated conditions. 
Endogenous metabolism has been evaluated with and without cell activation with thrombin 
by radioimmunoassay of the two major endothelial prostaglandins: prostacyclin and 
prostaglandin E2. Exogenous metabolism has been studied as above after cell activation with 
exogenous arachidonic acid. In addition , high performance liquid chromatography has been 
applied for separation and analysis of different arachidonic acid metabolites, ii) Prccoagluant 
activity. A method for studying this parameter was set up. This assay uses recalcificanon 
time evaluation and rabbit brain thromboplastin as standard. Procoagulant activity has been 
measured in cells activated with cytokines and endotoxin, iii) Fibrinolytic activity. This 
parameter has been studied on normal endothelial cells either unstimulated or activated with 
cytokines and heparinoids.Tissue type, urokinase type plasminogen activator and 
plasminogen activator inhibitor production has been measured by antigenic and functional 
assays.In addition the binding of plasminogen activators and plasminogen to the cell 
membrane has been evaluated. 
In order to develop a toxicological assay, cell lysis techniques were evaluated. Three 
different methods were compared: 1) lactate dehydrogenese leakage; 2) ^H adenine uptake 
and release; 3) 5'chromium release. Cells have been challenged with different toxic 
substances such as : xanthine-xanthine oxidase, anilides and minimal modified LDL. The 
most sensitive and reliable test has been found to be the ^H adenine uptake and release and 
this has been selected for further studies on endothelial cell lines. 
The work in the different laboratories proceeds with good integration of results and 
information accompanied by exchange of materials, cells and investigators. 
HIGHLIGHTS / MILESTONES: The work is proceeding as planned, the following 
milestones have been achieved: 
1) Two human endothelial cell lines transfected with retroviral constructs and two distinct 
oncogenes have been developed. These cells have been characterized for specific markers 
and for morphological parameters. 
2) Plasmid vectors have been prepared. 
3) Functional assays for evaluating a series of functional activities of endothelial cells have 
been set up. 
4) Assays for the screening of substances with potential toxicological effects have been 
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established. 
WIDER CONSIDERATIONS : The endothelium constitutes the internal lining of die 
circulatory system and plays a pivotal role in the maintenance of the vessel wall integrity. The 
alteration of the functional properties of endothelial cells is the first step in the development 
of cardiovascular diseases such as atherosclerosis and myocardial infarction. The possibility 
to isolate and study these cells in vitro is limited by their short life span. We are working on 
the possibility to immortalize cultured human endothelial cells by inserting specific 
oncogenes . Two cell lines have been already developed during this study. They are now 
under evaluation for growth potential and functional properties. 
COOPERATIVE ACTIVITIES: 
"Three meeting among participants have been organized: 
LONDON: January 28­30,1991 
MJLANO: June 19­20,1991 
BARCELONA : November 13­15,1991 
♦Participant 03 is currently spending a three months work period in Participant 01 
laboratory. 
* Endothelial cell lines and different constructs have been excanghed. 
LIST OF PUBLICATIONS WITH TRANS­NATIONAL AUTHORSHIP: 
­ Lauri D., Needham L., Martin Padura L, Dejana E. Tumor cells adhesion to endothelial 
cells: Endothelial leukocyte adhesion molecule 1 (ELAM­1) as an inducible adhesive 
receptor specific for colon carcinoma cells. NCI Journal, 83:1321­1324 (1991). 
­ Lampugnani.MG, Resnati, M, Raiteri, M, Pigott, R, Marchisio, PC, Pisacane, A, Ruco, 
LP, and Dejana, E. A novel endothelial specific memebrane protein is a marker of cell­cell 
contacts. J.Cell Biol.submitted 
OTHER PUBLICATIONS: 
­ FelezJ, Chanquia,CA,Levin, EG,Miles, LA and Plow,EF. Binding of tissue plasminogen 
activator to human monocytes and monocytoid cells. Blood 78:2318­2327,1991. 
­ Lopez,S,VilaX, de Castellamau.C. Interleukin­1 increases 15­hydroxy­eicosatetraenoic 
acid formation in cultured endothelial cells.Biochem. Biophys. Acta, submitted. 
­ Pich, I, Lopez,S, Vila,L, Lagunas.C, and de Castellamau, C. Influence of fatty acid 
anilides present in toxic on the metabolism of exogenous arachidonic acid in cultured 
human endothelial cells. Toxicology, submitted. 
­ Bussolino F., De Rossi M., Sica A., Colotta F., Wang J.M., Alessi D., Martin Padura I., 
Bosia A., Dejana E., Mantovani A. Murine endothelioma cell lines transformed by 
polyoma middle T oncogene as targets for and producers of cytokinesJ. Immunol., 
147: 2122­2129 (1991). 
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TITLE: Development of in vitro neural systems for the identification of agents with 
toxicological and pharmacological potential 
CONTRACT NUMBER: BIOT­CT90­0183­C 
OFFICIAL STARTING DATE: 01/01/91 
COORDINATOR: D.C. Williams, Dept Biochemistry, University of Dublin, 
Trinity College, Dublin, IE 
PARTICIPANTS: C Meredith, BIBRA Toxicology International. G.B. 
A Schousboe, Dept Biology, Royal Danish School of Pharmacy, 
Copenhagen, DK. 
R. Griffiths, Dept Biochemistry, University of St Andrews, St 
Andrews, GB. 
E. Rodriguez­Farré, Dept. Pharmacology & Toxicology; Dept. 
Neurochemistry, Consejo Superior Investigaciones Cientificas, 
Barcelona, ES. 
OBJECTIVES SET FOR THE 
REPORTING PERIOD: As defined in contract 
MAJOR PROBLEMS 
ENCOUNTERED: None 
RESULTS: 
The objective for the group at RSDP during the first year of the contract was to further 
develop primary cultures of neurons and astrocytes and to study neurodifferentiative and 
degenerative agents in such cultures. During the first year these culture techniques have been 
established at USTA having multiple exchanges of personnel between RSDP and USTA. 
Further the neurotoxic actions of extitatory amino acid have been analyzed with regard to 
characterization of mechanisms and development of strategies for protection of neurons. 
Moreover, differentiative agents affecting neuronal and astroglial functions such as GABA­
receptor/Ca^+­channel (neurons) or GABA transport (astrocytes) expression have been 
investigated. This will lead to a better understanding of mechanisms regulating development 
and differentiation in the central nervous system. 
CSIC have studied the basal Ca^­dependent 25 mM K+­evoked PH]­Noradrenaline (NA) 
release from rat hippocampal slices, preincubated with 100 nM [3H]­NA, under exposure to 
hexachlorocyclohexane (HCH) isomers and some GABAergic drugs (picrotoxinin: PTX, 
bicuculline: BIC, pentylenetetrazol: PTZ, and diazepam: DZ) as convulsant and 
anticonvulsant reference compounds. γ­HCH (lindane) enhanced and 5­HCH reduced K+­
evoked PH]­NA release. The α­ andβHCH isomers did not change the PH]­NA release. 
The convulsant compounds ­ PTX (1­100 µM), BIC (10, 100 uM) and PTZ (0.1­5mM) ­
did not modify the K*­evoked PH]­NA release at the concentrations studied. In contrast, 
the K+­induced PH]­NA release was potently reduced by the exposure to DZ. On basal 
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PH]-NA release only S-HCH and DZ induced a Ca ^-independent, time-dependent 
enhancement of about 200% of the control after 1 h of exposure. The present results 
demonstrate that neurotransmitter release from brain slices may be a useful assay method to 
test the mode of action of convulsant and anticonvulsant agents on synaptic events. 
Also t-[35S]butylbicyclophosphorothionate (TBPS) binding was performed in neuronal 
primary cerebellar cultures to study the characteristics of convulsant binding sites on the y-
aminobutyric acidj receptor in intact neuronal cells. Convulsant compounds like PTX and 
PTZ inhibited the binding in this in vitro system. Convulsant organochlorine pesticides 
belonging to the group of polychlorocycloalkanes - PCCAs (y-hexachlorocyclohexane - y-
HCH or lindane - and the cyclodienes aldrin, endrin, dieldrin and α-endosulfan) -
competitively inhibited [35S]TBPS binding in primary cerebellar cultures (Figure 2). 
Stereospecificity was also shown for HCH isomers, the non-convulsant isomers (a and 5-
HCH) being 15-30 times less potent in inhibiting [35S]TBPS binding than the convulsant y-
HCH, whereas the p-isomer did not inhibit the TBPS binding. A significant correlation was 
observed between the in vivo toxicity (LD50) of convulsant PCCAs and their affinity for the 
TBPS binding site. This work demonstrates the usefulness of neuronal primary cerebellar 
cultures to study the interaction of convulsant drugs with GABAA receptor. 
Studies of in vitro cytoxicity of PSSAs (HCH isomers and cyclodienes) in cerebellar granule 
cells are in progress. Toxic effects are quantified by leakage of the enzyme lactate 
dehydrogenase from neural cells. Preliminary studies with Y-HCH showed that cytotoxicity 
could be prevented in cortical cultures by adding GABA and benzodiazepines to the cell 
culture. 
The main neuroactive HCH isomers according to results obtained in the above mentioned in 
vitro test systems (NA release and GABAA receptor binding) are y and 5-HCH. These were 
tested for their ability to interact with inositol phosphate production in cultured cerebellar 
granule cells. Both agents increased that production at 100 lM. Studies to characterize this 
effect are in progress. 
USTAs progress is in line with the set timescales, current work being undertaken mainly in 
collaboration with RDSP. Four working exchanges of personnel have taken place to date. 
With help from RDSP, a brain cell culture facility has been established in USTA. Using the 
cytoplasmic release of lactate dehydrogenase as a marker, the screening of neuroactive agents 
(specifically the endogenous excitatory sulphur amino acids) for cytotoxicity has been 
successful and a joint manuscript is in preparation. Detailed mechanistic studies using 
second messenger systems as the end-points for assay of synaptic function can now be 
addressed. In order to follow a more logical experimental approach, certain aspects of 
USTAs objectives from Year 3 of the contract have been brought forward and assays for 
synaptic function using primary brain cell cultures of neurons and astrocytes, and isolated 
nerve endings, have been undertaken in relation to transmitter uptake, receptor interactions 
and release. This has resulted in 2 joint publications. 
USTAs joint venture with BIBRA and RDSP on the screening of EAAs for pro-
differentiation is set to start on time but these studies will extend into Year 3. This should not 
present a problem in terms of attaining objectives because (as discussed above) USTA have 
integrated some of Year 3 objectives into Year 1. 
The PC12 cell line is typically characterised as responsive to nerve growth factor (NCF) by 
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arresting cell division and differentiating to a neuronal phenorype exhibiting many features 
typical of a sympathetic neuron. An early consequence of culturing PC 12 cells with NGF is 
a significant increase in the expression of certain proto-oncogenes e.g. c-fos, c-jun. BIBRA 
therefore have two areas of interest when studying this particular cell line:- 1) as a model of 
the molecular events associated with differentiation to a neuronal phenorype, and 2) as an 
established neuronal cell culture for studying the molulatory effects of drugs and chemicals. 
Following treatment of PC12 cells with NCF (300 ng/ml of a 7.SS preparation) there was a 
transient expression of c-fos mRNA detectable as early as IS min after treatment and 
declining to background levels by 120 min. The level of detection of the assay (dot-blotting) 
was about 5 x 105 cells. Collaborative experiments with Paul Rumsby's group at BIBRA 
using competitive PCR technology have improved the sensitivity of the assay to less than 
1000 cells. 
Expression of a related proto oncogene, c-myc, was shown to be cell cycle related in PC12 
cells. Following serum deprivation, a peak of c-myc expression occurred after 6 hours 
which was slightly increased in NGF treated cells. No significant modulation could be 
detected in expression of the c-Ha-ras proto-oncogene. 
Both nicotine (10-100u.M) and muscarine (10-100μM) appeared to induce a transient 
expression of c fos mRNA in PC12 cells which had been cultured in the presence of NGF 
for 5 days or more. The level of c-fos expression was substantially less (about 5%) of that 
induced by NGF. The activity of acetylcholinesterase increased dramatically between 5 and 7 
days after NGF treatment and stabilized at a level about 4-fold above baseline. 
PCI 2 cells were also shown to respond to IL-6 (B-cell stimulatory factor) with a transient 
expression of c-fos mRNA; this effect was dependent upon serum deprivation and suggests 
that either IL-6 acts only at defined points in the cell cycle or that a natural inhibitor exists in 
serum. Further experiments will assess the relevance of this apparent interaction between the 
immune and the nervous system. 
Experiments in progress are investigating the effect of selected neurotoxins e.g. MPP* on the 
expression of proto-oncogenes in PC12 cultures and assessing the ability of these 
neurotoxicants to induce programmed cell death (apoptosis). 
The objective for Dublin in Year 1 was to set up cell culture systems for primary cultures of 
astrocytes and neurons and to continue studies using peripheral-type benzodiazepines and 
their receptors and the role of these agents in controlling cell proliferation, differentiation, and 
regulation of convulsive activity. 
Cell culture systems have been set up after initial training by other groups. Further work has 
been performed on studying the stabilization of the receptor by various agents including 
phospholipids in order to provide the receptor in an optimally native state for its use in 
screening agents. The role of the receptor has been further characterised in controlling 
mitochondrial respiration, our findings suggesting that the receptor does not play a significant 
role in this respect. An endogenous peptide ligand for the receptor has been purified and its 
interaction with the receptor studied in order to provide a 'standard' in addition to 
benzodiazepine drugs for studying the further development of screening methods with the 
receptor. A study of the influence of cytokines on the receptor in intact cells has been initiated 
and is well advanced, the role of the receptor as a target for HCH toxicity has been studied. 
The convulsive HCH isomer - γ-HCH (lindane) is a highly potent (Ki - 1 μM) inhibitor of 
benzodiazepine binding to the receptor whereas the inactive isomers do not inhibit, studies 
are in progress to assess whether lindane can influence the synthesis of either convulsive or 
anticonvulsive steroids in cells or brain in order to establish whether the convulsant actions of 
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lindane could be mediated through this receptor. 
HIGHLIGHTS/MILESTONES: 
Competitive PCR for low level fos expression (BIBRA).In studies on HCHs, 5­HCH and 
DZ showed similar effects on the Na release test at similar concentrations, suggesting a 
relationship with their known CNS depressant activity. 
Inhibition of P5S]TBPS binding by convulsant PCCAs correlates with their LD50 values. 
WIDER CONSIDERATIONS: Neural cell culture systems are being shown to have 
important uses in identifying and screening 
compounds for toxic and beneficial properies. These 
methods are strengthened by emphasis on the 
elucidation of mechanisms of action 
COOPERATIVE ACTIVITD2S: 
All participants ­ St Andrews May 1991. All participants ­ Puerto de la Cruz February 199Z 
Dublin ­ BIBRA planning visit Carshalton December 1991. Material exchange Dublin­
BEBRA ongoing.Technology exchange BIBRA ­ St Andrews ongoing. Planned experiments 
BIBRA ­ St Andrews. There has been intensive collaboration between RDSP and USTA 
involving multiple exchanges of personnel. There also has been collaboration with CSIC on 
cytotoxicity studies and a joint publication is planned. Exchange of personnel and material 
for the 2nd year between RDSP and Dublin has been planned and confirmed.There have been 
4 exchange visits between USTA and RDSP during Jan 1991­March 1992 (Feb. 1991 ­ 2 
workers USTA ­» RDSP far 10 days: cell culture tuition and experiments/transfer of freeze 
dried materials to USTA for analysis. June 1991­1 worker USTA ­> RDSP for 6 days: 
manuscript discussions. October 1991 ­ 1 worker RDSP ­> USTA for 7 days: aid in 
establishing a brain cell culture facility. November 1991 ­ 1 worker USTA ­» RDSP for 4 
days : manuscript preparation). Joint studies on lindane toxicity are in progress between 
Dublin, CSIC and RDSP. Training visit on cell culture has occurred (Mar 92) from Dublin to 
USTA. 
LIST OF JOINT PUBLICATIONS/PATENTS 
WITH TRANS­NATIONAL AUTHORSHIP: 
Grieve, A., Dunlop J., Schousboe, A. and Griffiths, R. Kinetic characterization of 
sulphur­containing excitatory acid uptake in primary cultures of neurons and astrocytes. 
Neurochem. Int. 12, 467­474 (1991). 
Dunlop J., Grieve A., Schousboe A., and Griffiths R. (1991) Stimulation of γ­
[3H]aminobutyric acid release from cultured mouse cerebral cortex neurons by sulphur­
containing excitatory amino acid transmitter candidates: receptor activation mediates two 
distinct mechanisms of release. J. Neurochem. 57, 1388­1397. 
OTHER PUBLICATIONS/PATENTS: 
Hansen, G.H., Belhage, B. and Schousboe, A. First direct electron microscopic 
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visualization of a tight spatial coupling between GABAA-receptors and voltage sensitive 
calcium channels. Neurosci. Lett. 135. in press (1992). 
Fransden, Aa, and Schousboe, A. Mobilization of dantrolene-sensitive intracellular 
calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-
aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate and kainate in 
cultured cerebral cortical neurons. Proc. Nad. Acad. Sci. (USA) 89 in press (1992). 
Nissen, J., Schousboe, A., Halkier, T. and Schousboe, I. Purification and 
characterization of an astrocyte GABA-carrier inducing protein (GABA-CIP) released from 
cerebellar granule cells in culture. Glia5 in press (1992). 
Grieve A., Butcher S.P., and Griffiths R. (1992) Synaptosomal plasma membrane 
transport of excitatory sulphur amino acid transmitter candidates: kinetic characterisation and 
analysis of carrier specificity. J. Neurosci. Res. 31, in press. 
Griffiths R. (1992) Sulphur-containing excitatory amino acids: metabolism and 
function. In Schousboe A., Diemer N.H., and Kofod H. (eds): Alfred Benzon Symposium 
32, Drug Research Related to Neuroactive Amino Acids." Copenhagen, Munksgaard, in 
press. 
R. Cristofol & E. Rodríguez-FarréDifferential presynaptic effects of 
hexachlorocyclohexane isomers on noradrenaline release in cerebral cortex. Life Sci. 
49:1111-1120(1991). 
A. Pomes, E. Rodriguez-Farré. and C. Sunol. Inhibition of t-
[35S]Butylbicyclophosphorothionate Binding at the γ-Aminoburyric AcidA Receptor by 
Con vulsant Agents in Primary Cultures of Cerebellar Neurons. Submitted for publication. 
Zisterer, D. M. Gorman, A.M.C. Williams, D.C and Murphy, MP. (in press) The 
Effects of The Peripheral-Type Benzodiazepine Receptor Ligands, Ro5-4864 and PK 11195 
on Mitochondrial Respiration. Methods Findings Exp. Clin. Pharmacol. 
Moynagh, P.N. and Williams, D.C. (in press) Stabilization of the peripheral-type 
benzodiazepine acceptor by specific phospholipids. Biochem. Pharmacol. 
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TITLE "Definition and scientific validation of an in vitro test for 
the screening of tumor promoters and protective chemicals, based on gap junctional intercellular 
communication assays in human and animal cells.' 
CONTRACT NUMBER: BIOT­ CT 91­0261 
OFFICIAL STARTING D A T E : 01/03/1991 
COORDINATOR: 
E. Honikman­Leban, L'Oréal Advanced Research Center, Aulnay­sous­Bois, FR. 
PARTICIPANTS: 
M Balls, F.R.A.M.E., Nottingham, GB; 
E. Honikman­Leban, L'OréaL Aulnay­sous­Bois, FR; 
V. Krutovskikh, LA.R.C, Lyon, FR; 
P. Martel LN.R.A., Jouy­en­Josas, FR; 
G. Ragnotti, Universities of Brescia & Milan, IT; 
L. Wärngard, Karolinska Institute, Stockholm, SE; 
K. Willecke, University of Bonn, Bonn, DE. 
OBJECTIVES SET FOR THE 
REPORTING PERIOD: Standardization of the dye transfer protocol : all 
participants (except Frame) have performed the microinjection on the same cell line and 
evaluate the activity of 5 compounds on the gap junction intercellular communication 
(GJIC). 
Development of other cell types, depending on the activities of the laboratories; 
U s e of molecular tools to identify specific GJIC proteins (connexins) of those cells. 
MAJOR PROBLEMS 
ENCOUNTERED: Nothing to report 
RESULTS: Standardization of the dye transfer assay, using IAR20 cells 
(rat liver epithelial cell line) to test 5 known molecules at 3 concentrations and at 4 incubation 
times: 
The laboratories obtained comparative results during this preliminary study: When IAR20 
were treated with the highest non­cytotoxic concentrations of tumor promoters, 12­o­
tetradecanoyl­phorbol­13­acetate(TPA), butylated hydroxyanisole(BHA), dichlorodiphenyl­
trichloroethane (DDT) and phenobarbital (PB), a dose and time­related inhibition of GJIC 
was observed: lOOng/ml TPA and 20uM D D T exerted their maximal effect (90% and 75% 
respectively) on GJIC after 1 h treatment, but the TPA action was reverted within 24 h. PB 
failed to show a significative effect on IAR20 GJIC but 30ug/ml BHA exerted its maximal 
effect on GJIC (65% ) after a 24 h treatment. A 1 h treatment with lOOng/ml of the non ­
promoter, 4α­phorbol­12,13­didecanoate(4α­PDD) caused no inhibition on GJIC. 
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After this encouraging preliminary interlaboratory evaluation of the microinjection 
protocol, the different laboratories performed the same protocol on their own cells 
depending upon their field of interest: 
The INRA group applied the microinjection methodology to study the modulation of GJIC 
by different compounds (retinoids, tocopherols and flavonoids) between rat liver epithelial 
cells. 3 of the tested molecules appeared to increase significantly cell communication 
capacity. The same molecules were tested on V79 cells with the metabolic cooperation assay 
by L'Oreal group. Molecular studies are now in progress to define at which level of GJ 
regulation these molecules exert their stimulating action: connexin43 (cx43) expression is 
studied both by immunofluorescence and westem-blot analysis; the expression of specific 
mRNA encoding cx43 is followed by northern -blot analysis. In parallel preliminary trials 
have been performed with the freeze-fracture analysis to detect structural effects on gap 
junctional complexes; new cells sy tis are being developped: rat liver epithelial cells 
transfected with c-fos and c-junc proio-oncogenes. 
In the Unit of Multistage Carcinogenesis of IARC the human hair follicule cell culture is in 
development to study GJIC and a possible screening system of tumor promoting agents 
relevant to human situation. Those cells can be routinely available from volunteering 
individuals by a non invasive technique. Hair follicule cells (keratinocytes) showed a 
reasonable level of GJIC measured by dye transfer assay. TPA inhibits GJIC and 
preliminary results suggest that a carcinogenic hair dye molecule (HC Blue 1) but not its 
non carcinogenic derivative (HC blue 2) inhibited GJIC of those cells. 
It seems also essential to study in vivo GJIC from which useful information can be 
generated. For this purpose, a simple method to quantify GJIC in liver slices (from rat and 
human) was developped. Briefly, the dye is microinjected into the a liver slice, followed by 
cryostat sectioning and observation of the dye spread under a fluorescent microscope. 
Employing this method, a progressive decrease in GJIC during multistage rat liver 
carcinogenesis was observed. Known liver tumor promoting agents, Le., PB, DDT, 
Clofibrate, PCB's and ethylene estradiol inhibit GJIC of rat liver in vivo while these 
chemicals are likely to act as hepatotumor promoters with different mechanisms. Further 
study is in progress in combination with the use of molecular probes (connexin 32 cDNA 
and antibodies). 
At the Karoiinska Institute, PCB-congeners were studied with the microinjection and the 
scrape-loading, both dye transfer techniques. The results are published in two articles which 
present the structure-activity relationships of these compounds. The immunostaining 
technique to study GJ proteins was implanted in the laboratory in collaboration with IARC. 
The cell culture technique was improved in collaboration with INRA. Also, the tissues from 
animals treated in the in vivo short-term promotion test were analysed for the amount of 
m-RNA in the Bonn laboratory. 
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Brescia-Milan Universities evaluate also the effect of compounds on their transformed fetal 
bovine aortic endothelial cells (F-BAE GM 7373) which has high basal GJIC capacity. As 
for the IAR20, all promoters tested induced a time-dose-related inhibition. In order to 
make the analysis of the results easier and more objective, a highly sensitive video-recording 
system was connected with the microinjector and the quantification of the extend of the dye 
through GJIC was performed on the video-recorded microscopic images. 
Work in the Institute of Genetics at Bonn University is directed towards characterization of 
connexins (ex) gene expression in mouse tissues and cell types suitable for testing of tumor 
promoting compounds. For example, hepatocyte specific phenotype correlates with high 
expression of cx32 and cx26 but very low expression of cx43. Keratinocyte derived cell line 
Hel37 expresses cx31, cx31.1, cx30.3 mRNA and most likely also cx43 as well as cx26 
transcripts. Since expression of these different ex seems to be regulated differently and the 
properties of the corresponding GJ channels may be different, it is possible that these GJ 
proteins represent different targets for tumor promoters. 
This group succeeded in functional expression of cx40 or cx43 after transfection in human 
Hela cells, thereby restoring GJIC in these transformed coupling deficient cells. This system 
will allow to study the electrical conductance and permeability of GJ channels comprised of 
only one type of ex proteins - in contrast to the situation found in normal cells or tissues. 
L'Oreal evaluates GJIC with the metabolic cooperation assay on V79 cells (Chinese 
hamster lung fibroblasts) which is based on the recovery of mutant colonies after treatment 
in a selective medium; this recovery is correlated with the interruption of the GJIC. The 
evaluation of metabolic cooperation will be carried out in association with Karolinska 
Institute. Beside this * V79 " assay, the dye transfer techniques , scrape-loading and 
microinjection, were adapted on IAR20. In collaboration with INRA, those complementary 
systems were used to study the activities of vitamins A and E, phenolic antioxydants (BHA 
and BHT) and flavonoids as possible antipromoting agents. In addition to the in vitro 
system on human hair follicule cells from IARC, we are also developping these dye transfer 
techniques on human skin cells (keratinocytes and dermal fibroblasts). 
HIGHLIGHTS/MILESTONES: 
Standardization of the dye transfer protocol is acheived and the assay system is now 
functional. 
WIDER CONSIDERATIONS:' 
Studies will be then performed with liver and skin cells to explore the mechanisms of GJIC. 
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COOPERATIVE ACTIVITIES: 
Meetings: 
L'Orial Aulnay, FR, 16/11/90: Standardization of dye transfer experiments; Distribution of 
the same batch of IAR20 cell line (obtained from IARC) and samples of the 5 selected 
chemicals. 
IARC, Lyon, FR, 22-23/11/91: Discussion of the evolution of the GJIC concept; 
Presentation of the results obtained for the standardization of dye transfer experiments. 
FRAME, Nottingham, GB, 27-28/03/92: Conditions for cytotoxicity and selection of 
chemicals; Setting the exchanges of techniques for mechanistic and molecular biology 
studies. 
Exchanges and Collaborations: 
L'Oreal - INRA: One day meeting every month to discuss results and litterature; 
L'Orial - Karolinska Institute: 2 meetings: 2 days in Stockholm (2-3/03/92) , 1 day in 
Aulnay (30/03/92), to discuss cytotoxicity and metabolic cooperation studies and structure-
activity relationships on compounds. 
Karolinska Institute - INRA: 1 week, September 1991, to practise cell culture techniques, 
Karolinska Institute - IARC: 2 months, to acquire and to improve immunostaining 
techniques, ( September 1991; March-April 1992), 
Karolinska InstiMe - Bonn University: 4 days, for the analysis of m-RNA in the tissues of 
animals treated with tumor promoters. 
INRA - IARC & Bonn University: Exchanges of molecular tools and protocols to characterize 
connexin (ex) genes expression. 
Milan & Brescia Universities - IARC: 1 month, to acquire techniques for ex gene expression, 
(July 1991). 
IARC - Bonn University: Both providing to INRA and Karolinska Institute ex cDNAs and 
m-RNAs to study the ex expression in the different cell types used. 
Interactions with other BRIDGE groups: 
ELWW proposal between our project and 2 other BRIDGE projects (PL 890177, PL 
890151): workshop on "the use of human skin cells systems to predict pharmacotoxicologic 
effects of chemicals"; 1 day meeting of the projects coordinators to organise the proposal 
(26/02/92). 
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LIST OF JOINT PUBLICATIONS/PATENTS 
WITH TRANS-NATIONAL AUTHORSHIP: 
MERCIER T , HONIKMAN-LEBAN E . , CHAUMONTET G, MARTEL P , SHAHIN M.M., Etude de la 
modulation des communications intercellulaires par l e s retinoides a l'aide de deux tests in vitro. Colloque de 
l'Association pour la Recherche en Toxicologie, Paris, FR, 4 Mars 1992. 
OTHER PUBLICATIONS 
/PATENTS: 
HEMMING H . , WARNGARD L., AHLBORG UG. (1991) Inhibition of dye transfer in rat liver WB cell culture 
by polychlorinated biphenyls, Pharmacology & Toxicology, 69,416-420. 
HEMMING H , FOLDSTROM S . , FRANSSON-STEEN R., WARNGARD L . , AHLBORG UG. (1992) 
Inhibition of intercellular communication in cell culture by polychlorinated compounds, Chemosphere(in press). 
STUTENKEMPER R , GEISSE S . , LOOK J , TRAUB O . , NICHOLSON BJ. and WILLECKE K. (1992) The 
hepatocyte specific phenotype of murine hver cells correlates with high expression of connexin32 and -26, but very 
low expression of connexm43, Exp. Cell Res. (in press). 
HENNEMANN H., SCHWARZ H-J. and WILLECKE K. (1992) Characterisation of gap junctions genes 
expressed in F9 embryonic carcinoma cells: molecular cloning of mouse connexin31 and -45 cDNAs, Europ. J. Cell 
B i o l . , 57, 51-58. 
HENNEMANN H . , D A H L E , WHITE E , SCHWARZ H-J., CHANG S., LALLEY P . A . , NICHOLSON BJ. and 
WILLECKE K. (1992) Two gap junction genes, connexin31.1 and -303 are closely linked on mouse chromosome4 
and preferentially expressed in skin, J. BioL Chem. (submitted for publication). 
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DEVELOPMENT OF A PREDICTIVE IN VITRO TEST 
FOR DETECTION OF SENSITIZING COMPOUNDS 
CONTRACT NUMBER: OFFICIAL STARTING DATE: 
BIOT-CT90-0186-C 1/6/91 
COORDINATOR: PARTICIPANTS: 
Alain BARBER, Jean-Luc STAMPF, Prof. Jan BOS, Department of 
SANOFI-RECHERCHE, Montpellier, FR Dermatology, UvA, Amsterdam, NL 
Prof. Jiirgen KNOP, Department of 
Dermatology, Mainz/Munster, DE 
Dr Jean-Pierre LEPOITTEVIN, Laboratoire 
de Dermatochimie, ULP, Strasbourg, FR 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Determination of optimal conditions of epidermal cells preparation respectively 
from guinea pigs, human and murine skin. Cytokine production assay and/or 
cytokine mRNA analysis. 
As a first step and as a necessary prerequisite technical procedures have to be optimized and 
standardized. These procedures include dermis/epidermis separation, single cell suspension 
preparation, expansion of keratinocyte cultures as a monolayer, haptenisation of epidermal 
cells. After haptenisation (contact with xenobiotics), cytokine secretion and/or surface markers 
expression of these epidermal cells are determined. 
Preparation and/or purification of natural and synthetic allergenic, or not 
allergenic compounds 
The contribution of the Dermatochemistry laboratory is to provide the other teams with haptens 
covering the whole spectrum of activity (from strong to weak allergens, including tolerogens, 
irritants and non allergenic products as controls) in a standardized, highly purified, and well 
characterized form. It is an important point that all the teams work on the same samples exempt 
from contaminants. This contribution for the first 6 to 12 months can be divided in two main 
phases. 
MAJOR PROBLEMS ENCOUNTERED: 
In our preliminary assays of measurement of MHC Class II expression with fluorescent 
antibodies by FACS, we noticed that all dinitrobenzenes-type haptens produced a very high 
fluorescence background which makes results unexploitable by this method. These haptens will 
probably be excluded from FACS analysis 
The preparation of epidermal cells by itself, requiring trypsinization and epidermal sheets 
disruption is a strong pro-inflammatory stimulus at the cellular level. All cytokines tested so far 
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(IL-6 and TNFα) are induced at a high level. Specific cytokine induction after contact with 
haptens may therefore be overlooked due to high background noise. The methodology has to be 
modified.Epidermal cells will be cultured for a long time (one to four weeks) to allow return to 
baseline value of cytokine production. Basal keratinocytes will be propagated as adherent cells 
and submitted to "pulse contact" with xenobiotics when they reach confluency. 
In some case subclones of B9 cells give unreproducible standard curves and contradictory 
interlaboratory results. We will share and exchange the cell line subclones mat are reliable. 
RESULTS: 
UNIVERSITY LOUIS PASTEUR OF STRASBOURG 
Purification of commercially available haptens. Synthesis of sensitizers and 
non-sensitizers 
Table I: Purification of commercially 
available haptens 
Table II: Preparation of synthetic sensitizers, 
non-sensitizers and tolerogens 
<7 
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The compounds have been purified and distributed to all other participants. 
SANOFI-RECHERCHE 
Optimization of Epidermal cell preparation 
Best yield and viability were obtained with cold trypsinization (4°C, overnight) using 
recristallised Trypsin Type IX (Sigma) at 0,1 % in PBS or HBSS. Epidermal sheets are 
separated easily from dermis with fine forceps. Gentle mechanical disruption of epidermal 
sheets separates cells from the fibrous matrix. We obtain routinely 1-1.5.108 cells with a 
viability of 98 %, from two guinea pig flanks. 
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Determination of optimal conditions for 
xenobiotics 
'Pulse contact" of Epidermal cells with 
The major problem with organic xenobiotics is their solubility in culture medium. Some of them 
(DNCB, DNFB, Oxazolone) are slightly soluble in water but others (PDC, Diphencyprone) are 
not. As a general methodology we have adopted after numerous different assays, a short-time 
(15 minutes) contact ("Pulse") of epidermal cells with haptens pre-emulsified in a soybean 
oil/culture medium mixture. The final concentration of oil is 2 % and has been determined as 
not toxic. Xenobiotics toxicity thresholds were determined (see table III). The cells are then 
washed thoroughly with culture medium to eliminate any remaining oil and free hapten. Lower 
levels of cytokine secretion were detected when haptens are not pre-emulsified. 
Table HI: Toxicity thresholds in vitro 
Xenobiotic 
Soybean oil 
DNBS 
DNCB 
DNFB 
Oxazolone 
conca 
2% 
500 ^M 
50 μM 
50 μM 
100 μM 
Xenobiotic 
PDC 
Diphencyprone 
Croton oil 
Nickel sulfate 
SDS 
cone 
100 nM 
100 μM 
0.05 % 
50 μM 
100μM 
a Sub-toxic final concentration of xenobiotic solubilized in culture medium or 
emulsified in culture medium/soybean oil (2% final). 
Measurement of IL-6 and TNFα secretion by bulk Epidermal cells 
IL-6 assay is done with the B9 cell line which growths specifically in the presence of IL-6 and 
does not discriminate between human, guinea pig and mouse IL-6. The cells are cultured in 
RPMI supplemented with a synthetic substitute for serum to avoid stimulation by contaminating 
endotoxins. As mentioned in section Problems encountered IL-6 (and to a lesser extend TNFα) 
is produced by freshly prepared epidermal cells without further stimuli by xenobiotics. TNFα is 
measured with the L929 cell line cytolytic assay. Table IV summarizes IL-6 and TNFa 
production (over background) of epidermal cells stimulated with xenobiotics. Quantitative 
analysis and kinetic profile determination are under progress. 
Table IV: Qualitative IL-6 and TNFa after stimulation with xenobiotics 
Xenobiotic 
Soybean oil 
DNBS 
DNCB 
DNFB 
Oxazolone 
IL-6 
++ 
-
++ 
++ 
+ 
TNFa 
++ 
+ 
--
+/-
Xenobiotic 
PDC 
Diphencyprone 
Croton oil 
Nickel sulfate 
SDS 
IL-6 
+/-
++ 
+ 
-
++ 
TNFa 
++ 
-
+ 
+ 
+ 
So far the results show that production of IL-6 is not specific to allergenic compounds. Irritant 
substances also do induce IL-6 secretion by epidermal cells. This has also been shown with 
human epidermal cells (CR2). Striking results are obtained with TNFa. We could not 
demonstrate specific induction with sensitizers in the guinea pig model whereas in the mouse 
model TNFa seems to be preferentially induces with allergenic haptens. Further investigations 
are necessary to determine if the L929 cell line is able to respond to guinea pig TNF. 
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UNIVERSITY OF AMSTERDAN (CR2) 
Epidermal cells (EC) are prepared from human foreskin. Epidermis/dermis separation, single 
cell suspension preparation and pulse with haptens are done as described for the guinea pig 
(CR1). Water­Insoluble haptens have not yet been tested. 
Cytokine (IL­1, IL­6, TNFα) induction of epidermal cells "pulsed" with 
haptens 
IL­1 is measured by using the NOB­1 cell line which possesses IL­lreceptors (IL­1R). In the 
presence of IL­1, the NOB­1 cells produce IL­2. IL­2 is measured by the CTLL­2 cell line 
assay, in a direct (mixture of NOB­1 and CTLL­2) or in a two way (NOB­1 cell supernatants + 
CTLL­2) assay. So far this assay due to CTLL­2 unresponsiveness, did not work as expected. 
11­6 production was tested with the B9 cell line as described above (CR1). No IL­6 could be 
detected in supernatant of EC pulsed with water­soluble haptens. As mentionned in the section 
Problems encountered some subclones of the B9 cell line gives unreproducible responses. 
TNFa production was measured with the L929 cytolytic assay. We could show that DNFB and 
DNCB were able to induce TNFa in human epidermal cells. Inhibition assay with specific anti­
TNF antibodies are under progress. 
UNIVERSITY OF MAINZ (CR3) 
Cytokine induction and mRNA analysis on cultured keratinocytes after contact 
with haptens 
Production of epidermal cytokines by human keratinocytes (KC) under the influence of contact 
allergens was measured. Epidermal cells were prepared from human foreskin and expanded for 
4 weeks by cell culture techniques. Freshly prepared epidermal cells are activated by the 
preparation procedures. For this reason long term culture of keratinocytes was established to 
circumvent this problem. The resulting keratinocytes were stimulated for 10 minutes with a 
subtoxic concentration (5 µM) of DNFB and cultured subsequently for 1 hour. Culture 
supernatants were harvested and cytokine­specific bioassays on D10­N4M (IL­1), 7TD1 (IL­6) 
and Wehi 164 (TNFa) were performed. In addition KC were lysed and total mRNA was 
prepared Using specific cDNAs, Northern blot hybridization was used for detection of mRNA 
of IL­1β, IL­6 and TNFa. 
Detection of IL­1 and TNFa was hampered by cytotoxic effects of keratinocyte culture 
supernatant IL­1 and IL­6 are produced constitutively in untreated as well as DNFB­treated 
keratinocytes. This was confirmed by Northern blot analysis of mRNAs. DNFB did not alter 
the IL­lp and IL­6 response. Nevertheless a strong increase of TNFa was detected after 
stimulation with DNFB, whereas untreated cells had very low amounts of TNFa­specific 
mRNA. 
Endocytic activity of Langerhans cells after contact with haptens 
A second in vitro model was developed to study the influence of contact allergens on the 
internalization of MHC class II molecules by murine epidermal Langerhans cells (LC). 
Epidermal cell suspensions were prepared from untreated mice by standard procedures. 
Langerhans cells which constitute about 1­3 % of the total cell population were specifically 
labelled with monoclonal antibodies to MHC class II molecules and gold­labeled secondary 
antibodies. These complexes are internalized spontaneously by untreated LC into large 
intracellular aggregates, which can be monitored by light microscopy after silver enhancement 
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or by electron microscopy. Under the influence of contact allergens a diffuse intracellular 
staining pattern with a pronounced submembranous labelling in numerous endocytotic 
organelles was seen. This pattern was found for subtoxic concentrations of the tested contact 
allergens (DNFB, DNCB, diphencyprone) but not for subtoxic amounts of irritants (SDS, 
Benzalkonium chloride). Toxic doses of the latter compounds result in a diffuse internalization 
pattern in combination with irreversible cellular damage. 
Taking together our present data suggest that in contrast to irritants strong contact sensitizers 
induce an endocytotic activation of murine Langerhans cells. 
HIGHLIGHTS / MILESTONES: 
Optimal conditions for in vitro testing of soluble and insoluble xenobiotics on bulk epidermal 
cells were defined. 
WIDER CONSIDERATIONS: 
Allergic Contact Dermatitis, a distressful disease is induced by substances present in our 
environment (household and industrial products, drugs, cosmetics, jewellery, plants...etc). 
Most new molecules, especially those that may enter in contact with skin, have to be tested as 
pure compounds or in the form of a manufactured product to assess their innocuity. The only 
available and reliable methods to determine the allergenic potential of a product are laboratory 
animal experimental sensitizations. These studies require a considerable amount of guinea pigs 
or mice. The scientific community has become aware that it is necessary to try to reduce 
laboratory living animals where possible by alternative in vitro studies. This is the aim of our 
investigations and some preliminary results are encouraging and there is good hope that we will 
soon be able to detect harmful allergenic or toxic substances in a total in vitro system using 
cultured epidermal cells. 
COOPERATIVE ACTIVITIES: 
Two work meetings were organized with all participants since the official start of the project. 
The first meeting was held at SANOFI-RECHERCHE (coordinator) in Montpellier, September 
16th, 1991. The second meeting took place at SANOFI-RECHERCHE, in Paris, March 9th, 
1992. 
The coordinator also induced the preparation of a ELWW booklet entitled "In vitro integrated 
approach to skin pharmaco-toxicology", with two other groups (BRIDGE PL 890177 and 
BRIDGE PL 890142) working on in vitro models of skin biology. 
JOINT PUBLICATIONS: 
Nothing to report 
OTHER PUBLICATIONS/PATENT: 
Nothing to report 
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PHARMACOLOGY AND TOXICOLOGY OF DIFFERENTIATED CELL TYPES, 
THEIR CELL­CELL AND CELL­MATRIX INTERACTION 
IN AN IN VITRO RECONSTRUCTED HUMAN SKIN MODEL. 
BIOT­CT90­0193­C (DSCN) 
Suiting date: I March 1991 
n°I DUBERTRET L., COULOMB B.­ INSERM 312 ­ H6p. H. Mondor ­ 94010 CRETEIL ­ France (Coordinator) 
o • 2 LAPIERE Ch.­ Univ. Liege ­ Tour de Palhologie ­ B23 ­ 4000 SAKT­TILMAN ­ Belgium 
n °3 KRIEG Th.­ Lab. Dermatology ­ Univ. Köln ­ Joseph­Stelzmann St9 ­ 5000 KÖLN 41 ­ Germany 
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OBJECTIVES SET FOR THE REPORTING PERIOD : 
The objective of this program is to develop in vitro reconstructed human living skin models 
reproducing physiological cellular regulations to determine the mechanisms of these processes 
and to use this knowledge to develop simpler, but predictive, models allowing drugs screening. 
As detailed in our work planning schedule, the first step is to complete the living human skin 
equivalent with different cell types (normal or pathological) or by adding other components of 
the extracellular matrix. This step involves the definition of new parameters for analysis and the 
development of appropriate tools. 
The second step is to identify, among the multiple interactions that the skin models allow to 
modulate, those of pharmacological and toxicological significance and to better understand the 
mechanisms that are involved. The validation of these skin models is focused on wound healing 
promoters, antipsoriatic drugs, pigmentogenic, antineoplastic and anti­aging substances. 
The third step is the development of simpler predictive models and the transfer to industry. 
During the first period of the program, each laboratory progressed mainly in the two first steps, 
working on its part of the program (cell types, diseases, cell­cell communications, cell­matrix 
interactions...) and know­how. Exchange of staff, tranfer of methodology, joined experiments 
were performed in accordance with specific questions of each laboratory. In parallel, the aim was 
also to compare cell behaviour according to the variations in the protocols of reconstruction of 
skin equivalents within the different laboratories using a same cell type. 
MAJOR PROBLEMS ENCOUNTERED : (Nothing to report) 
RESULTS : 
PARTICIPANT n°1 : 
1/ Fibroblasts, ­a) Growth factors and cytokines have been shown to be involved in wound 
healing. aFGF stimulates cell growth and inhibits matrix contraction. Doses, frequency of 
treatment and cellular response according to the degree of tissue reorganisation can be evaluated 
in the dermal equivalent (DE), permitting determination of an appropriate treatment. IL1 and 
PDGF both stimulate fibroblasts growth in monolayer and a matrix slows down this effect On 
the contrary, IL1 inhibits matrix contraction while PDGF stimulates i t These results suggest that 
IL1 and PDGF contribute to the regulation of tissue organization after injury, ­b) Joint 
experiments were made with Th. Krieg lab. (n°3) in order to make the matrix environment more 
complete by adding proteoglycans. The first proteoglycans studied had no effect on fibroblasts 
growth and matrix contraction. Various mRNAs are now studied in Th. Krieg lab. ­c) We have 
also compared F behaviour according to the culture conditions of N. Fusenig lab (n°4) and ours. 
2/ Fibroblasts and keratinocytes. ­TIMP: TIMP was found to stimulate keratinocytes growth. 
This proliferative effect appears to result from an interaction with keratinocytes membrane and to 
be unrelated to the metalloproteinase inhibitor function. ­PKC: While fibroblasts growth is 
inhibited by a PKC inhibitor, the growth of keratinocytes is stimulated. This difference is 
reinforced in the presence of EGF. These results suggest that the interaction between PKC and 
transduction pathway of EGF differs between the two cell types. With the help of Th. Krieg 
lab., we are now comparing the effect of this PKC inhibitor on mRNA expression of oncogenes, 
collagen and collagenase by fibroblasts and keratinocytes. 
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3/ Psoriatic fibroblasts. -KGF: Preliminary experiments showed that KGF could be over-
expressed in psoriatic fibroblasts. The aim is now to correlate the expression of KGF with the 
ability of psoriatic fibroblasts to stimulate normal keratinocyte growth and to study the regulation 
of KGF mRNA by the collagen matrix. -Pharmacology and predictability: We investigate the 
influence of psoriatic fibroblasts and psoriatic serum on the response of normal keratinocytes to 
acitretin in the skin equivalent model. Acitretin in the presence of serum of psoriatic patients 
inhibits keratinocyte growth in vitro, as it does in vivo in the psoriatic plaques. The presence of 
psoriatic fibroblasts is not necessary for the expression of this effect Acitretin acts mainly via 
specific serum factors rather than on the abnormality of dermal-epidermal communications. 
4/ Scleroderma) fibroblasts. Comparison between normal and scleroderma! fibroblasts with 
respect to cell growth and IL6 mRNA expression are now studied in coll. with Th. Krieg lab. 
5/ Fibroblasts from keloids. Keloids are abnormal scars anarchically present at the sites of 
injury. The contraction of DE by fibroblasts isolated from keloids has been shown to be faster 
and more pronounced than by fibrolasts from a normal skin area of a same patient In coll. with 
Ch. Lapiere lab. (n°2) we plan to extend these studies to a larger number of strains and to further 
define the phenotype of fibroblasts from keloids, by comparing their behaviour to that of normal 
cells, in monolayer and in DE, in response to corticoids and growth factors. 
(I Melanocytes. A collaborative work with I'Oréal (n°5) is planned for April. 
7/ In vivo • in vitro correlations. To complete the skin equivalent wound healing promoters 
and dressings were studied in an in vivo epidermal wound healing model (suction blister). 
PARTICIPANT n°2 : 
1/ Modulation of the fibroblasts phenotype by cell-matrix and cell-matrix-cell interactions. 
The steady-state level of mRNAs for extracellular matrix (ECM) macromolecules (collagens, 
fibronectin, elastin) is decreased in the retracting dermal equivalent (DE) populated by normal 
human skin fibroblasts (F) as compared to monolayer conditions and reactivated by the 
mechanical forces generated by the cells in a restrained DE. Collagenase and stromelysin are 
inversely regulated. The oncogenes c-fos and c-jun and the mechanisms of signal transduction 
by PKC are under investigation. Transfection experiments with the regulatory sequence coupled 
to a reporter gene are hampered by an activation of the endogenous gene of collagenase and a 
repression of the collagen genes by transfection procedures. Study of the regulation operated by 
the matrix has been extended to other types of F, gingival (HGF) and periodontal ligament 
(PDL). The physiological state of differentiation of skin F in the DE is further evidenced by the 
production of procollagen I N-proteinase undetectable in monolayer cultures. The interactions of 
F with the ECM also profoundly influence their response to growth factors, as EGF. Normal 
aging and premature aging F were also studied. In the skin equivalent, human keratinocytes 
modulate the biosynthetic activity of F through a paracrine secretion, n-1 a is able to mimick this 
effect Tumoral epithelial cells have also been shown to produce heparin-binding factors able to 
stimulate collagen synthesis by F. 
1/ Establishment of cultures of human endothelial (EC) and smooth muscle (SMC) cells 
and analysis of their pbenotypes and differentiation by ECM. EC cultures have been 
established from human umbilical cord vein. In monolayer they produce mRNAs for type IV and 
VI collagens, fibronectin, laminin, collagenases I and IV and TTMP1. Whereas they form a 
monolayer at the surface of a type I or III collagen gel, they organize into a microvascular 
network when the apical pole of the cell is in close contact with a type I or III collagen gel. This 
differentiation process is reversible by lifting the collagen gel, does not occur with an agarose 
gel, is dependent upon serum, active protein synthesis, intact cytoskeleton and is associated with 
a transitory increased interstitial collagenase mRNA expression. The comparison of the 
phenotype of human fibroblasts (F), smooth muscle cells (SMC) and myofibroblasts (MYOF) in 
culture allows to demonstrate that these cells retain some of their identity in vitro. 
3/ Measurement of mechanical forces as a pharmacological tool. The interactions between the 
cell and the supporting collagen gel is expressed by the development of mechanical forces 
resulting in the retraction of the gel. A device based upon the use of strain gauges was designed 
to measure these forces and use this parameter to monitor pharmacological agents able to 
influence these cell-matrix interactions. All the cell types studied were able to develop mechanical 
forces although with variable intensity (SMC > MYOF > F; F > EC; HGF > PDL) and 
responded by decreased (F: corticosteroids, cytochalasin B, cycloheximid) or increasd (SMC: 5-
HT, nor-epinephrin antagonized by ketanserin) mechanical activity. 
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PARTICIPANT n-3 : 
The main topic is to study cell matrix interactions in vitro. Previous data indicate that cell matrix 
interactions substantially change metabolic activities of fibroblasts. So far, an extracellular matrix 
consisting mainly of collagens types I and III was used in our studies. When cells were 
embedded within this matrix fibroblast collagen type I synthesis was reduced to approximatively 
10% compared to control values of cells maintained on plastic culture dishes. In contrast, 
collagenase synthesis and activity was significantly induced versus monolayer cultures. 
1/ Extracellular matrix constituents. In order to obtain a more physiological extracellular 
matrix in vitro (thus resembling connective tissue in vivo) several other components have been 
considered in their effect on dermal cells. The objective of our current efforts is to elucidate the 
impact of proteoglycans added to collagen gels on modulating cellular responses compared to 
plain collagen gels. This interest derives from the observation that in extracellular matrix, apart 
from collagenous proteins, proteoglycans are major constituents of the connective tissue. The 
effect of modulating cell matrix interactions by this group of molecules has not been studied in 
detail. In addition of analyzing collagen type I and collagenase regulation in fibroblasts, several 
other parameters are to be examined. Regulation of extracellular matrix receptors such as the 
hyaluronic acid (HA) receptor (CD44), cytokine expression (IL1, IL 6) and cytokine receptors 
(IL1 R, PDGF R) are most interesting markers of cell activation states. This basic work should 
enable us to distinguish effects of added cytokine and growth factors from changes already 
elicited by the extracellular matrix components. 
2/Signal transduction. In initial experiments the effect of several different glycosaminoglycan 
side chains on collagen gel contraction were examined in joined experiments of B.Coulomb's 
lab. (n°l) and ours. However no striking effects could be demonstrated. Future work is now 
progressing to identify changes on mRNA steady-state levels for the HA receptors and IL1, EL6, 
IL1 R and PDGF R due to glycosaminoglycan side chains. 
In parallel, work has been started to elucidate the molecular basis of cell matrix interactions and 
signalling mechanisms. We were able to demonstrate that integrin receptors are involved in the 
contraction process of collagen type I gels. However, signal transduction pathways mediated by 
collagen type I and integrin interactions are unknown so far. One biochemical mechanism 
involved in signal transduction is represented by post-translational modification of proteins. 
Especially, phosphorylation and dephosphorylation on tyrosine residues play a major role. Based 
on this knowledge, signal transduction in the contraction model is being studied by looking at 
tyrosine phosphorylation/dephosphorylation and tyrosine kinase/phosphatase activities in the 
course of contraction. Techniques required, such as western blotting with anti-phosphotyrosine 
antibodies, in vitro kinase assays, and co-precipitation assays are now established. 
PARTICIPANT n°4 : 
1/ Standardization of the basic organotypic coculture model and its comparison and 
adaptation with those of the other partners. By modified isolation and preparation techniques 
the collagen matrix was standardized in its collagen concentration, thickness and stability. After 
seeding fibroblasts, such matrices organized to a DE without considerable contraction when they 
were placed on metal grids and mounted in CRD culture chambers. Large amounts of 
keratinocytes and fibroblasts could be obtained from the same skin specimen and stored in liquid 
nitrogen to be used in large series of experiments. More important, endothelial cells from small 
blood vessels of the upper dermis could be isolated in good purity, characterized by functional 
parameters, propagated in culture to obtain large cell numbers, and stored deep-frozen. 
2/ Analysis of the effect of co-cultured capillar; endothelial cells in comparison with 
fibroblasts on growth and differentiation of normal skin keratinocytes. The effect of 
cocultured endothelial cells on keratinocytes was studied under different culture conditions. 
When used as irradiated (and thus non-proliferative) feeder layer cells, dermal capillary 
endothelial cells promoted clonal growth of keratinocytes at a higher rate as compared to dermal 
fibroblasts. After embedding in collagen gels, the effect on keratinocyte growth and 
differentiation was comparable to that of fibroblasts. There was first a strong stimulation of 
proliferation indicated by a rapid increase in cell number followed by the formation of organized 
epidermal strata. Within seven days a rather normal epidermal structure was formed and the cells 
synthesized the typical differentiation markers : keratin 1 and 10, involucrin, filaggrin. The 
aberrant localization of these components indicated that this reproducibly obtained in vitro 
epidermis is more comparable to a hyperplastic, irritated or regenerating skin. Thus, this culture 
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type may serve as a pharmacological model for diseased skin. By modulating mesenchymal cell 
number and functional state in the matrix, an equilibrium between growth and differentiation of 
the keratinocytes will be attempted. Results from transplantation of such cultures onto nude mice 
indicated a rather complete normalization of the reformed epidermis within one to two weeks. 
3/Study of the response of immortalized kcratinocytes (HaCaT cell line) and tumorigenic 
Mbclones on fibroblast interaction in vivo and in vitro. The typical response of the HaCaT 
kcratinocyte cell line to mesencbyme-mediated regulatory signals could be further substantiated 
in surface transplants on nude mice. In vitro, on collagen matrix HaCaT cells can also reform an 
epidermal structure depending on the influence of cocultured fibroblasts in the matrix. The tissue 
organization, however, is not as well manifested as with normal keratinocytes, so that further 
modifications of the model are presently underway to improve this situation. 
Migration on collagen and chemotactic response are well maintained in HaCaT cells, as could be 
demonstrated in a cooperative study with partner 3. 
Tumorigenic HaCaT-ras subclones have lost most of their dependence on cocultured fibroblast 
stimulation for proliferation and stratification in feeder layer and organotypic cultures. However, 
tissue organization seemed to be improved by cocultured fibroblasts, indicating a normalizing 
effect comparable to that seen in early stages of transplants. This indicates that HaCaT cells and 
the tumorigenic variants still respond to mesenchymal cell interaction. 
PARTICIPANT D*5 : 
It was established that melanocytes and keratinocytes interact in culture, but the cellular and 
molecular mechanisms of this interaction are unknown. 
When the two cell types are cultivated separately in the same medium, growth and proliferation 
of melanocytes requires the supplementation of melanocyte growth factors. In the absence of 
these factors, melanocytes survival requires the contact with keratinocytes. We have observed 
that in this case the two cell types organise themselves and reconstruct the epidermal melanin unit 
(EMU). This EMU constituted by a melanocyte and a pool of associated keratinocytes, in which 
the melanocyte synthesizes melanin and melanosomes, and the latter are transfered to 
keratinocytes and modified within them. In vivo, the melanocytes associates with keratinocytes 
in a ratio of about 1:36. Preliminary results indicates that adding melanocytes to confluent 
keratinocytes in the ratio 1:10 allows one to observe the cohabitation of these two cell types. One 
function of the EMU is to protect the skin from the detrimental effects of external stimuli. 
Exposures to external stimuli modify the EMU (synthesis of melanin, melanosomes and number 
of functional melanocytes). 
The chemical composition of the culture media, the state of proliferation of the two cell types at 
the moment of the contact and the ratio of the number of melanocytes/keratinocytes had first to be 
defined to permit the realisation of this coculture in vitro. 
These studies were realized with homologous or heterologous cells from different ethnic 
origins. For each culture condition we have observed the melanocyte position during the 
differentiation of the keratinocytes. 
In culture of melanocytes we can quantify the variation of intracellular melanin after the 
application of external stimulation by spectrophotometry and by the kinetic of incorporation of 
radioactive precursor of melanin synthesis. The evaluation of the melanocyte number can be 
measured using specific antibodies. 
With participant n°l, we plan to cultivate melanocytes and keratinocytes on dermal equivalents 
and to reproduce a functional epidermal melanin unit which respond to external stimulation. By 
these studies we want to understand the role of dermal fibroblasts in the EMU organisation. 
HIGHLIGHTS / MILESTONES : 
Cell-cell communications: The importance of fibroblasts-keratinocytes interactions was already 
demonstrated. Capillary endothelial cells are also implicated in this dermal-epidermal dialogue. 
Cell-matrix interactions: The mechanical forces developed by cells through interactions with 
the extracellular matrix are important biological regulators of the cell phenotype and are most 
significant in organogenesis in vivo and in many pathological processes. 
Predictability: The skin equivalent can be used as a predictive model for antipsoriatic efficiency 
of retinoids when the serum used in vino comes from psoriatic patients. 
WIDER CONSIDERATIONS : 
Even if some "skin equivalents" are on the market (Organogenesis, Marrow Tech), they are not 
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universal. A permanent research is necessary to develop, adapt and validate in vitro models, in 
order to obtain a predictability of the results for humans and progressively replace animal 
experimentation. The human in vitro reconstructed living skin equivalent can be considered as 
the most advance prototype of a reconstructed organ. It can serve as an example to develop blood 
vessels, tendons, periodontal ligaments, etc . . . for studying cellular physiology, creating new 
pharmacological tools and building organs for replacement therapy. 
COOPERATIVE ACTIVITY : 
MEETINGS : 24/06/91 : n°2 and n°5 in Chevilly­Larue 
02/07 /91: n°3 and n°4 in Cologne 12­13/09/91 : n°1 and n°2 in Reims 
11/10/91: n°l and n°3 in Paris 16/10/91: Plenary meet ing in Créteil 
17­18/12/91: n°l and n°3 in Cologne 20/01/92: n°2 and n°3 in Cologne 
25/01/92: n°l , n°2 and n°3 in Cologne 30/01/92: n°l and n°4 in Paris 
31/01/92 : n°4 and n°5 in Aulnay 28/02/92: n°l and n°5 in Paris 
EXCHANGE OF STAFF : 
­n°l : 02­06/12/91; 16­20/12/91 and 10­14/02/92: n°l ­> n°3 (Joint experiment in Cologne) 
­ D ° 2 : January­February 92 : n°2 ­> n°5 (learning techniques in Heidelberg) 
­D°3 :25­29/11/91; 06/12/91 and 19­20/12/91: n°3 ­> n°l (Joint experiment in Créteil) 
­n°4 : 18­21/06/91 : n°4 ­> n°l (Joint experiment in Creteil) 
EXCHANGE OF MATERIAL / METHODOLOGY : 
n°l ­> n°3 and n ° 4 : Procedure for fibroblast growth evaluation within a matrix. 
n°2 ­> n°3 : exchange of fibroblasts cultures (03/10/91 and 02/03/92). 
n°3 ­> n°l : mRNA extraction from fibroblasts embedded within a collagen matrix. 
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factor. Journal of Cell Science 100: 649­655,1991. 
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morphogenesis and keratin expression in c­Ha­ras­transfected tumorogenic clones of the human HaCaT cell line. 
Canc. Res. 51: 4402­4409,1991. 
­■•4 : MACKENZIE L., RnTMAN G., BOHNERT A, BREITKREUTZ D. and FUSENIG N.E^ Influence of connective 
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Establishment of immortal differentiated hepato­
cyte lines from transgenic mice and their use for 
studying viral and chemical agents. 
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PARTICIPANTS: Prof. Dieter Paul, Fraunhofer Inst. Hannover.FRG 
Dr. C.Guguen­Guillouzo, INSERM 49, Rennes. France 
OBJECTIVES SET 
FOR REPORTING 
PERIOD: 
MAJOR PROBLEMS 
ENCOUNTERED: 
To establish one adult hepatocyte line from 
transgenic SV­202 mice and initiate characte­
rization of established hepatocyte line BGK­202. 
Transfection of cells using the CaP04­DNA copre­
cipitation with the HBV genome and studies on the 
control of the cell cycle in these cells. 
The need to obtain new tools more efficient than thymidine 
incorporation for defining the differences between normal and 
immortalized hepatocytes. They include identification of cdc2, 
CDK2 and cyclin A and B kinase expression in the cells. 
Transfection of liver cells using the CaP04­DNA coprecipitation 
technique causes high toxicity to hepatocytes and the yield of 
tansfectants is therefore low. This is presumably due to alte­
rations of intracellular Ca++ in hepatocytes, to which hepato­
cytes have been shown to extremely sensitive. Alternative tech­
niques are being tested, including electrporation. 
Morphological criteria suggest that cell populations of the 
established line BGK­202 are heterogeneous. 
Fetal hepatocyte line FMH­202 is useful for assays to identify 
indirectly acting mutagens. However, highly active phase II 
enzyme activities appear to render genotoxic metabolites of 
aflatoxin Bl and cyclophosphamide inactive and can therfore not 
be assayed by employing chromosome aberrations as an endpoint. 
In contrast, induction of sister chromatid exchanges can readi­
ly be identified, presumably because distinct genotoxic metabo­
lites initiate SCEs as compared with chromosome breaks (clasto­
genic actovity). 
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RESULTS: 
ABSTRACT 
There is great demand for stable hepatocyte culture systems in 
areas such as pharmacology, toxicology, virology, carcinogenesis 
and biotechnology. At present, hepatocytes in primary culture 
maintain their differentiated functions only for a few days, which 
limits their usefulness in long-term studies. Therefore, hepatocy-
te lines were derived from transgenic mice that bear an immortali-
zing transgene which is expressed in the liver prior to the appea-
rance of tumor cells in the animal. Resulting hepatocyte lines are 
immortal, non-tumorigenic and stably maintain their differentiated 
functions for extended periods. A new hepatocyte line has been de-
rived from an adult mouse and is in the process of being adapted 
to multiply in serum-free medium in response to EGF and insulin. 
To characterize the control of the cell cycle of adult line BGK-
202, it was demonstrated that cells express the kinases cdc2, CDK2 
and cyclins. Sequential phosphorylation processes were shown that 
indicated that cdc2 clearly participates in the control of G2/M 
but not in Gl/S transition. Attempts are being made to obtain 
stably transfected cells using the complete HBV genome. Fetal 
transgenic mouse cell line FMH-202 was employed as target for 
assaying indirectly acting mutagens in attempts to set up a short-
term toxicity assay for the identification of indirectly acting 
mutagens. It was shown that the fetal line lends itself for such 
tests, however further validation is needed for standardizing the 
assay systems for routine use. 
1) Establishment of an adult hepatocyte line from transgenic 
SV-202 mice 
An adult transgenic hepatocyte line was established from a 12 week 
old SV-202 mouse. As expected, the line is not clonal, since cells 
require neighbors, i.e. cell-cell contacts for growth and 
maintenance of differentiated hepatic functions. The cells grow 
slowly in MX-83 medium free of serum in response to EGF and 
insulin. Initially, transfers can only be conducted once every 12 
- 16 days. After about 4 passages, the cultures apear homogeneous 
as judged by morphological criteria. Initial data suggest that the 
cells multiply every 48 hours, however transfer efficiency is, as 
expected on the basis of earlier experiments, quite low. 
Additional work has to be conducted to characterize the general 
properties of the cell line when it has adapted well to the 
culture conditions and can be passaged without great loss of 
cells. 
2) Characterization of the fetal transgenic mouse hepatocyte line 
FMH-202 as a target cell in short-term test systems for the 
identification of for indirectly acting mutagens. 
FMH-202 Cells were employed for experiments to assay for the 
genotoxic activity of indirectly acting mutagens including 
Dimethyl-benzanthracene (DMBA), Benzo(a)Anthracene (BaA), cyclo-
phosphamide (CP) and aflatoxin Bl (AFB1). Few known cell lines are 
-276-
endowed with metabolizing enzyme activities that are required for 
the activation of each one of these compounds to generate geno-
toxic metabolites which are responsible for the induction of muta-
tions, and no cell line has been described that responds to these 
compounds by metabolizing them into genotoxiic intermediates. End-
points chosen in our assays were both clastogenic activity as mea-
sured by chromosome aberations and the induction of sister 
chromatid exchanges (SCEs). 
All four compounds used in this study clearly induced SCEs at low, 
non-cytotoxic concentrations in the culture medium. However, only 
DMBA and BaA, however not CP or AFB1, induced chromosome aberra-
tions. Since the cells produce metabolites of these compounds and 
since the cells express phase II-enzymes (sulfatase, glucuronida-
se) , the genotoxic intermediates of these compounds that were pre-
sumably generated are inactivated quickly and before they can 
interact with DNA to form adducts. Form these preliminary data it 
appears that cell line is appropriate for detecting indirectly 
acting mutagens of different classes without the need of their 
metabolic activation in vitro, e.g. by S9 liver extracts or by 
preincubation with freshly isolated hepatocytes in primary culture 
prior to be added to the target cell culture. Additional work is 
being conducted to define the suitability of this cell line for 
short-term in vitro toxicological test systems. 
3) Characterization of hepatocyte line BGK-202 with respect to 
cell growth regulation to define alterations of the cell cycle 
controls that lead to progression towards immortalization. 
For this purpose we have developed tools and experimental condi-
tions for determining the kinase proteins which are known to con-
trol Gl/S and G2/M transition, the two main limiting steps of cell 
cycle progression. Little is known this general field concerning 
eukaryotic cells and no data on liver cells have are available as 
yet. We have demonstrated in normal hepatocytes the expression of 
the kinase proteins cdc2, CDK2 and cyclins and characterized their 
sequential activation of throughout phosphorylation/ dephosphory-
lation processes. We have clearly shown hat cdc2 participates in 
the control of G2/M transition, like in many other cell types, but 
not to that of Gl/S transition. Furthermore, we have shown that 
CDK2 could play a critical role in Gl/S transition. Moreover, we 
have defined the sequential expression of various oncogenes, par-
ticularly those normally expressed during Gl, plus p53 tumor 
suppressor gene which could be, together with the Rb protein, a 
substrate for the cdc2 kinase. Abnormal p53 expression has fre-
quently been reported for human hepatocarcinoma. A manuscript is 
in preparation on this topic. Experiments are in progress for 
anlayzing expression and activity of these kinases in the BGK-202 
hepatocyte line. 
4) Use of immortalized hepatocyte line BGK-202 to analyze mecha-
nisms by which HBV favours development of malignant cells. 
Transfeetion of the BGK-202 cell line using the CaP04-DNA copre-
cipitation procedure has met with limited success and/or reprodu-
cibility. This has led us to analyze the efficiency of electropo-
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ration to increase efficiency in obtaining transfectants. Trans-
fections of the complete HBV DNA genome into a new human hepatocy-
te hepatoma line HBG, which fails to grow in soft agar and to de-
velop tumors in nude mice, have been performed. The experiments 
show an increase in c-myc expression in transfected cells and not 
in non-transfected cells. The same induction was also observed 
when HBX gene was transfected, suggesting that c-mvc could in part 
be involved in the mechanism by which HBV induces hepatocellular 
carcinoma. 
HIGHLIGHTS/ 
MILESTONES: Establishment of a new adult transgenic hepato-
cyte line: 
WIDER 
CONSIDERATIONS: 
Novel differentiated liver cell lines were esta-
blished for immediate use in biotechnology, 
virology, biochemistry and toxicology. The cells 
appear to be useful for short-term toxicological 
test systems in vitro. 
COOPERATIVE No meetings were organized during the initial 
ACTIVITIES: year of the contract. During the second and 
third years at least three meetings including 
exchanges of pe rsonnel are being prepared. 
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DEVELOPMENT OF AN IMMORTALIZED HUMAN ARTICULAR CARTILAGE CELL 
LINE AND ITS USE IN PHYSIOLOGICAL, PHARMACOLOGICAL AND TOXICO-
LOGICAL IN VITRO INVESTIGATIONS 
CONTRACT NUMBER: BIOT 0196 
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COORDINATOR: EM.VEYS, Ghent University Hospital, B-9000 GENT. 
PARTICIPANTS: 
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L DE RIDDER, University of Ghent, B-9000 GENT. 
GS PANAYI, Guy's and St.-Thomas Medical School, LONDON, UK. 
A CLOAREC, Laboratoires UPSA, F-92506 RUEIL-MALMAISON. 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
The aim of this EEC-BRIGDE project was to study the possible 
use of in vitro cultured phenotypically stable human cartilage 
cells in pathophysiological, pharmacological and toxicological 
i nvest i gat i ons. 
Functional characterization of this cell line involved the stu-
dy of synthesis, secretion and turn-over of proteoglycan and 
collagen in an artificial extracellular matrix. To this end, 
the metabolic functions of the human chondrocyte maintained in 
suspension culture had to be characterized. 
The validity of this system for. the study of the effects of 
disease mediators (cytokines, O -radicals, co-cultured macro-
phages) and of pharmacological substances on mediated chondro-
cyte metabolism had to be determined. 
In order to obtain full control of the environment and complete 
standardization of this system, it had to be established in how 
far single or combined growth factors could replace serum in 
the incubation medium. 
Cartilage cells were obtained from human subjects with spontan-
eously occurring or from animals with experimentally induced 
degenerative and inflammatory joint diseases. It had to be de-
termined whether an in vivo observed abnormal function of these 
cells persisted in vitro. 
Since such cells are difficult to obtain, it was decided to 
construct immortalized human chondrocyte cell lines. To our 
knowledge, human articular chondrocyte immortalization has 
never been done. Because of a variety of control mechanisms, 
such as an efficient repair potential, the genetic apparatus 
of the human cell is relatively stable compared to that of most 
other animal species. It was necessary to study the problems 
inherent in the immortalization and propagation of the human 
chondrocyte in particular and of human cells in general. To 
this end, several clones of immortalized human cartilage cells 
had to be developed. It had to be defined in how far different 
clones of immortalized and transformed human chondrocytes 
differed from the original non-immortalized cell. 
The preservation of the original (in vivo) functions with res-
pect to the homeostasis of extracellular matrix macromolecules 
in an in vitro model (culture in different gelified matrices) 
had to be studied. 
Fully characterized immortalized chondrocyte cell lines may be 
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an interesting tool for researchers in university or industrial 
laboratories. Consequently, the possibility to preserve these 
cells at -180°C in a chondrocyte bank had to be evaluated. 
MAJOR PROBLEMS ENCOUNTERED: 
One of the major difficulties encountered was the fact that 
after the initial transformation the cells remained in a 6 to 
9 months long latency or 'crisis' period. It took almost a year 
to obtain the first clones of immortalized normal human articu-
lar cartilage cells. 
Attempts to immortalize human and animal chondrocytes from 
diseased cartilage (human osteoarthritic cartilage, adjuvant 
arthritis rabbit cartilage) had to be postponed. 
Since chondrocytes in articular cartilage of patients with 
rheumatic conditions may be involved in the pathogenesis of 
autoimmune diseases (antigen presentation), it was decided to 
focus on chondrocytes obtained from rheumatoid arthritis car-
tilage. However, so far it has been impossible to isolate 
sufficient numbers of these cartilage cells. 
RESULTS 
Several batches of human articular chondrocytes Here isolated 
at autopsy from articular cartilage of human femoral condyles. 
The investigations performed in 1991 resulted in : 
1- DEVELOPMENT OF A PROTOCOL FOR BIOLOGICAL FREEZING AND 
PRESERVATION OF VIABLE CHONDROCYTES AT -180°C. 
A collection of 'viable chondrocytes' is a useful tool when 
human articular cells of different origin (normal and various 
inflammatory, metabolic or inherited diseases) are studied. 
Having access to 'the bank' obviates the researcher's dependen-
ce on the availability - at a particular moment - of a certain 
type of cell. A biological freezing program for human lymphocy-
tes was slightly adapted to the needs and used to test the 
effects of dimethylsulfoxide (DMSO) as a protective agent on 
human articular chondrocytes suspended in a semisynthetic cul-
ture medium. Five percent of DMSO were found to be an optimal 
concentration. Approx. 80% of viable cells were recovered at 
this concentration. S-incorporation in newly synthesized 
proteoglycans was studied in cells recovered from -180°C and 
in the control cultures. The cryopreservation procedure did not 
affect proteoglycan synthesis rates or the proportions of the 
different proteoglycan subtypes (Table I). 
TABLE I: PROTEOGYCAN SYNTHESIS (picog S04incorp/106celIs/hour) 
AND PROTEOGLYCAN SUBTYPES (*). 
total PG t-aggr %-mono %-debr 
controls 2628 (14.6) 42.6 (9.7) 36.5 (8.5) 20.9 (6.9) 
after-180°C 2526 ( 9.6) 44.5 (6.5) 35.8 (7.8) 19.8 (3.4) 
aggr: PG-aggregates; mono: PG-monomera; debr: turn-over 
products and low mol weight PG; coefficients of variation 
between ( ). 
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2­ CHARACTERIZATION OF THE METABOLIC FUNCTIONS OF THE HUMAN 
CHONDROCYTE CULTURED IN SUSPENSION CULTURE IN AGAROSE 
Human chondrocytes were shown not to divide in 1.5 % of geli­
fied agarose. They continued to synthesize proteoglycans (PG) 
at constant synthesis rates for at least 8 weeks. 
Three subpopulations of PG were recovered from the agarose gels 
and from the incubation media: PG aggregates, monomeric PG and 
low molecular weight material (turn­over products, minor PGs); 
PG aggregates consisted of monomeric PG linked on a hyaluronan 
backbone, as was confirmed by electron microscopic analysis of 
the PGs (fig 1). 
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Fig 1 : electron microscope picture of native de novo synthesi­
zed PG. Fig 2: chondrocyte cultured in agarose with Alcian blue 
fixed PG surrounding the cell. 
Over 90% of the PG­aggregates were immobilised in the gel and 
remained in the immediate vicinity of the chondrocyte (fig2). 
Approx. 50* of monomeric PG and the bulk of the turn­over 
material were lost in the incubation medium. 
The biochemistry of the synthesized extracellular matrix macro­
molecules shows that these cells remained in their differen­
tiated state in the ex vivo condition. The immobilization of 
the newly synthesized PGs in the artificial surrounding matrix 
was comparable with that of in tissue cultured cartilage. 
It is an interesting finding that the total S­incorporation 
rates correlated with the age of the donor. Others have found 
that PG synthesis rates decline with age in human and in rabbit 
cartilage tissue culture. The results of these experiments 
allowed to conclude that articular cartilage cells keep their 
in vivo S­PG­synthesis rates in this culture condition. 
The total PG­synthesis rate of the chondrocytes was comparable 
with values observed in vivo in humans. 
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3- STANDARDIZATION OF THE CULTURE CONDITIONS - COMPLETELY 
DEFINED CULTURE MEDIA. 
Routinely, celis or tissues are grown in vitro in semisynthetic 
nutrient media. In order to supplement growth and differentia-
tion factors, fetal calf serum is added. Fetal serum contains 
these factors in variable and unknown concentrations. 
In a series of experiments fetal calf serum (FCS) was replaced 
by a single growth factor or a combination of these biological 
mediators. In the absence of FCS, PG synthesis rates dropped 
to about 10-15% of the values obtained in the presence of 
serum. 0.1% of bovine serum albumin did not improve metabolic 
activity. 
Human recombinant insulin, at concentrations ranging between 
10.0 and 100.0 nG per ml, increased PG synthesis rates to about 
60 % of the values obtained with FCS. Higher concentrations did 
not result in further improvement. Both insulin-like growth 
factor I and II were unable to enhance the effect of insulin. 
This was not surprising, considering that these three factors 
bind to the same receptors. 
Transforming growth factor beta (TGF-b), at concentrations of 
10 nG per ml, caused an increase in PG synthesis rates to about 
50 % of the values obtained with FCS. In combination with 100 
nG/ml of insulin, 10 nG of TGF-b completely restored the origi-
nal PG synthesis rates. 
4- STUDY OF THE INFLUENCES OF VARIOUS BIOLOGICAL MEDIATORS 
AND SOME PHARMACOLOGICAL AGENTS ON CHONDROCYTES. 
Chondrocyte metabolism is known to be affected by various cyto-
kines and drugs (i.e. NSAIDs). 
Interleukin(IL)-1 stimulates PG catabolism and decreases PG 
synthesis of chondrocytes cultured in agarose in a dose-depen-
dent manner. IL-1 dramatically enhances the release of IL-6 by 
these chondrocytes. More than 100,000 pg of IL-6 per ml of 
incubation medium are found when the chondrocytes are stimula-
ted with 1 U of IL-1/ ml. IL-6 has no effect on chondrocyte 
PG synthesis. 
Tumor necrosis factor-a also stimulates PG catabolism and de-
creases proteoglycan synthesis of chondrocytes cultured in 
agarose in a dose-dependent manner. The effects are less pro-
nounced than those of IL-1. 
Human recombinant interferon-g (IFN-g) inhibits PG-synthesis. 
PG-catabolism is not affected. 
NSAIDs were tested in this culture model. The inhibitory 
effects of salicylate (SAL), acetylsalicylic acid (AC-SAL) and 
niflumic acid (NA) on PG-synthesis were reproduced. Piroxicam 
(PIR) did not seem to depress PG synthesis by these cells. 
5- DEFINITION OF THE NONIMMORTALIZED CARTILAGE CELL. 
In order to analyse any changes in cell behaviour, or loss 
of specific functions after immortalization the 'normal' chon-
drocyte has to be defined. In table II the functions of the 
cartilage cell are listed. These functions will be tested in 
immortalized chondrocytes. 
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TABLE II: METABOLIC FUNCTIONS OF NORMAL HUMAN CHONDROCYTES 
EXPORT PRODUCTS PROTEOGLYCAN COLLAGEN TYPES 
CS KS DS AGGR I II IX 
++ ++ ++ ­ + nd 
INFLUENCES IL­1 TNF IFN IL­6 SAL A­SAL NA PIR MNC 
. . ­ . a + + 
nd — — — — nd 
++ 
nd 
PG­SYNTHESIS : 
PG­CATABOLISM : 
PGE2­RELEASE : 
IL­6­RELEASE : 
PROLIFERATION : 
­­
+ + 
+ + 
+ + 
__* 
­­
+ + 
nd 
++ 
nd 
­­­nd 
nd 
— 
++** 
CS: chondroitinsulfate; KS: keratansulfate; DS: dernatansulfa­
te; AGGR: aggregates. «: no effect; nd: not done; : irrele­
vant; * 'young' monolayer cultures; ** 'old' monolayer cultures 
6­ STUDIES OF THE SUITABILITY OF THIS CELL FOR RESEARCH ON 
CELL­CELL (MACROPHAGE­CONNECTIVE TISSUE CELL) INTERACTIONS 
IN PATHOLOGICAL CONDITIONS. 
For co­culture, chondrocytes are suspended in agarose and the 
agarose is allowed to gelify in micro insert culture wells, the 
bottom of which consists of a porous filter membrane. These in­
sert culture wells are then placed in standard culture dishes 
in which peripheral blood monocytes (MNC) are grown. The chon­
drocytes (in agarose) are thus maintained on top of the MNC 
(fig 5). Bacterial lipopolysaccharides (LPS) and IFN­g are used 
to activate these cells. Activated MNC release IL­1, TNF­a and 
other biologically active compounds. 
This co­culture system is a model for inflammatory cell/connec­
tive tissue cell interactions. The chondrocytes show a normal 
PG­metabol ism when they rest on non­activated MNC. When the 
same chondrocytes rest on LPS­activated MNC, which release 
abundant amounts of cytokines in the nutrient medium, their PG­
metabol ism is greatly disturbed. They stop synthesizing PG and 
release metalloproteinases which destroy the formerly synthe­
sized PG. 
7­ DEVELOPMENT OF IMMORTALIZED CHONDROCYTE CLONES ORIGINATING 
FROM DIFFERENT HUMAN SUBJECTS. 
Transfections were performed on human chondrocytes originating 
from 7 different donors. Cells were named AMA, PAPY, HUM, DEK, 
DAC, PIF and PAF. The calcium phosphate mediated DNA transfec­
tion procedure with plasmid encoding for various oncogens was 
used. Cells were co­transfected with a plasmid carrying the Neo 
gene to allow the selection of successfully transfected cells 
in the presence of G418. G418 treatment was continued on for 
at least 3 weeks. 
One of the major difficulties was the fact that after the 
initial transformation, the cells remained in a 6 to 9 month 
latency or 'crisis' period. 
Three batches of cells (AMA, PAPY, HUM) were transfected with 
a plasmid carrying the temperature sensitive SV40 large T 
antigen. 
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AMA cells: After a 9-month latency period, 11 clones emerged 
from the transfected cells (transfection efficiency 2x10" ). 
10 of these clones have been isolated but have not adhered to 
the culture dishes as yet. 
PAPY cells: After a 6-month latency period, 21 clones emerged 
from the transfected cells (transfection efficiency 3x10" ). 
15 of these clones have been isolated and expanded. 
HUM cells: After a 6-month latency period, 30 clones emerged 
from the transfected cells (transfection efficiency 5x10 ). 
27 of these clones have been isolated and 14 of them expanded. 
Two batches of cells (DEK, DAC) were transfected with a plasmid 
encoding the SV40 large T antigen. After transfection these 
cells failed to adhere to the plastic culture dishes. Immorta-
lized clones have not been detected as yet. PIF and PAF cells 
were transfected with a plasmid encoding the c-myc and the 
Polyoma large T antigen respectively. Immortalized clones have 
not been detected as yet. 
The characterization of the clones isolated from PAPY and HUM 
cells was started recently. SV40 large T antigen was detected 
by immunofluorescence. For some clones, 100* of the cells were 
intensively labeled. For others, labeling intensity varied 
according to the observed fields. 
Indirect immunofluorescence staining for type II and I col la-
gens showed a wide variety of phenotypes (table III). These 
results will be confirmed by the study of the RNA transscripts. 
Biochemical characterization of the collagen types and of the 
PG synthesized by the chondrocytes is in progress. 
TABLE III : COLLAGEN TYPE T-ANTIGEN 
COLL II COLL I 
CLONES (5th or 6th passage) 
HUM-1,-15; PAPY-12,-14,-15 + ++ 
HUM-9 ; PAPY-6 + -+ -+ 
HUM-18,-23,-24; PAPY-4,-10 -+ -/-+ ++/+ 
PAPY-7 -+ -+ -+ 
HUM-2,-3,-16,-25,• 
PAPY-1,-2,-3,-5,-11 - - ++/+ 
HUM-19, PAPY-8,-9,-19 - - -+ 
The metabolic properties (degree of transformation) of these 
cell lines are currently investigated. 
HIGHLIGHTS/MILESTONES 
To our best knowledge, these are the first human articular car-
tilage cell (chondrocyte) lines. The cells are cultured as phe-
notypically stable articular cartilage chondrocytes in a sus-
pension culture system. They export extracellular matrix pro-
ducts typical of articular cartilage. 
WIDER CONSIDERATIONS 
Immortal ized human articular carti 1 age cells (chondrocytes) can 
be used in in vitro assay systems for the study of physio(pa-
tho)logical processes in human diseases e.g. the destruction 
of joints in rheumatic disorders. Both beneficial and deleteri-
ous effects (toxicology) of pharmacological substances on car-
tilage cells can be investigated in such a model. The need of 
using experimental animal models could be partly obviated. 
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Title: 
The risk potential of biotechnology-derived polypeptides causing nephrotoxicity based on 
assessment in human and animal renal cell lines using molecular and cellular biology 
techniques. 
Contract No: 
BIOT-CT91-0266 
Official Starting Date: 1 March, 1991 
Coordinator: Dr Peter Bach, Polytechnic of East London, London, UK. 
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Dr. Jacque Diezi, University of Lausanne, Lausanne, Switzerland. 
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Objectives: The optimization of culture conditions, functional characterization of cell 
systems, response of cells to biotechnology products and validation of new cell systems, with 
a major emphasis on the design of novel human and animal renal cell lines. Current 
objectives include tailoring new cells, fully characterising them and developing sensitive 
methods to document cell modulation by potentially toxic molecules. 
Major Problems Encountered: None 
Results: 
Use of cell lines: Groups in Dublin, Rouen and Lausanne have concentrated on LLC-PKi 
(of proximal tubular origin) and MDCK (of distal tubule and collecting duct origin). Cells 
are being characterized in terms of enzymatic profiles, growth patterns from labelled 
precursor incorporation into DNA, mRNA and protein synthesis under control conditions 
and following exposure to nephrotoxins. Receptor characterization has confirmed the 
presence of angiotensin II receptors and cell responses have been monitored by flow 
cytometry. Work is in progress on effects of atrial natriuretic peptides and novel inhibitors 
of the renin-angiotensin-aldosterone system. 
Electrophysiologicalinvestigations: Techniques for growing cells on microporous membranes 
in Dublin, Innbruck, Rouen and Lausanne have been successfully employed and 
instrumentation developed to assess immediate alterations in ion transport properties for 
both low- or high-resistance transepithelial membranes under control and test conditions. A 
dose-response relationships to effects of gentamicin and metal ions has been established 
and confirmed by enhanced fluxes of C-mannitol. This could be prevented by treatment 
with magnesium-L-aspartate hydrochloride. 
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Weakness of proximal tubular cell lines: The LLC-PKi and OK cell lines of proximal tubule 
origin have been biochemically and functionally characterized and the LLC-RKi cell line is 
under study the LLC-PKi cell line lacks of gluconeogenic function, has high glycolytic 
function and an inappropriate pattern of adenylate cyclase response to hormonal 
stimulation. OK cell line lacks expression several brushborder marker enzyme and the lack 
of methyl-0-D-glucopyranoside transport The Rouen group has thus concentrated on 
primary culture of rabbit proximal tubule cells developed under strictly controlled 
conditions because LLC-PKi or OK cells may only be partially suitable for mechanistic 
studies and extrapolation to the in vivo situation. 
Primary rabbit cell lines: Major biochemical and functional phenotypic improvements have 
been gained on primary cultures of rabbit kidney proximal tubule cells, through the 
modulation of culture medium composition and the adaptation of the cell culture 
environment The use of hormonally defined conditions, using permanent rocking 
monolayers on uncoated plastic petri dishes in a 99.5% air 0.5% CO2 atmosphere has been 
optimized in Rouen. 
Cell fusion experiments: An OK-cell subline with new properties in culture media where 
glucose is replaced by pyruvate to stabilise expression of gluconeogenesis is being 
cytogenetically and biochemically characterized in Innbruck. More recent collaboration 
between the Dublin, Rouen and Innbruck groups has addressed the goal of tailoring new 
immortal renal epithelial hybrid lines which express the sum of the properties of their in 
vivo ancestor cells. 
Fusion was performed between gluconeogenic LLC-PKi FBPase+ with OK cells using 
specific procedures to select the fusion hybridomas, which is the most crucial step. We have 
transfected a gene imparting resistant against neomycin toxicity. Cells that lack this gene will 
die in the presence of high concentrations of the antibiotic. The other selection criterion is a 
metabolic property in the non-neomycin resistant fusion partner which is absent the 
neomycin resistant cells. We have succeeded in establishing hybridoma lines between 
neomycin resistant renal cell lines with those lines expressing the property of 
gluconeogenesis, i.e. being able to grow and proliferate in the absence of glucose from the 
culture medium. Trials to fuse neomycin resistant immortal cell lines with cells freshly 
isolated from rat rabbit and man (which can be kept transiently in the absence of glucose) 
are under investigation. 
The production of hybridoma cell lines between rabbit primary culture cells LLC-PKi wild 
type OK wild type and LLC-RKi wild type has just started. To characterize the response 
pattern of our model to gentamicin, we have examined the activities of two plasma 
membrane marker enzymes, two lysosomal marker enzymes, a mitochondrial marker 
enzyme, two enzymes involved in the detoxication metabolic system, the protein and DNA 
synthesis and methylglucose transport The biochemical, metabolic and transport properties 
of the newly tailored cell lines are being characterised and their usefulness for testing the 
effects of cephalosporins and recombinant Soeptase is being investigated. 
Surrogates for glomerular and medullary cells: The London group has used 3T3 fibroblasts as 
surrogates for glomerular epithelial and medullary epithelial and interstitial cells (active 
peroxidase system). 3T3-cells are sensitive to low concentrations of chlorpromazine, the 
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mechanism of which is thought to be due to inhibition of Na+ ,K+ -ATPase-mediated active 
transport, membrane stabilization, or metabolic activation of chlorpromazine to reactive 
species. Cytotoxicity was assessed for chlorpromazine, several metabolites and analogues 
and defined in terms of the concentration required to inhibit mitochondrial reduction by 
50% (IC50). The metabolite 7,8-dihydroxychlorpromazine and the analogue 
nor-1-chlorpromazine had greater cytotoxic (IC50 of 2uM and 5uM respectively) than 
chlorpromazine, 6,9-dihydroxychlorproraazine and 7-hydroxychlorpromazine HC1 (all about 
15uM). The remaining compounds were less cytotoxic (IC50 100-1000uM or > lOOOuM). 
The structural feature that are essential for cytotoxicity include the 
N,N-dimethylpropanamine moiety and either an unoxidised 6,7,8,9-ring, or 6,9-dihydroxy 
groups. Other data which suggest mat oxidative metabolism is the key to chlorpromazine's 
cytotoxicity are the protective effects of vitamin E, L-ascorbic acid and glutathione, and to a 
lesser extent ethoxyquin and catalase. 
Human mesangial cells: Workers in Giessen, Hannover and Koln have concentrated on 
human glomerular mesangial cells. These provide a useful in vitro model to study the 
metabolism by which fibronectin is released from cells and incorporated into the 
extracellular matrix, and then degraded as indicated by fibronectin fragments in the 
extracellular culture compartments. Exposure of cultured human glomerular mesangial cells 
to adriamycin resulted in an accumulation of newly synthesized fibronectin in both the 
culture medium and the extracellular matrix. This is assumed to be due to an inhibition of 
fibronectin degrading proteinases rather than an increased fibronectin synthesis. This is 
corroborated by the diminished fibronectin fragments in the culture medium and by the 
unchanged fibronectin-mRNA level of adriamycin-treated human glomerular mesangial 
cells. This suggests that the extracellular environment modulates fibronectin expression via 
direct cell-matrix interactions. 
Similarly work from Hannover on isolated hagfish glomeruli indicate that adriamycin 
reduced the aminoacid uptake into glomerular cells, due to adriamycin effects on 
membrane components, but increased aminoacid incorporation into glomerular proteins 
was increased. This was possibly due to metabolic disturbances in protein synthesis and/or 
protein degradation, with no concomitant increase in RNA-synthesis. These in vitro findings 
from human glomerular mesangial cells and isolated fish glomeruli confirm in vivo data on 
adriamycin-treated rats where a loss of urinary fibronectin-degradation products are of renal 
orign are an early marker for degenerative functional changes. 
Higher order systems: In Lausanne isolated S2 segments of rabbit proximal tubules are being 
incubated in vitro and the effects of chemicals on the basolateral uptake of standard organic 
anions and cations investigated. The technique is being validated with a selection of 
nephrotoxins and peptide effects will be evaluated. 
Specialised techniques: In Dublin flow cytometer (using fluorescein diacetate and propidium 
iodide) has been used to assess cell viability after exposure to nephrotoxins. The technique 
is objective, accurate and provides instant statistical analysis of cell responses. Other probes 
such as Semi-Naptho-Rhoda-Fluor (SNARF-1) fluorochrome shows that intracellular pH is 
reduced in both LLC-PK1 and MDCK cells exposed to gentamicin and Indo-IAM indicates 
an increase in [Ca]i. Flow cytometry has the potential to be used as an extremely sensitive 
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tool in monitoring initial interactions between biotechnology products and renal cells. Flow 
cytometry with appropriate antibodies will also be extremely useful in sorting cells from 
different nephron segments and also in monitoring and separating cell fusion products 
during development of new lines. The London group is developing similar probe based 
techniques to quantitate intracellaular ion changes by confocal laser microscopy. The role of 
shifts of intracellular calcium ions, measured simultaneously with membrane conductance in 
the same epithelial cell lines is going to be investigated by the Lausanne, Innbruck, Dublin 
and UK groups. 
Highlights and Milestones: The first tailored cells and cells with much improved phenotypic 
expression are being characterised biochemically and morphologically. The combined use of 
electrophysiology and fluorescent probes, and specialised biochemical and molecular 
biological techniques are giving new insight into the effects of chemicals and biotechnology 
products on cells. 
Wider Considerations: Several novel techniques and cell culture systems have already been 
developed which should allow for design of safer biotechnology-derived products and 
earlier detection of nephrotoxicity leading to more effective treatment 
Co-operative Activities: Contractors met on 7/12/1991 to discuss exchange of work and 
personnel between laboratories. The techniques of primary cell culture have been 
transferred from Dublin to Innsbruck to Dublin, and cell fusion from Innsbruck to develop 
fused primary animal and human cell lines. Characterization of new cell lines will be carried 
out in both laboratories with Innsbruck concentrating on biochemical and enzymatic 
characterization and Dublin concentrating on pharmacological and receptor 
characterization. Similar exchanges are planned with Dr. Morin, France. All BRIDGE 
groups will meet 24/4/1992 in London, at the First European Workshop on Biotechnology 
Applications for Microinjection, Microscopic Imaging and Fluorescence. 
Publications 
McGlynn, H. et al., (1991). Electrophysiological and flow cytometric studies on mechanism 
of gentamicin nephrotoxicity in cultured renal cells. Arch. Toxicol. Suppl. 15, Medical 
Toxicology, 140-143. Dublin group 
McGlynn, H., et al., (1991). Effects of gentamicin on glucose transport, transepithelial 
resistances and cell viability in established renal cell lines. Br. J. Pharmacol. Proc. 104,77P. 
Dublin group 
Soose, M., et al., (1991) Altered renal fibronectin excretion in early Adriamycin nephrosis of 
Rats. J. Pharmacol. Exp. Ther., 257:493-499. Hannover group 
Kastner, S., et al., (1991) The effects of Adriamycin and cis-platin on glomerular protein 
metabolism. Studies on the Atlantic hagfish Myxine glutinosa. Bull. Mt. Des. Isl. Biol. Lab., 
30:120-122. Hannover group 
Radermacher, J., (1991) The effect of arginine depletion on glomerular and tubular kidney 
function: Studies in the isolated perfused rat kidney. Araer. J. Physiol., 261: F779-786. 
Hannover group 
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Kastner, S., (in press) Mechanistic studies on the influence of Adriamycin on aminoacid 
uptake and aminoacid incorporation into isolated glomeruli of the Atlantic hagfish Myxine 
glutinosa. Bull. Mt. Des. Isl. Biol. Lab. 31, in press. Hannover group 
Kastner, S., et al., (1991) Metabolic studies on isolated rat glomeruli: A valuable tool to 
investigate glomeruli damage. In: Nephrotoxicity: Mechanisms, Early Diagnosis and 
Therapeutic Management, (Edit Bach, P.H., Gregg, N.J., Wilks, M.W. and Delacruz, L.), 
pp. 467-474. Marcel Dekker, New York. Hannover and London groups 
Bach, P.H. (1991) Better diagnosis and mechanistic understandings of nephrotoxicity using 
histochemistry and cytochemistry. Progress in Histochemistry and Cytochemistry, 23,178-186. 
Thomdike, J.M., Bach, P.H. and Moore, M.N. (1992) Chlorpromazine Cytotoxicity in 
3T3-Cells. Marine Environmental Research, , -. In Press London group 
Thomdike, J.M., et al., (1992) Lectin binding sites in the digestive gland of mussel. Marine 
Environmental Research, , -. In Press London group 
Wilks, M.F., et al., (1991) Effects of heavy metals on metabolic functions in isolated 
glomeruli and proximal tubule fragments. In: Nephrotoxicity: Mechanisms, Early Diagnosis 
and Therapeutic Management, (Edit Bach, P.H., Gregg, N.J., Wilks, M.W. and Delacruz, 
L.), pp. 363-366. Marcel Dekker, New York. London group 
Wilks, M.L. and Bach, P.H. (1992) Renal enzymes as the basis for alternative methods of 
safety screening in vitro and understanding the mechanism of nephrotoxicity. In: Urinary 
Enzymes in Clinical and Experimental Medicine, (Edits. Jung, K., Burchardt, U., and 
Mattenheimer, H.), pp. - . Springer-Verlag, Heidelberg. London group 
Bach, P.H. and Wilks, M.L. (1992) In vitro techniques for screening for nephrotoxicity, 
mechanism of injury and new discovery. In: In Vitro-Toxicology: An Alternative to Animal 
Testing?, (Edits. Jolles, G and Cordier, A.), pp. - . Academic Press, London. London group 
Communications 
McGuinness, S., et al., (1991). Comparison of renal tubules and slices for in vitro 
nephrotoxicity studies. Presentation at "Newer Aspects of Renal Cell Injury'. A Forefronts 
in Nephrology Symposium. International Society of Nephrology, Cape Cod, Massachusetts, 
U.S.A. Oct. 6-9, 1991. Dublin group 
McGlynn, H., et al., (1991). Flow cytometric and electrophysiological studies of gentamicin 
nephrotoxicity in renal cell lines. Presentation at 'Newer Aspects of Renal Cell Injury". A 
forefront in Nephrology Symposium. International Society of Nephrology, Cape Cod, 
Massachusetts, U.S.A. Oct. 6-9, 1991. Dublin group 
McGlynn, H. & Ryan, M.P. (1992) Models and mechanisms of gentamicin nephrotoxicity in 
cultured primary rat renal cells. Presentation at "First National Scientific Medical Meeting", 
Dublin, Ireland. March 13-14. 1992. Dublin group 
McGlynn, H., et al., (1992). Flow Cytometric assessment of gentamicin nephrotoxicity in 
established renal cell lines. Presentation at "First European Workshop on Biotechnology 
Applications of Microinjection, Microscopic Imaging and Fluorescence (BAMMIF). 
Polytechnic of East London, London, April 22-24. Dublin group 
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TITLE: Analysis of gene transfer between microorganisms and plants 
CONTRACT NUMBER: BIO-CT91-0282 (SSMA) 
OFFICIAL STARTING DATE: 1 October, 1991 
COORDINATOR: Charles Thompson, Institut Pasteur (IP), Paris, France 
PARTICIPANTS: 
R. Guerrero, University of Barcelona (UBA) SPAIN 
A. Puehler, University of Bielefeld (UBI), GERMANY 
P. Simonet, University Claude Bernard (UCB) FRANCE 
A. Tsiftsoglou, University of Thessaloniki (UT) GREECE 
M. Lebrun, Rhone Poulenc Agrochimie (RPA) FRANCE 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Not formalized. 
MAJOR PROBLEMS ENCOUNTERED: 
Work on the projects outlined in our proposal has been initiated in several 
laboratories but it should be noted that delays in receipts of funding has meant that most 
participants have not been able to start work prompdy. 
RESULTS: 
We are interested in the exploring the possibility that genetic information can 
transfer horizontally between distantly related organisms. A better understanding of this 
question is necessary in order to establish rules for for biological containment of 
genetically manipulated organisms which are consistent with potential hazards to man 
and the environment. We would like to establish both genetic and physiochemical factors 
which affect gene transfer both under well controlled conditions in the laboratory and in 
the natural environment. Our studies are designed to understand more about possible 
mechanisms which allow DNA transfer including conjugation, transformation, or 
unknown processes which might allow gene transfer between plants and microbes. In 
order to monitor gene transfer, the following genes were engineered to allow selection in 
bacteria and/or plant cells: 
- aacCl, the gentamicin acetyl transferase-3-I gene, mediates gemamicin (Gm) 
resistance in a broad range of Gram-positive and Gram-negative bacteria 
-pat, the phosphinothricin N-acetyltransferase gene, confers resistance to 
phosphinothricin itself (Pt) or phosphinothricin incorporated into a tripeptide (Ptt, 
bialaphos). pat has been modified to contain prokaryotic or eukaryotic 
transcriptional and translational sequences to allow expression in plants as well as 
bacteria (UBI) 
- nptll, the aminoglycoside phosphotransferase, confers resistance to neomycin, 
kanamycin, G418 
I. Effects of environmental conditions on conjugative gene transfer 
(UBA) 
Various physio/chemical factors such as water content, pH, temperature, as well as 
nutritional conditions may effect the efficiency of conjugation. Effects of these 
parameters on genetic exchange between Rhizobium meliloti and Escherichia coli in a soil 
environment are ongoing. Studies carried out under an previous BAP project had shown 
that soil water content influenced gene transfer frequency probably as a result of limited 
bacterial mobility in non-fluid conditions. 
In an extension of this work, we are now measuring the effects of pH and the 
nutritional conditions on rates of dispersion of E. coli and R. meliloti in soil. Dispersion 
- 2 9 0 -
rates of R. meliloti were were altered only at highly acidic or alkaline conditions over a 
pH range between 3 and 9 whereas E. coli strains showed a more stenotopic response. 
Both species displayed maximal frequencies of gene transfer at neutral pH. 
Adverse environmental condition probably exert their effects on gene transfer, at 
least partially, by altering the the metabolism of the bacteria. Polyhydroxyalkanoate 
(PHA), an energy and carbon polymeric reserve compound in most bacteria, has proven 
to be to be a good indicator of physiological state of microbial communities under natural 
conditions. The level of cellular PHA content is directly related to growth in soil 
ecosystems. In addition, there is some evidence that membrane-bound PHA could play a 
role in entry of DNA molecules into the cell. Our preliminary results show that R. 
meliloti cells having higher PHA levels show slightly higher gene transfer rates in 
intraspecific conjugation experiments. These results must be confirmed and tested in a 
soil microcosm. 
II. Bacterial conjugative mechanisms (IP, UT) 
Soil rhizospheres are largely populated by Actinomyces, Rhizobium, and 
Agrobacterium. We are now studying mechanisms by which these bacteria might 
transfer genetic material among themselves (intraspecifically and interspecifically) or 
with the plant roots. 
Previous studies (BAP, IP) demonstrated that Gram-negative bacteria (E. coli) can 
transfer genetic material to Gram-positive bacteria (Streptomyces and Mycobacteria). 
These RP4 and RSF1010 conjugative processes rely on some specific transfer functions 
supplied in trans as well as an origin of transfer carried by the conjugative plasmid. More 
recendy, electron microscopic studies have been undertaken in order to visualize how 
these genetic exchanges occur. Electron micrographs of mixtures of 5. lividans and E. 
coli or Mycobacterium smegmatis and E. coli under conditions where conjugation is 
taking place have revealed bridges between the two organisms. The structure of these 
points of contact suggest a fusion-like event which may allow mixing of the two 
cytoplasms or even genetic recombination between the two organisms. However, these 
points of contact between Gram-positive actinomycetes and Gram-negative E. coli are not 
dependent on plasmid-specific transfer functions. Genetic evidence (Institut Pasteur) has 
indicated that similar fusion events can take place between Streptomycetes strains. 
Apparently, these fusion events, in conjunction with plasmid fertility genes, allow 
chromosomal recombination. We are now pursuing studies of streptomycete plasmid 
genes (pIJlOl) which either induce recombination directly or possibly in conjunction 
with chromosomal genes. 
We have developed methods for analyzing possible gene transfer between 
agriculturally important organisms. Previous studies carried out under the previous BAP 
project (UBA, UT) have indicated that the aacCl gentamicin acetyltransferase gene can be 
transferred by conjugation from genetically engineered Rhizobium leguminosarum VF3a-c 
into plasmidless Agrobacterium tumefaciens via an RP4 mobilizing element. Attempts to 
transfer the gene from this recipient into R. leguminosarum and Pseudomonas syringae in 
the absence of the RP4 mobilizing system have revealed that no efficient gene exchange 
occurs. 
Presendy, we (UT) are pursuing these studies using as recipients our own soil 
isolates of A. tumefaciens. We have characterized these isolates both genetically 
(antibiotic resistance spectrum) and genetically by DNA analyses. In addition, we have 
begun to to define experimental conditions for conjugation experiments which will be 
carried out under both laboratory and field conditions. Transfer of the aacCl gene will be 
detected both by selecting for gentamicin resistance and by hybridization using the aacCl 
gene as a probe. 
III. Plant-bacteria transfer - Investigation of possible gene transfer from 
Niconiana tabacum to Agrobacterium tumefaciens (UBI, RPA) 
Interkingdom gene transfer is a potential risk factor to be considered when 
genetically manipulated plants are released into the environment. The A. tumefaciens-
induced callus is a natural environment where the close contact between bacteria and plant 
cells, creates conditions which might favour potential horizontal transfer of genetic 
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material. The transfer of genes from Nicotinana tabacum to the A. tumefaciens cells 
within the callus is currently under investigation. 
Leaf-discs of the wild type N. tabacum were infected with A. tumefaciens 
containing the plasmid pIV16.41-G. This plasmid contains aacCI, pat, and nptll genes. 
The regenerated shoots were placed on rooting medium (supplemented with Pt) to induce 
root formation. The stems of the plants were infected with A. tumefaciens (gentamicin 
sensitive) to induce calli formation. Nine calli were excised aseptically and plated on 
medium supplemented with gentamicin to select for potentially recombinant bacteria 
which might have received the aacCI gene from the tobacco cells in the callus. In all 
more than 10^ A. tumefaciens cells were recovered from the callus and a total of 429 
were gentamicin resistant. When these colonies were screened using aacCI as a 
hybridization probe, 26 gave positive signals These results need to be confirmed by 
more precise Southern blot hybridization experiments. 
Similar experiments are being planned for field trials in France. We are in the 
process of submitting a request to the French "Commission du Genie Biomoleculaire" in 
order to get authorization for field release of these transgenic plants in 1992. Field trials 
are planned for 1992 at RPA's experimental farm facility in Bergerac region of France. 
IV. Characterization of DNA/soil interactions and and its influence on 
transformation of plants and bacteria in the soil (UCB). 
There is very little information available related to what happens to DNA released 
from lysed organisms in the soil. The stability of this DNA as well as its efficiency in 
processes of natural transformation of other organisms must be a function of soil 
chemistry. 
We will investigate both physical interactions and reactivity of DNA with different 
soil components. Investigations will be focused on the relationships between DNA 
molecules and soil particles such as clay minerals and humic acids. Preliminary studies 
indicate that efficiency of DNA adsorption onto soil particles is related to to surface 
characteristics such as charge, hydrophobicity, and microaggregate formation. 
Adsorption of DNA on clay minerals, a major component of soil, will be investigated in 
the future using an adsorption isotherm technique. Parameters such as DNA 
concentration and chemical composition of the environment (presence of cations) will be 
studied. In order to investigate the natural fate of clay-adsorbed DNA in the soil, we will 
investigate the role of adsorption in protecting DNA against nucleolytic activities that 
would naturally exist in the soil. We will also determined whether adsorbed DNA 
remains active for transformation of microorganisms. This will be done using an 
artificial model composed of chromosomal or plasmid DNA, montmorillonite, DNasel 
and competent E. coli cells. We expect that studies outlined above will allow us to 
optimize conditions for recovery of DNA from the soil by chemical techniques or by 
transformation of a microbial host 
HIGHLIGHTS/MILESTONES: 
Although the results need to be confirmed by more precise hybridization 
experiments, it is very interesting to note at this preliminary stage that the UBI team has 
recovered Agrobacterium tumefaciens strains from tobacco calli which may may have 
received an antibiotic resistance gene as a result of horizontal interkingdom DNA transfer 
from plant to bacteria. 
Nothing to report. 
Nothing to report. 
WIDER CONSIDERATIONS: 
COOPERATIVE ACTIVITIES: 
LIST OF PUBLICATIONS/PATENTS WITH TRANS-NATIONAL 
AUTHORSHIP: 
Nothing to report. 
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TITLE : Fate of GEM'S and GEDS in some environmental hot spots : 
polluted soils, river sediments, decaying and diseased plants, 
role of broad host range plasmids and development of 
containment systems. 
CONTRACT NUMBER : BIOT - CT91 - 0284 (SSMA). 
OFFICIAL STARTING DATE : 1/10/1991. 
COÖRDINATOR : Dr. Max Mergeay, V.I.T.O.. 2400 Mol, Belgium. 
PARTICIPANTS : Dr. John Fry, University of Wales, Cardiff. UK. 
Dr. José Marques, I.B.E.T., Oeiras, Portugal. 
Dr. Willy Verstraete, University of Gent, Gent, Belgium. 
OBJECTIVES SET FOR THE REPORTED PERIOD : 
a) Monitoring of the fate of GEM'S and GEDS in potential 
environmental hot spots with special emphasis on the role of 
broad host range (BHR) plasmids. 
- Construction of GEM's and GEDS. 
- Monitoring of their fate in the microcosms. 
b) Study of the genetic transfer potential in the environmental 
hot spots using 'exogenous plasmid isolation*. 
c) Development of a rapid method for total extraction of DNA from 
soils. 
d) Development of bacterial containment systems. 
MAJOR PROBLEMS ENCOUNTERED : No significant scientific problems to be 
reported. 
RESULTS : 
a) Construction of GEM's and GEDS. 
Different GEM's and GEDS were constructed which will be used in the 
different microcosms to study gene escape. The GEM's contain marker 
genes based on heavy metal resistance and organic xenobiotioc 
degradation. The genes have been cloned and will be cloned in different 
replicons (Tra~Mob vector, Tra'Mob vector, chromosome) in the GEM's 
which include E. coli and P. putida. as models for accidental and 
deliberate release respectively. 
The czc (encoding resistance to cadmium, zinc and cobalt) and cnr 
(encoding resistance to cobalt and nickel) operons derived from 
Alcaligenes eutrophus CH34 were cloned in 1) a pBR322 based vector 
(ColEl,Tr^ ,Mob") 2) RSF1010 (IncQ) and 3) RP4 (IncPl) based vectors 
(Tra",Mob ) by the group of Mol and have been introduced in E. coli and 
P. putida (Tablel). These genes are not expressed in E^ coli and P. 
putida but are expressed if they are to be transferred into A. 
eutrophus. As such, the heavy metal resistance genes can be used as 
useful marker genes to study gene transfer from P. putida and E. coli to 
A. eutrophus in microcosms as they allow the use of very selective media 
against donor and the natural microbial population (also through a 
combination of selective metals). 
On the other hand, in order to study the escape of genes from an 
introduced micro-organism to the indigenous micropopulation, marker 
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genes are needed which are expressed in a broad range of bacteria. Genes 
encoding resistance to mercury (mer) and encoding the meta-cleavage of 
2,3-dihydroxybiphenyl (bphC) or catechol (tdnC) into a easily detectable 
yellow cleavage product were found to be expressed in a wide range of 
bacteria at least in the p- and 7-subgroup of the Proteobacteria 
(Cardiff, Mol). 
The biphenyl degradative genes of A. eutrophus A5 were found to be borne 
on a large transposable element, TnA371. The bphC gene of the pathway 
was cloned in pRK415 (IncPl, Tra , Mob , Tc ) by the group of Mol and 
subcloning is going on. The tdnC gene of P. putida and mer gene were 
cloned together on a Tn_5 transposon by the group of Cardiff and were 
used to mark broad host range (BHR) plasmids. 
b) Study of gene transfer in the microcosms. 
The transfer from E. coli to A. eutrophus of Mob'Tra and Mob'Tra" 
plasmids carrying the czc genes encoding resistance to cobalt, cadmium 
and zinc as marker genes (see above) was studied in unpolluted and heavy 
metal polluted soil microcosms by the group of Gent as a model to study 
the risks associated with accidental release of GEM's. Special emphasis 
was put on the presence of BHR plasmids in the microcosms. 
Direct transfer of the non-conjugative plasmid pDN705 
(pRK290: :czc;IncPl; Tra'Mob ;Tc ) from an E. coli strain harbouring the 
TRA-genes of RP4 in the chromosome to A. eutrophus was observed in 
polluted and non-polluted soils in sterile as well as in non-sterile 
conditions . Whereas in sterile conditions the presence of heavy metals 
in the soil did stimulate the formation of transconjugants, this was not 
the case in natural conditions. Moreover, only when nutrients were added 
to the soil, transconjugants were detected under natural conditions. 
Furthermore, in sterile conditions, it was shown that the IncPl plasmid, 
RP4, was able to mobilize plasmid pM0L155 (pKT210::czc; IncQ; Tra'Mob ; 
Cm ) by direct transfer, in triparental matings and by retromobilization 
from E. coli to A. eutrophus. as well in unpolluted as heavy metal 
polluted soils. Moreover, the presence of a selective pressure i.e. the 
presence of heavy metals in the polluted soils again stimulated the 
formation of transconjugants. 
In addition, it was shown that the czc heavy metal resistance marker 
cloned in pBR322 (-pM0L!A9: pBR322 ■•: czc; ColEl; Tra~Mob~ ;Tcr; Apf) can be 
picked up by plasmid RP4::Mu3A in E. coli and transferred to A. 
eutrophus in triparental matings and by retromobilization in sterile 
soil microcosms. Again a positive effect was observed in heavy metal 
polluted soils. These results emphasize the role of transposons and that 
even genes on a Mob plasmid can be transferred towards other strains in 
soil conditions. 
Several bacterial systems were evaluated for use as donor-recipient 
pairs by the group of Oeiras. A pair of E. coli K12 strains (XL-2 and 
RB85) was chosen for further "accidental release' studies. Strain XL2 
bears an F* plasmid conferring tetracyclin resistance and strain RB85 is 
streptomycin resistant. The strains were used to study the colonizing 
patterns on the roots of maize and the level of transconjugant 
formation. Results suggest" differences in spatial and temporal 
colonization patterns of the two strains. This may explain the low 
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frequency of transfer over roots detected with this system. In future 
studies, the E. coli and P. putida GEMS and gene escape system 
constructed by Mol will be assessed in the plant-soil microcosms. 
c) Study of the genetic transfer potential in the environmental hot 
spots using 'exogenous plasmid isolation*. 
Experiments were done to isolate BHR plasmids from some of the proposed 
environmental hot spots i.e. River Taff epilithon (Cardiff) and organic 
polluted soils and sludges (Gent) by exogenous plasmid isolation. 
Exogenous plasmid isolation is a technique that isolates plasmids from 
mixed bacterial communities by transfer into a known recipient during 
mating on filters. 
Plasmids were isolated from the river epilithon by the group of Cardiff 
using 9 recipient strains : 5 strains of P. putida. 2 strains of P. 
aeruginosa , 1 strain of E. coli and 1 strains of A. calcoaceticus. 
Mercury resistance was used as a selective marker. The recipients 
received plasmids from the epilithic bacteria although with various 
transfer frequencies. Most of the plasmids were very large (50-300 kb) 
and a few very small (<10 kb), but none were between 10 kb and 30 kb. 
15 (.21*1) of the isolated plasmids in E. coli were capable to transfer to 
E. coli and P. putida. 
To test the host range, transfers of two of the isolated plasmids 
(pQM705,52 kb and pQM706, 55 kb) were carried out (Table2) from P. 
putida into a variety of recipient bacteria selected on their position 
in the 16S rRNA evolutionary tree. Two other BHR plasmids were used for 
comparison : another natural epilithic plasmid (pQKH6) and a marked RP1 
derivative designated as pQM899 (- RP1: :Tn5: :mer: :tdnC). pQM899 
transferred most widely and was found to transfer even into the 
distantly related Cythophaga heparina. pQM706 and pQKH6 transferred into 
almost all the proteobacteria but not to Cytophaga heparina. None 
transferred into the Gram + bacteria tested. Natural BHR plasmids are 
thus present in river epilithon. 
Exogenous isolation of plasmids from polluted soils and activated sludge 
was done by the group of Gent. They used a modification of the procedure 
used by Cardiff. The plasmids were isolated by means of triparental 
matings in which the indigenous microbial population delivers mobilizing 
plasmids to mobilize pM0L155 (see above) from E. coli to a Rifr A. 
eutrophus recipient strain. Using this procedure, several mobilizing 
plasmids were isolated from organic polluted soils and their 
characterization is going on. Moreover, several plasmids were isolated 
from activated sludge. They all had a size of around 60 kb, were able to 
mobilize pM0L155 and to self-transfer from A. eutrophus to E. coli and 
showed Tc, Ap and Kn resistance. 
d) Development of a rapid method for total extraction of DNA from soils. 
To study the transfer of genes from released bacteria into the natural 
population and in particular to none-culturable bacteria, total DNA 
extraction and the use of appropriate probes and PCR may be a suitable 
way. Therefore, a rapid method was developed to purify DNA from soils 
by the group of Mol. The procedure takes no longer than 3 hours and the 
purified DNA can be used for DNA-DNA hybridization. The detection limit 
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for a single chromosomal target gene-carrying bacterium is 100 000 
CFU/0.5 gram of soil. Experiments are going on to see if the extracted 
DNA is applicable for PCR to lower the detection limit. 
e) Development of bacterial containment systems. 
The presence of natural broad host range plasmids in the environment may 
represent an enhanced risk considering the escape of genes from 
introduced GEM's as they may be able to invade the GEM and to pick up 
genes from it e.g. by means of retrotransfer. Therefore, the use of 
bacterial strains deficient in conjugation exchange (unable to be 
invaded by BHR plasmids) might be interesting to decrease the risks. 
A mutant of E. coli ED8739, defective in conjugation with a P-type donor 
(ConP ) was isolated by the group of Mol. The mutant was shown to be 50 
to 100 times less efficient as recipient in conjugations with an IncPl 
trans- fer system but was not affected in transformation efficiency nor 
in the capacity to maintain plasmids. Moreover, the Con P mutant was 
conjugation-proficient for IncW plasmids and was not affected in its 
donor capacities for IncPl plasmids. 
A mutant of P. aeruginosa impaired in survival (sss) was isolated by the 
group of Gent. This mutant shows promisses for a possible containment 
system. 
HIGHLIGHTS/MILESTONES : 
1. Retrotransfer of a Mob Tra pBR- plasmid into soilbacteria by means 
of a IncPl BHR plasmid in soil microcosms (RP4::Mu3A). 
2. Isolation of new BHR plasmids from river epilithon which can play a 
role in gene transfer in the river (RP1::Tn5::mer::tdnC). 
3. Transfer of the IncPl BHR plasmid RP1 into Cytophaga. 
4. Isolation of a mutant of E. coli defective in conjugation with a 
P-type donor (towards a possible containment system) 
WIDER CONSIDERATIONS : The present of BHR plasmids (especially those 
provided with efficient transposons) in a soil microflora do influence 
the dissemination of genes cloned in pBR-vectors. This puts a limit on 
the safety of such vectors. 
COOPERATIVE ACTIONS : A first meeting was hold in Mol (19/3/1992) 
attended by all partners to discuss practical details and time table the 
progress of the work, exchanges of people, organisms and methodologies 
etc. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL AUTHORSHIP : 
Work in progress. 
OTHER PUBLICATIONS/PATENTS . 
Isolation of a mutant defective in conjugation with a P-type donor 
(ConP") that is lacking the major outer membrane protein OmpF. D. van 
der Lelie, E. Top, G. Nuyts and M. Mergeay; submitted to Microbial 
Releases. 
Characteriration of the retrotransfer phenomenon using mechanistic 
mathematical modeling. E. Top, P. Vanrolleghem, M. Mergeay and W. 
Verstraete; submitted to Journal of Bacteriology. 
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Characterization of the retromobilization phenomenon by use of a mutant 
defective in conjugation with a Pl-type donor (ConPl). E. Top, D. van 
der Lelie, W. Vertstraete and M. Mergeay; submitted to Microbial 
Releases. 
Identification of a transposable element, Tn4371. encoding biphenyl and 
4-chlorobiphenyl degradation in A. eutrophus A5. D. Springael, S. Kreps 
and M. Mergeay; submitted to Journal of Bacteriology. 
Table 1 : GEM'S and GEDS for accidental release based on heavy metal 
resistance genes (Mol). 
Fragment Cloned Inc group Resulting 
genotype 
czc 
czc 
cnr 
cnr 
pBR325 
pRK290 
pKT210 
pKT210 
pRK415 
pKTZIO 
ColEl 
P 
plasmid 
pMOL149 
pDN705 
pMOL155 
pMOL155 
pM0L154 
PMOL164 
Vector 
markers 
Tc, Ap 
Tc 
Cm 
Tc 
Cm 
E. coli Application 
Host 
HB101 Mob",Tra" 
S17/1 Mob",Tra 
direct 
transfer 
S17/1 Mob'.Tra 
direct 
transfer 
BHB2600 Mob",Tra 
trip.mating 
retro-
transfer 
S17/1 direct 
transfer 
DH5 retro-
transfer 
Table 2 : Host range of some BHR plasmids from epilithic bacteria 
Transfers were from P. putida UWC3 on membrane filters with Plate Count 
Agar into rifampicin resistant recipients at 30° C for 24 h; nd = not 
yet done. 
Mean transfer frequency per recipient (n-2) for 
Recipient 
Comamonas acidovorans 
Pseudomonas putida 
Pseudomonas cepacea 
Pseudomonas maltophilia 
Acinetobacter 
Calcoaceticus 
Alcaligenes eutrophus 
Cytophaga heparina 
Escherichia coli 
Rhizobium leguminosarum 
Proteo-
bacteria 
group 
P-l 
r-3 
0-2 
r-3 
r-3 
0-2 • 
FLAVO 
r-3 
a-2 
PQKH6 
1.7x10"? 
7.0x10 * 
2.5x10 
3.6xl0"„ 
1.6x10 
i.8xio"j: 
<2.2xl0"* 
1.4x10"^ 
5.4x10 
PQM705 
nd 
3.0x10 
nd 
nd 
3.2x10 
nd 
n d -2 4.0x10 
nd 
PQM706 
1.2x10"* 
3.7x10 ° 
1.2x10"": 
1.7x10", 
2.4x10 
2.1x10"* 
<l.lxl0 
3.1x10" 
nd 
PQM899 
9.4x10"^ 
3.7x10 * 
S.Sxlo""' 
4.5x10"* 
4.2x10 
3.8x10"* 
1.6x10"* 
1.5x10" 
1.3x10" 
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Title The effects of selection on gene stability and transfer in populations of bacteria 
in soil. 
Contract number BIOT 910285 
Official starting date: 1/10/91 
Coordinator: 
Dr E. M. Wellington, Biol. Sci., Univ. Warwick, Coventry. CV4 7AL U.K. 
Participants: Dr. A. Karagouni, Inst. Gen. Bot., Univ. of Athens, 15784 Athens. GR , 
Dr. A. Akkermans, Dept. Microbiol., Agricultural Univ., Wageningen, N L 
Objectives set for the period of reporting 
The primary aim for the first 6 months was to obtain and distribute amoungst the 
participants, genetically marked Streptomycetes. Genes for antibiotic resistance to 
thiostrepton and neomycin/kanamycin were sought as these antibiotics had been selected for 
subsequent soil enrichments. The second objective was the development of a soil 
microcosm system which required the selection and characterisation of soil at specified sites 
by each participant, and use of batch, fed-batch and continuous microcosms with methods 
for the extraction of bacteria and antibiotics from the soil. The characterisation of selected 
soils, to be used throughout the two year study period, involved physical, chemical and 
biological study. The latter required assessment of indigenous resistance levels to 
thiostrepton and neomycin in streptomycete populations. 
The antibiotic extraction techniques were required for detection and identification of 
antibiotics produced in soil and added to soil. As the former was known to be very low, a 
high level of sensitivity was required. 
Cell extractions were required for monitoring both populations and DNA in soil. The aim 
here was to enable monitoring of cell replication during sporulation. Thus methods 
allowing differentiation of spores and vegetative cells were needed to determine if the fed-
batch and continuous microcosms were allowing rounds of replication. Molecular methods 
were intended as a secondary source of information concerning the fate of introduced 
genes. In this case differential extraction of DNA from spores and vegetative cells was 
needed together with exploitation of polymerase chain reaction (PCR) to improve 
sensitivity for detection of genetic markers. 
Division of labour: Each participant was responsible for development of a microcosm 
system and the workload for construction of strains was divided between Warwick and 
Wageningen, the former was responsible for development of chromosomal and plasmid 
markers and the latter for transposons (introduction of transposons on the chromosome and 
in plasmids). Warwick was responsible for developing methods for the extraction of 
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thiostrepton and athens and Wageningen for extraction of neomycin from soil. 
Major prpHrtpm encountered 
A present no major problems have been encounted, except that transposons were found to 
be extremely unstable and an alternative strategy for chromosomal marking was developed. 
This involved the use of the plasmid series pGM (Muth a al. 1989) which allow insertion 
of markers into the streptomycete chromosome as these plasmids act suicide vectors, unable 
to replicate at 35°C. At present plasmids are being constructed with chromosomal 
fragments to allow integration at specific sites. 
Results 
1) Selection of marked strains : The plasmid pIJ673 was stabily inherited in strains selected 
from the different sites and was selected for all studies. It carries both tsr and aphU. genes 
for resistance to the target antibiotics thiostrepton and neomycin. Greek isolates were 
transformed with plasmid DNA and selection of transformants is still in progress. 
Attempts were made to obtain transposon marked strains but all were found to be too 
unstable for use. Because of this problem an alternative strategy has been devised. This 
involved the use of integrating plasmids, specifically pGM4 and pGM9 (Muth et al. 1989). 
These plasmids are stably inherited at temperatures below 34°C, but are lost at incubation 
temperatures above this, allowing insertion of markers into the streptomycete chromosome. 
The effect of addition of antibiotics to soil can also be used to assess the retardation effect 
on loss of these plasmids. 
At Warwick a strain of S.lividans (TK64 KT) (P. Kaiser, pers. comm) which contains a 
chromosomal amplification containing both the tsr and aphU genes has been chosen for 
study. 
2) Characterisation of soil: Work has begun to assess local soil streptomycete populations 
from Warwick, Wageningen and Athens with respect to antibiotic resistances. Resistance to 
thiostrepton in the indigenous population has not been found in Wageningen, but in 
Warwick soil low levels were observed (resistance to 0.5 /tg/ml thiostrepton). Up to 10% 
of Wageningen indigenous soil streptomycetes expressed resistance to neomycin (1-10 
pg/mi) and at Warwick a small population of streptomycetes were kanamycin resistance up 
to 100 fig/ml. 
Resistant streptomycetes have were isolated and these will be probed using the aptil, aphU 
and aphV genes in Wageningen, the tsr and aphO. genes in Athens and the dag, tsr and 
aphll genes at Warwick. This probing should allow the determination of the origin of 
resistance phenotypes in these streptomycetes. 
In addition to analysis of the indigenous streptomycete population, soil from each 
laboratory has been subject to physicochemical analysis, wetting and drying curves and 
water holding capacity studies. 
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3) Development of fed-batch and continuous microcosms: In order for selection to be 
effected by an antibiotic it is necessary for a streptomycete to be in the active mycelial 
state. It is of great importance to determine the morphological state of this organism in situ. 
Many workers have shown that in soil Streptomyces species are almost entirely present as 
spores, which are by their nature resistant to antibiotics being investigated in this study. In 
addition, when streptomycete spores are added to natural soil, only a brief period of limited 
germination occurs, followed by an almost indefinate period of residence as spores. To 
overcome this problem, fed-batch microcosm systems were developed that resulted in 
repetitious rounds of germination induced after the initial period of activity. This involves 
feeding the system with nutrients as well as adding more soil in order to provide a habitat 
for the inoculated streptomycetes to colonise. 
In both Warwick and Wageningen fed-batch systems are being investigated. In Wageningen 
nutrient amendment, without soil replacement, was studied, whereas in Warwick and 
Athens between 10-20% of soil from microcosms was continually replaced at set intervals 
over a time period of several weeks, while ensuring that percentage water in the system 
remains constant. In Warwick, to date, this work has meant that continuous rounds of 
germination occurred, a phenomenon not observed in previous fed-batch systems (Fig. 1). 
Continuous rounds of germination were possible and antibiotic induced selection could be 
implemented during these cycles of activity. 
- A — I 
1> 14 1« » 
Streptomyces 
livkJansTK24 
Time (days) 
8pona * mycall 
B — *2".. 
Fig 1. Iterative germination and sporulation in the dynamic fed-batch soil system. 
In addition to fed-batch systems both Athens and Warwick are developing continuous 
microcosms, in which it is hoped that liquid nutrients (containing antibiotics if appropriate) 
can be added continuously to a soil body allowing, in addition to nutrient replacement, the 
leaching of spores for counting and possibly the continuous availability of micro-habitats 
for colonisation by the streptomycetes. 
4) Extraction and analysis ofbiomass and antibiotics from soil: All three laboratories are 
developing methods to monitor antibiotic concentration and stability in soil. While 
Wageningen has only recently begun to study the fate of neomycin in soil, Warwick has 
spent several months developing existing methods for thiostrepton detection and 
quantification. This method involved recovery of the antibiotic from soil using a solvent, a 
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number of which are presently under study, including chloroform, acetic acid and ethyl 
acetate, and subsequent separation by TLC, HPTLC and HPLC (Fig.2). 
Fig 2. TLC plate showing extracted thiostrepton from soil. Lanes 1-3 25, 2.5 and 0.25 µg 
thiostrepton CHCI3, lanes 4-7 soil extract 0, 50, 100,500 /xg added thiostrepton, 8-10 25, 
2.5 and 0.25 ng thiostrepton, CH3COOH. 
To confirm the antimicrobial activity of thiostrepton the TLC plate was subjected to 
bioautography and placed onto an agar plate seeded with Staphylococcus aureus. Detection 
levels of thiostrepton by TLC was as low as 0.25 to 0.05 /µg, although the detection level 
from soil is yet to be determined. The detection of extracted thiostrepton from soil was 
analysed by addition of a thiostrepton-containing soil extract to filter discs on seeded agar 
plates. Detection levels for this method were around 0.5 ng thiostrepton. 
All three laboratories investigated improved methods for extraction and analysis of 
biomass. Such methods include the use of Chelex which allows the specific extraction of 
spores and bead beating which extracts DNA from both spores and mycelia within the soil. 
Both methods are being continually assessed and updated. In addition to the isolation of 
spores and mycelia, methods for extraction and monitoring of DNA were investigated. 
Once DNA has been extracted from soil, probes can be used to monitor the presence of 
specific genes within the gene pool. This has previously been achieved using J p labelled 
probes, which allow the detection of as few as 0.174 mg dry weight mycelia / g soil. 
Attempts by Warwick have recently been made to use an alternative method of probing, in 
this case the non-radioactive digoxygenin labelling kit. Initial experiments using this system 
have allowed the detection of 10 mg dry weight mycelia / g soil, although it is likely that 
this value can be considerably improved. 32p labelled probes will also be further 
investigated. 
When DNA of sufficient purity has been obtained it is hoped that PCR can be used to 
detect low levels of a marked bacterial population, theoretically down to as little as a single 
genome. Primers for use in PCR were developed, including those for the tsr, dag and aphU 
genes. At present both tsr and dag have been amplified from purified plasmid controls 
using these primers, although no detection of specific genes isolated from soil DNA has yet 
been acheived. One possible reason for this is the inhibition of the PCR reaction by 
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impurities in soil extracted DNA. Methods of "cleaning" the DNA to remove impurities 
such as humic acid from the soil are still under investigation. 
Highlights/Milestone 
Development of a new soil model microcosm,the fed-batch system, allowing continuous 
rounds of germination, previously unavailable. This will provide a more accurate and 
realistic assessment of antibiotic resistance gene transfer and stability in soil. 
Detection of antibiotics in soil, new methods for sensitive extraction and identification of 
antibiotics produced in, or added to soil. 
Wider considerations 
The role of natural or artificial selection in soil must be measured to accurately assess the 
fate of genes in the natural environment and evaluate any risks associated with new gene 
introductions. Enabling technology is being developed to study the process of selection in 
the soil within a realistic time-scale. 
Cooperative activities 
Over the past six months there has been one plenary meeting at Wageningen 8-14th Dec 
1991, all participants were involved and plasmids and strains exchanged. 
Further meeting and exchange between Warwick and Athens from 9th-llth March 1992. 
Vist made to University of Kaiserslautern, 7th-9th Feb. 1992 to obtain plasmids from Prof. 
John Cullum, previous BAP partner and obtain technical expertise. 
List of joint publications with trans-national authersbip 
Survival and detection of a bald, auxotrophic Streptomyces lividans strain in soil. 
Toth I. K., E. M. H. Wellington, A. Vionis, A. Karagouni, J. Cullum, B. Kochte-
Clemens and D. McDowell. In preparation. 
Other publications 
Factors affecting the mobility of antibiotic resistance genes within populations of 
streptomycetes in the soil. E. M. H. Wellington, I. K. Toth, N. Cresswell, P. Marsh and 
M. Schilhabel. 
Submitted for publication in Proceedings ISME6, Barcelona, Spain 1992 
References 
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SAFETY ASSESSMENT OF THE DELIBERATE RELEASE OF 
TWO MODEL TRANSGENIC CROP PLANTS, 
OILSEED RAPE AND SUGARBEET. 
CONTRACT NUMBER: BIOT-CT91-0298 
OFFICIAL STARTING DATE: 01/10/92 
COORDINATOR: 
PARTICIPANTS: 
P. Riidelsheim, Plant Genetic Systems, Gent, Belgium 
M. Renard, INRA, Le Rheu, France 
W. Stiekema, CPO, Wageningen, The Netherlands 
P. Dale, IPSR, Cambridge, United Kingdom 
A. Buchter-Larsen, Danisco, Copenhagen, Denmark 
P. Gouyon, Univeisite Paris Sud, Paris, France 
S. Waters, Monsanto Europe, Brussels, Belgium 
J. Streibig, RVAU, Frederiksberg, Denmark 
S. Jensen, NFNA, Horsholm, Denmark 
OBJECTIVES SET FOR THE 
REPORTING PERIOD: 
MAJOR PROBLEMS 
ENCOUNTERED: 
RESULTS: 
Nothing to report 
Nothing to report 
Nothing to report. Much of the work is season 
dependent and the first results are expected to become 
available after the summer of 1992. 
HIGHLIGHTS/MILESTONES: Nothing to report 
WIDER CONSIDERATIONS: 
The range and scope of activities associated with the concept of 'plant breeding' have 
increased with time and with technological advances. 
Initially, plant breeding involved only the selection of 'superior' plants and lines from 
available populations in cultivation, perhaps in land-race varieties, or in nature. Such 
selection would not now usually be regarded as plant breeding. 
Conventional plant breeding which involves the cross-fertilization of selected parents, 
followed by the systematic evaluation of the resultant large and varied plant population, is an 
increasingly scientific process. In the past two decades this process has been improved by 
biotechnological techniques. Some of these may enhance and accelerate selection techniques, 
thereby shortening timescales in plant breeding programs (e.g. cell and tissue culture and 
RFLP probes). Others may promote the health status and rates of multiplication of improved 
varieties (e.g. micro-propagation). Finally, the biotechnological techniques may broaden the 
range of germplasm available to plant breeders by making accessible, or producing, new gene 
combinations containing desirable DNA sequences not available from other sources. 
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In understanding the impact of biotechnology on plant breeding it is essential to distinguish 
between analytical techniques, such as RFLP probes, which improve the efficiency of 
selection in breeding programmes, and 'engineering techniques' which exploit 'genetic 
modification' to produce transgenic plants. 
Theoretically, it should be possible to incorporate any gene from any organism into any host 
plant. However, before recombinant DNA technology can become a generally useful technique 
for plant breeders, a number of steps have to be achieved. These include: 
(i) gene identification 
(ii) isolation of specific DNA sequences 
(iii) DNA cloning 
(iv) transfer of DNA sequences 
(v) plant regeneration 
(vi) appropriate gene expression in transformed plants 
(vii) sexual transmission of the trait 
A number of genes controlling protein quality have been identified and isolated, and the 
genetic modification of seed quality genes is now becoming a reality. 
The incorporation of resistance to pests, diseases and herbicides is also showing promise. 
However, it is quite clear that genetic modification technology is not a substitute for 
conventional breeding but complementary to it. Once new genes have been introduced into 
a species, the plant breeder still has to carry out the painstaking and time consuming process 
of selection and multiplication. 
In contrast to most new technologies, guidelines, regulations and in some cases legislation 
have been set up (e.g. by the EC, USA, Japan) to control the scientific and commercial 
development of biotechnological products. There exists public concern, and corresponding 
demands for biosafety assessments. In the EC, Council Directive 90/220/EEC on the 
deliberate release of genetically modified organisms describes the regulatory framework 
within which such releases can be authorized. The potential and limitations of the new 
technologies are as yet not fully appreciated and there is therefore a demand for the 
precautionary approach reflected in such regulation. 
The organization for Economic Cooperation and Development (OECD) has also provided an 
international forum for its 24 members (all the major developed countries) to discuss and 
formulate common approaches and principles. 
In particular litde is known about the relative performance of modified and non-modified 
plants in the field. Therefore, under the BAP and BRIDGE initiative, the Commission of the 
European Communities decided to support a number of independent projects for the 
development of appropriate monitoring methods which may generally be applicable to 
genetically modified plants. A range of relevant experimental data are being gathered. At all 
stages there is close consultation between the projects and national competent authorities. 
Such an accumulation of data and information should enable future regulatory decisions on 
field work with genetically modified plants to be based on a detailed understanding of the 
parameters which are thought to have an effect on the survival and on the physical and 
genetic dispersal of plants and/or introduced genes in the environment 
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TITLE: STABILITY, GENETIC TRANSFER AND ECOLOGY OF FUNGI USED AS 
BIOCONTROL AGENTS 
CONTRACT NUMBER: BIOT - CT91 - 0290 (SSMA) 
OFFICIAL STARTING DATE: 01/10/1991 
COORDINATOR: RIBA GUY, INRA, Lutte biologique, GUYANCOURT, F. 
PARTICIPANTS: 
BRYGOO Y., UNTV PARIS XI, Lab. Cryptogamie, ORSAY, F. 
RHODES J., ICI, AGROCHEMICALS, Microbiology, BRACKNELL, UK 
GULLINO L., UNTV STUDI TORINO, DIVAPRA,TORINO, L 
PELSENEER-COREMANS I , ULB, Parasitologic, BRUXELLES, B. 
TURNER G., UNIV. SHEFFIELD, Mol. Biol. Biotec., SHEFFIELD, UK 
OBJECTIVES SET FOR THE PERIOD REPORTING PERIOD: 
* Genetic stability of heterologous DNA in Beaitveria 
* Stability of homologous recombinants ofBeauveria 
* Natural genetic transfer in Fusarium and Beauveria 
* Methodology for ecological studies 
MAJOR PROBLEMS ENCOUNTERED: Major problems encountered consist in : 
* the selection of the most informative and reproductible molecular technics to 
fungal strain characterization 
* the karyotyping of Fusarium spp. 
* the adaptation of molecular technologies for soil microbiology 
* the adaptation of molecular technologies to study fungal populations. 
RESULTS: 
1 Genetic stability of heterologous DNA (INRA and Univ. 
PARIS XI): The strain Beauveria bassiana 147 has been transformed by 
cotransformation procedure using the glucuronidase gene from E. coli and the 
nitrate reductase gene nia D from Aspergillus nidulans. Several transformants are 
stable and their virulence is identical to that of the parental strain. Now, the 
transformants will be submitted to several cultural and environmental conditions 
defined in microcosms (INRA, ICI). 
2 Stability of homologous recombinants (SHEFFIELD Univ, 
PARIS XI, INRA, ICI): A lambda bank of Beauveria is under construction and 
several selenate resistant mutants of this species have been selected. From this 
material it is aimed to isolate the ATP sulphurylase gene of Beauveria bassiana. Then 
frequency of homologous recombination during mitotic growth and plasmid stability 
in laboratory conditions will be estimated. 
3 Natural genetic transfer (INRA, Univ. TORINO, ULB): 
A Genetic characterization First we need to characterized the strains in 
order to follow their genetic stability within a mixture of several strains. Also it is 
necessary to estimate the generic distances through the phylogenetic studies of 
strains, species and generous comparing rRNA sequences. Informative DNA probes 
are researched in Beauveria bassiana, B. brongniartii and Fusarium spp. (INRA, 
PARIS XI). After selection, 1.5 to 2 kb probes are amplified by PCR and used for 
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RFLP analysis. The molecular karyotyping of Fusarium was obtained by pulsed 
field gel electrophoresis (CHEF). Nine chromosomal bands which ranged in size 
from 1.6 to 6.3 Mb have been found (Univ. TORINO). Then characterized strains 
will be mixted in polyclonal artificial populations and submitted to controlled or 
natural conditions in order to estimate competitivity of strains, selectivity of 
environmental factors and genetic transfer. 
B Parasexuality under natural conditions: Artificial mutants (benomyl 
resistant or orange colored) have been used to study parasexual exhanges between 
antagonistic or pathogenic strains of Fusarium (Univ TORINO). 
Hypervirulent interspecific diploids have been obtained by protoplast fusion of one 
B. bassiana and one B. sulfurescens strain. Now it is engaged to estimate the 
probability for those two strains to have genetic exhange within an insect host or in 
the soil. Also the genetic stability and the competitivity of those diploids is calculated 
in microcosm and natural conditions (TNRA, ULB). 
C Transposition ainiv. PARIS XI. INRA^: Some strains of 
Fusarium have a natural genetic instability for some characters. Following the 
genetic instability of nitrate reductase gene from such strains, 3 new transposons 
have been observed. They belong to the bacterian types, however the homology 
between those 3 transposons is very low. More, studying repeated dispersed 
sequences a retro-transposon has been isolated. We are using the same strategy to 
detect transposons within Beauveria bassiana. 
4 Methodology for ecological studies (INRA, Univ. PARIS XI): 
Tagging of fungal strains required specific and susceptible technics. Investigations 
are engaged in researching specific probes, or heterologous non coding sequences 
which could be amplified and used for detection in hosts or in the soils. 
HIGHLIGHTS/MILESTONES: Three major original achievements must be underlined: 
* Discovery of new type of transposons in fungi 
* Isolation of stable interspecific hypervirulent diploids within Beauveria spp. 
* Conception of molecular technics for fungal strain characterization 
WIDER CONSIDERATIONS: The discovery of transposons and interspecific 
parasexual phenomenum in fungal organisms under laboratory conditions, 
underlines the absolute necessity to develop researches to estimate the risk 
assessment linked to the agronomic use of fungi under natural conditions. 
COOPERATIVE ACTIVITIES: 
* INRA and Univ. PARIS XI have daily exhanges and collaborative activities 
* 20 march 92: Meeting between INRA and ULB staff to define protocols for 
ecological studies. 
* April 92: Exhange of strains from ULB to INRA 
* June 92: A one day meeting between INRA, ICI and Univ. SHEFFIELD. 
Coordination of researches and exhange of material. 
* March 93 to August 93: One researcher from INRA will stay in Univ. 
SHEFFIELD for a cooperative program on homologous recombination in 
Beauveria bassiana. 
LIST OF JOINT PUBLICATIONS: Nothing to report yet 
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OTHER PUBLICATIONS: 
DABOUSSI M-J, LANGIN T., BRYGOO Y.- 1992. Fot 1, a new family of fungal 
transposable elements. Mol. Gen. Genet, (under press). 
RIBA G. FORTINI D.-1992. Hypervimlent interspecific diploids between 
Beauveria bassiana and B. brongniartii. 25th Internal. Meeting Soc. Inverter. Pathol., 
Heidelberg, Germany 
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TITLE: Genetic tools for constructing GEMs with high predictabi-
lity in performance and behavior in ecological microcosms, 
soils, rhizospheres and river sediments. 
CONTRACT NUMBER: BIOT-CT91-0293(SSMA) 
OFFICIAL STARTING DATE: 01/10/91 
COORDINATOR: Juan L. Ramos, C.S.I.C., Granada, Spain 
PARTICIPANTS: Soren Holin, TUD, Lyngby, Denmark 
Kenneth N. Timmis, GBF-I, Braunschweig, Germany 
Victor de Lorenzo, CSIC, Madrid, Spain 
Daryl Dwyer, GBF-II, Braunschweig, Germany 
F. O'Gara / D. Dowling, UC, Cork, Ireland 
OBJETIVES SET FOR THE REPORTING PERIOD: 
I. Specialized vectors to obtain gene expression under 
environmental conditions and stable maintenance of 
engineered traits. 
II. Barriers to gene transfer. 
III. Conditional suicide systems. Analysis and performance of 
killing functions and adaptation of conditional suicide 
systems to suicide circuits. Improvement of TOL regulatory 
elements. 
IV. Construction of PCB-degraders. 
V. Validation tests under laboratory conditions and in micro-
cosms . 
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RESULTS 
To achieve the proposed goals, laboratory work was organized in 
three teams, so that a series of recombinant bacteria with and 
without a biological conditional suicide system were constructed. 
The work of the three teams should convergence in the near 
future into a large series of validation tests under laboratory 
growth conditions and in soil microcosms, including rhizospheres. 
The CSIC-CIB group at Madrid and group I at GBF were in charge 
of objectives I and II. The CSIC-EEZ at Granada and the group at 
Lyngby were in charge of objective III, while the University of 
Cork group and group II at GBF were in charge of objective IV. 
The latter two teams also performed preliminary soil and 
rhizosphere microcosm tests. 
For objective I the following two actions have been undertaken: 
1. Construction of transposon probes to detect promoters 
responsive to growth phase. We plan to use promoters active under 
starvation conditions as expression systems for heterologous 
genes under environmental conditions. We chose to develop a 
series of genetic probes for Pseudomonas putida as a straighfor-
ward means of identifying this type of promoter. We based some 
of our work on the transposons previously developed to identify 
sporulation genes in Bacillus (1). First, we constructed three 
lacZ-tet cassettes which contain, as a NotI restriction fragment, 
a promoterless bicistronic reporter system able to distinguish 
the type of promoter under study (lacZ: B-galactosidase; tet: 
resistance to tetracycline). One of the cassettes was tailored 
to produce translational/transcriptional fusions, whereas the 
other two were used for generating exclusively transcriptional 
fusions. These last two differed in the nature of the lacZ 
reporter, which was either an authentic intact lacZ gene or a 
trp-lacZ fusion. To examine whether the reporter system could be 
used as desired, we cloned the cassette with the lacZ-tet genes 
in front of the Pu promoter of the TOL plasmid (which is under 
strict growth phase regulation) and made a mini-Tn5 transposon 
(2) containing the whole unit, for insertion into the chromosome 
of Pseudomonas putida. The colonies containing this insertion 
showed intense luminescence on plates containing the Pu inducer 
p-chloro-benzylalcohol after they were sprayed with MUG, a 
fluorescent subtrate of B-galactosidase, but they were unable to 
grow on plates with tetracycline, thus confirming the expected 
phenotype. We then constructed three mini-Tn5 transposons 
containing each of the lac-tet cassettes, in such a way that upon 
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random insertion in the chromosome of a target strain, a defined 
phenotype could be followed to identify insertions downstream 
from genes subjected to growth-phase regulation. Development of 
a simple procedure to utilize the cognate promoters for 
heterologous expression is under way. 
2. Study of two new nonantibiotic selection Barkers: Resistance 
to silver salts and to the herbicide glyphosate. One of the 
concerns in the use of GEHs for environmental release is the 
undue spread of resistance genes to antibiotics of clinical 
importance. An alternative is the use of resistance to heavy 
metals and herbicides. We have obtained strains of JL. coli and 
Pseudomonas stutzeri resistant to silver salts, and the 
determinant genes will be used as selection markers for vector 
construction. We have used PCR to clone the gene aroA of £*. call 
(5-enolpyruvyl-3-phosphoshikimate synthetase), a variant of which 
provides resistance to the herbicide glyphosate, which is also 
used as a nonantibiotic marker. 
For objective II the following strategy has been used: 
1. The Colicin E production/inunity/lysis system was used as a 
source of killing functions for biological containment. 
Inhibition of the horizontal transfer of DNA by GEMs requires the 
construction of genetic circuits to avoid entry of recombinant 
genes by bacteria present in the same ecological niche, be it 
through conjugation, transformation or transduction. The specific 
approach that we are attempting should avoid all types of 
transfer, by associating at least two killing functions cloned 
in the chromosome. Acquisition of the recombinant material along 
with the killing function but without immunity should then result 
in the death of the recipient cells. The assembly of this type 
of circuit requires, first of all, the availability of universal 
killing functions and their corresponding immunity genes. Among 
possible candidates we have picked the colicin E3 system. The 
production and immunity genes have been independently cloned and 
expressed, and their combination with adequate reporter genes is 
in progress to test the above mentioned concept. 
The experimental work devoted to objetive III has been aimed at 
designing a suitable biological containment system to be used in 
concert with the degradation of xenobiotics. The strategy chosen 
has been to couple a killing gene to the regulatory loop of 
degradative pathways, such that expression of the killing 
function is repressed during the period of metabolization of the 
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the xenobiotic; after the compound has been removed, the killing 
function should be derepressed. The model system under study is 
a modified TOL meta.-cleavage pathway for the metabolism of 
alkylbenzoates (3) combined with the lac operon and the suicide 
gene, aef. 
1. The host killing function gef. The Ej. coli aef gene has been 
shown to express a very toxic cell killing polypeptide of 
approximately 50 amino acids. The lac gene was inserted 
downstream of the strong, synthetic lac promoter in pVHE24-3 
which has a very low basal level (uninduced), and a very high 
expression level after induction. Transcription is controlled by 
the lac.1 repressor. Induction of Gef protein results in killing 
of ILs. coli. 
2. Killing of Ei. putida bacteria by Gef protein. The killing 
cassette (P1%c::gst.; lad') was subsequently inserted in a mini-Tn5 
transposon (3), and transferred via bacterial conjugation into 
the chromosome of E_=_ putida 2440. It was found that induction of 
Gef protein resulted in cell killing. In particular, killing of 
P. putida 2440 was as efficient as that of EJ. coli. We therefore 
concluded that a single copy of the aef gene is sufficient to 
kill this organism. 
3. Coupling the killing cassette with the TOL degradative 
pathway. Previously, a fusion between a promoterless lad gene 
and the Pm promoter of the Egta-pathway of the TOL genes was 
constructed; in Ej. coli the simultaneous presence of a Plao::gef 
fusion resulted in cell death in the absence of benzoate acting 
as an inducer of the repressor (3). After insertion of the 
Pi„.: :aef fusion on the chromosome of EJ. putida bearing the fusion 
Pm::lac.I on plasmid pCC102, similar results were obtained, 
indicating that benzoate-conditioned killing of the cells can be 
transferred to E^ . putida. However, due to the high dose of the 
lad gene, the system was not sufficiently effective, and the 
next important step is therefore to move all components into the 
chromosome of P_,_ putida. 
4. Survival of EJ_ putida bearing aef gene in soil microcosms. The 
wild type Pseudomonas putida 2440 bearing recombinant TOL plasmid 
PWWO-EB62 and pCC102 (Pm:: lac.1) , and the same strain but also 
carrying a chromosomal insertion of the killing cassette 
Pi.c — asl, were introduced at low doses (about 10* CFU per g 
soil"1) in two different soils from the Granada area (a cambisol 
soil [poor in organic matter] and a fluvisol soil [rich in 
organic matter]) unamended or amended with 0.1% 3-methylbenzoate 
(3MB) or 0.1% glucose. In the cambisol soil unamended or amended 
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with glucose, the bacteria without the killing function became 
established at about 101 CFU g soil"1, while survival of the 
bacteria bearing the killing cassette was notably reduced. The 
number of CFU decreased with time, to less than 20 CFU per g 
soil"1 after 3 weeks. In contrast, the number of CFU per g soil"1 
was greater than 103 in soils amended with 3MB. In the fluvisol 
soil, in samples amended with glucose or without amendement, the 
number of CFU remained low with time (about 10* CFU g soil"1), 
while in the soils amended with 3MB, the number of bacteria 
increased to about 10' CFU g soil"1. 
Our current results show that aef prevents multiplication in 
soils of EJ. putida bearing rDNA. However, the high dose of lad 
makes the system less efficient than desired. A series of 
constructions bearing all components in the chromosome of P. 
putida 2440 is being prepared. New control systems including 
improved promoters of the TOL plasmid upper pathway are under 
development. 
The third team of laboratories has directed their efforts to the 
construction of PCB-degrading strains of Pseudomonas fluorescens. 
which are good colonizers of the sugar beet rhizosphere, and P. 
putida KT 2442. The engineered strains were characterized to see 
if colonization efficiency had been altered by the addition of 
the new genes under selective and nonselective conditions in the 
rhizosphere microcosms. Specific actions involved: 
1. Introduction of PCB genes into rhizosphere strains. Three 
rhizosphere strains, Pseudomonas F114 and M113, and Et putida 
KT2442, were chosen as recipients for the genes encoding 
biodegradation of PCBs, which were confined within a PCB 
cassette. Potential PCB degrading strains were constructed by 
mating recipients with a permissive EJ. coli donor carrying the 
PCB cassette on a suicide plasmid pDDPCB. Pseudomonas 
transconjugants bearing the transposon on the chromosome were 
selected as able to grow on biphenyl (BP) as a sole carbon 
source. Transconjugants were recovered at low frequency (10"* per 
recipient) and were confirmed by spraying with 2,3-
dihydroxybiphenyl, (2,30HBP) an intermediate in the breakdown 
pathway of PCBs, which results in a yellow color if the product 
of the bj2bC gene is expressed. 
2. Genetic stability in vitro. The stable maintenance of the PCB 
genes was assessed by growth in nonselective media followed by 
testing for the retention of the ability to grow on BP. Both 
F113PCB and KT2442PCB grew stably on minimal medium with BP after 
-312-
40 generations in nonselective media. 
3. Growth rates of F113 and F113PCB. Transconjugant F113PCB was 
chosen for further study. Growth rates in different media were 
compared with those of its parent strain, F113Km. No differences 
were found in growth rates, suggesting that the insertion of the 
transposon did not cause changes in the GEM. 
4. Behavior in natural settings: The sugar beet rhizosphere. The 
GEM F113PCB was applied to sugar beet seeds prior to sowing, and 
colonization and maintenance of the PCB degrading trait were 
followed over a period of 4 weeks. Strains containing the PCB 
cassette could be identified by their ability to use biphenyl 
(BP) as a sole carbon source, and by the production of a yellow 
product when sprayed with 2,3-OHBP. Inoculated seeds were sown 
in nonsterile soil with and without 100 ppm 4-CBP in a growth 
cabinet. Bacteria were isolated from the root system at different 
times and plated on selective medium. Total CFU were estimated, 
and those retaining the PCB genes were found by spraying with 
2,3-OHBP and by growth on BP as the sole C-source. Colonization 
efficiency of the GEM was found to be the same as that of the 
wild type in both amended and unamended soil. 
5. Stability in soil. The cassette was found to be stable, with 
100% of recovered F113PCB still retaining the BphC* phenotype 
after 4 weeks in the rhizosphere. 
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WIDER CONSIDERATIONS 
Novel genetic information was introduced into Pseudomonas 
bacteria through a series of mini-transposons lacking transposa-
ses within the inserting element. These bacteria survived well 
in natural settings, eg, soil microcosms and rhizospheres. Genes 
(including suicide killing functions) were expressed as expected 
and appeared to be stable. This proves that our strategy is an 
efficient approach to the engineering of strains for various 
environmental purposes. 
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MILESTONES 
1. A number of useful tools have been designed to obtain an 
efficient expression system under environmental starvation 
conditions. 
2. New nonantibiotic markers for tracking herbicide and heavy 
metal resistance in GEMs are being developed. 
3. The TOL meta.-cleavage pathway regulatory elements, the Pm 
promoter and the xyls regulator have been coupled to the qef 
gene, whose gene products kill cells when overexpressed. 
4. Pseudomonas putida bacteria bearing a recombinant TOL plasmid 
and the suicide function under Pm/XylS control have been shown 
to function both in the laboratory and in soils. 
5. The GEM F113PCB was sucessfully constructed using a suicide 
delivery system (pDDPCB). 
6. The PCB phenotype was stably maintained both in vitro and 
after growth in a nonsterile soil during 4 weeks. 
7. Colonization of sugar beet roots by the GEM was monitored, and 
was found to be similar to colonization of the parent in both BP 
amended and nonamended soil. 
COOPERATIVE ACTIVITIES 
Lars B. Jensen from the Technical University of Denmark visited 
J.L. Ramos's laboratory for three months to carry out joint work. 
J.L. Ramos visited Dr. Soren Molin to further define 
collaborative work. 
Dr. V. de Lorenzo provided partners with new suicide transposons. 
The PCB genetic cassette used in the University of Cork was 
constructed in K.N. Timmis's laboratories. 
Dr. D. Dwyer visited the University of Cork to further define 
details of collaboration. 
K.N. Timmis and J.L. Ramos exchanged strains. 
A plenary meeting will be held in June in Granada. 
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OBJECTIVES SET FOR THE REPORTING PERIOD: 
The objectives set for the working period are apparent from the work planning chart which makes 
part of the original workplan (annexed). It includes the insertion and further development of 
inducible killing genes into soil isolates, microcosm testing of non-biologically-contained (parent) 
bacteria, development of detection methodology from soil, selection of crucial parameters for a 
model, and studies on responses of bacteria to nutrient and other stresses. 
MAJOR PROBLEMS ENCOUNTERED: 
There are so far no major obstacles to the success of the project. As already indicated in the 
workplan, a crucial point in the project will be the availability of suitably working 'active" killing genes 
for the soil bacteria in use. This hurdle is expected to fall between month 6 and 12 of the project. An 
alternate strategy based on modification of starvation survival genes (e.g. dnaK) is being worked out 
should the development or functioning of active principles prove unexpectedly difficult. 
RESULTS: 
The involvement of the 4 groups in the project can be found in the work plan. Here, progress 
of each of the 4 groups will be briefly treated. 
The aim of the ISFR GEM project, of which this endeavour makes part, is the biocontrol of 
dipteran insects which damage gramineous plants. It is focussed on the insertion of the 3'-truncated 
fragment of the S-endotoxin gene from Bacillus thuringiensa var momiani (crylVB) in soil bacteria 
adapted to the rhizosphere of graminea. For this purpose, two Pseudanonas strains, P.fluoracats R2f 
and P. cepacia P2, were isolated. P. fluonsctns R2f was first selected as a carrier for ciylVB, since it is 
most amenable to genetic modification. Soil studies with marked derivatives revealed a decline of 
introduced organisms, and a stimulation in the rhizosphere of young wheat plants. Further work 
focused on competition between GEMMO and parent strains in soil. Two derivatives of a rifampicin-
rcsistant R2f mutant, Ar-1 (chnnpfU) and Art-3 (chr.jip<n-cryTVB) were tested versus the parent in 
loamy sand microcosms planted to wheal. During the 15-day experimental period, the introduced P. 
flucracens populations decreased slightly in the root free soil while there was an increase of the P. 
fluoracau cfu counts in the rhizosphere. Roots were also colonized. The proportion of both 
GEMMOs in the introduced populations (Ar-1/R2f and Art-3/R2f mixes) decreased in bulk and 
rhizosphere soil and in the rtuzoplane. There was no such trend in the mixture Ar-l/Art-3. The 
similarity in behaviour between strains Ar-1 and Ar-3 led to the conclusion that they were equally 
impaired in their fitness in soil as compared with the parent strain, either due to an effect of the nptll 
gene product on ceDular physiology or to an impairment of functioning of genes flanking the 
chromosomal insertion site. 
Effects of antibiotic pressure on GEMMO performance was a further focus, with the aim to study 
possible selective advantage in soil and rhizosphere of GEMMOs carrying antibiotic resistance 
markers. Transposon Tn5 carrying P. fluorescens R2f which expresses resistance to neomycin 
(kanamycin) and streptomycin, was used. Soil was supplemented with 100 or 1000 ug of either 
neomycin or streptomycin per ml soil moisture (equivalent to 20 and 200 ug per g of dry soil). 
Neomycin did not affect inoculant numbers, whereas streptomycin at 1000 ug/ml stimulated the 
inoculant in bulk soil and in the wheat rhizosphere. These results indicated a slight competitive 
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advantage for introduced strains carrying streptomycin resistance genes in soil microsites where 
streptomycin is present at high concentrations. 
For Geld release of the cj>TVB-loaded strains, it is necessary to reduce putative hazard using 
biological containment. One strategy could be based on killing outside the rhizosphere. For this, 
promoter activity specifically responding to signals in root-free or rhizosphere soil was screened for in 
the Pseudomonas strains. To select promoters responding to signals from soil, conditions likely to 
occur in soil, e.g. carbon starvation, low temperature (10°C) and low water activity were taken as 
factors. Estimations of the amount of organic carbon dissolved in soil water revealed concentrations 
of about 100 ppm (equivalent to 250 ppm glucose) in the soil used. Organic carbon released by wheat 
roots was estimated to amount to 300 - 3000 ppm per ml soil water (equivalent to 800 - 8000 ppm 
glucose) per cm root. Therefore, mineral medium (M9) supplemented with glucose at concentrations 
of 100, 250, 1000 and 4000 ppm was selected as a medium. Glucose was shown to be growth-limiting 
at 100 ppm for P2 and at 100 and 250 ppm for R2f. Carbon starvation promoters were looked for 
using 100 and 250 ppm for the "on* response and 2000 and 4000 ppm for the 'off* response. 
Temperatures in Dutch soils may differ between below-zero and 25-30°C Both R2f and P2 were 
shown to grow on M9 agar plates supplemented with glucose at temperatures ranging from 10 - 27°C 
To obtain differentially induced promoters, we used the promoter probe system of Simon et 
al., which is based on Tn5 containing a promoter-less lacX gene. TnSvdacX, located on suicide plasmid 
pSUP102, was delivered to rifampicin-resistant mutants of R2f and P2 via conjugation, using 
kanamycin and rifampicin selection, and promoter activity upstream of the Ta5:JacZ element was 
screened by assaying B-galactosidase activity. 
Two R2f mutants were obtained, which gave a 20 - 26 fold higher B-galactosidase activity in 
M9 medium containing 100 ppm glucose compared to 4000 ppm glucose. One, RA92, revealed 
differential B-galactosidase activity in both the late exponentional and stationary phase, whereas the 
second, RA74, only gave a differential response in the stationary phase. Further, 7 mutants of P2 
responded to carbon starvation; expression studies with these mutants will be performed. Furhter, a 
P2 mutant (PD19) was isolated which responded to 10°C as opposed to 27°C, whereas no cold-
induced R2f mutant was found. 
The experimental work at the Techn. U. of Denmark has been aimed at designing a suitable 
biological containment system to be employed in concert with the design of the Pseudomonas 
biopeslicides. The strategy chosen has been to couple a killing gene to a stochastically induced 
expression system. The purpose of this design is to limit the long-term survival of the bacteria as a 
consequence of a constant rate of elimination of cells from th: population. Several model systems are 
being designed and tested. Isolates of Pseudomonas, capable of colonizing plant roots, including 
strains R2f and P2, are the model organisms. The killing gene is either the E. coli gef gene or nuclease 
genes isolated from different microorganisms. The stochastic induction will be based on either 
homologous recombination or site-specific recombination during which process a negative expression 
control element is deleted. 
The E.coli gef gent expresses a very toxic cell-killing polypeptide of roughly 50 amino acids. The 
gene was inserted downstream of the strong, regulatable promoter in plasmid pUHE24-2 (H.Bujard, 
personal communication). The promoter is a synthetic lac promoter which has a low basal level 
(uninduced) and a very high expression level after induction. Transcription is controlled by the lacl 
repressor. Induction of Gef protein resulted in killing of E. coli. We have recently also designed 
killing systems based on highly active nucleases. The major idea is to kill and remove contaminating 
DNA at the same time. Two different extracellular nucleases have been redesigned such that they no 
longer are excreted (removal of signal peptide sequences). Induction of these enzymes results in 
severe growth inhibition, but optimization is still required for efficient killing to occur. 
The killing cassette thus obtained was subsequently inserted in the mini-Tn5 transposon 
system developed by de Lorenzo et al. (1990), and transfer of the derived transposons via bacterial 
conjugation resulted in chromosomal insertions in a number of gram-negative bacterial species. In all 
but one case it was found that induction of Gef protein resulted in cell killing. In particular, killing of 
P.putida strain 2440 was as efficient as that observed in E. coli. We therefore conclude that a single 
copy of the gef gene is sufficient for killing of this organism. 
A stochastic induction system based on homologous recombination has been designed in 
which two direct repeats of a 1000 bp sequence flank a marker gene (Km-resistance) and a lacl gene. 
On a separate repliant 
the above Flac-gef fusion was inserted, and it was shown that this design had the expected phenotype 
of inhibiting growth in slow-growing cultures in contrast to fast-growing cultures. The system appears 
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useful for multicopy plasmids, whereas the recombination frequencies with chromosomal inserts are 
probably too small 
An alternative strategy was started based on the plasmid resolution system of the broad host 
range plasmid RP4. In this system two repeats of ca. 100 bp will recombine very efficiently through 
the action of a site-specific resolvase. The advantages of this system are: the high rate of 
recombination, the requirement for only short sequences and the presumed broad host range of the 
recombination system. The first result using reporter genes looks very promising. 
Research of the U. of Goteborg group has focussed on stress responses and starvation survival of 
marine bacteria, Le. Vibrio prottolyticus S14 (CCUG 15956), and, for comparison purposes, V. 
anguillarum, V. vulnificus, V. DW1. The findings reported here will serve as a basis for comparison of 
stress responses in soil pseudomonads, as well as for alternate containment strategies. The role of C-
starvation as the determinant for the differentiation into starvation- and stress-resistant cells has been 
established. It was shown that N- and P-starvatioo are not sufficient triggers for induction of a 
successful adaptation programme. C-starvation, however, offered complete protection against a variety 
of inducers and allows for long-term survival. Similarly, experiments in which overall macromolecular 
synthesis rates and the signal molecule ppGpp were determined, identified C-starvation as the 
determinant for total or multiple starvation. 
Furthermore, starvation-induced differentiation appeared to include resistance against 
predation. In collaboration with Dr. Ingve B0rsheim at the University of Trondheim, it was shown 
that growing cells of Vibrio are taken up and digested by a mkroQagellate, while starved cells are not. 
Biological containment that prevents the development of predation resistance may facilitate removal 
of released GEMMOs by predators. The control regulons that are part of this response, such as the 
stringent control regukm, are likely targets for containment constructs. 
MiniMu (lac) insertion fusions, in which the reporter gene responds to starvation promoters, 
induced at different times during the initial period after growth arrest, have been generated. These 
mutants show little loss of viability as compared to the wild-type. The genes involved have not yet 
been identified. However, killing genes may be inserted in these sites to allow for a programmed die-
off. These fusions are further essential for the identification of regulatory genes of the carbon 
starvation stimulon, with predicted loss of viability during C-starvation. 
In collaboration with the U. of Denmark, pUT and pLOF transposon constructs have been 
evaluated and reconstructed. In particular, a mini-Tn 10 construct was very efficient in yielding high 
frequencies of transconjugants with single inserts in the chromosomes of several strains. This construct 
will be used for identifying late starvation promoters, for deletion or inactivation as well as for 
insertion of killing genes. Furthermore, this construct will be used to identify genes specifically 
involved in the upshift response: a series of mat (maturation) genes are induced sequentially and 
transiently - prior to induction of growth genes - during recovery by nutrients of long-term starved 
cells. Inactivation of these genes, or insertion of killing genes behind mat promoters may prevent the 
cells from exiting starvation and proliferating. 
Four genes have been identified as major regulators of the starvation-induced differentiation 
response. Three of these, re/A, dnaK and a Tn generated regulatory mutant, were explored while the 
fourth gene, kalF, so far has only been shown to exist in Vibrio by hybridization with an Escherichia 
coli probe. KatF is a newly discovered stationary phase or starvation sjgma factor in E. coli; it 
regulates at least 20 stationary phase or starvation genes, including morphogenes that allow for 
conversion of the rod to the coccus shape, est (carbon starvation) and pa (post exponential) genes in 
E. coli. A katF mutant rapidly lost viability after growth. The re/A gene product (stringent factor) 
controls formation of ppGpp in the stringent control response. The re/A gene was found by insertion 
of V. S14 DNA into a relX E. coli and screening for restoration of wild-type £. coli stringent 
physiology on aminotriazol plates (prevents growth of rc/A-strains). DnaK encodes a HsplO heat 
shock protein, a major chaperone in prokaryotes. A dnaK gene was cloned by PCR. 
The role of the stringent control as a regulator of the initial phase of starvation-induced 
differentiationy is well established. Evidence for DnaK as a major regulator has also accumulated. 
DnaK was shown to be synthesized at increased rate following starvation of 2 Vibrio spp. Two C-
starvation induced types of Hsp70 were found. It is suggested they are key regulators during 
starvation. DnaK may also be induced by the low water content of starved cells. 
A mutant in a regulatory gene of the C-starvation stimulon may prove to be lethal during 
starvation (possibly for kat?-, re/A- and dnaK-). By inserting a second transposon (mini-Tn 10) in a 
strain carrying a mini-Mu (lac) insertion in a gene which was induced exclusively during C-starvation, 
a clone no longer induced by C-starvation was obtained. Viability was reduced 100-fold after 4 days of 
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starvation. This regulatory mutant is presently being compared with its parent using 2D gel 
electrophoresis of pulse-labelled cells. Proteins of the C-starvation stimulon wul thus be identified. 
Several genes of potential interest for the design of disabled strains have thus been identified. 
Their inactivation, deletion or utilization for insertion of a lethal gene will allow us to evaluate the 
behaviour of organisms carrying them in microcosm experiments. 
The work of the IMW-TNO focused on models for the fate of bacteria in soil. This report 
examines the structure of models to be developed for the prediction of the fate of GEMMOs in soils, 
including biologically-contained ones. The model will be structured using factors which affect the fate 
of these bacteria in soil. These are: 1) cell properties (growth rate, survival, activity of killing genes, 
mobility) as affected by environmental conditions, 2) soil structure, 3) the localization of the bacteria 
in soil, i.e. in micropores of different size classes or in the rhizospbere, 4) the presence of competing 
bacteria or predators, and S) the availability of nutrients. The distribution of nutrients throughout soil 
compartments determines the growth potential in these compartments; replacement of used nutrients 
is also relevant. Transport will be modelled assuming mobility of bacteria in soil takes place with 
water flow, soil animals or mechanically with soil particles. The fate of the introduced genes depends 
on, besides on host fate: 1) the probability of transfer to other bacteria and 2) the persistence of DNA 
in soil following cell lysis. 
Factors important for modelling the fate of P. fluonscais in soil are obtained from experiments at 
ISFR. However, since the influence of several factors is unknown, some simplifying assumptions have 
to be made. Important points for the model are: 
- The structural diversity of the soil: sites (pores) with higher or lower growth capacity (nutrient 
availability), more or less predation, different bacteria already present, 
- the first come, first served principle: resident bacteria are assumed to have an advantage over 
intruders, not implying invasion is impossible, 
- transport by water fluxes: a simple model would only consider an overall transport probability 
from one point to another, neglecting the fine distribution of water, 
- The effect of a host killing gene: the mortality rate will be asuumed to be enhanced by the host 
killing gene, 
- Gene transfer: gene transfer will be assumed to occur only between bacteria in one patch; transfer 
is proportional to donor and recipient density. 
A tentative model description is as follows: 
Let there be K patches (index k (or /), from 1 to K), and / bacterial species (strains) (index ;' (or i), 
from 1 to J). The volume of patch k is Vb in that patch are N^ bacteria of species j , so the bacterial 
density in that patch is X^ = NjJVv The growth minus mortality rate of species j in patch k depends 
on the density of all other bacteria in that patch, and can be described by the function: 
R*[l-fjL<Xi)L where flL(0,0,-rXf>..,0,0) £ fJ0,0,-rXf,-.0,0) for each i. This rule ensures that an 
occupied patch cannot be invaded by intruding bacteria. The predation rate in a patch, P^, may 
depend on the patch and may differ between bacterial species. Transport between patches goes 
through a kind of 'transport patch', where no growth occurs. It wQl first be assumed that only one 
'transport patch' exist, i.e., from each patch bacteria wQl go with a certain probability to the transport 
patch, and from that patch each normal patch can receive bacteria. Transport is a random process, 
occurring in discrete units. The effect of the transfer of bacteria from a 'normal' patch to the 'transfer' 
patch on the bacterial density in that 'normal' patch wQl be considered negligible. If more than one 
transport patch is assumed, rules for transport between such patches have to be formulated, and each 
'normal' patch has to be linked to a specific 'transport patch'. A take-over of a patch by another 
species will generally only be possible if more than one bacterium enters that patch within a short 
timespan. Densities which correspond to less than one bacterium are considered to be 0. Most patches 
will only contain one bacterial species. For such a model, the function fa has to be chosen and its 
parameters have to be estimated, just as the parameters R^ and Py. Furthermore, estimates have to be 
made about the transfer rate and the volumes of each patch. Simple assumptions about these 
functions and parameters are: f^(XJ is a linear function in Xk and only a limited number of different 
patches (Le. patches with different parameter values and volumes) exist, for instance: 1) pore patches: 
no predation, low invasion rate, small volume, 2) rhizosphere patches: predation and a high growth 
rate, intermediate invasion rate, 3) standard patches: predation and a low growth rate, high invasion 
rate. This model will lead to a long coexistence of many bacterial species (those which are initially 
occupying a patch). In the long run, successful invasions in other patches will lead to a reduction in 
the number of species. The time span of this process, however, wQl make this species reduction not 
very relevant. When the number of patches becomes very high, it may be appropriate to start working 
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in densities of patches with a certain bacterial species, instead of in bacterial densities. This method 
has to be worked out further. 
Basic assumptions of this model are: 1) Spatial inhomogeneity of soil is a crucial aspect controlling 
soil microbiology; simplification of this leads to a "poor* model, 2) The effect of nutrients can be 
simplified to a competition model with direct competition between species instead of competition 
through depletion of nutrient, 3) Each patch can be considered to be homogeneous, 4) The transport 
mechanism chosen in this description is relevant for soil, 5) The mutual exclusive principle as a result 
of interaction is correct 
Other modelling options have been considered and will receive attention in the following period 
in parallel to the model proposed. 
HIGHLIGHTS/MILESTONES: 
The project is in a too early stage to have major achievements. It is foreseeable that a suitable 
biological containment system for use in soil will become available in the following period. 
WIDER CONSIDERATIONS: 
A biological system is being developed for the efficient control of bacterial populations released into 
soil for biocontrol purposes. The system is based on genes naturally present in bacteria. 
COOPERATIVE ACTIVITIES: 
The main contact between all participating groups has been a group meeting organized march 26 and 
27,1992 in Wageningen. Progress and strategies for the next period were discussed. Further, a 
collaborator of the ISFR group and collaborators of the U. of Goteborg visited the Techn. U. of 
Denmark laboratories for discussions and some cooperative work (dec 1991). The IMW­TNO 
collaborator has been in frequent contact with the ISFR for detailed discussions about factors for a 
model describing fate of inoculants in soil. Further contacts have been via normal communication 
channels. 
JOINT PUBLICATIONS: 
Time has not permitted any joint publications. The first output may be expected in the next 
experimental period. 
OTHER PUBLICATIONS: 
See under joint publications 
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TITLE: An Experimental Approach To Investigate Horizontal Gene Transfer Between 
Organisms. 
CONTRACT NUMBER: BIOT-CT91-0287 (SSMA). 
OFFICIAL STARTING DATE: 1 January 1991. 
COORDINATOR: Dr Richard Peter Oliver, UEA., Norwich, G.B. 
PARTICIPANTS: Dr. R-P.Oliver 
Dr. M.A. Grandbastien (Contractor INRA Versailles). 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
1. The creation and testing in Cfulvum and Tomato of chimeric marker genes. 
2. The creation of marked copies of both transposons and transformation into 
Cfulvum. and Tomato. 
3. Collection of world-wide Solanaceae strains. 
4. Screening of the plants by hybridisation and PCR and sequencing. 
5. Collection of world-wide Cfulvum strains. 
6. Screening of the Cfulvum strains by hybridisation and PCR and sequencing. 
MAJOR PROBLEMS ENCOUNTERED: The research work has not been in progress in 
Norwich for the duration of the reporting period. The post-doctoral position was not filled in 
Norwich until 17 February 1992 and the technician position was not filled until two weeks 
later. 
RESULTS :1 Chimeric marker genes have been created in both laboratories. In Norwich 
chimeric genes for either hygromycin phosphotransferase or ^-glucuronidase (GUS) using the 
gpd promoter have been created, whilst in Versaille these marker genes have been constructed 
using the CaMV 35S promoter/These chimeric marker genes have been exchanged between the 
participating laboratories and are currently being tested in Cfulvum and tomato. 
2.The creation of marked copies of both transposons is under way in both laboratories. 
Difficulty was encountered in the creation of marked copies of C/T-l since no unique site 
within a non coding region of the cloned retrotransposon was available for the insertion of a 
marker gene. These problems have largely been overcome and the construction of a marked 
copy of the CfT-l retrotransposon is nearing completion. 
3. The French group have initiated the world-wide collection of Solanaceae strains. 
4. In Versaille a Tntl LTR-GUS construct has been shown to be specifically activated 
by cell wall hydrolases. 
5. To date 31 Cfulvum strains have been collected world-wide. The possibility of 
obtaining further strains from South America is in progress. 
6. These 31 C fulvum strains have been screened by hybridisation. A probe P5 has 
hybridised to all 31 Cfulvum strains so far collected and although most fragments of the 
genome containing this element are the same between strains there are some which show 
polymorphisms. The probe P5 encodes part of the Reverse Transcriptase gene of CfT-l and 
shows homology to other Reverse Transcriptase genes and was used as a probe since it 
appears to be the most highly conserved region of the element. 
HIGHLIGHTS/MILESTONES: Nothing to report. 
WIDER CONSIDERATIONS: An assessment of the risks involved in the release of genetically 
engineered organisms must take into account the frequency of horizontal gene transfer. The 
frequency of horizontal gene transfer places an upper limit on the safety of the deliberate release 
of engineered organisms because it will indicate the likelihood of gene-escape to unrelated 
species in the environment. The observation that an element related to the Cfulvum 
retrotransposon C/Tl is present in tomato may indicate recent interspecies genetic exchange. 
The objective of this research is to experimentally measure the frequency of horizontal gene 
transfer between eukaryotic organisms. 
COOPERATIVE ACTIVITIES: The participating members met on the 31 March 1992 at INRA 
Versaille and discussed major scientific aspects of the project. Chimeric marker gene were 
exchanged together with tomato seeds. Freeze dried fungal exudates have been sent to Versaille 
to determine if they will specifically activate the Tntl retrotransposon. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL AUTHORSHIP: 
Nothing to report. 
OTHER PUBLICATIONS/PATENTS: Nothing to report. 
GENERAL REMARKS/SUGGESTIONS/COMPLAINTS: Nothing to report. 
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TITLE: Safety of genetically engineered retroviruses used for gene transfer 
CONTRACT: BIOT ­ CT91 ­ 0286 
OFFICIAL STARTING DA TE: 1/10/1991 
COORDINATOR: Finn Skou Pedersen, Aarhus University, Aarhus, DK (UA) 
PARTICIPANTS: Walter H. Gunzburg, GSF­Munchen, Neuherberg, DE (GSF) 
John Guardiola, IIGB, Napoli. IL (IIGB) 
Gerard Verdier, University Claude Bernard, Lyon, FR (UCB) 
Claire­Michelle Calberg­Bacq, University de Liege BE (UL) 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Task 3 (ii): Effect of steroid hormones on expression of integrated proviruses. 
Task 5 (i): Screening of infected animals for the presence of virus. 
Task 5 (iii): Production of amphotropic and ecotropic producer cells. 
MAJOR PROBLEMS ENCOUNTERED: 
Delay in transfer of money from EC­administration to the coordinator caused a delay in 
initiation of experimental work. 
RESULTS: 
UA: Personnel has been employed as foreseen in the contract. Work is progressing wi th 
respect to transfer, expression and genetic stability of murine leukemia virus derived 
vectors in cultured murine cells. Oligodeoxynucleotide primers for PCR amplification and 
sequence analysis have been designed and synthesized, and nucleotide sequence 
information of integrated vector proviruses has been obtained. Cell clones wi th integra­
ted proviruses selected for higher expression have been characterized by Southern 
hybridization and PCR sequence analysis. Experiments directed towards the analysis of 
long term stability of expression of integrated proviruses have been initiated and 
differences among individual proviruses have been observed. Tools for analysis of 
recombination between infecting vector proviruses and endogenous sequences are 
being generated. Discussions and scientific visits between the project leaders of the UA 
and GSF groups have led to new strategies based upon these materials and resulting in 
mutual exchange of co­workers. Studies analysing the relative influence of promoter­
enhancer elements of the vector and of the host chromosomal integration site are 
continuing. As part of this, studies of the inducibility of individual integrated vector 
proviruses by the steroid hormone dexamethasone have been completed and a 
manuscript is in preparation. Discussions between the groups of UA and GSF have led 
to further collaborative efforts concerning retroviral vector infection of embryonal cells. 
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GSF: Personnel has been employed as foreseen in the contract. Initial experiments 
aimed at determining the elements involved in the tissue specific expression of genes in 
the mammary gland have been completed and a manuscript has been submitted for 
publication. Based upon these initial findings, strategies have been set for the 
construction of tissue specific retroviral vectors targeted towards the mammary gland. 
PCR primers required for the construction of such retroviral vectors have been 
synthesized. In approaches aimed at the targeted integration of retroviral vectors at 
specific genomic loci, three classes of retroviral vector have been constructed carrying 
sequences of a impaired test gene, the Herpes Simplex Virus thymidine kinase gene in 
different locations within the vector. A number of cell lines have also been established 
carrying single copies of the test target gene (thymidine kinase). Using positive and 
negative selection strategies, the number of homologous recombination events between 
the retroviral vector carrying the test gene and the target gene in the cell can be 
determined. Amphotropic and ecotropic packaging cell lines containing the vector have 
been established and experiments carried out to increase the titre of infectious virus by 
"ping-pong" infection. Such virus has been used to infect the target cell lines and preli-
minary results as to the recombination efficiency have been obtained. In collaboration 
wi th the IIGB group, retroviral vectors have been introduced into animals to determine 
tfie risk of infection of the germ line. Progeny animals have been tested for acquisition 
of retroviral vector sequences. New rapid protocols for the screening of large numbers 
of progeny animals have been established. Discussions between the GSF and UA 
participants have led to new sub-projects related to retroviral infection and expression in 
embryonal cells. 
IIGB: MHC class II genes are expressed in mature cells of the lymphoerythropoietic 
system. A tissue-specific MHC class II promoter may thus constitute an ideal tool for 
targeting expression to different cell types of the lymphoid and the erythroid cell 
compartment. A promoter sequence from the human major histocompatibility class II 
gene HLA-DQA1 has been fused to the CAT reporter gene, for use in transient transfec-
tion assays, or the hph (hygromycin resistance) gene for permanent transfection 
studies. The HLA-DQA1/CAT and the HLA-DQA1/hph constructs have been introduced 
into retroviral vectors as well as conventional expression vectors. In order to establish 
the minimal promoter sequences required for tissue specific expression of MHC class II 
genes in different cell lineages, different fragments from the HLA-DQA1 promoter have 
been assayed in various human cells types in vitro. The ability of the minimal promoter 
thus identified to direct correct expression was verified upon stable transfection of HLA-
DQA1/hph constructs in the same cell types. We found that the minimal promoter 
element was faithfully regulated also when integrated at different chromosomal 
locations; the permanent transfectants obtained are now being studied in greater 
details. The HLA-DQA1/hph fusion was subsequently cloned into a retroviral vector, 
pLJ, in either orientation and transfected into helper cells. The retroviral particles 
obtained have been used to infect helper free cell lines. We have found that the 
presence of retroviral sequences interferes wi th regulated expression of the HLA-DQA1 
promoter used. We are now in the process of characterizing the clones obtained after 
infection in order to understand the mechanisms by which this interference is brought 
about. In collaboration wi th the group at the GSF we have continued our effort in the 
study of the ability of retroviral vectors to infect stem cell of the male germline in mice. 
Preliminary experiments have been performed in order to test the infectivity of retroviral 
particles in vivo after injection into the testes. Further, a methodology has been 
developed to transplant retrovirus producing cells into the testis of the animals, without 
affecting their ability to fertilize female mice and produce offspring. 
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UCB: The main focus of the UCB participant has been to develop avian leukosis virus 
based vector systems with an emphasis on reducing the risk of generation of helper 
viruses and on targeting vector infection and expression to specific tissues. To derive 
safe helper cells, packaging-mutants from ALVs have been crippled by separating qaq-
ool and env into two transcription units and by deleting noncoding sequences required 
for a complete virus life cycle. Shut-off of expression of the proviral genes in the 
packaging cells has been a major problem in past work. Such problems have been 
overcome by insertion of genes for selectable markers (hygro, phleo) into the trans-
criptional units of viral genes. These new packaging cells stably produce the packaging 
functions provided they are cultivated under selective pressure (hygromycin and 
phleomycin). The packaging cells generated from quail cells have been checked for 
absence of production of replication-competent viruses and for stable production of 
retroviral vectors in high titres. In contrast, the use of a chicken cell line as a helper that 
bears and expresses avian leukosis virus related sequences resulted in the generation of 
replication-competent viruses after various times. Preliminary analyses demonstrate a 
risk of transmission of some of the endogenous RNAs to the target cells causing either 
recombination or modification of the vectors and experiments are in progress to 
characterize such recombination mechanisms. With the overall aim of targeting vector 
expression to specific tissues, double expression vectors have been constructed. Two 
selectable marker genes are expressed from the retroviral promoter and from an SV40 
promoter in an internal transcriptional unit, respectively. Interference from the strong 
avian leukosis virus promoter may cause problems wi th respect to expression from an 
internal promoter. To reduce this problem the retroviral integration signals have been 
manipulated to allow integration of the provirus in a disorganized form. Infected cells of 
the expected characteristics have been obtained and the detailed structures of inserted 
vector genes are presently under investigation. 
UL: The UL participant has mainly been concerned wi th tasks dealing wi th the stability, 
infectivity, and penetration of retroviral particles into cells, all properties dependent 
upon the viral glycoproteins and on the integrity of the viral envelope. Current work 
uses three retroviral constructions, all derived from Moloney murine leukemia virus. 
Ecotropic and amphotropic producer cell lines have been prepared and the relative 
infectivity of the vector viruses produced are being characterized for mouse cells of 
different origin, made available in part through collaboration wi th the GSF-participant. In 
parallel experiments the infection risk of corresponding cell lines of human origin is 
being evaluated. Work relating to infection of cells in animals has been initiated. 
Experimental protocols have been set up to follow the fate of virus vectors after 
different routes of infection. Strategies aiming at sensitive and quantitative detection of 
retroviral vector infection and expression at the single cell level in animal tissues have 
been discussed among members of the participating laboratories. 
HIGHLIGHTS/MILES TONES: 
We have been able to reach all the milestones originally planned for this project period: 
Task 3 (ii) Effect of steroid hormones upon expression of integrated proviruses. This 
part of the task has been completed and a manuscript reporting these results is in pre-
paration by UA. 
Task 5 (i) Screening of infected animals for the presence of virus. To establish the basis 
for such screening experiments by UL, a large number of progeny animals from parents 
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infected wi th retroviral vectors has been tested for presence of retroviral vectors and a 
new fast screening protocol has been developed in collaboration wi th GSF. 
Task 5 (iii) Production of amphotropic and ecotropic producer cells. A number of such 
cell lines for murine viruses have been established and characterised (UL and GSF). 
In accordance wi th the time chart, a review meeting wi th members of all research 
groups has taken place. The meeting was organized by the IIGB participant on Capri, 
from March 22 to March 24 . A total of 18 members of the five groups participated in a 
schedule of presentations and discussions of results, research strategies and ideas for 
collaborative efforts. 
WIDER CONSIDERA TIONS: 
Recent developments in the field of retroviral vector mediated gene therapy in humans 
have demonstrated that the areas covered by this EEC-BRIDGE project are of even 
greater importance than originally anticipated during the planning of this collaborative 
effort in the spring of 1990. 
COOPERA TIVE ACTIVITIES: 
« 
The GSF and UA groups wil l undertake the construction of replication competent 
retrovirus vectors carrying different envelope genes as part of a collaboration wi th the 
UL group. These vectors wil l then be employed by the UL group to study the spread of 
retroviruses in animals as well as the influence of the env variants upon infection 
spectrum. Replication competent MMTVs will be useful for the study of the effects of 
superantigens on the establishment of viral infections. 
Currently there is little information about the ability of retroviruses endemic to one 
species (e.g. mouse) being able to package vector constructs based retroviruses 
endemic to another species (eg. chicken). We propose to take advantage of the 
expertise available among the participating labs of the EC Bridge project to address this 
in a collaboration between the UCB and the GSF. During the meeting on Capri it became 
apparent that these two groups have a common interest in the regulation of retrovrial 
integration using the microinjection of retrovrial cores as a test system. We propose to 
determine the ability of MLV cores to integrate into avian cells and ALV cores to 
integrate into murine cells, which would involve the UCB and GSF groups. 
Recombination between retroviral sequences is a major interest of the UA and GSF 
groups. The stratagies employed by both groups have been streamlined so that they are 
complementary rather than competit ive and it is envisaged that an exchange of 
constructs and expertise through exchange visits wil l occur. The efects of mutating the 
primer binding site (currently studied by the UA group) as well as the study of gag 
mutants may eventually lead to safer, more efficient retroviral vectors and the GSF and 
UA groups intend to form closer links wi th respect to these projects. 
The UCB and UA groups wil l collaborate on studies aimed at determining the stability of 
expression of retroviral constructs in avian and murine systems. Both groups have 
preliminary data from their respective systems and they intend to determine how 
generally applicable their respective data are for retroviral vectors based on different 
324-
systems. Finally, the UA group will provide some of its currently available vectors to the 
IIGB group in an attempt to overcome the interference of viral sequences with the HLA-
DQA1 promoter regulated expression that the IIGB group has observed. 
During the last 6 months Finn Pedersen has visited the GSF on two occassions and 
Walter H. Gunzburg spent four days (11-14/11/91) at the UA where he discussed 
possibilities for further collaborations and gave a seminar entitled "Negative regulatory 
elements of mammary genes:- a common mechanism of tissue specific expression?". 
Currently we are compiling a list of materials (such as vectors) and techniques that are 
available in each lab as well as an oligonucleotide bank within the framework of the 
EULEP-OLIGO bank. 
PUBLICATIONS: 
Sorensen, M., Duch, M.S., Paludan, K., Jorgensen, P. and Pedersen, F.S. (1992) 
Measurement of hygromycin B phosphotransferase activity in crude mammalian cell 
extracts by a simple dot-blot assay. Gene 112, 257-259. 
Gunzburg, W.H. and Salmons, B. (1992) Factors controlling the expression of mouse 
mammary tumour virus. The Biochemical Journal 283, 625-632. 
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TITLE: Assessment of environmental impact from the use of live 
recombinant virus vaccines. 
CONTRACT NUMBER: BIOT - CT91 - 0289 
OFFICIAL STARTING DATE: 1 October 1991 
COORDINATOR: 
Dr.D.N.Black,AFRC.,I.A.H.,Pirbright Lab,Woking,GU24 0NF,GB. 
PARTICIPANTS: 
Dr. A.L.J.Gielkens,,CDI.fP.O.Box 365,NL-8200 AJ,Lelystad,NL 
Dr.M.A.Skinner,AFRC,I.A.H.,Houghton Lab.,Houghton,PE17 2DA,GB 
Prof.P.P.Pastoret,Univ. de Liege,FMV.IVI.,BE-1070,Bruxellee,BE 
Dr.R.M.Gaskell,Univ. of Liverpool, DVPMM, Neston, L64 7TE, GB 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
i) Initial stages of the construction of the different recombinant 
viruses based on capripox, Aujeszky's disease and fowl pox virus. 
ii)Construction of vectors to assess recombination between fowl pox 
virus and vaccinia virus. 
iii) Recombination in vivo; Wild type ADV and modified ADV. 
Cowpox and vaccinia virus. 
iv) Ecological survey; Sera and tissue collection and screening. 
v) Pathogenesis of cowpox in mammals. 
MAJOR PROBLEMS ENCOUNTERED: Nothing to report. 
RESULTS: 
Coordinator. 
Recombinant plasraids containing a selectable gene (E.coli 
gpt), under the control of the vaccinia virus promoter p7.5, and either 
the rinderpest virus F gene or H gene, under the control of the 
vaccinia promoter pll, have been constructed. Several recombinant 
plasmids have been constructed each targeting the F (or H) gene to a 
different non-essential region of the capripoxvirus genome. Expression 
of the F gene and the H gene, with these plasmids, was demonstrated 
using transient expression in capripoxvirus infected lamb testis cells. 
Preliminary transfection studies have indicated it has been possible to 
generate a recombinant capripox F gene recombinant virus. 
Plasmids containing the rinderpest F (or H) gene have been 
constructed for supplying to CDI for the construction of the 
recombinant ADV-rinderpest F (or H) recombinants. 
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CDI-Lelvstad. 
A recombinant ADV (NIA-3 gX", El*) containing the envelope 
glycoprotein El of classical swine fever (HCV) within the non-essential 
gX gene has been constructed. A recombinant plasmid (pMZ67) containing 
the HCV El gene fused in frame with the first 58bp signal sequence of 
the ADV gX gene was constructed. EcoRV-NCOI digestion generated a 
plasmid fragment containing the El gene flanked by NIA-3 sequences. 
Swine kidney cells were co-transfected with this fragment and virus 
NIA-3 DNA and the virus harvests screened for El expression using 
immunoscreening with El specific HAB. The recombinant virus was plague 
purified and integration of the El gene verified by endonuclease 
analysis and blot hybridization. 
The virulence of the "worst case" recombinant virus, NIA-3 gX" 
El* was compared with that of the virulent parent virus NIA-3 gX~. Five 
of the three-week-old SPF piglets were infected intra-nasally with 10s 
pfu of the parent virus NIA-3 gX" and the recombinant virus NIA-3 gX" 
El*. Preliminary findings indicate that both of the viruses cause sever 
and typical Aujeszky's disease and death. Three out of five died after 
inoculation with the recombinant and five out of five died after 
inoculation with the parent virus. Thus it appears that the "worst 
case" recombinant virus ( a virus with the El gene of HCV located in 
the gX locus of a virulent field ADV) will not result in increased 
virulence of the virus in the field. 
The development of a discriminatory PCR assay for 
discrimination between field viruses and any possible recombinants 
which may evolve in the field is in progress. 
The gll plasmid and serum specific to GII have been prepared 
for transfer to the coordinator (IAH, Pirbright). 
IAH. Houohton Laboratory. 
i)Recombination between fowlpoxvirus 
Recombinant poxviruses containing different marker genes 
inserted into different non-essential genes in the fowlpoxvirus genome 
have been constructed. 
The first contains the E.coll gpt gene under the control of the 
vaccinia virus promoter p7.5 inserted into a non-essential genes within 
the terminal repeat of fowlpoxvirus DNA. 
The second recombinant fowlpoxviruses contains the E.coli lacZ gene 
under the control of the vaccinia virus promoter p7.5 inserted in the 
D8 and D9 genes of fowlpoxvirus. The marker in the former recombinant 
will be used for the positive selection of possible recombinants. 
ii)Recombination between heterologous viruses carrying a 
region of homology. 
A plasmid containing the spike gene from infectious bronchitis 
virus has been prepared (pGSSl). Following removal of the vaccinia 
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virus promoter p7.5 from this plasmid a p7.5-£.coii gpt cassette was 
inserted into the spike gene sequences to produce the plasmid PGSS1/ 
p7.5/A p7.5 gpt. This will be used to construct a recombinant plasmid, 
with the spike gene/p7.5 gpt cassette embedded in the terminal repeats 
of fowlpoxvirus genome. 
A recombinant vaccinia virus containing the IBV spike gene has 
been constructed and characterised. 
University of Liege. 
Sera samples have been collected from wild mammals for 
analysis for the presence of orthopoxvirus antibodies. These will be 
screened both at the University of Liege and at the University of 
Liverpool. 
Sera samples have also been collected from domestic animals in 
Continental Europe. These will be tested by Pirbright Laboratory for 
the presence of antibodies to capripox or capripox-related viruses. 
University of Liverpool. 
Samples from human and domestic animals with suspected cowpox 
have been screened. A further 14 strains of cowpox virus have been 
isolated, thus identifying geographical regions in which wild rodents 
will be sampled in an attempt to identify the reservoir host of the 
virus. Samples of these new cowpox virus strains have been sent to 
Prof. P.P. Pastoret (participant 04) for studies on the pathogenesis in 
foxes. 
WIDER CONSIDERATIONS: 
Preliminary assessment of recombinant Aujeszk's disease virus 
have indicated that no alteration, as compared to the parent virus,in 
their pathogenecity has occurred. 
COOPERATIVE ACTIVITIES: 
At this early stage of the programme only limited interchange 
has taken place. The Veterinary School,University of Liverpool has 
delivered samples of the recently isolated field strains of cowpox 
virus to the University of Liege. However, several recombinant plasmide 
containing specific virus genes have been prepared for distibution to 
the different participants. 
LIST Or JOINT PUBLICATIONS/PATENTS 
WITH TRANS-NATIONAL AUTHORSHIP: Nothing to report 
OTHER PUBLICATIONS/PATENTSt Nothing to report 
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ITTTLE 
Identification of genes involved in latency and reactivation of pseudorabies virus, 
use in biological containmant study of viral genomes in pigs. 
n CONTRACT NUMBER 
BIOT CT 91-0297 (SSM) 
HI OFFICIAL STARTING DATE 
October 1 - 1991 
IV COORDINATOR 
.A.JESTIN 
.CNEVA 
'. 22440 PLOUFRAGAN 
.FRANCE 
V PARTICIPANTS 
1 - A. JESTOJ - CNEVA PLOUFRAGAN - FRANCE 
2 - H J. RZIHA - FRCVDA - TUBINGEN - GERMANY 
3 - 1 . ALMEIDA - NVRL LISBON - PORTUGAL 
4 - P. SHELDRICK - IRSC - VILLEJUIF - FRANCE 
5 - M. RIVIERE - RHONE-MERIEUX - LYON - FRANCE 
VI OBJECTIVE SET FOR THE REPORTING PERIOD 
The goal of the project is the identification of viral genes influencing establishment of 
and reactivation from latency of Pseudorabies virus (PRV). The major objective will be 
a detailed analysis on the biosafety of PRV mutants specifically manipulated in latency-
associated (LA) functions. LA transcripts (LATs) will be identified (cDNA bank, in situ 
cytohybridization), characterized, and the molecular organization of this genomic region 
will be elucitated. 
Neural cell culture will be produced and in vitro assays on these porcine neural cells 
reflecting a natural terget cell of PRV, with strain and mutants can be studed as in vivo 
on pigs to analyse their latency characteristics. 
\TI MAJOR PROBLEMS ENCOUNTERED: 
This common project was planned for three years in the first version and all partners 
were well linked : cDNA bank, neural cell cultures, in vitro and in vivo study. When the 
CEC reduced the programme to 2 years all partners reduced the objectives. Nevertheless 
the difficulties persist. Ex : neural cell culture, cDNA Bank. 
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VIII RESULTS : 
PARTNER 1: JESTIN CNEVA PLOUFRAGAN 
Characterisation of strains in vivo 
Characteristics of the mutants at the molecular level will be examined in acutely 
infected, latent and reactivated animals emphasising a comparison of these mutants to 
the wild type. Studies have been done on various organs and on various cells : white 
blood cells, bone marrow cells. Immediate early, early, and late transcripts will be 
looked for by in situ cytohybridization to determine any modifications of organ and cell 
tropism and latency reactivation properties. 
PARTNER 2: RZIHA FRCVDA TUBINGEN 
Analysis of: (1) LAT ('latency-associated transcrip1) region of PRV, 
(2) Viral gene expression of lymphocytes from latently infected pigs 
(1) One genomic region of PRV specifically transcribed during the latent state of 
infection could be determined by in situ cytohybridization (to detect viral RNA), 
Northern blot analysis and protection assays. It was found that LAT(s) start near the 
right end of 'unique long' part and pass into the internal repeat region of the PRV-
genome comprising in total ca. 13 kbp. LAT is over-lapping and orientated antisense to 
the immediate early mRNA. As reported recently by Cheung, at least the large LAT is 
spliced with a 4.6 kbp intron. We accomplished a transcriptional map and the DNA 
sequence of the region around LAT. To this end, the ca. 8.6 kbp Kpnl-fragment I was 
subcloned. Strand-specific probes (cRNAs) are used in Northen blot analysis of total 
and poly(A)-RNA prepared from infected cells. Up to now, a contiguous stretch of ca. 7 
kbp of this viral DNA-fragment has been sequenced. The data obtained so far can be 
summarized as follows: 
(a) Three open reading frames (ORF) and corresponding mRNAs have been identified 
in lyrically infected cells, which are homologous to "UL3", "UL4" and "UL5" of herpes 
simplex virus (HSV). 
(b) One additional gene specifying a 1.1 kb mRNA has been detected which exhibits no 
homology to other known herpesviral genes. 
(c) Upstream of the LAT start site an intergenic region could be identified in the PRV-
genome, which is non-essential for virus replication. 
(d) Overlapping and antisense to the LAT(s) a new early gene of PRV (EPO) was found 
with significant homology to an immediate early gene of HSV. 
(e) Cloning of different parts of the PRV-LAT promotor region has been initiated to 
provide suitable plasmids for testing LAT promotor activity in different cells. 
(2) A large number of organ tissues and lymphocytes of peripheral blood (PBL) and 
bone marrow (BM) derived from latently infected pigs was investigated for the presence 
of PRV DNA and virus-specific transcripts. Except of the well established neuronal 
latency of this alphaherpersvirus, additionally we found the regular persistence of PRV 
DNA in PBL and BM cells of latently infected animals. Using polymerase chain 
reaction (PCR), in situ hybridization and immunohistochemistry the following 
conclusions can be made : 
(a) During latency the viral genome is harboured in lymphocytes of PBL and BM in the 
same or even a higher percentage of animals exhibiting PRV DNA in neural tissues. The 
number of PRV DNA-positive lymphocytes, abtained from different times p.i., 
remained constant over the tested time periode (1 to 7 months p.i.). This indicates that 
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usually no possible spontaneous reactivation of latent PRV in those cells does occur. 
(b) During acute phase of infection and after reactivation of latency, a subset of PBL 
and BM cells was found productively infected. Comparison to other organ tissues of the 
same pigs indicated that reactivation of latent PRV is independent of virus production in 
e. g. neural tissues. 
(c) More detailed analysis of in vivo latently infected lymphocytes demonstrated the 
expression of both LAT as well as early and early-late PRV genes in c.a. 0.1 % of 
these cells. 
PARTNER 3:1. ALMEIDA N. V.R.L. USBONPORTUGAL 
In Vitro Study of Aujeszky Virus Interactions with cultured Cells from the 
[Nervous System 
Several in vitro systems have been developed to assay the neuropathogenic properties of 
Pseudorabies virus strains (PRV) (Aujeszky). 
The cellular tropism, viral cythopathic characteristics and replication were investigated 
in various cellular substrates. 
Cell lines (human neuroblastoma, IMR 32 and mouse neuroblastoma, Neuro2A) and 
dissociated embryonic cells (obtained from rat dorsal root ganglia, DRG and the 
cerebral cortex) were assayed for their susceptibility to PRV virus infection. These cells 
were infected either with the Kojnok wild-type, or the Bartha vaccine strain. Infection 
of cells were evaluated by both virus titration and virus-specific fluorescence staining 
whereas the type of cells obtained from dissociated cultures was evaluated by GFA 
staining for glia and neurofilament or tetanus toxin markers for neurons. 
A1 Infection of Neuroblastoma cells 
SUSCEPTIBILITY 
Both cell lines are susceptible to the wild-type and vaccine strains. However, infection 
of Ncuro2A cells is far more efficient (with a MOI in the range of 0.0001 pfu/cell for 
Kojnok and 0.001 pfu/cell for Bartha, whereas both strains infect the human 
neuroblastoma cells in the range of 0.1 pfu/cell). 
CYTOPATHOLOGY 
Kojnok-infected mouse neuroblastoma cells exhibit extensive cytopathology affecting 
all the cells, with PVR antigen-positive multinucleated cells whereas human neurons 
predominantly exhibit viral antigens in cytoplasm, only in foci of syncytial cells. 
Bartha infections result in less number of infected Neuro2A cells than Kojnok with a 
nuclear localization of viral antigens and rather little evidence of alteration on cellular 
morphology. Surprisingly, IMR 32 infected cells exhibit similar pattern of infection as 
the Kojnok strain. 
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VIRAL YIELDS 
The viral yields obtained from Kojnok strain-infected Neuro2A cells is in the range of a 
10 fold increase compared to that obtained from IMR 32 infected cells, confirming the 
observations from susceptibility and cytopathic criteria. 
Titration of Bartha viral yields is under way. It is presumed that viral titers would be 
lower. 
B) Dissociated Embryonic Cultures of RATS 
Preliminary results show that DRG derived cells are susceptible to Kojnok strain 
infection with an early and predominant involvement of glia. Some neurons are infected 
only later. Cytopathic effects as multinucleated cells affecting the glia and swelling of 
neurons are also observed. Forty-eight hours after infection, most neuritic extensions 
have collapsed. 
Q Dissociated embryonic cultures of piglets 
An attempt to culture dissociated cells from the porcine nervous system succeed in 
obtaining viable cells in preliminary trial, cells from DRG are collected on 48 days old 
fetus as cortex cells. 
Conclusion 
The data show clearly the high susceptibility of Neuro 2 A cells to Kojnok strain, and 
the restriction to infection of IMR-32 cells, mainly to Bartha strains. IMR-32 cells are 
apparently capable to down-regulate the expression of the PVR genome. This may be 
of interest for establishment of a persistently infected cell line. The fact that glia may be 
more susceptible to PRV infection than neurons in DRG cells may need further 
confirmation using glia cell lines. 
Remark 
The above experiments have been performed using the facilities and routine rat 
dissociated cultures from neural tissues at the Rabies Unit, Pasteur Institute, Paris (H. 
Tsiang). 
PARTNER 4:P. SHELDRICKThFOULONIRSCCNRS VKLEJUIF FRANCE 
Characterization of mRNA's expressed in tissues of latently infected pigs. 
Construction ol a clJINA bang 
Using two herpesviral model systems, pseudorabies virus (PRV) and a cottontail rabbit 
herpesvirus (CTHV), the latter of which has in the past been extensively studied in our 
laboratory, we have examined cDNA banks produced from productively infected cells 
in tissue culture as a prelude to subsequent studies on latently infected animals. In 
particular, we are concerned with the reproducibility of various methods for the 
production of cDNA (enzymes, reaction conditions, etc) and the reprcsentativity 
(whether all mRNA's are detected) of the cDNA banks generated. 
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OUT more complete results with CTHV indicate, for example, that a substantial fraction 
(ca. 20%) of the genome is refractory to cloning in several vectors and that the cDNA 
technique will not detect RNA from these regions. Our results since six months indicate 
that, in the regions of PVR examined thus far, lack of representativiry is not a major 
problem, and we will soon proceed to an analysis of tissue samples (with initial 
emphasis on peripheral blood lymphocytes and bone marrow) supplied by the Tubingen 
laboratory (participant 2). 
PARTNER 5: M. RIVIERE RHONE MERIEUXLYONFRANCE 
Not involved in this period. 
IX fflGHOGHTS MILESTONES; 
The briefly described results of a latent reactivable infection of porcine lymphocytes in 
vivo has been not reported before. Thus, part of the studies of this project shall now 
focus on furthem more detailled characterization of lymphocytes supporting a latent and 
productive PRV infection. Because of the available tools experiments for testing 1AT 
promotor activity and unequivocal proof of PRV lytic gene expression (e.g. by cDNA 
cloning) in those cells should be possible. The expected results will not only show 
whether regulation of latency in PBL/BM might be different from that in neuronal cells, 
but also might open new perspectives in testing and diagnosing latently infected pigs. 
Furthermore, this natural virus-host system will provide new insights in 
alphaherpesvirus latency, in general. 
The preliminary results of primary neuronal cell culture has been not reported before. 
We can consider the protocole is well defined and stocks of neuronal cells cultured 
derived from dissociated embryonic DRG of piglets will be produced for in vitro 
characterization of mutants and molecular constructs. 
X WIDER CONSIDERATIONS : NOTHING TO REPORT 
XI COOPERATIVE ACTIVrnES; 
- Meeting PARIS September 10th 1991 (all parts) 
- Transfer! of fetuses of piglets from PLOUFRAGAN to PASTEUR INSTiTUT 
(ALMEIDA working in rabies lab, Dr TSIANG) 
- Transfert of positive samples from TURBINGEN to VILLEJUIF to produce a cDNA 
bank) 
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OBJECTIVES SET FOR THE REPORTING PERIOD: 
The objective of the project is the construction of baculoviruses with enhanced insecticidal 
activity, but reduced survival in the field. This will be achieved by introduction of a 'built-
in' suicide mechanism or gene deletions into baculoviruses that would impair their 
survival, but not their short-term efficacy. After their construction these genetically 
modified, biologically contained viruses, will be tested in the laboratory (host-range) and 
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in a microcosm (persistence and spread). In this way information can be obtained about 
the biological behavior of such 'biosafe' viruses, which allows a prediction to be made on 
the consequences when released in the field. 
In the reporting period the objective has been to start the construction of the various 
recombinant viruses (1 and 3), to determine their biological activity (2 and 3) and host 
range (3) and to preliminarily test those recombinants already available in a microcosm (1 
and 2). 
MAJOR PROBLEMS ENCOUNTERED: 
Nothing to report. 
RESULTS: 
Construction of recombinants. 
Experiments have been initiated to produce a "suicide" Autographa califomica nuclear 
polyhedrosis virus (AcNPV) insecticide. The strategy involves the modification of the 
polyhedrin gene promoter to incorporate lacO (operator), together with a copy of the lad 
under the control of the plO promoter into a recombinant. Production of lad in virus-
infected insect cells in the absence of the substrate IPTG (binds lacl) should prevent 
transcription from the polyhedrin gene promoter and thus abolish polyhedra production. 
In the presence of IPTG the lacO is repressed and polyhedra should be synthesized 
normally. 
Baculovirus transfer vectors have been constructed based on the polyhedrin gene region 
(containing the hybrid polyhedrin gene promoter lacO) and the plO gene region (containing 
the lacl coding sequences). These have been characterized at the sequence level to confirm 
authenticity. The vectors are presently being used in co-transfection experiments to derive 
recombinant viruses; these will be characterized for polyhedra production in the presence 
(polyhedra-positive) and absence (polyhedra-negative) of IPTG. 
The construction of baculovirus recombinants with deletions of genes that affect the virus 
persistence in the field has been focusing on three genes, which have been described not 
to be essential for viral replication, increase virulence and reduce persistence of the vims. 
These genes are plO, the polyhedron-envelope gene (pp34) and the ecdysteroid UDP-
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glycosyl transferase (egt), respectively. Due to the fact that viruses containing deletions 
in these genes cannot be detected phenotypically, a marker gene is being inserted in or 
substituted for each of these three genes. The marker gene, the bacterial /S-galactosidase 
gene (lacZ), allows convenient screening of recombinant viruses by blue coloring of their 
plagues using the chromogenic indicator X-gal. Subsequent elimination of the lacZ gene 
by recombination with a transfer vector with a deletion in the gene of interest then leads 
to the desired deletion mutant. The deletion of a gene thus requires a two-step procedure. 
The various transfer vectors are now being constructed. 
The marker gene can be conveniently obtained from a previously designed transfer vector 
pAcDZl as a gene cassette in which the lacZ gene is under the control of a constitutive 
promoter (the Drosophila heat shock promoter, hsp70) and 3'-flanked by a SV40 
transcription terminator sequence. This gene cassette avoids the need to clone the lacZ 
gene as a fusion with the gene of interest. 
The availability of nearly all transfer vectors allows the introduction of the various single 
and double deletions and eventually the deletion of all three genes. Subsequently these 
recombinant viruses can be analyzed including the possible reduced capacity for survival 
in the field. 
Behavior of recombinants in microcosms 
The biological and behavioral properties of an AcNPV recombinant AS3 (plO-minus) and 
wild type AcNPV were analyzed in bio-assays and in a microcosm. The plO-minus 
recombinant AcNPV-AS3 has a deletion of the plO gene and has a reporter gene (lacZ) 
cassette (see above). AcNPV-AS3 was serially passaged (four times) in insects by feeding 
third-instar larvae of S. exigua and A. califomica through the diet. The DNA of progeny 
viruses was analyzed by DNA-gel-electrophoresis after each passage and found to be 
unaltered. 
The biological activity of recombinant AcNPV-AS3 and wild type AcNPV expressed as 
LCjo-value (lethal concentration 50%) was compared in standard bioassays. Five 
concentrations were used against first instar larvae of Spodoptera exigua and Autographa 
gamma (Table 1). No statistically significant differences in infectivity was determined 
between wild type and recombinant AcNPV. Standard curves were made for interpolation 
of the results of soil sample bioassays. 
A field release of the genetically manipulated AcNPV-AS3 and wild type AcNPV was 
simulated in a contained model-ecosystem, or miciccosm. This microcosm, constructed 
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during BAP, simulated the situation in vivo, including rain, solar UV, soil, sugar beet 
plants, and second instar larvae of the beet army worm S. exigua as much as possible. 
Each of the two viruses (wild type AcNPV and recombinant AcNPV-AS3) was applied in 
a 0.4 m2 compartment at a single dose of 4 x 107 polyhedral inclusion bodies (PIBs), 
equivalent to 1012 PIBs per hectare. After one larval generation (25 days), soil, plants and 
infiltration water were collected from the ecosystem and are being bio-assayed for virus 
quantitation. 
Equal quantities of the wild type AcNPV and AcNPV-AS3 (plO-minus) applied to 200 
larvae of 5. exigua showed no difference in response to infection (82 and 81% mortality). 
Budgetary studies of NPV production and partitioning involved foliage and soil extractions 
are being carried out at present. This suggests that 
Table 1: Bioassay of wild type AcNPV and (plO minus) AcNPV-AS3 against first 
instar larvae of S. exigua and A. gamma after 6 and 12 days. 
A, ganuno 
LCW (PBs/ml medium) 
S. exigua 
LC„ (PIBs/ml medium) 
7.12 x 10* 
7.87 x 104 
AcNPV 2.22 x 10> 
AcNPV-AS3  3.03 x 10> 
WIDER CONSIDERATIONS: 
Baculoviruses are insect pathogens which are successfully used as biological control agents 
of insect pests in agriculture and forestry. Notable successes have been in the control of 
forest, orchard and greenhouse pests. For instance, control of the pine sawfly, Neodiprion 
sertifer, with the respective nuclear polyhedrosis virus NsNPV, brassica pests by 
Mamestra brassicae NPV and the codling moth, Cydia pomonella, by its granulosis 
virus. Although baculoviruses are effective, there is a necessary period when disease must 
develop in the pest. During this time severe damage to the crop may occur. This slow 
speed of action is a major drawback to a much wider commercial application of these 
viruses and is most relevant for crops with low damage thresholds. Genetically modified 
baculoviruses with improved insecticidal properties could overcome this problem and may 
lead to the wider use of this ecorational and more environmentally sound control approach. 
Information on the ecological and environmental behavior of genetically modified 
baculoviruses is essential for the proper use in the future. 
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COOPERATIVE ACTIVITIES: 
All participants exchanged ideas and materials (transfer vectors and recombinants). They 
also agreed to meet twice a year, if possible in conjunction with a major international 
meeting. In addition, site visits are envisaged to support the transfer of technology. A 
promotional pamphlet (Blue Brochure) is being prepared for public interest to explain the 
activities of the group. 
LIST OF JOINT PUBLICATIONS / PATENTS WITH TRANSNATIONAL 
AUTHORSHIP: 
Undorf, K., Huber, J. and J.M. Vlalc. 1990. Freisetzung eines gentechnisch veranderten 
Kernpolyedervirus von Autographa califbrmca (AcMNPV) in einem Model-dkosystem. 
Mitteilungen der Biologischen Bundesanstalt. Berlin-Dahlem. 266: 322 
Roelvink, P.W., VanMeer, M.M.M., DeKort, C.A.D., Possee, R.D., Hammock, B.D. and J.M. 
Vlak. 1992. Dissimilar expression of Autographa califbmica multiple nucleocapsid nuclear 
polyhedrosis virus poiyhedrin and plO genes. Journal of General Virology 73: 000-OOO. 
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Hawtin, R.E., King, L.A. and R.D. Possee. 1992. Prospects for the development of a genetically 
engineered baculovirus insecticide. Pesticide Science 34: 9-15. 
Martens, J.W.M., J.W.M. van Lent, G. Honee, D. Zuidema, L. Visser and J.M. Vlak. 1991. 
Insecticidal activity of a Bacillus thuringiensis toxin expressed by baculovirus recombinants. 
IOBC/WPRS Bulletin 14: 185-190. 
Stewart, L.M.D., Hirst, M., Ferber, M.L., Merryweather, A.T., Caylay, P.J. and R.D. Possee. 
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Combat of Pests". Butterworth en Heinemann Ltd., Oxford, U.K., p. 221-242. 
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OBJECTIVES FOR THE FIRST YEAR OF THE PROJECT: 
1. Development of vector and reporter systems 
1.1.Exploit the natural selection method to obtain 
various Rhizobium and Bradvrhizobium s t ra ins 
defective in thymidilate synthase 
1.2.Evaluate the performance of the thv vector in the 
rhizosphere under greenhouse and field conditions 
1.3.Construction of inducible r epor te r systems 
2. Construction of a suicide system for R.meliloti 
2.1.Evaluate the performance of the R.meliloti thv in the 
rhizosphere under greenhouse and field conditions 
2.2.Genetic manipulation of the Lactococcus lactis thv 
car t r idge in preparat ion for a conditional expression 
system 
3. Evaluation of genetically modified inoculum strains 
3.1.During inoculant manufacturing process 
3.2.Evaluation at microcosm and greenhouse level 
4. Evaluation of natural occurring populations 
4.1.To use pyrolysis mass spectrometry (PYMS) to look for 
distances between isolates of Bradvrhizobium 
iaponicum isolated from soybean plants grown in Itaiy 
4.2.To s tudy isolates from Italy using DNA hybridization 
4.3.To look at population of Rhizobium in soil of 
differing character is t ics and from different 
geographic regions 
4.4.To look at the effect of factors, such as 
manipulating the water table, on survival 
MAJOR PROBLEMS ENCOUNTERED: 
Overall considered, the work programme is in progress as outlined. The 
following problems have been encountered to date: 
- the PYMS equipment in Bristol universi ty became unavailable to 
develop it as a research tool for this project and l inks are being 
established with Professor M. Goodfellow and G.Manfio at .Newcastle 
University 
- DNA hybrydization is too slow and the th roughput of strains is 
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res t r i c ted : the use of PCR fingerprint ing has s tar ted to overcame the 
above difficulties, but DNA hybridization still provides a very useful 
backup procedure for s train testing 
- at the University of Bristol the team is waiting for a licence to 
import soil 
- at UCC the experiments for the evaluation of GM rhizobia under 
greenhouse conditions are delayed because the soil intended for these 
experiments was found to contain a resident R.meliloti s train able to 
outcompeting the test s train 
- at the University of Padova the team is awaiting for permission to 
ca r ry small-scale field experiments with GM rhizobia; the notification 
and permit application were received in 1991 at the Ministry of 
Agriculture; the notification was found to comply with the rules set by 
the Directive 220/EEC; however the need to have the detailed 
regulatory framework approved through the Parliament has greatly 
affected the procedure for permit notification to the applicant 
RESULTS: 
1. Development of vector and r epo r t e r systems 
1.1. The selection of spontaneous thy mutant s t ra ins in the presence of 
antifolate d rugs has proven to be readily applicable for selection of 
R.meliloti thv mutant s t ra ins . Under greenhouse and field conditions, 
revers ion to wild type has been observed. The R.meliloti thv gene has 
been cloned by complementation of a spontaneous R.meliloti thv mutant. 
The availability of this gene opens the way to a reverse genetic 
approach to obtain stable R.meliloti thv mutant s t ra ins . 
The natural selection procedure has been proven to be unsuitable for 
the generation of B.iaponicum thv mutant s t ra ins . These organisms 
displayed a high intr insic resis tance tc the antifciate d rug . We 
envisage cloning the B.iaponicum thv gene by complementation of either 
R.meliloti or E.coli thv mutants. A reverse genetic approach will then 
adopted to obtain definite B.iaponicum. 
1.2. The thv vector system has been evaluated for R.meliloti under field 
conditions. It was found to perform exceptionally well. The R.meliloti 
thv mutant s t ra in was found to rever t back to wild type at a 
frequency of 85% . However, this figure may be distorted because the 
thv mutants are impaired in their capacity for survival . Even so, 
plasmid retention in the thv mutant complemented with an IncP plasmid 
was found to be virtually 100% . This is a significant improvement 
compared with 81% retention of the same plasmid in the wild type. 
Analysis of symbiotic efficiency indicated a marginal reduction in 
acetylene reduct icn, but no effect on the shoot dry weight of the 
p lants . 
1.3. A synthet ic promoter, which has proven to be of great efficiency 
in Rhizobium. has been linked to a promoterless lacZ gene; the la£ 
operator , a ribosome binding site and a translation s ta r t codon have 
been conveniently placed. The creation of two additional restr ict ion 
sites for the enzymes Xbal and Bglll by site directed mutagenesis has 
allowed the addition of a functional i ac l q gene which will provide a 
basis for the regulation of such repor te r casset te . The mercury 
res i s tance gene is present ly being cloned aside the lac unit and the 
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final product will be inser ted in Rhizobium leguminosarum both 
chromosomally via homogenotization of a Rhizobium recA copy, and on a 
broad host range plasmid vector. In addition, the efficiency of lac+ and 
mercury-resis tance as phenotypical markers in Rhizobium has been 
assessed. The data indicate 8 ug/ml HgC12 as the tolerable limit for a 
s train containing the mercury-res is tence determinant in TY medium, 
where the wild type strain will not grow above 1 ug/ml. As r ega rds 
lactose utilization a s t ra in bearing a lacZ gene showed a much be t t e r 
growth on minimal medium plus lactose. 
2. Development of a suicide system for R.meliloti 
2.1. The capability of the mutants to survive in the rh izosphere and to 
nodulate alfalfa was examined under greenhouse and field conditions. 
The interpretat ion of the field data was complicated by the fact that 
the thy mutant inoculum strain rever ted to wild type and that it 
proved to be difficult to reisolate the mutants from the nodules. 
However, the fact that thv bacteria could be reisolated from the 
nodules at the end of the growth season demonstrated that the mutants 
can survive the ent i re lenght of the experiment. It is possible that the 
rever ted bacteria may be responsible for sustaining the thv mutants . 
Only one nodule out of 58 was found that was apparent ly entirely 
occupied by the thv mutant. Others were either 100% rever ted or 
contained a mixture of t hv + and thv bacteria. Greenhouse experiments 
current ly in p rogress are designed to evaluate if the host plant can 
sustain the thv mutant s t ra in in hydroponic cul tures . 
2.2. The Lactococcus lactis thv gene is being cloned and manipulated in 
order to remove the expression signals and to facilitate the cionig of a 
suitable promoter to conditionally express the gene. The na ture of the 
expression signals will be decided upon evaluation of the plant data 
current ly being accumulated, concerning the survival and effectiveness 
of the thv mutant s t ra ins . 
3. Evaluation of genetically modified inoculum strains 
3.1. The conditions to process the vermiculite matrix to be used in the 
production of (genetically modified) inoculants were identified. From 
our experience and from data in l i tera ture , this car r ier seems the most 
appropria te in ensur ing both survival and performances of the 
inoculant. vermiculite samples packaged in polyethylene bags have 
been irradiated with 2.5, 5 and 7.5 Mrad. 
The treatment with 5Mrad seems to provide the best steri le conditions 
vs . minimum radiation used. In order to carry out a serological 
identification test , a New Zealand rabbit has been immunized against 
B.iaponicum 602/A. The immune serum will be used for rapid 
identification and confirmation tes ts in the experiments dur ing the 
programme phases. 
3.2. These experiments are expected to be terminated in the next phase. 
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4. Evaluation of natural ly occuring populations 
4.1. The PYMS analysis indicated that there was genetic drift, on the 
basis that some isolates differed slightly from the introduced s t rains . 
One isolate was very different and couid have been another strain 
used as an inoculant elsewhere in Italy. We are checking to see 
whether the strain had been released locally and are examining the 
isolates fur ther . 
4.2. Using a cloned insert ion sequence as a probe for DNA 
hybridization s tudies , we were able to character ise s t ra ins in a very 
reproducible manner. However, this technique is res t r ic ted in 
th roughput because it requi res that good quality DNA be prepared 
from each s t ra in to be tes ted. 
4.3. It is possible to produce a f ingerprint of an isolate by adding a 
small amount from a colony to an eppendorf tube, adding reagents for 
DNA synthes is , boiling briefly to lyse cells and denature DNA, and then 
synthesizing DNA using the polymerase chain reaction (PCE). The DNA 
is synthesized from "universal" primers which recognize similar 
sequences in the genome if conditions for DNA annealing are not too 
s t r ingen t . The pa t t e rns produced can be scanned and the data fed to a 
computer programme which will produce dendrograms showing 
re la tedness . At least 50 samples a day can be handled with ease. This 
technique is being developed. 
4.4. In order to assess the influence of water- table depth and soil pH 
on survival of B.iaponicum the field is being prepared for the 
experiment. The water table will be controlled piezometrically and the 
ins t ruments have been installed. Two sites have been identified, one at 
pH 6 and the other at pH 7.7. The physical-chemical trai ts have been 
character ized and the cropping history recorded. The main biological 
t ra i t s are being defined, including the number of resident B.iaponicum 
by the MPN technique. 
HIGHLIGHTS/MILESTONES: 
The thy system proved highly effective in ensuring stable maintenance 
of the piasmid under field conditions. Ih i s was found to be the case 
even though the thy mutant s t ra in was found to rever t at a ra ther 
high frequency. This demonstrates that the presence of the thy gene 
on a self-replicating piasmid removes the p res su re for the thv host 
s t ra in to r eve r t to wild-type. 
The lac and lac /Hg r casse t tes provide a tool which is based on a 
catabolic inducible r epor te r system without antibiotic resistance 
markers . The expression levels, comparable or higher than those 
obtainable with tac promoter, allow unambiguous detection of the 
genetically modified microbe. 
WIDER CONSIDERATIONS: 
Stable vector system based on thv will bw available for the 
introduct ion of novel genetic t ra i ts in commercial inoculant s t ra ins . 
They will also give improved consistency to experiments designed to 
evaluate the effects of such t ra i t s on symbiotic efficiency of the host 
organism. 
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COOPERATIVE ACTIVITIES: 
One progress meeting has been organized at Gaiba on december 17th, 
1991. Representatives of all partecipat ing insti tutions were present . 
LIST OF JOINT PUBLICATIONS: -
OTHER PUBLICATIONS/PATENTS: 
Nuti, M.P., Squartini A., Guerra E., Ollero F.J., Corich V., and Giacomini 
A. (1992). Monitoring genetically modified soil microbial inoculants. In 
"Genetically modified organisms for the 1990's", G.Tzotzos et al. Eds. (in 
the p ress ) . 
- 3 4 3 -
TITLE : METHODOLOGY FOR THE FAST DESIGN OF FUNGAL 
DNA PROBES AND PCR PRIMERS 
CONTRACT NUMBER: BIOT - CT91- 0301 
STARTING DATE: DECEMBER 1st, 1991 
COORDINATOR OF THE CONSORTIUM: 
W. MOENS, IHE - Biosafety rDNA & Biotechnologies, Brussels, BE 
PARTICIPANTS: 
J. FRISVAD, Danmark Teknische Hojskole, Dpt of Biotechnology, Lingby, DK 
F. GANNON, University College Galway, Dpt of Microbiology, Galway, EI 
N. NOLARD, HE- IHEM Fungal Culture Collection , Brussels, BE 
O. RASMUSSEN, Biotechnological Institute, Lingby, DK 
V. RUBIO, Inst, de Investigaciones Biomedicas, Lab. de Hongos Filamentosos, Madrid, ES 
OBJECTIVES: 
Main 
Fungal strains representative of the major genera and species involved in several areas of 
biotechnology have been selected by the consortium and will be studied under two coordinated 
approaches: 
-taxonomy and culture collection standardization, 
-molecular typing (including validation and sampling) and computerization of 
results. 
Potential genera-, species-, strain- specific PCR primers and derived DNA probes are designed 
and validated by the participants. The specificity of the primers or probes is defined and 
controled on basis of the ecological niches to which belongs the fungi of interest.. 
The aim is to use PCR primer design for fungal molecular typing and taxonomy, identification 
and ownership certification, environmental & health biosafety and description of fungal 
biodiversities. 
Reporting period 
1) Assessment of the methodological model: design of PCR primers for the taxon identification 
and diagnostic of human pathogenic fungi of general epidemiological interest. 
-Standardization of a fast preparation method for PCR-quality fungal DNA and building 
a bank of certified DNA batches 
-Standardization of PCR formats and validation by participants 
2) 1st contact group meeting 
-Taxonomy & culture collection management 
-Coordination of PCR and sequencing strategies 
-Management of Bibliographic review 
-Definition of the specific contribution of each participant 
-Negociations about formal consortium foundation 
3) Next objectives 
-Testing families of consensus primers 
-Standardization of common PCR and PCR products sequencing protocols 
-Computer networking and design of shared core of laboratory and results database 
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MAJOR PROBLEMS ENCOUNTERED: 
The available fungal DNA sequences of the ribosomal 18S subunit only provide a low number 
of target for species-specific primers. A first alternative strategy aims to systematically sequence 
and align interspaced regions between the fungal 18S and 23S subunits. In the second 
alternative, the same approach is applied to the description of the DNA sequences upstream the 
5' part of the 18S subunit. These regions of the ribosomal genes being under lower 
evolutionary pressure, it is expected to increase the number of species-specific PCR priming 
areas. 
RESULTS 
Coordinator's 
The first 4 months of this concerted action include the results of a research undergone one year 
during the grant application of the project. They concerns: 
-the set up of the standardized DNA preparation method and PCR format; 
-the develoment of fungal genera- and family-specific PCR consensus primers 
-the assessment of the whole methodology when applied to the seek of PCR primers for the 
taxonomical certification and the clinical diagnostic of fungi pathogenic or lethal to 
immunocompetent and immunocompromised humans. 
From the later, highly specific primers for 4 very important fungal pathogens where designed 
and validated in the coordinator's laboratory. The biological background of the primers 
involves 32 fungal species representative of the most prominent species encountered in the 
human ecological niche. The DNA bank builded from certified strains of the IHEM collection -a 
culture collection specialized in fungi of environmental and health interest- allowed to 
systematically study the inter- and intraspecificities but also the intergenera specificities of 
several PCR primer candidates within 5 months. Till now, this work has involved about 90 
strains and the results will be continued along the building of the consortium fungal DNA bank. 
Apan from the usefullness of the found primers, this study has shown that the concepts 
underlying the methodology are at first glance correcdy defined. 
Participants 
1)Along the first contact group meeting, the participants have agreed on the basic concepts 
underlying the methodology of the concerted action and on the quality insurance aspects. 
Among the last, three major requirements were defined: 
-Taxonomical certification by Prof. Frivad and Dr. Nolard and registration of all fungal strains 
in the IHEM collection before starting any DNA study; 
-Harmonization of the DNA preparation, oligonucleotide synthesis, DNA sequencing and PCR 
protocols in Gannon's, Moens', Rassmussen's and Rubio's teams. 
-Use, exchange of strains, DNA batches, PCR products, and DNA sequences in the frame of a 
common DNA bank and common raw data and sequence databases. 
2) Fungal DNA batches, consensus primers and protocols have been distributed to the 
participants for control and improvement at start of the concerted action. 
3) Each participant has selected a set of fungal strain of taxonomical and/or biotechnological 
interest for which species-specific PCR primers have to be designed. 
This goals involve computer analysis of fungal ribosomal DNA sequences and further 
production of new DNA sequences, particularly in the intergenic DNA sequences of the 
345-
ribosomal operon (ITS region). The ITS region will be amplified by PCR in one or two pans 
using consensus primers for the 3' end of the 18S subunit, the 5' Stan of the 23S subunit and 
the middle of the 5S subunit. The two first consensus primers available in the literature failed to 
prime DNA amplification in several families of fungi. Therefore the consensus primers will be 
improved to match the broadest interfamily consensus (F. Gannon and W. Moens). Family 
consensus for the 5S subunit are presently designed and studied (W. Moens). Sequencing of 
PCR products is a key pan of the study and requires a good interlaboratory standardization (O. 
Rassmussen). Automated sequencing facilities are available for large scale sequence production 
(V. Rubio and F. Gannon). 
HIGHLIGHTS/MILESTONES 
A set a species-specific PCR primers for fungi pathogenic to humans has been designed in a 
very short period of time along a background of 32 species involving a set of 90 strains. 
Along the building of the consortium DNA bank and ribosomal DNA sequence database, the 
rate at which PCR primers can be designed for a given species in a given ecological niche 
should increase rapidly. 
WIDER CONSIDERATIONS 
The European consortium for fungal molecular typing aims to the fast design of PCR primers 
and DNA probes of clinical, agronomical, aquatic, food, environmental and taxonomical 
interest. Each participant may act has a representative of the consortium for contacts with third 
party. 
When engaged by third parties, the consortium manages the research according to the specific 
requirements of the demander . Given the adaptative character of such system of laboratories 
without wall and his concerted data sharing, any collaboration with the consortium further 
increases his potentialities. 
COOPERATIVE ACTTVTnES 
Next contact group meeting: June 25-26th, Madrid 
Exchange of scientist: 
From coordinator's lab an V. Rubio's lab to O. Rassmussen's lab: 2 and 1 scientists for 1 week 
Exchange of certified material: fungal strains and/or DNA batches 
Shared material: PCR primers, PCR products, DNA sequences, sequence alignments 
LAST NON JOINT PUBLICATIONS 
T. Barry, G. Colleran, M. Glennon, L. Dunican and F. Gannon (1991) 
The 16S/23S Ribosomal Spacer Region as the target for DNA probes to identify Eubacteria 
in "PCR methods and Applications" CSHLP ISSN 1054-9803/91 p51-56 
O. Rassmussen and J.C. Reeves (1992) 
DNA probes for the detection of plant pathogenic bacteria (Minireview) 
Accepted in "Journal of Biotechnology" 
O. Rassmussen et al. (1991) 
Listeria monocytogenes Isolates can be classified into two major types according to the 
sequence of the Listeriolysin gene 
Infection and Immunity 59:3945-3951 
O. Rassmussen et al. (1991) 
A rapid polymerase Chain Reaction (PCR) -based assay for the identification of Listeria 
monocytogenes in food samples 
Intern. J. Food Microbiology 
C Dawson and B. Van Vaerenbergh, N. Nolard and W. Moens (1992) 
A model for the fast design of taxon-specific PCR primers: application to the diagnostic of the 
four major human fungal pathogens, Aspergillus spp, C. albicans, C. Krusei and Cryptoccus 
neoformans 
(in preparation) 
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BRIDGE 
T-PROJECTS 

T-PROJECT 
SEQUENCING OF THE YEAST GENOME 

TITLE SEQUENCING OF THE YEAST GENOME 
CONTRACT NO. BIOT 0167 
STARTING DATE 
OBJECTIVES 
January 1st 1991 
Sequencing of the entire chromosomes II (840,000 bp) and 
XI (630,000 bp) and of 230,000 bp duplications for controls 
(15%) and 40,000 bp overlappings (700 bp for each of the 
60 cosmids). A total of 1,800,000 bp is thus to be sequenced 
between January 1991 and December 1993. 
ADMINISTRATIVE 
COORDINATOR Frangoise Foury, Universit6 de Louvain, B 
DNA COORDINATOR Chromosome II, Horst Feldmann, Universitat Munchen, D 
( see page 355) 
Chromosome XI, Bernard Dujon, Institut Pasteur, Paris, F 
(see page 358) 
INFORMATIC 
COORDINATORS Werner Mewes, Martinsried Institut fur Protein Sequences 
(MIPS), D (see page 366) 
John Sgouros, MIPS, chromosome II 
Martina Haasemann, MIPS, chromosome XI 
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SEQUENCING SUBCONTRACTORS 
Michel Aigle/Marc Crouzet, University de Bordeaux, F 
Wilhelm Ansorge, European Molecular Biology Laboratory, Heidelberg, D 
Claus Christiansen, Genetic Engineering Group, Lyngby, DK 
Horst Domdey, Genzentrum, Munchen, D 
Bernard Dujon, Institut Pasteur, Paris, F 
Karl-Dieter Entian, Universitat Frankfurt, D 
(with Martin Brendel, Goethe-Universitat, Frankfurt, D and 
Fred Zimmerman, Technische Hochschule Darmstadt, Darmstadt, D) 
Horst Feldmann, Universitat Munchen, D 
Walter Fiers, Rijksuniversiteit Gent, B 
Francoise Foury, University Catholique Louvain, B 
(with Claude Jacq, Ecole Normale Sup6rieure, Paris, F) 
Hiroshi Fukuhara, Institut Curie, Orsay, F 
(with Monique Bolotin, University de Paris-Sud, Orsay, F) 
Nicolas Glansdorff, Research Institute CERIA-COOVI, Bruxelles, B 
Les Grivell, Univesiteit van Amsterdam, NL 
Francois Hilger/Daniel Portetelle, Faculty Sciences Agronomiques, 
Gembloux, B 
Corn Hollenberg, Institut fur Mikrobiologie, Dusseldorf, D 
Michel Jacquet, University de Paris-Sud, Orsay, F 
Jean-Claude Jauniaux, University Libre de Bruxelles, Bruxelles, B 
Antonio Jimenez, Universitad Autonoma Madrid, Madrid, E 
David McConnel, Trinity College, Dublin, IRL 
Steve Oliver, Manchester Biotechnology Center, Manchester, UK 
Peter Philippsen, University of Giessen, Giessen, D 
Rudi Planta, Vrije Universteit Amsterdam, Amsterdam, NL 
Fritz Pohl, Universitat Konstanz, Konstanz, D 
Michael Rieger, Biotechnologische und Molekularbioiogische Forschung, 
Wilhelmsfeld, D 
Claudia Rodrigues-Pousada, Instituto Gulbenkian de Ciencia, Oeiras, P 
Piotr Slonimski, Centre de Genetique Moleculaire, Gif-sur-Yvette, F 
Yde Steensma, Rijksuniversiteit Leiden, Leiden, NL 
George Thireos, Institute of Molecular Biology and Biotechnology, 
Heraklio, GR 
Dieter von Wettstein, Carlsberg Laboratory, Copenhagen, DK 
PREPARATION OF CHROMOSOMAL LIBRARIES FOR THE NEXT 
BIOTECH PROGRAMME 
Chromosome VIII: Steve Oliver, Manchester Biotechnology Center, Manchester, UK (se< 
page 363) 
Chromosome X: Francis Gallibert, Bernard Dujon, Hdpital St. Louis and Institut Pasteur 
Paris, F (see page 364) 
Chromosome XIV: Peter Philippsen, Universitat Giessen, D (see page 365) 
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RESULTS 
DNA COORDINATION 
Thanks to the preparative work carried out in 1991 by Horst Feldmann and 
Bernard Dujon, all sequencing subcontractors have received their first 
cosmid in February or March 1991. 
SEQUENCING 
At the end of March 1992, the 28 principal subcontractors had submitted a 
total of 542,161 bp, including about 50,000 bp of preliminary data. This 
amounts to near 15.000 bp per year and per principal contractor. During the 
first 14 months of the BRIDGE Programme, only 11 subcontractors have 
submitted more than 25,000 bp, 7 others have submitted less than 10,000 
bp and 4 have not submitted any data yet. 
DATA ANALYSIS 
Two listing of homologies of the open reading frames have been circulated 
to YIP members and the coordinators. 
Each contractors have received a summary listing of the homologies of the 
open reading frames detected in their submitted sequences. 
PREPARATION OF ORGANIZED COSMID CHROMOSOMAL 
LIBRARIES FOR THE NEXT BIOTECH PROGRAMME. 
The preparation of cosmid libraries from chromosomes V, VIII, X, XIV, and 
XVI were considered. However chromosomes V and XVI were abandoned. 
The construction of the chromosome X library is terminated, that of 
chromosome XIV is expected to be finished in 1992. 
ADMINISTRATIVE COORDINATION 
All principal contractors have received an advance payment of 45,000 ecus 
within the two weeks after signature of their subcontract. A second payment 
of 45,000 ecus has been made within two weeks after reception by the 
administrative coordinator of the approval by the DNA coordinators of the 
quality statement (including the description of sequencing strategy) provided 
by the sequencing contractors. 
-353-
COMMENTS 
During the remaining 22 months of the BRIDGE programme about 1,300,0 
bp of additional final sequence will have to be carried out. This correspor 
to a steady submission of slightly more than 26,000 bp per year and | 
principal sequencing subcontractor. 
The average rate of sequence submissions will have to be increased by 
73% during the 22 remaining months compared to the submissions 
performed during the first 14 months. In particular, the problems 
encountered' by the slow sequencers have to be sorted out 
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TITLE: 
Sequencing of Yeast Chromosome II BIOT - 0167 
OFFICIAL STARTING DATE: 
January 1st, 1991 
COORDINATOR: 
Prof. Dr. Horst Feldmann, Universitat Munchen, D 
PARTICIPANTS: 
The following laboratories participated in sequencing 
Prof. Dr. Michel Aigle, Universite de Bordeaux, F 
Dr. Claus Christiansen, Genetic Engineering Group, Lyngby, DK 
Prof. Dr. Horst Domdey, Genzentrum, Munchen, D 
Prof. Dr. Karl-Dieter Entian, Universitat Frankfurt, D 
Prof. Dr. Horst Feldmann, Universitat Munchen, D 
Prof. Dr. Walter Fiers, Rijksuniversiteit Gent, B 
Dr. Francoise Foury, Universite Catholique Louvain, B 
(with Prof. Dr. Claude Jacq, Ecole Normale Superieur, Paris, F) 
Dr. Nicolas Glansdorff, Res. Inst CERIA-COOVI, Bruxelles, B 
Prof. Dr. Les Grivell, Universiteit van Amsterdam, NL 
Prof. Dr. Michel Jacquet, University de Paris-Sud, Orsay, F 
Prof. Dr.David McConnell, University of Dublin, EI 
Prof. Dr. Fritz Pohl, Universitat Konstanz, D 
Prof. Dr. Pjotr Slonimski, CNRS, Gif-sur-Yvette, F 
Prof. Dr. H. Yde Steensma, University of Leiden, NL 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Each of the above contractors should receive one appropriate cosmid clone of 
chromosome II for mapping and sequencing, whereby the sequencing strategy was left to 
his discretion. The data (final contigs >5kb) should be entered into the dataset 
administered by Martinsried Institute of Protein Sequences (MIPS) under the 
supervision of the DNA coordinator. The data should be analysed for genetic entities 
and other criteria by MIPS and the results be communicated to the contractors. 
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MAJOR PROBLEMS ENCOUNTERED: 
No problems were encountered with the stability and the tractability of the clones. Some 
of the sequencing data were transmitted to MIPS rather late. A few contractors have 
delivered no sequencing data as yet. 
RESULTS: 
Prior to this project, we had prepared an ordered cosmid library covering yeast 
chromosome II (strain C836). A set of ca. 40 overlapping clones was used to assemble a 
physical map and to correlate it with the genetic map of chromosome II known at that 
time. It was found that both of these maps were largely co-linear. On this basis, a cosmid 
library of strain aS288 was established and clones for chromosome II (840 kb) were 
selected and mapped. A schematic overview is presented in Figure 1. 
In a first round, each contractor received a (non-overlapping) aS288 cosmid clone 
containing 30-40 kb of yeast DNA insert to undertake restriction fine mapping and 
sequencing. Extending cosmids have been supplied, whenever the contractor had 
submitted > 25 kb of final data from his first cosmid. 
The status of data obtained from the contractors (as of the end of February 1992) is 
documented in Table 1. 
Analysis of the sequence data was carried out by MIPS in collaboration with the DNA 
coordinator. The results are listed in Table 2. Altogether, 130 open reading frames were 
encountered including 6 genes for tRNAs, several singular delta, sigma and tau 
elements, and a complete Ty2 element 27 of the protein encoding entities can be 
attributed to known functions or already gentically mapped loci. For 35 ORFs, 
significant FASTA scores were obtained, from which putative functions can be 
predicted. 
HIGHLIGHTS/MILESTONES: 
The analysis of the larger contigs allows to conclude that the genetic information on 
yeast chromosome II is tightly packed: on the average, one genetic entity is encountered 
every 1.8 kb. The average GC-content of chromosome II is extrapolated to be 38.7 %. 
This figure is similar to the one obtained from total chromosome III (38.5%). Normally, 
the coding regions on chromosome II exhibit a higher GC-content (up to 46.9%) than 
the non-coding regions (as low as 27.8%); this seems to be a general rule for the yeast 
genome. As it appears, the leftmost cosmid clone contains telomeric sequences. 
Among the new proteins on chromosome II are several that reveal significant similarity 
with interesting regulatory factors from other species, particularly higher eukaryotes. 
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WIDER CONSIDERATIONS: 
The complete sequences of yeast chromosomes HI, II and XI will render information on 
the genomic organisation and the structures of about 1000 new genes. Together with the 
1000 sequences in the databanks and data from activities outside the EC, the repertoire 
of known yeast genes should amount to some 2500 by the end of 1993. We are confident 
that the final goal of the yeast genome project can be reached within a reasonable period 
of time, thus establishing the entire DNA sequence of this eukaryotic organism with a 
coding capacity for some 8000 different functions. This will contribute a wealth of 
information to understand the molecular biology of a living cell and, at the same time, 
be of benefit for any other genome project. There is accumulating evidence that all of 
the basic functions, such as enzymes, structural proteins and regulatory factors, in yeast 
share high similarity with their counterparts in higher organisms. In a large variety of 
cases, it has already been possible to functionally exchange such entities between yeast 
and other species. In fact, yeast offers a unique opportunity to study functional aspects 
by concomitant genetic and biochemical approaches. Furthermore, techniques 
experienced along with the yeast genome project will be of invaluable help in other 
genome projects. At the same time, yeast can be used to clone and to propagate large 
pieces of genetic material from other organisms. Finally, it should be emphasized that 
yeast is of outstanding industrial importance, both as a source of interesting novel 
protein products as well as a potent instrumental system in biotechnology. 
COOPERATIVE ACTIVITIES: 
In general, interaction between the contractors and the coordinator was good; 
communication and feedback was mainly achieved through E-Mail or Fax. In addition to 
the cosmids, the contractors received probes of the vector and the following information 
material: (1) continuously updated maps of chromosome II; (2) a list of all elements 
genetically mapped and physically characterized on chromosome II; (3) catalogues of 
chromosome II sequences, special sequence entries for Ty-derived elements and tRNA 
genes; (4) documentation on yeast regulatory proteins and sequences. 
A meeting for all contractors of chromosomes II and XI was organized by the Yeast 
Industrial Platform (YIP) in Brugge, September 22-24, 1991, where any relevant 
information concerning the project was exchanged and future strategies were discussed. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL 
AUTHORSHIP: 
Too early at this stage of the project. 
OTHER PUBLICATIONS/PATENTS: 
Too early at this stage of the project. 
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TITLE: SEQUENCING OF YEAST CHROMOSOME XI 
B I O T - 0 1 6 7 
OFFICIAL STARTING DATE: 0 1 / 0 1 / 9 1 
COORDINATOR: BERNARD DUJON, INSTITUT PASTEUR. PARIS, FR 
PARTICIPANTS: W. ANSORGE, EMBL, HEIDELBERG, DE 
B. DUJON, INSTITUT PASTEUR, PARIS, FR 
M. BOLOTIN-FUKUHARA, U. PARIS XI. ORSAY, FR 
F. FOURY, U. C. LOUVAIN. LOUVAIN-LA-NEUVE, BE 
H. FUKUHARA, INSTITUT CURIE. ORSAY, FR 
F. HILGER, FAC SC. AGRO. GEMBLOUX. BE 
C. HOLLENBERG, U. DUSSELDORF, DUSSELDORF. DE 
J.C. JAUNIAUX, U. L. B. BRUXELLES, BE 
A. JIMENEZ, U. AUTONOMA, MADRID, ES 
S. OLIVER, UMIST, MANCHESTER, GB 
P. PHILIPPSEN, U. GIESSEN, GIESSEN, DE 
R.J. PLANTA, VRIJE U., AMSTERDAM, NL 
F. POHL, U. KONSTANZ, KONSTANZ, DE 
M. RIEGER, BIOT. M. BIO. FORSCH. WILHELMSFELD. DE 
C. RODRIGUES, INSTITUTO GULBENKIAN, OEIRAS, PT 
G. THIREOS, IMBB, IRAKLIO, GR 
D. VON WETTSTEIN, CARLSBERG LAB., K0BENHAVN. DK 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Construction of a library of overlapping clones to cover the entire yeast 
chromosome XI as a unique contig. Sorting of clones and construction of 
a high resolution physical map of chromosome XI. Distribution of clones 
to participants for sequencing. Determination of the complete sequence 
of chromosome XI from the set of overlapping clones over the period of 
three years i.e. determination of ca. 240 kb for 1991. 
MAJOR PROBLEMS ENCOUNTERED: 
Actual starting dates for sequencing: Due to the time necessary to built 
up the cosmid libraries and establish the physical map of chromosome 
XI, cosmid clones could only be distributed to the participants on 
January 29th, 1991. 
All distributed cosmids proved suitable for sequence determination 
except for three (DNA instability, erroneous map assignments). 
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Therefore, three participants (F. HILGER, S. OLIVER and C. RODRIGUES) 
have received new cosmids on march 7th, 1991 and could only start 
sequencing at this date. 
RESULTS 
Coordination: 
Three cosmid libraries covering, altogether, 380 times the yeast 
genome, have been constructed and stored. They have been sorted in 
parallel for chromosome XI and X, by hybridization. As judged from 
these two chromosomes, the libraries are complete and allowed the 
isolation of the entire chromosomes as single contigs. The average 
insert size is 35 kb. 
Colinearity between inserts of all cosmids of chromosome XI with the 
native chromosome XI itself has been checked by restriction mapping 
and hybridization. 
The set of chromosome XI sorted cosmid has been mapped by four 
different criteria: fingerprinting, terminal RNA probe hybridizations, 
EcoRI digestions, cosmid to cosmid cross hybridizations. In addition, the 
physical map has been directly verified using the nested chromosome 
fragmentation strategy based on the l-Sce I endonuclease (see below). 
The physical map has a 3 kb average resolution and shows complete 
internal consistency. Cosmids covering almost the entire chromosome 
have been distributed (see annex 4). 
Sequencing: Each participant (including the coordinator) has received 
one cosmid clone with an insert of 30-40 kb. Each participant has the 
choice of its sequencing strategy, sequencing methods and internal 
organization of his/her own sequencing team. Most participants have 
subcloned the cosmid into smaller pieces prior to sequencing. It follows 
that the number of contigs of final sequence is at present larger than 
the number of cosmid distributed. Assembly of those contigs will have 
to be done in the future. All participants have received the overall plan 
of the distribution of tasks as well as the EcoRI map of the entire 
chromosome. Participants with neighbouring or overlapping fragments 
have been individually informed and encouraged to exchange 
information. The table given in annex 3 shows contribution of each 
participant, calculated as the number of base pair of final sequence 
submitted to MIPS as of february 18th, 1992. Participants having 
submitted more than 25000 bp or having terminated their assigned 
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fragment have sent detailed strategy protocols and quality statements 
to the coordinator. When necessary, they have been sent new cosmid 
clones or DNA material in february 1992. 
HIGHLIGHTS / MILESTONES: 
Cosmid libraries: Three cosmid libraries covering, altogether 380 times 
the yeast genome, have been constructed and stored and can be used 
for continuation of the sequencing project on other yeast chromosomes. 
Mapping strategies: A new mapping strategy with potential application 
to the entire yeast genome as well as to mapping YAC inserts has been 
developed on chromosome XI. It is based on the possibility to cleave 
total yeast genome at a single artificial site using the new endonuclease 
I -See I. A set of transgenic yeast strains with artificial l-Sce I sites is 
constructed and used to sort cosmid libraries and build physical map 
using nested chromosomal fragments as probes. This method has 
potential application to other organisms as well. 
Physical map of chromosome XI: 
The complete EcoRI maps of chromosome XI with a 3 kb average 
resolution shows complete internal consistency. Placing genetic markers 
on the physical map by hybridization and sequencing, reveals that the 
published genetic map used so far by all yeast researchers contains 
major inversions/ translocations in the left arm of chromosome XI. 
Sequence analysis: 
A total of 45 % of all sequences from chromosome XI have been 
determined in final form. 
WIDER CONSIDERATIONS: 
A high resolution physical map of chromosome XI has been constructed 
from overlapping cosmid clones of three complete genomic libraries of 
yeast, constructed for this purpose. The coordinated effort of 17 labs 
from 9 different E.C. countries has resulted in 45 % of the entire 
chromosome XI sequence being already determined in final form and 
stored at MIPS. More than 200 putative protein coding genes have 
already been discovered among which only 22 genes where known 
from classical genetic and molecular studies. Ca. 70% of the new genes 
have no clear homolog in data bases, hence represent new type of 
genes, not discovered before in any other organism and not belonging 
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to any of the known protein families. 
COOPERATIVE ACTTVTnES: 
Plenary meeting: First BRIDGE meeting at Brugge (BE) September 22-
24th, 1991: All participants of the sequencing program for yeast 
chromosomes XI and II. 
Information exchange: Two reports with ongoing results were prepared 
for YIP. Three "newsletters" with maps, protocols, progress reports and 
other relevant data were sent to all participants. 
Staff exchange: 
Martina Haaseman from MIPS visited B. Dujon's lab for one day for 
coordination of sequence analysis 
Bernard Dujon visited MIPS, Martinsried, DE for two days for 
coordination of sequence analysis 
Muus de Haan from L. Grivell's lab, Amsterdam, NL visited B. Dujon's 
lab for a week for random subcloning of cosmids 
Benedicte Purnelle from F. Foury's lab visited J.C. Jauniaux's lab for 
three weeks to learn and import automatic sequencing 
technique, shotgun strategy and software utilisation. 
A.M. Becam from P. Slonimski's lab, Gif sur Yvette FR visited J.C. 
Jauniaux's lab for three days for sequencing double stranded 
DNA with the ALF (EMBL) fluorescent sequencer. 
Micheline Vandebol from F. Hilger's lab visited J.C. Jauniaux's lab for 
sequencing with ALF (EMBL) fluorescent sequencer and 
software utilisation. 
Kathrein Hamberg from P. Phillipsen's lab visited B. Dujon's lab for two 
days for chromosome fragmentation. 
Jean Claude Jauniaux visited several times F. Foury's lab for discussion 
about DNA sequencing strategies and software analysis. 
Laurent Gaillon from B. Dujon's lab participated in the two-weeks 
"Sequencing course" organized by W. Ansorge at EMBL, in 
November, 1991. Bernard Dujon gave a lecture at this course. 
Two technical assistants from D. Von Wettstein's lab participated in the 
following training courses: i- Advanced training course in 
nucleotide sequencing, February 3-9, 1992, ABI, Foster City, 
CA, USA.; I'I- Kebo Users Course, January 15th,1992, 
Stockholm, SE. 
Corien Maat from L. Grivell's lab visited H. Fukuhara's lab for 
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discussions on automatic sequencing and software analysis. 
Materials exchanged: Cosmid clones and other DNA and strain materials 
were sent by the coordinator to all other participants. Unpublished 
sequences from several participants were sent to the coordinator for 
mapping or other applications. 
LIST OF JOINT PUBLICATIONS / PATENTS WITH TRANS­NATIONAL 
AUTHORSHIP: 
None as yet. 
OTHER PUBLICATIONS / PATENTS: 
A. Jacquier, P. Legrain, B. Dujon. YEAST (1992) 8, 121­132 
Additional publications from different participants are in press or submitted 
ANNEX 4 
THE OVERALL ORGANIZATION OF THE SEQUENCING EFFORT 
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The Generation of a Cosmid Bank of S. cerevisiae Chromosome VIII. 
S G Oliver, Manchester Biotechnology Centre, UMIST, PO Box 88, Manchester M60 
1QD, UK. 
Chromosome V and Vm co-migrate as band 5 in pulsed-field electrophoretograms of 
chromosomal DNA from S. cerevisiae S288C and its close relatives. The EC Yeast 
Genome Sequencing Consortium has taken responsibility for sequencing chromosome 
VIII, whereas chromosome V will be sequenced in Stanford by the Botstein/Davis 
Group. At UMIST, we are adopting two parallel strategies in order to create a cosmid 
clone bank of chromosome VHI DNA; A total genomic bank of S. cerevisiae S288C has 
been prepared in the cosmid vector pWE15. This bank is being screened for 
chromosome VIII clones using specific gene probes from that chromosome (e.g. CUP1 
and SOD11 and ' walking' out with the clones so identified to cover the rest of the 
chromosome. At the same time, chromosome VIH DNA from strain YP148, which 
carries a polymorphism permitting the separation of chromosomes V and VHI on pulsed-
field gels, is being used as a probe to identify chromosome VIII cosmids directly. 
Unfortunately the chromosome VIII in this strain carries a 45 kb deletion and so not all 
such clones can be identified by this route. The second major strategy being employed 
is the creation of a band-5-specific clone bank in p\VE15 using DNA from S288C. A 
collection of chromosome V-specific lambda clones has been obtained from Prof Isono 
(Kobe, Japan) and these are being used in the first stage to exclude chromosome V 
clones from this cosmid bank of the two chromosomes. 
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BUILDING A COSMID CONTIG OF CHROMOSOME X 
Meng-Er HuangO), Jean-Claude ChuatC1), Agnes ThierryP), 
Bernard Dujon(2) and Francis GalibertC1) 
(1) Laboratoire de Recombinaisons Geneuques (UPR 41-CNRS), Centre Hayem, Hdpital Saint-Louis, 1 
avenue Claude Vellefaux, F-7547S Paris cedex 10, France. 
(2) Unit* de Genitique Moleculaire des Levures (URA 1149-CNRS), institut Pasteur, 25 rue du Docteur 
Roux, F-75724 Paris cedex 15, France. 
Total yeast DNA was obtained from a diploid strain (FY 1679) obtained by 
selfcrossing of S288C after switching mating type. Fragments resulting from partial 
digestion with Sau3Al were ligated to linearized pWE15, a cosmid vector with T3 and T7 
promoters. Two other libraries were made in the cosmid vector pOU61 COS. The insert 
size averaged ca 25 kb. The yeast genome size was covered 380 times by the 3 libraries 
taken as a whole. Pools of clones covering 12-25 times the genome size were stored at 
-80°. 
Recombinant colonies were grown on two sets of 137-mm nylon filters (120 per 
filter). After lysis of the colonies by NaOH, chromosome-X-specific clones were sorted 
out by hybridization with radiolabeled PFG-purified chromosome X. Two hundred ninety-
two clones out of a total of 3940 colonies were derived from the pWE15 library (7.4 %). 
A hundred and four additional clones were sorted out from the pOU61 COS library. 
The clones were subcultured, dispensed into several sets of 96-well plates and 
streaked onto several sets of nylon filters. Clones taken at random were independently 
digested with HaeTll and Alul. The digests were mixed to either T3 or T7 promotors. 
Radiolabeled RNA probes were obtained after addition of T3 or T7 RNA polymerase and 
[a32P] UTP. The filters were independendy hybridized with either T3 or T7 probes. 
Clones overlapping with the T3 or T7 probes were further used as probe templates. The 
procedure was discontinued when 350 clones were aligned in one contig of over 600 kb, a 
figure to be compared with the size of chromosome X (760 kb + 5 %). 
Ten sequences taken from databases and corresponding to genes mapped to 
chromosome X were used to make oligonucleotide probes that were hybridized with the 
clones. All the clones labelled by a given gene probe were found to map to a unique 
position in the contig. The distances between the genes on the physical and on the genetic 
maps were consistent. Da/5 was located very close to one end of the contig, as on the 
genetic map. No sequenced gene marker close to the other end was available. However, 
since the physical map and the genetic map appear to be colinear, and since the distance 
between the last gene (cdc6) and the end of both maps seems roughly proportional, the 
contig most probably encompasses the whole of chromosome X (except for the telomeric 
region, that will be dealt with later). 
£coRI digests of selected groups of overlapping clones were comigrated in agarose 
gels. Southern blots were prepared and within each group each clone was successively 
used as a probe. The interpretation of these results gives the exact number and size of 
EcoRI fragments and allows to drawn an EcoRI restriction map of the contig. 
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Construction of a chromosome XIV library from S.cerevisiae 
Progress Report to the Commission of the European Communities (March 1992) 
Kathrein Hamberg and Peter Philippsen 
The scientific goal of our project is the physical mapping of cosmid clones covering the 
complete chromosome XIV (820 Kb) of S.cerevisiae by using a series of new mapping 
vectors. A DNA segment cloned into these so-called pMACS vectors will direct a gene 
conversion starting at the homologous sequence of a chromosome and finishing at the end of 
this chromosome, thereby generating a chromosome fragment. Due to the genetic outfit of the 
pMACS vectors, in 50% of the conversion events genetically stable chromosome fragments are 
established. The size of these new chromosomes is a direct measure of the distance between 
the chromosomal location of the cloned DNA and the end of the chromosome. The assignment 
to the left or right arm of the chromosome can be done prior to the actual mapping experiments 
(see below). 
We started with a cosmid library of total DNA from strain FY 1676 (isogenic to S288C) 
obtained from Dr. Bernard Dujon, Paris. This library is based on the ligation of size-
fractionated partial Sau3A fragments into BamHI cleaved pWE15 and is the same library used 
for mapping clones of chromosomes X and XI. 2400 colonies were screened with 
chromosome XIV DNA which was isolated from pulse field gels and radioactively labelled by 
random priming. The DNA of 625 colonies hybridized to this probe which corresponds to 
26% of the clones. This is much higher than expected since chromosome XIV (820 Kb) 
represents only 6% of the S.cerevisiae genome. One reason is most likely an unavoidable 
contamination of the probe with chromosome fragments of larger chromosomes. EcoRI 
digestions of cosmids from colonies showing strong hybridization signals revealed an 
unusually high percentage of clones carrying solely ribosomal DNA (chromosome XII). It 
was therefore necessary to rescreen all clones with a ribosomal DNA probe. 
267 of the total 625 putative chromosome XIV clones were finally analysed by Southern 
hybridization of EcoRI digested cosmid DNA, again using gel purified chromosome XIV as 
probe. With this method we found 86 cosmid clones all EcoRI fragments of which hybridized 
with the chromosome XIV probe. In the other cosmids only some of the EcoRI fragments 
hybridized probably due to repetitive DNA or to inserts consisting of fragments from 
chromosome XIV and other chromosomes. The 86 chromosome XIV clones carry inserts that 
are 30 - 35 Kb in length representing 3 - 3.5 times the chromosome XIV. 
We are just separating the clones into two parts representing the two chromosome arms. By 
fragmentation at CEN 14 we constructed a new haploid yeast strain carrying the right arm 
(190 Kb) and the left arm (630 Kb) as genetically stable chromosomes. DNA of both arms 
was isolated from pulse field gels and used as hybridization probes. Till now we could clearly 
map 7 clones to the right arm and 27 clones to the left arm of chromosome XIV. In parallel, 
fragments of the cosmids were cloned into pMACS vectors to allow precise mapping. 
As stated last fall at the Brugge-Meeting we expect to finish most of the mapping by May 1992. 
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TITLE: Informatics Network (Sequencing the Yeast 
Genome) 
CONTRACT NUMBER: BIOT-CT90-161 
OFFICIAL STARTING DATE: 01/01/1991 
COORDINATOR: H.W. Mewes, Max-Planck-Institut f. Biocheraie 
W-8033 Martinsried, Germany 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
MAJOR PROBLEMS ENCOUNTERED: 
A major problem encountered was the lack of manpower to serve the sequencing com-
munity in a timely manner. During 1991 a serious effort had to be undertaken to verify 
the experimental results of sequencing chromosome HI and to finish their publication. 
In addition, the amount of data to be processed increased significantly, thereby increas-
ing the workload even more. 
The conflict of interest between the creators of the data, i.e., the sequencing laborato-
ries, and the recipient scientific community has not yet been solved. The rules for the 
release of data to the public databases turned out to be unsatisfactory. A better solution 
to provide public access to the data in time has to be worked out. 
RESULTS: 
As the informatics coordinator, MIPS has been responsible for the collection, storage 
and analysis of all sequence data submitted by the 35 laboratories involved. Since 
January 1991, two other yeast chromosomes, II and XI, are under sequencing. As of 
February 18, 1992, 200 kb from chromosome II and 290 kb from chromosome XI had 
been sequenced; the total length comprises 620 and 830 kb, respectively. 
Data were submitted by e-mail or on magnetic media. Preliminary sequence data were 
also sent to MIPS; they provided valuable information about clone orientation and over-
lapping regions, and helped in the rapid identification of known genes. A detailed plot 
displaying the clones used in sequencing, all open reading frames as well as previously 
mapped genes, and other elements (Ty, delta, tRNA) was constructed. 
The processing scheme is summarized below. The analyses were performed using the 
PIR-NBRF Experimental Query System (ATLAS/XQS) and the Genetics Computer Group 
(GCG) Sequence Analysis Software, as well as several programs for sensitive sequence 
comparisons obtained from the EMBL file server. 
A novel software tool that greatly facilitates data handling has been developed (S. 
Liebl). Using an X-windows interface, the program allows the rapid display of chro-
mosome clones as well as restriction sites and open reading frames (see Fig. 1). It is 
capable of scaling up a selected region, handling all restriction enzymes available, and 
marking sequenced fragments within clones. 
The following databases have been created and are maintained for the yeast project: 
• YeastProt yeast protein sequence database. All entries already existing in databases 
were checked for errors by comparing to the nucleic acid sequence, where this was 
available. Errors were corrected accordingly and partial sequences merged to elimi-
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nate redundancy of information. AU YeastProt entries are fully annotated. The da-
tabase is continuously updated using data from the scientific literature as well as 
direct submissions of data to the EMBL Data Library that are forwarded to MIPS on 
a daily basis. YeastProt is maintained by M. Haasemann. The current release in-
cludes 978 entries comprising 431,867 residues. 
• YeastNuc yeast nucleic acid sequence database. This is a merged dataset, i.e., as-
sembled using yeast sequences from several databases and eliminating entries con-
taining identical sequences. However, entries differing in at least one nucleotide 
are present in YeastNuc. This has the advantage of providing an up-to-date dataset 
for fast searches at the cost of partially redundant information and entry format di-
versity (each YeastNuc entry inherits the format of the parent database). The data 
used to assemble YeastNuc are obtained from EMBL, GenBank, EMBLKEEP and 
EMBLNEW. The latter two databases contain most recent data forwarded from EMBL 
to MIPS prior to checking. YeastNuc is maintained by J. G. Sgouros. The current 
release includes 1,889 entries comprising 3,261,167 bases. 
An on-line computing facility was established that enables the participating laborato-
ries to analyze their data and perform database queries. P. Kreisl is responsible for this 
service. 
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Figure 1 Display from the program Xchromo 
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Summary of sequence data processing scheme: 
A sequence submitted to MIPS is analyzed using the following scheme: 
1. Construction of a restriction map based on the sequence. This map is compared to 
the map of the clone library to verify clone orientation. 
2. The sequence is used to check for overlaps: 
with vectors, using the VecBase vector database 
with known yeast sequences (identification of known genes as well as Ty and 
delta sequences) 
with other clones of the same chromosome 
3. Partem search is then performed at the DNA level in order to detect: 
promotors 
upstream activating sequences (UAS) 
autonomously replicating sequences (ARS) 
introns 
tRNA genes 
- other yeast-specific regulatory sequences 
- repeats 
4. Extraction of open reading frames (ORFs) using a cutoff value (100 amino acid 
residues). The locations of these ORFs are correlated with the positions of promo-
tors and terminators in order to assess the probability of expression. Furthermore, a 
codon frequency algorithm is employed in localizing potential coding regions. 
5. For the analysis of ORFs, the following steps are employed: 
- FASTA comparison with the MIPSX merged protein sequence database. This 
step is essential not only for detecting similarities of ORFs to other sequences in 
the databases, but also for reidentifying known genes detected already at the 
DNA level and thus exclude frameshift errors. 
- for FASTA scores in the "twilight zone", the Interactive Sensitive Sequence 
Comparison (ISSC) algorithm (P. Argos, EMBL) is employed in order to evalu-
ate the significance of the result and optimize the alignment-
pattern search is then performed at the protein level using the ProSite Diction-
ary of Protein Sites and Patterns (A. Bairoch, Geneva). This allows the detec-
tion of possible posttranslationally modified sites and may assist in assigning a 
function to an otherwise unknown ORF. 
- the ORFs are scanned for internal repeats; search for putative transmembrane 
segments is performed if the methods outlined above give indications for a 
membrane protein. 
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The chromosome contig is gradually assembled based on the clone overlap data. 
The locations of previously mapped genes are correlated with the existing physical 
map of the chromosome. The new physical map is compared to the genetic map. 
Work in progress 
A major problem that has to be faced and circumvented in the yeast sequencing project 
is that sequences submitted by the contractors stay private for a long period and cannot 
be analyzed be any other participating laboratory. We propose to store these sequences 
in a database that is build by INQ (a transaction oriented database system) and fre-
quently updated. As long as access to data is restricted, queries to this database will 
result in a sequence code containing the chromosome number, the submission date and 
the submitting laboratory. Only when these data become public, entry-code, title and 
sequence alignment will be displayed. 
A drawback of the present sequence database query systems is their passive behavior, 
i.e. queries about sequence data entries or comparisons of test sequences against the 
database must be repeated frequently. Unless the user repeats a query very often, he 
will miss the appearance of the information he searches for. We plan to establish an 
automatic system to distribute electronic messages whenever information associated 
with a new sequence is found that matches the query. For example, one could ask for 
all yeast sequences that are new in the database. Such a service would be highly inter-
esting for the laboratories participating in genome analysis. 
HIGHLIGHTS/MILESTONES 
Up to march 1992, 320,423 bases submitted from chromosome XI and 228,383 bases 
from chromosome II have been analyzed. MIPS has analyzed all open reading frames 
by comparison to the latest available sequence databanks. Results have been forwarded 
to the laboratories. With the help of careful sequence analysis, sequencing errors have 
been corrected and a number of problems has been solved. 
WIDER CONSIDERATIONS 
The task of efficiently analyzing, handling, and assembling chromosome data gready 
benefits from the experience of the protein sequence databank. The informatics coordi-
nation of a large sequencing project will not be successful when done by a 'stand-
alone' type of group. The continuous cooperation and information exchange between 
the yeast and databank groups within MIPS on one hand and between MIPS and the 
sequencing laboratories on the other is of great importance for the successful comple-
tion of the project 
The experience with the informatics coordination of the chromosome III project made 
clear that a change of policy is necessary in order to guarantee timely access of the sci-
entific community to project data, while at the same time giving contractors the oppor-
tunity to publish their results. 
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COOPERATIVE ACTIVITIES 
The coordination of the data processing and evaluation is a highly interactive process. 
Frequent communication with each of the laboratories by electronic mail, phone and 
meetings with the DNA-distributors took place. M. Haasemann visited B. Dujon's 
laboratory, H. Feldmann is a frequent visitor at MIPS. B. Dujon was guest for a semi-
nar and work on the chromosome XI data. 
LIST OF JOINT PUBLICATIONS 
A detailed report for the Yeast Industry platform is issued bimonthly. Two 'Chromo-
some' Newsletters were distributed to the contractors in collaboration with the DNA-
coordinators. 
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T-PROJECT 
MOLECULAR IDENTIFICATION OF NEW PLANT GENES 

n n F- Development and use of Arabidopsis ihaliana as a tool for isolating genes of agronomic 
importance 
CONTRACT 
NUMBER: BIOT CT90 0207 
OFFICIAL STARTING DATE: 1st February 
COORDINATOR: M. Bevan, AFRC, Norwich, UK 
PARTICIPANTS: see pages 376-401 
The first year of the Arabidopsis T project has seen major successes both in terms of the scientific goals 
achieved, and in the organisation and effective operation of a large interdependent network of scientists. 
This has been achieved primarily through the willingness of the individual scientists to link their efforts 
with others, in order to achieve the required effort to push European Arabidopsis science to higher 
achievement, and through the assistance of EC staff. I am convinced that the success of the T-programmes 
will encourage the formation of other networks of scientists, under the auspices of the EC In this way the 
variety and creativity of European scientists can be fostered in a long term manner. 
The main Contract was signed on 1st February, 1991 and the appointment of 30 positions took place soon 
after this. We held our first Meeting in Perpignan, France, with Michel Delseny (CNRS University of 
Perpignan) and his colleagues as hosts. This was the first time that the full scope of the programme of the 
T programme was apparent to many participants, and interesting presentations describing the activities 
of other large EC-sponsored scientific programmes were given by Jean Guem, who described our sister 
T programme in Regeneration, and Andre Goffeau, who described the EC-sponsored effort to sequence 
chromosome III of yeast Specialist working groups then convened to plan in more detail their interactions 
after the general presentations. The next general meeting will be in Gent, Belgium on Sept 9-11, 1992, 
hosted by Marc Van Montagu and colleagues, while the third and final meeting is planned to be held in 
Cambridge in September 1993. 
Databases and genome analysis 
In June Caroline Dean, Jeff DangI, George Murphy and I attended an EC Conference on Genome 
Sequencing at Elounda, Crete, at which we presented the relevant work of the T programme. Much benefit 
was gained by interactions with leaders in the field such as John Sulston, and we departed convinced that 
the time was ripe for the beginnings of an Arabidopsis sequencing effort A substantial part of the rest of 
the year was devoted to this aim. This included forming a committee to investigate the *bioinformatics* 
needs of a putative Arabidopsis sequencing programme, consisting of Jerome Giraudat (F), Dirk Inze (B), 
Marc Zabeau (NL), and Jeff Dangl (D). We met in Koln on Dec 12 1991 to form our ideas, and again on 
January 6, 1992, in Boston (as guests of Howard Goodman), to discuss an international effort to 
coordinate the sequencing effort Considerable goodwill exists on both sides to harmonise our efforts, 
particularly in respect to databases and data sharing. An important outcome of the Committee's work was 
the inclusion of elements of cDNA sequencing in the forthcoming Biotech programme, and the provision 
of a framework for large-scale sequencing. While in Boston the AATDB database system, adapted for use 
in Arabidopsis work by Howard Goodman, Mike Cherry and colleagues at MGH in Boston, was 
demonstrated. This database will soon be available to those with the appropriate hardware, and its primary 
function will be to assemble physical and genetic map information in a very convenient format This will 
be available to the T programme after April 1992. 
Interaction with other T programmes and with Industry 
In November 1991 I gave a presentation of the Arabidopsis T programme to the participants of the 
Regeneration T programme. This meeting was a pleasant and important occasion, as it also involved a first 
meeting with representatives from industry involved or interested in fundamental plant sciences. This 
meeting lead to a further meeting of interested industrialists in Basel and it now appears that a group of 
them is willing to form an industrial platform which will serve both the Regeneration and Arabiaopsis T 
projects. A further meeting between the Coordinators of the two programmes and industrial 
representatives, with the aim to set up the Industrial Platform, will take place in Lyon in May 1992. It is 
hoped that greater industrial participation will lead to further funding opportunities and to a degree of 
closer integration of fundamental work with the long-term goals of European industry. 
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Development of Resource Centres 
This was seen as a major objective during the first year of the programme. Together with the AFRC 
and the University of Nottingham (GB), a large and efficient operation has sprung up, directed by 
Mary Anderson and Bernard Mulligan. Collections of mutants and ecotypes have been assembled, 
characterised and catalogued, including collections that would otherwise have been lost. Significantly, 
the Nottingham collection has also serviced the new US Stock Centre in Ohio by providing them with 
the entire collection to start their operation. The two Centres will continue to develop their operations 
in a coordinated way, and will soon use a common database and ordering system called AIMS, 
developed specifically for that task by scientists at Michigan State University. In addition, the 
Nottingham Centre is providing the AATDB database system with information on mutants etc. 
Finally, collections of recombinant inbred and T-DNA-tagged lines will be deposited, which should 
provide the Arabidopsis community with valuable tools for mapping. The DNA Resource Centre in 
Koln has made a good start to collecting recombinant libraries and probes for use by participants. As 
its role becomes more widely known and more libraries are prepared it will serve an increasingly 
important role, especially in relation to the proposed sequencing work in the Biotech programme. 
Securing long-term funding for a Resource Centre will be a preeminent goal in the coming years. 
Scientific Highlights 
Brief descriptions of the progress achieved in all of the programmes can be found in the relevant 
section of this Report. More details of scientific progress, including scientific interactions, can be 
obtained in a comprehensive report available from the Coordinator. I wish to present some of the 
major scientific goals met in the first year of the Programme, and discuss the importance of the trans-
European scientific network in achieving these. 
The accomplishments of the Resource Centre in centralising and collating mutant and ecotype 
collections, and distributing these are especially significant, as activities such as these require the 
concerted action of several groups. Their success is a concrete demonstration of the value and 
effectiveness of coordinated actions such as T programmes. The Physical Mapping Programme, lead 
by Caroline Dean, has made enormous strides towards establishing a physical map of the genome. 
Together with colleagues in an international collaboration, about 1/3 of the genome has been mapped, 
techniques for rapidly screening YAC libraries developed, and the AATDB database established for 
collating mapping and genetic data. Lothar Willmitzer's lab, part of the Gene Replacement Group, 
has made significant advances in a difficult area by demonstrating, for the first time, useful 
frequencies of homologous recombination in Arabidopsis using the reconstruction of a hygromycin 
resistance gene as a selection for these rare events. These constructs are being made available to 
others in the Group for testing their recombination methods and DNA delivery systems. The T 
programme has aided collaborations that have enabled these important tools to be distributed for 
further refinement and testing. Further examples of such collaborations are evident in the Seeds 
Programme. In the group of Maarten Koomneef, important new mutations affecting abscisic acid 
action have been isolated, and the effect of these on gene expression, lipid and 2sugar metabolism, 
and interactions with other mutants are being investigated by this group. A major achievement by the 
group of Jerome Giraudat has been the identification of an l lkb piece of DNA, using chromosome 
walking, that complement abi3 mutations. With this gene identified, its sequence will help reveal the 
mode of action of a key growth regulator in plants. In the Embryogenesis Group, a large effort in the 
lab. of Keith Lindsey has identified T-DNA tagged loci that affect the tissue-specificity of GUS 
expression. Several of these effect embryo-specific patterns of expression, and the coming year will 
probably see a some of the genes directing these patterns of expression identified. Impressive progress 
has been made in the Floral Induction Programme. A gene encoding the APETALATA2 product has 
been tagged using T-DNA and isolated in the group of Marc van Montagu. This gene, which 
determines floral morphology together with a small group of other homeotic genes, has been further 
characterised by sequencing. In the group of George Coupland, a walk using YACs of about l,600kb 
has covered the co locus, which conditions flowering time. Several recombinants have narrowed down 
the region containing the gene, and complementation experiments are underway to isolate clones 
containing the gene. Similar walks are progressing towards the/ca, Jwa, and_/ve loci. In addition, 
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epistatic interactions between the different classes of mutants are being studied. In the Transposon 
Tagging Programme several groups have developed systems that drive high frequency excision and 
methods have been developed for selecting reintegration events. Notably, the groups of Lothar 
Willmitzer and George Coupland are at the stage of screening large populations of plants for 
mutations. Future work will involve making derivatives that can detect gene fusions. 
Cooperative Activities. 
These have been too numerous to mention in detail, but interactions have occurred in all of the 
programmes that have lead to collaborations beyond those expected at the beginning of the project. 
In addition to the annual meetings of the T project, in April 1992 there will be a joint EMBO/EC 
Workshop on Arabidopsis Molecular Genetics, organised by Csaba Koncz and colleagues in Koln. 
Finally, international collaborations have been fostered and it is hoped these will continue to develop, 
particularly in the field of genome analysis. 
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Title: Transposon tagging in Arabidopsis thaliana 
Principal Investigator(s): M. van Montagu, Rijksuniversiteit Gent, Laboratorium Genetika, 
Ledeganckstraat 35, Gent, B-9000, Belgium. 
Participant No: 36 
Expression patterns of pollen-specific promoters were only described in general (e.g. anther specific) 
or expression was observed in specific anther cell layers and not in the pollen itself (e.g. tapetum). 
Therefore it was unlikely that transposase constructs driven by these promoters would result in higher 
germinal excision rates. However, in our laboratory two promoters were characterised which show 
strong pollen specific expression (mns-1, mns-2) patterns. Currently these promoters are used to drive 
Ac transposase cDNA. 
We established a two-element transposon mutagenesis system in Arabidopsis thaliana using the well-
characterised maize Activator/Dissociation (Ac/Ds) transposon family. 
Our system consists of three elements: 
1. Ds elements: Ds elements have been made that carry a chimeric bar gene conferring resistance 
to the herbicide phosphinotricin. These elements can thus be followed genetically. One hundred 
fifty independent transformed lines of Arabidopsis were generated. 
2. Activator elements: Ac elements that deliver transposase activity have been cloned and 
transformed into Arabidopsis. These elements bear terminal deletions and are unable to 
transpose themselves (Ac "wings clipped" elements). In order to enhance transposase 
expression we constructed an Ac transposase CDNA under the control of the strong 
Agrobacterium Tr2' promoter. An Ac transposase CDNA under the control of pollen specific 
promoters (mns-1, mns-2) is under construction. 
In addition, all activator constructs bear the Gus gene and a hygromycin resistance gene which 
allow to score for their presence. 
3. Excision assay: All Ds elements are cloned in the 5' leader sequence of a chimeric NptH 
gene. Ds excision will result in resistance to Km . 
In order to circumvent the problem of low germinal excision using Ac in heterologous systems, 
transactivation of Ds in transformed lines was done using Agrobacterium transformation followed 
by selection on restoration of the Nptll resistance after transposition. In that way plants can be 
regenerated that are clonal for the excision event. 
Ds transactivation measured by the excision assay, ranged from 1 to 50% in the first generation 
depending on the Ds transgenic line transformed by Ac. 
Segregation of different DS and Ac elements in transactivated lines is followed in detail. Mapping 
of different stabilized Ds lines is going on. Transposition could be shown using the marker genes, 
PCR and Southern analysis. 
Title: Enhancer detection with the En-1 transposable element system. 
Principal Investigator(s): M. Aarts and A. Pereira. 
Participant No: 42 
This project was initiated to develop the maize En-I transposable element system to use it for enhancer 
detection in the Arabidopsis genome. First it was necessary to demonstrate that the deletion derivative 
/ was able to transpose in Arabidopsis. For this experiment we used plants transformed with a 
construct containing an /-element within the reading frame of a TR 1 '-NPTII gene, as well as a 'wing-
clipped' En (i.e. without border sequences) controlled by a CaMV 35S promoter. Imprecise excision 
of the /-element could restore the reading frame of the NPTII gene, giving kanamycin resistance. 
Assuming that only one in three excisions will restore the NPTII reading frame, this suggests a first 
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generation excision frequency of 0 to 60 %. Polymerase Chain Reactions were performed on DNA 
of T, plants. Excision of the transposon would give an empty donor site on the integrated T-DNA. 
The PCR analysis and subsequent sequence analysis revealed that also in a family not showing any 
kanamycin resistant progeny, excision had taken place. It also confirmed restoration of the reading 
frame of NPTII in kanamycin resistant plants. The sequence contained footprints typical for / element 
excision. Experiments are underway to determine the reinsertion frequency of the transposon. 
To use the En-1 transposable element system for enhancer detection in Arabidopsis lhaliana. En had 
to be modified to get a better control over the activity of the element. For this reason we separated 
the transposase functions from the actual transposon parts by constructing two types of T-DNA binary 
plasmids. The transposon type contains a marker gene for selection for transformation (kanamycin 
resistance, NPTII) and a marker gene for selection for excision of the transposon (streptomycin 
resistance, SPT). The enhancer detector unit is formed by the 5' border fragment of En together with 
the GUS gene. In total 14 constructs, of which the efficiency in enhancer detection use has to be 
tested. The 9 most promising constructs have been transferred to Arabidopsis by root transformation 
with Agrobaaerium tumefaciens. Transgenic progeny of plants containing one of these constructs, 
have been assayed histochemically for GUS activity. The transposase type of T-DNA construct 
consists of a hygromycin resistance gene (HPT) for selection for transformation, cDNAs coding for 
the two proteins (TnpA and TnpD) necessary for transposition and the tms2 gene to select against 
plants containing the transposase construct after crossing to transposon containing plants. The tnpA 
gene is under transcriptional control of the TR 2' promoter and the mpD gene is controlled by the 
chiB promoter, which is tapetum specific. Transgenic plants have been obtained containing this type 
of construct, which will be analysed for copy number and T-DNA loci. Crosses have been made with 
transposon lines to test for expression of the transposase genes and ability to induce excision of the 
transposon. 
Joint activities of the insertional mutagenesis group. 
All six members of the insertional mutagenesis sub-group met at the BRIDGE meeting in Perpignan, 
which was an important opportunity for detailed discussions to set the agenda for the first year of the 
programme. Since then detailed discussions between members have occurred on several occasions and 
the programme has fostered a general spirit of co-operation and collaboration. For example, plasmid 
constructions have been exchanged between the Berlin and Norwich groups along with detailed 
information on experimental protocols. Members of the group have had detailed discussions at 
International meetings such as at Tucson in October 1991 (members of the groups from Ghent, Berlin, 
K61n and Norwich) and in Zurich in November 1991 (members from Berlin and Norwich). Four of 
the six members will meet at the EMBO course on Arabidopsis which is to take place in Koln in April 
1992. 
Title: Establishing a transposon-tagging system in Arabidopsis by use of the 
maize transposon Ac. 
Principal Investigators): G. Coupland, D. Long, L. Balcells and J. Swinburne, Molecular 
Genetics Department, Cambridge Laboratory, John Innes Centre, Colney 
Lane, Norwich, Norfolk, NR4 7UJ. 
Participant No: 1 
1. Establish use of streptomycin resistance gene to select excisions of Ds. 
2. Increase rates of germinal excision by the use of different promoters expressing Ac transposase. 
It was previously shown that the Ac element transposes at low frequency in Arabidopsis. We have 
introduced into Arabidopsis constructs which contain fusions of different promoters to the Ac 
transposase (TPase) gene. The abundance of the Ac mRNA in transformants containing each of the 
fusions was then examined. Between the most active 35S::TPase transformant and the least active 
Ac: :TPase transformant the abundance of the mRNA varied around 1,000 fold. Moreover, the mRNA 
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level varied between transformants containing the same fusion; for example the five 35S::TPase 
transformants varied across a range of IS fold. To test the activity of each of these fusions all 
nineteen transformants were crossed to a single line containing Ds inserted within the SPT gene. All 
of the populations of hybrid seedlings contained some which were variegated: the frequency with 
which variegated seedlings arose and the numbers of sectors present on the cotyledons varied between 
TPase transformants. In general those which contained most mRNA produced most variegated 
seedlings with a high density of resistant sectors. For example the 35S::TPase transformants which 
contained most mRNA were extremely active: approximately 100% of Fl seedlings were variegated 
and these contained many green sectors. 
In general the 35S::TPase fusion gives rise to very high frequencies of germinal excision: in excess 
of 35% of F2 plants inherited an active streptomycin resistance gene. This is very much higher than 
was previously shown for wild-type Ac or indeed than we detected with OUT Ac:: TPase transformants. 
Only 5 of the 27 contained Ds inserted at a new location. This low ratio would greatly reduce the 
number of streptomycin-resistant F2 plants which could carry mutations induced by Ds insertion. To 
overcome this problem we have constructed a Ds which contains a hygromycin-resistance gene. By 
activating this with the 3SS::TPase fusion we can select for F2 plants which are resistant to both 
antibiotics and therefore probably contain a transposed Ds. Preliminary data obtained using this 
construct support the earlier experiments: most streptomycin-resistant F2 plants do not contain Ds. 
However, we find that around 50% of F2 families contain at least one seedling which is resistant to 
both antibiotics. This will form the basis of a transposon tagging strategy and most of our effort 
during the second year of this project will be expended in testing the efficiency with which mutations 
arise in the F2 individuals. 
Title: Gene tagging 
Principal Investigator(s): L. Willmitzer, H. Pena-Cortes and T. Altmann, Institut fur 
Genbiologische Forschung Berlin gmBH, 63, Ihnestrasse, Berlin 1000, 
Germany. 
Participant No: 39 
1. Carry out large scale mutagenesis programme with wild-type Ac. 
2. Use of herbicide resistance to monitor Ac excision. 
3. Demonstrate new positions of Ac in genome. 
In a large scale experiment about 40,000 F3 plants originating from 8 independent transgenic 
Arabidopsis thaliana lines carrying the /ic-element between the Tr-promoter and the NPT II gene 
were assayed for kanamycin-resistance in the greenhouse by kanamycin spraying. 58 (0.15%) 
kanamycin-resistant plants were detected in the population of the 40,000 plants sown out in the 
greenhouse. DNA-blot analysis performed on 40 resistant plants demonstrated that in 33 of these 
plants the expected excision band appeared indicating the excision of Ac and that in 22 of the 33 
plants new fragments hybridizing with Ac were present and thus indicating integration. 
To establish a more rapid procedure to select for Ac excision under greenhouse conditions, transgenic 
Arabidopsis thaliana lines carrying a construct with the wild-type Ac located between the Tr-promoter 
and the bar-gene were constructed. Upon excision of Ac from this construct the bar gene will be 
expressed and lead to resistance of the plant against the herbicide phosphinotricin. F2-plants derived 
from phosphinotricin-sensitive Fl-plants of 37 independent transgenic lines were examined for 
resistance by spraying phosphinotricin in the greenhouse. Phosphinotricin-resistant plants were 
further tested by Southern analysis and 6 independent germinal excision events were identified 
offspring of these plants showed a mendelian segregation for the resistance marker. 
In a third approach, experiments were performed trying to determine whether or not procedures could 
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be developed allowing a higher proportion of the somatic excisions/transpositions to be fixed in the 
germ-line. To this end F3-seeds of transgenic Arabidopsis lhaliana lines carrying the above 
mentioned Tt-Ac NPT II construct were germinated under axenic conditions in the presence of 
kanamycin. Though large parts of the plantlets bleached and turned white, in 10-68% of the plants 
green sectors developed which organized into shoot-like structures and finally a plant which flowered 
and set seed. 85% of the fully resistant plants showed the expected excision band and 55% showed 
new bands indicative for reintegration of Ac thus proving that in this way somatic events could 
become fixed in the germ-line. 
Title: Characterization of an activator/dissociation (Ac/Ds) transposable element 
system in Arabidopsis lhaliana 
Principal Investigator^): R. Masterson, Max Planck Institut fur Zuchrungsforschung, 5000, Koln 
30, Germany. 
Participant No: 23 
The main objectives were to demonstrate efficient transposition of Ds receptor elements suitable for 
mutagenesis, show the utility of methotrexate selection for the detection of transposed DsDHFR 
elements, and to begin assigning the location of single copy DsDHFR T-DNA insertions on the RFLP 
map. We have successfully demonstrated germinal transposition of our marked Ds element, DSDHFR, 
which contain a dihydrofolate reductase (DHFR) gene element by a CaMV promoter. The DHFR 
marker confers resistance to methotrexate and selection conditions have been established in order to 
transform Arabidopsis and to follow the DsDHFR element in progeny generations. Selection of 
seedlings on medium containing kanamycin has allowed the determination of plantlets in which 
DsDHFR elements have excised from the leader sequence of an NPTII gene. The over-expression of 
the Ac transposase gene, using CaMV-Ac fusions, has resulted in a minimal germinal transposition 
frequency of 27% in which independent Ds insertions were observed in progeny plants. High 
frequencies of somatic tranposition have been observed and independent germinal events were 
identified in F-2 generation progeny plants. Similar transposition rates have been determined using 
reciprocal Ac/Ds crosses. In addition, the CaMV-zic fusions were able to activate Ds excisions in 
transgenic plants containing single or multiple Ds copies. 
Title: T-DNA insertion mutagenesis 
Principal Investigators: (C. Koncz, Max-Planck-Institut fur Zuchrungsforschung, 
D-5000 Koln 30, Carl-von Linne-Weg 10, Germany) 
Participant No: 19 
When T-DNA vectors carrying promoterless reporter genes (such as the neomycin 
phosphotransferase (ap/i(3')H), B-glucuronidase (gus) and fused bacterial luciferase (luxV) genes) at 
their termini are used for transformation, T-DNA inserts in plant genes can simply be identified by 
screening or selection for the expression of reporter genes in diverse tissues of transgenic plants. This 
gene fusion technique combined with high frequency transformation facilitates the identification of 
gene mutations. In addition, transformation with gene fusion T-DNA vectors yields a great number 
of transcriptional plant gene-reporter gene fusions which permit the in situ analysis of regulation of 
plant gene expression in vitro or in vivo. By determination of the frequency of T-DNA induced gene 
fusions in diverse plant species it was observed that T-DNA frequently integrates into potentially 
transcribed chromosomal loci. On average over 30% of T-DNA inserts generate transcriptional gene 
fusions in Arabidopsis. Isolation of gene fusions from transgenic plants permits further studies of ex-
acting promoter elements and transcriptional factors regulating the expression of T-DNA tagged 
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genes. To simplify the recovery of T-DNA inserts from the plant genome, T-DNA vectors used in 
Arabidopsis carry a bacterial selectable marker gene and a plasmid replicon. After physical mapping 
of insertion mutant loci by Southern DNA hybridisation, T-DNA inserts and flanking plant DNA 
sequences (i.e. promoter and coding regions of tagged plant genes) are rescued by transformation 
in E. coli. Before exploiting the T-DNA for large scale insertion mutagenesis in Arabidopsis, it was 
necessary to study the integration events in detail. Analysis of plant DNA target sites before, and the 
T-DNA-plant DNA functions after T-DNA integration revealed that T-DNA integration into the plant 
nuclear genome occurs via illegitimate recombination, a process aided by a T-DNA linked bacterial 
virulence protein VirD2. A viable yellow-pale mutant, designated as cs, was identified which was 
demonstrated to be allelic with a known lethal photosynthetic mutation, ch-42 located on chromosome 
4. Molecular analysis of the cs insertional mutant demonstrated that a T-DNA insertion in the ch-42 
locus did not result in lethality because the insertion has generated a gene fusion that encodes a 
partially active C-terminal fusion protein. The ch-42 locus encodes a novel chloroplast protein which 
has recently been shown to mediate the chelation of Mg2*-ions into protoporphyrin DC, a key 
precursor of chlorophyll. To provide the growing European Arabidopsis Community with a collection 
of T-DNA tagged Arabidopsis lines, generation of 2500 individual transformants has been proposed 
within the frame of Bridge T project. This proposal has been fulfilled in 1991. These lines were 
derived from a collaborative effort with Prof. G.P. Rgdei (Univ. Missouri-Columbia), who has 
recently added to the collection further ca. 300 transgenic lines. From the collection M2 seeds from 
480 families have already been provided for the Arabidopsis Seed Stock Center in Nottingham in 
1991. Upon enrichment of available seed material, the remaining lines will be similarly delivered. 
Genetic characterisation of the collection has been initiated during the last year. 
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Title: Site directed mutagenesis of endogenous genes in Arabidopsis thaliana 
Principal Investigator(s): P. van den Elzen and S. Ohl, Mogen International NV, Einsteinweg 
97, 2333 CB Leiden, The Netherlands. 
Participant No: 35 
1. Construct vectors for Agrobacterium-med'Med gene replacement 
2. Initiate transformation and selection for gene fusion 
We decided to establish a targeting system for the gene encoding the large subunit of RNA 
polymerase II (AtrpII) for the following reasons: 
The gene encompasses 8 kbp and thus offers a large region of homology which is an 
important factor for targeting efficiency in animal systems. The low targeting frequencies 
obtained in plants so far (10"M0'3) might be due to a limited length of homology. 
Gene targeting had been demonstrated in mouse ES cells based on a selection for resistance 
to amanitin. A small specific change in the highly conserved enzyme confers resistance to the 
toxin by reducing its binding affinity. 
Experimental evidence suggests that in order to introduce a small (1 nucleotide) change an 
additional mechanism (DNA repair of a transient heteroduplex) might further increase the 
frequency of gene targeting. 
Genomic clones for AtrpII were provided by C. Koncz, MPI Cologne. 
Initially two constructs were cloned, a control construct required to establish selection conditions and 
a targeting construct The amanitin resistance-conferring mutation was introduced in both constructs 
by recombinant PCR. The control construct contains the entire coding region and 3'end of the AtrpII 
gene fused to the CaMV 35s promoter, the targeting construct lacks the first 4 exons of the gene (1 
kbp) and should give rise to a functional amanitin resistant enzyme only upon targeted integration into 
the homologous locus. Both constructs were cloned into a small vector for direct DNA transfer via 
PEG and into a binary vector for Agrobaaerium-mediaxed transformation. 
To determine selection conditions protoplasts were transformed with the control construct and 
regenerating calli selected on amanitin. 
Selection on amanitin unexpectedly revealed that Arabidopsis protoplasts are at least a factor 100 less 
sensitive to the toxin than mouse ES cells. Since in vitro sensitivity of plant and animal RNA 
polymerase II is in the same range and spectrophotometric measurements indicate that amanitin is not 
rapidly degraded in the culture medium the difference is probably due to a slower uptake of the toxin 
in plant cells.Therefore a number of experiments were conducted trying to increase the uptake of 
amanitin. A number of parameters such as regeneration stage and pH of the medium, and permeability 
of the membranes were modified but amanitin sensitivity was not significantly increased under any 
of the tested conditions. 
Current experiments are aimed at making use of the specific and rapid uptake of biotin and biotin-
protein conjugates into plant cells.If this strategy turns out not to improve sensitivity of the calli 
sufficiently to make a selection feasible, an alternative approach will be to start screening pooled calli 
for recombinants via PCR. This approach will be more time consuming than a selection scheme and 
its success will depend on the targeting frequency which we expect to be higher than in previous 
studies. 
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Title: Site directed mutagenesis in Arabidopsis thaliana using Agrobacterium 
as a gene delivery system 
Principal Investigator^): P.J.J. Hooykaas and A.C. Vergunst, Department of Plant Molecular 
Biology, Clusius Laboratories, Wassenaarseweg 64, 2333, AL 
Leiden, THe Netherlands. 
Participant No: 14 
1. Construct Agrobacterium strains and host plants with defective hph-gene. 
2. Start transformation work using protoplasts. 
In Prof. Willmitzers' group, (participant no. 38) gene targeting was obtained in Arabidopsis hph-
defective lines using a method of direct gene transfer. Since gene targeting in plants occurs at very 
low frequencies, a very efficient transformation system is necessary. 
The main focus of the project has been to work out a protocol for the efficient transformation of 
Arabidopsis protoplasts via Agrobacterium. The first step was to establish a way to co-cultivate 
protoplasts and bacteria. In the established protocol for Arabidopsis regeneration protoplasts are 
embedded in an alginate matrix directly after isolation. It appeared that the dense alginate matrix 
makes passage of the bacteria and thus transformation of plant cells impossible. 
Two alternative directions were followed: 
1. Liquid culture of Arabidopsis protoplasts: Most convenient would be to culture protoplasts 
as well as co-cultivate with bacteria in liquid medium. Culturing of protoplasts in liquid 
medium however gives rise to partial cell wall formation and only very low cell division rates 
with as a consequence that the cells die within two weeks of culture. For division complete 
cell wall formation is necessary. 
It was suggested we use a different hormone regime (high kinetin), to obtain division in liquid 
medium. This worked, although the frequency of division was still low. Experiments will be 
done to optimize this. 
2. Experiments have been initiated to test whether 2,6-dichlorobenzonitril (DB), a cellulose 
biosynthesis inhibitor, can be used to extend the time protoplasts survive in liquid culture. We 
found that regeneration from Arabidopsis protoplasts is not impaired after a 3 to 4 day 
treatment of protoplasts in liquid medium supplied with 2,6-DB, followed by embedding in 
alginate. Experiments are being performed to test whether 2,6-DB will be helpful in 
Agrobacterium-medined transformation of Arabidopsis protoplasts. 
Title: Transfer of homologous DNA-fragments into Arabidopsis thaliana using 
recombinant YAC-clones 
Principal Investigator(s): P. Meyer, Max Delbruck Laboratorium, Carl von Linne Weg, 10, 
D-5000, Koln 30, Germany. 
Participant No: 24 
The goals of the first year was the construction of two types of vectors: a vector which could be 
transferred into Arabidopsis to establish a number of receptor plants for gene replacement because 
they carry a negative selectable marker and vectors based on YACs which contain positive selection 
markers for spheroplast/protoplast fusion experiments and which carry a negative selection marker 
to allow for selection against non-homologous recombination events. The second goal was the 
initiation of transformation experiments, the test of selection conditions for a negative marker gene 
and the initiation of fusion experiments between yeast spheroplasts and plant protoplasts. 
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A plant transformation vector pl'2'tk has been constructed for the establishment of transgenic 
Arabidopsis lines which serve as receptors for gene replacement experiments. The plasmid contains 
a positive selectable NPTTI gene and the two negative selectable marker gene tms2 of Agrobacterium 
and TK of herpes simplex virus which are both driven by the bidirectional 1 '2'promoter.Two YAC­
based transformation vectors have been constructed. pYKHG (20kb) serves as a model vector for gene 
transfer from yeast into protoplasts. Based on pYAC4 it contains HPT. and NPTII­genes as selection 
markers and a unique EcoRI­ cloning site. pYAC­G2 (14kb) serves as a vector for selection against 
non­homologous integration events as it carries a tms2 gene inserted into the Sail­site of pYAC45. 
The technique of DNA transfer into Arabidopsis via PEG mediated transfer was established in our 
lab after a training visit to the lab of Lothar Willmitzer. Primary tests of tms2­function as a negative 
selectable marker were conducted with a transgenic line R 4018 derived from Agrobacterium­mediated 
transformation of Landsberg erecta. Southern analysis revealed that R4018 contains two copies of a 
tms2 gene which are both located on a 12kb Notl­fragment and a 70­80 kb Xbal­fragment. 
Functionality of tms2 as a negative marker was tested on medium containing 3uM 
Naphthaleneacetamide which should be converted into Naphthaleneacetic acid by tms2. While no 
obvious effect could be observed for wild­type plants R4018 showed an inhibition of root 
development in germinating seeds and the formation of adventitious roots on seedlings. 
Direct transfer of pl'2'tk into C24 was initiated, resulting in numerous transgenic calli which still 
have to be regenerated and tested for tms2­ and ik­activity. pYKHG was transferred into yeast as a 
linear vector. Pilot experiments for PEG­mediated fusion of YKHG containing yeast and Arabidopsis 
protoplasts were initiated. 
Title: Gene Replacement 
Principal Investigator(s): L. Willmitzer and P. Morris, Institut fur Genbiologische, 63, 
Ihnestrasse, Berlin, 1000, Germany. 
Participant No: 38 
1. Construct vectors and host plants with defective hpt gene. 
2. Start transformation work using protoplasts. 
In order to establish a system to monitor the success of gene targeting in Arabidopsis thaliana, a non­
functional hygromycin phosphotransferase (hpt) gene was inserted into Arabidopsis to supply a 
chromosomally located target for homologous recombination experiments. A chimaeric gene 
consisting of the CaMV 3SS promoter, the polyadenylation signal of the octopine synthase iocs) gene, 
and the coding region of the bacterial hpt gene with a 19 bp deletion, including a PstI restriction site, 
was introduced by Agrobacterium-medialed transfer into Arabidopsis. The deletion resulted in a 
frame­shift and a premature stop in the translated region. 
Protoplasts were prepared from the transgenic Arabidopsis lines and transformed by PEG­stimulated 
direct DNA uptake with DNA containing the promoter­less, intact coding region of the hpt gene, 
both in the single stranded and in the double stranded form. The expectation was that a recombination 
event between the defective chromosomal target and the intact targeting DNA would repair the 
chromosomal deletion and thus restore hygromycin resistance. In total 3.46 x 10* protoplasts were 
transformed and ISO hygromycin resistant calli were found. Since these could also arise from a 
fortuitous insertion of the intact hpt coding region next to an endogenous promoter. Of the ISO calli, 
4 gave a positive signal by PCR analysis. That the target gene had indeed been repaired was 
confirmed by the fact that the PstI site in the deletion was now cleavable in amplified DNA from the 
corrected lines, whereas in the parental lines, this was not the case. A frequency of homologous 
recombination of 3x10"* was observed, comparable to the frequencies observed in homologous 
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transformation studies on tobacco. In order to increase the recombination frequency in Arabidopsis, 
a strategy was adopted to increase the available length of homology above lOSObp. 
To this end, one of the recombinant lines which by Southern analysis was known to contain a single 
repaired chromosomal target gene was chosen. This gene was known to lie within an l lkb genomic 
fragment. A genomic library was prepared from HindlU digested DNA and positive plaques obtained 
were further characterised. This clone is currently being sequenced to analyse the events which 
occurred during the repair of the hpt gene, and a deletion is being introduced at the 3 'end to ensure 
non-functionality of the targeting gene. 
This 11 kb sequence will then be retransformed into protoplasts of the original parental line, in 
parallel with the original hpt targeting sequence of 1050 bp. This will allow us to make a comparison 
and assessment of the influence of length of homology on the frequency of homologous recombination 
in Arabidopsis thaliana. 
Title: Development and use of Arabidopsis thaliana as a tool for isolating genes of 
agronomic importance. 
Pricnipal Investigator(s): B. Reiss, Abteilung Genetische Grundlagen der Pflanzenzuchtung, 
Max Planck Institut fur Zuchtungsforschung, Carl von Linne weg, 
10, D-5000, Koln 30 (Vogelsang), Germany. 
Participant No: 32 
Stimulation of recombination bv recA 
1. Construction of expression vectors and plant transformation 
The proposed objective of this research was to improve the frequency of gene targeting in Arabidopsis 
by the use of the recombination promoting enzyme recA. A dual strategy was proposed to reach this 
goal: 1(a) expression of recA enzyme under the control of plant expression signals and determination 
of its effect on the frequency of gene targeting and 1(b) formation of recombination competent 
complexes of recA enzyme and DNA, transformation of these complexes into target lines and 
determination of the frequency of gene targeting. 
1(a) RecA was clonedfrom an E. coli source and its coding region was fused with a nuclear targeting 
signal at the amino terminus of the recA protein in order to direct it to the nucleus. This was 
transferred into plants. 
1 (b) The formation of recA protein/DNA complexes under conditions for plant transformation was 
established. For this purpose, recA protein was purified and single stranded DNA, the complements 
of our target genes, were obtained from M13 vectors. To obtain nts-recA in sufficient quantity for 
biochemical characterisation and complex formation, the nts-recA gene was cloned into an E.coli 
expression vector. RecA protein complexes were formed with ssDNA and it was showen that these 
are stable under conditions used for plant transformation. 
2. Establish expression levels and localisation of recA 
Plants were tested for the presence of recA. However.in none of over 40 plants tested, a recA specific 
signal was detected. To investigate this lack of expression further, the integration events were 
analysed by Southern blots. Of the plants tested, only 3 posessed an intact recA transgene. Instead, 
most plants contained deleted or rearranged recA gene fragments. 
recA protein/DNA complexes in a concentation optimal for recombination in vitro were formed and 
plant cells transformed. However, none of the protoplasts in a series of experiments survived 
selection and, moreover, around 80% of the protoplasts died without selection when comared to 
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control cells which had not been treated with recA. At present, strategies are developed to covercome 
this problem. 
Title: Application of intra chromosomal recombination for Arabidopsis 
chromosomes mapping. 
Principal Investigators): J. Paskowski and J. Masson, Institute of Plant Sciences, ETH 
Zentrum, Universitatstrasse 2, Zurich, 8092 Switzerland. 
Participant No: 28 
The aim of this project is to use homologous recombination mechanism between genomic repeats 
introduced in plant genome to generate deletion mutants in Arabidopsis. 
It was shown that such recombination events do occur during mitosis and recombinant clones can be 
selected from appropriate transgenic plants derived protoplasts at a frequency of 10"4 in tobacco. The 
utilization of mitotic homologous recombination in Arabidopsis thaliana requires: 
1. An efficient plant regeneration procedure from Arabidopsis thaliana protoplasts. 
2. The evaluation of the appropriate markers necessary for the selection of transformants and 
recombinants. 
3. The construction of recombination substrates and their introduction in Arabidopsis plants. 
1. Improvement of plant regeneration efficiency from Arabidopsis protoplasts 
Procedures previously established for plant regeneration from mesophyll II protoplasts of Arabidopsis 
thaliana have been optimized. The protoplast plating efficiency (number of microcalli per number 
of planted protoplasts) is strongly dependent on the growth conditions of the donor plant, especially 
medium composition and illumination conditions. The yield of microcalli is markedly influenced by 
the nitrogen source in the protoplast culture medium. The developed procedure gives reproducible 
plating efficiencies of 7-10% i.e. 15-20 times higher than previously published (0.5%) for Arabidopsis 
thaliana race C24. The time required for all procedure, from protoplast to shoots has been reduced 
from 108 to 50 days. 
2. Evaluation of appropriate markers for the selection of protoplast derived colonies 
The different coding sequences of the genes conferring resistance to Kanamycin (1), Hygromycin (2), 
Phosphinotrycin (3), Chlorsulfuron (4), Methotrexate (5), Stretomycin (6), Streptomycin (7) will be 
cloned in a pUC derivative plasmid under the control of 35S promoter and termination sequences. 
Plasmids 1, 2, 3 were existing, 4 has been cloned and 5 and 6 are under progress. 
The establishment of precise dose-response for the different selectable markers on protoplast derived 
colonies, obtained with our optimized procedure, is under review. 
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ITille: Physical mapping of the Arabidopsis thaliana genome. 
Principal Investigator^): C. Dean, R. Schmidt and G. Cnops, Molecular Genetics Department, 
Cambridge Laboratory, John Innes Centre, Colney Lane, Norwich, 
Norfolk, NR4 7UJ. 
Participant No: 9 
1. Establish an international collaboration in YAC mapping; 
2. Construct a YAC library with larger insert sizes; 
3. Devise rapid screening methods and techniques to generate end-probes from the YAC clones 
eg. inverse PCR; 
4. Hybridize RFLP probes mapping to the tops of chromosomes 4 and 5 to YAC libraries; 
5. Contribute data to the international database; 
6. Establish methods of subcloning YAC clones into vectors suitable for plant transformation. 
An international collaboration has been established with the initial aim of hybridizing all the currently 
mapped RFLP markers to the YAC libraries. The next stage of the project will be to walk from each 
YAC clone until the one hybridizing to the next RFLP marker is reached. Different laboratories have 
agreed to focus on specific regions of the genome and the current division of the work is: 
chr 1 Ecker (USA), Scolnik (USA); chr 2 Goodman (USA); chr 3 Goodman (USA); chr 4 Dean 
(UK), Somerville (USA); chr 5 Dean (UK), Somerville (USA). 
Three different YAC libraries were obtained sonn after starting the programme. These libraries were 
each composed of 2300 clones with an average insert size of ISOkb and each represented > 3 genome 
equivalents. We have also received an additional two libraries, one from Dr J Ecker and another from 
Dr C Somerville. Since the library provided by J. Ecker has significantly larger inserts than the other 
libraries, with an average size of250kb, we chose not continue our efforts in constructing more YAC 
clones but focused on overlapping the YAC clones in the available libraries. 
Based on protocols used in the C. elegans project obtained from Dr A. Coulson (MRC Cambridge) 
we have made the screening of the libraries as efficient as possible. We can now do a 25 offset plating 
which enables us to get one whole library on one plate and thus on one 11x8cm filter. This is many 
times more clones/filter than most robotic machines can achieve. Up to 30 replica copies of each 
master filter can be made and these are processed using streamlined methods. 
All 33 RFLP markers mapping to the tops of chromosomes 4 and 5 have now been hybridized to at 
least two of the YAC libraries. All the positively hybridizing YAC colonies have been confirmed by 
Southern blot analysis. This effort, together with others in the International programme, resulted in 
approximately 30% of the Arabidopsis genome being represented in mapped YAC clones. 
Linking of the YAC clones hybridizing to adjacent RFLP markers is being achieved by chromosome 
walking experiments. We have so far concentrated on a 10 cM chromosomal region on chromosome 
4 lying between RFLP markers 210 and 226. Currently, three contiguous regions of 920, 820 and 
420kb lie within this region, involving 59 YAC clones. 
We are establishing Norwich as a node for the Arabidopsis database (AATDB) which is being 
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assembled in the laboratory of Dr Howard Goodman. This will carry all current information on the 
Arabidopsis physical map, current visible marker and RFLP maps, bibliography etc. 
Title: Resource Centre 
Principal Investigator^): B. Mulligan, Botany Department, Nottingham University, University 
Park, Nottingham. 
Participant No: 26 
1. Set up sub contract with AIS 
We have set up the subcontract with Professor Kranz (Frankfurt) for the transfer of the AIS seed 
collection to Nottingham. The form mutants have been received and re-characterized. The new 
information gained from this exercise will be incorporated into an updated seed list which will be sent 
to Arabidopsis T-Project participants. The colour mutants and biochemical mutants will be transferred 
to Nottingham shortly. The AIS database has been received. 
2. Continue to collect and catalogue mutants 
a) Collection 
We have had a major publicity drive to inform people about the Stock Centre and to call for seed 
donations. As part of this initiative, seed lists etc have been sent to European agroindustries and 
participants in the T-Project "Regeneration". 
(b) Cataloguing 
We have characterized the AIS form mutants of Professor Kranz and are now awaiting the delivery 
of the next batches of mutants. We have also started to characterize several other donated sets of 
mutants. The catalogued information will, following discussion with the donors, be incorporated into 
Arabidopsis databases as described below. Much of the information will also be included in a seed 
list to be circulated to T-Project participants in July/August 1992. 
(c) Distribution of seed samples 
1991=791 seed lines distributed. This number includes the transfer of all our stocks to the 
Arabidopsis Resource Centre at Ohio, USA. Geographical breakdown: Europe 60 requests, 284 lines 
distributed; rest of the world 63 requests, 507 lines distributed. 
1992 ( to the end of February) = 215 lines distributed. Geographical breakdown: Europe 15 
requests, 73 lines distributed; rest of the world 23 requests, 140 lines distributed. 
In total, approximately 600 seed lists have now been distributed around the world. 
3. Set up international database and distribution system. 
Two American databases, which are independently funded, have been established for the development 
and administration of international Arabidopsis resources. Both databases will share the same 
information, but the emphasis placed on different pieces of information will be different. These 
developments mean that it would be redundant to establish a separate database at Nottingham. As 
a more efficient alternative, therefore, good working links between Nottingham and both American 
database projects have been set up and the appropriate communications systems (eg.E-mail) have been 
established. The AIMS database being developed in the US should become a master database for both 
Ohio and Nottingham. The second database is AATDB ("an Arabidopsis thaliana database"). At the 
moment AATDB is a stand alone system. This database already carries a copy of the Nottingham 
Arabidopsis Stock Centre Seed List, our subscribers list and scanned images of several of our mutant 
stocks. The first release will be in the Spring 1992. The program will be distributed free of charge 
and will be available via anonymous ftp from several computers. 
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Title: Resource Centre 
Principal Investigator(s): J. Dangl, Max Delbruk Laboratorium, Carl von Linne weg 10, D-
5000, Koln 30, Germany. 
Participant No: 7 
In the course of the last year, the DNA Resource Center has met several of its initial goals. We 
assembled, in the first year of the BRIDGE program, "cloning tools" of general use to members of 
the Arabidopsis research community. These tools fall into three categories: RFLP mapping markers 
(both phage and cosmid), YAC libraries, and phage libraries containing both genomic and cDNA 
inserts. We developed a useful routine for storage and distribution of these tools. Finally, we began 
distribution of cloning tools to researchers around the world. Our goals have also included 
communication with the newly established AIMS center at the Ohio State University. As a prelude 
to a larger Arabidopsis sequencing effort, we placed a very high emphasis on the collection of 
relevant cDNA and genomic Arabidopsis phage banks. Our efforts included a "call for deposition" 
of phage banks advertised in the AFRC newsletter and international meetings. Several deposits were 
made; they are listed below: 
Genomic banks: From ecotype Col-0 (2 sources, in two different vectors) 
From Ecotype Landsberg-erecra 
cDNA banks: From mature, sterile seedlings 
From aerial tissue (no roots) 
From flowers 
We have also amplified and made available the 90 random phage genomic clones which are the basis 
of the Meyerowitz laboratory RFLP map. Recently, Dr. Meyerowitz has made available 48 more 
phage and cosmid mapping probes, which have been added to the collection. In the last few weeks, 
we have made arrangements to receive the 96 cosmid clones which form the basis of the Goodman 
lab RFLP map. Two complementary YAC libraries, those most commonly used by the international 
Arabidopsis community, are also stocked and available from the DNA Resource Center. An 
Arabidopsis library in a T-DNA transfer vector "carried" in Agrobacterium has been made and will 
be deposited in the collection. Direct utilization of this library during chromosome walking may 
obviate, and will certainly complement, use of cosmid clones. 
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Title: Floral Induction in Arabidopsis thaliana 
Principal Investigators): M. Koornneef and A.J.M. Peelers (EC Post-doc), Department of 
Genetics, Wageningen Agricultural University, 2 Dreijenlaan, 6703 
HA, Wageningen, The Netherlands. 
Participant No: 21 
The initial goal of the project was: 
1. The construction and physiological analysis of double mutants of the eleven late flowering 
genes identified in our laboratory (Koornneef et al. 1991). 
2. The study of the interaction between phytochrome and flowering by the combined analysis 
of flowering time and phytochrome deficient mutants. 
3. Thegenetical and physiological analysis of new flowering time loci. 4. The cloning of thejwa 
locus. 
1. Late flowering double mutants: 
For six combinations this process is already completed and it is expected that at the end of 1992 all 
possible double mutants are available for physiological analysis. This will give further insight in the 
epistatic relations of the various loci, thereby allowing a further elaboration of the tentative models 
for floral induction as presented by Martinez-Zapater and Somerville (1990) and Koornneef et al. 
1991. 
2. The interaction between phytochrome and floral initiation: 
Mutants defective in phytochrome chromophore biosynthesis (fry/ and hy2) and in the light 
stable PHYB (hy3) were found to be early, especially in short day conditions (Goto et al. 
1991). Apparently phytochrome promotes inhibitors of floral induction under these conditions. 
The hy2/hy3 double mutant, which is more reduced in phytochrome content flowers even 
earlier. Double mutants between representatives of the various phenotypic late flowering 
mutant group (co.gijwa and fca3 ) have been made and triple mutants (hy2/hy3 with the 
various late flowering mutants) are being made. These genotypes will be analysed in 
daylength and light quality experiments (in collaboration with Dr Whitelam, Leicester, UK). 
3. New flowering time genes: 
Several mutants in genetic backgrounds different than Landsberg erecta (Let) have been 
obtained. These included previously described mutants such as R&iei's Id, McKelvie's F, J2 
and _p. Their often extreme lateness and the dominant nature of several of these mutants 
suggested that some of these represent new loci. Thus far 3 and possibly 4 loci in addition 
to the 11 loci have been identified of which 2 have been mapped on the top arm of 
chromosome 5, where some 4 late flowering genes are located at a relatively short distance. 
4. The cloning of fwa. 
Mutants at \hejwa locus are dominant and are relatively insensitive to vernalization but 
responsive to daylength. This gene was mapped at position 51 on chromosome 4 in the 
vicinity of the abil locus (Koornneef et al. 1991). Genomic subtraction was applied to an 
irradiated induced mutant allele and has yielded some fragments which are being tested for 
their genetic relation with the locus. In addition a map based cloning approach was started. 
YAC's have been identified by Jeff Leung in Giraudat's group (walking to abil), which 
seems to cover the fwa region. 
• 390-
Title: MOLECULAR GENETIC ANALYSIS OF THE VERNALIZATION 
REQUIREMENT IN ARABIDOPSIS THAUANA 
Principal Investigator(s): C. Dean and L. Westphal, Molecular Genetics Department, 
Cambridge Laboratory, John Innes Centre, Colney Lane, Norwich, 
Norfolk, NR4 7UI, UK. 
Participant No: 10 
1. Initiate high-resolution mapping around/ca; 
2. Initiate YAC walking to/ca from adjacent RFLP markers. 
Our first step in walking to the/ca gene was to map the locus with respect to the RFLP markers. The 
fca mutant, which is in the Landsberg ereaa background, was crossed with each of the polymorphic 
parents, Columbia and Niederzenz.These experiments enabled us to map the/ca locus between the 
two RFLP markers LEM 580 and 226 (approximately 1.2cM from the RFLP marker LEM 226). 
These RFLP markers were hybridized to the different YAC libraries. End-probes from the different 
YAC clones were then generated using inverse PCR or plasmid rescue and were hybridized back to 
the YAC libraries. In this way, YAC contigs were built up on either side of the/ca locus. The 
recombination break points on either side of fca were used to direct these chromosome walks, us. 
Many plants are being screened for recombination break-points lying very close to the/ca locus using 
the end-probes isolated from the YAC clones closest to the fca locus. We should soon obtain 
recombinants every 0. lcM with this number of plants allowing the fine mapping of the fca gene to 
within approximately 14kb. The chromosome walk over the/ca locus, joining the two contigs has 
proved to be difficult due to the presence of repeated DNA sequences flanking the locus. This gap 
is likely to be a small physical distance however, based on the genetic distance. 
Title: Molecular characterization of the 
APETALA2 gene 
Principal Investigator(s): M. van Montagu, Rijksuniversiteit Gent, Laboratorium Genetika, 
Ledeganckstraat 35, Gent, B-9000, Belgium. 
Participant No: 37 
1. Obtain sequence of the APETALA2 from T-DNA-tagged gene 
2. Start to examine the role of the encoded protein 
The APETALA2 gene has been isolated. To isolate the T-DNA and flanking AP2 plant sequences we 
generated a genomic library from the tagged Ap2 mutant. A T-DNA-containing region was isolated. 
Sequence analysis of the flanking plant sequences revealed an open reading frame. These flanking 
sequences were subsequently used to screen a flower-specific cDNA library as well as two genomic 
libraries. One of Ap2-1, a weak ap2 allele and one genomic library of wild-type Landsberg erecta. 
Several overlapping wild-type AP2 gene regions were used to rescue two alleles, ap2-l and our 
tagged mutant. These experiments allowed us to confine the AP2 gene to a 7.2-kb gene region. 
The wild-type AP2 gene, the ap2-l allele and several AP2 cDNA clones have all been sequenced. 
Based on the sequence data we can say the AP2 protein has a molecular mass of 47 kDa. There is 
a repeated motif of two amphipatic helices present within the AP2 protein. Comparison of the AP2 
sequence with that of other proteins did not reveal any significant homology to known proteins. 
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The repeated motif seems to be present in a family of related genes in Arabidopsis as well as in 
petunia and tomato (results based on Southern hybridization data). In fact, we have isolated 
cross-hybridizing clones from a flower-specific cDNA library from petunia. Preliminary sequence data 
indicate that these clones contain at least one and possibly both amphipatic helices that are present in 
the AP2 protein. 
Title: Isolation of the co <fg) locus and identification of other mutations affecting 
flowering- time in Arabidopsis 
Principal Investigator^): G. Coupland, J. Putterill, F. Robson, K. Ingle and S. Dash, 
Molecular Genetics Department, Cambridge Laboratory, John Innes 
Centre, Colney Lane, Norwich, Norfolk, NR4 7UJ, UK. 
Participant No: S 
1. Initiate YAC walking \ofg (co) using RFLP probes 
2. Isolate recombinants around fg(co) 
We are interested in the co mutation since this dramatically delays flowering of Arabidopsis under 
long days, co is located on the upper arm of chromosome 5 and is 2cm proximal to Jt4. The latter 
mutation prevents the synthesis of anthocyanin and the gene encodes the enzyme chalcone synthase. 
The average physical distance between thse loci is likely to be about 300kb. 
We started a walk to this locus by hybridising the 4 RFLP markers which are closely linked (within 
ca. 2cM) to chalcone synthase to the EG and EW YAC libraries. This allowed us to deduce how the 
YACs lay in relation to each other. In most cases this arrangement was later confirmed by the 
isolation of inverse polymerase chain reaction generated fragments which are located at the ends of 
the Arabidopsis DNA inserted within the YAC, and hybridisation of these to the appropriate YACs. 
The short contigs around the RFLP markers were then extended. Two sets of overlapping cosmid 
clones from this area were obtained from others and the appropriate ones were probed against the 
YAC libraries. This identified two new YACs. End probes derived from most of the 20 YACs we 
had identified were then used to screen the libraries and new YACs extending the cloned region in 
both directions were isolated. It has allowed us to assemble one contiguous segment of Arabidopsis 
DNA which includes RFLP markers 6833, CHS, pCIT1243 and 5962 and is approximately 1550kb 
long. 
The location of co within the contig was determined by detailed RFLP analysis after the isolation of 
recombinants containing cross-overs very closely linked to co. 
Title: Floral induction: Identification and characterization of genes evolved in floral 
induction. 
Principal Investigator(s): J.M. Martinez-Zapater, Dpto. de Proteccion Vegetal, CIT-INIA, 
Ctra. de la Coruna, Km 7, 28040, Madrid, Spain. 
Participant No: 22 
1. Initiate YAC walking to fve from adjacent RFLP markers. 
2. Initiate high resolution mapping around fve. 
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Information provided by the International Mapping effort allowed us to find appropriate markers and 
recombinant YACs to begin our walk to fve.. The right ends of YACs EW6A7, EW15H11, and 
EW20F11 have been amplified using IPCR and the left ends are currently under cloning by plasmid 
rescue in the laboratory of George Coupland. These ends will be used to detect polymorphisms 
around the fve locus and to map them and orientate the YACs. 
Progress towards the second objective is currently more advanced. A Landsberg fve homozygous line 
marked with the cp2 mutation and other mutations on chromosome 2 was obtained. This line was 
crossed with Niedersenz and Columbia ecotypes and recombinants between the two loci, fve and cp2, 
were isolated in the F2. Sixty three recombinants have been isolated in this short region of 6cM that 
will allow the construction of a 0.1 cM resolution map at this side of fve. These DNA preparations 
are currently being used for Southern hybridization and a high resolution RFLP map at this side of 
fve will be ready soon. For mapping the other side of fve, we have constructed a line homozygous 
for fve and sti, a mutation that produce non-branched trichomes. We think this collection of 
recombinants around the fve locus will be invaluable in the following steps of chromosome walking. 
Finally, a physiological and morphological characterization of the fve alleles has been performed. The 
purpose of this analysis was to get more information about the function of the locus and to identify 
the best conditions to perform the complementation of the mutant phenotype. From this study we have 
concluded that mutations at the fve locus produce not only a delay in the transition from the vegetative 
to the reproductive phase, but also affect elongation of the internodes in the floral stem. 
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Title: Expression of aba-response genes in Arabidopsis seeds 
Principal Investigator(s): M. Pages, CSIC, Departamento de Genetica Molecular, Jorge 
Girona, Salgado, 18-16, 08034, Barcelona, Spain. 
Participant No: 27 
1. Screen libraries with maize clones known to be ABA-induced. 
2. Initiate constructions of hybrid promoter reporter genes 
3. Initiate studies of ABA-regulated genes in mutant lines 
Developmental regulation of the ABA-responsive rab-Yl promoter in Arabidopsis thaliana and ABA 
deficient and insensitive mutants. 
To elucidate the mechanisms by which abscisic acid (ABA) regulates specific expression of the rob 
17 gene we have obtained transgenic plants of Arabidopsis thaliana (L.) ecotype Landsberg erecta 
and ABA-deficient (abi) and ABA-insensitive (aba) mutants derived from it, carrying a large 5' 
upstream fragment of rab 17 (-1330/+29) and the reporter gene GUS. 
The plasmid containing the rab 17 /GUS gene fusion was transferred to Arabidopsis thaliana by root 
transformation. Lines homozygous for the T-DNA insertion were initiated from T2 plants that gave 
100% of kanamycin resistant seedlings after selling. Six independent insertions were fixed in this 
way. The integration of the raM7/Gus construct was confirmed by Southern analysis. 
The effect of ABA-insensitivity or deficiency on the activity of the rab\l promoter was analyzed by 
constructing lines homozygous for aba and abi mutations and carrying the T-DNA insertions. 
The genotype of these plants was confirmed by analyzing the phenotypes of the F3 derived plants. 
To investigate developmentally regulated expression of the raZ>17/Gus chimeric gene, Gus activity was 
measured during embryo development in wild type and mutants. Localization of Gus activity was 
revealed by histochemical staining. Developing embryos stained blue when they were dissected around 
IS d.a.f. and between 18 and 25 d.a.f. a rapid accumulation of Gus activity occurred reaching a 
maximum in wild type dry embryos. This profile mimics the normal time course of rail7 mRNA 
accumulation in the developing maize embryo. Analysis of Gus expression in seed sections of both 
transgenic wild type and mutants revealed that the highest level of Gus activity was in the 
endosperm. This result was unexpected because of the absence of expression of rabYl mRNA in 
maize endosperm tissues. It has been reported that various ABA-induced responses are decreased or 
eliminated in Arabidopsis mutants carrying ABA-deficiency and insensitivity mutations. However, the 
induction of the 1.3kb rabYl promoter fragment in transgenic wild type and mutants has been shown 
to display the same kinetics. These results were expected and correlate well with the observed 
accumulation of the rabYl mRNA of the endogenous maize gene during embryo development in the 
maize viviparous mutants where only lower levels of expression were detected in the mutants. Work 
is in progress to elucidate the promoter sequences involved in the induction of rab genes by ABA in 
embryo and endosperm both in wild type and mutant plants. 
Title: Seed development and Abscisic Acid 
Principal Investigator:(s) M. Koornneef, K.M. Leon-Kloosterziel (PhD student) and E.P. van 
Loenen-Martinet (part-time technician), Department of Genetics, 
Wageningen Agricultural University, 2 Dreijenlaan, 6703 HA, 
Wageningen, The Netherlands. 
Participant No: 20 
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The goal of the project is the isolation and characterization of mutants affecting abscisic acid (ABA) 
metabolism and seed development. 
Dormancy mutants: 
Mutants without dormancy were found by isolating seeds, which germinated within 1 -3 days after 
incubation on water. Freshly harvested M2 derived from mutagen (EMS or gamma irradiation) treated 
abi3 or wild type Landsberg erecta seeds. This screen yielded approximately 20 mutants that showed 
this phenotype upon rescreening in the M3 generation. The most dramatic phenotype was represented 
by a mutant that in addition to a lack of dormancy, a green colour of mature seeds, extreme 
insensitivity to ABA and a reduced resistance to desiccation. Genetic analysis indicated that this 
mutant was an allele of the abi3 locus, which recently has been cloned by Giraudat. This result 
indicates that the previously isolated alleles of abi3 were "leaky" and that this gene is probably the 
most crucial gene that regulates seed development. This mutant and 3 additional new less extreme 
alleles were sent to Dr. Giraudat for further analysis at the DNA level. The physiological analysis 
of this extreme abi3 allele with emphasis on the relation between desiccation tolerance and sugar 
metabolism is being performed in collaboration with the group of Dr Karssen. 
Among the non-dormant mutants 5 are characterized by excessive wilting indicating a lack or non 
functioning of ABA synthesis or action. Genetic analysis of these mutants is in progress. 
Abscisic acid insensitive mutants. 
Mutants have been isolated from and abi3-l M2 population , which are resistant to 100 pM ABA. 
These mutants do not show symptoms of wilting and genetic analysis is in progress. 
A seed shape mutant. 
A mutant has been isolated with a heart shaped seed instead of the oval shape of a wild type seed. 
Reciprocal crosses and the analysis of segregating generations indicated that this aberrant seed shape 
is determined by the maternal genotype. This indicates the importance of the testa the determination 
of the seed shape, despite the fact that the embryo makes up most of the seed volume in the mature 
seed. 
The characterization of the mat mutant (in collaboration with Valvekensl 
The mat mutant has been isolated by Dr. Valvekens in the van Montagu lab in Gent and is 
characterized by a premature collapse of growth and development including seed development. We 
have mapped this gene on the lower arm of chromosome 1 and will analyse in detail seed 
development in this mutant to understand the lack of dormancy observed when this mutant grows in 
vitro. 
The expression of seed specific and ABA inducible genes in ABA related mutants. 
We obtained from Dr. Pages (Barcelona) an Arabidopsis genotype containing the GUS gene under 
control of the RAB17 promoter and from Dr Delseny (Perpignan) a genotype with GUS under control 
of the EM2 promoter. We are combining these GUS constructs with the various aba and obi mutants 
by crossing to obtain isogenic genotypes, which can be studied for the expression of these genes 
during seed development and after ABA and stress application. 
Title: Acquisition of desiccation tolerance in developing seeds of Arabidopsis 
thaliana. 
Principal Investigator^): C M . Karssen, Department of Plant Physiology, Agricultural 
University, Arboretumlaan 4, 6703 BD Wageningen, The 
Netherlands. 
Participant number: 16 
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Assist in mutant screening affect seed development and desiccation tolerance. 
Results: 
Desiccation intolerance is thought to be due to insufficient protection of membranes, resulting in 
serious leakage of intracellular constituents upon seed imbibition. Three mechanisms have been 
proposed by which leakage can be avoided; 1) protection of membranes by sugars, preferentially by 
di- or trisaccharides, 2) changes in composition of phospholipids and/or chain length and saturation 
level of acyl chains, 3) protection by specific, possibly ABA induced, proteins. Thus far, all three 
possible mechanisms have received attention in our group. 
A) Sugar composition. Sugars were determined in wild-type and double-mutant seeds throughout 
development. The following differences were found in sugar composition: 1) Only the wild-type seeds 
accumulate stachyose. 2) Glucose, fructose and sucrose accumulate in higher amounts in the double-
mutant seeds than in wild-type. However these differences do not seem to be a major factor in 
desiccation tolerance as it was found that: 1) Developing wildtype seeds are already fully desiccation 
tolerant at 13-14 days after pollination (dap), whereas stachyose becomes only detectable after 16 dap. 
2) The tri-saccharide raffinose is synthesised in relatively small amounts during seed development, 
but decreases at the later stage of seed ripening in both wildtype and double-mutant seeds. 3) The 
amount of sucrose in the desiccation intolerant double mutant seeds is about 2-3 times higher than the 
amount found in the wildtype seeds. 4) Double mutant plants treated with LAB 173 711 (an ABA 
analog) develop phenotypically as wild type plants do and form desiccation tolerant seeds. However, 
no changes in sugar composition are evident as a result of treatment within LAB 173 711. 
B) Lipid analysis. Three major differences were found between wild-type and double mutant seed 
phospholipids: 1) During development, in wild-type seeds the relative amount of 18:1 increases, 
whereas this does not occur in double mutant seeds. Moreover, the absolute amount of 18:1 is lower 
than in the wildtype seeds. 2) Wildtype seeds contain 20:1 which is absent in the double mutant seeds. 
3) The green double mutant seeds contain far more 18:3 than wild-type seeds..This might be due to 
the fact that the double mutant seeds contain a lot of MGDG and DGDG which are important 
constituents of the chloroplast membranes. 
C) Protein analysis. Differences have been found earlier (C. Meurs et a). Plant Physiol. (1992), in 
press), the significance of which will be further explored in a separate line of research. 
D) These preliminary data form an interesting starting point for further investigations in the 
relationship between desiccation tolerance and the membrane protecting characteristics of the above 
mentioned factors. 
Title: Isolation and characterization of Arabidopsis genes involved in abscisic acid 
actions 
Principal Investigator^): J. Giraudat, Institut des Sciences Veggtales, CNRS, 91198 Gif sur 
Yvette, France. 
Participant No: 12 
Koornneef et al. have identified three distinct abscisic acid-insensitive mutants in Arabidopsis thaliana 
(abil, abi2, abi3) that can germinate in the presence of toxic levels of ABA. We have undertaken to 
clone the abil and abi3 loci which, on the basis of the mutant phenotypes, are likely to encode 
elements of two partially distinct ABA-signal transduction pathways. The strategy used is that of 
chromosome walking, by taking advantage of the available RFLP maps, physical maps and YAC 
libraries of the Arabidopsis genome. The abil locus had been previously mapped to position 44.7 on 
chromosome 4. We have constructed a high resolution RFLP map in the vicinity of this locus. This 
was accomplished by crossing Landsberg mutants bearing both the abil and flanking visual markers 
(cert or cer2) to wild-type polymorphic Columbia strain. By such an approach, we have determined 
that the closest RFLP marker (in the interval between cer4 and abil) maps approximately 2.5 
centimorgans from the target gene, separated by six recombinant break points. Since no existing 
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contigs were available in this area, we have used this RFLP as a starting probe to initiate a walk using 
available YAC banks. In successive steps, we have so far isolated a total of 13 overlapping clones 
extending towards abi 1. Conservative estimates suggest that this set of YACs spans approximately 500 
kb of contiguous sequences in the region. The ends of the new YAC clones were used as probes for 
RFLP mapping; this revealed that three of the six recombinant break points have been crossed. In 
terms of genetic distance, this is translated roughly into 1.25 centimorgans walked. 
The abi3 locus had been previously mapped to position 23.5 on chromosome. By a strategy similar 
to that described above for abil, we have constructed a high resolution RFLP map in the vicinity of 
the abi3 locus, using the hy2 and gll flanking visual markers. This initially allowed us to identify an 
RFLP site located at approximately 0.25 cM from the abi3-l mutation. This RFLP probe belonged 
to a contig of overlapping cosmids. Further RFLP analysis, using the various members of this contig, 
revealed that the original marker actually detected several polymorphic sites located on both sides of 
the abi3-l mutation. We then established that these flanking polymorphic sites were located within 
the insert of the cosmid, which was thus likely to contain the abi3 gene. Overlapping restriction 
fragments of this wild-type genomic clone were tested for their ability to complement the abi3-l 
mutation, that is to restore wild-type sensitivity to exogenous ABA at the germination stage. An 11 
kb fragment did achieve functional complementation. This fragment contains at least one gene which 
is expressed in green siliques, as expected for abi3 since all available mutations at this locus affect 
various aspects of seed development. We are presently analyzing various abi3 mutant alleles induced 
by 7-radiation in order to firmly establish the identity of the abi3 gene within the complementing 
fragment. 
When subjected to progressive drought, Arabidopsis plants develop over weeks an adaptive response 
which includes new root morphogenesis. This characteristic new root system (short tuberized roots) 
is able to survive in a desiccated soil and to rapidly resume growth upon rehydration. Bidimensional 
gel electrophoresis has revealed numerous proteins the expression of which is modulated during this 
adaptive process. We are attempting to clone the corresponding genes, initially by using a differential 
(watered versus drought adapted) screening approach on cDNA libraries. The Arabidopsis Columbia 
ecotype has been selected as displaying a strong tolerance to desiccation and a well developed root 
system. Root systems from over 100 drought-adapted and 50 control watered plants (grown 
individually) have been harvested at a stage (7 weeks) when drought rhizogenesis is still a dynamic 
process. Poly(A) RNA has been purified from roots and is presently being used for constructing the 
cDNA libraries. 
Title: Research area Seed Development 
Principal Investigator(s): M. Delseny, University of Perpignan, Plant Physiology and 
Molecular Biology, URA 565 CNRS, Avenue de Villeneuve, 66860, 
Perignan-cedex, France. 
Participant No: 11 
1. Isolate genes induced by aba in late seed development. 
2. Characterise expression in mutant lines made by participant 20 and 16 
1. The aim of our programme was to isolate new genes from Arabidopsis^, regulated by ABA 
and expressed during seed maturation using probes previously isolated in our group from a 
dry seed radish cDNA library. 
During this year, we have concentrated our efforts on Em-like genes. Two genes have been isolated 
from an Arabidopsis genomic library and completely sequenced on ca 3500 bp. The two genes do not 
seem to be closely linked. Sequence of the two genes revealed that one of them is similar to the 
classical Em described in wheat and cotton, but that the second encodes a much longer protein 
397-
because a motif of 20 amino-acids is repeated 4 times instead of being present once. We have 
established that the two genes are expressed by using genes specific probes and by isolating 14 cDNA 
clones which have been sequenced. Initiation site for transcription of both genes has been determined. 
Sequencing of the cDNA revealed that polyadenylation was not precise since 3 or 4 sites were found 
for each gene. Northern blot experiments established that the two genes were not expressed exactly 
at the same time. 
In situ hybridization experiments were carried out with one of the two genes, in collaboration with 
Montserrat PAGES (BARCELONA) and they revealed preferential expression of gene 1 in the 
provascular tissues. 
Fusion of the full length promoter with the GUS reporter gene have been made, as well as fusions 
with serial deletions. Constructions have been transferred to transgenic tobacco and Arabidopsis and 
in both case embryo specific expression has been observed. Seeds from GUS-expressing Arabidopsis 
have been forwarded to Marteen KOORNNEEF so that the construction be transferred in aba, abi 3 
and aba/abi3 background . 
We have also used 2 other radish probes to select Arabidopsis genes for a RAB 17 homologue 
(dehydrin)and for a new gene coding for a protein with a cystein rich motif in the C-terminus (4F11). 
Two different genomic clones have been purified for RAB 17 like, and a single 4F11 gene. 
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Title: Gene expression during embryogenesis studied by in situ hybridisation 
Principal Investigator(s): F. T. Okkels, K. Henriksen and J.E. Nielsen, DANISCO A/S, 
Copenhagen, Denmark 
Participant No: 45 
Goal: Development of an in situ hybridization (ISH) method for detecting GUS mRNA in GUS 
transgenic Arabidopsis embryos. 
Work has been carried out with biotin labelled 24 bases pair oligo-nucleotides against a number of 
mRNA's in paraffin sections of various fixations of various plant tissues and Arabidopsis embryos. 
Although we have obtained good results with some of these probes it seems that the GUS mRNA is 
just at the detection level of the used methods. 
A biotinylated poly-T oligo was used to detect the poly-A tails of the mRNA's available for ISH in 
the sections. Poly-T ISH hybridization together with Acridin Orange proved to be good tools for 
evaluation of fixations, proteinase treatment and other variations in the ISH procedures used. The 
Poly-T ISH results show a very strong reaction to the nuclei and a less strong reaction in the 
cytoplasm of all types of plant tissues used. 
To be able to optimize the ISH procedure further we have tested three different oligo probes against 
the GUS mRNA in leaves of double-haploid beets (with at least 2 copies of the introduced GUS genes 
from E. coli) and analogue material from non-transgenic leaves as control. Promising results were 
achieved with reactions in GUS-positive leaves a little bit over the background reactions seen in the 
GUS-negative leaves, but no clear positive results were obtained when increased stringency in 
hybridization and washing steps were introduced. Each and every step in the ISH procedure has been 
tested for its possible contribution to the background reactions. No single step had any effect on the 
background level. Therefore we must conclude that GUS mRNA was at the detection level of the 
used methods. The best oligo probe against GUS mRNA was hybridized to a hybond nylon filter 
with GUS transgenic beet DNA, a good hybridization was found, only one band in each lane. 
Therefore we have turned to cloned ribo probes, biotin, digoxigenin and -"S-labelled, transcripts of 
the whole GUS mRNA. These probes were then hydrolyzed to pieces of approx. 100-250 bp. We 
have tested a number of ISH methods and variations of these without any clear positive results on 
sectioned material. But with the digoxigenin labelled probe against GUS mRNA we have a clear 
reaction above background on small pieces of double transgenic leaves. 
Title: Molecular Identification of New Plant Genes: Insertional Mutagenesis to 
Isolate Genes Controlling Embryogenesis in Arabidopsis. 
Principal Investigator(s): K. Lindsey, University of Leicester, Leicester, UK 
Participant No: 43 
1. To construct a T-DNA vector for generating GUS fusions; 
2. To generate multiple transformants of Arabidopsis; 
3. To initiate GUS assays in siliques of Tl (F0) plants, to identify GUS expression in early 
embryos. 
1. T-DNA vector construction 
Work to construct a T-DNA vector which could be used to create fusions between a promoterless 
gusA. gene and native gene promoters, following random T-DNA insertion in populations of 
Arabidopsis plants, was initiated previously. The vector comprises a promoterless gusA coding region 
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plus nos termination sequence, inserted into the multiple cloning site of the Bin 19 binary 
transformation vector, for Agrobacterium tumefaciens-mediated gene transfer. The gusA coding region 
has its own translation initiation ATG codon, which is oriented with the 5' end adjacent to the T-DNA 
left border. The npt-ll selectable marker of Binl9 allows selection for transformants on kanamycin. 
Since the sequence between the gusA ATG and the left border contains translation stop codons in all 
reading frames, this construct is expected to generate primarily transcriptional fusions with native 
gene promoters, but translational fusions may be possible if left border sequences become deleted 
during integration. This vector, pAgusBinl9, was provided to the participants in Perpignan, for the 
beginning of the project. 
2. Transformation of Arabidovsis 
Our early attempts to transform Arabidopsis by Agrobacterium wmefaciens used the root explant 
transformation system as described by Valvekens et al. (1988: PNAS 85, 5536). By following this 
procedure, we obtained transformants at a relatively low frequency, and have developed a modified 
protocol which improves the efficiency of recovery of transformants by between 10-100-fold. 
3. Screening of transformants 
The following screening protocol was established. Primary transformants (Tl plants) are assayed for 
activation of the promoterless gusA gene by fluorimetric GUS enzyme assays in extracts of whole 
siliques. Of the GUS-positive lines, T2 seed is bulked up and both quantitative GUS assays and 
histochemical GUS localizations are earned out in developing T3 embryos. T-DNA copy numbers 
are determined by genetic segregation analysis and Southern blot/hybridization, using T-DNA 
sequences as probes. The segregation of mutant phenotypes is looked for in the T2 and T3 progeny. 
To date, 423 independent primary transformants have been screened for GUS enzyme activity in 
siliques. Of these, 74 (17.5%) were GUS-positive. Preliminary studies of GUS expression in the T2 
plants have revealed diverse spatial and temporal patterns. Of 30 T2 lines which exhibited GUS-
positive siliques and which have been studied to date, 11 have been found to express in the immature 
seed. One line, for example, shows strong expression in the root apical region of the T3 embryo, and 
a developmental study is in progress to determine the timing of initiation of GUS activation. 
Preliminary work has also been carried out to identify putative T-DNA insertional mutations that 
affect embryogenesis or seed development. We have identified putative mutants which fall into three 
classes: embryonic lethals, which fail to complete embryogenesis; altered pigmentation, including 
albinos and a 'transparent testa' line; and seedling defectives, which may affect tissue pattern 
formation. We currently are carrying out some genetic studies to establish co-segregation of aberrant 
phenotype and T-DNA. 
Title: T-DNA insertional mutagenesis to isolate genes regulating embryogenesis in 
Arabidopsis thaliana 
Principal Investigator(s): P. Gallois and M. Devic, Laboratoire de physiologie et biologie 
moleculaire (CNRS URA 565), University de Perpignan, Perpignan, 
France. 
Participant No: 44 
1. Assist in vector construction at Leicester 
2. Make multiple transformants together with participant 43. 
3. Initiate screen of transformants for late embryo expression of GUS 
The aim of the project is to tag and isolate genes expressed during embryogenesis in plants by 
promoter trapping and/or T-DNA insertional mutagenesis. The strategy consists of introducing a T-
DNA containing a promoterless GUS reporter gene into a population of Arabidopsis plants (C24). The 
insertion of the T-DNA may lead to expression of the GUS gene by transcriptional fusion and/or to 
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gene inactivation. 
1. During the course of the first year 750 transformants were regenerated. Initial transformants 
were kept in vitro until they set seeds. With the number of transformants increasing, a 
protocol was developed which allowed the transfer into soil of the in vitro plantlets as soon 
as they started to root. 
2. A first screening was carried out to assess the validity of the promoter trapping approach. 100 
transformants were assayed by fluorometry for GUS activity in 5 different organs: root, 
developed cotyledon, leaf, flower and seed. Seeds, (the primary interest for the present bridge 
contract), were screened at 4 stages: from fertilisation to torpedo stage, from torpedo stage 
to late cotyledon stage, from late cotyledon stage to the end of maturation and dry seeds. 
Whole siliques containing the seeds were analysed. 53 % of the transformants expressed GUS 
in at least one organ and all organs tested expressed GUS in at least one transfonnant. More 
importantly, 51% of the plants expressing GUS did so in silique+seeds including 14% which 
showed GUS activity specifically in silique+seeds and not in others organs. These plants are 
currently being tested in a second round of screening at the T2 generation in order to establish 
the stability of T-DNA integration. These results demonstrate the validity of the promoter 
trapping strategy to identify temporal and tissue specific genes expressed during 
embryogenesis in Arabidopsis. 
More transformants are now being screened for GUS expression in silique+seed. 
Mutant phenotypes (albinos, dwarfs) have been observed during the progeny analysis of the 
transformants. Co-segregation in the progeny of the T-DNA insertions and the mutations is being 
studied. 
A screening for embryo lethal mutants has been initiated and is expected to be completed during the 
course of second year. 
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CATALYTIC MECHANISM 
CONTRACT 
NUMBERS: BIOT 0274, 0180, 0258, 0194 and 0272. See relevant reports and 
names of participants on pages 410, 414, 417, 421, 424. 
OFFICIAL STARTING 
DATE: 1st March 1991 
COORDINATOR: R. Verger, C.N.R.S., Marseille (F) 
A general overview 
Objectives set for the reporting period 
Lipases (glycerol ester hydrolases EC 3.1.1.3.) are enzymes that catalyze the hydrolysis 
of ester bonds of long chain glycerides. First of all, one of the most intriguing and unique 
features of lipases is the way in which they are "activated" by interfaces. This 
phenomenon was reported very early. The fact that it is the substrate that forms an 
insoluble lipid-water interface makes lipolysis a very attractive system for studies on 
interfacial enzyme kinetics. One molecule of enzyme can catalyze the release of up to 
9 10s molecules of fatty acid per minute under optimal conditions; this value is one of 
the highest turnover numbers to have been measured in catalyzed biochemical reactions. 
Generally speaking, lipases are assumed to be suitable models for complex membrane-
bound enzymes which are more difficult to investigate experimentally. No specific and 
definite molecular mechanism has been proposed to account for this interfacial 
behaviour. 
On the other hand lipases are becoming of increasing importance for European 
Biotechnology. Lipases are a class of enzymes with high commercial potential, but so far 
only few industrial applications have been developed. In order to optimize lipase 
catalyzed reactions, it is essential to have access to the 3-dimensional structure of the 
protein itself as well as controlling the physico-chemical parameters of the substrate. 
The aim of the project is the structural and functional characterisation of the 10-15 
Upases in order to establish the basic understanding of their catalytic functions. New 
knowledge on a number of these enzymes will make it possible to understand why they 
are lipases and how they functions as such. 
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1. Triacylglycerol lipases and colipases of the digestive tract and exocellular fungal 
lipases: structure, interfacial binding and catalysis. Coordinator: R. Verger, CNRS, 
Marseille, FR. BIOT-CT91-0274 (DTEE), starting from 1/03/91. 
2. Three-dimensional Structure and catalytic mechanism of 2-3 selected lipases of 
industrial relevance. Coordinator: L. Thim, Novo-Nordisk, Copenhagen, DK. BIOT-
CT90-0181 (SMA) starting from 1/02/91. 
3. Molecular structure and specificity relationship of microbial triacylglycerol lipases. 
Coordinator: R.D. Schmid, GBF, Braunschweig, DE. BIOT-CT91-0258 (LNBE) 
starting from 1/06/91. 
4. Characterization of lipases from procaryotic origin. Coordinator: M. Egmond, 
Unilever Research Laboratorium, Vlaardingen, NL. BIOT-CT90-0194 (EDB) starting 
from 1/04/91. 
5. Structure-function relationship of Pseudomonas and Bacillus lipases. Coordinator: 
O. Misset, Royal Gist Brocades, Delft, NL. BIOT-CT 91-0272, starting from 
1/08/91. 
MAJOR PROBLEMS ENCOUNTERED. 
The initial budget was received with a delay of nearly one year compared to the work 
planning chart. Thus, the bar chart in the project proposal should be understood with a 
starting date of January 1992 instead of January 1991. In the absence of funding, initial 
work was carried out with internal resources of the laboratories participating in the project. 
MAJOR RESULTS. 
Three-dimensional structures. 
1. Mucor Miehei Lipase, structure refined. 
2. A model for interfacial activation in lipases was proposed from the structure of a 
fungal lipase-inhibitor complex. 
3. Fusarium solani cutinase structure, a lipolytic enzyme with a catalytic serine 
accessible to solvent, has been solved at 1.25 A resolution. 
4. An almost complete native data set has been obtained at 3 A resolution of 
Pseudomonas glumae lipase. 
5. The modelling of the 3-D structure of Pseudomonas aeruginosa was performed using 
existing lipase and other hydrolase structures as well as amino acid sequence 
homologies. 
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The interfacial activation of 
lipase. Diagrammatic representa-
tion of the conformational change 
in Mucor Michei Lipase. The 
native enzyme (a) and the 
complex (b) are drawn with their 
Cce backbone. The catalytic triad, 
the tryptophan 88 and the lid. and 
the inhibitor are drawn with all 
atoms and highlighted with thick 
bonds. The complete atomic 
structures drawn with their van 
der Waals' radii of the native 
molecule (c) and the complex 
(d). The nonpolar atoms are 
shaded. The increase in the extent 
of the nonpolar surface is readily 
seen in this view. 
Stereoselectivity of lipases selected bv the partners of the BRIDGE T-proiect: Lipases. 
The laboratory in Marseilles received about 20 purified lipases of microbial and 
animal origin thanks to the collaborative network set-up within the framework of the EEC 
T-Lipase Program. This gave a valuable opportunity of comparing the catalytic activities 
and stereopreferences of a group of enzymes which is sufficiendy large to be presumably 
representative of the whole lipase family. 
The stereoselectivity of twenty four lipases towards homogeneous prochiral 
triglycerides was determined. All the lipases tested catalyze the hydrolysis of the chemically 
alike but sterically nonequivalent ester groups in trioctanoin and triolein with different 
degrees of stereobias, depending on the fatty acyl chain length of the substrate. Hydrolysis 
of the sn-2 ester group is catalyzed by very few lipases and only CAA shows a clear 
preference for this position. Most of the lipases investigated (11 with trioctanoin and 16 
with triolein) show a stereopreference for the sn-\ position. Using trioctanoin as substrate 
we observed a total stereospecificity for positions sn-\ and sn-3 with PSp and CAB, 
respectively. Among the twenty four lipases studied here, fifteen show a higher 
stereoselectivity with trioctanoin than with triolein. With three mold lipases as well as 
GPL, the stereopreference switches from sn-3 to sn-1 when increasing the acyl chain 
length from 8 to 18 carbon atoms. The main conclusion to emerge from the present study 
was that the specific stereopreference of each lipase for a given substrate and under given 
lipolytic conditions can be said to be its fingerprint. 
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Abbreviations: HL, Humicola lanuginosa lipase; PF, Pseudomonas fluorescens lipase; 
CR, Candida rugosa lipase; MM, Mucor miehei lipase; GPL, Guinea pig pancreatic 
lipase; PG, Pseudomonas glumae lipase; PPL, Porcine pancreatic lipase; CAA, Candida 
antarctica A lipase; GCM, Geotrichum candidum lipase (Münster); RA, Rhizopus 
arrhizus lipase; FSC, Fusarium solani cutinase; PSp, Pseudomonas species lipase; 
HPL, Human pancreatic lipase; PC, Penicillium camemberti lipase; DPL, Dog pancreatic 
lipase; HGL, Human gastric lipase; DGL, Dog gastric lipase; LPL, Lipoprotein lipase 
(bovine milk); PS, Penicillium simplicissimum lipase; RGL, Rabbit gastric lipase; CAB, 
Candida antarctica B lipase; GCA, Geotrichum candidum A lipase; GCB, Geotrichum 
candidum B lipase; CV, Chromobacterium viscosum lipase. 
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COOPERATIVE ACTTVTnES. 
Utrecht, November 21si-22nd (1988). Preliminary meeting "Lipases and 
phospholipases" organized by Dr. H.M. Verheij and Dr. B. Nieuwenhuis. 
Brussels, April 26* (1989). Invitation to the national experts meeting on 
"Multidisciplinary characterization of (phospho)lipases" organized by Dr. B. 
Nieuwenhuis. 
Troia (Portugal), November 14ih-17th (1989). Closing meeting of the Biotechnology 
Action Programme of the EEC. Planing discussions about BRIDGE-T-Lipase project 
with S. Petersen, J. Cabral, F. Gotz, H.M. Verheij, M.D. Legoy, G. Dodson, O. 
Misset, B. Nieuwenhuis and R. Verger. 
Brussels, June 5 * (1990). Participation to a meeting of the project leaders of the 
selected BRIDGE-T-lipase proposals with M. Egmond, R. Schmid, L. Thim, W. 
Quax, A. Albert, M. Soares, B. Nieuwenhuis and R. Verger. 
Brussels, July 3rd (1990). Participation to the lipase industrial platform, organized 
by Dr. Nieuwenhuis. 
Braunschweig, September 12th-l5th (1990). Co-organization with Prof. R.D. 
Schmid, Prof. L. Alberghina and Dr. R. Verger of a G.B.F./E.E.C. workshop 
entitled "Lipases: Structure, Mechanisms and Genetic Engineering". 
Marseilles, January 23rd (1991). Working meeting with B. Nieuwenhuis and R. 
Verger about the elaboration of the rules and guidelines of the BRIDGE-T-lipase 
project. 
Brussels, February 27th (1991). Meeting of the monitoring unit of the BRIDGE-T-
lipase project with Dr. B. Nieuwenhuis, Prof. A. Albert and Dr. R. Verger. 
Copenhagen, April 23rd (1991). Meetings of the coordinators and the monitoring 
unit at Novo-Nordisk with B. Nieuwenhuis, A. Albert, L. Thim, G. Dodson, M. 
Egmond, O. Misset, R.D. Schmid and R. Verger. 
Delft, April 7>h (1992). Meetings of the coordinators and the monitoring unit at Gist 
Brocades with B. Nieuwenhuis, A. Albert, L. Thim, O. Misset, M. Egmond, F. 
Spener and R. Verger. 
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TITLE : "Triacylglycerol lipases and colipases of the digestive tract and exocellular fungal 
lipases : structure, interfacial binding and catalysis". 
CONTRACT NUMBER : BIOT-CT91 -0274 (DTEE) 
OFFICIAL STARTING DATE : 1/03/1991 
COORDINATOR: Dr. Robert VERGER, CNRS, MARSEILLE, FR. 
PARTICIPANTS : - Prof. R. Kaptein, University of Utrecht, Utrecth, NL. 
- Prof. L. Sarda, Universite de Provence, Marseille, FR. 
- Dr. G. Matthyssens, Corvas International, Gent, BE. 
- Prof. M.D. Legoy, Universite Technologique de Compiegne, 
Compiegne, FR. 
- Prof. J.M.S. Cabral, Instituto Superior Tecnico, Lisboa, PT. 
- Dr. C. Cambillau, CNRS, Marseille, FR. 
- Prof. G.H. de Haas, University of Utrecht, Utrecht, NL. 
- Prof. P. Cozzone, Faculte de Medecine, Marseille, FR. 
- Dr. R. Verger, CNRS, Marseille, FR. 
OBJECTIVES FOR THE REPORTING PERIOD : 
For many years, lipases have been attracting the attention of scientists in academic and 
industrial circles. One of the most intriguing and unique features of lipases is the way in which 
they are "activated" by interfaces. The aim of this proposal is to elucidate of (i) the structure ; 
(ii) the interfacial binding ; (iii) the catalytic mechanism of triacylglycerol lipases and colipases 
of the digestive tract and exocellular fungal lipase (PGS-lipase). 
PGS-lipase was chosen because of its potential industrial applications. 
There is indirect evidence that colipase activates the pancreatic lipase-catalyzed interfacial 
hydrolysis by anchoring lipase to its substrate in the presence of bile salts. The 
colipase/lipase/interface is a challenging system of lipolytic regulation via protein/lipid and 
protein/protein interactions. 
MAJOR PROBLEMS ENCOUNTERED : Nothing to report. 
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RESULTS: CUTINASE 
In order to obtain useful heavy atom derivatives, all 14 serine to cysteine single mutants 
were constructed. Four of these mutants turned out to crystallize in the same space group as the 
native enzyme. 
The three-dimensional structure of a recombinant cutinase from F. solani pisi has been 
solved at 1.25 A resolution. Cutinase is an a - p protein (figure 1). Its active site is composed 
of the triad Ser 120, His 188 and Asp 175. As opposed to other known lipases, the catalytic 
serine is not buried under surface loops, but is accessible to solvent. This could explain why 
cutinase does not display interfacial activation. 
(a) 
Figure 1 : Stereo views of the backbone tracing of cutinase. Views a and b are drawn 90° from 
each other. 
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HIGHLIGHTS/MILETONES : 
17 Successful construction and production of 16 cutinase mutants for crystallization purposes. 
2 7 The 3D-structure of a recombinant cutinase has been solved at 1.25 A resolution. 
37 Preparation of 160 mg of pure porcine procolipase and trypsin-acrivated colipase for NMR 
and X-ray structural studies. 
47 Epitope mapping specificity of eight antiporcine procolipase monoclonal antibodies. 
57 The spatial interactions between histidine and tyrosine residues is a common feature for pig, 
horse and ox colipases, as shown by high resolution proton NMR. 
6 7 A large number of 2D-NMR spectra at 500 and 600 MHz have been recorded for 
procolipase. 
7 7 Isoform purification of gastric lipases was achieved. 
87 The stability of cutinase in reversed micelles of AOT/isooctane could be increased 45-fold 
by encapsulating the lipase with hexanol. 
97 The crucial role of water was evidenced by 'H and '^C-I^JMR studies of cutinase-catalyzed 
synthesis of ester in liquid-solid media. 
107 Transesterification reactions catalyzed by lipases were observed in gas phase. 
117 Six isomeric pseudoglycerides : didecanoyl-deoxyamino-O-methyl glycerol, were 
synthesized in optically pure form. 
127 The stereoselectivity of twenty four lipases of animal and microbial origin towards 
homogeneous prochiral triglycerides was determined. 
WIDER CONSIDERATIONS : Nothing to report. 
COOPERATIVE ACTIVITIES : 
- Compiegne, November 20th (1989), November 8th (1990) and Gent, June 6th (1990). 
Scientific discussions of a common lipase project involving PGS and l'Universite 
Technologique de Compiegne. 
- Marseilles, September 17th-October 8th (1990). Visit of A.M.T.J. Deveer (Utrecht 
University) to perform a collaborative study on lipases by using the monomolecular film 
technique. 
- Marseilles, June 14th (1991). Scientific presentations during the starting up meeting with B. 
Nieuwenhuis, L. Sarda, R. Kaptein, P. Cozzone, M.D. Legoy, J.N. Barbotin, G. 
Matthyssens, J. Cabral, C. Cambillau and R. Verger. 
- From January 6th to March 28th (1992), E. Melo (Instituto Superior Tecnico, Lisbon) stayed 
in Marseilles to perform monolayer experiments. 
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LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANS-NATIONAL AUTHORSHIP: 
1. Crystallization and premiminary X-ray study of recombinant cutinase form Fusarium solani 
pisi. C. Abergel, C. Martinez, J. C. Fontecilla-Camps, P. De Geus and M. Lauwereys.. J. 
Mol. Biol. 215 (1990) 215-216. 
2. Fusarium solani cutinase is a lipolytic enzyme with a catalytic serine accessible to solvent. 
C. Martinez, P. de Geus, M. Lauwereys, G. Matthyssens and C. Cambillau. Nature (1992), 
accepted for publication. 
3. Stereoselectivity of lipases. S. Ransac, E. Rogalska, Y. Gargouri, A.M.T.J. Deveer, F. 
Paltauf, G.H. de Haas and R. Verger. J. Biol. Chem. 265 (1990) 20263-20270. 
OTHER PUBLICATIONS/PATENTS : 
1. Immunochemical determination of porcine pancreatic colipase : differentiation between 
procolipase and its activated form. L. de la Fourniere, G. Forte, J. Rathelot, G. Pieroni, R. 
Julien and L. Sarda, Pancreas 6 (1991) 63-69. 
2. Antigen specificity of anticolipase monoclonal antibodies : characterization of colipase-Fab 
complexes using gel filtration HPLC. N. Rugani, C. Dezan, B. Bellon and L. Sarda. Biochem. 
Biophys. Res. Commun. 177 (1991) 726-733. 
3. Antigen specificity and cross-species reactivity of a monoclonal antibody (mAb 72.11) 
against porcine pancreatic procolipase. C. Dezan, N. Rugani, L. de la Fourniere, L. Sarda and 
B. Bellon. Biochimie73 (1991) 1417-1425. 
4. The hydrophobic-aromatic domain of porcine pancreatic colipase A : complete assignments 
of tyrosine aromatic resonances by proton 2D-NMR. P. Canioni, C.F. Martin, E. Guittet, J.Y. 
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OBJECTIVES: 
The project will include the study of 2 or 3 lipases: 
A. Guinea Pig Pancreatic Lipase (GPL) 
B. Mucor Miehei Lipase (MML) and: 
C. Human Bile Salt Activated Lipase (BSAL), if possible within the time period. 
MAJOR PROBLEMS ENCOUNTERED: 
Nothing to report 
RESULTS: 
A. Guinea Pig Pancreatic Lipase (GPL) 
A total amount of approx. 0.1 mg (—2 nmol) of guinea pig lipase was purified to 
homogeneity from acetone powder of guinea pig pancreas. The purified GPL was 
reduced with DTT and derivatized with 4­vinyl pyridine. The resulting PE­Cys­
GPL was purified by reverse phase HPLC. By direct sequencing of PE­Cys­GPL 
it was possible to identify the N­terminal 20 amino acid residues. This sequence 
showed a large degree of homology to human, dog and pig pancreatic lipases. PE­
Cys­GPL was digested with trypsin and tryptic fragment purified by HPLC. Seve­
ral of these fragments including the C­terminal fragment was sequenced. On the 
basis of the partial amino acid sequence, two synthetic oligonucleotides were 
constructed and used for screening in a cDNA library from guinea pig pancreas. 
From these studies, it was possible to isolate and sequence a full length of cDNA 
encoding GPL, and to reduce from these results the complete amino acid sequence 
of the lipase. The cloned GPL has been expressed in relatively high yield in As­
pergillus. Recombinant GPL from the Aspergillus expression system has been 
purified by affinity chromatography followed by gelfiltration. Several batches of 
purified, lyophilized rGPL for preliminary crystallographic and enzymatic analysis 
have been produced. 
In general, rGPL proved to be quite susceptible to proteolysis. Freshly dissolved 
samples consisted almost entirely of intact molecules, although the proportion of 
the latter decreased upon standing at room temperature. This effect was magnified 
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in the presence of SDS: a sample incubated at 30°C for 20 min. became totally 
degraded. This suggests that the samples contained proteolytic activity which was 
possibly associated with the lipase itself. Perhaps the catalytic triad has proteolytic 
as well as lipolytic activity. 
Despite these problems, crystals were obtained under several conditions, although 
the best were grown from PEG 10,000 in 10 mM DTT/10 mM CaCl^O mM 
HEPES pH 7.2. DTT was added to prevent oxidation of the free cysteine residue, 
and CaCl2 was added to ensure full occupancy of a calcium binding site. The 
largest crystal was 0.3 x 0.2 x 0.1 mm. Unfortunately, these crystals were extre-
mely fragile and a suitable stabilizing solution could not be found. Several crystals 
were mounted directly from the crystallization drops and exposed to X-rays. An 
attempt to collect data on the largest crystal using the Xentronics area detector 
gave very weak diffraction to about 8A resolution. These data indexed reasonably 
well in a large rhombohedral cell with parameters a=b=c=225.2A, 
a=B=7=81,4° (this can be re-indexed into a hexagonal cell a=b=302.3A, 
c=429.2A, a=B=90°, 7=120°). Data reduction was less than satisfactory giving 
a merging R-factor of 28.5% for 87% of the data to 8A resolution. Subsequent 
analysis of the hkO reciprocal lattice plane suggested that the space group was 
R32. In order to calculate a realistic solvent content in the range 40-60%, there 
would need to be at least 12 molecules per asymmetric unit (possibly as many as 
18!). 
Therefore, because of the fragility of the crystals, their poor diffraction and large 
number of molecules per asymmetric unit, this crystal form was not analysed fur-
ther. Experiments are continuing towards obtaining new crystal forms for X-ray 
diffraction work using both active and inhibited protein. Use of the latter has the 
advantage that any proteolytic activity should also be inhibited. 
B. Mucor Miehei Lipase (MML) 
A series of different potential lipase inhibitors have been synthesized. One of these 
compounds, n-hexyl phosphonate ethyl ester, has shown to form a stable inhibitor 
complex with MML. The crystal structure at 3A resolution of this complex 
showed that the enzymes active site (Asp, His, Ser - triad) is exposed by the 
movement of a small helical peptide fragment (the "lid"). It has been proposed that 
the structure of MML in the lipase-inhibitor complex is equivalent to the activated 
state generated by the oil-water interface. Thus the structure of the MML-inhibitor 
complex has formed the basis for a general model of interfacial activation of lipa-
ses (ref. 1). The coordinates cf the atoms of MML and the MML-inhibitor com-
plex have been deposited in the Brookhaven protein data bank. The enzymatic 
properties including the stereoselectivity of MML are, as in the case or rGPL, to 
be reported elsewhere. 
C. Human Bile Salt Activated Lipase (BSAL) 
Nothing to report. 
HIGHLIGHTS/MILESTONES: 
1. Guinea pig pancreatic lipase (GPL) purified to homogeneity 
2. Partial sequence of GPL determined on protein level 
3. GPL cloned 
4. Complete GPL cDNA sequence determined 
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5. Expression of rGPL in Aspergillus achieved 
6. Semilarge scale purification of rGPL started 
7. Preliminary crystallographic analysis of rGPL started 
8. Stereoselectivity of GLP and rGPL analyzed 
9. Mucor Miehei Lipase (MML) structure refined (ref. 2) 
10. Co-crystallization of MML with inhibitor achieved 
11. Data collection of MML inhibitor complex finished 
12. Model for interracial activation (ref. 1) 
13. Stereoselectivity of MML analyzed 
WIDER CONSIDERATIONS: 
The crystal structure of the Mucor Miehei inhibitor complex (ref. 1) and the com-
plete sequence of GPL have shown that the elucidation of the 3D structure around 
the active site (Asp, His, Ser) and around the lid is extremely important in under-
standing the mechanism of action of lipases. As a consequence of these results, it 
has been decided not to work on human bile salt activated lipase (BSAL), but 
instead to concentrate the activities on the importance of the lid area for the me-
chanism of action of lipases (e.g. by site-directed mutagenesis in the lid area of 
GPL). 
COOPERATIVE ACTIVITIES: 
Copenhagen, June 2nd, 1988. Preliminary discussions CNRS/Novo Nordisk. 
Copenhagen, February 1st, 1989. Discussions CNRS/Novo Nordisk. 
Copenhagen, June 6th, 1989. Discussions of a common lipase project between 
CNRS/University of York/Novo Nordisk. 
Copenhagen, November 21st, 1989. Contract discussions CNRS/Novo Nordisk. 
Copenhagen, October 9th, 1990. Working seminar. Approx. 20 participants from 
CNRS, York and Novo Nordisk. 
Marseilles, October 17th, 1990. Working visit of Dr. M. Barfoed (Novo Nordisk) 
to CNRS Marseilles to set up a future collaboration in order to transfer the mono-
layer know-how (K.S.V. Instrument) to Copenhagen. 
Copenhagen, April 22nd, 1991. Scientific meeting between Novo Nordisk, York 
and CNRS. Approx. 25 participants. 
Copenhagen, April 23rd, 1991. Meetings of the Coordinators and the monitoring 
unit at Novo Nordisk with B. Nieuwenhuis, A. Albert, L. Thim, G. Dodson, M. 
Egmond, O. Misset, R.D. Schmid and R. Verger. 
Marseilles, June 10th, 1991. Scientific discussions and oil drop tensiometer de-
monstration to Dr. Kim Borch and Dr. Erik Gormsen (Novo Nordisk). 
JOINT PUBLICATIONS: 
1. Brzozowslri, A.M., Derewenda, U., Derewenda, Z.S., Dodson, G.G., Lawson, D.M., 
Turkenburg, J.P., Bjorklin, F., Huge-Jensen, B.. Patkar, S.A., and Thim, I_ 
A mode] for interfacial activation in lipases from the structure of a fungal lipase-inhibitor 
complex. 
Nature 251 (1991) 491-494. 
2. Brady, l_, Brzozowslti, A.M., Derewenda, Z.S., Dodson, E., Dodson. G.C., Tolley, S., 
Turkenburg, J.P., Oiristianvn, J_, Huge-Jensen, B., Norskov, l~, Thim, I_, and Menge, 
U. A serine protease triad forms the catalytic centre of a triacylglycerol lipase. 
Nature J41 (1990) 767-770. 
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OBJECTIVES SET FOR THE REPORTING PERIOD: 
Purification and crystallization of various microbial lipases. Initial studies on their x-ray structure elucidation. 
Raising of antibodies against various lipases. Cloning, sequencing and expression of selected lipases. Kinetic 
and inhibition studies aiming at the understanding of their mechanism of action. 
MAJOR PROBLEMS ENCOUNTERED: 
The initial budget for the project was received late in February, 1992, with a delay of nearly one year 
compared to the bar chart plan. Thus, the bar chart in the project proposal should be understood with a 
starting date of Jan. 1992 instead of Jan. 1991. 
RESULTS: 
The project is focussed on the structure elucidation, protein engineering and mechanistic investigation of 
various fungal and bacterial lipases. In the absence of funding, initial work was carried out by internal 
resources of the 7 laboratories participating in the project. 
Lipases of Geotrichum candidum 
Investigations were carried out on 3 lipases from this organism, namely G. candidum Amano (GCL-4) and 
two industrial enzymes (GCL-A and GCL-B). Whereas GCL-B is unique with respect to its high specificity, 
GCL-A, GCL-4 and a G. candidum lipase isolated from the ATCC 34614 strain, whose structure has been 
published recently by M. Cygler et al., Montreal, are less specific and bear strong resemblance to each 
other. 
Lipase GCL-4: the enzyme, but not the strain, is available from Amano Co., Japan. The Munster group 
has developed a purification protocol for the preparation of 260 mg pure enzyme from 300g commercial 
product within <24 hrs. MW was 62 kDa. Heterogeneity during IEF procedures (5 bands) was lost after 
deglycosylation with endoglycosidase H. The deglycosylated enzyme was crystallized at the GBF and a 
native x-ray data set was obtained with a resolution of 2.5 A. Comparison of GCL-4 with the lipase analyzed 
by Cygler through peptide sequencing at the GBF showed 98% homology (based on 110 from 545 amino 
acids). Inhibition studies of the Munster group showed that carbidiimide inhibits the enzyme in aqueous 
solution, but organophosphate inhibits only in the presence of a lipid/water interface or after addition of 
isopropanol, suggesting that the serine in the catalytic triad is protected from the solvent in aqueous solution. 
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Lipase GCL-B: the Unilever group has prepared, by fermentation at the SO 1 scale, several 100 mg of pure 
enzyme. Extensive after-treatment and crystallization experiments at the GBF led to a protocol for the 
generation of long needles which are yet unsuitable for x-ray analysis. The Unilever group has produced 
antibody sera (rabbits) specific for GCL-B and GCL-A. Both sera cross-reacted. The antibodies were purified 
using immobilized GCL-A and GCL-B. The Unilever group has constructed a cDNA library for G. 
candidum CMICC 33S426 which produced GCL-A and GCL-B. 19 clones were isolated, 3 of which might 
contain complete structural genes; 2 of these clones are currently being sequenced in a M13 sequencing 
vector. 
The Unilever group and the Marseille group have jointly examined the specificities of GCL-A and GCL-B 
and confirmed the high specificity of GCL-B. With selected substrates, V_/K_ values of the immobilized 
enzymes were determined in a predominantly non-aqueous assay system. 
Lipases of Candida 
Investigations were carried out on the lipases of Candida cylindracea from Meito Sangyo (CCL-M) and from 
strain ATCC 14830 (CCL-UP1-LIP4). 
Candida cylindracea, Meito Sangyo: a purification protocol for the commercial product (OF type) was 
developed by the Munster group. In SDS-PAGE, a homogenous 67 kDa protein was seen, but on IEF, 
CCL-M was separated into 3 isoforms. Attempts of enzymatic deglycosylation via endoglycosidase H and F 
were not successful. 
Candida cylindracea ATCC 14830: the Rome group succeeded to purify the enzyme (recovery of 80 %, 
no further details indicated) via affinity chromatography based on a freshly synthesized lauroylated and cross-
linked PVA. The Milano group screened a genomic library of the strain with oligonucleotide probes and 
successfully isolated 3 positive clones containing 4 different lipase sequences, namely CCL-LTP1 to CCL-
LIP4. Sequence homology was about 80 % and corresponds to a 57 kDa enzyme. N-glycosylation sites were 
identified and the consensus sequence around active-site serine-209 is conserved among all isoforms. 
Lipases of Rhizopus 
Investigations were carried out on 3 Rhizopus lipases, namely the enzyme from Rhizopus niveus (RNL), 
from Rhizopus arrhizus (RAL) and from Rhizopus oryzae (ROL). 
Rhizopus niveus: neither the enzyme nor the producing strain are commercially available. The GBF group 
has used the patented amino acid sequence of this enzyme to model its 3-D structure on the basis of the 
Rhizomucor miehei lipase (MML) coordinates, available at the GBF from our own investigations. Sequence 
homology between MML and RNL is 63 %. The model has been subjected to several steps of molecular 
dynamics operations but is yet unproven by physicochemical studies. 
Rhizopus arrhizus: the enzyme, but not the strain, is available from Sanofi Co., France. The Munster 
group has elaborated a purification procedure to obtain 2 homogenous lipase fractions (RAL-I, 39 kDa, and 
RAL-n, 32 kDa). 
Rhizopus oryzae: the enzyme was screened by the GBF group from various DSM strains. After production 
at the GBF, in a 70 1 bioreactor, the enzyme was isolated and purified to homogeneity by the Munster 
group. The pure ROL is a 30 kDa protein which, in Western blotting, reveals immunological crossreactivity 
with RAL-II (Munster group). N-terminal sequenzing at the GBF led to a complete alignment with amino 
acid 28-67 of RNL. The GBF group was successful in cloning the ROL gene from a genomic library into 
E. coli. After sequencing about 50 56 of the gene, sequence homology to RNL and to Rhizopus delemar 
lipase (recently cloned and sequenced by a group at the ERRL, USDA, Philadelphia) was 97 %. Thus, the 
computer model of RNL may constitute a good approximation to the ROL structure, allowing for the 
imnyM*'* definition of protein engineering experiments. 
Lipases of Pseudomonas, Penirilliirm and Chromobacterium 
Investigations were carried out on 3 lipases, namely on the lipase from Pseudomonas spec. (PSL), the lipase 
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from Penicillium simplicissimum (PEL) and the lipase from Chromobacterium viscosum (CVL). 
Fseudomonas spec: the GBF group developed a purification protocol for a homogenous enzyme 
preparation. Crystals were obtained and precession photographs revealed a space group C2 and the lattice 
constants. 
Fenidllium siinplicissixnum: the GBF group developed a simple purification protocol resulting in a 
homogenous enzyme preparation of which diffracting crystals were obtained. 
Chromobacterium viscosum: the enzyme, but not the strain, is available from Toyo Jozo, Japan. The 
Munster group developed a purification protocol allowing for the isolation of 400 mg pure lipase from 50 
g commercial product within 3 days. In SDS-PAGE, the molecular weight was determined at 30 kDa, but 
under reducing conditions 2 bands formed at 10 kDa and 20 kDa, respectively. In IEF, considerable 
heterogeneity was observed. Several isoforms were isolated by chromato focussing or preparative IEF. The 
subunits of one isoform were separated and about SO % of the protein sequence of the cryptic digest was 
determined by the GBF group, confirming the DNA sequence published by Toyo Jozo. This isoform was 
crystallized by the GBF group and a native data set with a resolution of about 2.2 A was obtained. The 
Lisboa group produced monoclonal antibodies for "fraction A" and "fraction B" lipase obtained from crude 
Chromobacterium viscosum lipase by gel filtration. By applying immunoblotting and electrophoretic 
techniques, evidence was obtained that "fraction B" lipase (molecular weight around 30 kDa) consists of 
more than one isoform, whereas 'fraction A" lipase is probably a high molecular weight aggregation of 
'fraction B" lipases. 
Other microbial lipases 
The GBF group screened a number of thermophilic bacteria for lipases. Whereas screening in the genus 
Thermus did not reveal the presence of lipases, the screening of several thermophilic Bacilli was more 
successful. First steps for the purification of thermophilic lipase from Bacillus stearothennophilus (BSL) 
were investigated. 
Kinetic and mechanistic studies 
The Marseille group investigated the stereoselectivity, towards prochiral triglycerides, of 24 purified lipases 
of animal and microbial origin. Most of the lipases showed stereopreference for the sn-1 position; hydrolysis 
of the sn-2 bond was catalyzed by few lipases. The Munster group studied active-site inhibition of 
Geotrichum candidum lipase (GCL-4) (see above). The Graz group attempted to prepare photoaffuuty labels 
for the binding site of Chromobacterium viscosum lipase but the two labels used so far did not lead to 
positive results. The Graz group further synthesized various substrate analogs of triacylglycerols, namely 
rac-l-hexadecyl-2,3-dioleoylglycerol (HOH) and 2-hexadecyl-l,3-dioleoylglycerol (HOO). Comparison of 
these substrates with triolein led to the surprising result that both lipases from Rhizopus arrhizus and from 
Chromobacterium viscosum exhibited higher enantioselectivity if HOH was used as a substrate, i. e. when 
position 2 of the glyceride was changed to an alkyloxy moiety. 
HIGHLIGHTS/MILESTONES 
Purification protocols available for most lipases under study. Diffracting crystals obtained for 4, needle-form 
crystals obtained for 2 more lipases. 1 Lipase structure obtained by modelling. 2 lipases cloned. Pertinent 
observations as to stereo- and regioselectiviry of various lipases obtained. 
WIDER CONSIDERATIONS 
The project proceeds smoothly and has good chances to benefit European chemical industry on the long term. 
Severe delays in project funding reduced competitiveness to North American and Japanese efforts, 
particularily in structure elucidation and cloning. 
COOPERATIVE ACTIVITIES: See under results. 
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Characterization of lipases for industrial application 
Contract number Biot-CT-90-0194 
Official starting date: 01/04/1991 
Coordinator: M.R. Egmond, Unilever Research Laboratory, Vlaardingen (NL) 
Participants: A. Cleasby, University of Oxford (UK) 
G.H. de Haas, University of Utrecht (NL) 
R. Verger, CBBM / CNRS (FR) 
Objectives set: 'Obtain structural information of lipases from procaryotic species, in 
particular Pseudomonas species. 
•Gather information concerning mechanism of action, substrate 
specificity and inhibitory compounds. 
•Generate tailor-made lipases for application in e.g. Detergent industry 
using understanding of structure-function relationships 
Major problems encountered 
•Pseudomonas lipases are difficult to obtain in pure form, often leading 
to generation of different crystal forms in crystallization experiments. 
•Poor solubility and aggregation hampers exploitation of NMR 
techniques in structural investigations of lipases 
Results 
1. Progress of crystallographic studies on Pseudomonas glumae lipase 
(A. Cleasby) 
Since the start of the project an almost complete native dataset (87% completion) has been 
obtained at 3 A resolution. Also datasets of three heavy atom derivatives1 were collected at 3.0 
A, giving rise to isomorphic changes of 13%, 22% and 12%, respectively. The derivatives 
were solved for the positions of the heavy atoms using a combination of Patterson and 
difference Fourier techniques. After refinement of their occupancy and positional parameters 
the derivatives were used in the calculation of phases. The figure of merit at 3.0 A for the three 
derivatives is 0.64. By now 75% of the reflections have been phased. The quality of the 
crystallographic data is summarized in Table I. An electron density map was calculated using 
these phases. It clearly showed the boundaries of the molecule, along with some helical 
regions. The Wang method of solvent flattening was applied to the map in a cyclical manner, 
while the resultant phases were used to calculate a second map. Interpretation of these maps is 
now in progress. There are four molecules in the asymmetric unit. The known amino acid 
sequence is being fitted to one of them. The latter effort is currendy carried out in collaboration 
with Unilever Research. 
2. Progress of synthetic effort (G.H. de Haas) 
Pseudoglycerides containing, respectively, ester, ether and amido linked groups (compounds 
shown in Figure 1) were synthesized in optically pure form. Obviously, only the ester bond 
will be hydrolyzed by lipases. These triglyceride analogues have been investigated as 
substrates for two highly purified lipases, from porcine pancreas and Pseudomonas glumae, 
respectively. The lengths of the two acyl-groups and the alkylether chain allowed kinetic 
analyses both by titrimetric as well as surface film techniques. 
The findings obtained with the pancreatic enzyme confirmed the well-known properties of this 
enzyme: hydrolysis takes place exclusively of primary ester bonds and the enzyme possesses 
no stereopreference for either the 1- or 3-position. The Pseudomonas lipase attacks the 3-
ester bond slightly better than the 1-esterbond (see also Verger) , but is able to effectively 
hydrolyze secondary ester bonds as well. Moreover, in the hydrolysis of the secondary ester 
bond the Pseudomonas glumae lipase appeared to possess a strong stereopreference: the R-
isomer (R3 in Figure 1) is hydrolyzed 50 times more rapidly than S3. This property is rather 
unique and could allow interesting application in stereospecific synthetic reactions. 
Comparison of lipase activity on pseudo-glycerides (only allowing one site of attack) and 
1 one gold, a mercury and a platinum containing compound, respectively 
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Abbreviations: 
CAArCandida AnlarctfcaA; CAB Candida AnlarcllcaB:CR:Candlda rugosa; 
CV:Chromooaclerlum vlscosum;DGL:Dog gaslrlc llpase:DPL: Dog panaaatle llpaso;FSC: 
Fusarlum lolanl cutlnase; OCA: Geolrtchum candid urn A ;OCB: Geolrtchum candidumB; 
GCM: Goolrlchum candidumM; GPL:gulnoa pig pancreatic lipase; HGL:Human gastric 
lipase; HL: Humlcola lanuginosa Hpaso;HPL:Human pancreatic lipase; LPL' Lipoprotein 
lipase; MM: Rhizomucor mlehal lipase: PC: Peniciillum camemberill lipase; PF: 
Pseudomonas fluorescens lipase; PQ: Pseudomonas ghjmae lipase. PPL: Porcine 
pancreatic lipase; PS: Penldlllum slmpHdsslmum lipase; PSp Pseudomonas species 
(unknown) lipase: RA: Rhlzopus arrhizus lipase; RGL: Rat gaslrlc lipase 
Table I. Summary of ciystnllographic data 
Statistics 
%complete 
merging R 
Rise-
Nsiles 
PWE 
R(Cullii) 
FOM 
Native 
82 
3.6 
Qald 
62/46 
3.2 
13 
3 
2.21 
47.1 
30.1 
Mercury 
50/62 
4.B 
18/23 
fi/5 
2.45 
43.8 
49 1 
Platinum 
68/97 
4.4 
12 
5 
1.95 
50.0 
51.0 
several triglycerides (see R.Verger) will provide further understanding of the mechanism of 
preferential attack exerted by lipases. 
3. Progress of kinetic and mechanistic studies on lipases (R. Verger) 
Lipases are able to recognize triglyceride substrates in several ways. In principle, the two 
chiral forms of triglycerides, or their prochiral forms will be recognized. This recognition will 
depend on the nature (e.g. chain lengths) as well as on the positions of the acyl chains attached 
to the glycerol backbone. The overall steric course of the enzymic reaction will provide 
evidence of reaction pathways and deepen our understanding of the reaction mechanism of 
lipolytic attack. In particular, this understanding will be obtained by comparing steric 
preferences of a series of lipases collected within the framework of the EEC T-Lipase 
programme. The results show stereopreferences ranging from 0% to 100% for some 20 
lipases using the method developed at the CNRS laboratory (shown in Figure 2). These 
studies demonstrate the fine-tuning of interactions involved. Even within lipase families (e.g. 
based on high amino acid sequence homology) this stereopreference may differ. However, 
combined with structural information of the active site architecture, a thorough understanding 
will emerge of the mechanisms underlying substrate recognition and turnover. This 
information is also of vital importance for application of lipases in synthetic reactions. 
HIGHLIGHTS 
X-ray analysis: an almost complete native dataset has been obtained at 3 A resolution. 
Synthesis and analysis of pseudoglvcerides: when P.glumae lipase is forced to act on the ester 
at the he 2-position, a strong stereopreference is found for the R-isomer. 
Kinetics and mechanism:For triglyceride substrates the stereopreference of a wide range of 
lipases has been revealed. Some lipases switch preference depending on the acyl chain length. 
WIDER CONSIDERATIONS 
The first steps on the elucidation of structure function rules for lipases have been taken. It has 
become clear that only an integrated effort will allow us to be successful in our objective to 
understand lipolytic action - based on many lipase structures, as well as large series of 
mechanistic studies. These mechanistic studies require not only pure triglycerides, but also 
specially designed pseudo-glycerides to track down specific interactions with the enzyme. 
COOPERATIVE ACTIVITIES 
Copenhagen (DK), April 23rd (1991); Coordinators meeting at Novo Nordisk 
with A.Albert, G.Dodson, M.R.Egmond, O.Misset, B.Nieuwenhuis, R.D.Schmid, L.Thim, 
and R.Verger 
Oxford (UK), October 2nd (1991); Scientific meeting with A.Cleasby, M.R.Egmond 
Utrecht (NL), October 5th (1991); Scientific meeting with A.M.T.J.Deveer, M.R.Egmond, 
G.H.de Haas, S.Ransac, H.M.Verheij and R.Verger. Subject "competitive inhibition of 
lipolytic enzymes" 
Oxford (UK), January 21/22nd (1992); Scientific meeting with A.Cleasby, M.R.Egmond 
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Haas, G.H. (1992) Biochim. Biophys. Acta , 1123, 92-100 
Deveer, A.M.T.J., Dijkman, R., Leuveling-Tjeenk, M., van den Berg, B., Ransac, S., 
Batenburg, M.,Egmond, M., Verheij, H.M., de Haas, G.H., (1991), Biochem., 30, 10034-
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TITLE: EXPLORING THE STRUCTURE-FUNCTION 
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BACILLUS LIPASES 
CONTRACT NUMBER: BIOT CT91 0272 
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OBJECTIVES SET FOR THE REPORTING PERIOD 
The first reporting period covers the period 01/08/1991 until 31/03/1992 which means the 
first 8 months of the total 36 month project period. 
According to the Working Programme (Annex I of the EC-contract and Annex I of the 
Consortium agreement) the first 8 months should be used to obtain highly purified lipase 
preparations and to start the crystallization of this material. Furthermore, a kinetic 
characterization of the purified enzymes was estimated to start after month six. 
-424-
MAJOR PROBLEMS ENCOUNTERED 
1. Project management problems The major problem which was encountered during the execution of the project was the fact that the "Advanced Payment" by the EC was made much too late! It prohibited that the project could start efficiently on the first day of the contract period (01/08/1-991). 
2. Scientific problems 
2.a Pseudomonas lipase Lipase was isolated from cell-free growth medium obtained from Gist-brocades where Pseudomonas aeruginosa was grown under conditions of maximum lipase production. A significant variability in the chemical composition of the superna-tants led to a necessary modification of the purification procedure for every new batch of supernatant (extra work). The current expression level (ca. 30-60 mg/liter) is not enough to obtain hundreds of milligrams of highly purified lipase in an easy way. Attempts to obtain overexpression of the structural lipase gene in E. coh failed which was attributed to the requirement of at least one additional gene product termed lip H (Helper gene-unpublished results). Overexpression in the homologeous system (i.e. Pseudomonas aeruginosa) will now be performed by using suitable plasmids. An increase in expression level of 5-10 fold is expected to be realized by the end of April 1992. 
2.b Bacillus lipase The expression level of Bacillus lipase is estimated to be even lower than that for the Pseudomonas lipase. Also in this case overexpression in Bacillus will be performed by using suitable plasmids. An overexpression strain will be available by the end of April 1992. 
RESULTS 
It should be noted that the results described here were obtained only partly at the expenditure of the EC-grant(s). 
1. Pseudomonas aeruginosa lipase 
l.a Purification of Pseudomonas aeruginosa lipase (RUB) The cell-free growth medium obtained from Gist-brocades contained 30-60 fig/ml of lipase. After purification via gel filtration chromatography on a Hiload Superdex 200 FPLC column and preparative electrophoresis (Rotofor) as major steps, two samples of 1 mg each were obtained and given to Dijkstra for crystallization experiments (see below). 
l.b Enzymatic characterization of Pseudomonas aeruginosa lipase (RUB) Inhibition studies with phenylmethanesulfonylfluoride (PMSF) and hexadecylsul-fonylfluoride (ASF) solubilized in detergent showed that Pseudomonas aeruginosa lipase activity was 10" times more sensitive against ASF as compared to PMSF under identical experimental conditions. The presence of a disulfide bridge formed by the two cysteine residues present in the native lipase protein could be demon-
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strated by showing (i) an alteration in migration behaviour in gel electrophoresis 
(SDS-PAGE) of the lipase depending on treatment with dithiothreitol and lodoace-
tamide, and (ii) the rapid ana complete loss of enzymatic activity when lipase was 
treated with ditiotreitot or /3-mercaptoethanol in the presence of 0.1% (w/v) SDS. 
Digestion of lipase with proteases trypsin and arg C led to formation of fragments 
of Mr 23 and 25 kDa, respectively, which both contained the NH,-terminus of'the 
lipase protein as shown 
j 'I 
by western-blotting using the appropriate antibodies. 
Source 
Human pancreas 
Rhizomucor miehei 
Geotrichum candidum 
Bacillus subtilis 
Pseudomonas species 
Torpedo califomica Wheat germ 
Xanthobacter autotrophics 
Sequence Structure 
known 
+ + 
+ + 
+ + 
+ 
+ (5x) -
+ + 
+ + i + + 
+ + 
available 
-
c. C. (1) 
-
+ (2) 
+ 
+ 
+ (3) 
l.c Crystallizaton of Pseudomonas aeruginosa lipase (RUG) 
With two different batches of purified Pseudonomas lipase material (each approxi-
mately 1 me) various crystallization conditions were explored. As precipitants 
fNHJjSO, (10-60% saturated), polyethylene glycol 4000 (10-40%) and 2-methyl-
2,4 pentane diol (10-40% v/v) were used in buffers with a pH value ranging from 
5.5-8.5. In some cases precipitants were found, but none of the conditions led so 
far to suitable crystals. More lipase is required in order to allow for higher protein 
concentration in the crystallization experiments (now approximately 1.5 mg/ml). 
l.d Model building of Pseudomonas aeruginosa lipase fRUG) 
Since no suitable crystals of this enzyme were available, a 3D-model was build 
using the sequence and structural information from the following enzymes: 
Enzymes 
lipase 
lipase 
lipase 
lipase 
lipase 
Acetylcholinesterase 
Serine carboxypeptidase 
Haloalkane dehalogenese 
Diene lactone hydrolase 
(1) gift from dr. M. Cygler, (2) gift from dr. J. Sussmann, (3) gift from dr. D. 
Based on the sequence comparisons and secondary structure analysis, we tried to 
use the coordinates of known structures to build our model. The Geotrichum 
candidum lipase was chosen as the source model, since its secondary structure 
elements are more similar to those of the other enzymes used in this comparison 
than the R. miehei lipase. However, we have only the coordinates of the alpha 
carbons of the Geotrichum candidum lipase, but fortunately, the acetylcholinestera-
se has a structure very similar to that of G. candidum, except in the flap region 
where a deletion in the sequence is present. The coordinates of the acetylcholines-
terase have thus been used, and the structure build. Using FRODO, the amino 
acids have been replaced in order to correspond to those of the P. aeruginosa 
lipase sequence. Next, gaps were removed and the structure was energy minimi-
zed. 
The superposition of the model on the structure of G. candidum and R. miehei 
lipase is reasonable with respect to the conserved 0-strands and conserved a-
helices. Also, the side-chains of the active-site residues superimpose quite well. 
Currently, we are working towards improvement of the model. We also hope to 
build a preliminary model for the B. subtilis lipase within the next month. 
2. Bacillus subtilis lipase 
2.a Amino acid sequence of Bacillus subtilis lipase 
The amino acid sequence has now been completed and verified. The gene is coding 
for a precursor lipase molecule consisting of a leader of 32 amino acids and a 
mature lipase of (only!) 184 amino acids. This makes the Bacillus lipase the 
smallest of all lipases. In contrast with other lipase sequences, no consensus 
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sequence of Gly­X­Ser­X­Gly around the active site Ser could be identified but instead this sequence is likely to be composed of Ala­X­Ser­X­Gly. Recently, the amino acid sequence of Bacillus pumilis lipase was disclosed in a patent application of Solvay (WO 91/16422). It appeared that both lipases revealed a homology of 74.1%. The B. pumilis lipase does also not contain the Gly­X­Ser­X­Gly sequence but instead the Ala­X­Ser­X­Gly sequence at a position "homolo­gous to the one in the Bacillus subtilis lipase. 
2.b Mutagenesis of Bacillus subtilis lipase Lipase mutants A106G and A106I have been constructed on DNA level and will be expressed in Bacillus subtilis. The rationale behind these mutations is to unravel the role of Ala 106, in the consensus sequence. 
2.c Purification of Bacillus subtilis lipase A purification procedure for the lipase from the culture supernatant is presently under investigation. Promising results were obtained with a procedure consisting of ammonium sulphate precipitation and hydroxyapatite chromatography. A 250­fold purification could be established with a recovery of approximately 10%. The final preparation reveals two major bands on SDS­gels of which one (with a MW *> 19 kDa) is most likely the lipase. However, there is still not enough material available for crystallization experiments. The construction of an overexpressing Bacillus strain will facilitate both the purification of lipase as well as achieving the required amount of lipase. 
2.d Enzymatic characterization of Bacillus subtilis lipase The lipase activity was measured with paranitrophenyl palmitate (0.8 mM) in a buffer containing 0.1 M phosphate (pH = 8), 2 mg/ml deoxycholate and 1 mg/ml gum arable. C a " markedly stimulated the activity when added up to 40 mM but became inhibitory beyond that concentration. No effects were observed with Fe5*, Mn2* or EDTA (all at 1 mM). Acetone was found to strongly inhibit the activity (up to 20% v/v). The enzyme could be inhibited by PMSF but only at very high concentrations of the latter (> 4 mM). The enzyme showed roughly the same activity with 0.8 mM of the following substrates: 
CH^Cjy.­C­pNP (n = 0, 2, 8, 10, 14, and 16) 
O 
fflGHLIGHTS/MILESTONES 
1. Pseudomonas aeruginosa lipase has been purified in reasonable amounts of sufficient 
quality to start the crystallization experiments. 
2. The confirmation of the Bacillus subtilis lipase sequence by the work of Solvay 
(Bacillus pumilis lipase sequence) reinforces the importance of the Bacillus subtilus 
lipase work in our project. The Bacillus subtilis lipase can be regarded as one of the 
most unique and interesting lipases of the entire T­project. 
3. The modelling of the 3D­structure of Pseudomonas aeruginosa using existing lipase 
and other hydrolase structures as well as amino acid sequence homologies is very 
original and stimulating. This modelled structure therefore has to be considered as a 
serious attempt to achieve the result of the T­project. 
WIDER CONSIDERATIONS 
Nothing to report. 
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COOPERATIVE ACTIVITIES 
1. Meeting 
The project team had the following project meetings in the reporting period (01/08/91 
­ 31/03/92): 
* 28/10/91 in Delft (minutes, d.d. 20/11/91) 
* 05/03/92 in Louvain­la­Neuve (minutes in preparations) 
The next meeting is scheduled for 30/06/92 in Groningen. 
2. Materials and staff exchanged 
* Gist­brocades received the wild type Pseudomonas aeruginosa and Bacillus subtilis 
strains for fermentation purposes. 
•Bochum has obtained cell­free supematants of several Pseudomonas aeruginosa 
fermentations from Gist­brocades. 
♦Gist­brocades has made available plasmids (to allow for overexpression in Bacillus 
subtilis and Pseudomonas aeruginosa) to Colson and Winkler respectively. 
•Groningen has received in total 2 mgs purified lipase of Pseudomonas aeruginosa. 
*A small amount of purified lipase from Pseudomonas aeruginosa was sent to Robert 
Verger for kinetic analysis (August 1991). 
♦10­21/2/1992, Dr. S. Ransac (RUG) worked in Winkler's laboratory (RUB) on the 
purification of the Pseudomonas lipase. 
3. Lectures 
As a result of the formation of the lipase project teams, the following lectures were 
presented: 
♦February 1, 1991, Ruhr Universitat Bochum 
Dr. B. Dijkstra (Groningen): "Structure and function of Phospholipase Aj". 
♦April 19, 1991, Ruhr Universitat Bochum 
Dr. O. Misset (Gist­brocades): "Protein engineering of industrial enzymes". 
♦July 1, 1991, CNRS­Marseille 
Dr. O. Misset (Gist­brocades): "Protein engineering of industrial enzymes". 
LIST OF JOINT PUBLICATIONS WITH TRANS­NATIONAL AUTHORSHIP 
Dartois, V., Baulard, A., Schanck, K. and Colson, C. (1992) B.B.A. (in press), 
"Cloning, nucleotide sequence and expression in JL co]i of a lipase gene from Bacillus 
subtilis 168". 
OTHER PUBLICATIONS/PATENTS 
Nothing to report. 
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ORGANISATION OF THE PROJECT: 
The project is organised on a CORE and LEAF structure that facilitates coordination 
and provides maximum integration of participating groups whose research is targeted to 
specific objectives. CORE groups emphasise developments in genetic analysis of Lactic Acid 
Bacteria (LAB) and link to the LEAF groups that focus on key sectors of research needed to 
underpin a more scientific and controlled use of these bacteria. 
CORE-LEAF INTERACTIONS IN THE 
T-PROJECT ON LACTIC ACID BACTERIA 
CORE CHROMOSOME ANALYSIS 
A P T i v r T i r c REGULATION OF GENE EXPRESSION 
A C l l V l l l J L b : CONJUGATION SYSTEMS 
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CORE TECHNOLOGIES: 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
1. Gene analysis and the study of gene expression in LAB including mapping of 
chromosomal genes and elements in Lactococcus. 
2 . Development of genetic tools, i.e. integration/delivery vectors. 
3. Study of conjugation mechanisms in Lactococcus and Lactobacillus. 
4. Analysis of recombination systems in Lactococcus. 
5 . Characterisation of plasmid replication, stability and incompatibility functions in 
Lactococcus. 
RESULTS: 
1. Gene analysis and gene expression 
(a) Transcriptional fusions between lac promoter DNA fragments of varying sizes and a 
cat&6 reporter gene were introduced in L. lactis MG5267 containing a single 
chromosomal copy of the toe operon. Determination of the CAT activities in glucose 
or lactose-grown cells of the resulting strains revealed that the lac promoter is strongly 
affected by LacR repressor and regions flanking the promoter. DNAse footprinting 
studies showed that the LacR repressor, purified from LacR-overproducing E.coli 
cells, binds to two operator sequences, one located near the 35 region of the lac 
promoter and the other upstream of the lacR initiation codon. A lacR deficient strain 
was constructed by replacement recombination. Detailed analysis of the resulting 
strain showed that expression of the lac operon is not only controlled by the LacR 
repressor but is also subject to catabolite repression. 
(b) Translational fusions of the lactose promoter to E. coli (J-galactosidase and 
transcriptional fusions to Vibrio fischeru luciferase genes were constructed. Induction 
was demonstrated in both reporter systems and evidence of a glucose repression 
phenomenon was obtained. Expression of luciferase under control of the promoter 
for the lactose repressor was also found to be lactose inducible. 
(c) Gene replacement experiments were used to target the gene for phospho-pVD-
galactosidase. Both Campbell integration and gene replacement events were obtained 
using selection on glucose-containing media and, unexpectedly, replacement of lacG 
with an erythromycin resistance marker did not cause a lactose negative phenotype. 
The lacF gene is being targeted as an alternative and an explanation for the lactose 
positive phenotype of the lacG mutant is being sought. 
(d) The Lactococcus lactis chromosomal region containing the seven structural genes 
required for tryptophan biosynthesis has been characterised by cloning and 
sequencing. The seven genes are present in the npEGDCFBA order. The trp genes 
are transcribed on a single monocistronic mRNA and its transcription start has been 
mapped. A region strongly resembling a transcription terminator has been identified 
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between the transcription start and the 5' end of the trp genes. A trpE-.lacZ fusion has 
been introduced by single cross-over in the Lactococcus lacris chromosome. The 
expression of the fused protein responds to the presence or absence of tryptophan in 
the medium by a 100-fold factor.The Lactococcus lactis chromosomal regions 
containing the functional genes for histidine and branched-chain amino acids (leucine, 
isoleucine and valine) biosynthesis have been characterised by cloning and 
sequencing.The nine genes required for the biosynthesis of histidine are present in a 
twelve ORFs cluster in the to CGDBHAFIE order. The nine genes required for the 
biosynthesis of branched-chain amino acids are present in a ten ORFs cluster in the 
/euABCDi/vDBNCA order. The region upstream of the leu genes has the potential 
for forming two alternative stem and loop secondary structures, one containing a 
transcription terminator. This suggests that regulation by transcription attenuation 
could modulate the expression of the leu genes. 
(e) Pulsed field gel analysis has led to the identification of various chromosomally 
integrated elements in L. lactis MG1363 including the IS elements ISSJ and IS 904x 
the transposons Tn979 and Tn5301, the temperate bacteriophage 0T712, the sex 
factor pF1430 and integrated lactose genes. 1SS1 promoted chromosomal integration 
has been exploited to develop a superior physical mapping strategy. 
(f) The genes encoding galactose 1-phosphate uridyltransferase (gaTT) and galactokinase 
(gaiK) were cloned from the chromosone of Lactobacillus helveticus 1829 and 
expressed in E. coli. The galK gene encoded a protein with an apparent molecular 
mass of 49 kDa and was located upstream of gaTT. gafV was sequenced (ORF of 
1464 bp, peptide of deduced molecular mass of 55.6 kDa). 
(g) The surface layer protein of Lactobacillus helveticus was subjected to extensive 
characterisation. The genetic determinant encoding this protein was cloned in E. coli. 
2 . Development of Genetic Tools 
(a) A Bacillus subtilis strain in which the rep gene of pWVOl was integrated into the 
chromosome was constructed. In this host, pWVOl defective in replication functions, 
but still carrying the origin of replication (ori +), can multiply. This system has now 
also been developed in lactococci. It was shown that in a repr Lactococcus, the ori* 
plasmid integrates if it is supplied with a chromosomal segment of lactococcal DNA. 
The system has been made foodgrade by replacing the antibiotic gene (erm) by sucrose 
gene(s) of Pediococcus, which are expressed in Lactococcus. Transformants are 
easily selected because they grow in sucrose-containing media. 
(b) A.4.2 HindU fragment of the conjugative transposon Tn979 was cloned into a 
replicating Cmr plasmid and formed the basis for the construction of a range of 
integration vectors which were capable of inserting into chromosomally-located 
transposon DNA. These vectors successfully integrated into Tn°/9 present on the 
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chromosomes of Enierococcus and Lactococcus by Campbell-type cross-over 
recombination. These Tn919: vector structures could subsequently be transferred to 
recipient hosts by conjugation. The abiS29 phage resistance gene was integrated and 
expressed in the chromosome of L. lactis subsp. lactis MG1363. Constructs that 
mediated replacement recombination generated a Cm1 variant of Tn9/9, designated 
Tn9i9 Cm. 
(c) A thermosensitive plasmid with a broad host range has been isolated. This plasmid is 
non-replicative at temperatures above 35°C, thus making it ideal for use as a delivery 
vector in the mesophilic lactic acid bacteria. The origin of conjugative transfer (oriT) 
of plasmid pIP501 has been characterised. A plasmid vector containing a 1.6 kb oriT 
segment can be mobilized (in the presence of a helper plasmid which supplies transfer 
functions in trans ) into a wide range of LAB recipients. The thermosensitive plasmid 
has been adapted for transfer to numerous lactic acid bacteria by cloning in oriT and 
has been used as a delivery vector of DNA fragments homologous to the chromosone. 
Single crossover plasmid integration via homologies of 0.5 and 3 kb between the 
vector and chromosome have been readily selected in L. lactis at 37°C. 
3 . Conjugation 
(a) The mechanism mediating high frequency plasmid conjugal transfer was studied in an Lb. 
plantarum strain. Bacterial cell structures involved in this mechanism were identified. 
Further aims of this work are the comparison of HF conjugation systems in Lactobacillus 
and Lactococcus and the elucidation of roles payed by secreted proteins in the two 
bacterial genera. 
(b) Pulsed-field gel electrophoresis revealed that a 25kb fragment of plasmid pLP712 
which was originally integrated into the host chromosome by transduction was 
maintaned in the same location in a 140KB Smal fragment even following repeated 
rounds of transduction and conjugal transfer. Analysis of a chromosomally integrated 
sex-factor suggests that conjugal transfer of the integrated lactose genes reflects then-
passive transfer during polarized transfer of the whole chromosome. This could lead 
to a novel strategy for mapping the genome of L. lactis. Detailed analysis of the 
integrated pLP712 DNA precisely determined the region involved as that between co-
ordinates 0.26/1.5 and 24.6/27.0. 
4 . Analysis of Recombination (Rec) Systems in Lactococcus 
(a) Cloning of the L. lactis recA gene. Degenerate primers were designed, using two 
highly conserved RecA protein domains as templates determined by aligning 
previously sequenced RecA proteins. Using Polymerase Chain Reaction, an internal 
segment of the lactococcal recA gene was isolated. This segment was used as a probe 
to recover the entire rec A gene of L. lactis. Using the same primer pairs, internal 
segments of 8 other gram-positive recA genes were isolated and sequenced (species 
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include Lactobacillus, Corynebacterium, Listeria, Leuconostoc and Staphylococcus). 
These segments facilitate the isolation and cloning of recA genes which would be 
difficult to achieve by other means. 
5 . Studies of inherent plasmid functions. 
(a) The replication region of the cryptic 8.7 kb plasmid pCI305 from L. Lactis subsp. 
lactis UC317 was cloned and sequenced. A trims-acting region, designated repB 
(ORF of 1158bp, peptide of deduced molecular mass of 46 kDa) was found to be 
essential for replication as was repA, a replication origin-like region. This contained 
22 bp direct repeats repeated three and one half times, in addition to a number of 
smaller direct and inverted repeat sequences. Studies with pCI305 (which does not 
produce single-stranded intermediates during replication) indicated that it is 
incompatible with pAM401 and pIL253 (theta replicating plasmids containing pIPSOl 
and pAM|3l replication regions, respectively). 
PROTEOLYSIS LEAF 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
1. Biochemical analysis of proteinase from Lactobacillus delbruckeU subsp. bulgaricus 
2. Molecular analysis of proteinases of lactococci 
3. Biochemical and genetic studies of peptidases of lactococci and lactobacilli. 
4. Biochemical and genetic analysis of amino acid and peptide transport systems in 
lactococci 
RESULTS: 
1 . Proteinase 
Proteinase production by the Lactobacillus delbrueckii subsp.bulgaricus strain 
ACADC235 was studied. Maximum yield was obtained at the end of the exponential growth 
phase in media at pH greater than 5.5. The properties of the extracted enzyme were 
demonstrated. Plasmid DNA was not detected in the producing strain, suggesting that the 
proteinase gene is chromosomally located. Hybridisation studies, using lactococcal proteinase 
genes as probes, have been initiated with a view to localising the proteinase gene on the 
Lactobacillus chromosome. 
The proteinase gene complex from pCBOl (bomLactococcus lactis sub./actu 
UC317) was cloned. Two derivatives which encoded a cell-envelope and secreted proteinase 
were generated. The UC317 proteinase had a hybrid PI/m activity. 
Cheddar cheese was made with derivatives of strain UC317 (cured of its native prt 
genes) which produced either the cell envelope-associated or the secreted proteinase and results 
indicated that the former generated greater proteolytic activity in the cheese. Cheddar cheese 
was also made with L. lactis subsp. cremoris SKI 1 (PH type proteinase), the wild-type 
UC317 (PI/PIE type) and its Prr derivative. Water soluble peptides unique to SKI 1 and 
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UC317 were detected by PAGE and HPLC. Sensoric evaluation showed that the flavours of 
cheese made with Prt+ strains were similar but those made with the Prt" isolate lacked flavour. 
Control of proteinase production in L. lactis SKI 1 appeared to be host specific and 
medium dependent Construction of strains that produced different levels of SKI 1 proteinase 
showed that production of the enzyme is rate limiting for growth in milk. The control of 
proteinase production in SKI 1 was shown, using LacZ fusions, to be less tightly controlled 
(2-3 fold) than expected. 
Expression of prr P and prr M, using various reporter genes, was measured in several 
lactococcal strains. In strain MG1363, the activities of the regulatory sequences of both genes 
were approximately three-fold higher than in strain E8. 
2 . Peptidase 
A novel peptidase assay, using capillary electrophoresis has been developed. 
A dipeptidase has been purified from Lactococcus lactis subsp. lactis NCD0712. 
The enzyme shows slight differences in substrate specificity when compared to other 
lactococcal dipeptidases. 
A five-step procedure was used for the purification of an aminopeptidase and a 
dipeptidase from cell-free extracts of Lactobacillus delbrueckii subsp. bulgaricus B14. Both 
were metal dependant-enzymes. Suitable substrates for assay of the amino peptidase were L-
Lys-NA and N-Ala-L-Arg-NA. The dipeptidase was most active on dipeptides containing an 
aminotenninal hydrophobic amino acid such as Leu-Leu and Leu-Gly. 
The enzymes present in the proteinase/peptidase complex of a strain of Lactobacillus 
delbrueckii subsp. lactis have been characterised by elucidation of their physical properties 
and, particularly, their substrate specifities. A special staining procedure, using chromogenic 
substrates, was developed to detect peptidase enzymes in colonies of strains containing 
plasmids from the L. delbrueckii gene banks. Three genes, pep A for the gene of X-prolyl-
amino-peptidase, pepB for the gene of an amino peptidase and pepC for an iminopeptidase 
have been isolated. After minimising the genomic DNA, the nucleotide sequence oipepA, 
pepB andpepC has been determined. Using an alternative approach, a 1.8 kb DNA fragment 
which encodes the ability to utilise leucine-containing peptides has been isolated. The 
nucleotide sequence of this gene showed high homology to a gene required for the transport of 
branched amino acids in Pseudomonas. 
The gene for lysine-aminopeudase (rap, or pepN) from the Lactococcus lactis subsp. 
cremoris strain Wg2 has been isolated and sequenced. The lap gene was demonstrated in 
several Lactococcus strains but not in strain AM2. Companion of the deduced amino acid 
sequences showed that LAP has extensive homology to mammalian aminopeptidases and 
belongs to the super family of Zn2+ metallohydrolases and shows identity to the core deca-
peptide concensus sequence for the Zn2+ binding motif of these enzymes. 
The determinants for the amino-peptidases API and APII from the Lactococcus lactis 
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subsp. cremoris strain AM2 have been cloned. The determinant for API was sequenced. The 
specified protein shares homology with the cysteine proteinases family and was thus 
designated PepC. No signal sequence was identified, indicating that PepC is intracellularly 
located, as previously suggested by electron microscopy studies. 
Two endopeptides genes from Lactoccous strains have been cloned and have been 
partially sequenced. 
Insertional mutagenisis in pepX showed that this gene was not essentia] for casein 
utilisation and growth of Lactococcus strains in milk. 
3 . Transport 
It has previously been shown that the di/tripeptide transport system of Lactococcus 
lactis is essential for the degradation of casein to small peptides and free amino acids. In 
addition, the di-tripeptide transport system is required for growth of the organism on media 
containing casein as sole source of amino acids. The transport system delivers di- and 
tripepddes to the intracellularly located peptidases. 
The gene encoding the di/tripeptide transport protein (DtpT) of L. lactis has been 
isolated by complementation of an Escherichia coli strain which carried a deletion in the dppA 
gene (encoding the binding protein of the dipeptide transport system) and in which the 
oligopeptide transport system was inactiviated by random mutagenesis. The origin of the 
lactococcal di/tripeptide transport gene has been confirmed by Southern analysis, and the 
functional properties of the protein encoded by the gene have been assessed by transport 
studies using [14 C]-L-ala-L-glu as substrate. The gene has been subcloned in suitable 
expression vectors and is currently being characterized by DNA sequence analysis. 
To establish whether additional peptide transport systems are present in L. lactis, 
mutants have been isolated which lack the DtpT system and/or individual amino acid transport 
systems. Amino acid (alanine, glycine) negative transport mutants have been isolated in order 
to exclude possible interference of extracellularly located peptidases in the peptide transport 
assays. Various single and double mutants and triple mutants lacking the ala/gly, the di-
tripeptide and the oligopeptide transport mutants have been characterized with respect to their 
ability to transport amino acids and peptides using reverse-phase HPLC and radiolabeled 
substrates. The results, obtained so far, indicate that L. lactis possesses an ATP-driven 
oligopeptide transport system in addition to the proton motive force-driven (DtpT) system. 
The oligopeptide transport system appears to be highly sensitive to variations in the 
intracellular pH. The properties of the peptide transport systems in relation to growth of L. 
lactis are currently being analyzed. 
■ 4 3 8 -
PHAGE LEAF 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
1. Characterisation and molecular analysis of LAB phages 
2. Analysis of phage-resistance mechanisms. 
RESULTS: 
1 . Characterisation and Analysis of Phages 
Comparsion of nineteen Leuconostoc mesenteroides phages isolated from coffee 
fermentation or dairy products by DNA- hybridisation, morphology and composition of major 
structural proteins revealed the existence of six genetic groups, four containing only one 
phage. Twelve phage belonged to a unique group represented by phage 0cc59A. 
Eight Leuconsotoc oenos phages were characterised into two genetic groups 
containing seven and one phage, respectively. 
Lactobacillus plantation phages isolated from milk and silage samples belonged to the 
family Styloviridiae. 
The phage genome of phage TUC2009 (small isometric-headed phage induced from 
Lactococcus lactis subsp. cremoris UC507) was mapped and shown to be circularly permuted 
with terminal redundancy. Early and late expression functions were assigned to specific 
regions of the TUC2009 map. 
The gene for the lysin of the lactococcal phage P001 was cloned using the E. coli 
vector pLG339 and sequenced. An identified open reading frame would encode for a protein 
of molecular weight 22,327 and was in agreement with an isolated protein with lytic activity. 
Inside the open reading frame a second putative ribosomal binding site followed by an in-frame 
stan codon at the appropriate distance was found. A lytic protein corresponding to the deduced 
molecular wight, 8,262, was also isolated. The POOI lysin gene showed a high degree of 
sequence homology with that of Lactococcus lactis subsp. lactis phage 0vML3. 
The genome of the temperate phage mv4, which is representative of a widespread 
phage genetic group of Lactobacillus delbrueckii subsp. lactis or bulgaricus, is circularly 
permuted and terminally redundant A circular map of the 36 kb mv4 genome was established 
and the location of the par site and the an site determined. The genes coding for the two main 
structural proteins and for a phage associated lysin were also mapped. Phage mv4 is capable 
of transducing a limited set of pieces of bacterial DNA and several specific attachment sites of 
mv4 into the cell chromosome were identified. Phage mv4 lysogenic bacteria were shown to 
be immune to infection by L. delbrueckii virulent phages related to mv4. 
Despite difficulties to-date in obtaining a high frequency transformation system in L. 
delbrueckii subsp. bulgaricus, one early phage promoter has been characterised in the 
heterologous host L. casei. Using an alternative strategy based on the analysis of the 
regulatory regions upstream of the phage operons, the nucletodie sequences of two operons 
have been determined; one contained the endolysin encoding gene and the other included the 
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genes encoding the phage structural proteins. 
While lysogeny is rare among thermophilic lactic acid streptococci, S. ihermophilus 
J34 harbours a prophage. Prophage curing and relysogenisation have been achieved. The 
genome of temperate phage TP-J34 consisted of a circularly permuted and terminally redundant 
linear DN A ranging in size from 41.5 to 48.7 kbp. On the circular map the pac-siie and att-
site were localised. A close relationship between TP-J34 and virulent phages of different 
subgroups of 5. thermophilic was shown by DNA-DNA hybridisation and confirmed by 
immuno blotting and immuno electron microscopy. 
2 . Phage Resistance 
The five abortive infection determinants abi-105, abi-416, abi-420, abi-750 and abi-
829 were shown to be different. The sequenced abi-&29 gene was found to be identical to the 
hsp gene from pTR2030. 
The abi-105 and abi-416 targets were located on a 2.7 kb DNA fragment from phage 
bIL66 and on a 8.3 kb DNA fragment from phage ML41, respectively. 
pCI528, a 46kb absorption-blocking plasmid, was found to alter the cell surface 
characteristics of its host, L. lactis subsp. cremoris UC503, by directing the production of a 
galactose and rhamnose containing hydrophilic polymer. 
Infection with phages P008 and P416 labeled in vivo with the fluoresence dye 4-6-
diamidino-2-phenylindole (DAPI) showed that adsorption and DNA injection were not affected 
by the lactococcal phage resistance plasmids pBul-8 and pi 149-3. In resitant cells carrying 
either of the plasmids, phage DNA was replicated over more than five hours post infection but 
transcription of the phage DNA could not be observed. 
Lactococcal plasmids pFNk/094 and pJW563 encode for type IIR/M systems. In the 
case of plasmid pFW094, the methylase gene has been located on a 2. lkb fragment The 
endonuclease has been purified and characterised by its ability to digest DNA under different 
conditions. The recognition sequence of the enzyme, LlaU, was found by sequencing. The 
enzyme is sensitive for <ftzm-methylation (isochizomer to NdeU and MboV). 
The genes encoding the R/M system of plasmid pJWS73 have been located on a 5.0 
kb DNA fragment. Two non-homologous genes encoding ScrFl methylase enzymes have 
been cloned from the chromosome of £,. lactis subsp. cremoris UC503 and expressed in £. 
coli. One of the genes has been sequenced and significent homology to the methylase (genes) 
of EcoR II and Dcm was observed. 
Two strains of Lactobacillus plantarum produced cell wall bound nucleases that may 
play a role in phage resistance. Phage resistant mutants of a strain of Lactobacillus heheticus 
and a strain of Streptococcus ihermophilus were obtained. The resistance was linked to a 
modification of the phage receptor in the Lb. helveticus strains and to a restriction and 
modification system in the streptococcal strain. 
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ANTIMICROBIALS LEAF 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
1. Extend the available range of Lactic Acid Bacteria capable of producing antimicrobials 
as determined by standardised methodology and agreed target strains. 
2. Localise, isolate and characterise the genetic determinants of bacteriocin production. 
3. Develop conditons for the production and purification of bacteriocins. 
4. Determine the mode action of bacteriocins. 
5. Characterise the nisin transposon. 
RESULTS: 
A test panel of 28 target strains was composed and together with a detailed descripton 
of methods to be used, distributed to the LEAF participants. This facilitated comparison of 
bacteriocins produced by strains in different laboratories and ensured that duplication was 
minimised. 
Approximately 70 Lactobacillus strains isolated from successful olive fermentations 
were screened far bacteriocin production. A number of promising strains are being examined 
in detail. The Lb. plantation strain LPCO-10 produced the bacteriocin designated plantaracin S 
which was active against strains of Lactobacillus, Pediococcus, Propionibacterium and 
Clostridium. The latter two genera are important spoilage agents in olive fermentations. 
Preliminary experiments suggested that Lb. plantation LPCO-10 produced a compound which 
cross reacted with antiserum to nisin. However, hybridisation experiments now being 
finalised suggest that plantaricin S is not the same molecule as nisin. Plamaricin S showed a 
bacteriocidal mode of action and was active in the pH range 3.0 to 7.0. Ultrafiltration studies 
suggested a molecular wight in the range 3,000 to 10,000 daltons. 
A number of LAB isolated from Spanish dry fermented sausages showed antagonistic 
activity against spoilage and pathogenic bacteria. For example, Lactobacillus sake 148 
produced a compound active against various lactobacilli and several Gram-positive foodbome 
pathogens but not against Gram-negative bacteria tested. The activity was eliminated by 
treatment with proteases, heat resistant and was bacteriostatic rather than bacteriocidal. 
Biochemical analysis suggested a molecular weight of 4640 daltons. 
A number of LAB isolated from meat environments showed antimicrobial activity 
against the target indicator strains. One isolate, Lactobacillus sake P6, inhibited 18 of 32 
Listeria monocytogenes strains examined. The antimicrobial involved was sensitive to 
proteolytic degradation (papain, pronase, trypsin and chymotrypsin) and heat resistant (no 
effect at 115°C for IS minutes). While no correlation between plasmid DNA content and the 
ability to produce the antimicrobial has yet been observed, genetic studies are continuing. 
Approximately 20% of 130 LAB isolated from dairy products showed evidence of 
inhibitory activities and two were chosen for further study on the basis of their broad spectrum 
of activity and their stability in broth cultures. The activities were heat resistant and sensitive to 
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proteases. Preliminary characterisation suggests that the apparent size of one of the 
bacteriocins studied was over 100,000 d., although after SDS-PAGE it was less than 5,000 d, 
indicating a certain degree of aggregation. 
Lactobacillus sake L-45 and Lactobacillus acidophilus M247 produced antimicrobials 
with a very narrow spectrum of activity. 
Pediococcus pentosaceus FBB61 produced a plasmid encoded antimicrobial active 
against several Gram-positive bacteria while Pediococcus acidilactici P-2 produced a 
bacteriocin identical to the one produced by P. acidilactici PAC1.0. 
Production of the antimicrobial from Lb. acidophilus M46 has been optimised by 
modifying the culture conditons. The use of a very clean production medium (which did not 
support growth of the culture) and an organic solvent extraction procedure provided an almost 
pure (>90%) antimicrobial after just one purification step. The molecular weight was estimated 
at 2400 (SDS-PAGE). The gene(s) encoding this antimicrobial were located within a 4kb 
fragment of the 14kb plasmid pCV461. Introduction of this fragment into Lb. pfantarum 
LP80 resulted in transformants producing antimicrobial activity. 
With a view to improved antimicrobial production by Lactobacillus strains, gene 
expression and protein secretion were studied and expression vectors constructed. The 
applicability of the expression vector for heterologous gene expression has been demonstrated. 
For the first time a detailed analysis was made of the mode of action of a lactococcal 
bacteriocin (lactococcin A). It was convincingly demonstrated that LcnA increases the 
permeability of the cytoplasmic membrane, and that the immunity protein prevents lactococcin 
A-induced permeabilization. 
A second bacteriocin, lactococcin B was specified by plasmid p9B4-6. This 
bacteriocin resisted standard purification procedures. A new method, including a rotoforesis 
and cut off centrifugation-filtration step was successfully developed. 
By means of fusing the immunity protein against LcnA to MalE, sufficient fusion 
product could be purified for raising antibodies against the immunity protein. These will be 
helpful to investigate the immunity mechanism. 
The mode of action of pediocin PA-1, produced by Pediococcus acidilactici PAC1.0, 
was examined and appeared to be comparable to that of Lactococcin A. By means of cloning a 
DNA fragment carrying the presumptive immunity gene against pediocin in an expression 
vector, the fragment was shown to carry the immunity gene. 
Characterisation of the nisin transposon involved chromosomal walking from the ends 
of the element using clones from a lambda library. The objective is an ordered collection of 
lambda clones to cover the entire element. Sequencing from the ends of the element has also 
begun to build a picture of the arrangement of nisin biosynthetic genes. 
METABOLISM AND SCREENING 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
1. Screening and characterisation of Lactic Acid Bacteria isolated from natural 
food and feed sources such as wines, olives, meat, sourdough and cheeses. 
2. Use of numerical and molecular taxonomic methods to improve classification and 
identification of LAB. 
3. Creation of a deposit and distribution centre for strains of LAB. 
4. Biochemical analysis of fermentation pathways and products thereof in LAB 
5. Cloning and characterisation of selected key genes relevant to sugar and citrate 
metabolism. 
RESULTS: 
1 . Screening, Characterisation and Identification of Lactic Acid Bacteria 
LAB were screened from Portoguese wines and selected for their ability to perform 
the malolactic fermentation under conditions present during wine-making. 
Twenty-four out of 31 LAB isolates from spoiled port wine formed a single 
homogenous cluster when analysed by SDS-PAGE and may represent a new species. The 
determination of lorRNA of representative isolates is underway. The major fermenting 
isolates in natural substrates were isolated and included the following: 
rye and wheat sourdough: Lactobacillus sanfrancisco and Lb. brevis 
sorghum sourdough: Lb. amylovorus, Lb. reuteri and Lb. fermentum 
sausage: Lb. sake and Lb. curvatus 
Over 500 strains from natural food sources were screened for the production of 
bacteriocins, proteolytic activity and production of exopolysaccharides(EPS). Eight 
Lactococcus strains showed nisin-like antimicrobial production. Based on proteolytic activity, 
the strains were placed in four groups. Sixteen strains showed a very proteolytic activity. 
Twenty-seven strains produced exopolysaccarides. A synthetic medium for EPS production 
has been developed as well as a quantitive isolation and analysis procedure for rapid analysis of 
different EPS's. 
SDS-PAGE fingerprinting identified the majority of LAB isolates from natural 
sources. Normalised SDS-PAGE protein fingerprints of all the LAB isolates were added to the 
database developed. Identification to species level was successful for over 80% of the strains 
obtained. The technique of adding as many strains as possible for every database entry has 
proved to be extremely valuable for heterogenous taxa. 
At least six different protein electrophoretic groups were found within the species 
Lactobacillus acidophilus. Specified r RNA-target oligonucleotide probes for Lb. acidophilus 
and Lb. gasseri were developed and excellent agreement was found between the specificity of 
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the probes and groupings on the basis of protein patterns. 
The taxonomic status of Streptococcus salivarus subsp. thermophilus has been 
reinvestigated by DNA-DNA hybridisation studies of 24 industrially used strains with the type 
strains of S. salivarius subsp. salivarius and S.salivarius subsp. thermophilus. The two 
species could be clearly distinguished under stringent hybridisation conditons. These studies, 
together with phenetic data, led to the proposal to revive the species S. thermophilus. 
A 23SrRNA targeted oligonucleotide probe for the specific identification of 5. 
thermophilus has been developed. 
2 . Metabolic Studies 
The effects of aeration and the presence of malic acid on the metabolism of glucose 
were monitored in growing and non-growing cells of Leuconostoc oenos and revealed 
considerable alterations to the patterns of end products when aerobic and anaerobic conditions 
were compared. 
Erythritol and glucose were detected as the two major products of glucose metabolism 
investigated using in vivo 18C-NMR. The metabolites detected and the fermentation shift 
observed in the presence of oxygen indicated that glucose was catabolised heterofermentatively 
as well as via a novel erythritol-forming pathway. 
Strains of Lb. sanfrancisco isolated from rye and wheat sourdough grew readily on 
maltose but required adaption times of up to ISOh for growth on glucose. After subsequent 
transfer of glucose-grown cells to fresh media, the cells were able to grow on glucose or 
maltose, but lost this ability to utilise glucose upon renewed exposure to maltose. During 
fermentation of maltose, Lb. sanfrancisco strains accumulated glucose in the buffer and 
produced lactic acid, acetic acid and ethanol. 
The utilisation of lactose by Lactobacillus hetveticus involved the enzyme pV 
galactosidase whose activity was inducible by lactose and IPTG but repressed by glucose. The 
basal level of the activity of the enzyme increased 25 fold as the incubation temperature was 
increased from 37 to 44°C. Investigation of instability of the lac+ phenotype suggested that 
the lac determinants were not solely plasmid linked. 
Hybridisation studies suggested that the ^-galactosidase gene of Lb. bulgaricus and 
the lac permease gene of S. thermophilus showed litde homology to the toe genes of Lb. 
hetveticus. 
An EcoRI restriction fragment of chromosomal DNA from Lb. hetveticus expressing 
P-galactosidase has been cloned and is being analysed. 
Lactate dehydrogenase is a key enzyme in sugar metabolism and offers opportunities 
to engineer citrate metabolism. From published sequences for bacterial lactate dehydrogenase 
genes, primers were designed and used to generate a PCR probe for lactococcal lactate 
dehydrogenase. Clones for this gene were isolated from a lambda gene library of L. lactis 
MG1363 and the lactate dehydrogenase gene was sub-cloned and fully sequenced. The 
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lactococcal gene was 975 bp encoding a protein of 325 aa. The lactococcal enzyme had 
homology with other published lactate dehydrogenase sequences including S. Mutans 
(76.4%), Lb. casei (68.2%), Lb. plantarum (57.5%) and various Bacillus species (>50%). 
During purification of cc­acetolactate decarboxylase, the enzyme was found to be 
highly unstable. In contrast, purification of diacetyl reductase proceeded without obstacles and 
presently antibodies are being raised against the purified enzyme. 
In growing cells of Leuconostoc Uteris NCW1, citrate decreased lactose uptake and 
simultaneously increased the growth rate at pH 4.5,5.5 and 6.5. No acetoin, ethanol, diacetyl 
or acetolactate (ALA) were produced but higher than the theoretical amounts of acetate and 
lactate were formed. Production of ethanol began as soon as citrate consumption decreased to 
zero. In non­growing cells, little uptake of citrate occurred unless glucose was added at pH 
4.5,5.0 or 5.5. Citrate uptake was more rapid than glucose uptake. ALA was produced in 
significant amounts from citrate and glucose only when the glucose level was low. 
With resting cells of Leuc. mesenieroides Fr8/1, the rate of citrate uptake was lower 
than that of glucose in acetate buffer and faster than that of glucose in phosphate buffer and no 
citrate was taken up in the absence of sugar. Both citrate and glucose utilisation were non­
linear at pH 4.5 and linear at pH 5.0 and 5.5. At the latter two pH values, acetoin and ALA 
were produced from a mixture of glucose and citrate but only after glucose utilisation was 
complete. 
In contrast to the leuconostocs, resting cells of Cit+ Lactococcus lactis subsp. lactis 
19B metabolised considerable amounts of citrate in the absence of glucose and produced 
acetoin and ALA in the presence of glucose. 
MAJOR PROBLEMS ENCOUNTERED: 
Although the Lactic Acid Bacteria are difficult targets for genetic analysis, problems 
encountered did not inferfere with the specific objectives of the project 
HIGHLIGHTS/MILESTONES: 
Successful use of luciferase to monitor controlled gene expression Lactococcus. 
Discovery of a chromosomal mobilisation in L. lactis MG1363. Development of a reliable 
foodgrade integration system for lactococci. Definition of promoter­operator regions and 
identification of a new catabolite repression control circuit. Identification of the aggregation 
promoting factor and the binding substance responsible for the high frequency of conjugation 
in Lb. plantarum.. Construction of expression vectors for Lactobacillus. 
Construction of strains that overproduce the cell envelope located serine proteinase 
and demonstrate improved growth in milk. Cloning of a range of peptidase genes. The 
isolation of the DtpT gene representing the first example of a bacterial transport system that is 
encoded by a single gene, and is driven by a proton motive force. Isolation of amino acid and 
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peptide transport mutants that allow a full analysis of the role of the individual transport 
systems in the degradation of caseins. 
Characterisation of the temperate phage mv4 of Lb. delbrueckii subsp.bulgaricus. 
Identification of the receptor for a Lactobacillus hehieticus lytic phage. Isolation of nuclease 
and methylase genes involved in R/M systems. Elucidation of the structure of the regulatory 
region of a phage late operon. 
Isolation of strains with broad spectrum antimicrobial activity. Purification of the 
antimicrobial from Lb. acidophilus M46. Successful transfer of the genes responsible for 
antimicrobial production from l i . acidophilus M46 to Lb. plantarum. Elucidation of the mode 
of action of Lactococcin A. 
Cloning and sequencing of the lactoccccal lactate dehydrogenase gene. Isolation of 
strains of Lb. sanfrancisco with an effective but unusual maltose metabolism. Demonstration 
of a new pathway leading to the formation of erythritol by Leuconstoc oenos. 
Major advances in the screening and identification of LAB. Excellent correlation 
between DNA probes and protein profiles of investigated LAB. Development of a synthetic 
medium in which lg/litre of exopolysaccharide can be produced. 
WIDER CONSIDERATIONS: 
The T-Project on Biotechnology of Lactic Acid Bacteria has already, in its first year, 
demonstrated the success of the approach of forming and fostering a large transnational team to 
tackle a major research objective. The industrially important LAB include several genera that 
are vitally important in key indigenous industries throughout Europe e.g. dairy, meat and bread 
fermentations and winemaking. The present project is making essential advances in the 
knowledge of the genetics, physiology and biochemistry of a range of LAB. 
Considerable advances have been achieved in aspects of the molecular biology of 
plasmids, transposons, the chromosome, individual genes and their expression, as well as 
strain improvement and protein engineering. Technologies for chromosome integration, the 
construction of food grade markers and cell lysis are being developed. 
The CORE and LEAF concept of the project ensures that the research findings underpin 
important aspects of the application of LAB in industry. 
The very significant progress achieved in the molecular analysis of the proteolytic 
activity of LAB has created the basis for understanding fundamental factors concerning growth 
of these bacteria in milk. It will, in addition, help unravel the complex questions regarding 
the specific role of starter cultures in ripening and flavour development in a range of fermented 
dairy products. 
Modem analytical techniques have been successfully applied to the study of 
bacteriophages of LAB and to the elucidation of the molecular basis for their interaction with 
their hosts. A "food grade" strategy, involving the transfer of phage resistance plasmids by 
conjugation to appropriate recipient strains has been used to construct lactococcal strains with 
enhanced phage resistance. Strains constructed in this manner are currently used in commercial 
cheesemaking and represent one of the first tangible benefits to industry stemming from genetic 
analysis of lactic acid bacteria. Furthermore, the imminent availability of self-cloning strategies 
for these hosts, coupled with knowledge of factors controlling gene expression and regulation, 
plasmid stability and incompatibility, will soon allow for the provision of an expanded range of 
phage resistant strains for commercial use. 
The discovery of a range of antimicrobials produced by LAB is an exciting 
development The research programme being undertaken includes studies on the purification, 
biochemical characterisation, mode of action and genetics of several bacteriocins and should 
permit targeted applications in food systems with the objective of enhancing quality and safety. 
The metabolism research is focused on the fermentations of lactose, maltose, citrate and 
malate which are vital to the industrial use of LAB in the dairy, bread and wine industries. Key 
traits of LAB used in meat fermentations are also targeted. In addition to conventional 
biochemical assays, the powerful technique of in vivo NMR is being exploited. An important 
aspect of the research is the cloning and analysis of the enzyme genes in the various pathways. 
As well as adding to the overall characterisation of the important metabolic pathways, this will 
facilitate a metabolic engineering approach to the elevation of the yield of flavour compounds in 
food fermentations. 
In the screening activity, large numbers of LAB are being tested for a variety of key 
industrially relevant properties. This activity is backed up by taxonomic studies including the 
analysis of protein profiles using SDS-PAGE and the use of ribosomal RNA probes. In 
addition to ensuring the correct characterisation and identification of LAB, these studies will 
provide valuable "tags" for industrially useful strains. 
The T-Project provides a network that continues to keep Europe at the forefront of the 
industrially important research on LAB. The award of the 1992 Rhone-Poulenc International 
Award of the American Dairy Science Association to Professor Gerard Venema of Groningen 
University, who has participated in CEC sponsored LAB research since 1982, is a fitting 
reflection of the esteem in which European research in this field is held. 
COOPERATIVE ACTIVITIES 
A plenary meeting of all 34 groups participating in the project was hosted by Prof. 
Helena Santos at Estoril, Portugal in April 1991. The second plenary meeting is scheduled for 
Cork in May 1992. 
Meetings of the CORE and LEAF subgroups were hosted by INRA, Jouy-en-Josas, 
F; TNO-Zeist, NL; NIZO, Ede, NL; Unilever Research, Vlaardingen, NL and University of 
Groningen, Haren, NL in the period October to December, 1991. 
Several participants met, in addition, at LAB conferences at Caen, F and Sevilla, E. 
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There is very extensive collaboration between laboratories, featuring exchange of 
materials e.g. bacterial strains, DNA probes, cloned genes and antibodies, as well as 
methodologies. Within the LEAF, Antimicrobials, assay methods have been standardised and 
a set of target strains have been distributed to all participating laboratories. Close collaboration 
is a feature of the activities associated with the screening, characterisation and identification of 
LAB from natural sources. 
Staff exchanges have included 9 extended visits totalling 49 man-months and an 
additional 21 short visits of up to two weeks duration. Three scientists financed under the 
Training Activity of the CEC BRIDGE Programme are being hosted at Cranfield Institute of 
Technology, UK; University College, Cork, IRL and University of Groningen, NL. 
Thirteen joint publications with transnational authorship have been published. Three 
other publications featured collaboration between laboratories within individual countries. 
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WITH TRANS-NATIONAL AUTHORSHIP: 
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Cocconcelli, P.S., Gasson. M.J., Morelli. L., Bottazzi, V. (1991). Single-stranded DNA plasmid, vector construction 
and cloning of Bacillus stearothrmophilus - amylase in Lactobacillus Res. Microbiol. 142, 643-652. 
Hayes, F., Vos, P., Fitzgerald, G.F., de Vos, W.M. and Daly, C . (1991). Molecular organisation of the minimal 
replicon of the novel, narrow-host-range, lactococcal plasmid pCI305. Plasmid 25, 16-26. 
Jarvis, A.W., Fitzgerald. G.F., Mata, M., Mercenier, A., Neve, H , Powell.I.B., Ronda. C Sazelin, M., and Teuber, M. 
(1991). Species and type phage of lactococcal bacteriophages. Intervirology, 32, 2-9. 
Law, J. .Vos. P., Hayes. F . Daly, C de Vos, W.M. and Fitzgerald . G.F. (1992). Cloning and partial sequencing of 
the proteinase gene complex from Lactococcus lactis subsp. lactis UC317 J. Gen. Microbiol. 138, 709-718. 
Mayo, B., Kok, J.. Venema. K., Bockelman. W., Tueber. M . , Reinke, H. and Venema G. (1991). Molecular cloning 
and sequence analysis of an X-prolyl dipeptidyl aminopeptidase form Lactococcus lactis subspec. cremoris. Appl. 
Environ. Microbiol. 57 38-44. 
Poolman. B., Molenaar, D. , Smid. E.J., Ubink.T., Abee, T.. Renault, P.P.and Konings, W.N. (1991). Malolactic 
fermentation: electrogenic malate uptake and malate/lactate antiport generate metabolic energy. J. Bacteriol. 173. 
6030-6037. 
Tan. P.S.T.. Chapol-Chartier, M.P.. Pos. K.M., Rousseau, M., Boquin, C.Y.. Gripon. J.C. and Konings,W.N.(1992). 
Localization of peptidases in lactococci. Appl. Environ. Microbil. 58, 285-293. 
Tiehaczek, P., Nixxen-Meyer, J., Nes. I.F. Vogel . R.F. and Hammes, W.P. (1992). Characterization of curvacin A of 
Lactobacillus curvatus LTH1174 and sakacin P. of L. sake LTH673 System. AppL Microbiol, (in press). 
van Belkum, MJ., Kok. J., Venema. G. Holo, H., Nes, IF. Konings. W.N. Abee, T. (1991) The bacteriocin 
tactococcin A specifically increases permeability of lactococcal cytoplasmic membranes in a voltage-independent, 
protein-mediated manner. J. Bacteriol 173, 7934-7941. 
van der Lelie. D., Chavarri, F., Venema,G., and Gasson, MJ.(1991). Identification of a new genetic determinant for 
cell aggregation associated with lactose plasmid transfer in Lactococcus lactis . Appl. Environ. Microbiol 57, 201-
206. 
van Rooijen. R.J., Gasson, M J. and de Vos, W.M. (1992) Characterisation of the promoter of the Lactococcus lactis 
lactose operon: contribution of flanking sequences and lacR repressor to its activity. J. Bacteriol. 174 (in press). 
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Bockelmann, W„ Schulz, Y. and Teuber, M. (1992). Purification and characterisation of a dipeptidase from 
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Casey, J., Daly, C , and Fitzgerald, G.F. (1991). Chromosomal integration of plasmid DNA by homologous 
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Environ. Microbiol.. 57, 2677-2682. 
Chapot-Chartier M.P., Nardi. M., Chopin. M.C., Chopin, A. and Gripon, J.C. (1992). Cloning and DNA sequencing 
of pepC, a cysteine aminopeptidase gene from Lactococcus lactis subsp. cremoris AM2 (submitted to Appl. Environ. 
Microbiol). 
Cocconcelli, P.S., Triban, E., B assort, M. and Bottazzi.V. (1991). Use of DNA probes in the study of silage 
colonization by Lactobacillus and Pediococcus strains. J. Appl. BacterioL, 71, 296-301. 
Coffey, A., Costello, V., Daly, C. and Fitzgerald, GJ\ (1991). Plasmid-encoded bacteriophage insenstitivity in 
members of the genus Lactococcus with special reference to pC1829. Genetics and Molecular Biology of 
Streptococci, Lactococci and Enterococci, Ed. G.M. Dunny et. al. (American Society for Microbiology) pp 131-135. 
Coffey, A.G. (1990). Genetic analysis of plasmid encoded bacteriophage insensitiviry in Lactococcus.. PhD Thesis 
Cork. 
Coffey, A.G., Fitzgerald. G.F.. and Daly, C. (1991). Cloning and characterisation of determinant for abortive 
infection of bacteriophage from lactococcal plasmid pCI829. J. Gen. Microbiol. 137, 1355-1362. 
Collins, M.A. andThompson, J.K. (1992). Lactose metabolism and lactose gene sequence homologies amongst 
lactobacilli. J. Applied Bacteriology (submitted). 
Ehrmann, M-, Ludwig, W. and Schleifer, K.H. (1992). Species specific oligonucleotide probe for the identification of 
Streptococcus thermophilus. Syst. Appl. Microbiol. 15 (in press). 
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Le Bourgeois, P., Lauder, M„ Mata, M. and Ritzenthaler P. (1992). New tools for the physical and genetic mapping of 
Lactococcus strains. Gene 111, 109­114. 
Leenhouts, KJ., Gietema, J., Kok. J. and Venema, G. (1991). Chromosomal stabilization of the proteinae genes in 
Lactococcus lactis . Appl. Environ. Microbiol. 57, 2568­2575. 
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T-PROJECT 
FACTORS REGULATING PLANT CELL 
GROWTH AND DIFFERENTIATION 

Factors Regulating Growth and Differentiation of Plant Cells 
A Basis for the Understanding of Plant Regeneration 
Coordinator: J. Guem 
Institut des Sciences Vegdtales 
CNRS Gif-sur-Yvette (F) 
Contract: BIOT 900206 
Sub-Coordinators: K. Palme, Max-Planck-Inst., Koln, (D) (see page 456) 
P. Costantino, Univ. di Roma "LaSapienza", (I) (see page 461) 
P. Pechan, Max-Planck-Inst., Koln, (D) (see page 465) 
S. de Vries, Agricultural Univ. Wageningen, (NL) (see page 468) 
M. Hall, Univ. College Wales, Aberysthwyth, (UK) (see page 471) 
Contracts: BIOT 900178, BIOT 900179, BIOT 900160, BIOT 900177, 
BIOT 900158 (see following reports) 
Duration: 36 months from January 1991 
After one years work, 25 laboratories structured in 5 groups, working together in the 
frame of the T-Project, have built a strong network, involving more than 120 researchers, 
aiming to understand the mechanisms by which growth factors control the differentiation 
of plant cells. 
Well in line with the initial goals of the T-Project, genes and gene products corresponding 
to putative auxin receptors, genes coding for G-proteins, genes and gene products 
involved in the regulation of the cell cycle, putative ethylene and fusicoccin receptor 
binding proteins, have been isolated and characterized. The isolation and 
characterisation of extracellular glycoproteins involved in the regulation of somatic 
embryogenesis, the characterisation of cell wall epitopes specific for differentiation steps, 
the isolation of well defined oligosaccharides with growth regulating activities, the detailed 
dissection of promoters of the ml genes from Agrobacterium rhizogenes, the analysis of 
the function of some of these genes have also been significant achievements of this first 
phase of the T-Project. More than 80 papers have been published. Powerful tools (c-
DNAs, antibodies, oligosaccharides, labelled ligands, transgenic plants, etc) have been 
built and circulated during this period, offering new languages to describe early events 
of plant morphogenesis. 
An impressive scale of cooperation between the members of the T-Project has been 
established during this first year. Frequent sectoral meetings, a general meeting, 
considerable exchange of tools and personnel, efficient cooperation with the industrial 
partners clearly demonstrate the strength of the multidisciplinary character of the T-
Projects. The second phase of the project will certainly accelerate progress of our 
knowledge of the regulation of growth and differentiation in Plant cells. 
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TITLE: Molecular Analysis of Auxin-Specific Signal 
Transduction in Plant Cell Communication 
CONTRACT NUMBER: BIOT-CT90-0178 
OFFICIAL STARTING DATE: 03/01/91 
COORDINATOR: K. Palme, Max-Planck-Institut, Koln, DE (MPI) 
PARTICIPANTS: 
K. Palme, Max-Planck-Institut, Koln, DE (MPI) 
M. Venis, Horticulture Research Int., Kent, UK (HRI) 
H. Barbier-Brygoo.Institut Sciences Vegetales CNRS, Gif-sur Yvette, FR (ISV) 
D. Inze", Rijksuniversiteit Gent, Gent BE (RUG) 
P.A. Millner, University of Leeds, Leeds, UK (ULeeds) 
F. Okkels Danisco/AS, Copenhagen, DK (Danisco) 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Molecular, structural and functional analysis of ER located auxin binding proteins (MPI); 
production of antibodies to auxin binding site or other important epitopes, epitope mapping 
(HRI); development of an assay system for auxin induced membrane potential changes 
(ISV); cloning and analysis of cell division control genes and genes encoding small 
GTP-binding proteins (RUG); to identify and study heterotrimeric G proteins (ULeeds); to 
identify and study novel auxin binding proteins (MPI, Danisco). 
MAJOR PROBLEMS ENCOUNTERED: 
Difficulties to immunolocalize ERabp in tissue sections with a wide variety of poly- and 
monoclonal antibodies. 
RESULTS: 
Research in our subgroup has focused on the (i) identification and characterization of genes 
encoding putative auxin receptors, (ii) to understand at the molecular level the primary 
physiological and morphogenic consequences of auxin action, (iii) the characterization of cell 
cycle control genes, and (iv) the analysis of small and heterotrimeric GTP-binding proteins. 
Auxin is involved in the control of various aspects of growth and development in higher 
plants, including cell division, stem elongation, xylem differentiation, gravitropism, and 
senescence. Receptor like proteins have been assumed to play an important role in 
recognition and transmission of the auxin signal. Additional members of a gene family 
encoding maize auxin bindig proteins, termed Zm-ERabp's for Zea mays auxin binding 
protein located in the lumen of the endoplasmic reticulum (ER), have been isolated and 
shown to be expressed in specific tissues. In vitro studies demonstrated that the Zm-ERabpl 
protein was translocated into ER derived microsomes, processed and glycosylated (MPI). A 
gene encoding the Arabidopsis homologue for Zm-ERabpl was isolated and mapped to a 
single locus on chromosome 4. To obtain more information on possible in planta functions 
of these proteins, transgenic tobacco plants overproducing Zm-ERabpl were constructed and 
analyzed for changes in auxin sensitivity. As expected auxin sensitivity was increased in 
these transgenic plants. Protoplasts isolated from these plants showed a 30-fold increase in 
auxin sensitivity of transmembrane potential (ISV, MPI). This increase was selectively 
abolished using monoclonal antibodies that recognize only Zm-ERabpl, but not endogenous 
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tobacco ER-abps. These results suggest that at least a fraction of this protein is released 
from the ER and located at the plasma membrane. It was shown that Zm-ERabpl stimulated 
root elongation growth in a novel tobacco mutant identified by T-DNA mutagenesis and 
impaired in auxin related growth characteristics (MPI). A region of the maize auxin binding 
protein (Zm-ERabpl) containing several amino acids likely to be present at the active auxin 
binding site was identified. A polypeptide embracing this region was synthesised, coupled 
to carrier protein, and polyclonal antisera produced (HRI). Several of these antisera 
recognised all three isoforms of maize ERabp's on Western blots, as well as ABP 
homologues in other species, both monocots and dicots, and IgG fractions from two of these 
sera were shown (ISV, HRI) to hyperpolarise protoplast membrane potential characteristic 
of auxin action. The anti-peptide antibodies have apparent auxin "agonist" activity, showing 
that the selected peptide probably is part of the auxin binding site and supporting the role of 
Zm-ERabpl as an auxin receptor (ISV, HRI). Using an epitope mapping kit, the epitopes 
recognised by all these antibodies have been located, providing information for structural 
and functional analysis (HRI). All anti-ABP sera, including those from MPI (recombinant 
Zm-ERabpl) or other sources recognise two or three dominant epitopes clustered around the 
glycosylation site. Two monoclonals are directed at the endoplasmic reticulum (ER) retention 
sequence KDEL at the C-terminus of ABP. Interestingly, none of these antibodies were able 
to interfere with the auxin-induced transcriptional activation of the chimeric rolB 
promoter:GUS reporter gene (ISV). This raises the possibility of multiple auxin-perception-
transduction pathways in various plant tissues and cells. To probe further into novel auxin 
binding proteins and their function, a joint PhD project (MPI, Danisco) has recently been 
started. Immunolocalization studies have been performed to identify the specific localization 
of some of these proteins. In addition antibodies against recombinant abps were used to 
search in Xgtl 1 expression libraries for clones that represent potential candidates for novel 
auxin binding proteins. 
As a first step for studying the regulation of cell division in plants, several Arabidopsis 
genes with high homology to cell cycle regulation genes characterized in other organisms 
were isolated. A c<fc2-homologous cDNA was cloned from Arabidopsis thaliana (RUG) 
encoding a polypeptide with extensive homology to -phO** protein kinases. 
Complementation experiments of ts-mutants in yeast confirmed that the Arabidopsis cDNA 
encodes a functional homologue for the piA'^'1 kinase. Analysis of promoter/B-glucuronidase 
fusions in transgenic Arabidopsis and tobacco plants is currently in progress and will provide 
new insights into how plant hormones affect their expression during development. A second 
class of characterized genes with a key role in cell division are encoded by cyclins and we 
have shown that there are at least five different cyclin genes in Arabidopsis. A second part 
of work in our group deals with the characterization of small GTP-binding proteins in 
Arabidopsis (RUG). Small GTP-binding proteins constitute a superfamily of eukaryotic 
proteins which are thought to play a key role in the regulation of diverse cellular processes. 
Arabidopsis cDNAs encoding a GTP-binding protein, called Rhal, has been cloned encoding 
a small G protein protein with high homology involved in early endocytosis. Antibodies 
raised against the Arabidopsis protein are currendy used to determine its subcellular 
localization. Research in the Leeds laboratory has concentrated on identification of novel 
heterotrimeric G proteins. This is important as cloning approaches in several laboratories, 
which were based on homology, resulted in isolation of only one particular class of 
heterotrimeric G proteins. Heterotrimeric guanine nucleotide binding regulatory proteins (G-
proteins) transduce signals across cell membranes by coupling receptors for chemical and 
sensory stimuli to effectors such as enzymes and channels. Biochemical and immunological 
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techniques were applied to search for novel members of the G protein family in plants. This 
will present a basis for molecular cloning and functional analysis of these proteins. Several 
putative Go subunit proteins were identified including a 40 kDa protein related to GPA1. 
Using a Gia specific antiserum a 37 kDa protein was identified in Arabidopsis membrane 
fractions (ULeeds). Currently antisera to peptides corresponding to the Gq class of G protein 
subunits are being raised, a group of proteins known to act in vertebrates in gating 
phosphoinositol metabolism. Further biochemical analysis resulted in partial purification of 
G proteins from peas indicating that some of these plant G proteins significantly differ from 
their animal counterparts. Understanding these proteins, the receptors and effectors to which 
they couple will represent an important step towards understanding plant signal transduction 
and hence control of regeneration. 
HIGHLIGHTS/MILESTONES: 
Several novel ERabp genes have been cloned from maize and Arabidopsis to allow structural 
and functional analysis of their role in auxin perception; transgenic tobacco plants have been 
generated expressing these proteins and demonstrating increased auxin sensitivity and altered 
root growth characteristics (MPI, GIF). Analysis of their cellular expression and trafficking 
will present a major step forward to understand their function. Anti-peptide antibodies with 
auxin agonist activity identify the auxin binding region of an auxin receptor; two monoclonal 
antibodies against the auxin receptor are excellent markers for ER, especially in mammalian 
cells (HPJ). Development of an assay system for early auxin responses; functional analysis 
of auxin "agonist" antibodies; demonstration of increased auxin sensitivity in transgenic 
tobacco plants overexpressing an auxin binding protein (GIF). Mutant cdc2 genes influence 
cell division in plants and provide perspectives to alter development; the availability of two 
cdc2 genes and five cyclin genes allow us now to study the influence of plant hormones, in 
particular auxins and cytokinins, on cell division; the cell-specific expression pattern of an 
Arabidopsis gene encoding a small GTP-binding protein is a major step forward to 
understand its cellular function (RUG). Peptides have been synthesized that correspond in 
sequence to a number of G-protein sequences (ULeeds), and antisera raised against these 
peptides have been characterized and distributed to a number of participant laboratories 
(MPI, HRI, GIF). 
WIDER CONSIDERATIONS: 
Progress obtained from our subgroup (MPI, HRI, ISV, ULeeds, Danisco) has confirmed 
that an auxin-binding protein is involved in influencing cellular auxin sensitivity. This will 
allow - for the first time - to probe into the mechanisms of auxin action. The identification 
of proteins and genes involved plant signal transduction and cell cycle control provides the 
basis for the links between the signal, e.g. auxin, and cell division control. 
COOPERATIVE ACTIVITIES: 
Joint Meetings: sub-group meeting, MPI, Koln; general T-project meeting in Dourdan. 
Several visits have been organized between the different laboratories: visits by Napier (1 
day) and Venis (2 days) to ISV lab for discussions; by Lovegrove to ULeeds for 1 month for 
work on G proteins. Anti-abp antibodies, seeds, materials exchanged between sub-group 
partners ISV, MPI, RUG and provided to other T-project labs - Klambt (Bonn), Libbenga 
(Leiden), Terzi (Padova), Costantino (Rome), Van Lammeren (Wageningen), Hall 
(Aberystwyth). Transgenic tobacco plants provided to subgroup partner (ISV), exchange of 
materials with DANISCO/AS. 
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TITLE: The rol genes as privileged tool to study plant morphogenesis 
CONTRACT NUMBER: BIOT-CT90-0179 (SMA) 
OFFICIAL STARTING DATE: March 1st 1991. 
COORDINATOR: 
P. Costantino, Dip. Gen. Biol. Mol., Universita "La Sapienza", Roma, IT (DGBM). 
PARTICIPANTS: 
A. Spena, Max-Planck-Instirut, Koln, DE (MPI); 
J. Tempe, Institut Sciences Vegetales CNRS, Gif-sur Yvette, FR (ISV); 
H. Van Onckelen, Universitaire Instelling Antwerpen, Antwerp, BE (UIA); 
D. Chriqui, Cytol. EmbrioL Vegetales, Universite P. et M. Curie, Paris, FR (CEMV); 
F. Souq, Louis Vuitton Moet Hennessy Recherche, Paris, FR (LVMH); 
D. Mariotti, Istituto RadiobioL Ecofisiol. Vegetali CNR, Monterotondo, IT (IREV). 
OBJECTIVES SET FOR THE REPORTING PERIOD: 
Analysis of: regulation of rol genes (DGBM, MPI) and other relevant Ri T-DNA genes 
(ISV); biochemical role of the rolB (DGBM, MPI) and rolC (MPI) gene products; 
interaction of rol genes with plant genes (DGBM, MPI); hormonal levels of different 
tissues and plants transgenic for rol constructs (UIA); morphological and developmental 
traits of rol transgenic plants (CEMV); effects of other T-DNA genes (ISV) . 
Exploitation as useful traits of the effects of rol and other T-DNA genes (MPI, LVMH, 
IREV). 
MAJOR PROBLEMS ENCOUNTERED: 
Impossibility to visualize the rolB gene product with specific anti-RolB antisera (DGBM, 
ISV). Impossibility to overexpress rolA in Escherichia coli (MPI). Difficulties in 
defining regeneration procols for rose (LVMH) and woody species (IREV). 
RESULTS: 
The research projects of our subgroup as a whole concern various aspects and levels of 
the morphogenesis triggered by the T-DNA genes of Agrobacterium rhizogenes in 
plants. DGBM has been concentrating on the regulation of rolB, whose promoter has 
been shown to be under hormonal, developmental and tissue-specific regulation. Detailed 
histological analysis of GUS gene fusion expression has pointed out a developmental 
regulation of the rolB promoter which has also been followed during zygotic 
embryogenesis (DGBM). The hormonal response of the rolB promoter has also been 
characterized - the gene has been shown to be auxin-inducible (DGBM, ISV) - and is 
currently being linked to the developmental control of expression of this gene. Very 
recent data point to an unexpected role of the TATA box in determining tissue specificity 
and hormonal and developmental regulation of rolB (DGBM). The role of rolB in 
triggering rooting is being studied at MPI, where an indoxyl-|}-glucosidase activity has 
been assigned to RolB, and at DGBM, where a RolB-related auxin binding activity in 
normal plant cells has been identified. This auxin-binding activity is much enhanced in 
ro/S-transformed cells (DGBM) where a greatly increased sensitivity to auxin has been 
measured (ISV). At MPI also rolC is being studied and a conjugated cytokinin hydrolase 
activity assigned to its gene product. The intracellular localization of the rolB and rolC 
gene products has been defined (MPI). Plant genetic mosaics for the expression of a 
cytokinin gene and plants expressing constitutively rol genes have been constructed 
(MPI) and analysed in collaboration with UIA and CEMV. ISV is mainly concerned with 
ORFs 13 and 14 of the Ri T-DNA, the characterization of their promoters and the 
identification of their gene products. In particular, ORF13 has been shown to be 
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controlled by a wound-inducible promoter and to encode for an as yet uncharacterized 
low molecular weight morphogenic substance (ISV). UIA is currently measuring 
hormone levels of plants transgenic for prom35S-ORF13 gene fusions. CEMV has 
characterized at the hystological and ultrastructural level the developmental and 
morphological modifications induced by the rol genes A, B and C in collaboration with 
MPI and UIA. At UIA various advanced microanalytical techniques are being utilized to 
measure hormone levels in even small districts of plant tissues transformed by the rol 
genes. These techniques have allowed to correlate alterations of endogenous hormones to 
specific developmental patterns of transgenic plants (UIA, MPI, CEMV). At the MPI-
associated laboratory of LVMH, Agrobacterium-based transformation techniques have 
been developed for woody roses in order to exploit the developmental modifications 
induced by rol genes. Evaluation of the consequences of rol gene expression by a vast 
morphological and agronomical survey is currently underway at LVMH. The possible 
exploitation of the ro/-induced morphological alterations in agronomical plants such as 
alfalfa and kiwi is the object of the research at the DGBM-associated laboratory REV. 
ro/B-transgenic kiwi plants show an improved rooting capability, while other interesting 
modifications are induced by rol genes in alfalfa (IREV). 
HIGHLIGHTS/MILESTONES: 
Specific regulatory sequences within the rolB promoter which interact with endogenous 
plant regulatory factors and confer tissue specificity, hormonal and developmental 
control have been identified (DGBM). A non -systemic, wound-inducible promoter 
(ORF13) has been characterized, which could be used to control expression of plant 
defense genes (ISV). The existence on the membranes of untransformed tobacco cells of 
an auxin-binding activity immunologically related to the gene product of the plant 
oncogene rolB has been pointed out (DGBM). The biochemical activities of the rolB and 
rolC gene products - capable of hydrolysing indole glycosides and, respectively, 
cytokinin-n-glucoside - have been defined, suggesting a primary role of hormone 
metabolism in the alterations induced by the rol genes (MPI). A novel, low molecular 
weight substance capable of interfering with morphogenesis, encoded by ORF13 has 
been evidenced (ISV). 
WIDER CONSIDERATIONS: 
The results obtained from our subgroup as a whole (DGBM, ISV, MPI, UIA, CEMV, 
LVMH, IREV) has more than confirmed that the study of the rol genes provides unique 
entry points on several critical and complex aspects of plant differentiation and provides 
unique tools to manipulate plant growth and development. Access to plant genes 
involved in differentiation and possibly to plant cellular oncogenes will be possible 
through the rol gene system. Investigation on the biochemical role of the rol gene 
products has demonstrated for the first time that plant physiology and development can 
be modified by enzymatic systems able to synthesize or hydrolyse plant hormone 
conjugates. 
COOPERATIVE ACTIVITIES: 
A post-doc from DGBM has spent two years at ISV. Students have been exchanged 
between CEMV and UIA. Exchange of all types of tools (strains, constructs, transgenic 
plants, antibodies, protocols and techniques, early preprints) has taken place between all 
participating laboratories. Collaborative efforts within our subgroup (in particular 
DGBM with ISV and IREV; MPI with UIA, CEMV and LVMH) and with other 
laboratories within the T-Project (e.g. DGBM with the laboratory of Mario Terzi) has led 
to several joint publications. Joint meetings: Several meetings between partners in the 
subgroup: three ISV-DGBM in Gif; four UIA-CEMV in Paris; four MPI-UIA in Koln 
and Antwerp; two general meetings of the subgroup in Paris (Nov.'90 and Jan.'92); one 
general T-Project meeting in Dourdan (Nov.'91). 
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Regulation of the inductive phase of microspore embryogenesis. 
Contract Number BIOT 900160 
Official starting date: 01.01.1990 
Coordinator: Dr Paul Pechan, MPI, Koln, G. 
Participants: Dr Andre van Lammeren, Agricultural University, Wageningen, NL. 
Dr Antonio Martin, IAPV, Cordoba, ES. 
Mr Andrew McQueen, Nickersons, Cambridge, UK. 
Dr Hans Dons, CPRO-DLO, Wageningen, NL. 
Objectives: Many plant species cannot be regenerated from single cells in vitro. We are 
investigating the mechanism controlling the induction of cell proliferation in plants using 
Brassica napus microspores as a model system. It is envisaged that the information obtained 
will be useful to elucidate not only how microspore embryogenesis but also plant cell 
proliferation in general is initiated. The research will help to establish why some agronomically 
important plant species cannot be regenerated from microspores in vitro. The production of 
double haploid plants from microspores is of major commercial importance to plant breeding 
companies. 
We wish to identify some of the genes required for the induction of microspore 
embryogenesis, structural and functional cellular components associated with the induction 
process and how the genes required for the induction of microspore embryogenesis are 
inherited in a plant population. 
The following main objectives were set for the first year of our study, (a) Creation of 
Brassica cDNA libraries and isolation of clones associated with induction of microspore 
embryogenesis (MPI). (b) Investigate the B. napus cytoskeleton (microtubules and 
microfilaments) under normal and stress conditions (Agricultural University), (c) Investigate 
the cytoskeletal targets of the phosphorylation cascade leading to induction of microspore 
embryogenesis (CPRO-DLO). (d) Cross low and high embryogenesis responsive Brassica 
varieties (IAPV). (e) Identify potentially embryogenic barley microspores (Nickersons Int. 
Co.). 
Major problems 
Nothing to report. 
Results 
A 32°C temperature treatment of 8 h duration induces the embryogenic process in freshly 
isolated late uni- to early binucleate microspores. Consequently, molecular and cellular 
comparisons, based on the developmental stage of microspores, the severity of stress treatment 
and duration of the treatment, can be made. 
(a) Max Planck Institute (MPI) 
Because of the limited amount of microspores available, new techniques had to be adapted and 
developed to generate cDNA libraries. The techniques were based on PCR technology. 
Approximately 5 ng of cDNA can be synthesized from as little as 10,000-20,000 cells. Genes 
associated with induction of microspore embryogenesis were enriched for by subtractive 
hybridization. 15 cDNA libraries have so far been created in this fashion. Screening of the 
libraries is in progress. A number of clones have been isolated. An additional investigative 
approach is based on protein comparisons during the inductive phase of microspore 
embryogenesis. Microspores were also successfully transformed by electroporation mediated 
delivery of DNA into microspores. This and other techniques will be used to ascertain in the 
future the function of genes associated with the induction of microspore embryogenesis. 
(b) Agricultural University 
Changes in the organization of the microtubular and the microfilamental cytoskeletons were 
investigated during the normal development of Brassica microspores. The visualization of 
cytoskeletal elements was successful with immunological, fluorescence and electron 
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microscopical techniques. Stage specific arrangements were detected. The results point to a 
specific function of the microtubules in inducing or maintaining polarity within the 
microspores. Changes in the organization of the microtubular and microfilamental 
cytoskeletons in microspores under induction conditions were monitored during the first 12 h 
of culture and compared with the in vivo development. Clear differences were noted as 
compared with the in vivo development. Additionally, we observed differences in the structure 
between microspores cultured under inductive (32°C) and non-inductive (25°C) conditions. The 
detection of mRNA coding for tubulin and acrin in normal developing microspores has been 
started. For this purpose probes were developed in Wageningen and digoxigenated at the MPI. 
(c) Institute of Plant Breeding and Plant Reproduction (CPRO-DLO) 
Continued microspore culture at 32°C leads to the formation of embryos. In contrast to this 
continuous culture at 18CC resulted in continuation of the normal gametophyric development 
giving rise to about 80% of the cells becoming mature pollen. Consequently, a simple culture 
system has been developed allowing comparison of in vitro sporophytic and gametophyric 
microspore development 35S Met-labelled proteins were separated on 2-D gels and analysed. 
Most proteins were present under both conditions, but a limited number appeared to be specific 
for the initial phase of embryo induction. Both under embryogenic and non-embryogenic 
conditions a large number of proteins were phosphorylated, but mainly quantitative differences 
were observed. Using Western blotting several isotypes were detected for a- and b-tubulin and 
also for actin. By combining the results of the Western blotting and the 32 Pi labelling, it was 
demonstrated that some of the isotypes of the cytoskeletal proteins were phosphorylated. 
(d) Insrituto de Agronomas y Proteccion Vegetal (IAPV) 
Crosses among Topas and Hanna were carried out. Fl, F2 and backcrosses generations of the 
two reciprocals have been obtained. We also tested the possibility of speeding up the flowering 
cycle of plants under starving conditions at high sowing density. We found that three 
generations could be obtained per year. Three rapid cycling varieties were crossed with Hanna, 
Topas and the low embryogenic response Topas line developing a diallel. The hybrid nature of 
the Fl was tested using electrophoresis (ADH, ACP, LAP, GPI and GPM systems). The 
RAPDs analysis of the different parentals will start in the near future, including the three plant 
clones brought from Koln. These, as the other lines, have been crosses to create SSD families 
for the study of the genetic system controlling somatic microsporogenesis and for relating this 
character with some ADN markers. 
(e)Nickerson International Seed Company 
The technology transfer unit is currently involved in research on anther/microspore culture in 
both mono- and dicotyledonous crop species including barley, maize and vegetable Brassicas. 
A system for the culture of isolated barley microspores (cv. Igri) has been developed whereby 
green plants may be recovered at a high frequency. Transfer of this system to MPI will facilitate 
a comparison of Brassica napus microspores and Hordeum vulgare microspores to identify 
common molecular features of microspore embryogenesis induction in di- and 
monocotyledonous species. 
Highlights/Milestones 
1. Rapid and simple methodology has been developed for creation and screening of cDNA 
libraries. A number of clones associated with induction of microspore embryogenesis have 
been isolated. 
2. Procedures to visualize microtubules in sectioned microspores and microfilaments in whole 
microspores as well as for detection of mRNAs in situ have been established. 
3. A system has been developed for the gametophytic and sporophytic development of 
microspores under in vitro conditions. 
4. The first documentation of the phosphorylation of cytoskeletal proteins in plant cells. 
5. Crosses between various tissue culture responsive and non-responsive Brassica napus 
varieties have been carried out. 
Wider considerations 
The Brassica napus microspore culture system proved to be a very good model to study plant 
embryogenesis. The microspore culture is unique in that it is both a vehicle for the study of 
plant cell proliferation and an important tool for the plant breeder. A programme of research on 
the production of double haploids from microspores has been assigned a high priority in many 
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plant breeding companies since the rapid production of homozygous plants is of major 
commercial value in many crop species. Double haploids would: (a) permit the efficient 
selection of desirable gene combinations and (b) enable new traits to be incorporated into 
product lines or hybrids more quickly. 
Cooperative activities 
Throughout the year a number of meetings were held between the coordinating laboratory 
(MPI) and members of participating laboratories. 
IAPV 
Total of two meetings were held. The April meeting in Cordoba dealt with practical aspects of 
setting up the experimental system for carrying out crossing experiments between low and 
high embryogenic B. napus lines. Theoretical considerations for such experiments were also 
discussed. The second meeting was held in Koln. Dr D. Cabrera visited K61n for three days in 
June to continue discussions on the genetic aspects of microspore embryogenesis and to leam 
microspore in vitro culture. 
Agricultural University 
Total of four meetings were held (three in Wageningen, one in Koln) between January and 
December 1991. The meetings were held to inform the participants about the present state of the 
art in the various laboratories and to coordinate future research activities. 
CPRO-DLO 
Regular meetings were held with project partners at the Department of Plant Cytology and 
Morphology, Agricultural University, Wageningen. Moreover, coordinator Paul Pechan paid 
several visits to the institute. Dr F Corke from the John Innes Research Centre UK (Group 
Keith Roberts) visited CPRO-DLO on 13-14 February 1992 to improve 2-D gel electrophoresis 
of cell wall proteins. 
Meeting of group 5 took place in Koln on November 11-12,1991 
Training in microspore culture was given by the MPI to the laboratories participating. Seeds of 
various inbred lines were provided by the MPI to the participating laboratories. More recently, 
exchange of antibodies and cDNA probes has also taken place. 
Publications 
J.G. Duijs, R.E. Voorrips, D.L. Visser and J.B.M. Custers. Microspore culture is successful 
in most crop types of Brassica oleracea L. Euphytica 1992 (in press). 
J.B.M. Custers, Y. Nollen, J.H.G. Cordewener and R. Busink. Temperature control of 
sporophytic and gametophytic development in microspore culture of Brassica napus L. (In 
preparation.) 
G. Hause, B. Hause and A.A.M. van Lammeren. Microtubular and actin-filament 
configurations during microspore and pollen development in Brassica napus L. cv. Topas. 
Can. J. Bot. 1992 (in press). 
P. Pechan. Heat shock proteins and cell proliferation. FEBS 1991,280:1-4. 
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TITLE: The molecular analysis of higher plant embryogenesis 
CONTRACT NUMBER: BIOT-CT90-0177 (T-project 'Regeneration' Group 4) 
OFFICIAL STARTING DATE: 01 April 1991 
COORDINATOR: S.C. de Vries, AUW, Wageningen, NL 
PARTICIPANTS: 01. T. Hendriks and E.A. Meijer, AUW, Wageningen, NL 
02. H.A. Verhoeven, CPRO, Wageningen, NL 
03. M. Terzi and F. Cozzani, Univ. Padova, Padova, I 
04. K. Roberts and T. Baldwin, JII, Norwich, UK 
06. J.D. Mikkelsen and K.M. Kragh, Maribo, Kopenhagen, DK 
07. S.C. Fry and R. Hetherington, Univ. Edin., Edinburgh, UK 
OBJECTIVES SET FOR THE REPORTING PERIOD: The central themes in 
this project are a.) analysis at molecular and biochemical level of several secreted 
glycoproteins that influence somatic embryogenesis in carrot cultures and b.) analysis of 
molecular markers specific for different stages of embryogenic cell formation in carrot 
cultures. In the first year several objectives have been pursued by each of the participants. 
01/02.: Small scale purification of 32 and 46 kD secreted glycoproteins shown to 
influence somatic embryogenesis, preparation of antibodies and cDNAs for these 
proteins, fluorescence activated flow sorting of single embryogenic cells, functional 
analysis of 32 and 46 kD proteins. 03.: establishment of new complementable and non-
complementable somatic cell mutants. 04.: small and large scale purification of 
arabinogalactans (AGPs) from the culture medium, AGP distribution during somatic and 
zygotic embryogenesis. 06.: large scale purification of 32 and 46 kD proteins, role of PR 
and stress proteins (chitinases and glucanases) in embryogenesis. 07.: biochemical 
analysis of 32,46 kD and other secreted proteins in relation to embryogenesis. 
MAJOR PROBLEMS ENCOUNTERED: None 
RESULTS: 01/02.: Both the 32 and 46 kD secreted glycoproteins have been purified 
to homogeneity and tested for their effects on impaired embryo development in the carrot 
line tsl 1. The 32 kD protein consistently showed rescue activity allowing the formation 
of globular and heart stage embryos at the non-permissive temperature. The effect of the 
46 kD protein, resulting in an increase of the number of embryos obtained in tsl 1, could 
not be reproduced. Both specific antisera as well as partial cDNA clones for these 
proteins have been obtained. The 32 kD protein has been identified as an acidic 
endochitinase, both on the basis of sequence homology and catalytic properties. A 10 kD 
seceted lipid transfer protein, that marks the presence of embryogenic cells in suspension 
cultures, has been purified to homogeneity. The purified protein has been shown to be 
able to transfer fatty acids and phospholipids in vitro. A system to follow the fate of up to 
10,000 individual immobilized carrot suspension cells over a 14 d period has been 
developed. This involved the simultanous testing of new cell-embedding compounds, 
media composition as well as the computer-controlled recording of phase-contrast or 
CSLM images on video tape or on WORM discs. To aid in discriminating between 
actively proliferating and inactive cells, the RNA-specific fluorochrome thiazol-orange 
was succesfully tested as a vital stain for immobilized cells during several days of culture. 
03.: Biological tests have been developed employing various cell lines to evaluate the 
role of secreted glycoproteins on somatic embryogenesis. The results show that 
embryogenic efficiency can be either increased or decreased upon addition of partially 
purified glycoproteins to either wild-type or variant cell lines. New variant lines obtained 
are unable to produce even the earliest embryo stages. All these new lines exhibit a 
greater resistance to auxin when compared with the wild-type lines. For many of these 
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new variant lines, the ability to produce somatic embryos can be acquired by preculture in 
the presence of high concentrations of auxin. In addition, it was shown that auxin 
induces its own binding sites and that this induction was different in embryogenic cells 
when compared to non-embryogenic cells. 04.: An anti-AGP monoclonal antibody, JIM 
8, has been used to map the complex appearance of its cognate oligosaccharide epitope 
during all stages of flower development in both Brassica and Arabidopsis. The same 
antibody labels a complex pattern of stele cells in Arabidopsis roots that includes the 
endodermis. The relationship of these patterns to those revealed by MAC 207 has been 
clarified. A secreted AGP has been irnmunoaffinity-purified to homogeneity in large 
amounts from carrot cell suspension medium and is being used for a.) deglycosylation 
prior to sequencing and antibody production, b.) identification of putative receptor 
molecules in the extracellular matrix and c.) high resolution EM studies and FTTH 
microspectroscopy. 06.: A system for large scale culruring (100 L) of embryogenic cell 
suspensions of carrot in a rotating drum fermentor has been developed. The pattern of 
extracellular proteins from cultures grown in the fermentor and cultures grown in 
Erlenmeyer flasks are very similar and cultures grown in the fermentor retain their 
embryogenic potential. Large scale purification of an acidic 32 kD protein have been 
performed by batch and column anion exchange chromatography, gelfiltration, and 
hydrophobic interaction chromatography. This protein has chitinolytic activity. 
Antibodies raised against the basic sugar beet chitinase 4 crossreact with the acidic 32 kD 
protein. Partial amino acid sequences obtained from tryptic peptides of the 32 kD protein 
show similarity to sequences from the sugar beet chitinase 4 and other chitinases and 
indicate that the 32 kD protein is a chitinase with an N-terminal chitin binding domain. 
07.: The question has been addressed whether the secreted proteins that are active in 
somatic embryogenesis are involved in a process that results in small, adherent cell types, 
either by releasing oligosaccharides that are biologically active, or by causing direct 
physical changes in the cell walls. Conversely, cell wall enzymes that would loosen the 
ceU wall by hydrolysis of wall polymers would be expected to antagonize the formation 
of small adherent cell types. One of these enzymes is xyloglucan endotransglycosilase 
(XET) that was found to be present in carrot culture media. The enzyme activity was 
shown to decrease during the first four days of somatic embryogenesis. Both the 32 and 
46 kD as well as a previously purified 52/54 kd secreted glycoprotein did not have XET 
activity. The seceted protein exhibiting high XET activity is now being purified to 
homogeneity. None of the proteins purified sofar (32,46 and 52/54 kD proteins) did 
release measurable amounts of oligosaccharides from preparations of random 
radiolabeled cell walls. These experiments are currently being repeated with cell walls 
labeled with specific sugars. On the basis of these findings it is likely that the secreted 
proteins active in somatic embryogenesis cause direct changes in the cell walls, rather 
then releasing biologically active oligosaccharides. 
HIGHLIGHTS/MILESTONES: 01/02. Biochemical identification of the 32 kD 
secreted protein able to rescue tsl 1 somatic embryogenesis as an acidic endochitinase, 
establishment of regeneration system starting from single cells. 03. Use of high levels of 
auxin shown to initiate embryogenic potential in otherwise non-embryogenic cell lines. 
04.: Pure AGP produced in large quantities and shape determined by electron 
microscopy. 06.: Culruring of up to 100 L of embryogenic cell suspension cultures in a 
fermentor allowing large scale purifications of extracellular proteins involved in 
embryogenesis and AGPs. 07.: Detection of high amounts of XET activity in 
conditioned media. 
WIDER CONSIDERATIONS: The aim of this research project is twofold, to obtain 
and characterize molecular markers specific for different stages of the acquisition of 
embryogenic potential in plant cell suspension cultures, and to identify and characterize 
compounds that promote the formation of somatic embryos in plant cell suspension 
cultures. As a model system somatic embryogenesis in carrot is employed in which the 
focus of interest is on compounds secreted into the culture medium. This approach has 
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yielded non-destructive molecular markers for embryogenic potential and also purified 
compounds that promote somatic embryogenesis after addition to the culture medium. In 
addition, procedures have been developed to increase embryogenic potential in 
suspension cultures. Significant progress has been made in all areas of the project and 
most of the objectives set for the first year have either been achieved or have exceeded the 
expectations. This is strikingly illustrated by the very rapid establishment of a large scale 
culturing system in the laboratory of the industrial partner (06). The purification of not 
only glycoproteins but also of AGPs in the amounts necessary for meaningful 
experiments has been a major step forward and is of great benefit to all participants of the 
project. A characteristic feature of this project is the unusually high level of mutual 
interactions that have resulted in numerous joint and complementary experiments. It is 
clear that this is a direct result of the transnational collaborations that would be very 
difficult to maintain without the continued support of the EC. 
COOPERATIVE ACTIVITIES: General activities: A meeting of Group 4 was held 
in Wageningen in May 1991, a general meeting as well as the second Group 4 meeting 
were held in Dourdan in November 1991. Specific activities: Working discussions have 
been held between participants 01 and 06 in May 1991 and in March 1992 and also 
between 04 and 06. A technician of 01 has been to 04 for training in 
immunolocalization of proteins. There have been numerous and regular exchanges of cell 
lines, cDNA libraries, crude and partially purified culture media, specific mono-and 
polyclonal antibodies, cDNA clones, purified secreted proteins, purified cell wall 
fragments as well as experimental protocols between all participants. 
LIST OF JOINT PUBLICATIONS/PATENTS WITH TRANSNATIONAL 
AUTHORSHIP: 
De Jong, A.J., Cordewener, J.H.C., Lo Schiavo, F., Terzi, M., Vandekerckhove, J., 
van Kammen, A., de Vries, S.C. (1992) A carrot somatic embryo mutant is 
rescued by chitinase. Plant Cell (in press) 
OTHER PUBLICATIONS/PATENTS: 
Filippini, F., Terzi, M., Cozzani, F., Lo Schiavo, F. (1992) Modulation of auxin-
binding proteins in cell suspensions. U. Isolation and initial characterization of 
carrot cell variants impaired in somatic embryogenesis. TAG (in press) 
Fry, S.C, Smith, R.C., Renwick, K.F., Martin, D.J., Hodge, S.K., Metthews, KJ . 
(1992) Xyloglucan endotransglycosylase, a new wall-loosening enzyme activity 
from plants. Biochem. J. (in press) 
Knox, J.P., Linstead, P.J., Peart, J., Cooper, C , Roberts, K. (1991) Developmentally 
regulated epitopes of cell surface arabinogalactan proteins and their relation to root 
tissue pattern formation. Plant J. 1, 317-326 
Lo Schiavo, F., Filippini, F., Cozzani, F., Vallone, D., Terzi, M. (1991) Modulation of 
auxin-binding proteins in cell suspensions. I. Differential responses of carrot 
embryo cultures. Plant Physiol. 97, 60-64 
Pennell, R.I., Janniche, L., Kjellbom, P., Scofield, G.N., Peart, J.M., Roberts, K. 
(1991) Developmental regulation of a plasma membrane arabinogalactan protein 
epitope in oilseed rape flowers. Plant Cell 3, 1317-1326 
Smith, R.C., Fry, S.C. (1991) Endotransglycosylation of xyloglucans in plant cell 
suspension cultures. Biochem. J. 279, 529-535 
Sterk, P., Booij, H., Schellekens, G.A., van Kammen, A., de Vries, S.C. 
(1991) Expression pattern of the carrot EP2 gene encoding an extracellular 
lipid transfer protein. Plant Cell 3, 907-921 
Van Engelen, F.A., De Vries, S.C. (1992) Extracellular proteins in plant embryogenesis. 
Trends in Genet. 8, 66-70 
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TITLE: Plant Growth Regulators: perception, 
interaction and response. 
CONTRACT NUMBER: BIOT-CT90-0158 
OFFICIAL STARTING DATE: 01.02.1991 
COORDINATOR: Professor M A Hall, UCW Aberystwyth, UK. 
PARTICIPANTS: Professor K R Libbenga, Univ. of Leiden Professor D Klambt, Univ. of Bonn Professor P Aducci, Univ. of Rome 'Tor Vergata' Dr A Hoekema, Mogen International NV 
OBJECTIVES SET FOR THE REPORTING PERIOD: The objectives set involved progress in the following with the emphasis on items 1 to 3. 1. Isolation and characterisation of gene(s) for ABP. 2. Isolation and characterisation of gene(s) for EBP. 3. Isolation and characterisation of gene for FCBP. 4. Separation of components of transduction chains. 5. Development of protoplast systems to test functionality and testing of components. 6. Development of in vitro reconstitution systems to test functionality and testing of components. 
MAJOR PROBLEMS ENCOUNTERED: Difficulties in obtaining sufficient solubilized membrane-bound ABP in an active form from tobacco. Similar problems with putative transduction proteins integral to the plasmalemma. N-terminal blockage of protein preparations. Strategies are being developed to solve those problems by means of new methods for the separation of hydrophobic integral membrane proteins and a method to analyse C-terminal residues of polypeptides. 
RESULTS: In Leiden, several genes encoding ABP-like proteins have been isolated from rice and are currently under investigation. Tobacco protoplasts from a transgenic cell line have been used to investigate the role of membrane-bound factors involved in signal transduction using antibodies from Bonn and from Dr M A Venis. Anti-binding site antibodies blocked NAA-induced gene expression in the protoplasts. Promoter-GUS fusions have been used to investigate the promoters of auxin-induced genes and have led to the identification of a region important for auxin-induced and root tip specific expression. 
In Bonn, studies have centred on attempts to detect ABP at the plasmamembrane. The use of two phase separation of membranes or additional free flow electrophoresis has demonstrated the association of ABP with plasmamembrane, perhaps via a disulphide link. Iodinated ABP binds to microsomes and plasmamembrane vesicles but not to those from the endomembrane system. Auxin has been shown to modulate the secretion of ot-amylase by exocytosis. 
In Rome, the FCBP has been successfully isolated and its 
-471 -
structural analysis is in progress at Mogen where the 
development of techniques for C-terminal analysis is likely 
to prove most useful. There is now preliminary evidence 
regarding the structure of an endogenous ligand suppressing 
FC-stimulated H + extrusion. Progress with reconstituted 
systems has shown that the response of such systems is 
specific to FC which does not alter the 1^ of the H+-ATPase 
but rather the VmaJ£. There is evidence for the involvement 
of the phosphoinositide cycle in signal transduction vis a 
vis fusicoccin. 
In Aberystwyth, a new electrophoretic method for the 
separation of hydrophobic proteins has been developed. 
Using this technique, samples of the EBP have been sent to 
Mogen and preliminary N-terminal sequences of subunits 
obtained. There is no homology with any known protein. 
Studies on protein kinases indicate that ethylene may 
modulate the phosphorylation of its own receptor which in 
turn appears to modulate the affinity of the receptor for 
ethylene. 
There have been frequent meetings to discuss progress 
in the various laboratories and, as noted in other sections, 
considerable exchange of tools and personnel. In particular 
the progress made on sequencing the EBP and the FCBP could 
not have been achieved in anything like the timescale 
without the wholehearted cooperation of the partners 
involved. 
HIGHLIGHTS/MILESTONES: 
1. Partial sequence of subunits of EBP. 
2. Progress with sequencing of FCBP. 
3. Development of patch-clamp technique to investigate 
transduction mechanisms; characterisation of inward and 
outward directed K + channels in tobacco protoplasts. 
4. Initial characterisation of involvement of protein 
kinase activity in transduction of the ethylene signal. 
5. Detection of ABP at the plasmamembrane. 
6. Demonstration that exocytosis by non-growing cells is 
mediated by auxin. 
7. Possible involvement of phosphoinositide signalling 
pathway in transduction of the fusicoccin effect. 
WIDER CONSIDERATIONS: 
The progress being made in the elucidation of the perception 
and transduction pathways does render feasible the 
production of transgenic crop plants improved in a number of 
characteristics. 
COOPERATIVE ACTIVITIES: 
a) Within group: EBP, FCBP to Mogen; anti-EBP antibodies 
to Leiden; anti-ABP antibodies from Bonn to Leiden. 
b) With other groups within T-project: Impermeable auxin-
conjugates from M A Venis to Bonn; anti-ABP antibodies from 
M A Venis to Aberystwyth, Leiden and Bonn. 
c) With other groups in EC programmes: Group of M van 
Montagu (Dr D v.d. Straeten) - screening (by Aberystwyth) of 
ethylene insensitive mutants for ethylene binding. 
Dr N V J Harpham from Aberystwyth is spending a year in 
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Leiden (in collaboration with the Institute of Molecular 
Plant Sciences and Mogen International NV) for the purpose 
of cloning the EBP gene. 
Visit by Dr E.J. v.d. Zaal to Aberystwyth to discuss 
protein purification. 
- Two day meeting in Leiden immediately prior to beginning 
of contract (December 1990) involving all contractors and 
associated personnel as well as the group of H. Barbier-
Brygoo. 
- Meeting of whole T-group at Dourdan (November 1991). 
- Meeting of N-group in Rome (May 2 to 5 1992) involving all 
contractors and associated personnel and also the groups of 
P. Constantino, M. Terzi and other interested parties. 
- Meeting between the Lei.den and Bonn participants and the 
group of Professor J Guern at Gif-sur-Yvette (Nov 15 1991). 
In accordance with the original agreement there has been 
considerable interaction with other groups in the T-project 
particularly that coordinated by K Palme, both in the 
exchange of appropriate tools, cooperative activities and 
joint meetings. 
JOINT PUBLICATIONS: 
A M Mennes, A Maan £. M A Hall (1991) In: Cell to Cell 
Signals in Plants and Animals: Progress Report (eds. V 
Neuhoff & J Friend), NATO/ASI Series H: Cell Biology, Vol. 
51, pp. 301-314. Springer/Verlag. 
H Barbier-Brygoo, G Ephritikhine, D Klambt, C Maurel, K 
Palme, J Schell & J Guern (1991) The Plant Journal 1, 83-93. 
OTHER SELECTED PUBLICATIONS: 
I O Sanders, A R Smith & M A Hall (1991) Planta 183, 
209-217. 
N V J Harpham, A W Berry, E M Knee, G Roveda-Hoyos, I 
Raskin, I O Sanders, A R Smith, C K Wood and Hall, M A 
(1991) Annals of Botany 68, 55-61. 
I O Sanders, N V J Harpham, I Raskin, A R Smith and M A 
Hall (1991) Annals of Botany 68, 97-104. 
D Klambt, B Knauth, I Dittman (1992) Physiol. Plant., 
submitted. 
D. Klambt (1992) Planta, submitted. 
P Aducci, A Ballio, M R Fullone & M Marra (1992) In: 
"Biochemical mechanisms involved in growth regulation", Smith, CJ, 
ed., Oxford University Press, in press. 
P Aducci, A Ballio, V Fogliano, M R Fullone, M Marra & D 
Verzili (1992) In: "Transport and receptor proteins of 
plant membranes", Clarkson, D.T. & Cooke,. r.T., eds., Plenum 
Publishing Corp., in press. 
M Marra, A Ballio, M R Fullone & P Aducci (1992) Plant 
Physiology, in press. 
E J van der Zaal, F N J Droog, C J M Boot, L A M 
Hensgens, J H C Hoge, R A Schilperoort & K R Libbenga (1991) 
Plant Mol. Biol. 16, 983-998. 
A M Mennes, A Quint, J H Gribnau, C J M Boot, E J van der 
Zaal, A C Maan & K R Libbenga (1992) Plant Mol. Biol. 18, 
109-117. 
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ASH ROAD, PIRBRIGHT 
UK GU24 ONF WOKING, SURREY 
Tel.: 44483232441 
Telex: 44483232448 
Fax: 859137 AVRI G 
DR. J.-P. BELTRAN PORTER 
INVESTIGADOR CIENTIFICO 
INST. DE AGROQUIMICA Y TECNOLOGIA DE 
AUMENTOS 
CS.I.C. 
JAIME ROIG 11 
E 46010 VALENCIA 
Tel.: 3463690800 
Telex: 64 197 AYTVE 
Fax: 3463930001 
E-mail: BIOVEG@IATA.CSIC.ES 
PROF. J. BENNEDSEN 
HEAD OF DEPARTMENT 
STATENS SERUMINSTITUT 
ARTILLERIVEI 5 
DK 2300 S COPENHAGEN 
Tel.: 45319528172701 
Telex: 4531952869 
E-mail: TELECOM GOLD 10075:DBI0706 
DR. K BERGEMANN 
STAFF SCIENTIST 
ABT. BIOTECHNISCHE PRODUKTION 
DR. KARL THOMAE GMBH 
BIRKENDORFER STRASSE 65 
D 7950 BIBERACH 
Tel.: 497351544836 
Telex: 497351542167 
DR. J.E. BERINGER 
HEAD OF BOTANY DEPARTMENT 
BOTANY DEPARTMENT 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF BRISTOL 
WOODLAND ROAD 
UK BS8 1UG BRISTOL 
Tel.: 44272303759 
Telex: 44272732657 
Fax: 445938 BSUNTV G 
DR. M. BEVAN 
SENIOR SCIENTIFIC OFFICER 
AFRC INSTITUTE OF PLANT SCIENCE RESEAR 
CAMBRIDGE LABORATORY 
JOHN INNES CENTRE 
COLNEY 
UK NR4 7UJ NORWICH 
Tel.: 4460352571 
Telex: 44603502270 
Fax: 975122 JIINOR G 
DR. M.E. BIANCHI 
ASSOCIATE PROFESSOR 
DIPARTIMENTO DI GENETICA E 
MICROBIOLOG 
UNIVERSITA DEGLI STUDI DI PAVIA 
SANT'EPIFANIO 14 
I 27100 PAVIA 
Tel.: 39382303016 
Telex: 3938232234 
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PROF. D. BITTER-SUERMANN 
FULL PROFESSOR 
INSTITUT FUER MEDIZINISCHE 
MIKROBIOLOG 
MEDIZINISCHE HOCHSCHULE HANNOVER 
KONSTANTY-GUTSCHOW-STRASSE 8 
D 3000 HANNOVER 
Tel.: 495115324369 
Telex: 495115324366 
DR. D.N. BLACK 
GROUP LEADER 
INSTITUTE FOR ANIMAL HEALTH 
PIRBRIGHT LABORATORY 
ASH ROAD 
UK GU24 ONF WOKING, SURREY 
Tel.: 44232141 
Telex: 44212448 
Fax: 859137 AVRI G 
E-mail: BLACK@1UKACAFRC.AVRI 
PROF. C. BLANCO 
PROFESSOR 
CNRS -URA LSG - LABORATOIRE DE GENETIQ 
PHYSIOLOGIE MICROBIENNE 
UNIVERSITE DE RENNES 
CAMPUS DE BEAULIEU 
UFR SVE AVENUE DU GENERAL LECLERC 
F 35042 RENNES 0 4 2 
Tel.: 3399286140 
Telex: 3399286700 
DR. A. BI.EASBY 
SEQNET MANAGER 
DARESBURY LABORATORY 
SCIENCE AND ENGINEERING RESEARCH 
COUNC 
DARESBURY 
UK WA4 4AD WARRINGTON 
Tel.: 44925603348 
Telex: 44925603100 
E-mail: AJB(rfDLVH.DARESBURY.AC.UK 
DR. H. BLOECKER 
HEAD OF RESEARCH GROUP 
DNA-SYNTHESE 
GBF - GESELLSCHAFT FUER 
BIOTECHNOLOGIS 
FORSCHUNG MBH 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181220 
Telex: 495316181292 
Fax: 952667 GEBIO D 
E-mail: BLOECKER@VENUS.GBF-
BRAUNSCHWEIG.DBP.DE 
PROF. K. BOCK 
PROF/HEAD OF DEPT. 
CARLSBERG LABORATORY 
G A M L E C A R L S B E R G V E J 1 0 
D K 2 5 0 0 V A L B Y - C O P E N H A G E N 
Tel.: 45312210225221 
Telex: 4531211366 
E-mail: CARLKEM@NEUVM1 
DR. L. BOE 
ASSISTANT PROFESSOR 
DEPARTMENT OF MICROBIOLOGY 
TECHNICAL UNIVERSITY OF DENMARK 
BUILDING 221 
DK 2800 LYNGBY 
Tel.: 45428840663506 
Telex: 4545932809 
Fax: 37529 DTHDIADK 
DR. P. BOISTARD 
DIRECTOR OF THE LABORATORY 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
DE 
RELATIONS PLANTES-MICROORGANISMES 
CNRS-INRA 
BP27 
F 31326 CASTANET TOLOSAN CEDEX 
Tel.: 3361285046 
Telex: 3361285061 
Fax: 520009 
E-mail: COLLEC@TOULOUSE.INRA.FR 
DR. M. BOLOTIN 
INSTITUT DE GENETIQUE ET 
MICROBIOLOGIE 
URA 1354 CNRS 
UNIVERSITE DE PARIS-SUD 
BATIMENT 400 
F 91405 ORSAY CEDEX 
Tel.: 33169416206 
Telex: 33169417296 
DR. U. BONAS 
STAFF SCIENTIST 
INSTITUT FUER GENBIOLOGISCHE 
FORSCHUNG 
IHNESTRASSE 63 
D 1000 BERLIN 33 
Tel.: 493083000783 
Telex: 493083000736 
DR. C.Y. BOQUIEN 
JUNIOR SCIENTIST 
LABORATOIRE DE GENIE DES PROCEDES 
BIOTECHNOLOGIQUES AGRO-AUMENTAIRES 
F 78850 THIVERVAL GRIGNON 
Tel.: 33130815353 
Telex: 33130815457 
Fax: 697388 
DR. J. BOS 
SENIOR LECTURER 
DEPARTMENT OF DERMATOLOGY 
UNIVERSITEIT VAN AMSTERDAM 
ACADEMISCH MEDISCH CENTRUM 
MEIBERGDREEF 9 
NL 1105 AZ AMSTERDAM 
Tel.: 31205662587 
Telex: 31205664440 
DR. A A BOSMA 
ASSISTENT-PROFESSOR (UNIVERSITAIR HOOF 
DEPARTMENT OF FUNCTIONAL 
MORPHOLOGY 
FACULTY OF VETERINARY MEDICINE 
RUKS UNIVERSITEIT UTRECHT 
P.O. BOX 80.157 
NL 3508 TD UTRECHT 
Tel.: 3130534336 
Telex: 3130516863 
PROF. V. BOTTAZZI 
FULL PROFESSOR 
ISTITUTO DI MICROBIOLOGIA 
FACOLTA DI AGRARIA 
UNIVERSITA DEL SACRO CUORE 
EMILIA PARMENSE 84 
I 29100 PIACENZA 
Tel.: 3952368275 
Telex: 3952365205 
E-mail: MICROB(a'IPCUCSC3ITNET 
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DR. C. BOUCHER 
DIRECTEUR DE RECHERCHE 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
DE 
RELATIONS PLANTES-MICROORGANISMES 
CENTRE DE RECHERCHES INRA 
BP27 
F 31326 CASTANET TOLOSAN CEDEX 
Tel.: 3361285028 
Telex: 3361285280 
Fax: 520009 F 
DR. A. BRADBURY 
HEAD OF PROJECT 
SEZIONE BIOTECHNOLOGIE 
SOCIETA ITALIANA PER LA RICERCA SCIENT 
GIOVANNI PAISIELLO 47/C 
I 00198 ROMA 
Tel.: 3968442224 
Telex: 3968442579 
DR. B. BRAEU 
SCIENTIST 
HOECHST AG 
BRUENINGSTRASSE 50 
POSTFACH 80 03 20 
D 6230 FRANKFURT/MAIN 80 
Tel.: 49693056447 
Telex: 4969331320 
Fax: 41234-OHO D 
DR. G.M. BRESSAN 
TBC 
INSTITUTE OF HISTOLOGY AND 
EMBRYOLOGY 
UNIVERSITY OF PADOVA 
VIA TRIESTE 25 75 
I 35100 PADOVA 
Tel.: 39498286613 
Telex: 39498072213 
DR. S.WJ. BRIGHT 
RESEARCH MANAGER 
JEALOTT'S HILL RESEARCH STATION 
I d SEEDS 
WAREFIELD 
UK RGI2 6EY BRACKNELL 
Tel.: 44344424701/4821 
Telex: 44344434996 
Fax: 847556 ICIPPJG 
DR. S. BRON 
ASSISTANT PROFESSOR 
DEPARTMENT OF GENETICS 
UNIVERSITY OF GRONINGEN 
KERKLAAN30 
NL 9751 NN HAREN 
Tel.: 3150632105 
Telex: 3150635205 
E-mail: BRON@HGRRUG52 
PROF. G.G. BROWNLEE 
PROFESSOR OF CHEMICAL PATHOLOGY 
CHEMICAL PATHOLOGY UNIT 
SIR WILLIAM DUNN SCHOOL OF PATHOLOGY 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
UK OX1 3RE OXFORD 
Tel.: 44865275559 
Telex: 44865275556 
DR. A. BRUNEL 
DIRECTION DU DEVELOPPEMENT 
SEPIA INTERNATIONAL 
ECLOSERIE MARINE DE GRAVEUNES 
VOIE DES ENROCHEMENTS 
F 59820 GRAVELINES 
Tel.: 3328655151 
Telex: 33130579745 
Fax: 6990734 
DR. Y. BRYGOO 
DIRECTEUR DE RECHERCHES 
CRYPTOGAMIE, INRA 
UNIVERSITE PARIS-SUD 
BAT. 400 
F 91405 ORSAY 
Tel.: A3316169417006 
Telex: 3316169417296 
Fax: 602166 F 
E-mail: LAFAY@FRCITI513rrNET 
PROF. O. BUCHARDT 
PROFESSOR 
H.C. OERSTED INSTITUTE 
UNIVERSITY OF COPENHAGEN 
UNIVERSITETSPARKEN 5 
DK 2100 COPENHAGEN 
Tel.: 4531353133 
Telex: 4531350766 
IR. A.F. BUECKMANN 
SENIOR SCIENTIST 
DEPARTMENT OF ENZYME TECHNOLOGY 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181307 
Telex: 495316181302 
E-mail: ABU@VENUS.GBF-
BRAUNSCHWEIG.DBP.DE 
DR. J.-M. BUHLER 
LABORATOIRE DTNGENIERIE DES 
PROTEINES 
CENTRE D'ETUDES NUCLEAIRES DE SACLAY 
COMMISARIAT A L'ENERGIE ATOMIQUE 
F 91191 GIF-SUR-YVETTE CEDEX 
Tel.: 33169086418 
Telex: 33169084712 
PROF. M. BUIATTI 
FULL PROFESSOR OF GENETICS 
DIPARTIMENTO DI BIOLOGIE ANIMALE 
E GENETICA 
UNIVERSIAT DEGLI STUDI DI FIRENZE 
VIA ROMANA 17 
I 50125 FIRENZE 
Tel.: 3955229453 
Telex: 3955222565 
PROF. H. BUJARD 
PROFESSOR 
ZENTRUM FUER MOLEKULARE BIOLOGIE 
(ZMBH 
UNIVERSITAET HEIDELBERG 
IM NEUENHEIMER FELD 282 
D 6900 HEIDELBERG 
Tel.: 496221566800 
Telex: 496221565507 
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DR. J. BULLERDIEK 
HEAD OF LABORATORY 
CENTER FOR HUMAN GENETICS 
UNIVERSITY OF BREMEN 
LEOBENER STRASSE ZHO 
D MOO BREMEN 33 
Tel.: 494212183589 
Telex: 494212184039 
DR. M. CABOCHE 
DIRECTEUR DE RECHERCHES 
LABORATOIRE DE BIOLOGIE CELLULAIRE 
INST. NATIONAL DE LA RECHERCHE 
AGRONOM 
ROUTE DE SAINT CYR 
F 78026 VERSAILLES 
Tel.: 33130833017 
Telex: 33130833111 
PROF. J. CABRAL 
ASSOCIATE PROFESSOR 
SECTION OF BIOTECHNOLOGY 
DEPT. OF CHEMICAL ENGINEERING 
INSTITUTO SUPERIOR TECNICO 
AVENIDA ROVISCO PAIS 
P 1000 LISBOA 10% 
Tel.: 3511802045/1233 
Telex: 35118480072 
Fax: 63423 ISTUTL P 
DR. C.-M. CALBERG-BACQ 
CHEF DE TRAVAUX 
DEPARTEMENT DE MICROBIOLOGIE 
UNITE DE VIROLOGIE FONDAMENTALE ET 
IMM 
UNIVERSITE DE LIEGE 
INSTITUT DE PATHOLOGIE B23 
SART-TILMAN 
B 4000 LIEGE 
Tel.: 3241562451 
Telex: 3241562433 
PROF. J.A. CALLOW 
PROFESSOR 
UNIVERSITY OF BIRMINGHAM 
P.O. BOX 363 
UK B15 2TT BIRMINGHAM 
Tel.: 01044214145559 
Telex: 0214145925 
Fax: SPAPHY G 338938 
DR. CHR CAMBILLAU 
CHARGE DE RECHERCHES 
LABORATOIRE DE CRISTALLOGRAPHIE ET 
CRISTALLISATION DES MACROMOLECULES 
BIOLOGIQUES / CNRS 
BD PIERRE DRAMARD 
FAC. DE MEDICINE NORD 
F 13326 MARSEILLE 15 
Tel.: 3391698908 
Telex: 3391698913 
DR. G.N. CAMERON 
HEAD OF DATA LIBRARY 
DATA UBRARY 
EUROPEAN MOLECULAR BIOLOGY 
LABORATORY 
MEYERHOFSTRASSE 1 
D 6900 HEIDELBERG 
TcL: 496221387257 
Telex: 496221387306 
Fax: 461613 EMBL D 
E-mail: CAMERON@EMBL-HEIDELBERG.DE 
DR. J.M. CARAZO 
CHIEF OF BIOCOMPUTING UNIT. SCIENTIST 
UNIDAD DE BIOCOMPUTACION 
CENTRO NACIONAL DE BIOTECNOLOGIA 
UNIVERSIDAD AUTONOMA DE MADRID 
E 28049 MADRID 
Tel.: 3413978430 
Telex: 3413974799 
E-mail: CARAZO(»EMDCCIll.BITNET 
DR. M. CARILLO 
INVESTIGADOR CIENTIFICO DEL CSIC 
INSTITUTO DE ACUICULTURA DE TORRE 
DE L 
CS.I.C. 
RIBERA DE CABANES 
E 12595 TORRE DE LA SAL 
Tel.: 3464310325 
Telex: 3464310350 
Fax: 42182 
DR. RJ. CARR 
ASSISTANT HEAD OF GROUP 
CENTRE FOR APPLIED MICROBIOLOGY & 
RESE 
PORTON DOWN 
UK SP4 OJG SALISBURY, WILTSHIRE 
Tel.: 44980610391 
Telex: 44980611320 
PROF. MJ. CARRONDO 
ASSOCIATE PROFESSOR/DIRECTOR OF THE 
LA 
INSTITUTO DE BIOLOGIA EXPERIMENTAL 
E TECNOLOGICA (IBET) 
APARTADO 12 
P 2780 OEIRAS 
Tel.: 35114427787 
Telex: 35114421161 
DR. J.I. CASAL 
IMMUNOLOGIA Y GENETICA APUCADA S.A. 
MOLECULAR BIOLOGY UNIT (INGENASA) 
HERMANOS GARCIA NOBLEJAS 41 
E 2S037 MADRID 
Tel.: 3412680501 / 3412680 
Telex: 3414087598 
PROF. A. CATTANEO 
FULL PROFESSOR 
ISTITUTO SISTEMI INTELLIGENTI 
ISAS 
STRADA COSTIERA 11 
I 34014 TRIESTE 
Tel.: 394022491 
Telex: 39402249249 
Fax: 460269 SISSA 
E-mail: CATTANEO@ITSSISSA 
PROF. E. CERNIA 
CTB PRESIDENT 
CONSORZIO PER IL TRASFERIMENTO 
DELLE BIOTECHNOLOGIE 
VIA SARDEGNA 38 
I 00187 ROMA 
Tel.: 396485451 
Telex: 3964885614 
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DR. F. CERVONE 
ASSOCIATE PROFESSOR 
LABORATORIO DI FISIOLOGIA VEGETALE 
DIPT. DI BIOLOGIA VEGETALE 
UNIVERSITA DI ROMA TA SAPIENZA' 
PIAZZA ALDO MORO 5 
I 00185 ROMA 
Tel.: 39649912641 
Telex: 396463865 
PROF. G. CESARENI 
PROFESSOR OF MOLECULAR GENETICS 
LABORATORIO DI GENETICA MOLECOLARE 
DIPARTIMENTO DI BIOLOGIA II 
UNIVERSITA DI ROMA TORVERGATA 
VIA CARNEVALE 
LA ROMANINA 
I 00173 ROMA 
Tel.: 39679794315 
Telex: 3962023500 
Fax: 626382 FIUNTVI 
E-mail: CESARENI@VAXBTV.INFN.IT 
DR. J. CHAMBAZ 
MAITRE DE CONFERENCES DES UNIVERSITES 
LAB. DE BIOCHIMIE 
FAC. MEDECINE SAINT-ANTOINE 
UNIVERSITE PIERRE ET MARIE CURIE 
CHALIGNY 27 
F 75012 PARIS CEDEX 
Tel.: 33140011341 
Telex: 33143453687 
DR. G. CHARALAMBOS 
RESEARCH SCIENTIST 
DEVELOPMENT & TECHNOLOGY TRANSFER 
OPTIMUM LTD. RESEARCH 
ARISTOTELOUS STREET 177 
GR 11251 ATHENS 
Tel.: 3018670234 
Telex: 3018677747 
MR. M. CHAUVET 
SECRETARY GENERAI, BRG 
BUREAU DES RESSOURCES GENETIQUES 
(BRG) 
RUE CUVIER 57 
F 75231 PARIS CEDEX 05 
Tel.: 33147071575 
Telex: 33145357015 
Fax: FFSPN 260921 F 
DR. DJ. CHISWELL 
HEAD OF R&D, GENERAL MANAGER AND 
CHIEF 
CAMBRIDGE ANTIBODY TECHNOLOGY 
LIMITED 
THE DALY RESEARCH LABORATORIES 
BABRAHAM HALL 
UK CB2 4AT CAMBRIDGE 
Tel.: 44223837526 
Telex: 44223837524 
DR. M.-C CHOPIN 
DIRECTEUR DE RECHERCHE 
LABORATOIRE DE GENETIQUE 
MICROBIENNE 
INRA 
DOMAINE DE VILVERT 
F 78352 JOUY EN JOSAS CEDEX 
Tel.: 33134652530 
Telex: 33134652273 
E-mail: ACHOPIN@BIOTECJOUY.INRA.FR 
DR. D. CHOURROUT 
CHARGE DE RECHERCHES, INRA 
DIRECTEUR D 
LABORATOIRE DE GENETIQUE DES POISSONS 
INRA 
DOMAINE DE VILVERT 
F 78352 JOUY-EN-JOSAS 
Tel.: 33134652391 
Telex: 33134652390 
Fax: INRACRZ695431F 
PROF. D. CHRIQUI 
PROFESSOR 
UNIVERSITY PIERRE AND MARIE CURIE 
PLACE JUSSIEU 4 
BAT. N2 
F 75252 PARIS 
Tel.: 33144274583 
Telex: 33144273866 
DR. C. CHRISTIANSEN 
MANAGING DIRECTOR 
MOLECULAR BIOTECHNOLOGY SECTION 
BIOTECHNOLOGICAL INSTITUTE 
BUILDING 227 
LUNDTOFTEVEJ 100 
P.O. BOX 199 
DK 2800 LYNGBY 
Tel.: 4545876699 
Telex: 4545932888 
DR. G. CILIBERTO 
PROJECT LEADER 
ISTITUTO DI RICERCHE DI BIOLOGIA MOLEC 
MERCK, SHARP AND DOHME RESEARCH 
VIA PONTINA 
KM 30,600 
I 00040 POMEZIA (ROMA) 
Tel.: 3963125530 
DR. D. CLAUS 
HEAD OF THE INFORMATION CENTRE 
INFORMATION CENTRE FOR EUROPEAN 
CULTUR 
COLLECTIONS (ICECC) 
MASCHERODER WEG IB 
D 3300 BRAUNSCHWEIG 
Tel.: 49531618715/22 
Telex: 49531618718 
E-mail: TELECOM GOLD 10075:DBI0274 
DR. A. CLOAREC 
DIRECTOR OF THE BIOLOGY DEPARTMENT 
DEPT. OF BIOLOGY 
LABORATORIES UPSA 
DANTON 128 
F 92500 RUEIL-MALMAISON 
Tel.: 33147490500 
Telex: 33147516879 
Fax: 203269 
PROF. M. CLYNES 
PROFESSOR OF BIOTECHNOLOGY/DIRECTOR 
NA 
NATIONAL CELL AND TISSUE CULTURE 
CENTR 
SCHOOL OF BIOLOGICAL SCIENCES 
DUBLIN CITY UNIVERSITY 
GLASNEVIN 
IRL 9 DUBLIN 
Tel.: 35317045720 
Telex: 35317045484 
Fax: 353130690 
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DR. D. COCCO 
PROFESSOR OF BIOCHEMISTRY 
UNIVERSITY OF CAGUARI 
VIA DELLA PINETA 77 
I 09125 CAGUARI 
Tel.: 3970300728 
DR. ES. COEN 
SENIOR SCIENTIFIC OFFICER 
JOHN INNES INSTITUTE 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Telex: 4460356844 
Fax: 975122 JII NOR G 
DR. T.M. COGAN 
HEAD, DAIRY MICROBIOLOGY DEPARTMENT. 
TEAGASC 
MOOREPARK 
FERMOY 
IRL CO. CORK 
Tel.: 3532531422 EXT. 227 
Telex: 3532532563 
Fax: 75020 IE 
DR. M.A. COLLINS 
LECTURER 
DEPARTMENT OF FOOD MICROBIOLOGY 
THE QUEEN'S UNIVERSITY OF BELFAST 
NEWFORGE LANE 
UK BT9 5PX BELFAST 
Tel.: 44232661166 EXT. 231 
Telex: 44232669551 
Fax: QUBADM 74487 
DR. M.D. COLLINS 
HEAD, MOLECULAR BIOLOGY SECTION 
DEPARTMENT OF MICROBIOLOGY 
READING LABORATORY 
AFRC INSTITUTE OF FOOD RESEARCH 
SHINFIELD 
UK RG2 9AT READING 
Tel.: 447348831032225 
Telex: 44734884763 
PROF. L. COLOMBO 
FULL PROFESSOR OF COMPARATIVE 
ENDOCRIN 
DEPARTMENT OF BIOLOGY 
LABORATORY OF COMPARATIVE 
ENDOCRINOLOG 
UNIVERSITY OF PADOVA 
VIA TRIESTE 75 
I 35121 PADOVA 
Tbl.: 390498286114 
Telex: 39498286100 
E-mail: BIOCOUa}UNIPAD.UNIPD.IT 
PROF. C. COLSON 
LECTURER 
LABORATOIRE DE GENETIQUE 
MICROBIENNE ( 
UNIVERSITE CATHOLIQUE DE LOUVAIN 
PLACE CROIX DU SUD 4 
B 1348 LOUVAIN-LA-NEUVE 
Tbl.: 3210473483 
Tblcx: 3210473109 
Fax: 59037 UCL-B 
E-mail: COLSON@BUCLLNll 
DR. HS. CONRADT 
TBC 
DEPARTMENT OF GENETICS 
PROJECT GROUP "PROTEIN GLYCOSYLATION-
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181212/219 
Ttlcx: 495316181202 
Fax: 952668 GEBIO D 
DR. HJ. COOKE 
ACTING HEAD OF STRUCTURE STUDIES DIVIS 
MRC HUMAN GENETICS UNIT 
WESTERN GENERAL HOSPITAL 
CREWE ROAD 
UK EH4 2XU EDINBURGH 
Tel.: 44313322471 
Telex: 44313432620 
DR. B.J.C. CORNELISSEN 
GROUPLEADER 
MOGEN INTERNATIONAL NV 
EINSTEINWEG 97 
NL 2333 CB LEIDEN 
Tel.: 3171258282 
Ttlcx: 3171221471 
DR. R. CORTESE 
ISTITUTO DI RICERCHE DI BIOLOGIA MOLEC 
(IRBM) 
MERCK, SHARP AND DOHME RESEARCH 
VIA PONTINA 
KM 30,600 
I 00040 POMEZIA (ROMA) 
Tel.: 3969124582 
Telex: 3969125530 
PROF. P. COSTANTINO 
PROFESSOR OF MOLECULAR BIOLOGY/ 
GROUP L 
DIP. GENETICA E BIOLOGIA MOLECOLARE 
UNIVERSITA DI ROMA "LA SAPIENZA" 
PIAZZALE ALDO MORO 5 
I 00185 ROMA 
Tel.: 3964455344 
Telex: 3964440812 
DR. G. COUPLAND 
SENIOR SCIENTIFIC OFFICER 
INSTITUTE OF PLANT SCIENCE RESEARCH, 
CAMBRIDGE LABORATORY 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Telex: 4460356844 
Fax: 975122 
PROF. P. COZZONE 
DIRECTOR OF CRMBM 
CENTRE DE RESONANCE MAGNETIQUE 
BIOLOGI 
ET MEDICALE (CRMBM), UNITE CNRS 1186 
FACULTE DE MEDICINE DE MARSEILLE 
BOULEVARD JEAN MOULIN 27 
F 13005 MARSEILLE 
Tel.: 33912556529 
Telex: 3391256539 
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PROF. M. CRESTI 
FULL PROFESSOR BOTANY 
DIPARTIMENTO DI BIOLOGIA AMBIENTALE 
UNIVERSITA DEGLI STUDI DI SIENA 
VIA P.A. MATTIOU 4 
I 53100 SIENA 
Tel.: 49577298854 
Telex: 49577298860 
Fax: 572459 UNIV SI I 
E-mail: VAXTIEZZI@SIVAX.CINECA.IT 
DR. R.R. CROY 
SENIOR EXPERIMENTAL OFFICER 
PLANT MOLECULAR BIOLOGY GROUP 
DEPT. OF BIOLOGICAL SCIENCES 
UNIVERSITY OF DURHAM 
SOUTH ROAD 
UK DH1 3LE DURHAM 
TcL 44913742433 
Telex: 44913743741 
Fax: 537 351 DURLIB G 
E-maU: CROY@UK-AC.DURHAM 
PROF. E. CUNDUFFE 
PROFESSOR OF BIOCHEMISTRY 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
Tel.: 44533523451 
Telex: 44533523369 
Fax: 342318 LEI BIO G 
DR. PJ. DALE 
DEPUTY HEAD OF BRASSICA AND 
OILSEEDS R 
INSTITUTE OF PLANT SCIENCE RESEARCH 
CAMBRIDGE LABORATORY 
JOHN INNES CENTRE FOR PLANT SCIENCE RE 
COLNEY LANE 
UK NR4 7(U NORWICH 
Tel.: 446035271 
Telex: 44603502270 
Fax: 975122 JILNOR G 
DR. MJ. DANIELS 
HEAD OF LABORATORY 
THE SAINSBURY LABORATORY 
NORWICH RESEARCH PARK 
COLNEY 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Telex: 4460356844 
Fax: 975122JIINORG 
DR. R. DANKERT 
DIRECTOR RZ RESEARCH BV 
RZ RESEARCH BV 
ROPTAWEG 4 
NL 9123 ZR METSLAWIER 
Tel.: 3151921442 
Telex: 3151921774 
Fax: 46050 ZPCLNL 
DR. L. DAVIDSE 
ROYAL SLUIS 
P.O. BOX 22 
NL 1600 AA ENKHUIZEN 
Telex: 31228014404 
DR. W. DAVIES 
RESEARCHER 
NORWEGIAN COLLEGE OF VETERINARY 
MEDICI 
ULLEVAALSVEIEN 72 
P.O.BOX 8146 
N 0033 OSLO 
Tel.: 472964500 
Telex: 472600985 
E-mail: WILUAM@BIOMED.UIO.NO 
DR. C. DAVIES 
RESEARCH AND ENGINEERING DIVISION 
UNILEVER RESEARCH 
COLWORTH HOUSE 
UK MK44 11Q SHARNBROOK, BEDFORD 
Tel.: 44234222559 
Telex: 44234222552 
Fax: 82229 
DR. K. DALSGAARD 
DEPT. CHEMISTRY/IMMUNOLOGY SECTION 
STATE VETERINARY INSTITUTE FOR VIRUS R 
UNDHOLM 
DK 4771 KALVEHAVE 
Tel.: 4555814523 
Telex: 4555811766 
Fax: 40306 VIRUS DK 
PROF. C. DALY / DR. G. FITZGERALD 
PROFESSOR AND LECTURER 
FOOD MICROBIOLOGY DEPARTMENT AND 
THE NATIONAL FOOD BIOTECHNOLOGY 
CENTRE 
UNIVERSITY COLLEGE 
WESTERN ROAD 
IRL CORK 
Tel.: 35321276871 EXT. 284 
Telex: 35321276318 
Fax: 76050 UNIC EI 
DR. JX. DANGL 
GROUP LEADER 
MAX-DELBRUECK-LABORATORIUM IN DER 
MPG 
CARL-VON-LINNE -WEG 10 
D 5000 KOELN 30 
Tel.: 492215062430 
Telex: 492215062613 
DR. I.C. DE ALMEIDA 
PRINCIPAL INVESTIGATOR 
DEPARTAMENTO DE VIROLOGIA 
LABORATORIO NACIONAL DE INVESTIGACAO 
VETERINARIA 
ESTRADA DE BENFICA 701 
P 1500 LISBOA 
TcL: 3517162075 
Telex: 35117160039 
Fax: 18248VETERI P 
DR. J.A.M.P. DE ALMEIDA 
PROFESSOR AUXILIAR 
INSTITUTO SUPERIOR DE AGRONOMIA 
TAPADA DA AJUDA 
P 1399 LISBOA CODEX 
Tel.: 35113638161 
Telex: 35114428766 
Fax: 44700 ISATEL 
PROF. P. DE BAETSELIER 
PROFESSOR 
IMB/VUB - INSTITUUT VOOR MOLECULAIRE B 
VRIJE UNIVERSITEIT BRUSSEL 
PAARDENSTRAAT 65 
B 1640 SINT-GENESIUS-RODE 
Tel.: 3223590358 
Telex: 3223590390 
Fax: 61091 VUBCO B 
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PROF. JA.M. DE BONT 
HEAD OF DEPARTMENT 
DIVISON OF INDUSTRIAL MICROBIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
BOMENWEG 2 
NL 6703 HD WAGENINGEN 
Tel.: 31837084749 
Telex: 318370847^ 
MR. J. DE BRABANDEitB 
PROGRAM MANAGER 
BELGIAN COORDINAT D COLLECTIONS OF 
MICROORGANISMS 
SCIENCE POLICY OFFICE DE BELGIUM 
RUE DE LA SCIENCE b 
B 1040 BRUSSELS 
Tel.: 3222383411522 
Telex: 3222305912 
Fax: 24501 PROSCI B 
DR. C. DE CASTELLARNAU 
CHIEF OF THE ATHEROTHROMBOSIS UNIT 
ATHERO THROMfcCi— UNIT 
INSTITUT RICERCA BIOMEDICA, DEPT. OF L 
FUNDACIO' D'INVESTIGACIO' ST.PAU (FISP 
AVDA SANT ANTONI M.CLARET 167 
E 08025 BARCELONA 
Tel.: 3433473133 EXT. 409 
Telex: 3432552331 
PROF. G. DE HAAS 
PROFESSOR IN BIOCHEMISTRY 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY OF UTRECHT 
PADUALAAN 8 
CBLE / TRANSITORIUM III / "DE UITHOP 
NL 3584 CH UTRECHT 
Tel.: 3130533186/3186 
Telex: 3130522478 
DR. V. DE LORENZO 
COLABORADOR CIENTIFICO / CIB-STAFF MEM 
CENTRO DE INVESTIGACIONES BIOLOGICAS 
CS.I.C. 
VELAZQUES 144 
E 28006 MADRID 
Tel.: 3415854243 
Telex: 3415627518 
PROF. W.M. DE VOS 
RESEARCH GROUP LEADER NIZO, 
PROFESSOR 
NIZO 
KERNHEMSEWEG 2 
P.O. BOX 20 
NL 6710 BA EDE 
Tel.: 31838059558 
Telex: 31838050400 
E-mail: NIZO@CAOS.CAOS.KUN.NL 
DR. S.C. DE VRIES 
SENIOR LECTURER 
DEPARTMENT OF MOLECULAR BIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
DREIJENLAAN 3 
NL 6703 HA WAGENINGEN 
Tel.: 31837084325 
Telex: 31837083S84 
PROF. R. DE WACHTER 
PROFESSOR 
ONDERZOEKSGROEP MOLEKULAIRE 
BIOLOGIE 
DEPARTEMENT BIOCHEMIE 
UNIVERSITAIRE INSTELLING ANTWERPEN 
B 2610 ANTWERPEN 
Tel.: 3238202319 
Telex: 3238202248 
Fax: 33646 
E-mail: DEWACHTER@CCV.ULA.AC.BE 
DR. PJ.G.M. DE WIT 
SENIOR LECTURER 
DEPT. OF PHYTOPATHOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
BINNENHAVEN 9 
NL 6709 PD WAGENINGEN 
Tel.: 31837083130 
Telex: 8341283412 
Fax: 45854 
DR. C. DEAN 
SENIOR SCIENTIFIC OFFICER 
INSTITUTE OF PLANT SCIENCE RESEARCH, 
CAMBRIDGE LABORATORY 
COLNEYLANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Telex: 4460356844 
Fax: 975122 
DR. L. DE RIDDER 
DIRECTOR OF DEPARTMENT OF 
HISTOLOGY, R 
LABORATORIUM VOOR HISTOLOGIE 
RUKSUNIVERSITEIT GENT 
LOUIS PASTEURLAAN 2 
B 9000 GENT 
Tel.: 3291240224 cxt 351 
Telex: 3291240499 
DR. E. DE SIMONE 
STAFF SCIENTIST 
CEINGE-CENTRO DI INGEGNERIA 
GENETICAS 
C/O DIPARTIMENTO DI BIOCHIMICA 
E BIOTECHNOLOGIE MEDICHI 
VIA SERGIO PANSINI 5 
1 80131 NAPOLI 
Tel.: 39817463073 
Telex: 39817463074 
DR. E. DEJANA 
CHIEF OF THE LABORATORY OF 
VASCULAR BI 
VASCULAR BIOLOGY LABORATORY 
ISTITUTO DI RICERCHE FARMACOLOGICHE 
"MARIO NEGRI' 
VIA ERITREA 62 
I 20157 MILANO 
Tel.: 39239014480 
Telex: 3923546277 
Fax: 331268 NEGRI I 
PROF. F. DEL REY 
ASSOCIATE PROFESSOR OF MICROBIOLOGY 
INSTITUTO DE MICROBIOLOGIA BIOQUIMICA 
FACULTAD DE BIOLOGIA 
UNIVERSIDAD DE SALAMANCA 
PLAZA DE LA MERCED 
E 37008 SALAMANCA 
Tel.: 3423294461 
Telex: 3423294513 
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PROF. S. DELROT 
CO DIRECTOR OF UA CNRS 574 
UNITE ASSOCIEE CNRS 574 
UNIVERSITE DE POITIERS 
RUE DU FAUBOURG SAINT-CYPRIEN 25 
F 86000 POITIERS 
TcL: 334941186 
Telex: 3349559374 
DR. M. DELSENY 
DIRECTEUR DE RECHERCHE CNRS 
LABORATOIRE DE PHYSIOLOGIE ET 
BIOLOGIE 
MOLECULAIRE VEGETALE (URA CNRS 565) 
UNIVERSITE DE PERPIGNAN 
AVENUE DE VILLENEUVE 
F 66025 PERPIGNAN CEDEX 
Tel.: 3368668848 
Telex: 3368668499 
DR. PH. DESSEN 
DIRECTEUR DE RECHERCHE - CNRS -
LABORATOIRE DE BIOCHIMIE 
ECOLE POLYTECHNIQUE 
F 91128 PALAISEAU 
Tel.: 33169334884 
Telex: 33169333013 
E-mail: DESSEN@FRCnT513ITNET 
DR. K.M. DEVINE 
UNIVERSITY LECTURER 
DEPARTMENT OF GENETICS 
TRINITY COLLEGE 
UNIVERSITY OF DUBLIN 
IRL 2 DUBLIN 
Tel.: 3531772941 EXT. 1872 
Telex: 3531798558 
Fax: 93782 TCDEI 
E-mail: KDEVINE@VAX1.TCD.IE 
DR. D. DI LORENZO 
CNR RESEARCHER 
ISTrrUTO DI CHIMICA E PROPEDEUTICA BIO 
UNIVERSITY OF BRESCIA 
PIAZZALE SPEDALI CIVIU 1 
OSPEDALE CIVILE 
I 25100 BRESCIA 
Tel.: 393039951554 
Telex: 3930307251 
PROF. H.G. DICKINSON 
PROFESSOR AND HEAD OF SCHOOL OF 
PLANT 
DEPARTMENT OF PLANT SCIENCES 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
UK OX1 3RB OXFORD 
Tel.: 44865275800 
Telex: 44865275074 
DR. B. DIDERICHSEN 
HEAD OF DEPARTMENT 
NOVO NORDISK 
NOVO ALLE 
DK 2880 BAGSVAERD 
Tel.: 45444900333401 
Telex: 4544490070 
Fax: 37173 
DR. J. DIEZI 
TBC 
INSTITUT DE PHARMACOLOGIE ET DE 
TOXICO 
UNIVERSITE DE LAUSANNE 
RUE DE BUGNON 27 
CH 1005 LAUSANNE 
TcL: 41213132700 
Telex: 41213132775 
PROF. L. DIJKHUIZEN 
SENIOR LECTURER IN MICROBIOLOGY 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY OF GRONINGEN 
KERKLAAN30 
NL 9751 NN HAREN 
Tel.: 3150632153 
Telex: 3150635205 
Fax: 53410 RUGRO 
PROF. B.W. DIJKSTRA 
UNIVERSITAIR HOOFDDOCENT (ASSOC. 
PROFE 
LABORATORY OF CHEMICAL PHYSICS 
UNIVERSITY OF GRONINGEN 
NUENBORGH 16 
NL 9747 AG GRONINGEN 
Tel.: 3150634381 
Telex: 3150634200 
Fax: 53935 
E-mail: BAUKE@HGRRUG52 
PROF. G. DODSON 
PROFESSOR 
DEPARTMENT OF CHEMISTRY 
UNIVERSITY OF YORK 
UK YOI 5DD HESLINGTON, YORK 
Tel.: 44904430000 
Telex: 44904410519 
DR. R. DOELZ 
BIOCOMPUTING 
BIOZENTRUM DER UNIVERSITAET BASEL 
KUNGELBERGSTRASSE 70 
CH 4056 BASEL 
Tel.: 41612672247 
Telex: 41612616760 
E-mail: DOELZIgURZ.UNIBAS.CH 
DR. H. DOMDEY 
LABORATORIUM FUER MOLEKULARE 
BIOLOGIE 
GENZENTRUM DER LMU MUENCHEN 
AM KLOPFERSPITZ 18A 
D 8033 MARTINSRIED 
Tel.: 498985783942 
Telex: 498985783795 
Fax: 521740MPIB 
PROF. E. DOMINGO 
PROFESOR DE INVESTIGACION 
CENTRO DE BIOLOGIA MOLECULAR 
UNIVERSIDAD AUTONOMA DE MADRID 
CSIC 
CANTO BLANCO 
E 28049 MADRID 
TcL: 3413975070 
Telex: 3413974799 
Fax: 42182 
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PROF. A. DOMINGUEZ 
PROFESOR TITULAR DE MICROBIOLOGIA 
DEPTO. DE MICROBIOLOGIA, GENETICA, 
MEDICINA PREVENTIVA Y SALUD PUBLICA 
FAC. DE BIOLOGIA / UNIVERSIDAD DE SALA 
PLAZA DE LA MERCED S/N 
E 37071 SALAMANCA 
Tel.: 3423294461 
Telex: 3423294513 
Fax: 26828 EDUCI 
DR. J. DOMMES 
PROJECT LEADER 
EUROGENTEC SA 
ALLEE DU AOUT, B6 
CAMPUS DU SART-TILMAN 
B 4000 LIEGE 
Tel.: 3241563310 
Telex: 3241562968 
PROF. P. DONINI 
FULL PROFESSOR 
DIPARTIMENTO Dl BIOLOGIA 
CELLULARE E D 
SEZ. DI SCIENZE MICROBIOLOGICHE 
UNIVERSITA' DI ROMA "LA SAPIENZA' 
VIA DEGLI APULI 1 
I 00185 ROMA 
Tel.: 396493232 
Telex: 39649910789 / +39649 
DR. H. DONS 
CENTRE FOR PLANT BREEDING AND 
REPRODUCTIVE RESEARCH 
DROEVENDAALSESTEEG 1 
POSTBUS 16 
NL 6700 AA WAGENINGEN 
Tel.: 31837077000 
Telex: 31837018094 
DR. D. DOWLING 
PROJECT MANAGER 
DEPT. OF FOOD MICROBIOLOGY 
BIOTECHNOLOGY CENTRE 
UNIVERSITY COLLEGE 
IRL 30 CORK 
Tel.: 35321272097 
Telex: 35321275934 
Fax: 76050 UNIC EI 
E-mail: STDM 8008 
DR. A. DOYLE 
HEAD OF ECACC GROUP 
ECACC - EUROPEAN COLLECTION OF 
ANIMAL CELL CULTURES 
PHLS CENTRE 
PORTON DOWN 
UK SP4 OJG SALISBURY 
Tel.: 44980610391 
Telex: 44980611315 
E-mail: TELECOM GOLD 10075:DBI0008 
PROF. L. DUBERTRET 
DIRECTEUR DE L'UNITE INSERM 312 
LAB. DE PHARMACOLOGIE CUTANEE 
UNITE INSERM 312 
AV. D U MARECHAL DE LATTRE DE 
TASSIGNY 51 
HOPITAL HENRI MONDOR 
F 94010 CRETEIL 
Tel.: 33149813606 
Telex: 33142070704 
PROF. J.A. DUINE 
PROFESSOR IN APPLIED ENZYMOLOGY 
BIOTECHNOLOGY 
FACULTY OF CHEMICAL TECHNOLOGY 
DELFT UNIVERSITY OF TECHNOLOGY 
JULIANALAAN 67 
NL 2628 BC DELFT 
Tel.: 31157891115051 
Telex: 3115782355 
Fax: 38151 BUTUD NL 
PROF. B. DUJON 
PROFESSOR 
DEPARTEMENT BIOLOGIE MOLECULAIRE 
INSTITUT PASTEUR 
RUE DU DOCTEUR ROUX 25 
F 75724 PARIS 15 
Tel.: 33145688482 
Telex: 33145688521 
Fax: 2506O9F 
E-mail: DUJON@PASTEUR 
PROF. C. DUMAS 
PROFESSOR 
RECONNAISSANCE CELLULAIRE ET 
AMELIORAT 
LA INRA 879 
INSTITUT DE LA RECHERCHE 
AGRONOMIQUE 
BOULEVARD DU 11 NOVEMBRE 1918 43 
F 69622 VILLEURBANNE CEDEX 
Tel.: 3372448302 
Telex: 3372448501 
Fax: 810310 
PROF. L.K. DUNICAN 
PROFESSOR OF MICROBIOLOGY; 
HEAD OF THE 
UNIVERSITY COLLEGE 
IRL GALWAY 
Tel.: 3539124411 
Telex: 3539125700 
Fax: 50023 UCG E.I. 
DR. J.M. DUNWELL 
PROJECT LEADER 
JEALOTTS HILL RESEARCH STATION 
ICI SEEDS 
UK RGI2 6EY BRACKNELL 
Tel.: 44344414823 
Telex: 44344414818 
Fax: 847556 ICIPPJG 
PROF. G. DURAND 
PROFESSEUR 
DEP. DE GENIE BIOCHIMIQUE ET AUMENTAI 
INSTITUT NATIONAL DES SCIENCES 
APPLIQUEES (INSA) 
AVENUE DE RANGUEIL 
F 31077 TOULOUSE 
Tel.: 3361559720 
Telex: 3361559652 
DR. D. DWYER 
PROJECT LEADER 
DEPARTMENT OF MICROBIOLOGY 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181400 
Telex: 495316181411 
Fax: 952667 GEBIOD 
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DR. MR. EGMOND 
RESEARCH MANAGER 
UNILEVER RESEARCH LABORATORIUM 
OLIVIER VAN NOORTLAAN 120 
NL 3133 AT VLAARDINGEN 
TcL: 31104605039/5037 
Telex: 31104605303 
Fax: 23261 
DR. SX>. EHRUCH 
DIRECTEUR DE RECHERCHE, 
HEAD OF THE LA 
LABORATOIRE DE GENETIQUE 
MICROBIENNE 
INRA 
DOMAINE DE VILVERT 
F 78350 JOUY EN JOSAS 
Tel: 33134652511 
Telex: 33134652521 
E-mail; EHRUCH@BIOTECJOUYJNRA.FR 
DR. V. ELFERINK 
RESEARCH COORDINATOR / PROJECT 
MANAGER 
ANDENO B.V. 
GRUBBENVORSTERWEG 8 
NL 5928 NX VENLO 
Tel.: 31778995558992 
Telex: 3177899300 
Fax: 58310 AVE NL 
PROF. K.-D. ENTIAN / DR. M. BRENDEL 
INSTITUT FUER MIKROBIOLOGIE 
J.W. GOETHE-UNIVERSITAET FRANKFURT/M. 
THEODOR-STERN-KAI 7 
HAUS 75A 
D 6900 FRANKFURT 
Tel.: 496963016468 
Telex: 496963017639 
DR. E. FALSEN 
CCUG CULTURE COLLECTION 
DEPARTMENT OF CLINICAL BACTERIOLOGY 
UNIVERSITY OF GOTEBORG 
GULDHEDSG. 10 
S 413 46 GOTEBORG 
TcL: 4631604625 
Telex: 4631825484 
E-maifc TELECOM GOLD 1007S:DBI0070 / 
TLXCOglSEG 
PROF. H. FELDMANN 
UNIVERSITAETS PROFESSOR 
INSTITUT FUER PHYSIOLOGISCHE CHEMIE 
LUDWIG-MAXIMHJANS-UNTVERSITAET 
SCHILLERSTRASSE 44 
D 8000 MUENCHEN 2 
TcL: 49895996451 
Telex: 49895996316 
Fax: 529860 
PROF. I. FERRERO 
PROFESSOR OF GENETICS 
INSTITUTE OF GENETICS 
UNIVERSITY OF PARMA 
VIALE DELLE SCIENZE 
I 43100 PARMA 
TcL: 39521580601 
Telex: 39521580665 
PROF. A.R. FERSHT 
DIRECTOR 
MRC UNTT FOR PROTEIN FUNCTION AND 
DESI 
DEFT. OF CHEMISTRY 
UNIVERSITY OF CAMBRIDGE 
LENSFIELD ROAD 
UK CB2 IEW CAMBRIDGE 
TcL: 44223336341 
Telex: 44336362 
PROF. DR. W. HERS 
LABORATORY OF MOLECULAR BIOLOGY 
RUKS UNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
B 9000 GENT 
TcL: 3291645131 
Telex: 3291645348 
Fax: 11995 GENGEN 
DR. J. FIGUEIREDO MARQUES 
SENIOR RESEARCHER/DIRECTOR OF THE 
LAB. 
LABORATORIO DE MICROBIOLOGIA 
INSTITUTO DE BIOLOGIA EXPERIMENTAL 
E TECNOLOGICA 
APARTADO 12 
P 2780 OEIRAS 
Tel.: 35114427787 
Tblcx: 35114421161 
DR. R. FLEER 
SENIOR SCIENTIST. RESEARCH GROUP 
UGENE 
CENTRE DE RECHERCHE DE VITRY ET 
ALFORT 
INSTITUT DE BIOTECHNOLOGIE (IBV) 
RHONE POULENC SANTE 
QUAI JULES GUESDE 13 
F 94403 VITRY SUR SEINE 
TcL: 33145737890 
Telex: 33145737796 
PROF. M. FONSECA 
ASSISTANT PROFESSOR 
INSTITUTO SUPERIOR TECNICO 
AVENIDA ROVISCO PAIS 
P 1000 USBOA 1096 
TcL: 3511802045 EXT. 1682 
Telex: 35118480072 
Fax: 63423 ISTUTL P 
DR. B.G. FORDE 
ROTHAMSTED EXPERIMENTAL STATION 
BIOCHEMISTRY AND PHYSIOLOGY DEPT. 
THE LAWES AGRICULTURAL TRUST 
UK AL5 2JQ HARPENDEN 
Tel.: 44582763133 
Telex: 44582760981 
DR. F. FOURY 
UNITE DE BIOCHIMIE PHYSIOLOGIQUE 
FYSA 
UNIVERSITE CATHOLIQUE DE LOUVAIN 
PLACE CROIX DU SUD 1 
BTE8 
B 1348 LOUVAIN LA NEUVE 
Tel.: 3210473618 
Telex: 3210473872 
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DR. F.C. FRANKLIN 
LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY O F BIRMINGHAM 
UK BIS 2TT BIRMINGHAM 
Tel.: 44214145910 
Tblcx: 44214145925 
DR. M. FREDHOLM 
SENIOR SCIENTIST 
DEPARTMENT O F ANIMAL SCIENCE AND 
ANIMA 
DIVISION O F ANIMAL GENETICS 
THE ROYAL VETERINARY AND 
AGRICULTURAL 
BUELOWSVEJ 13 
DK 1870 FREDERIKSBERG C 
Tel.: 4535283074 
Tblcx: 4535283042 
DR. H. FREDRICKSON 
PROJECT LEADER 
ABTEILUNG MIKROBIOLOGIE 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181419 
Telex: 495316181411 
Fax: 952667 GEBIO D 
PROF. J. FRISVAD 
DEPT. O F BIOTECHNOLOGY 
DANMARK TEKNISCHE HOEJSKOLE 
BUILDING 221 
DK 2BO0 LYNGBY 
Tel.: 4545931222 
Telex: 4542884922 
Fax: 37529 DTHDIA DK 
DR. R. FRITZ 
DIRECTOR 
DIMDI - DEUTSCHES INSTITUT F U E R MEDIZI 
DOKUMENTATION UND INFORMATION 
WEISSHAUSSTRASSE 27 
P.O. BOX 420580 
D 5000 KOELN 41 
Tel.: 4922147241211 
Telex: 49221411429 
Fax: 8881364 
PROF. L. FRONTALI 
PROFESSOR 
DEPARTMENT OF CELL AND 
DEVELOPMENTAL BIOLOGY 
UNIVERSITY O F ROMA "LA SAPIENZA' 
PIAZZALE ALDO MORO 5 
I 00185 ROMA 
Tel.: 3964453950 
Telex: 396499123S1 
DR. S.C. FRY 
READER 
DEPT. O F BOTANY 
UNIVERSITY O F EDINBURGH 
THE KING'S BUILDINGS 
MAYFIELD R O A D 
UK EH9 3JH EDINBURGH 
TcL: 44316671081330 
Telex: 44316683870 
Fax: 727442 UNIVED G 
DR. J.C. FRY 
SENIOR LECTURER 
SCHOOL O F PURE AND APPLIED BIOLOGY 
COLLEGE OF CARDIFF 
UNIVERSITY O F WALES 
P.O. BOX 915 
UK CF1 3TL CARDIFF 
TcL: 442228740005878 
Tblcx: 44222874305 
Fax: 498635 
DR. S.C. FRY 
READER 
DEPARTMENT OF BOTANY 
UNIVERSITY O F EDINBURGH 
MAYFIELD ROAD 
THE KING'S BUILDINGS 
UK EH9 3JH EDINBURGH 
Tel.: 44316671081330 
Telex: 44316683870 
Fax: 727442 UNIVED G 
PROF. DR. H. FUKUHARA 
INSTITUT CURIE, SECTION D E BIOLOGIE 
CENTRE UNIVERSITAIRE, BATIMENT 110 
RUE GEORGES CLEMENCEAU 15 
F 91405 ORSAY 
Tel.: 33169863063 
Telex: 33169861703 
Fax: CURIE 270479F 
E-mail: FUKUHARA(ffiFRCITT51 
PROF. H. FUKUHARA 
HEAD OF LABORATORY 
LABORATOIRE D E GENETIQUE 
MOLECULAIRE 
INSTITUT PASTEUR 
RUE GEORGES CLEMENCEAU 15 
F 91405 ORSAY 
Tel.: 33169863063 
Tblcx: 33169869429 
Fax: FACORS 692 116 F 
E-mail: FUKUHARA@FRCITT51 
PROF. N . E FUSENIG 
PROFESSOR, HEAD O F DIVISION 
INSTITUTE O F BIOCHEMISTRY 
DEUTSCHES KREBSFORSCHUNGS-ZENTRUM -
DK 
IM NEUENHEIMER FELD 280 
D 6900 HEIDELBERG 
Tel.: 4962214841507 
Telex: 496221474457 
Fax: 461 S62 DKFZ D 
PROF. C. GAILLARDIN 
PROFESSOR 
LABORATOIRE DE GENETIQUE DES MICRO-
O R G 
INAPG - CENTRE DE BIOTECHNOLOGIE 
AGRO-
INRA 
F 78850 THIVERVALGRIGNON 
Tel.: 33130544510 
Tblcx: 33130545690 
Fax: 697388 
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DR. F. GAUBERT 
HEAD OF LABORATORY 
LABORATOIRE RECOMBINAISON GENETIQUE 
HOPITAL ST LOUIS / CENTRE HAYEM 
CNRS 
VELLEFEAUX 1 
HOPrTAL ST LOUIS 
F 75010 PARIS 
Tbl: 33142021605 
Tblcx: 33142411470 
Fax: IRM2L2309F 
DR. P. GALLOIS 
MAITRE DE CONFERENCES 
LABORATOIRE DE PHYSIOLOGIE VEGETALE 
UNIVERSITE DE PERPIGNAN 
AVENUE DE VILLENEUVE 
F 66025 PERPIGNAN 
Tbl.: 3368668848 
Telex: 3368668499 
PROF. F. GANNON 
ASSOCIATE PROFESSOR AND DIRECTOR. NAT! 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY COLLEGE GALWAY 
UNIVERSITY ROAD 
IRL GALWAY 
Tel.: 3539124411 
Telex: 3539166570 
Fax: 55023 EI 
DR. MI. GARCIA LUQUE 
ASSISTANT PROFESSOR 
CS.I.C. 
VELAZQUEZ 44 
E 28006 MADRID 
Tel.: 3412611800 
Telex: 3412627518 
DR. R.M. GASKELL 
RESEARCH FELLOW 
DEPARTMENT OF VETERINARY PATHOLOGY 
AND 
MEDICAL MICROBIOLOGY 
UNIVERSITY OF LIVERPOOL 
VETERINARY HELD STATION LEAHURST 
UK L64 7TE NESTON. WIRRAL 
Tbl.: 44517946019 
Tblcx: 517946005 
Fax: 62095 UNILPL G 
PROF. MJ. GASSON 
HEAD OF DEPARTMENT 
AFRC INSTITUTE OF FOOD RESEARCH 
NORWICH RESEARCH PARK 
COLNEY 
UK NR4 7UA NORWICH 
Tbl.: 4460356122 EXT. 248 
Iblcx: 44603507723 
Fix: 975453 
DR. A. GEIS 
BUNDESANSTALT FUER MILCHFORSCHUNG 
KIEL 
HERMANN-WEIGMANN-STRASSE 1 
D 2300 KIEL 
Tbl: 49431609352 
Tblcx: 49431609222 
PROF. H. GELDERMANN 
UNIV.- PROF. 
INSTITUET FUER TIERHALTUNG AND 
TIERZUE 
FACHGEBIET TIERZUECHTUNG 470 
UNTVERSITAET HOHENHEIM 
GARBENSTRASSE 17 
D 7000 STUTTGART 70 
Tbl.: 497114592474 
Tblcx: 497114593290 
DR. P. GIACOMONI 
LABORATOIRE DE RECHERCHE DE L'OREAL 
AVENUE EUGENE SCHUELLER 1 
BP22 
F 93601 AULNAY SOUS BOIS 
Tel.: 33148689710 
Telex: 33148699889 
DR. A.LJ. GIELKENS 
HEAD DEPARTMENT MOLECULAR BIOLOGY 
DEPARTMENT OF MOLECULAR BIOLOGY 
CENTRAL VETERINARY INSTITUTE 
HOUTRIBWEG 39 
P.O. BOX 365 
NL 8200 AJ LELYSTAD 
Tbl.: 31320076611/76604 
Tblcx: 31320042804 
Fax: 47907 
DR. J. GIRAUDAT 
CHARGE DE RECHERCHE, GROUP LEADER 
INSTITUT DES SCIENCES VEGETALES 
CENTRE NATIONAL DE LA RECHERCHE 
SCIENT 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
TcL: 331698236% 
Telex: 33169823695 
Fax: 601137F 
DR. G. GIUUANO 
STAFF SCIENTIST 
ENEA - COMITATO NAZIONALE PER LO SVILU 
RICERCA DELLA ENERGIA NUCLEARE E 
DELLE ENERGIE ALTERNATIVE. 
STRADA PROVINaALE ANGUILLARESE 
P.O. BOX 2400 
I 00100 AD ROMA 
TcL: 39630486343 
Tblcx: 39630484995 
PROF. N.N. GLANSDORFF /DR. A. PIERARD 
RESEARCH INSTITUTE OF THE CERIA - COOV 
AVENUE E. GRYSON 1 
B 1070 BRUXELLES 
Tel.: 3225267275 / 3225267 
Tblcx: 3225267042 
E-mail: R1310@BBRFE01 
DR. T. GODEFROY-COLBURN 
DIRECTEUR DE RECHERCHE 2E CLASSE, 
CNRS 
INSTITUT DE BIOLOGIE MOLECULAIRE DES P 
RUE DU GENERAL ZIMMER 12 
F 67084 STRASBOURG 
Tbl: 3388417255 
Tblcx: 3388614442 
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DR. JX. GORDON 
DIRECTOR OF RESEARCH 
RESEARCH DIVISION 
BRITISH BIO-TECHNOLOGY LIMITED 
BROOK HOUSE 
WATLINGTON ROAD 
COWLEY 
UK OX4 SLY OXFORD 
Tel.: 44865748747 EXT. 226 
Telex: 44865717598 
Fax: 838083 BIOTEC G 
PROF. P.H. GOUYON 
PROFESSEUR 
LABORATOIRE D'EVOLUTION ET 
SYSTEMATIQUE DES VEGETAUX 
UNIVERSITE DE PARIS SUD 
BATIMENT 362 
F 91405 ORSAY 
Tel.: 33169417222 
Telex: 33164461992 
PROF. DR. L. GRIVELL 
SECTION FOR MOLECULAR BIOLOGY 
DEPT. OF MOLECULAR CELL BIOLOGY 
UNIVERSITY OF AMSTERDAM 
KRUISLAAN 318 
NL 1098 SM AMSTERDAM 
Tbl.: 31205257924 
Telex: 31206685086 
E-mail: U00193HASARA5 
DR. MAM. GROENEN 
BIOTECHNICAL RESEARCHER 
DEPARTMENT OF ANIMAL BREEDING 
AGRICULTURAL UNIVERSITY WAGENINGEN 
MARUKEWEG 40 
P.O. BOX 338 
NL 6700 AH WAGENINGEN 
Tel.: 31837083747 
Telex: 31837083962 
Fax: 45015 NL 
E-mail: GROENEN@ZOA.LUW.NL 
DR. M A GRANDBASTTEN 
STAFF SCIENTIST (CR1) 
LABORATOIRE DE BIOLOGIE CELLULAIRE 
INRA 
CENTRE DE VERSAILLES 
F 78026 VERSAILLES 
Tel.: 33130833024 
Telex: 33130833099 
Fax: 695269 
PROF. P. GRAY 
PROFESSOR (FULL) 
DEPARTMENT OF COMPUTING SCIENCE 
UNIVERSITY OF ABERDEEN 
KINGS COLLEGE 
UK AB9 2UB ABERDEEN 
Tel.: 44224272292 
Telex: 44224274322 
E-mail: PGRAY@CSDJVBDN.AC.UK 
DR. SB. GRIFFITHS 
DEPUTY HEAD DIVISION OF BIOLOGICS 
DIVISION OF BIOLOGICS 
PUBLIC HEALTH LABORATORY SERVICE 
CAMR 
PORTON DOWN 
UK SP4 OJG SALISBURY, WILTSHIRE 
Tbl.: 449806103912340 
Telex: 44980611310 
Fax: 47683 PH CAMR G 
E-mail: TELECOM GOLD 10O75:DBIO222 
DR. R. GRIFFITHS 
LECTURER IN BIOCHEMISTRY 
DEPARTMENT OF BIOCHEMISTRY AND 
MICROBI 
UNIVERSITY OF ST. ANDREWS 
NORTH STREET 
UK KY16 9AL ST ANDREWS 
Tel.: 4433476161 
Telex: 4433474674 
PROF. PAX). GRIMONT 
CHIEF OF UNIT 
UNITE DES ENTEROBACTERIES 
INSTITUT PASTEUR 
RUE DU DOCTEUR ROUX 28 
F 75724 PARIS CEDEX 15 
Tbl.: 33145688340 
Telex: 33145688837 
Fax: 250609 F 
PROF. F. GRUMMT 
PROFESSOR 
UNIVERSITAET WUERZBURG 
ROENTGENRING 11 
D 8700 WURZBURG 
Tbl.: 4993131648 
DR. J. GUARDIOLA 
SENIOR RESEARCHER AND GROUP LEADER 
ISTrrUTO INTERNAZIONALE DI GENETICA E 
CNR 
VIA GUGLIELMO MARCONI 10 
I 80125 NAPOU 
Tel.: 39815935370 
Telex: 39815936123 
E-mail: NA0402@ICNUCEVM 
DR. W.H. GUENZBURG 
SENIOR SCIENTIST AND PROJECT LEADER 
INSTITUT FUER MOLEKULARE VIROLOGIE 
GSF - FORSCHUNGSZENTRUM FUER UMWELT 
UND GESUNDHEIT 
INGOLSTAEDTER LANDSTRASSE 1 
D 8042 NEUHERBERG 
Tel.: 498931873126 
Telex: 498931873329 
Fax: 523125 STRAL D 
E-mail: WOLFI@DMOGSFII 
Telclcx: 898947 
PROF. J. GUERN 
CN.R.S. 
SCE DE PHYSIOLOGIE CELLULAIRE 
VEGETALE 
AVE DE LA TERRASSE 
BJ>. N " l 
F 91190 GIF-SUR-YVETTE 
Tbl.: -1-33.1.69823868 
Telex: +33.1.69823768 
PROF. R. GUERRERO 
DIRECTOR GRUPO INVESTIGAaON 
DEPARTAMENTO DE MICROBIOLOGIA 
UNIVERSIDAD DE BARCELONA 
AV. DIAGONAL 645 
E 08028 BARCELONA 
Tel.: 3434021484 
Telex: 3434110592 
E-mail: D3MUMCl@EBOUBOH 
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DR. M. GUILLON 
RESEARCH AND DEVELOPMENT MANAGER 
CALLIOPE S.A. 
RUE DU CHAPEAU ROUGE 7 
F 34325 BEZIERS 
Tbl.: 3367281678 
Telex: 3367288902 
Fax: 480947 F 
DR. CHR. GUILLOUZO 
DIRECTOR OF RESEARCH 
INSERM U 49 
HOSPITAL DE PONTCHAILLOU 
F 35033 RENNES 
Tel.: 331699543737 
Telex: 33145856856 
PROF. M L GULUNO 
PROFESSEUR 
UNWERSITA DEGU STUDI DI TORINO 
VIA GIURIA 15 
I 10126 TORINO 
Tel.: 39116505236 
Telex: 39116502139 
DR. L GUSTAVSSON 
PROFESSOR 
DEPARTMENT OF ANIMAL BREEDING AND 
GENE 
SWEDISH UNIVERSITY OF AGRICULTURAL 
SCI 
BOX 7023 
S 750 07 UPPSALA 
TcL: 4618671000 
Telex: 4618302965 
DR. J. HACHE 
SCIENTIFIC DIRECTOR 
BERTIN AND CIE 
RUE PIERRE CURIE 59 
Z.I. DES GATINES / BP N* 3 
F 78373 PLAISIR CEDEX 
TcL: 33134818500 
Telex: 33130540414 
Fax: 69623 F 
DR. C. HADFIELD 
RESEARCH GROUP LEADER 
LEICESTER BIOCENTRE 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
TcL: 44533522269 
Telex: 44533551219 
PROF. M A HALL 
PROFESSOR OF BOTANY 
DEPARTMENT OF BIOLOGICAL SCIENCES 
THE UNIVERSITY COLLEGE OF WALES 
PENGLAIS 
UK SY23 3DA ABERYSTWYTH 
TcL: 0970622313 
Telex: 0970617172 
Fax: 35I8IABYUCWG 
E-mail: MZH UICACABERYSTWYTH 
DR. W£>. HAMILTON 
GROUP LEADER OF APPLIED PLANT 
TECHNOLO 
AGRICULTURAL GENETICS COMPANY 
LIMITED 
SCIENCE PARK MILTON ROAD 154 
UK CB4 4GG CAMBRIDGE 
TcL: 44223420882 
Telex: 44223420801 
Fax: 817568AGGENEG 
PROF. W.P. HAMMES 
DIRECTOR OF THE INSTITUTE 
HOHENHEIM UNIVERSITY 
GARBENSTRASSE 25 
D 7000 STUTTGART 70 
TcL: 497114592305 
Telex: 497114593443 
DR. E.B. HANSEN 
HEAD OF DEPARTMENT, PH.D. 
CHR. HANSEN'S LABORATORIUM DANMARK 
A/S 
BOEGE ALLE 10 
DK 2970 HOERSHOLM 
Tel.: 4545767676 EXT. 4027 
Telex: 4545765455 
Fax: 19184 HANSN DK 
PROF. C. HARDISSON 
CATEDRATICO DE UNIVERSIDAD 
DEPARTAMENTO DE BIOLOGIA FUNCIONAL 
AREA MICROBIOLOGIA 
UNIVERSIDAD DE OVIEDO 
JULIAN CLAVERIA S/N 
E 33006 OVIEDO 
Tel.: 3485103557 
Telex: 3485232255 
Fax: 84322 
DR. R. HARPER 
RESEARCH SCIENTIST 
CENTRE FOR SCIENTIFIC COMPUTING 
FINNISH STATE COMPUTER CENTRE 
P.O. BOX 40 
SF 02101 ESPOO 
Tel.: 35804572076 
Telex: 35X04572302 
E-mail: HARPER@CSC.FI 
DR. H. HAUSER 
GROUP LEADER 
GESELLSCHAFT FUER BIOTECHNOLOGISCHE 
FORSCHUNG MBH 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
TcL: 495316181250 
Telex: 495316181202515 
Fax: 952668 GEBIO D 
PROF. DL. HAWKSWORTH 
DIRECTOR CMI 
CAB INTERNATIONAL MYOOLOGICAL 
INSTITUT 
(IMI) 
FERRY LANE 
UK W9 3AF KEW 
Tel.: 44819404086 
Telex: 44813321171 
Fax: 9312102252 MIG 
E-mail: DIALCOM 84:CAU009 
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DR. Y. HENRY 
CRi CNRS 
LABORATOIRE DE GENETIQUE VEGETALE 
UNIVERSITE PARIS SUD 
BT360 
F 91405 ORSAY 
Tel.: 33169417960 
Telex: 33169853715 
Fax: 692166 F 
DR. P.E HERNANDEZ CRUZ 
ASSISTANT PROFESSOR 
DPTO. NUTRICION Y BROMATOLOGIA III 
FACULTAD DE VETERINARIA 
UNIVERSIDAD COMPLUTENSE 
AVDA. PUERTA DE HIERRO S/N 
E 28040 MADRID 
Tel.: 3413943747 
Telex: 3413943883 
Fax: 41805 UCVET 
DR. J. HIGGINGS 
CRANFIELD BIOTECHNOLOGY LTD. 
UK BEDFORD 
Tel.: 44234750665 
Telex: 44234750907 
Fax: 825072 CITECH G 
PROF. C.W. HILBERS 
HEAD OF DEPARTMENT. PROFESSOR OF 
PHYSI 
NUMEGEN SON RESEARCH CENTRE (NSR 
CENT 
LABORATORY FOR BIOPHYSICAL CHEMISTRY 
FAC. NATUURWETENSCHAPPEN / K.U. NUMEG 
TOERNOOIVELD 
NL 6525 ED NUMEGEN 
Tel.: 3180612160 
Telex: 3180652112 
DR. F. HILGER / DR. D. PORTETELLE 
LABORATOIRE DE MICROBIOLOGIE 
FACULTE DES SCIENCES AGRONOMIQUES 
AVENUE MARECHAL JUIN 6 
B 5800 GEMBLOUX 
Tel.: 3281612355 
Telex: 3281614544 
Fax: 59482FSAGXT 
DR. J. HILLE 
UNrVERSITAIR HOOFDDOCENT 
DEPT. OF GENETICS 
FACULTY BIOLOGY 
VRUE UNrVERSITEIT AMSTERDAM 
DE BOELELAAN 1087 
NL 1081 HV AMSTERDAM 
Tel.: 31205485753 
Telex: 3120442556 
Fax: 11329 DPWU 
E-mail: HILLE@BIO.VU.NL 
PROF. H.-J. HINZ 
PROFESSOR 
INSTITUT FUER PHYSIKAUSCHE CHEMIE 
ABTEILUNG BIOPHYSIKAUSCHE CHEMIE 
UNIVERSITAET MUENSTER 
SCHLOSSPLATZ 4/7 
D 4400 MUENSTER 
TeL: 49251833427 
Telex: 49251839163 
DR. D.A. HODGSON 
LECTURER IN MICROBIOLOGY 
DEPARTMENT OF BIOLOGICAL SCIENCES 
UNIVERSITY OF WARWICK 
UK CV4 7AL COVENTRY 
TeL: 44203523559 
Telex: 44203523701 
Fax: 317472 UNIREG 
DR. M.G. HOEFLE 
ASSOCIATE SCIENTIST 
ABTEILUNG MIKROBIOLOGIE 
GBF 
MASCHERODER WEG 1 
D 3000 BRAUNSCHWEIG 
Tel.: 495316181419 
Telex: 495316181411 
Fax: 952667 GEBIO D 
DR. A. HOEKEMA 
GROUP LEADER 
MOGEN INTERNATIONAL NV 
EINSTEINWEG 97 
NL 2333 CB LEIDEN 
Tel.: 3171258282 
Telex: 3171221471 
DR. F. HOEKSTRA 
ASSOCIATE PROFESSOR 
DEPARTMENT OF PLANT PHYSIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 31837082454 
Telex: 31837084740 
Fax: NL45015 
E-mail: HOEKSTRA@RCL.WAU.NL 
PROF. W. HOL 
PROFESSOR OF BIOSTRUCTURAL CHEMISTRY 
LABORATORY OF CHEMICAL PHYSICS 
UNIVERSITY OF GRONINGEN 
NUENBORGH 16 
NL 9747 AG GRONINGEN 
Tel.: 3150634383 
Telex: 3150634800 
Fax: 53935 CHRUG NL 
PROF. CP. HOLLENBERG 
PROFESSOR FUER MIKROBIOLOGIE 
HEINRICH-HEINE-UNIVERSITAET 
UNIVERSITAETSSTRASSE 1 
D 4000 DUESSELDORF 
TeL: 492113114720 
Telex: 49211342229 
Fax: 8587348 UNI D -
E-mail: HOLLENB@DDORUD8I 
DR. E. HONIKMAN-LEBAN 
PHD BIOLOGY RESEARCH INGENEER 
DEPARTMENT OF CHEMICAL PROTECTION 
AND 
PHOTOBIOLOGICAL RESEARCH IN VITRO 
UNIT OF CELL CULTURES / L'OREAL RESEAR 
AVENUE EUGENE SCHUELLER 01 
F 93600 AULNAY SOUS BOIS 
TeL: 33148689224 
Telex: 33148689004 
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DR. PJJ HOOYKAAS 
UNIVERSITAIR HOOFDDOCENT 
CLUSIUS LABORATORY 
DEPT. PLANT MOLECULAR BIOLOGY 
LEIDEN UNIVERSITY 
WASSENAARSEWEG 64 
NL 2333 AL LEIDEN 
Tel.: 3171274933 
Telex: 3171274999 
PROF. D.A. HOPWOOD 
PROFESSOR AND HEAD OF GENETICS 
DEPARTM 
JOHN INNES INSTTTUTE 
COLNEYLANE 
UK NR4 7UH NORWICH Tel: 4460352571 
Telex: 4460356844 
Fix: 975122 G 
DR. J. HUBER 
ACTING DIRECTOR 
INSTITUTE FOR BIOLOGICAL CONTROL 
BBA 
HEINRICHSTRASSE 243 
D 6100 DARMSTADT 
TcL: 49615144061 
Telex: 4961S1422S02 
DR. J.HJ. HUIS IN T VELD 
HEAD DEPARTMENT OF MICROBIOLOGY 
TNO NUTRITION AND FOOD RESEARCH 
UTRECHTSEWEG 48 
NL 3704 HE ZEIST 
TcL: 31340444730 
Telex: 31340454186 
Fax: 40022 OVO NL 
DR. R. HULL 
SENIOR PRINCIPAL SCIENTIFIC OFFICER (U 
JOHN INNES INSTITUTE 
JOHN INNES CENTRE 
NORWICH RESEARCH PARK 
COLNEYLANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Telex: 4460356H44 
Fix: 975122JIINORG 
E-mail: HULL@UKACAFRCJII 
DR. M. HUMPHREYS 
AFRC INSTITUTE OF GRASSLAND AND 
ENVIRONMENTAL RESEARCH 
WPBS 
PLAS GOGERDDAN 
UK SY23 3EB ABERYSTWYTH, DYFED 
Tel.: 44970828255 
Telex: 44970828357 
DR. J.C HUTTON 
BDA READER 
DEPARTMENT OF CLINICAL BIOCHEMISTRY 
ADDENBROOKE'S HOSPITAL 
UNIVERSITY OF CAMBRIDGE 
HILLS ROAD 
UK CB2 2QR CAMBRIDGE -
TcL: 44223336790 
Telex: 44223216862 
Fax:-
E-mail: JCH@UKACCAM.PHX 
Tclclcx: -
DR. M. HUYSMANS 
SENIOR ENGINEER 
SSI/RJ). 
BIM 
KWIKSTRAAT4 
B 3078 EVERBERG 
TcL: 3227595925 
Telex: 3227594783 
Fax: 63518 
E-mail: MARTINA@SUNBIM.BE 
DR. M. IACCARINO 
INTERNATIONAL INSTITUTE OF GENETICS AN 
BIOPHYSICS, CNR 
VIA MARCONI 12 
I 80125 NAPOU 
TcL: 39815932428 
Telex: 39815936123 
E-mail: NA0402@ICNUCEVM.BITNET 
DR. D. INZE / M. VAN MONTAGU 
GROUP LEADER 
LABORATORIUM VOOR GENETICA 
RUKSUNIVERSITEIT GENT 
K.L LEDEGANCKSTRAAT 35 
B 9000 GENT 
TcL: 3291645170 
Telex: 3291645349 
E-mail: JECOP@GENGENP.RUG.AC.BE 
DR. E. JACOBSEN 
DEPARTMENT OF PLANT BREEDING 
AGRICULTURAL UNIVERSITY WAGENINGEN 
LAWICKSE ALLEE 166 
P.OBOX 386 
NL 6700 AJ WAGENINGEN 
Tel.: 31837082859 
Telex: 31837083457 
PROF. C. JACQ 
GENETIQUE MOLECULAIRE 
ECOLE NORMALE SUPERIEURE 
RUE DTJLM 46 
F 75230 PARIS 
TcL: 33143258737 
Iblcx: 33143298172 
DR. M. JACQUET 
UNIVERSITE DE PARIS-SUD 
BATIMENT 400 
F 91405 ORSAY CEDEX 
Tel.: 33169417963 
Telex: 33169417296 
Fax: 602166FACOR 
E-mail: UBEX001@FROS 
DR. J.-C. JAUNIAUX 
DR. 
LABORATOIRE DE MICROBIOLOGIE 
UNIVERSITE LIBRE DE BRUXELLES 
BD DU TRIOMPHE 
CP244 
B 1050 BRUXELLES 
Tel.: 322640015 
Telex: 3226463148 
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DR. SJrf. JENSEN 
SCIENTIFIC OFFICER 
ECOLOGICAL DIVISION 
MINISTRY OF THE ENVIRONMENT 
THE NATIONAL FOREST AND NATURE 
AGENCY 
SLOTSMARKEN 13 
DK 2970 HORSHOLM 
Tel.: 45765376 
Telex: 45765477 
DR. A. JESTIN 
CHARGE DE RECHERCHES 
LABORATOIRE CENTRAL DE RECHERCHES 
AVICOLE ET PORCINE 
CENTRE NATIONAL ETUDES VETERINAIRES 
ET 
B.P. 9 
F 22440 PLOUFRAGAN 
Tel.: 3396941090 
Telex: 3396786861 
Fax: 950743 
PROF. A. JIMENEZ 
RESEARCH PROFESSOR 
CENTRO DE BIOLOGIA MOLECULAR 
CS.I.C. 
UNIVERSIDAD AUTONOMA CANTOBLANCO 
E 28049 MADRID 
Tel.: 3413975070 
Telex: 3413974799 
Fax: 27H10 EDUCI E 
DR. R. JIMENEZ DIAZ 
COLABORADOR CIENTinCO , 
INSTITUTO DE LA GRASA Y SUS DERTVADOS 
I. DE BIOTECNOLOGIA DE ALIMENTOS 
PADRE GARCIA TEJERO 4 
E 41012 SEVILLA 
Tel.: 3454691054 
Telex: 3454691262 
Fax: 72497 IGSE E 
DR. M. JOHN 
SCIENTIST / GROUP LEADER 
MAX-PLANCK-INSTrrUT FUER 
ZUECHTUNGSFOR 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062235 
Telex: 492215062213 
Fax: 498881028 MPIZ D 
PROF. LM. JOHNSON 
PROFESSOR OF MOLECULAR BIOPHYSICS 
LABORATORY OF MOLECULAR BIOPHYSICS 
DEPARTMENT OF BIOCHEMISTRY 
REX RICHARDS BUILDING 
SOUTH PARKS ROAD 
UK 0X1 3QU OXFORD 
TcL: 44865275397/5365 
Telex: 44865510454 
Fax: 83147 
DR. M. JOIGNY 
DIRECTEUR 
INSTTTUT DU TABAC DE BERGERAC 
SEITA 
DOMAINS DE LA TOUR 
F 24100 BERGERAC 
Tel: 3353636600 
Telex: 3353636608 
Fax: 570 220 SEITABE 
DR. J. JONES 
SENIOR SCIENTIST 
THE SAINSBURY LABORATORY 
JOHN INNES CENTRE 
COLNEYLANE 
UK NR4 7UH NORWICH 
TcL: 4460352571 
Telex: 44603250024 
Fax: 975122 JIINORG 
E-mail: JONES@JII.AFRC.ACUK 
DR. J. JOSEPHSEN 
ASSOCIATE PROFESSORS 
ROYAL VETERINARY AND AGRICULTURAL 
UNIV 
BUELOWSVEJ 13 
DK 1870 FREDERIKSBERG C 
Tel.: 4535283215 
Telex: 4535282079 
DR. A. JOYEAUX 
DIRECTOR R AND D 
LABORATOIRE DE SAINT SIMON 
SOCIETE EQUIPHARM 
F 15130 SAINT SIMON 
Tel.: 3371471195 
Telex: 3371471248 
Fax: 306022 
PROF. G.-G. JUNG 
PROFESSOR OF ORGANIC CHEMISTRY AND 
BIO 
INSTITUT FUER ORGANISCHE CHEMIE 
EBERHARD-KARLS UNIVERSITAET 
AUF DER MORGENSTELLE 18 
D 7400 TUEBINGEN 
Tel.: 497071296237 
Telex: 497071296925 
PROF. G. KALANTZOPOULOS 
PROFESSOR GREEK COORDINATED 
COLLECTION OF MICROO 
AGRICULTURAL UNIVERSITY OF ATHENS 
BOTANIKOS 
GR 118 55 ATHENS 
Tel.: 3013465333 
Telex: 3013469160 
Fax: 225018 AGSA 
E-mail: TELECOM GOLD 10075:DBI0256 
DR. E.F. KALETA 
RESEARCH SaENTIST 
INSTITUT FUER GEFLUEGELKRANKHEITEN 
JUSTUS-LIEBIG UNIVERSITAET 
FRANKFURTER STRASSE 87 
D 6300 GIESSEN 
TcL: 496417024865 
Telex: 496417024911 
DR. J. KALLERHOFF 
RESEARCH PROGRAM COORDINATOR FOR 
PLANT 
LABORATOIRE DE BIOLOGIE CELLULAIRE ET 
MOLECULAIRE BIOSEM SA. 
AVENUE DES LANDAIS 24 
CAMPUS UNIVERSITAIRE 
F 63170 AUBIERE 
TcL: 3373427970 
Telex: 3373275736 
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PROF. PJ. KALTSIKES 
DEPT. OF PLANT BREEDING AND BIOMETRY 
ATHENS AGRICULTURAL UNIVERSITY 
IERA ODOS 75 
GR 11855 ATHENS 
Tel.: 3013471504 
Telex; 3013460885 
PROF. R. KAPTEIN 
PROFESSOR 
DEPARTMENT OF ORGANIC CHEMISTRY 
UNIVERSITY OF UTRECHT 
PADUALAAN8 
NL 3584 CH UTRECHT 
Tel.: 3130533787/2652 
Telex: 3130540980 
DR. A. KARAGOUNI 
LECTURER 
INSTITUTE OF GENERAL BOTANY 
UNIVERSITY OF ATHENS 
PANEPISTIMIOUPOLIS 
GR 15784 ATHENS 
TcL: 3017243345 
Telex: 3017231634 
DR. A. KARP 
UG7 (PRINCIPLE SCIENTIFIC OFFICER) 
DEPARTMENT OF AGICULTURAL SCIENCES 
UNIVERSITY OF BRISTOL 
AFRC INSTITUTE OF ARABLE CROPS 
RESEARC 
LONG ASHTON RESEARCH STATION 
UK BS18 9AF BRISTOL 
Tel.: 44275392181 
Telex: 44275394007 
DR. C. KARSSEN 
PROFESSOR 
DEPARTMENT OF PLANT PHYSIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 33837083645 
Telex: 33837084761 
DR. T. KAVANAGH 
LECTURER IN MOLECULAR GENETICS 
TRINITY COLLEGE 
UNIVERSITY OF DUBLIN 
COLLEGE GREEN 
IRL 2 DUBLIN 
Tel.: 3531772941 EXT.1908 
Telex: 3531798558 
Fix: 93782 TCD EI 
E-mail: KAVANAGH@VAX1.TCD.IE 
DR. G.M. KEIL 
DR.RER.NAT., SENIOR SCIENTIST, LEADER 
INSTITUTE FOR MICROBIOLOGY 
FEDERAL RESEARCH CENTRE FOR 
VIRUS DISEASES OF ANIMALS 
PAUL-EHRLICH-STRASSE 28 
D 7400 TUEBINGEN 
Tel.: 497071603323 
Telex: 497071603201 
Fix: 17707131 
DR. G.D. KEIZER 
HEAD OF RESEARCH, DEVELOPMENT AND 
PROD 
HBT HOLLAND BIOTECHNOLOGY BV 
NIELS BOHRWEG 13 
NL 2333 CA LEIDEN 
TcL: 3171219521 
Telex: 3171211507 
Fix: 39350 
DR. FJ. KENNEDY 
CAPTEC 
COMPUTER APPLIED TECHNIQUES LTD 
ST JAMES' TERRACE 3 
IRL MALAHIDE, CO DUBLIN 
TcL: 3531450921 
Telex: 3531450136 
E-mail: FRED@CAPTEC.IE 
PROF. K. KERSTERS 
ASSOCIATE PROFESSOR 
LABORATORIUM VOOR MICROBIOLOGIE 
UNIVERSITEIT GENT 
K.L LEDEGANCKSTRAAT 35 
B9000 GENT 
Tel.: 3291645105 
Telex: 3291645346 
E-mail: GELS@LMGMICRO.RUG.AC.BE 
PROF. K. KERSTERS 
ASSOCIATE PROFESSOR 
LABORATORIUM VOOR MICROBIOLOGIE 
FACULTY OF SCIENCES 
RLIKSUNIVERSITEIT GENT 
K.L LEDEGANCKSTRAAT 35 
B 9000 GENT 
TcL: 3291645105 
Telex: 3291645346 
Fix: 9312133486 GK G 
E-mail: KERSTERS@LMGMICRO.RUG.AC.BE 
PROF. H. KESSLER 
TECHNICAL UNIVERSITY MUNICH 
UCHTENBERGSTRASSE 4 
D 8046 GARCHING 
Tel.: 498932093300 
Telex: 498932093210 
MS. B. KIRSOP 
EXECUTIVE DIRECTOR 
MICROBIAL STRAIN DATA NETWORK 
(MSDN) 
HUNTINGDON ROAD 307 
UK CB3 OJX CAMBRIDGE 
Tel.: 44223276622 
Telex: 44223277605 
Fax: 9312133976 MS G 
E-mail: TELECOM GOLD 10075:DBI0001/DBI0005 
PROF. S. KJELLEBERG 
PROFESSOR 
DEPARTMENT OF GENERAL AND MARINE 
MICROBIOLOGY 
UNIVERSITY OF GOTEBORG 
CARL SKOTTSBERGS GATAN 22 
S 41319 GOTEBORG 
TcL: 4631418700 
Telex: 4631826790 
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DR. D. KLAMBT 
PROFESSOR 
BOTANISCHES INSTITUT 
UNIVERSITAET BONN 
MECKENHHMER ALLEE 170 
D 5300 BONN 1 
Tel.: 49228732680 
Telex: 49228735545 
DR. J. KNOP 
HEAD, DEPARTMENT OF DERMATOLOGY, 
ASSIS 
DERMATOLOGIE KLINIK 
KLINIKUM DES JOHANNES GUTENBERG-
UN FVER 
LANGENBECKSTRASSE 1 
POSTFACH 3960 
D 6500 MAINZ 
Tel.: 496131177112 
Telex: 496131176614 
Fax: 4187402 UK MZ 
DR. M. KOKKINIDIS 
PROF UNIV CRETE; GROUP LEADER AT IMBB 
DEPARTMENT OF PROTEIN STRUCTURE 
AND FUNCTION 
IMSB. 
P.O. BOX 1527 
GR 71110 HERAKLION 
Tel.: 3081210031 
Telex: 3081239735 
Fax: 26282896 IMBB GR 
E-mail: KOKKINIDIS$>GRIMBB.BITNET 
DR. F.N. KOUSIS 
RESEARCHER 
THE NATIONAL HELLENIC RESEARCH 
FOUNDAT 
VAS.CONSTANTINOU AVENUE 48 
GR 116 35 ATHENS 
Tel.: 3017239965 
Telex: 3017212729 
Fax: 224064 
DR. C. KONCZ 
MAX-PLANCK-INSnTUT FUER 
ZUECHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062350 
Telex: 492215062413 
Fax: 8 881 028 MPIZ D 
DR. A. KOOL 
MANAGER BIOTECHNOLOGY 
ZAADUNIE B.V. 
WESTEINDE 62 
P.O. BOX 26 
NL 1600 AA ENKHUIZEN 
Tel.: 31228011411 
Telex: 31228012818 
Fax: 57053 SGNL 
DR. M. KOORNNEEF 
SENIOR LECTURER 
DEPARTMENT OF GENETICS 
AGRICULTURAL UNIVERSITY WAGENINGEN 
DREIJENLAAN 2 
NL 6703 HA WAGENINGEN 
Tel.: 318370X2150 
Telex: 31837084731 
PROF. U. KOSZINOWSKI 
PROFESSOR OF VIROLOGY, MEDICAL 
DIRECTO 
INSTITUTE OF MICROBIOLOGY 
DEPT. OF VIROLOGY 
UNIVERSITY OF ULM 
ALBERT-EINSTEIN-ALLEE 11 
D7900 ULM 
Tel.: 497315023340 
Telex: 497315023337 
PROF. M. KREIS 
PROFESSOR 
INSTITUT DE RECHERCHE SUR LES PLANTES 
BIOLOGIE MOLECULAIRE VEGETALE 
UNIVERSITE DE PARIS-SUD 
BATIMENT 430, RDC 
F 91405 ORSAY 
Tel.: 33169417239 
Telex: 33169853715 
Fax: 692 166 F 
E-mail: BMV@FRUPS51 
PROF. TH. KRIEG 
UNIVERSITATSPROFESSOR 
KLINIK UND POUKLINIK FUER 
DERMATOLOGI 
UND VENEROLOGIE DER 
UNIVERSITAET ZU KOELN 
JOSEPH-STELZMANN STRASSE 9 
D 5000 KOELN 41 
TcL: 492214784500 
Telex: 492214784549 
DR. A. KONDOROSI 
DIRECTEUR DE RECHERCHE, 
DIRECTOR OF IS 
INSTITUT DES SCIENCES VEGETALES 
CNRS 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
Tel.: 331698236% 
Telex: 33169823695 
E-mail: ADAM-K@FRCTn51J3ITNET 
PROF. W.N. KONINGS 
PROFESSOR OF MICROBIOLOGY; CHAIRMAN 
OF 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY OF GRONINGEN 
KERKLAAN30 
NL 9751 NN HAREN 
Itt : 3150632152 
Telex: 3150635205 
DR. R. KRON-MORELLI 
AGRIFUTUR SRL. 
VIA CAMPAGNOLE 8 
I 25020 ALFIANELLO (BRESCIA) 
TcL: 39309305697 
Telex: 39309305048 
DR. R.M. KROPPENSTEDT 
DIRECTOR 
DSMDEUTSCHE SAMMLUNG VON 
MIKROORGANIS 
UND ZELLKULTUREN GMBH 
MASCHERODER WEG 1 B 
D 3300 BRAUNSCHWEIG 
TcL: 4953161870 
Telex: 49531618718 
Fax: 531104 DSM 
E-mail: TELECOM GOLD 10075:DBI0225 
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DR. V. KRUTOVSKIKH 
INTERNATIONAL AGENCY FOR RESEARCH 
ONC 
COURS ALBERT THOMAS 150 
F 69372 LYON 08 
Tel.: 3372738496 
Telex: 3372738575 
Fax: 380 023 
DR. HE. KURZWELLY 
DIMDI 
DEUTSCHES INSTITUT FUER MEDIZINISCHE 
DOKUMENTATION UND INFORMATION 
POSTFACH 420580 
D 5000 KOELN 41 
Tel.: 492214724252 
Telex: 49221411429 
Fix: 8881364 
DR. W.E. LANCASHIRE 
BIOTECHNOLOGY MANAGER, RESEARCH 
AND DE 
RESEARCH AND DEVELOPMENT 
DEPARTMENT 
WHITBREAD AND COMPANY PLC 
WHITBREAD TECHNICAL CENTRE 
PARK STREET 
UK LU1 3ET LUTON 
Tel.: 44582424200 
Telex: 44582416750 
Fax: 824204 
DR. L. LANFRANCONE 
DIRECTOR OF THE RESEARCH 
LABORATORIA DI BIOLOGIA MOLECULARE 
ISTTTUTO CLINICA MEDICA I 
UNTVERSITA DEGLI STUDI 
VIA BRUNAMONTI 51 
I 06100 PERUGIA 
Tel.: 39755783255 
Telex: 39755783444 
PROF. CM. LAPIERE 
PROFESSOR - HEAD OF DEPARTMENT 
LABORATORY OF EXPERIMENTAL 
DERMATOLOGY 
CENTRE HOSPITALO-UNIVERSrrAIRE 
UNIVERSITY OF LIEGE 
TOUR DE PATHOLOGIE B23 
B 4000 SART-TILMAN 
Tel.: 3241562456 
Telex: 3241307234 
Fix: UNTVLG 41397 
DR. DJ. LEAK 
LECTURER 
CENTRE FOR BIOTECHNOLOGY 
THE IMPERIAL COLLEGE OF SCIENCE, 
TECHNOLOGY AND MEDICINE 
EXHIBITION ROAD 
UK SW7 2AZ LONDON 
Tel.: 44715K95111 EXT. 709 
Telex: 44712258942 
DR. M. LEBRUN 
INGENIEUR DE RECHERCHE 
SERVICE DE BIOLOGIE MOLECULAIRE ET 
CELLULAIRE VEGETALE 
RHONE-POULENC AGROCHIMIE 
RUE PIERRE BAIZET 14 
BP9163 
F 69263 LYON CEDEX 09 
Tel.: 3372292848 
Telex: 3372292297 
Fax: 310O9HF RHONE 
DR. C. LECOMTE 
PROJECT LEADER 
EUROGENTEC S.A. 
RUE BOIS ST JEAN 14 
B 4102 SERAING 
Tel.: 3241654393 
Telex: 3241562968 
E-mail: U218101@BLEULG11 
DR. AM. LEDEBOER 
TBC 
UNILEVER RESEARCH LABORATORIUM 
OLIVIER VAN NOORTLAAN 120 
NL 3133 AT VLAARDINGEN 
Tel: 31104606933 EXT. 554 
Telex: 31104605383 
Fax: 23261 
DR. J. LEEMANS 
PLANT GENETIC SYSTEMS N.V. 
J. PLATTEAUSTRAAT 22 
B 9000 GENT 
TcL: 3291358498 
Telex: 3291240694 
PROF. M.-D. LEGOY 
PROFESSOR 
LABORATOIRE DE TECHNOLOGIE 
ENZYMATIQUE 
UNIVERSITE TECHNOLOGIE DE COMPIEGNE 
BP649 
F 60206 COMPIEGNE 
Tel.: 3344200037 
Telex: 3344203910 
Fax: 150110 
PROF. J. LEHMANN 
PROF. OF CELL CULTURE TECHNOLOGY 
TECHNISCHE FAKULTAET 
AG ZELLKULTURTECHNIK 
UNIVERSITAET BIELEFELD 
UNrVERSITAETSSTRASSE 25 
D 4800 BIELEFELD 
Tel.: 495211066319 
Telex: 495211066328 
DR. J.-P. LEPOITTEVIN 
CHARGE DE RECHERCHE AU C.N.R.S. 
LABORATOIRE DE DERMATOCHIMIE 
CUNIQUE DERMATOLOGIQUE 
CHJt. DE STRASBOURG 
F 67091 STRASBOURG 
Tel.: 3388350664 
Telex: 3388161032 
DR. K.R. UBBENGA 
FULL PROFESSOR 
DEPARTMENT OF PLANT MOLECULAR 
BIOLOGY 
BOTANICAL LABORATORY 
LEIDEN UNIVERSITY 
NONNENSTEEG 3 
NL 2311 VJ LEIDEN Tel.: 3171275064 Telex: 3171274900 
Fax: 39427 BURUL NL 
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DR. K. LINDSEY 
LEADER PLANT MOLECULAR BIOLOGY 
RESEARC 
LEICESTER BIOCENTRE 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
Tel: 44533522263 
Telex: 44533551219 
Fax: 342318 LEIBIO G 
PROF. HJ. UPPS 
PROFESSOR DOKTOR, STIFTUNGSPROFESSOR 
MEDIZINISCH-NATURWISSENSCHAFTUCHES 
FORSCHUNGSZENTRUM 
UNIVERSITAET TUEBINGEN 
OB DEM HIMMELREICH 7 
D 740O TUEBINGEN 
Tel.: 497071295025 
Fax: 49707187815 
DR. F. MALPARTIDA 
INVESTIGADOR CIENTinCO DEL CSIC 
BIOTECHNOLOGY DEPARTMENT 
CENTRO NAaONAL DE 
BIOTECNOLOGLVMICRO 
CSIC 
SERRANO 115, BI 
E 28006 MADRID 
Tel: 3413975452 
Telex: 3413150075 
Fax: CSIC E-42182 
E-mail: FMALPART@EMDCNB51 
DR. G. MARIGO 
MAITRE CONFERENCES 
UNIVERSITE PAUL SABATIER/CNRS 
ROUTE DE NARBONNE 118 
F 31062 TOULOUSE CEDEX 
Tel.: 3361556753 
Telex: 3361556210 
DR. M. LOMBARD 
D.V.M. DIRECTOR OF FMDV PRODUCTION 
RHONE MERIEUX DIRECTOR FA 
RUE MARCEL MERIEUX 254 
BJ. 7009 
F 69342 LYON 07 
Tel.: 3372723380 
Telex: 3372723480 
DR. H. LORZ / DR.P.T.H. BROWN 
PROFESSOR AND HEAD OF DEPARTMENT 
INSTITUT FUER ALLGEMEINE BOTANIK 
UNIVERSITAET HAMBURG 
OHNHORSTSTRASSE 18 
D 2000 HAMBURG 52 
Tel.: 494OK222410 
Telex: 49408222229 
DR. D. MARIOTTI 
SENIOR STAFF SCIENTIST/GROUP LEADER 
ISTITUTO DI RADIOBIOCHIMICA ED 
ECOFISIOLOGIA VEGETALI 
CONSIGUO NAZIONALE DELLE RICERCHE 
VIA SALARIA Km 29J 
I 00016 MONTEROTONDO SCALO (ROMA 
Tel.: 39690020542 
Telex: 3969005849 
PROF. E. MARRE 
FULL PROFESSOR 
DEPARTIMENTO DI BIOLOGIA 
VIA CELORIA 26 
I 20133 MILANO 
Tel.: 39226604390 
Telex: 39226604407 
DR. G. LUCCHINI 
DIPARTIMENTO DI GENETICA 
E DI BIOLOGIA MOLECOLARE 
UNIVERSITY OF MILANO 
VIA CELORIA 26 
I 20133 MILANO 
Tel.: 3922663498 
Telex: 3922664551 
E-mail: GENETTC@IMIUCCA 
DR. H. LUCIUS 
Z.I.M.B. - ZENTRAUNSTTTUT FUER MOLEKU 
ROBERT-ROESSLE-STRASSE 10 
D 0-1115 BERUN BUCH 
Tel.: 3729462362 
Telex: 3729494161 
PROF. A. MAGGI 
PROFESSOR 
INSTITUTE OF PHARMACOLOGICAL SCIENCES 
LAB. DI BIOTECNOLOGIE APPUCATE ALLA F 
BALZARETTI9 
I 20133 MILANO 
Tel.: 392204881375 
Telex: 39229404961 
DR. V.M. MARSHALL 
HEAD OF CENTRE FOR SCIENCES OF FOOD 
AN 
OXFORD POLYTECHNIC 
GIPSYLANE 
HEADINGTON 
UK OX3 OBP OXFORD 
Tel.: 44865819248 
Telex: 44865819073 
Fax: G83L47VIA 
DR. P. MARTEL 
RESEARCH RESPONSIBLE 
LABORATOIRE DE NUTRITION 
ET SECURrTE ALIMENTAIRE 
INRA 
DOMAINS DE VILVERT 
F 78352 JOUY-EN-JOSAS CEDEX 
Tel.: 33134652254 
Telex: 33134652311 
Fax: INRACRZ 695 431 F 
E-mail: CHRONOPOSTE 
DR. GJJtf. MARTENS 
STAFF ASSISTANT PROFESSOR 
DEPARTMENT OF ANIMAL PHYSIOLOGY 
UNIVERSITY OF NUMEGEN 
TOERNOOIVELD 
NL 6525 ED NUMEGEN 
Tel: 3180652601 
Telex: 3180553450 
Fax: 48228 WINA NL 
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PROF. J. MARTIAL 
PROFESSOR 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
ET 
GENIE GENETIQUE / INSTITUT DE CHIMIE 
UNTVERSITE DE LIEGE 
CAMPUS SART TILMAN B6 
B 4000 LIEGE 
TcL: 3241563311 
Telex: 3241562968 
Fax: 41397 UNIVLG 
PROF. J.F. MARTIN 
PROFESSOR OF MICROBIOLOGY 
DIVISION OF MICROBIOLOGY 
DEPT. OF ECOLOGY, GENETICS AND MICROBI 
UNIVERSITY OF LEON 
CAMPUS DE VEGAZANA, S/N 
E 24071 LEON 
Tel.: 3487291505 
Telex: 3487291506 
Fax: 89892 EDUCI E 
DR. C. MARTIN 
SENIOR SCIENTIFIC OFFICER 
JOHN INNES INSTITUTE 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 EXT. 279 
Telex: 4460356844 
Fax: 975122 
DR. A. MARTIN 
SENIOR RESEARCHER 
CS.I.C. 
E 14080 CORDOBA 
Tel.: 3457218509 
Telex: 3457218563 
DR. J. M. MARTINEZ ZAPATER 
RESEARCHER A 
DEPARTAMENTO DE PROTECCION VEGETAL 
CENTRO DE INVESTIGACION Y TECNOLOGIA 
INSTITUTO NACIONAL DES INVESTIGACIONES 
CARRETERA DE LA CORUNA KM 7 
E 28040 MADRID 
Tel.: 3413572294209 
Telex: 3413572293 
PROF. A. MARTINI 
FULL PROFESSOR, CURATOR OF THE 
DBVPGC 
COLLEZIONE DEI LIEVm INDUSTRIAL! DBV 
DIPART. BIOLOGIA VEGETALE 
UNIVERSITA' DI PERUGIA 
BORGO 20 GIUGNO 74 
I 06100 PERUGIA 
TcL: 397530458 
Telex: 39755856299 
Fax: UNIPG I 662078 
DR. R. MASTERSON 
SENIOR SCIENTIST 
ABT. GENETISCHE GRUNDLAGEN DER 
PFLANZE 
MAX-PLANCK-INSnTUT FUER 
ZUECHTUNGSFOR 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
TcL: 492215062245 
Telex: 492215062213 
Fax: 8 881 028 MPIZ D 
PROF. P i . MATEO ALARCON 
DEPARTMENT OF PHYSICAL CHEMISTRY 
UNIVERSITY OF GRANADA 
SEVERO OCHOA S/N 
E 18071 GRANADA 
Tel.: 3458272879 
Telex: 3458274258 
Fax: 345878435 
DR. G. MATTHUSSENS 
GENERAL MANAGER 
CORVAS INTERNATIONAL N.V. 
JOZEF PLATEAUSTRAAT 22 
B 9000 GENT 
TcL: 3291358406 
Telex: 3291255005 
DR. S.G. MAYHEW 
STATUTORY LECTURER 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY COLLEGE DUBLIN 
BELFIELD 
IRL 4 DUBLIN 
Tel.: 35317061572 
E-mail: MAYHEWS@IRLEARN.BITNET 
DR. DJ. MCDONNELL 
PROF. 
NATIONAL CENTRE OF PHARMACEUTICAL 
BIOT 
DEPARTMENT OF GENETICS 
TRINITY COLLEGE 
IRL DUBLIN 2 
Tel.: 3531772941 EXT. 2008 
Telex: 3531798558 
Fax: 93782 TCD EI 
E-mail: DMCCNNLL@VAXXI.TCD.IE 
DR. W. MCDOWELL 
GROUP LEADER GLYCOBIOLOGY 
MRC COLLABORATIVE CENTRE 
BURTONHOLE LANE 1 
MILL HILL 
UK NW7 IAD LONDON 
TcL: 44819063811 
Telex: 44819061395 
Fax: 9413459 
DR. A.P. MCQUEEN 
NICKERSON INTERNATIONAL SEED COMPANY 
CAMBRIDGE SCIENCE PARK 
MILTON ROAD 200 
UK CB4 4GZ CAMBRIDGE 
TcL: 44223423933 
Telex: 44223420925 
DR. P.A. MEACOCK 
DEPUTY DIRECTOR AND RESEARCH GROUP 
LEA 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
UK LEI 7RH LEICESTER 
TcL: 44533522268 
Telex: 44533551219 
Fax: 342318 LEI BIO G 
DR. R.H. MELOEN 
LABORATORY FOR MOLECULAR 
IMMUNOLOGY 
CENTRAAL DIERGENEESKUNDIG INSTITUUT 
EDELHERTWEG 15 
NL 8219 PH LELYSTAD 
TcL: 31320073911 
Telex: 31320073473 
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PROF. A. MENDES FAIA 
PROFESSORA ASSOCIADA 
UNIVERSIDADE DE TRAS-OS-MONTES 
E ALTO DOURO 
APARTADO 202 
P 5001 VILA REAL CODEX 
Tbl.: 3515925031/9 
Tblcx: 3515974480 
Fax: 24436 
DR. U. MENGE 
GROUP LEADER 
DEPARTMENT OF ENZYME TECHNOLOGY 
GROUP FOR SCREENING AND DESIGN OF 
TECH 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181310 
Telex: 495316181302 
DR. C. MEREDITH 
SCIENTIFIC OFFICER, 
IMMUNOTOXICOLOGY D 
DEPT. OF IMMUNOTOXICOLOGY 
BRITISH INDUSTRIAL BIOLOGICAL 
RESEARCH ASSOCIATION (BIBRA) 
WOODMANSTERNE ROAD 
UK SMS 4DS CARSHALTON. SURREY 
Tel.: 4416434411 
Telex: 4416617029 
Fax: 2343H 
DR. M. MERGEAY 
HEAD OF LABORATORY 
LABORATORY OF GENETICS A 
BIOTECHNOLOGY 
VLAAMSE INSTELUNG VOOR 
TECHNOLOGISCH 
ONDERZOEK (SCK-CEN/VITO) 
BOERETANG 200 
B 2400 MOL 
Tel.: 3214333111 EXT. 5112 
Telex: 3214320372 
Fax: 31922 
E-mail: MERGEAY(ijBMLSCKl 1 
DR. H.W. MEWES 
PROJECT LEADER MIPS DATENBANK FUR 
PROT 
MIPS AM MAX PLANCK INSTITUT FUER BIOCH 
AM KLOPFERSPITZ 18 
D 8033 MARTINSRIED 
Tel.: 498985782657 
Telex: 498985782655 
E-mail: MEWES@MIPS 
DR. P. MEYER 
LEADER OF AN INDEPENDENT WORKING 
GROUP 
MAX-DELBRUEK-LABORATORIUM IN DER 
MPG 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
Tel: 492215062490 
Telex: 492215062319 
DR. G. MIGNOT 
HEAD OF CELL CULTURE LABORATORY 
CELL CULTURE LABORATORY 
TM INNOVATION 
AVENUE DES TROPIQUES 3 
BP. 100 
F 91943 LES UUS 
Tel.: 33169077871 
Tblcx: 33169071903 
Fax: 602729 
DR. J. MIKKELSEN 
DANISCO A/S 
LANGEBROGADE 1 
P.O. BOX 17 
DK 1001 COPENHAGEN 
Tel.: 45319541002210 
Tblcx: 4531953022 
Fax: 31430 DANSUK DK 
DR. P. MILLNER 
LECTURER 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY OF LEEDS 
UK LS2 9JT LEEDS 
Tel.: 44532333149 
Tblcx: 44532336017 
Fax: 44532556473 
DR. O. MISSET 
HEAD DEPARTMENT PROTEIN CHEMISTRY & 
EN 
ROYAL GIST BROCADES N.V. 
WATERINGSEWEG 1 
NL2611 XT DELFT 
Tbl.: 3115799111/2659 
Tblcx: 3115793890 
Fax: 38103 GB NU NL R&D 
DR. W. MOENS 
SENIOR RESEARCH OFFICER 
INSTITUT D'HYGIENE ET D'EPIDEMIOLOGIE 
RUE JULIETTE WYTSMAN 14 
B 1050 BRUXELLES 
TbL: 3226425512 
Telex: 3226425519 
Fax: 21034 IHE BRU 
PROF. S. MOUN 
PROFESSOR 
DEPARTMENT OF MICROBIOLOGY 
THE TECHNICAL UNIVERSITY OF DENMARK 
BUILDING 221 
DK 2800 LYNGBY 
Tel.: 4542882222 
Tblcx: 4545932809 
Fax: 37529DTHDIADK 
DR. J.-P. MORIN 
CHARGE DE RECHERCHE INSERM 
INSERM - UNITE 295 
FACULTE MEDICINE-PHARMACIE 
UNIVERSITE DE ROUEN 
AVENUE DE L'UNTVERSITE 
BP. 47 
F 76800 ST.ETIENNE DU ROUVRAY 
TcL: 3335655274 EXT. 21 
Tblcx: 3335661278 
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DR. I. MOURA 
ASSOCIATE PROFESSOR 
CENTRO DE TECNOLOGIA QUIMICA E 
BIOLOGICA (CTQB) 
RUA DA QUINTA GRANDE 6 
APARTADO 127 
P 2780 OEIRAS 
Tel.: 35114428616346 
Telex: 35114428766 
DR. F. MULHOLLAND 
HEAD, DEPARTMENT OF BIOTECHNOLOGY 
AND 
READING LABORATORY 
AFRC INSTITUTE OF FOOD RESEARCH 
UK RG2 9AT SHINFIELD 
Tel: 44734883103228 
Telex: 44734884763 
Fax: 9312102022 LBG 
DR. B. MULLIGAN 
LECTURER 
DEPARTMENT OF BOTANY 
UNIVERSITY OF NOTTINGHAM 
UK NG7 2RD NOTTINGHAM 
Tel.: 44602484848 EXT. 346 
Telex: 44602420825 
DR. F. NAUN 
TBC 
LYVEN 
ROUTE DE PARIS 
F 14630 CAGNY 
TcL: 3331234532 
Telex: 3331234572 
Fax: 170305 
DR. I.F. NES 
LABORATORY OF MICROBIAL GENE 
TECHNOLOG 
NLVF 
AGRICULTURAL RESEARCH COUNCIL 
P.O. BOX 51 
N 1432 AAS 
Tel.: 479949471/63 
Telex: 479941465 
E-mail: BIOIFN@NLH10000.NLH.NO 
DR. HJ. NEWBURY 
UNIVERSITY LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UK B15 2TT BIRMINGHAM 
Tel.: 44214145581 
Telex: 44214145925 
Fax: SPAPHY G 338938 
DR. H.O. NIELSEN 
SECTION MANAGER 
LABORATORY FOR TECHNICAL OPTICS 
HIORTEKAERSVEJ 99 
DK 2800 LYNGBY 
TcL: 4542888333 
Telex: 4545930353 
Fax: 37529 DTHDIADK 
DR. N. NOLARD-TINTIGNER 
SENIOR RESEARCH OFFICER 
INSTITUT D'HYGIENE ET EPIDEMIOLOGIE (I 
RUE JULIETTE WYTSMAN 14 
B 1050 BRUXELLES 
Tel.: 3226425517 
Telex: 3226425519 
Fax: 21034 IHE BRU 
PROF. C. NOMBELA 
FULL PROFESSOR AND HEAD OF 
DEPARTMENT 
DEPARTAMENTO DE MICROBIOLOGIA II 
FACULTAD DE FARMACIA 
UNIVERSIDAD COMPLUTENSE DE MADRID 
aUDAD UNIVERSITARIA 
E 28040 MADRID 
TcL: 3413941743 
Telex: 3415440667 
Fax: 41806 UCFAR 
DR. JJL NOORDIK 
DIRECTOR/PROJECT MANAGER CAOS/CAMM 
CEN 
CAOS/CAMM CENTER 
UNIVERSITY OF NUMEGEN 
TOERNOOrVELD 
NL 6525 ED NUMEGEN 
Tel.: 3180653386 
Telex: 3180553450 
E-mail: NOORDIK@CAOS.CAOSJCUN.NL 
PROF. M.P. NUTI 
PROFESSOR, AGRICMICROBIOLOGY -
HEADO 
DIPARTIMENTO DI BIOTECNOLOGIE 
AGRARIE 
UNIVERSITA DEGLI STUDI DI PADOVA 
VIA GRADENIGO 6 
I 35125 PADOVA 
Tel.: 3949H071442 
Telex: 39498070517 
Fax: 430176 UNPADU 
DR. F. O' GARA 
DIRECTOR - BIOTECHNOLOGY CENTRE. 
MICROBIOLOGY DEPARTMENT 
BIOTECHNOLOGY CENTRE 
UNIVERSITY COLLEGE 
IRLCORK 
Tel.: 353212768712351 
Telex: 35321275948 
Fax: 76050 UNIC EI 
KDR. M. O'CONNELL 
LECTURER 
DUBLIN CITY UNIVERSITY 
GLASNEVIN 
IRL 9 DUBLIN 
TcL: 3531370077318 
Telex: 3531360830 
Fax: 30167 
DR. F. O'GARA 
DIRECTOR -NATIONAL FOOD 
BIOTECHNOLOGY 
NATIONAL FOOD BIOTECHNOLOGY CENTRE 
DEPT. OF FOOD MICROBIOLOGY 
UNIVERSITY COLLEGE CORK 
IRLCORK 
Tel.: 35321276871 EXT. 264 
Telex: 35321275934 
Fax: 76050 UNICCEI 
E-mail: STDM 8008 
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DR. DJ. OCKENDON 
PROJECT LEADER 
AFRC INSTITUTE OF HORTICULTURAL 
RESEAR 
WELLESBOURNE 
UK CV35 9EF WARWICK 
Tel.: 44789470382 
Telex: 44789470552 
E-mail: kING@UKACAFRC.NVRS 
PROF. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
BIOTECHNOLOGY 
MARIBO SEED 
LANGEBROGADE 
P.O. BOX 17 
DK 1001 COPENHAGEN 
Tel.: 4531954100 EXT. 2210 
Telex: 4531953022 
Fix 31169 MARIBO DK 
DR. R. OLIVER 
LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF EAST ANGUA 
UK NR4 7TJ NORWICH 
Tel.: 4460356161/2889 
Telex: 4460358553 
Fax: 975334 
PROF. S.G. OLIVER 
PROFESSOR OF BIOTECHNOLOGY 
MANCHESTER BIOTECHNOLOGY CENTRE 
UNIVERSITY OF MANCHESTER 
INSTITUTE OF SCIENCE AND TECHNOLOGY 
SACKVILLE STREET 
P.O. BOX 88 
UK M60 1QD MANCHESTER 
Tel: 44612004222 
Telex: 44612360409 
Fax: 666094 UMIST G 
Email: S.G.OUVER@UK-AC.UMIST 
DR. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
DANISCO A/S 
LANGEBROGADE 1 
P.O. BOX 17 
DK 1001 COPENHAGEN K 
Tel.: 4531954100 
Telex: 4531953022 
Fax: 31430 DANS UK 
PROF. F. OLLEVIER 
FULL PROFESSOR 
ZOOLOGICAL INSTITUTE 
LABORATORY FOR ECOLOGY AND 
AQUACULTURE 
KATHOLIEKE UNIVERSITEIT LEUVEN 
NAAMSESTRAAT 22 
B 3000 LEUVEN 
Tel.: 3216283966 
Telex: 32162H3902 
E-mail: FGDCB01@BLEKUL11 
DR. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
DANISCO A/S 
LANGEBROGADE I 
P.O. BOX 17 
DK 1001 COPENHAGEN K 
Tel.: 45319541002210 
Telex: 4531953022 
Fax: 31430 DANSUK DK 
DR. P. OLESEN 
RESEARCH PLANNING MANAGER, 
PROFESSOR 
DANISCO A/S 
LANGEBROGADE P.O. BOX 17 1 
DK 1001 COPENHAGEN K 
Tel.: 45319541002210 
Telex: 4531953022 
Fax: 31430 DANSUK DK 
DR. J. OUVARES 
PROFESOR DE INVESTIGACION 
DEPT. DE MICROBIOLOGIA 
ESTACION EXPERIMENTAL DEL ZAIDIN, 
PROFESOR ALBAREDA 1 
E 18006 GRANADA 
Tel.: 3458121011258 
Telex: 3458129600 
DR. R. OLIVER 
LECTURER 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF EAST ANGUA 
UK NR4 7TJ NORWICH 
TcL: 4460259492 
Telex: 4460358553 
Fax: 975B4 
DR. L. OLLIVIER 
DIRECTEUR DE LA STATION DE 
GENETIQUE Q 
INRA STATION DE GENETIQUE 
QUANTITATIVE 
DOMAINE DE VILVERT CRJ 
F 78350 JOUY-EN-JOSAS 
Tel.: 33134652190 
Telex: 33134652210 
Fax: INRACRZ 695431 
E-mail: VGENLOL@FRINRAll 
DR. F.R. OPPERDOES 
HEAD RESEARCH UNIT FOR TROPICAL 
DISEAS 
INTERNATIONAL INSTITUTE OF CELLULAR 
AN 
MOLECULAR PATHOLOGY 
(ICP) 
AVENUE HIPPOCRATE 74 
B 1200 BRUSSELS 
TcL: 3227647439 
Telex: 3227626853 
Fax: 23722 UCLWOLB 
E-mail: OPPERD@TROP.UCLAGBE 
DR. M. PAGES TORRENS 
DEPTO DE GENETICA MOLECULAR. 
CENTRO DE INVESTIGAaON Y DESARROLLO 
C.S.I.C. 
JORDI GIRONA 18 
E 08034 BARCELONA 
TcL: 772046851 
Telex: 772045904 
Fax: 97977 
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DR. K. PALME 
SENIOR SCIENTIST 
MAX-PLANCK-INSTTTUT FUER 
ZUECHTUNGSFOR 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
TcL: 4902215062385 
Telex: 492215062213 
Fax: 8 (Mil 028 MPIZ D 
E-mail: PALME@VAX.MPIZ-OELN.MPG.DBP.DE 
PROF. F. PALTAUF 
DEPARTMENT HEAD 
DEPARTMENT OF BIOCHEMISTRY 
AND FOOD CHEMISTRY 
GRAZ UNIVERSITY OF TECHNOLOGY 
SCHLOEGELGASSE 09 
A 8010 A GRAZ 
TcL: 43316030642 
Iblcx: 43316827685 
DR. CS. PANAYI 
TBC 
RHEUMATIC DISEASE UNIT 
GUVS AND ST.THOMAS'S HOSPITALS 
UNITED MEDICAL AND DENTAL SCHOOLS 
ST. THOMAS STREET 
UK SE1 9RT LONDON 
TcL: 4419554394 
Iblcx: 4414075134 
DR. NJ. PANOPOULOS 
ASSOCIATE RESEARCH SCIENTIST, PROF UNI 
INSTITUTE OF MOLECULAR BIOLOGY AND 
BIO 
FOUNDATION FOR RESEARCH AND 
TECHNOLOGY 
P.030X 1527 
GR 711 10 HERAKLION 
IbL: 3081210091 
Iblcx: 3081239735 
Fax: 262896 IMBB GR 
E-mail: SECRETARIAT@GRIMBB 
DR. B. PARODI 
MEDICAL DOCTOR, LABORATORY ASSISTANT 
SERV1ZIO TECNOLOGIE BIOMEDICHE 
ISTrrUTO NAZIONALE PER LA RICERCA 
SUL CANCRO 
VIALE BENEDETTO XV 10 
I 16132 GENOVA 
TcL: 39103534515 
Telex: 3910352888 
Fax: 286353 ISTEX I 
Email: TELECOM GOLD 10075:DB10503 
PROF. P.P. PASTORET 
PROFESSOR 
VIROLOGY-IMMUNOLOGY 
FACULTY OF VETERINARY MEDICINE 
UNIVERSITY OF LIEGE 
INSTITUT DE CHIMIE - B6 
LOCAL R80 
B 4000 SART TILMAN-UEGE 
TcL: 3241563469 
Telex: 3241563580 
DR. J. PASZKOWSKI 
WISSENSCHAFTUCHER ADJUNCT 
INSTITUT FUER PFLANZENWISSENSCHAFTEN 
EIDGENOESSISCHE TECHNISCHE 
HOCHSCHULE 
UNIVERSITAETSTRASSE 2 
CH 8092 ZUERICH 
Tel: 4112564438 
Telex: 4112529613 
DR. D. PAUL 
HEAD OF DEPARTMENT OF CELL BIOLOGY 
DEPT. OF CELL BIOLOGY 
FRAUNHOFER INSTITUTE FOR TOXICOLOGY 
AND AEROSOL 
NIKOLAI-FUCHS-STRASSE 1 
D 3000 HANNOVER 61 
Tel: 4951153500263 
Telex: 49511S350155 
PROF. H. PAULSEN 
PROFESSOR 
INSTITUT FUER ORGANISCHE CHEMIE 
UNIVERSITAET HAMBURG 
MARTIN-LUTHER-KING-PLATZ 6 
D 2000 HAMBURG 13 
Tel.: 494041232820 
Telex: 494041233834 
Fax: 214732 UNIHHD 
E-mail: BUSCH@RZ.INFORMATIK.UNI-
HAMBURG.DBP.DE 
DR. E. PAULSSEN 
PH.D. STUDENT 
THE BIOTECHNOLOGY CENTRE OF OSLO 
BLINDERN 
P.O. BOX 1125 
N 0317 OSLO 3 
Tel.: 472454093 
Iblcx: 472454058 
E-mail: L—PAULSSEN-E@USE.UIO.UNlNETT 
DR. FJ. PAZ-ARES RODRIGUEZ 
COLABORADOR CIENTinCO DEL C.S.I.C. 
UNIDAD ESTRUCTURAL DE INGENIERIA 
GENET 
LABORATORIO DE BIOLOGIA MOLECULAR 
CENTRO DE INVESTIGACIONES BIOLOGICAS 
VELAZQUEZ 144 
E 28006 MADRID 
Tel.: 3412611800 EXT. 206 
Iblcx: 3412627518 
DR. P. PECHAN 
MAX PLANCK INSTITUT FUER 
ZUECHTUNGSFOR 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
TcL: 492215062350 
Telex: 492215062413 
Fax: 8 881 028 MPIZ D 
E-mail: PECHAN@VAX.MPIZ-
KOELN.MPG.DBP.DE 
PROF. FS. PED E R S E N 
ASSOCIATE PROFESSOR 
INSTITUT FOR MOLEKYLAER BIOLOGIE 
UNIVERSITY O F A A R H U S 
C F . MOELLERS ALLE 130 
D K 8000 A A R H U S 
TcL: 4586125177 
Telex: 4586196226 
Fax: 64767 AAUSCI DK 
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DR. J.E. PELSENEER-COREMANS 
CHARGE DE COURS 
LABORATOIRE DE PARASITOLOGIE 
UNIVERSITE LIBRE DE BRUXELLES 
ROUTE DE LENNIK 808 
B 1070 BRUXELLES 
TcL: 3225556251 
Telex: 3225366160 
DR. M. PENALVA 
COLABORADOR CIENTinCO DEL C.S.I.C. 
LAB. DE GENETICA MOLECULAR DE 
ASPERGIL 
UNIDAD ESTRUCTURAL DE CITOGENET1CA 
CENTRO DE INVESTIGACIONES BIOLOGICAS 
VELAZQUEZ 144 
E 28006 MADRID 
Tbl.: 3415854358 
Telex: 3412627518 
DR. L. PILSTROM 
SENIOR LECTURER 
DEPARTMENT OF IMMUNOLOGY 
BIOMEDICAL CENTRE 
UPPSALA UNIVERSITY 
BOX 582 
S 75123 UPPSALA 
Tel: 4618174218 
Telex: 4618157579 
DR. D. PIOU 
PRINCIPAL RESEARCH SCIENTIST 
BIOTECHNOLOGY DEPARTMENT 
I d PHARMACEUTICALS 
ALDERLEY PARK 
UK SKIO 4TG MACCLESFIELD 
Tel.: 44625512986 
Telex: 44625514463 
Fix: 669095/669388 
DR. A. PEREIRA 
MOLECULAR BIOLOGY DEPARTMENT 
ONDERZOEK INSTTTUUT 
KEUENBERGSEWEG 6 
NL 67O0 AA WAGENINGEN 
TcL: 31837091911 
Telex: 31837014435 
PROF. W. PFALLER 
UNIVERSITAETSPROFESSOR 
INSTITUT FUER PHYSIOLOGIE UND 
BALNEOLO 
UNIVERSITAET INNSBRUCK 
FRITZ-PREGLSTRASSE 3 
A 6010 INNSBRUCK 
Tel.: 435125072221 
Telex: 43512581740 
Fax: UNITE A 533808 
E-mail: C50701@AINUNI01 
PROF. RJ. PLANTA 
PROF.DR. 
BIOCHEMISCH LABORATORIUM 
VRIJE UNIVERSITEIT 
DE BOELELAAN 1083 
NL 1081 HV AMSTERDAM 
Tel.: 31205485606 
Telex: 3120461479 
PROF. R. PLAPP 
PROFESSOR 
UNIVERSITAET KAISERSLAUTERN 
ERWIN SCHROEDINGER STRASSE 23 
POSTFACH 3049 
D 6750 KAISERSLAUTERN 
Tel.: 496312052353 
Telex: 496312052998 
Fax: 45627 UNIKL D 
E-mail: RPLAPPRK.UNI-KI_DE 
PROF. P. PHIUPPSEN 
PROFESSOR 
INSTITUT FUER MIKROBIOLOGIE UND 
MOLEKULARBIOLOGIE 
JUSTUS-LIEBIG-UNIVERSITAET 
FRANKFURTER-STRASSE 107 
D 6300 GIESSEN 
Tel.: 496417025934 
Telex: 496417027390 
DR. F.M. POHL 
DR. 
FAKULTAET FUER BIOLOGIE 
UNIVERSITAET KONSTANZ 
POSTFACH 5560 
D 7750 KONSTANZ 
TcL: 497531882134 
Telex: 497531882966 
Fax: 0733359 
DR. W. PIEPERSBERG 
PROFESSOR OF MICROBIOLOGY, C4 
CHEMISCHE MIKROBIOLOGIE, FB 9 
GESAMTHOCHSCHULE WUPPERTAL 
BERGISCHE UNIVERSITAET 
GAUSS-STRASSE 20 
D 5600 WUPPERTAL 
TcL: 492024392521 
Telex: 492024392698 
Fax: 8592262 BUGHW 
DR. L. PUNACKER 
SCIENTIST 
CENTRE BIOLOGICAL SCIENCES 
DEPARTMENT OF GENETICS 
UNIVERSITY OF GRONINGEN 
KERKLAAN30 
NL 9751 NN HAREN 
TcL: 3150632132 
Telex: 3150632348 
DR. R.D. POSSEE 
SENIOR SCIENTIFIC OFFICER 
INSTITUTE OF VIROLOGY AND 
ENVIRONMENTAL MICROBIOLOGY 
NATURAL ENVIRONMENT RESEARCH 
COUNCIL 
MANSFIELD ROAD 
UK OX1 3SR OXFORD 
TcL: 44865512361 
Telex: 4486559962 
Fax: 83147 
E-mail: POSSEE@VAX.OXjkCUK 
DR. P.W. POSTMA 
SENIOR LECTURER IN BIOCHEMISTRY 
E.C. SLATER INSTITUTE FOR BIOCHEMICAL 
RESEARCH FACULTY OF CHEMISTRY 
UNIVERSITY OF AMSTERDAM 
PLANTAGE MUIDERGRACHT 12 
NL 1018 TV AMSTERDAM 
TcL: 31205255126 
Telex: 31205255124 
E-mail: A311POST@HASARAll 
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DR. J£. PRENOSIL 
DOZENT 
TECHNISCH-CHEMISCHES LABORATORIUM 
(TCL 
EIDGENOESSISCHE TECHNISCHE 
HOCHSCHULE 
ZUERICH (ETH-Z) 
UNTVERSITAETSTRASSE 6 
CH 8092 ZUERICH 
TcL: 4112563080 
Telex: 4112521827 
DR. JJL PRIGENT 
RESEARCH MANAGER 
TEXEL (RHONE POULENC GROUP) 
ZA. DE BUXIERES 
BP. 10 
F 86220 DANGE SAINT ROMAIN 
Tel.: 3349937100 
Iblcx: 3349937110 
Fax: 791061 F 
PROF. A. PUEHLER 
HEAD OF THE DEPARTMENT 
LEHRSTUHL FUER GENETIK 
FAKULTAET FUER BIOLOGIE 
UNIVERSITAET BIELEFELD 
UNIVERSITAETSSTRASSE 25 
POSTFACH 8640 
D 4800 BIELEFELD 1 
Tel.: 495211065607 
Telex: 495211065626 
Fax: 932362 UNIBI 
Email: PUEHLER@BIOGENEL.UNI-
BIELEFELD.DE 
DR. G. RAGNOTTI 
DEPT. OF BIOMEDICAL SCIENCES AND BIOTE 
UNIT OF GENERAL PATHOLOGY AND 
IMMUNOLO 
UNIVERSITY OF BRESCIA 
VIA VALSABBINA 19 
I 25123 BRESCIA 
Tel.: 39303996310 
Telex: 39303701157 
DR. JA. RAMOS 
INVESTIGADOR CIENTIFICO 
ESTAOON EXPERIMENTAL DEL ZAIDIN 
C.S.I.C. 
PROFESOR ALBAREDA 1 
E 18008 GRANADA 
TcL: 3458121011 
Telex: 3458129600 
Fax: 78798 EEZG E 
E-mail: ZAIDIN@IAA£S 
DR. O.F. RASMUSSEN 
SENIOR SCIENTIST 
BIOTECHNOLOGICAL INSTITUTE 
LUNDTOFTEVEI 100 
BUILDING 227 
DK 2800 LYNGBY 
TcL: 4542876699 
Telex: 4545932888 
DR. CJ. RAWLINGS 
ADVANCED RESEARCH FELLOW 
BIOMEDICAL COMPUTING UNIT 
IMPERIAL CANCER RESEARCH FUND 
LABORATO 
LINCOLN'S INN FIELDS 44 
P.O. BOX 123 
UK WC2A 3PX LONDON 
Tel.: 44712693389 
Telex: 44714301787 
E-mail: C-RAWLINGS@ICRF.ACUK 
DR. L. RECHAUSSAT 
DIRECTOR 
CERDIC - CENTRE EUROPEEN DE 
RECHERCHES DOCUMENTAIRES SUR LES 
IMMUN 
ROUTE DES CRETES 2229 
coacA 
F 06560 VALBONNE 
Tel.: 3392942288 
Telex: 3392942294 
E-mail: TELECOM GOLD 10075:DBI009B 
DR. B. REISS 
GROUP LEADER 
MAX-PLANCK-INSTITUT FUER 
ZUECHTUNGSFOR 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062220 
Telex: 492215062213 
DR. M. RENARD 
RAPESEED BREEDER 
STATION D'AMELIORATION DES PLANTES 
INRA 
RUE DE L'UNIVERSITE 147 
F 75341 PARIS 07 
Tel.: 3399285126 
Telex: 3399285120 
DR. A. RENARD 
SCIENTIFIC DIRECTOR 
SOCIETE EUROPEENNE DE BIOTECHNOLOGIE 
S 
EUROGENTEC 
CAMPUS SART TILMAN B6 
B 4000 LIEGE 
Tel.: 3241563379 
Telex: 3241562968 
DR. A. REY-SENELONGE 
SENIOR SCIENTIST 
LABORATOIRE IFFA 
RHONE MERIEUX 
RUE MARCEL MERIEUX 254 
BP. 70O9 
F 69342 LYON 07 
TcL: 3372723380 
Telex: 3372723480 
Fax: 375470 IFFA LYON 
DR. DJ. RHODES 
TEAM LEADER 
JEALOTTS HILL RESEARCH STATION 
BIOTECHNOLOGY SECTION 
I d AGROCHEMICALS 
UK RG12 6EY BRACKNELL 
TcL: 44344414201 
Telex: 44344414996 
Fax: 847556 kip8j9 
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DR. G. RIBA 
DIRECTEUR DE RECHERCHES 
STATION DE RECHERCHES DE LUTTE 
BIOLOGI 
INRA 
LA MINIERE - INRA 
F 78285 GUYANCOURT 
Tbl.: 33130833635 
Telex: 33130438097 
Fax: 698450 F 
DR. M. RIEGER 
BIOTECHNOLOGISCHE UND 
MOLEKULARBIOLOGI 
FORSCHUNG 
ANGELHOFWEG 39 
D 6916 WILHELMSFELD 
Tel.: 4962208724 
Telex: 4962208724 
PROF. P. RITZENTHALER 
CENTRE DE RECHERCHE DE BIOCHIMIE ET 
DE 
GENETIQUE CELLULAIRES DU CNRS (LP8201) 
ROUTE DE NARBONNE 118 
F 31062 TOULOUSE 
Tel.: 3361559657 
Telex: 3361559500 
E-mail: RITZENTH@FRCICT81.BITNET 
DR. S. RIVA 
ISTITUTO DI GENETICA BIOCHIMICA ED 
EVOLUZIONISTICA 
CNR 
ABBIATEGRASSO 207 
I 27100 PAVIA 
Tel.: 39382422384 
Telex: 39382422286 
Fax: 32288JIGBEPVI 
E-mail: GENPOP@IPVCCN 
DR. M. RIVIERE 
LAB. IFFA / DIRECTION DES RECHERCHES 
DEP. VIROLOGIE, UNITE DE BIOCHIMIE ANA 
RHONE MERIEUX 
RUE MARCEL MERIEUX 254 
B.P. 7009 
F 69342 LYON 07 
Tel.: 3372723453 
Telex: 3372723480 
Fax: 375887 
DR. K. ROBERTS 
HEAD: DEPARTMENT OF CELL BIOLOGY 
JOHN INNES INSTITUTE 
JOHN INNES CENTRE 
NORWICH RESEARCH PARK 
COLNEY LANE 
UK NR4 7UH NORWICH 
Tel.: 4460352571 
Telex: 4460356844 
Fax: 975L22JIINORG 
DR. C. RODRIGUES-POUSADA 
INSTITUTO GULBENKIAN DE CIENCIA 
APARTADO 14 
P 2781 OEIRAS CODEX 
Tel.: 35114431331 / 351443 
Telex: 35114431643 
Fax: 12345 GULBENP 
DR. E. RODRIGUEZ-FARRE 
HEAD O F THE DEPARTMENT O F 
PHARMACOLOGY 
DEPARTMENT O F PHARMACOLOGY AND 
TOXICOL 
DEPARTMENT OF NEUROCHEMISTRY 
CSIC 
JORDI GIRONA 18-26 
E 08034 BARCELONA 
Tel.: 3432040600 
Telex: 3432045904 
Fax: 97977 
PROF. A.M. R O L U E R 
ASSOCIATE PROFESSOR UNIVERSITY O F MILA 
DIPARTIMENTO DI BIOLOGIA E GENETICA 
PER LE SCIENZE MEDICHE 
UNIVERSITA D E G U STUDI DI MILANO 
VIA VIOTTI 3/5 
I 20133 MILANO 
Tel.: 39226680356 
PROF. J. ROMMELAERE 
PROFESSOR 
LABORATOIRE D E BIOPHYSIQUE ET 
RADIOBIO 
UNIVERSITE LIBRE DE BRUXELLES 
RUE DES CHEVAUX 67 
B 1640 RHODE ST GENESE 
Tel.: 3226509723 
Telex: 326509744 
DR. L-I. ROSS 
RESEARCH SCIENTIST 
DIVISION O F MOLECULAR BIOLOGY 
INSTITUTE FOR ANIMAL HEALTH 
HOUGHTON LABORATORY 
HOUGHTON 
UK PEI7 2DA HUNTINGDON 
Tel.: 4448064101 
Telex: 4448067870 
Fax: 329154 HPRS 
DR. C. ROSSI 
ISTITUTO ZOOPROFILATTICO 
LABORATORIO DI BIOTECHNOLOGIA 
I 25125 BRESCIA 
Tel.: 39302290309 
Telex: 3930225613 
DR. V. RUBIO SUSAN 
HEAD O F FILAMENTOUS FUNGI 
LABORATORY 
INSTITUTO DE INVESTIGACIONES 
BIOMEDICA 
C.S.I.C. 
ARTURO DUPERIER 4 
E 28029 MADRID 
Tel.: 3413975408 
Telex: 3415854015 
DR. P. RUDELSHEIM 
H E L D TRIALS SUPERVISOR 
PLANT GENETIC SYSTEMS N.V. 
J O Z E F PLATEAUSTRAAT 22 
B 9000 GENT 
Tel.: 3291358440 
Telex: 3291240694 
Fax: 11J61 PGSGEN 
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DR. T. RUZZON 
BS RESPONSIBLE FOR SERVIZIO TECNOLOGIE 
1ST - ISTITUTO NAZIONALE PER LA RICERC 
VIALE BENEDETTO XV 10 
I 16132 GENOVA 
Tel.: 3910354027 
Telex: 3910352888 
Fu: 286353 ISTEX I 
E-mail: TELECOM GOLD 1OO75JDB10503 
PROF. M.P. RYAN 
PROFESSOR / HEAD OF DEPARTMENT 
DEPARTMENT OF PHARMACOLOGY 
UNIVERSITY COLLEGE DUBLIN 
FOSTERS AVENUE BLACKROCK 
IRL CO DUBLIN 
Tel.: 35317061558 
Telex: 35312837211 
Fax: 32693 EI 
DR. H.-J. RZIHA 
SCIENTIHC DIRECTOR. SENIOR SCIENTIST 
INSTITUT FUER IMPFSTOFFE 
FEDERAL RESEARCH CENTRE FOR VIRUS 
DESE 
PAUL-EHRLICH-STRASSE 28 
D 7400 TUEBINGEN 
Tel.: 497071603324 
Telex: 497071603201 
Fax: 17707131 
Tclclcx: 707131 
PROF. C. SACCONE 
FULL PROFESSOR IN MOLECULAR BIOLOGY 
DIPARTIMENTO DI BIOCHIMICA 
E BIOLOGIA MOLECOLARE 
UNIVERSITA DI BARI 
TRAVERSA 200 RE DAVID 4 
I 70125 BARI 
Tel.: 3980482100 
Telex: 3980482607 
E-mail: SACCONE@MVX36.CSATA.IT 
PROF. H.-G. SAHL 
PROFESSOR OF MICROBIOLOGY, RESEARCH 
GR 
INSTITUTE FOR MEDICAL MICROBIOLOGY 
AND 
IMMUNOLOGY 
RHEINISCHE FRIEDRICHWILHELMS 
UNIVERSI 
SIEGMUND-FREUD-STRASSE 25 
D 5300 BONN-VENUSBERG 
Tel.: 492282802704 / 49228 
Telex: 492282803763 
PROF. H. SAHM 
HEAD OFIBTI 
INSTITUT FUER BIOTECHNOLOGIE I 
FORSCHUNGSZENTRUM (KFA) JUEUCH 
P.O. BOX 1913 
D 5170 JUELICH 
Tel.: 492461613294 
Telex: 492461612710 
Fax: 833556b KFA D 
DR. G. SAKELLARIS 
RESEARCH SCIENTIST 
THE NATIONAL HELLENIC RESEARCH 
FOUNDAT 
VASSILEOS CONSTANTINOU AVENUE 48 
GR 116 35 ATHENS 
Tel.: 3017239965 
Telex: 3017212729 
Fax: 224064 
PROF. F. SALA 
PROFESSOR 
DEPARTMENT OF GENETICS AND 
MICROBIOLOG 
UNIVERSITY OF PAVIA 
VIA S. EPIFANIO 14 
I 27100 PAVIA 
TcL: 39382391533 
Telex: 39382528496 
PROF. J.A. SALAS 
PROFESOR TITULAR DE UNTVERSIDAD 
DEPARTAMENTO DE BIOLOGIA FUNCIONAL 
AREA MICROBIOLOGIA 
UNIVERSIDAD DE OVIEDO 
JULIAN CLAVERIA S/N 
E 33006 OVIEDO 
Tel.: 3485103652 
Telex: 3485232255 
Fax: 84322 
PROF. M. SALAS 
PROFESSOR OF RESEARCH 
CENTRO DE BIOLOGIA MOLECULAR 
UNIVERSIDAD AUTONOMA 
CSIC 
CANTO BLANCO 
E 28049 MADRID 
Tel.: 3413975070251 
Telex: 3413974799 
Fax: 27810 EDUCI E 
DR. M. SALDEN 
DIRECTOR R&D 
EURO DIAGNOSTICS B.V. 
WILMERSDORF 24 
NL 7327 AC APELDOORN 
Tel.: 3155422433 
Telex: 3155425017 
Fax: 52452 RCN 
DR. C. SANDER 
PROGRAMME COORDINATOR 
BIOCOMPUTING GROUP 
EUROPEAN MOLECULAR BIOLOGY 
LABORATORY 
MEYERHOFSTRASSE 1 
D 6900 HEIDELBERG 
Tel.: 496221387361 
Telex: 496221387306 
Fax: 461613 EMBL D 
E-mail: SANDER@EMBL-HEIDELBERG.DE 
DR. M.H. SANTOS 
ASSISTENT PROFESSOR/DIRECTOR, MOL. BIO 
INSTITUTO DE BIOLOGIA EXPERIMENTAL E 
TECNOLOGICA (IBET) 
ESTACAO AGRONOMICA NACIONAL 
APARTADO 12 
P 2780 OEIRAS 
Tel.: 35114427787/6146 
Telex: 35114421173 
PROF. L. SARDA 
PROFESSOR 
INSTITUT DE CHIMIE BIOLOGIQUE 
UNIVERSITE DA1X-MARSEILLE 
PLACE VICTOR HUGO 3 
F 13331 MARSEILLE 3 
Tel.: 3391959071/514 
Telex: 3391501300 
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DR. B. SAVAKIS 
ASS PROF UNIV CRETE, IMBB RESEARCH S a 
INSTITUTE FOR MOLECULAR BIOLOGY 
AND BIOTECHNOLOGY 
GR 71110 HERAKLION-CRETE 
Tel.: 3081212647 
Telex: 30X123130K 
Fax: 262896 IMBB GR 
E-mail: SAVAKIS@GRIMBB3ITNET 
PROF. C. SCAZZOCCHIO 
PROFESSOR 
INSTITUT DE GENETIQUE ET 
MICROBIOLOGIE 
CNRS URA 1354 
CENTRE D'ORSAY - UNTVERSITE PARIS-SUD 
BATIMENT 409 
F 91405 ORSAY CEDEX 
Tel.: 33169416356 
Telex: 33169417808 
DR. M. SCHARTL 
RESEARCH GROUP LEADER 
PHYSIOLOGISCHE CHEMIE I 
BIOZENTRUM DER UNIVERSITAET 
WUERZBURG 
THEODOR-BOVERI-INSTTTUET FUER 
BIOWISSE 
AM HUBLAND 
D 8700 WUERZBURG 
Tel.: 499318884148 
Telex: 499318884150 
Fax: 521740 
DR. TH. SCHEPER 
UNIVERSITY ASSISTENT 
INSTITUT FUER TECHNISCHE CHEMIE 
UNIVERSITAET HANNOVER 
CALLINSTRASSE 3 
D 3000 HANNOVER 
Tel.: 495117622509 
Telex: 495117623004 
Fax: 923868 UNIHN D 
PROF. K.-H. SCHLEIFER 
FULL PROFESSOR 
LEHRSTUHL FUER MIKROBIOLOGIE 
TU MUENCHEN 
ARCISSTRASSE 21 
D 8000 MUENCHEN 2 
Tel.: 498921052375 
Telex: 49K921052000 
Fax: 522854 TUMUE D 
PROF. R.D. SCHMID 
HEAD ENZYME TECHNOLOGY DIVISION 
DIVISION OF ENZYME TECHNOLOGY 
GESELLSCHAFT FUER BIOTECHNOLOGISCHE 
FORSCHUNG MBH 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181300 
Telex: 495316181302 
Fax: 952667 GEBIO D 
PROF. A. SCHOUSBOE 
PROFESSOR 
DEPT. OF BIOLOGY 
ROYAL DANISH SCHOOL OF PHARMACY 
UNIVERSITETSPARKEN 2 
DK 2100 COPENHAGEN 
Tel.: 4531370850 
Telex: 4535375744 
DR. Z. SCHWARZ-SOMMER 
SENIOR SCIENTIST 
MAX-PLANCK-INSTITUT FUER 
ZUECHTUNGSFOR 
MAX-PLANCK-GESELLSCHAFT FUER 
FOERDERUN 
DER WISSENSCHAFTEN 
CARL-VON-LINNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062140 
Telex: 492215062113 
Fax: 8881 028 MPIZD 
DR. P. SHELDRICK 
DIRECTOR. LABORATOIRE DE VIROLOGIE DE 
LAB. DE VIROLOGIE DE L"HERPES 
INSTITUT DE RECHERCHES SCIENTIFIQUES S 
CNRS - UPR 272 
RUE GUY MOCQUET 7 
F 94801 VILLEJUIF 
Tel.: 33147264658355 
Telex: 33147268836 
DR. M.W. SHIRLEY 
PRINCIPAL SCIENTIST 
DIVISION OF MOLECULAR BIOLOGY 
HOUGHTON LABORATORY 
INSTITUTE FOR ANIMAL HEALTH 
UK PE17 2DA HUNTINGDON 
Tel.: 4448064101 
Telex: 4448067870 
Fax: 329154 HPRS 
DR. RJ. SIEZEN 
HEAD OF DEPARTMENT 
NEDERLANDS INSTITUUT VOOR 
ZUIVELONDERZ 
KERNHEMSEWEG 2 
P.O. BOX 20 
NL 6710 BA EDE 
Tel.: 31838059511 
Telex: 31838050400 
E-mail: NIZO(g>CAOS.CAOS.KUN.NL 
DR. G. SILVESTRI 
PRESIDENT 
COSPAG 
CENTRO COOPERATIVO SPERIMENTAZIONE 
AGR 
CABRIOLO 93 
I 43036 FIDENZA 
Tel.: 3952482763 
PROF. H. SIMON / DR. H. GUENTHER 
LEHRSTUHL FUER ORGANISCHE CHEMIE 
UND BIOCHEMIE 
TU MUENCHEN 
UCHTENBERGSTRASSE 4 
D 8046 GARCHING 
Tel.: 498932093340 
Telex: 17898174TUMGAR 
Fax: 498932093345 
DR. P. SIMONET 
CHERCHEUR 
LABORATOIRE DE MICROBIOLOGIE DES SOLS 
URA CNRS 1450 
UNIVERSITE DE LYON I 
BOULEVARD DU 11 NOVEMBRE 1918 43 
F 69622 VILLEURBANNE 
Tel.: 3372448289 
Telex: 3372448466 
Fax: 330722 F 
E-mail: NORMAND@CISM.UNIV-LYONl.FR 
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DR. M A SKINNER 
RESEARCH SCIENTIST 
DIVISION OF MOLECULAR BIOLOGY 
HOUGHTON LABORATORY 
INSTITUTE FOR ANIMAL HEALTH 
HOUGHTON 
UK PE17 2DA HUNTINGDON 
Tel.: 4448064101 
Telex: 4448067870 
Fax: 329154HPRS 
E-mail: SKINNER@UKACAFRCJRAD 
PROF. DR. P.P. SLONIMSKI 
CENTRE DE GENETIQUE MOLECULAIRE DU 
CNR 
CENTRE NATIONAL DE LA RECHERCHE 
SCIENT 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
Tel.: 33169823208 
Telex: 33169075322 
Fax: 1603579 
E-mail: SLONIMSKI@FRCGM51 
DR. JA. SMITH 
LECTURER 
DEPT. OF PLANT SCIENCES 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
UK OX1 3RB OXFORD 
TcL: 44865275009 
Telex: 44865275074 
DR. W. SOMERS 
SCIENTIST 
DEPARTMENT OF BIOTECHNOLOGY 
TNO - NETHERLANDS ORGANIZATION FOR 
APPLIED SCIENTIFIC RESEARCH 
UTRECHTSEWEG 48 
P.O. BOX 48 
NL 3700 AJ ZEIST 
Tel.: 31340444144718 
Telex: 31340454186 
Fax: 40022 CIVO NL 
DR. F. SOUQ 
STAFF SCIENTIST 
DIRECTION DU DEVELOPPEMENT 
LVMH RECHERCHE 
AVE. HOCHE 30 
F 75008 PARIS 
Tel.: 33145630101 EXT. 231 
Telex: 33142258407 
DR. A. SPENA 
STAFF SCIENTIST/GROUP LEADER 
MAX-PLANCK-INSTITUT FUER 
ZUECHTUNGSFOR 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062329 
Telex: 492215062413 
Fax: 8 881 028 MPIZ D 
PROF. I. SPENCER-MARTINS 
DIRECTOR PYCC 
PORTUGUESE YEAST CULTURE COLLECTION 
GULBENKIAN INSTITUTE OF SCIENCE 
APARTADO 14 
RUA DA QUINTA GRANDE 
P 2781 OEIRAS CODEX 
Tel.: 35114431431 
Telex: 35114431631 
E-mail: TELECOM GOLD 10075:DBIO261 
PROF. F. SPENER 
PROFESSOR 
INSTITUT FUER BIOCHEMIE 
WESTFAEUSCHE WILHELMS UNTVERSITAET 
WILHELM-KLEMM-STRASSE 2 
D 4400 D MUENSTER 
Tel.: 49251833100 
Telex: 492518358 
Fax: 892 529 UNI MS D 
DR. J.-L. STAMPF 
STAFF RESEARCHER 
SANOFI RECHERCHE 
RUE DU PROFESSEUR J. BLAYAC 371 
F 34184 MONTPELLIER CEDEX 04 
Tel.: 33674001333815 
Telex: 3367405513 
Fax: 480240 F 
DR. P. STEEN 
RESEARCH MANAGER 
MARIBO SEED 
DANISCO A/S 
HOSBYGAARDVL 4 
P.O. BOX 29 
DK 4960 HOLEBY 
Tel.: 4553906031 EXT. 244 
Telex: 2553907419 
Fax: 31162 MARIBODK 
DR. H.Y. STEENSMA 
CLUSIUS LABORATORIUM 
RUKSUNIVERSITEIT LEIDEN 
WASSENAARSEWEG 64 
NL 2333 AL LEIDEN 
Tel.: 3171274947 
Telex: 3171274863 / 3171274 
DR. M.W. STEER 
HEAD OF DEPARTMENT 
UNIVERSITY COLLEGE DUBLIN 
IRL 4 DUBLIN 
Tel.: 35317062254 
Telex: 3531694409 
Fax: 32693 EI 
DR. WJ. STIEKEMA 
HEAD DEPARTMENT OF MOLECULAR 
BIOLOGY 
DEPARTMENT OF MOLECULAR BIOLOGY 
CENTRE FOR PLANT BREEDING RESEARCH 
CPO 
DROEVENDAALSESTEEG 1 
P.O. BOX 16 
NL 6700 AA WAGENINGEN 
Tel.: 31837041276 
Telex: 31837014435 
Fax: 45856 ITAL NL 
PROF. H. STOLTE 
PROFESSOR OF MEDICINE, HEAD OF 
EXPERIM 
ARBEITSBEREICH EXPERIMENTELE 
NEPHROLOG 
ABTEILUNG FUER NEPHROLOGIE 
MEDIZINISCHE HOCHSCHULE HANNOVER 
KONSTANTY-GUTSCHOW-STRASSE 8 
D 3000 HANNOVER 61 
Tel.: 495115323780 
Telex: 4951IS37898 
Fax: 922044 MHHWI D 
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PROF. J.C. STREIBIG 
ASSOCIATE PROFESSOR 
SECTION OF CROP SCIENCE 
DEPT. OF AGRICULTURAL SCIENCES 
THE ROYAL VETERINARY AND 
AGRICULTURAL 
THORVALDSENSVEJ 40 
DK 1871 FREDERIKSBERG C 
Tel.: 4531351788 EXT. 2613 
Telex: 4531390423 
PROF. I.E. SUAREZ 
CATEDRATICO DE UNIVERSIDAD 
DEPARTAMENTO DE BIOLOGIA FUNCIONAL 
AREA DE MICROBIOLOGIA 
FACULTAD DE MEDICINA 
JULIAN CLAVERIA S/N 
E 33006 OVIEDO 
Tel.: 3485103559 
Telex: 3485232285 
DR. S. SUHAI 
PROJECT LEADER 
MOLECULAR BIOPHYSICS 
GERMAN CANCER RESEARCH CENTRE 
(DKFZ) 
IM NEUENHEIMER FELD 280 
D 6900 HEIDELBERG 
Tel.: 496221422369 
Telex: 496221401271 
E-mail: DOK252@CVX12.DKFZ-HEIDELBERG.DE 
DR. M. SUNDVALL 
COMPUTER DEPARTMENT 
UPPSALA BIOMEDICAL CENTRE 
BOX 570 
S 751 23 UPPSALA 
Tel.: 4618174909 
Telex: 461K551759 
E-mail: MATS.SUNDVALL@BMC.UU.SE 
DR. I. TAYLOR 
LECTURER IN PLANT GENETICS 
DEPT. OF PHYSIOLOGY & ENVIRONMENTAL 
SC 
FACULTY OF AGRICULTURAL AND FOOD 
SCIEN 
UNIVERSITY OF NOTTINGHAM 
UK LEI2 5RD LOUGHBOROUGH 
Tel.: 44602484848 EXT. 825 
Telex: 44509673917 
Fax: 37346 UN1NOT G 
DR. J. TEMPE 
DIRECTEUR DE RECHERCHE, GROUP 
LEADER 
INSTITUT DES SCIENCES VEGETALES 
C.N.R.S. 
AVENUE DE LA TERRASSE 
F 91198 GIF-SUR-YVETTE CEDEX 
Tel.: 33169823689 
Telex: 33169823695 
PROF. M. TERZI 
PROFESSOR OF GENETICS 
DIPARTIMENTO DI BIOLOGIA 
UNIVERSITA DEGLI STUDI DI PADOVA 
VIA TRIESTE 75 
I 35121 PADOVA 
Tel.: 39498286284 
Telex: 39498072213 
DR. K. THERES 
DIRECTOR 
INSTITUT FUER GENETIK 
AM MPI FUER ZUECHTUNGSFORSCHUNG 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062670 
Telex: 492215062513 
Fax: 8882291 UNIK 
DR. L. THIM 
NOVO NORDISK A/S 
NOVO ALLE 
DK 2880 BAGSVAERD 
Tel.: 4544448888/2176 
Telex: 4544444565 
Fax: 37173 
DR. G. THIREOS / DR. E. ALEXANDRAKI 
DRS. 
INSTITUTE OF MOLECULAR BIOLOGY AND 
BIO 
FOUNDATION OF RESEARCH AND 
TECHNOLOGY 
P.O.BOX 1527 
GR 71110 HERAKLION, CRETE 
Tel.: 3081210361 / 3081210 
Telex: 3081238824 / 3081239 
Fax: 262860 RCC GR 
E-mail: THIREOS@GGRIMBB 
DR. CH. THOMPSON 
DEPARTEMENT DES BIOTECHNOLOGIES 
UNITE DE GENIE MICROBIOLOGIQUE 
INSTITUT PASTEUR 
RUR DU DOCTEUR ROUX 25 
F 75724 PARIS CEDEX 15 
Tel.: 33456K8828 
Telex: 334568843 
Fax: PASTEUR 250.609 F 
E-mail: DAVIES@PASTEUR 
DR. R.D. THOMPSON 
MPG-STIPENDIAT 
MAX-PLANCK-INSTTTUT FUER 
ZUECHTUNGSFOR 
CARL-VON-UNNE-WEG 10 
D 5000 KOELN 30 
Tel.: 492215062439 
Telex: 492215062413 
Fax: 8881028 MPIZ D 
DR. J.M. THORNTON 
SENIOR LECTURER 
DEPARTMENT OF BIOCHEMISTRY AND 
MOLECULAR BIOLOGY 
UNIVERSITY COLLEGE LONDON 
GOWER STREET 
UK WC1E 6BT LONDON 
Tel.: 44713807048 
Telex: 44713807193 
E-mail: THORNTON@CR.BBILAC.UK 
DR. A. TIEZZI 
RESEARCHER 
DIPARTIMENTO DI BIOLOGIA AMBIENTALE 
UNIVERSITA' DEGLI STUDI DI SIENA 
VIA P.A. MATTIOU 4 
I 53100 SIENA 
Tel.: 39577298856 
Telex: 39577298860 
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DR. K.N. TIMMIS 
DIRECTOR OF DIVISION AND 
DEPARTMENT OF 
ABTE1LUNG MIKROBIOLOCIE 
GBF 
MASCHERODER WEG 1 
D 3300 BRAUNSCHWEIG 
Tel.: 495316181400 
Telex: 495316181411 
Fax: 952667 GEBIO D 
DR. C TONELLI 
SENIOR SCIENTIST 
DPTO DI GENETICA E DI BIOLOGIA DEI MIC 
UNTVERSITA' DEGLI STUDI DI MILANO 
CELORIA 26 
I 20133 MILANO 
Tel.: 3922663498 
Telex: 3922664SS1 
E-mail: GENETIC@IMIUCCA.BITNET 
DR. M. TRICK 
SENIOR SCIENTIFIC OFFICER 
CAMBRIDGE LABORATORY 
JOHN INNES CENTRE 
COLNEY LANE 
UK NR4 7UJ NORWICH 
TcL: 4466352571 
Telex: 44603502270 
Fax: 975122 JIINOR G 
PROF. A. TSIFTSOGLOU 
PROFESSOR PHARMACOLOGY 
LABORATORY OF PHARMACOLOGY 
DEPT. OF PHARMACEUTICAL SCIENCES 
ARISTOTLE UNIVERSITY OF THESSALONIKI 
SCHOOL OF HEALTH SCIENCES 
GR 54006 THESSALONIKI 
Tel.: 3199147332 
Telex: 3031991492 
DR. E.M. TUCKER 
HEAD OF DEPARTMENT OF MOLECULAR 
PHYSIO 
DEPT. OF MOLECULAR PHYSIOLOGY 
CAMBRIDGE RESEARCH STATION 
AFRC INSTITUTE OF ANIMAL PHYSIOLOGY 
AN 
UK CB2 4AT BABRAHAM. CAMBRIDGE 
Tel.: 44223832312 
Telex: 44223836122 
PROF. G. TURNER 
PROFESSOR 
DEPARTMENT OF MOLECULAR BIOLOGY 
AND 
BIOTECHNOLOGY 
THE UNIVERSITY OF SHEFFIELD 
UK S10 2UH SHEFFIELD 
Tel.: 44742768555 
Telex: 44742728697 
Fax: 347216 UGSHEF G 
PROF. F. URUBURU 
DIRECTOR OF DEPARTMENT OF 
MICROBIOLOGY 
COLLECION ESPANOLA DE CULTTVOS TIPO 
DEPARTAMENTO DE MICROBIOLOGIA, 
FACULTA 
UNIVERSIDAD DE VALENCIA 
E 46100 BURJASOT (VALENCIA) 
Tel.: 3463864612 
Telex: 3463864372 
E-mail: TELECOM GOLD 1007SX>BI0428 / 
BELLOCH@E 
DR. A. VAGNO PEDERSEN 
HEAD OF APPLIED TECHNOLOGY 
LABORATORY 
CHRISTIAN HANSEN'S LABORATORIUM 
DANMAR 
BOEGE ALLE 10 
DK 2970 HORSHOLM 
Tel.: 4545767676 EXT. 4022 
Telex: 4545765455 
Fax: 19184 HANSEN DK 
DR. E.W. VAN BREUKELEN 
COORDINATOR SPECIAL PROJECTS 
NICKERSON-ZWAAN B.V. 
GEBROKEN MEELDUK 74 
P.O. BOX 19 
NL 2990 AA BARENDRECHT 
Tel.: 31180613277 
Telex: 31180614079 
Fax: 20117 ZWAV NL 
PROF. WJ.M. VAN DE VEN 
RESEARCH PROFESSOR 
CENTER FOR HUMAN GENETICS 
KU. LEUVEN 
HERESTRAAT 49 
B 3000 LEUVEN 
TcL: 3216215987 
Telex: 3216215997 
DR. A.R.G. VAN DE WEGHE 
RESEARCHER 
FACULTY OF VETERINARY MEDICINE 
DEPT. OF ANIMAL GENETICS AND BREEDING 
RUKS UNrVERSITEIT GENT 
HEIDESTRAAT 19 
B 9820 MERELBEKE 
Tel.: 3291521941 
Telex: 3291525304 
DR. H.WJ. VAN DEN BROEK 
SENIOR LECTURER 
SECTION MOLECULAR GENETICS 
DEPT. OF GENETICS 
AGRICULTURAL UNIVERSITY WAGENINGEN 
DREIJENLAAN 2 
NL 6703 HA WAGENINGEN 
TcL: 31837083141 
Telex: 31837083146 
DR. HJV ULLTTZ-MOELLER 
CAND. SCIENT. SYSTEM MANAGER 
BIOBASE 
AARHUS UNIVERSITET 
OLE WORMS ALLE 
BYGNING 170 
DK 8000 AARHUS C 
Tel.: 4586202711/2776 
Telex: 4586131160 
Email: HUM@BIOBASEJVAU.DK 
DR. PJ.M. VAN DEN ELZEN 
LABORATORY OF MOLECULAR BIOLOGY 
MOGEN INTERNATIONAL NV 
E1NSTEINWEG 97 
NL 2333 CB LEIDEN 
TcL: 3171258282 
Telex: 3171221471 
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DR. N. VAN DER HOEVEN 
SCIENTIST 
DEPARTMENT OF BIOLOGY 
TNO - NETHERLANDS ORGANIZATION FOR 
APP 
SCIENTIFIC RESEARCH 
SCHOEMAKERSTRAAT 97 
NL 2628 VK DELFT 
Tel.: 3115696900 
Telex: 3115616812 
Fax: 38071 ZPTNO NL 
DR. D. VAN DER MEI 
DIRECTOR CBS 
CENTRAALBUREAU VOOR 
SCHIMMELCULTURES 
P.O. BOX 273 
NL 3740 AG BAARN 
TcL: 31215481238 
Telex: 31215416142 
E-mail: TELECOM GOLD 10075:DBI0548 
DR. C. VAN DIJK 
HEAD OF THE DIVISION 'BIOCHEMICAL TREA 
AGROTECHNOLOGICAL RESEARCH 
INSTITUTE 
ATO 
HAAGSTEEG 6 
NL 6708 PM WAGENINGEN 
Tel.: 31837075054 
Telex: 31837012260 
DR. J.D. VAN ELSAS 
RESEARCH SCIENTIST-SOIL BIOTECHNOLOGY 
DEPARTMENT OF SOIL BIOLOGY 
INSTITUTE FOR SOIL FERTILITY RESEARCH 
KEYENBERGSEWEG 6 
NL 6700 AA WAGENINGEN 
Tel.: 31837091202 
Telex: 31837014435 
Fax: 458S6 ITAL NL 
DR. A.A. VAN LAMMEREN 
SENIOR RESEARCHER 
DEPARTMENT OF PLANT CYTOLOGY AND 
MORPH 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 31837084318 
Telex: 31837084761 
Fax: NL 45015 
E-mail: KIEFT@RCL.WAU.NL 
DR. JA. VAN MOURIK 
HEAD OF DEPARTMENT OF BLOOD 
COAGULATIO 
DEPARTMENT OF BLOOD COAGULATION 
CENTRAL LABORATORY OF THE 
NETHERLANDS 
RED CROSS TRANSFUSION SERVICES 
PLESMANLAAN 125 
NL 1066 CX AMSTERDAM 
TcL: 31205123120 
Telex: 31205123332 
Fax: 13159 BLOOD NL 
DR. J.T. VAN OIRSCHOT 
HEAD OPEN VIROLOGY DEPARTMENT 
CENTRAL VETERINARY INSTITUTE 
EDELHERTWEG 15 
P.O. BOX 65 
NL 8200 AB LELYSTAD 
Tel.: 31320073308 
Telex: 31320073473 
Fax: 4027 CDI NL 
DR. H. VAN ONCKELEN 
RESEARCH DIRECTOR OF THE BELGIAN 
NATIO 
DEPT. OF BIOLOGY 
UNIVERSITY OF ANTWERP 
UNIVERSITEITSPLEIN 1 
B 2610 WILRIJK 
Tel.: 3238202267 
Telex: 3238202249 
PROF. J.L. VAN WENT 
HEAD OF DEPARTMENT, PROFESSOR IN 
BOTAN 
DEPARTMENT OF PLANT CYTOLOGY AND 
MORPH 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL 6703 BD WAGENINGEN 
Tel.: 31837083499 
Telex: 31837084761 
Fax: NL 45015 
E-maiL' PLANTCM@RCL.WAU.NL 
DR. A. VASQUEZ 
DEPT. DE GENETICA 
FAC. DE BIOLOGIE 
UNIVERSIDAD COMPLUTENSE DE MADRID 
E 28040 MADRID 
TcL: 3415496785 
Telex: 3413941638 
DR. M. VAN MONTAGU 
LABORATORIUM VOOR GENETICA 
RUKSUNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
B9000 GENT 
Tel.: 3291645170 
Telex: 3291645349 
Fax: 11995GENGENB 
E-mail: JECOP@GENGENP.RUG.AC.BE 
PROF. G. VENEMA 
FULL PROFESSOR 
DEPARTMENT OF GENETICS 
UNIVERSITY OF GRONINGEN 
KERKLAAN30 
NL 9751 NN HAREN 
TcL: 3150632093 
Telex: 3150632348 
DR. H A VENIS 
HEAD OF PHYSIOLOGY 
AFRC INSTITUTE OF HORTICULTURAL 
RESEAR 
EAST MA LUNG 
BRADBOURNE HOUSE EAST MALUNG 
UK MEI9 6BJ MAIDSTONE 
TcL: 44732843833 
Telex: 44732849067 
Fax: 957251 
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DR. JMA. VERBAKEL 
RESEARCHMANAGER 
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Summary 
The Commission of the European Communities is implementing several priority 
actions specifically designed for improving the competitiveness of European 
biotechnology. One of these actions aims at the establishment of a Community 
network for training and research and has been executed from 1982 to 1989 in the 
framework of two successive Community programmes: the Biomolecular Engineer-
ing Programme (BEP; 15 million ECU; April 1982-March 1986) and the Biotechnol-
ogy Action Programme (BAP; 75 million ECU; 1985-1989). These programmes 
aimed therefore at establishing a supportive infrastructure for biotechnology 
research in Europe and at eliminating bottlenecks which prevented the exploita-
tions of materials, data and methods originating from modern biology. The current 
programme BRIDGE (Biotechnology for /nnovation, Development and Growth in 
Europe) covers the period 1990-1993, with a budget of 100 million ECU. The 
research activities in the new biotechnology programme BRIDGE are conducted 
via two different types of projects: N-projects and T-projects. Following three suc-
cessive calls for proposals in 1989 and 1990, 69 N-projects and 7 T-projects were 
launched during 1990 and 1991. These encompass 579 participating organizations 
(388 for the N-projects and 191 for the T-projects) from 11 Member States and 
5 EFTA countries. A 'BRIDGE catalogue of contracts' (EUR 14278 — Editor: 
B. Nieuwenhuis) listing the participating laboratories together with a description of 
their objectives was published in early 1992. On a regular basis the project coor-
dinators introduce a progress report covering the scientific results achieved in the 
different laboratories, the evidence of an increasing integration of work and addi-
tional relevant considerations. These contributions are assembled in this '1992 
report' which presents, for the first time since the programme started, a complete 
overview of research progress achieved under the EC BRIDGE programme over 
the period 1991-March 1992. 
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The BRIDGE Programme (biotechnology, 
.Research for /nnovation, Development and 
Growth in .Europe) covers the period 1990­93, 
with a budget of 100 million ECU. The research 
activities in the BRIDGE programme are 
implemented via two different types of projects: 
N­projects and T­projects. Following three suc­
cessive calls for proposals in 1989 and 1990, 
69 N­projects and 7 T­projects were launched 
during 1990 and 1991. These encompass 579 
participating organizations (388 for the 
N­projects and 191 for the T­projects) from 11 
Member States and five EFTA countries. This 
first BRIDGE progress report covers the 
period 1991­March 1992 and gives for each 
project the results achieved in the different 
laboratories, the evidence of an increasing 
integration of work and additional relevant 
information. 
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